Unnamed: 0,datetime,title,source,link
0.0,6/30/2006 2:27:00 PM,"Vertex Pharmaceuticals and Tibotec Pharmaceuticals, a Johnson & Johnson Company, Announce Plans for Global Health Initiative to Increase Worldwide Prevention, Diagnosis and Treatment of HCV",PR Newswire,/news/stocks/vertex-pharmaceuticals-and-tibotec-pharmaceuticals-a-johnson-&-johnson-company-announce-plans-for-global-health-initiative-to-increase-worldwide-prevention-diagnosis-and-treatment-of-hcv-1001238385
1.0,12/20/2006 11:37:00 PM,Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare,PR Newswire,/news/stocks/johnson-johnson-completes-acquisition-of-pfizer-consumer-healthcare-1002273502
2.0,9/23/2016 6:40:21 PM,"BRIEF-Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis (GSK, JNJ)",Reuters,/news/stocks/brief-janssen-biotech-submits-application-for-approval-of-sirukumab-in-u-s-for-rheumatoid-arthritis-gsk-jnj-1001416187
3.0,9/23/2016 10:30:23 PM,"BRIEF-Achillion announces data from phase 2 trial for combination treatment for Genotype 1 Treatment-Na√Øve HCV (ACHN, JNJ)",Reuters,/news/stocks/brief-achillion-announces-data-from-phase-2-trial-for-combination-treatment-for-genotype-1-treatment-naive-hcv-achn-jnj-1001416124
4.0,9/26/2016 6:20:22 PM,BRIEF-Janssen Biotech says FDA approves STELARA (ustekinumab) (JNJ),Reuters,/news/stocks/brief-janssen-biotech-says-fda-approves-stelara-ustekinumab-jnj-1001418635
5.0,9/26/2016 7:30:22 PM,FDA approves J&J's autoimmune drug Stelara for Crohn's disease (JNJ),Reuters,/news/stocks/fda-approves-j&js-autoimmune-drug-stelara-for-crohns-disease-jnj-1001418766
6.0,9/28/2016 4:50:21 PM,BRIEF-Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation - JJDC Inc (JNJ),Reuters,/news/stocks/brief-tracon-pharmaceuticals-announces-a-strategic-licensing-collaboration-for-two-janssen-oncology-assets-and-a-$5-mln-equity-investment-from-johnson-&-johnson-innovation-jjdc-inc-jnj-1001423841
7.0,10/3/2016 10:10:21 AM,"Novartis psoriasis drug maintains efficacy after 4 years - study (JNJ, AMGN)",Reuters,/news/stocks/novartis-psoriasis-drug-maintains-efficacy-after-4-years-study-jnj-amgn-1001431486
8.0,10/3/2016 11:00:21 AM,"J&J psoriasis drug tops placebo, Humira in late stage study (JNJ)",Reuters,/news/stocks/j&j-psoriasis-drug-tops-placebo-humira-in-late-stage-study-jnj-1001431490
9.0,10/3/2016 11:30:24 AM,"Morphosys moves closer to getting first antibody drug on market (MOR, BAYN, JNJ)",Reuters,/news/stocks/morphosys-moves-closer-to-getting-first-antibody-drug-on-market-mor-bayn-jnj-1001431705
10.0,10/3/2016 12:10:22 PM,"Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001431817
11.0,10/3/2016 2:20:21 PM,"RPT-Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/rpt-big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001432682
12.0,10/5/2016 1:10:26 AM,"UPDATE 3-J&J warns diabetic patients: Insulin pump vulnerable to hacking (JNJ, MDT, PFE)",Reuters,/news/stocks/update-3-j&j-warns-diabetic-patients-insulin-pump-vulnerable-to-hacking-jnj-mdt-pfe-1001436547
13.0,10/5/2016 11:30:22 AM,"BRIEF-U.S. FDA warns about the risk of Hepatitis B (BMY, GILD, JNJ, MRK)",Reuters,/news/stocks/brief-u-s-fda-warns-about-the-risk-of-hepatitis-b-bmy-gild-jnj-mrk-1001436685
14.0,10/5/2016 1:30:24 PM,"PRESS DIGEST - Wall Street Journal - Oct 5 (CRM, BLK, 8630, ENH, JNJ)",Reuters,/news/stocks/press-digest-wall-street-journal-oct-5-crm-blk-8630-enh-jnj-1001436934
15.0,10/5/2016 10:20:21 PM,BRIEF-U.S. Department of Homeland Security warns on vulnerabilities in J&J insulin pumps (JNJ),Reuters,/news/stocks/brief-u-s-department-of-homeland-security-warns-on-vulnerabilities-in-j&j-insulin-pumps-jnj-1001439013
16.0,10/7/2016 2:40:27 PM,"BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US (AZN, JNJ)",Reuters,/news/stocks/brief-astrazeneca-divests-rights-to-rhinocort-aqua-outside-us-azn-jnj-1001442619
17.0,10/10/2016 12:40:22 AM,"BRIEF-Genmab  says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma (GEN, JNJ)",Reuters,/news/stocks/brief-genmab-says-u-s-fda-grants-priority-review-for-daratumumab-in-relapsed-multiple-myeloma-gen-jnj-1001444863
18.0,10/11/2016 10:50:23 PM,"BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere's INRatio (ALR, JNJ, BAYN)",Reuters,/news/stocks/brief-fda-concludes-xarelto-clinical-trial-results-not-affected-by-aleres-inratio-alr-jnj-bayn-1001450092
19.0,10/11/2016 11:00:20 PM,"U.S. FDA clears Xarelto blood thinner despite faulty trial device (BAYN, ALR, JNJ, PFE)",Reuters,/news/stocks/u-s-fda-clears-xarelto-blood-thinner-despite-faulty-trial-device-bayn-alr-jnj-pfe-1001450199
20.0,10/17/2016 12:40:22 PM,"Wall St Week Ahead-Investors seek profit turnaround to drive stocks higher (JNJ, MSFT, GE, BAC)",Reuters,/news/stocks/wall-st-week-ahead-investors-seek-profit-turnaround-to-drive-stocks-higher-jnj-msft-ge-bac-1001458024
21.0,10/18/2016 2:40:23 AM,"Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001460992
22.0,10/18/2016 8:20:19 AM,"UPDATE 1-Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/update-1-pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001461028
23.0,10/18/2016 2:30:22 PM,J&J quarterly sales rise 4.2 pct (JNJ),Reuters,/news/stocks/j&j-quarterly-sales-rise-4-2-pct-jnj-1001462296
24.0,10/18/2016 2:50:20 PM,BRIEF-Johnson & Johnson reports Q3 EPS $1.53 (JNJ),Reuters,/news/stocks/brief-johnson-&-johnson-reports-q3-eps-$1-53-jnj-1001462388
25.0,10/18/2016 2:50:20 PM,"UPDATE 1-J&J quarterly revenue, profit edge past Street (JNJ)",Reuters,/news/stocks/update-1-j&j-quarterly-revenue-profit-edge-past-street-jnj-1001462383
26.0,10/18/2016 4:30:21 PM,BRIEF-Ortho Regenerative announces changes in executive leadership (JNJ),Reuters,/news/stocks/brief-ortho-regenerative-announces-changes-in-executive-leadership-jnj-1001462692
27.0,10/18/2016 8:30:24 PM,J&J says stable patients likely to stay with Remicade (JNJ),Reuters,/news/stocks/j&j-says-stable-patients-likely-to-stay-with-remicade-jnj-1001463054
28.0,10/18/2016 10:40:20 PM,"UPDATE 4-J&J shares lose ground on fears of Pfizer's answer to Remicade (JNJ, PFE)",Reuters,/news/stocks/update-4-j&j-shares-lose-ground-on-fears-of-pfizers-answer-to-remicade-jnj-pfe-1001463467
29.0,10/20/2016 11:38:23 PM,BRIEF-J&J sets quarterly cash dividend of $0.80 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-080-per-share-2016-10
30.0,10/25/2016 3:52:21 PM,BRIEF-Janssen Therapeutics receives funding from a special RFA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-therapeutics-receives-funding-from-a-special-rfa-2016-10
31.0,11/8/2016 1:36:17 PM,BRIEF-British artificial intelligence firm announces license agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-british-artificial-intelligence-firm-announces-license-agreement-with-janssen-2016-11
32.0,11/9/2016 6:28:14 PM,"Drug stocks rip higher after Trump's upset victory signals easing pressure on prices (MRK, PFE, AMGN, JNJ, AGN, ABBV, SNY, NVS, AZN, GSK, IBB)",Business Insider,http://www.businessinsider.com/drug-company-stocks-morning-after-election-2016-11
33.0,11/9/2016 10:16:20 PM,"J&J vaccine plus Gilead immune booster shows promise as HIV fighter (JNJ, GILD)",Reuters,http://www.businessinsider.com/r-jj-vaccine-plus-gilead-immune-booster-shows-promise-as-hiv-fighter-2016-11
34.0,11/10/2016 5:06:17 PM,"BRIEF-Genmab says combination of drugs from J&J, Amgen will be tested in study (GEN, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-combination-of-drugs-from-jj-amgen-will-be-tested-in-study-2016-11
35.0,11/10/2016 5:40:18 PM,"BRIEF-Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib (AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-reports-clinical-trial-collaboration-and-supply-agreement-with-amgen-to-evaluate-daratumumab-in-combination-with-carfilzomib-2016-11
36.0,11/14/2016 8:22:18 AM,"J&J arthritis drug goes up against Humira, with mixed results (JNJ)",Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-goes-up-against-humira-with-mixed-results-2016-11
37.0,11/14/2016 12:22:20 PM,"Drugmakers improve access for poor, GSK ranked top (GSK, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-drugmakers-improve-access-for-poor-gsk-ranked-top-2016-11
38.0,11/14/2016 8:22:19 PM,The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11
39.0,11/14/2016 10:14:20 PM,BRIEF-Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharma-says-new-late-stage-results-from-pioneer-af-pci-study-meets-main-goal-2016-11
40.0,11/15/2016 2:36:18 AM,"BRIEF-Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson (ALXN, FDX, EBAY, JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-cuts-share-stake-in-alexion-pharmaceuticals-johnson--johnson-2016-11
41.0,11/15/2016 1:32:20 PM,RPT-The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-rpt-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11
42.0,11/15/2016 4:20:21 PM,BRIEF-Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssens-guselkumab-shows-promise-in-psoriatic-arthritis-treatment-in-phase-2-trial-2016-11
43.0,11/16/2016 1:24:18 PM,BRIEF-Samsung Biologics says it wins $261.8 mln order from Cilag GmbH International (JNJ),Reuters,http://www.businessinsider.com/r-brief-samsung-biologics-says-it-wins-2618-mln-order-from-cilag-gmbh-international-2016-11
44.0,11/16/2016 10:24:21 PM,BRIEF-Janssen announces data from two late-stage studies for sirukumab in RA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-data-from-two-late-stage-studies-for-sirukumab-in-ra-2016-11
45.0,11/17/2016 3:26:32 PM,BRIEF-Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-application-to-fda-seeking-approval-of-anti-interleukin-23-monoclonal-antibody-guselkumab-2016-11
46.0,11/21/2016 10:56:52 PM,"BRIEF-Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-us-fda-approval-of-darzalex-daratumumab-for-relapsed-multiple-myeloma-2016-11
47.0,11/25/2016 5:56:17 AM,J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11
48.0,11/25/2016 5:56:17 AM,BRIEF-J&J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-said-to-make-takeover-approach-for-swiss-drugmaker-actelion---bloomberg-2016-11
49.0,11/25/2016 7:28:21 AM,"UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11
50.0,11/25/2016 11:28:18 AM,"Costly leukaemia pill wins UK green light after price cut (JNJ, PFE, BMY, 4523)",Reuters,http://www.businessinsider.com/r-costly-leukaemia-pill-wins-uk-green-light-after-price-cut-2016-11
51.0,11/25/2016 6:02:43 PM,"CONFIRMED: Johnson & Johnson is looking to buy a nearly $20 billion drugmaker (ATLN, JNJ)",Business Insider,http://www.businessinsider.com/actelion-confirms-johnson-and-johnson-offer-2016-11
52.0,11/25/2016 6:54:20 PM,"US STOCKS-Wall St hit record highs as consumer staples, techs gain (JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-record-highs-as-consumer-staples-techs-gain-2016-11
53.0,11/25/2016 6:54:20 PM,BRIEF-J&J confirms discussions with Actelion regarding potential deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-confirms-discussions-with-actelion-regarding-potential-deal-2016-11
54.0,11/25/2016 6:54:20 PM,Actelion confirms Johnson & Johnson approach (JNJ),Reuters,http://www.businessinsider.com/r-actelion-confirms-johnson--johnson-approach-2016-11
55.0,11/28/2016 3:11:41 PM,The drugmaker that Johnson & Johnson is looking to buy could significantly boost its takeover price,Reuters,http://www.businessinsider.com/r-actelions-ambitious-independent-minded-ceo-will-drive-up-takeover-price-2016-11
56.0,11/29/2016 10:20:15 AM,"PRESS DIGEST- Financial Times - Nov 29 (TSCO, BT., JNJ, SPD)",Reuters,http://www.businessinsider.com/r-press-digest--financial-times---nov-29-2016-11
57.0,11/29/2016 12:02:07 PM,"Actelion shares plunge on report it eyes ""complicated"" J&J deal (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shares-plunge-on-report-it-eyes-complicated-jj-deal-2016-11
58.0,11/29/2016 12:02:07 PM,"Swiss stocks - Factors to watch on Nov.29 (PAXN, AIRE, VCH, ESUN, ALPN, COPN, JNJ)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-nov29-2016-11
59.0,11/29/2016 1:36:10 PM,European shares steady as firmer banks offset weaker miners (JNJ),Reuters,http://www.businessinsider.com/r-european-shares-steady-as-firmer-banks-offset-weaker-miners-2016-11
60.0,11/29/2016 4:56:10 PM,BRIEF-Depuy Synthes says new UK joint registry data confirms positive early results for Depuy Synthes Attune Knee system (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-says-new-uk-joint-registry-data-confirms-positive-early-results-for-depuy-synthes-attune-knee-system-2016-11
61.0,11/29/2016 8:10:05 PM,"BRIEF-Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources (JNJ)",Reuters,http://www.businessinsider.com/r-brief-actelion-has-given-jj-access-to-some-of-its-financial-information-as-part-of-the-deal-negotiations---bloomberg-citing-sources-2016-11
62.0,11/30/2016 2:00:05 PM,"BRIEF-Achillion announces initiation of patient dosing by Janssen in phase 2B study (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-initiation-of-patient-dosing-by-janssen-in-phase-2b-study-2016-11
63.0,11/30/2016 5:30:05 PM,Rejecting J&J could leave Actelion with 'lot of explaining to do',Reuters,http://www.businessinsider.com/r-rejecting-jj-could-leave-actelion-with-lot-of-explaining-to-do-2016-11
64.0,12/1/2016 12:04:06 PM,"Swiss stocks - Factors to watch on Dec 1 (STMN, JNJ, ESUN, FORN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-dec-1-2016-12
65.0,12/2/2016 3:14:03 AM,Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12
66.0,12/2/2016 5:32:09 AM,UPDATE 1-Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12
67.0,12/2/2016 6:34:06 PM,EU health regulator warns some hep C drugs could reactivate hep B,Reuters,http://www.businessinsider.com/r-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12
68.0,12/2/2016 7:16:03 PM,"UPDATE 1-EU health regulator warns some hep C drugs could reactivate hep B (JNJ, BMY, GILD)",Reuters,http://www.businessinsider.com/r-update-1-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12
69.0,12/2/2016 8:24:03 PM,"Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12
70.0,12/5/2016 1:00:05 AM,"RPT-Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-rpt-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12
71.0,12/5/2016 3:36:06 AM,Novartis CEO plays down prospects for Actelion bid: Blick,Reuters,http://www.businessinsider.com/r-novartis-ceo-plays-down-prospects-for-actelion-bid-blick-2016-12
72.0,12/5/2016 11:56:05 PM,"BRIEF-Sanofi to explore counterbid for Actelion amid J&J talks - Bloomberg, citing sources (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-brief-sanofi-to-explore-counterbid-for-actelion-amid-jj-talks---bloomberg-citing-sources-2016-12
73.0,12/6/2016 12:18:07 AM,"Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12
74.0,12/6/2016 5:40:10 AM,"UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12
75.0,12/6/2016 12:00:07 PM,"DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12
76.0,12/6/2016 2:02:03 PM,"RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-rpt-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12
77.0,12/6/2016 7:06:03 PM,BRIEF-Janssen Research & Development reports final Phase 2 data for ibrutinib (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-reports-final-phase-2-data-for-ibrutinib-2016-12
78.0,12/6/2016 7:26:03 PM,BRIEF-AbbVie reports positive Phase 2 data for ibrutinib in cGVHD patients (JNJ),Reuters,http://www.businessinsider.com/r-brief-abbvie-reports-positive-phase-2-data-for-ibrutinib-in-cgvhd-patients-2016-12
79.0,12/8/2016 5:54:04 PM,"BUZZ-DJI: On a run (XLI, DIA, GS, AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-on-a-run-2016-12
80.0,12/9/2016 3:49:52 PM,"Under Trump, the medical device industry will likely be the first to benefit from tax cuts",Reuters,http://www.businessinsider.com/r-under-trump-congress-likely-to-pull-plug-on-medical-device-tax-2016-12
81.0,12/14/2016 1:34:03 AM,BRIEF-Johnson & Johnson says it has ended discussions with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-it-has-ended-discussions-with-actelion-2016-12
82.0,12/14/2016 1:44:07 AM,J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-jj-ends-takeover-talks-with-actelion-2016-12
83.0,12/14/2016 2:10:07 AM,UPDATE 1-J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ends-takeover-talks-with-actelion-2016-12
84.0,12/14/2016 3:40:03 AM,BRIEF-Actelion says in discussions with another party regarding possible strategic transaction (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-in-discussions-with-another-party-regarding-possible-strategic-transaction-2016-12
85.0,12/14/2016 4:14:03 PM,"BRIEF-FDA clears wireless integration for WellDoc, Lifescan project (JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-clears-wireless-integration-for-welldoc-lifescan-project-2016-12
86.0,12/15/2016 7:08:03 AM,"PRESS DIGEST- Wall Street Journal - Dec 15 (YHOO, VZ, VIV, MS, VOW3, SAN, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---dec-15-2016-12
87.0,12/15/2016 2:52:03 PM,BRIEF-Veritex Holdings public offering of 3.9 mln shares priced at $22.50/share,Reuters,http://www.businessinsider.com/r-brief-veritex-holdings-public-offering-of-39-mln-shares-priced-at-2250/share-2016-12
88.0,12/16/2016 6:02:03 AM,Sanofi discusses $275 per Actelion share for potential deal: Bloomberg,Reuters,http://www.businessinsider.com/r-sanofi-discusses-275-per-actelion-share-for-potential-deal-bloomberg-2016-12
89.0,12/23/2016 10:49:48 PM,"Johnson & Johnson's on-again, off-again pursuit of Actelion is back on (JNJ, ALIOF)",Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnsons-actelion-pharmaceuticals-aquisition-2016-12
90.0,12/28/2016 1:18:05 PM,"BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178 (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-clinical-milestone-for-the-advancement-of-jnj-4178-2016-12
91.0,12/29/2016 11:00:05 PM,"BRIEF-Mylan launches generic Concerta tablets (JNJ, MYL)",Reuters,http://www.businessinsider.com/r-brief-mylan-launches-generic-concerta-tablets-2016-12
92.0,12/30/2016 7:52:03 AM,"Swiss stocks - Factors to watch on Friday (JNJ, ALPN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-friday-2016-12
93.0,1/3/2017 12:48:03 PM,BRIEF-Johnson & Johnson announces quarterly dividend for Q1 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-quarterly-dividend-for-q1-2017-2017-1
94.0,1/3/2017 7:32:06 PM,BRIEF-J&J's DePuy Synthes acquires technology from Interventional Spine Inc (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-depuy-synthes-acquires-technology-from-interventional-spine-inc-2017-1
95.0,1/4/2017 7:00:05 AM,Judge halves $1 bln award in J&J hip implants case (JNJ),Reuters,http://www.businessinsider.com/r-judge-halves-1-bln-award-in-jj-hip-implants-case-2017-1
96.0,1/6/2017 8:10:03 AM,"J&J, Actelion approach Swiss takeover board over deal structure -paper (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-jj-actelion-approach-swiss-takeover-board-over-deal-structure--paper-2017-1
97.0,1/11/2017 2:44:03 PM,"BRIEF-Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase...",Reuters,http://www.businessinsider.com/r-brief-bird-rock-bio-receives-approval-to-start-first-in-human-clinical-trial-for-namacizumab-enters-into-agreement-with-ge-healthcare-for-process-development-and-scale-up-to-provide-clinical-phase-2-cgmp-material-2017-1
98.0,1/11/2017 7:16:03 PM,"UPDATE 1-Trump says pharmaceutical companies ""getting away with murder"" (MYL, LMT, BA, PFE, JNJ, GILD, IBB)",Reuters,http://www.businessinsider.com/r-update-1-trump-says-pharmaceutical-companies-getting-away-with-murder-2017-1
99.0,1/12/2017 1:48:06 AM,BRIEF-Orthocell announces collaboration with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-orthocell-announces-collaboration-with-johnson--johnson-2017-1
100.0,1/14/2017 6:42:15 AM,Johnson & Johnson will begin disclosing drug price increases (JNJ),Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnson-drug-price-increases-2017-1
101.0,1/20/2017 8:40:07 AM,"INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-insight-sanofis-ma-misses-frustrate-some-investors-in-drugmaker-2017-1
102.0,1/20/2017 2:54:10 PM,BRIEF-Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-endo-surgery-announces-acquisition-of-megadyne-medical-products-2017-1
103.0,1/23/2017 9:30:05 AM,UPDATE 1-Actelion's Opsumit drug missed trial endpoint - doctor (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelions-opsumit-drug-missed-trial-endpoint---doctor-2017-1
104.0,1/23/2017 2:40:07 PM,"UPDATE 1-Silgan buys WestRock's dispensers unit for about $1 bln (SLGN, CPB, JNJ, KR, PEP)",Reuters,http://www.businessinsider.com/r-update-1-silgan-buys-westrocks-dispensers-unit-for-about-1-bln-2017-1
105.0,1/23/2017 3:54:05 PM,"Trump to company executives: We think we can cut regulations by 75 pct (JNJ, GLW, IP, LMT, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-trump-to-company-executives-we-think-we-can-cut-regulations-by-75-pct-2017-1
106.0,1/23/2017 5:50:05 PM,"CEO's discussed tax, regulations and trade with Trump -Liveris (DOW, JNJ, GLW, IP, LMT, X, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-ceos-discussed-tax-regulations-and-trade-with-trump--liveris-2017-1
107.0,1/24/2017 12:58:05 PM,BRIEF-Johnson & Johnson reports Q4 adj. earnings $1.58 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-reports-q4-adj-earnings-158-per-share-2017-1
108.0,1/24/2017 4:26:05 PM,BRIEF-J&J sees 2017 effective tax rate 19-20 percent (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sees-2017-effective-tax-rate-19-20-percent-2017-1
109.0,1/25/2017 2:04:05 PM,"BRIEF-Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-pharmaceuticals-collaborates-with-depuy-synthes-to-support-promotion-education-and-training-of-exparel-in-orthopedics-2017-1
110.0,1/26/2017 9:08:05 AM,UPDATE 1-Johnson & Johnson to buy Actelion for $30 bln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-to-buy-actelion-for-30-bln-2017-1
111.0,1/26/2017 10:28:15 AM,Johnson & Johnson will buy Swiss biotech firm Actelion for $30 billion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson-johnson-to-buy-actelion-for-30-bln-2017-1
112.0,1/26/2017 1:45:57 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://www.businessinsider.com/opening-bell-january-26-2017-2017-1
113.0,1/26/2017 3:35:20 PM,"10 things you need to know today (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://markets.businessinsider.com/news/stocks/opening-bell-january-26-2017-2017-1-1001697085
114.0,1/26/2017 4:22:05 PM,BRIEF-DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-receives-fda-clearance-for-cement-augmented-pedicle-screw-systems-2017-1
115.0,1/26/2017 6:24:08 PM,Advisers could land $100 million payday from Actelion sale (JNJ),Reuters,http://www.businessinsider.com/r-advisers-could-land-100-million-payday-from-actelion-sale-2017-1
116.0,1/26/2017 6:40:13 PM,"M&A boost helps European shares stay at one-year high (JNJ, STM, DGE, RBS)",Reuters,http://www.businessinsider.com/r-ma-boost-helps-european-shares-stay-at-one-year-high-2017-1
117.0,1/26/2017 10:22:49 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://www.businessinsider.com/closing-bell-january-26-2017-2017-1
118.0,1/26/2017 10:52:53 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://markets.businessinsider.com/news/stocks/closing-bell-january-26-2017-2017-1-1001699144
119.0,1/27/2017 2:56:06 PM,UPDATE 1-Drugmaker AbbVie's quarterly revenue misses estimates (JNJ),Reuters,http://www.businessinsider.com/r-update-1-drugmaker-abbvies-quarterly-revenue-misses-estimates-2017-1
120.0,1/27/2017 10:08:06 PM,J&J loses venue fight for talc lawsuits in Missouri,Reuters,http://www.businessinsider.com/r-jj-loses-venue-fight-for-talc-lawsuits-in-missouri-2017-1
121.0,1/27/2017 10:30:08 PM,BRIEF-Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable (JNJ),Reuters,http://www.businessinsider.com/r-brief-fitch-affirms-johnson--johnsons-idr-at-aaa-outlook-stable-2017-1
122.0,1/31/2017 2:34:07 PM,"Actelion, Syngenta takeovers set to shake up Swiss SMI index",Reuters,http://www.businessinsider.com/r-actelion-syngenta-takeovers-set-to-shake-up-swiss-smi-index-2017-1
123.0,1/31/2017 3:16:07 PM,BRIEF-ChemDiv announces multi-year hit identification collaboration with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-chemdiv-announces-multi-year-hit-identification-collaboration-with-janssen-2017-1
124.0,1/31/2017 3:18:04 PM,"BUZZ-DJI: Post-election rally on shaky ground (BA, IBM, AAPL, GS, DIA, DIS, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-post-election-rally-on-shaky-ground-2017-1
125.0,1/31/2017 4:10:07 PM,"Trump meets with drugmakers, seeks lower prices, U.S. production (MRK, JNJ, CELG, LLY, AMGN)",Reuters,http://www.businessinsider.com/r-trump-meets-with-drugmakers-seeks-lower-prices-us-production-2017-1
126.0,1/31/2017 7:06:07 PM,"UPDATE 3-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-3-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1
127.0,1/31/2017 9:30:07 PM,"UPDATE 4-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-4-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1
128.0,1/31/2017 10:40:10 PM,"UPDATE 1-Roche said to consider options for Diabetes unit- Bloomberg (JNJ, BAYN, KKR, 6752)",Reuters,http://www.businessinsider.com/r-update-1-roche-said-to-consider-options-for-diabetes-unit--bloomberg-2017-1
129.0,2/1/2017 11:40:10 PM,"BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-upon-termination-of-transaction-agreement-under-some-circumstances-actelion-may-be-obligated-to-pay-co-a-fee-2017-2
130.0,2/2/2017 2:36:04 PM,BRIEF-Janssen Human Microbiome Institute announces multiple collaborations to accelerate translation of microbiome science into health solutions (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-human-microbiome-institute-announces-multiple-collaborations-to-accelerate-translation-of-microbiome-science-into-health-solutions-2017-2
131.0,2/6/2017 5:38:08 PM,BRIEF-Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-renova-therapeutics-enters-into-agreement-to-receive-stresscopin-investigational-new-drug-file-from-janssen-2017-2
132.0,2/8/2017 10:06:11 AM,"UPDATE 1-Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A (SAN, JNJ, REGN, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-drugmaker-sanofi-sees-weak-2017-earnings-not-in-hurry-for-ma-2017-2
133.0,2/8/2017 5:08:09 PM,"BRIEF-Bayer late-stage rivaroxaban trial meets primary endpoint early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-late-stage-rivaroxaban-trial-meets-primary-endpoint-early-2017-2
134.0,2/8/2017 7:54:11 PM,Bayer's blood thinner also effective for artery disease,Reuters,http://www.businessinsider.com/r-bayers-blood-thinner-also-effective-for-artery-disease-2017-2
135.0,2/10/2017 7:22:09 AM,"Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2
136.0,2/10/2017 1:08:09 PM,"RPT-Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-rpt-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2
137.0,2/10/2017 2:30:09 PM,EMA panel recommends that use of Actelion's Uptravi may continue,Reuters,http://www.businessinsider.com/r-ema-panel-recommends-that-use-of-actelions-uptravi-may-continue-2017-2
138.0,2/10/2017 2:54:10 PM,UPDATE 1-EMA panel says that use of Actelion's Uptravi may continue (JNJ),Reuters,http://www.businessinsider.com/r-update-1-ema-panel-says-that-use-of-actelions-uptravi-may-continue-2017-2
139.0,2/10/2017 7:04:09 PM,"BRIEF-Bayer says phase III compass study shows efficacy of Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-says-phase-iii-compass-study-shows-efficacy-of-xarelto-2017-2
140.0,2/13/2017 1:36:10 PM,BRIEF-Akebia Therapeutics provides update on Janssen deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-akebia-therapeutics-provides-update-on-janssen-deal-2017-2
141.0,2/14/2017 7:58:10 AM,"Actelion, being bought by J&J, says FY profit rose 26 pct (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-being-bought-by-jj-says-fy-profit-rose-26-pct-2017-2
142.0,2/14/2017 8:18:10 AM,"UPDATE 1-Actelion, being bought by J&J, says FY core net income rose 27 pct (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-actelion-being-bought-by-jj-says-fy-core-net-income-rose-27-pct-2017-2
143.0,2/15/2017 1:00:10 AM,"BRIEF-Paulson & Co takes share stake in Achaogen, dissolves in J&J (JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-takes-share-stake-in-achaogen-dissolves-in-jj-2017-2
144.0,2/15/2017 1:12:12 PM,Integra LifeSciences To Buy J & J Codman Neurosurgery Business For $1.045 Bln ,RTTNews,/news/stocks/integra-lifesciences-to-buy-j-j-codman-neurosurgery-business-for-1-045-bln-1001752636
145.0,2/15/2017 1:38:11 PM,"BRIEF-Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-plans-to-acquire-codman-neurosurgery-business-from-johnson--johnson-for-1045-bln-2017-2
146.0,2/15/2017 1:44:11 PM,"UPDATE 1-Integra offers to buy J&J's Codman neurosurgery business (JNJ, IART)",Reuters,http://www.businessinsider.com/r-update-1-integra-offers-to-buy-jjs-codman-neurosurgery-business-2017-2
147.0,2/15/2017 2:46:10 PM,"BRIEF-Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-says-depuy-synthes-entitled-to-get-termination-fee-of-60-million-if-co-fails-to-complete-deal-2017-2
148.0,2/15/2017 3:06:13 PM,BRIEF-X-Chem expands collaboration with Janssen in inflammatory diseases (JNJ),Reuters,http://www.businessinsider.com/r-brief-x-chem-expands-collaboration-with-janssen-in-inflammatory-diseases-2017-2
149.0,2/15/2017 3:18:10 PM,BRIEF-Trianni signs licensing agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-trianni-signs-licensing-agreement-with-janssen-2017-2
150.0,2/16/2017 7:50:11 AM,Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2
151.0,2/16/2017 9:44:10 AM,UPDATE 1-Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2
152.0,2/16/2017 9:52:10 AM,BRIEF-Swiss Takeover Commission OKs J&J offer for Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-swiss-takeover-commission-oks-jj-offer-for-actelion-2017-2
153.0,2/16/2017 11:04:12 AM,"UPDATE 2-How Sanofi lost out to J&J in $30 bln battle for Actelion (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-update-2-how-sanofi-lost-out-to-jj-in-30-bln-battle-for-actelion-2017-2
154.0,2/17/2017 1:08:10 PM,"EU mergers and takeovers (Feb 17) (6753, 2354, TKA, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-17-2017-2
155.0,2/17/2017 4:20:11 PM,BRIEF-Ethicon announces agreement to acquire Torax Medical (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-announces-agreement-to-acquire-torax-medical-2017-2
156.0,2/21/2017 3:32:12 PM,"EU mergers and takeovers (Feb 21) (MAERSK , ACA, UCG, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-21-2017-2
157.0,2/22/2017 6:42:12 PM,"Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2
158.0,2/22/2017 7:36:13 PM,"EU mergers and takeovers (Feb 22) (KKR, 6501, 6581, JNJ, ABT, TECD, AVT, SIE, MENT, NKT, AKE, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM, BX, NG.",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-22-2017-2
159.0,2/22/2017 9:00:12 PM,"Genmab's Darzalex could achieve peak annual sales of $9 bln -CEO (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-genmabs-darzalex-could-achieve-peak-annual-sales-of-9-bln--ceo-2017-2
160.0,2/22/2017 9:28:12 PM,"UPDATE 1-Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2
161.0,2/23/2017 5:48:17 PM,Trump tells CEOs he plans to bring back millions of jobs,Reuters,http://www.businessinsider.com/r-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2
162.0,2/23/2017 5:52:12 PM,"UPDATE 1-Trump tells CEOs he plans to bring back millions of jobs (GE, LMT, DOW, IP, F, JNJ, GLW, MRK, CAT, MMM, X, ADM, GD, WHR, 067900)",Reuters,http://www.businessinsider.com/r-update-1-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2
163.0,2/24/2017 1:44:12 PM,"BRIEF-EMA recommends approval of Daiichi Sankyo's anticoagulant (4568, JNJ, GEN)",Reuters,http://www.businessinsider.com/r-brief-ema-recommends-approval-of-daiichi-sankyos-anticoagulant-2017-2
164.0,2/27/2017 4:05:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786515
165.0,2/27/2017 4:53:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786683
166.0,2/27/2017 8:50:13 PM,"J&J says kept drug price increases below 10 pct since 2012 (JNJ, MRK, AGN, NOVO )",Reuters,http://www.businessinsider.com/r-jj-says-kept-drug-price-increases-below-10-pct-since-2012-2017-2
167.0,2/27/2017 11:30:13 PM,BRIEF-Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-received-a-subpoena-in-feb-from-the-us-attorneys-office-for-the-district-of-massachusetts-2017-2
168.0,2/28/2017 12:22:24 AM,The world's biggest drugmaker just pulled back the curtain on drug pricing (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-breakdown-on-drug-pricing-2017-2
169.0,3/3/2017 9:42:20 AM,"UPDATE 1-Japan's GPIF posts record $92 bln quarterly gain thanks to stock rally (8306, 9433, JNJ, MSFT, 7267, 9432, 7203, XOM, AAPL)",Reuters,http://www.businessinsider.com/r-update-1-japans-gpif-posts-record-92-bln-quarterly-gain-thanks-to-stock-rally-2017-3
170.0,3/3/2017 2:00:22 PM,"BRIEF-Johnson & Johnson's Janssen says new results from second phase 3 study show significant efficacy of guselkumab (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnsons-janssen-says-new-results-from-second-phase-3-study-show-significant-efficacy-of-guselkumab-2017-3
171.0,3/3/2017 10:40:20 PM,J&J wins fourth trial in talc product liability lawsuits,Reuters,http://www.businessinsider.com/r-jj-wins-fourth-trial-in-talc-product-liability-lawsuits-2017-3
172.0,3/3/2017 11:04:20 PM,UPDATE 1-J&J wins trial in talc product liability lawsuits (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-trial-in-talc-product-liability-lawsuits-2017-3
173.0,3/6/2017 10:00:21 AM,BRIEF-Janssen provides Nuevolution with further technology access fee payment (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-provides-nuevolution-with-further-technology-access-fee-payment-2017-3
174.0,3/6/2017 1:44:21 PM,UPDATE 1-TG Therapeutics' leukemia drug clears hurdle in key study (JNJ),Reuters,http://www.businessinsider.com/r-update-1-tg-therapeutics-leukemia-drug-clears-hurdle-in-key-study-2017-3
175.0,3/7/2017 1:25:00 PM,"Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-pfizer-merck-abbvie-and-johnson-johnson-1001810747
176.0,3/7/2017 4:30:22 PM,"US STOCKS-Wall St slips as Trump tweet pummels drug stocks (JNJ, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-trump-tweet-pummels-drug-stocks-2017-3
177.0,3/7/2017 5:56:21 PM,"US STOCKS-Wall St pares losses as techs offset pharma decline (JNJ, AAPL, MSFT, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-pares-losses-as-techs-offset-pharma-decline-2017-3
178.0,3/8/2017 5:42:22 PM,"INSIGHT-'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks (JNJ, MRK, LLY, CELG, AMGN, GM, F, CPB, TGT, LUV, UAL, DAL)",Reuters,http://www.businessinsider.com/r-insight-its-like-kumbaya-trumps-genial-private-meetings-with-ceos-jar-with-public-attacks-2017-3
179.0,3/9/2017 5:54:22 PM,"US STOCKS-S&P, Dow on track to snap 3-day losing streak as banks gain (JNJ, AAPL, AIG)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-on-track-to-snap-3-day-losing-streak-as-banks-gain-2017-3
180.0,3/9/2017 7:44:22 PM,"US STOCKS-Wall St fights to hold on to gains as oil slips again (CVX, JNJ, AAPL, SIG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-fights-to-hold-on-to-gains-as-oil-slips-again-2017-3
181.0,3/9/2017 9:46:22 PM,"US STOCKS-Wall St slips as energy shares fall further; banks pare gains (JNJ, AAPL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-energy-shares-fall-further-banks-pare-gains-2017-3
182.0,3/9/2017 10:52:27 PM,US STOCKS-Wall St ends up slightly; energy shares rebound (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ends-up-slightly-energy-shares-rebound-2017-3
183.0,3/9/2017 11:12:25 PM,"GLOBAL MARKETS-Oil prices slump amid ample supply, gold falls (UKX, BP., BLT, GLEN, JNJ, XOM, WFC)",Reuters,http://www.businessinsider.com/r-global-markets-oil-prices-slump-amid-ample-supply-gold-falls-2017-3
184.0,3/13/2017 4:17:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829909
185.0,3/13/2017 4:35:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829985
186.0,3/14/2017 7:00:00 AM,Johnson & Johnson Names Winners of First Africa Innovation Challenge,PR Newswire,/news/stocks/johnson-johnson-names-winners-of-first-africa-innovation-challenge-1001831566
187.0,3/14/2017 12:56:24 PM,"BRIEF-Pacira says phase 4 study shows its drug reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-says-phase-4-study-shows-its-drug-reduces-opioid-consumption-and-postsurgical-pain-in-patients-undergoing-total-knee-arthroplasty-2017-3
188.0,3/14/2017 4:30:50 PM,"An experimental vaccine could leave the world far better prepared for the next Ebola outbreak (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3
189.0,3/14/2017 5:40:24 PM,"RPT-Two-part Ebola vaccine offers long-lasting protection (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-rpt-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3
190.0,3/15/2017 8:22:45 AM,BRIEF-Actelion says drug discovery business to be called Idorsia (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-drug-discovery-business-to-be-called-idorsia-2017-3
191.0,3/15/2017 1:50:42 PM,BRIEF-J&J CEO Alex Gorsky's 2016 total compensation $26.9 mln (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-ceo-alex-gorskys-2016-total-compensation-269-mln-2017-3
192.0,3/18/2017 3:18:46 PM,"J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study (JNJ, BAYN, PFE)",Reuters,http://www.businessinsider.com/r-jj-and-bayers-xarelto-cuts-recurrence-of-dangerous-blood-clots-in-study-2017-3
193.0,3/19/2017 9:12:46 PM,Newer type 2 diabetes drugs show heart protective quality in study,Reuters,http://www.businessinsider.com/r-newer-type-2-diabetes-drugs-show-heart-protective-quality-in-study-2017-3
194.0,3/23/2017 1:40:45 PM,BRIEF-Johnson & Johnson says to pause all YouTube digital advertising globally (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-to-pause-all-youtube-digital-advertising-globally-2017-3
195.0,3/23/2017 1:54:45 PM,"J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3
196.0,3/23/2017 2:16:50 PM,"UPDATE 1-J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-update-1-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3
197.0,3/24/2017 4:42:45 AM,YouTube's bid to grab TV dollars imperiled by advertiser revolt,Reuters,http://www.businessinsider.com/r-youtubes-bid-to-grab-tv-dollars-imperiled-by-advertiser-revolt-2017-3
198.0,3/28/2017 3:30:49 PM,Twitter to let advertisers buy video ads on Periscope,Reuters,http://www.businessinsider.com/r-twitter-to-let-advertisers-buy-video-ads-on-periscope-2017-3
199.0,3/28/2017 3:52:49 PM,"BRIEF-Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology (LGND, JNJ)",Reuters,http://www.businessinsider.com/r-brief-ligand-announces-licensing-partner-janssen-has-filed-an-ind-for-an-antibody-discovered-using-the-omniab-technology-2017-3
200.0,3/28/2017 7:06:47 PM,"US STOCKS-Dow on track to snap 8-day losing streak as banks gain (BAC, GS, JPM, AAPL, GM, TSLA, 700)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-on-track-to-snap-8-day-losing-streak-as-banks-gain-2017-3
201.0,3/28/2017 7:06:47 PM,U.S. senator launches probe into five top opioid drugmakers,Reuters,http://www.businessinsider.com/r-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3
202.0,3/28/2017 8:40:47 PM,"UPDATE 1-U.S. senator launches probe into five top opioid drugmakers (JNJ, MYL, DEPO)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3
203.0,3/29/2017 8:23:58 AM,"Johnson & Johnson just launched a $100,000 burnout prevention bootcamp for CEOs (JNJ)",Business Insider,http://www.businessinsider.com/johnson-johnson-ceos-burnt-out-2017-3
204.0,3/29/2017 8:26:49 AM,"PRESS DIGEST- New York Times business news - March 29 (005930, 9984, 700, TSLA, BLK)",Reuters,http://www.businessinsider.com/r-press-digest--new-york-times-business-news---march-29-2017-3
205.0,3/30/2017 7:04:50 PM,"BRIEF-Genmab A/S says Phase II study in NHL will not proceed (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-a-s-says-phase-ii-study-in-nhl-will-not-proceed-2017-3
206.0,3/31/2017 1:30:48 AM,"DEALS-Trump helps make cross-border M&A great again (JNJ, ULVR, AKZA, PPG, RB., MJN, BARC, BAC)",Reuters,http://www.businessinsider.com/r-deals-trump-helps-make-cross-border-ma-great-again-2017-3
207.0,3/31/2017 7:00:00 AM,Johnson & Johnson Publishes Interim Result for Actelion Tender Offer and Declares the Tender Offer Successful,PR Newswire,/news/stocks/johnson-&-johnson-publishes-interim-result-for-actelion-tender-offer-and-declares-the-tender-offer-successful-1001550374
208.0,3/31/2017 7:12:02 AM,Johnson & Johnson Announces Interim Result For Actelion Tender Offer ,RTTNews,/news/stocks/johnson-johnson-announces-interim-result-for-actelion-tender-offer-1001884307
209.0,3/31/2017 7:50:50 AM,"Swiss stocks - Factors to watch on March 31 (JNJ, HELN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-march-31-2017-3
210.0,3/31/2017 12:14:48 PM,"Deals of the day-Mergers and acquisitions (AVGO, 6502, JNJ, CM, PVTB, BX, 10015031, ROSN, MNZS, BN, 2881)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-3
211.0,4/4/2017 5:58:00 PM,"Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017",PR Newswire,/news/stocks/ortho-clinical-diagnostics-to-present-data-on-early-detection-of-acute-kidney-injury-total-lab-automation-and-transfusion-medicine-at-medlab-asia-pacific-2017-1001895502
212.0,4/5/2017 8:12:50 AM,"Swiss stocks - Factors to watch on April 5 (JNJ, GAM, LECN, VONN, VAHN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-april-5-2017-4
213.0,4/5/2017 1:10:52 PM,"Actelion shareholders back R&D spinoff, keep J&J deal on track (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shareholders-back-rd-spinoff-keep-jj-deal-on-track-2017-4
214.0,4/6/2017 2:20:52 AM,Experts want special clinics to prescribe ketamine as antidepressant,Reuters,http://www.businessinsider.com/r-experts-want-special-clinics-to-prescribe-ketamine-as-antidepressant-2017-4
215.0,4/6/2017 3:16:53 PM,U.S. trade group hacked with Chinese software ahead of Xi summit,Reuters,http://www.businessinsider.com/r-us-trade-group-hacked-with-chinese-software-ahead-of-xi-summit-2017-4
216.0,4/7/2017 12:36:57 PM,BRIEF-PeptiDream enters into collaboration with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-peptidream-enters-into-collaboration-with-janssen-pharmaceuticals-2017-4
217.0,4/7/2017 1:58:53 PM,EMA gives green light to Actelion's Uptravi after safety review,Reuters,http://www.businessinsider.com/r-ema-gives-green-light-to-actelions-uptravi-after-safety-review-2017-4
218.0,4/7/2017 2:18:12 PM,PeptiDream Reports Discovery Collaboration Agreement With Janssen ,RTTNews,/news/stocks/peptidream-reports-discovery-collaboration-agreement-with-janssen-1001906569
219.0,4/10/2017 12:10:00 PM,"Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie",PR Newswire,/news/stocks/drug-makers-stocks-on-investors-radar-pfizer-merck-johnson-johnson-and-abbvie-1001909734
220.0,4/10/2017 2:14:58 PM,"BRIEF-Geron Corp and Janssen Research & Development LLC has completed second internal data reviews of Imerge and Imbark (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-corp-and-janssen-research--development-llc-has-completed-second-internal-data-reviews-of-imerge-and-imbark-2017-4
221.0,4/11/2017 10:37:10 AM,"Swiss billionaire Wyss gets nearly 10 pct of Molecular Partners (JNJ, AGN)",Reuters,http://www.businessinsider.com/r-swiss-billionaire-wyss-gets-nearly-10-pct-of-molecular-partners-2017-4
222.0,4/12/2017 1:22:17 PM,BRIEF-Phagelux announces collaboration with Johnson & Johnson Innovation for new antibacterial solution (JNJ),Reuters,http://www.businessinsider.com/r-brief-phagelux-announces-collaboration-with-johnson--johnson-innovation-for-new-antibacterial-solution-2017-4
223.0,4/17/2017 2:33:07 PM,BRIEF-Janssen receives Health Canada approval of Darzalex by priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-health-canada-approval-of-darzalex-by-priority-review-2017-4
224.0,4/18/2017 12:40:00 PM,Johnson & Johnson Reports 2017 First-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-first-quarter-results-1001926238
225.0,4/18/2017 12:48:12 PM,Johnson & Johnson Q1 Profit Rises 4%,RTTNews,/news/stocks/johnson-johnson-q1-profit-rises-4-1001926265
226.0,4/18/2017 12:59:08 PM,BRIEF-Johnson & Johnson Q1 earnings per share $1.61 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q1-earnings-per-share-161-2017-4
227.0,4/18/2017 1:01:05 PM,J&J's quarterly sales rise 1.6 pct (JNJ),Reuters,http://www.businessinsider.com/r-jjs-quarterly-sales-rise-16-pct-2017-4
228.0,4/18/2017 1:21:06 PM,"BRIEF-Genmab Q1 net sales of Darzalex at $255 million (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-q1-net-sales-of-darzalex-at-255-million-2017-4
229.0,4/18/2017 1:21:06 PM,UPDATE 1-J&J revenue misses on lower-than-expected pharmaceutical sales (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-revenue-misses-on-lower-than-expected-pharmaceutical-sales-2017-4
230.0,4/18/2017 1:35:33 PM,Johnson & Johnson Q1 Profit Tops Estimates; Lifts FY17 View ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-lifts-fy17-view-1001926523
231.0,4/18/2017 1:41:08 PM,"US STOCKS-Futures dip as investors weigh tax cut delays, earnings (BAC, GS, UNH, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-dip-as-investors-weigh-tax-cut-delays-earnings-2017-4
232.0,4/18/2017 1:55:03 PM,"UPDATE 1-Cardinal Health to buy Medtronic units for $6.1 bln (CAH, MDT, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-cardinal-health-to-buy-medtronic-units-for-61-bln-2017-4
233.0,4/18/2017 2:00:00 PM,5 Stocks to Watch as Canada Gets Hooked on Cannabis,PR Newswire,/news/stocks/5-stocks-to-watch-as-canada-gets-hooked-on-cannabis-1001926681
234.0,4/18/2017 3:33:03 PM,"US STOCKS-Wall St set to open lower as earnings gather pace (GS, BAC, MS, WFC, JPM, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-earnings-gather-pace-2017-4
235.0,4/18/2017 3:53:03 PM,BRIEF-Johnson & Johnson sees Actelion adding 35-50 cents to 2018 EPS (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-sees-actelion-adding-35-50-cents-to-2018-eps-2017-4
236.0,4/18/2017 3:57:05 PM,"EU mergers and takeovers (April 18) (COL, LEA, JNJ, KKR, SAF, RR., BOL, VIV, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-18-2017-4
237.0,4/18/2017 4:39:03 PM,"US STOCKS-Wall St falls as Goldman, J&J results disappoint (JNJ, GS, MS, WFC, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-goldman-jj-results-disappoint-2017-4
238.0,4/18/2017 6:07:05 PM,"US STOCKS-Weak Goldman, J&J results drag down Wall Street (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-goldman-jj-results-drag-down-wall-street-2017-4
239.0,4/18/2017 6:53:06 PM,"WRAPUP 2-U.S. housing starts drop; automobiles undercut factory output (GS, JNJ)",Reuters,http://www.businessinsider.com/r-wrapup-2-us-housing-starts-drop-automobiles-undercut-factory-output-2017-4
240.0,4/18/2017 7:13:05 PM,"US STOCKS-Wall St down as Goldman, J&J's results disappoint (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-down-as-goldman-jjs-results-disappoint-2017-4
241.0,4/18/2017 8:49:03 PM,"US STOCKS-Wall Sheet falls as Goldman, J&J weigh (JNJ, CAH, BAC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-sheet-falls-as-goldman-jj-weigh-2017-4
242.0,4/18/2017 9:36:48 PM,Johnson & Johnson Leading The Pharmaceutical Sector Lower ,RTTNews,/news/stocks/johnson-johnson-leading-the-pharmaceutical-sector-lower-1001928365
243.0,4/18/2017 10:27:03 PM,"US STOCKS-Goldman Sachs, J&J pull Wall Street lower (JNJ, CAH, MDT, BAC)",Reuters,http://www.businessinsider.com/r-us-stocks-goldman-sachs-jj-pull-wall-street-lower-2017-4
244.0,4/19/2017 1:55:06 PM,"US STOCKS-Futures rise as earnings take center stage (MS, AXP, EBAY, QCOM, GS, JNJ, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-rise-as-earnings-take-center-stage-2017-4
245.0,4/19/2017 4:51:04 PM,"EU mergers and takeovers (April 19) (EDF, AREVA, SAF, RR., BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-19-2017-4
246.0,4/20/2017 4:51:04 PM,"BRIEF-Genmab to present seven abstracts at annual ASCO meeting (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-to-present-seven-abstracts-at-annual-asco-meeting-2017-4
247.0,4/20/2017 6:31:07 PM,"EU mergers and takeovers (April 20) (RR., 3653, SAF, AVGO, BRCD, BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-20-2017-4
248.0,4/21/2017 3:15:05 PM,"UPDATE 1-Valeant prices psoriasis treatment at $3,500 per month (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-valeant-prices-psoriasis-treatment-at-3500-per-month-2017-4
249.0,4/21/2017 9:51:09 PM,"EMA panel recommends nod for Sanofi, Regeneron's arthritis drug (SAN, REGN, JNJ, LLY, INCY)",Reuters,http://www.businessinsider.com/r-ema-panel-recommends-nod-for-sanofi-regenerons-arthritis-drug-2017-4
250.0,4/21/2017 10:13:04 PM,"BRIEF-FDA approves Renflexis, biosimilar to Remicade (MRK, JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-renflexis-biosimilar-to-remicade-2017-4
251.0,4/22/2017 2:51:04 AM,"U.S. FDA approves Samsung Bioepis' copy of J&J's Remicade -company (JNJ, AMGN, MRK, PFE, 068270)",Reuters,http://www.businessinsider.com/r-us-fda-approves-samsung-bioepis-copy-of-jjs-remicade--company-2017-4
252.0,4/24/2017 10:12:54 AM,Janssen Holding Acquires 92.51% Of Actelion ,RTTNews,/news/stocks/janssen-holding-acquires-92-51-of-actelion-1001940983
253.0,4/24/2017 12:21:05 PM,"India to expand access to J&J's TB drug this year (JNJ, 4578)",Reuters,http://www.businessinsider.com/r-india-to-expand-access-to-jjs-tb-drug-this-year-2017-4
254.0,4/24/2017 1:11:08 PM,"RPT-INSIGHT-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-rpt-insight-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4
255.0,4/24/2017 3:21:10 PM,"EU mergers and takeovers (April 24) (6752, KKR, GE, BHI, BOL, VIV, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-24-2017-4
256.0,4/24/2017 5:05:05 PM,"J&J, Novartis and Takeda in talks for Brazil's Hypermarcas, sources say (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas-sources-say-2017-4
257.0,4/24/2017 5:31:10 PM,"UPDATE 1-J&J, Novartis and Takeda in talks for Brazil's Hypermarcas -sources (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-update-1-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas--sources-2017-4
258.0,4/24/2017 5:35:06 PM,"EMERGING MARKETS-Brazil real, Mexico peso strengthen on French vote (HYPE3, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-emerging-markets-brazil-real-mexico-peso-strengthen-on-french-vote-2017-4
259.0,4/24/2017 7:39:00 PM,Johnson & Johnson to Host Pharmaceutical Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-pharmaceutical-business-review-1001943321
260.0,4/24/2017 8:17:06 PM,"UPDATE 1-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-update-1-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4
261.0,4/25/2017 3:11:10 PM,"Japan's Otsuka aims to apply for TB drug approval in India in 90 days (4578, JNJ)",Reuters,http://www.businessinsider.com/r-japans-otsuka-aims-to-apply-for-tb-drug-approval-in-india-in-90-days-2017-4
262.0,4/25/2017 3:11:10 PM,"US STOCKS-Wall St set to open higher as earnings take center stage (CAT, MCD, BIIB, CNC, T, TSN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-center-stage-2017-4
263.0,4/25/2017 5:29:10 PM,"EU mergers and takeovers (April 25) (BOL, VIV, SAF, 600115, EDF, 8058, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, KKR, TEF, CS, LIN, JNJ, AREVA, GE, BHI)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-25-2017-4
264.0,4/26/2017 10:46:06 PM,"Digital ad spend jumps 22 percent to $72.5 bln in 2016 -report (VZ, JNJ)",Reuters,http://www.businessinsider.com/r-digital-ad-spend-jumps-22-percent-to-725-bln-in-2016--report-2017-4
265.0,4/27/2017 7:59:06 AM,BRIEF-Actelion says J&J deal on track to close towards end of Q2 (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-jj-deal-on-track-to-close-towards-end-of-q2-2017-4
266.0,4/27/2017 10:01:11 AM,"UPDATE 1-Strong pharma unit drives Bayer earnings beat (BAYN, MON, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-update-1-strong-pharma-unit-drives-bayer-earnings-beat-2017-4
267.0,4/27/2017 5:29:06 PM,BRIEF-J&J increase qtrly dividend by 5 pct to $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-increase-qtrly-dividend-by-5-pct-to-084-per-share-2017-4
268.0,4/28/2017 12:49:07 PM,"CORRECTED-UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21) (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-update-2-valeant-prices-psoriasis-treatment-at-3500-per-month-april-21-2017-4
269.0,4/28/2017 3:05:09 PM,"Global med-tech firms, India locked in tussle after stent price sting (ABT, BSX, JNJ, MDT, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-global-med-tech-firms-india-locked-in-tussle-after-stent-price-sting-2017-4
270.0,4/28/2017 3:21:07 PM,"Deals of the day-Mergers and acquisitions (SIE, BBD., AKZA, PPG, 1880, 9437, OML, KOTAKBANK, BAYN, MON, ZC, SAF, KKR, TTS, APO, 600887, DG, SU, ATL, ALV)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-4
271.0,4/28/2017 3:51:09 PM,"BRIEF-Genmab announces new late stage combination study of Daratumumab in multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-new-late-stage-combination-study-of-daratumumab-in-multiple-myeloma-2017-4
272.0,4/28/2017 4:41:09 PM,"EU mergers and takeovers (April 28) (BMW, DAI, PAH3, F, RTO, 6201, 2354, VIV, TIT, KKR, TEF, CS, LIN, JNJ, EDF, AREVA, GE, BHI, SAF, 600115, 8058, ANA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-28-2017-4
273.0,4/28/2017 10:53:12 PM,BRIEF-Janssen Research & Development submits supplemental application to FDA to update prescribing information for Xarelto (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-submits-supplemental-application-to-fda-to-update-prescribing-information-for-xarelto-2017-4
274.0,5/1/2017 2:13:00 PM,Johnson & Johnson Introduces Two New Interactive Experiences Showcasing More Than 130 Years Of Healthcare Innovation,PR Newswire,/news/stocks/johnson-johnson-introduces-two-new-interactive-experiences-showcasing-more-than-130-years-of-healthcare-innovation-1001965506
275.0,5/3/2017 10:30:04 PM,"Bayer, J&J win first product liability trial over Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-first-product-liability-trial-over-xarelto-2017-5
276.0,5/3/2017 11:10:05 PM,"UPDATE 1-Bayer, J&J win first trial over Xarelto bleeding risks (BAYN, JNJ, BMY)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-first-trial-over-xarelto-bleeding-risks-2017-5
277.0,5/5/2017 2:44:03 AM,J&J ordered to pay $110 million in talc product liability trial (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-110-million-in-talc-product-liability-trial-2017-5
278.0,5/5/2017 3:54:05 AM,UPDATE 1-J&J ordered to pay $110 million in U.S. talc-powder trial (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-110-million-in-us-talc-powder-trial-2017-5
279.0,5/5/2017 5:00:52 AM,Johnson & Johnson Ordered To Pay $110 Mln In Talc-Powder Trial ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-110-mln-in-talc-powder-trial-1001982133
280.0,5/5/2017 8:03:00 PM,Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-ubs-global-healthcare-conference-1001985138
281.0,5/6/2017 3:02:05 AM,BRIEF-Janssen Pharmaceuticals says evidence shows oral invokana 300 mg demonstrates comparable A1C reduction (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceuticals-says-evidence-shows-oral-invokana-300-mg-demonstrates-comparable-a1c-reduction-2017-5
282.0,5/8/2017 11:06:03 PM,"BRIEF-J&J says in March 2017, New Jersey attorney general division of consumer affairs issued subpoena to Janssen Pharmaceuticals (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-in-march-2017-new-jersey-attorney-general-division-of-consumer-affairs-issued-subpoena-to-janssen-pharmaceuticals-2017-5
283.0,5/9/2017 1:20:04 AM,J&J discloses U.S. probe related to arthritis drugs (JNJ),Reuters,http://www.businessinsider.com/r-jj-discloses-us-probe-related-to-arthritis-drugs-2017-5
284.0,5/10/2017 6:10:02 PM,"UPDATE 1-Sanofi says has no ""absolute need"" to do acquisitions (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-says-has-no-absolute-need-to-do-acquisitions-2017-5
285.0,5/11/2017 8:16:00 PM,Johnson & Johnson to Participate in the Jefferies 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-jefferies-2017-global-healthcare-conference-668201
286.0,5/12/2017 7:46:05 PM,"EU mergers and takeovers (May 12) (AVGO, BRCD, KKR, TEF, LIN, 2354, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-12-2017-5
287.0,5/15/2017 12:15:00 PM,"Drug Makers Stocks Under Scanner -- Alliqua BioMedical, AbbVie, Johnson & Johnson, and Merck",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-alliqua-biomedical-abbvie-johnson-johnson-and-merck-1002012055
288.0,5/15/2017 12:26:05 PM,"U.S. companies push hard for lower tax rate on offshore profits (AAPL, MSFT, PFE, GE, JNJ, MRK, XOM, IBM, CSCO)",Reuters,http://www.businessinsider.com/r-us-companies-push-hard-for-lower-tax-rate-on-offshore-profits-2017-5
289.0,5/15/2017 2:14:03 PM,"Israel's BiomX raises $24 mln in private funding round (JNJ, 4502)",Reuters,http://www.businessinsider.com/r-israels-biomx-raises-24-mln-in-private-funding-round-2017-5
290.0,5/15/2017 3:54:07 PM,BRIEF-Depuy Synthes awarded U.S. Department of Defense contract for orthopaedic products (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-awarded-us-department-of-defense-contract-for-orthopaedic-products-2017-5
291.0,5/15/2017 6:06:07 PM,"EU mergers and takeovers (May 15) (2354, GS, RF, JLL, NK, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-15-2017-5
292.0,5/15/2017 6:40:05 PM,BRIEF-J&J appoints Jane Griffiths to head Actelion unit (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-appoints-jane-griffiths-to-head-actelion-unit-2017-5
293.0,5/15/2017 7:30:02 PM,"South Korea's Celltrion sees rapid take-off for Roche drug copy (068270, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-south-koreas-celltrion-sees-rapid-take-off-for-roche-drug-copy-2017-5
294.0,5/15/2017 9:26:05 PM,"US STOCKS-Wall St hit records as technology, energy stocks rise (JNJ, CSCO, SYMC, XOM, CVX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-records-as-technology-energy-stocks-rise-2017-5
295.0,5/15/2017 9:53:40 PM,Johnson & Johnson Posting Strong Gain On Upgrade By JPMorgan ,RTTNews,/news/stocks/johnson-johnson-posting-strong-gain-on-upgrade-by-jpmorgan-1002014293
296.0,5/16/2017 5:16:09 AM,"UPDATE 1-New York county sues Purdue, J&J over opioid marketing (JNJ, TEVA, ENDP)",Reuters,http://www.businessinsider.com/r-update-1-new-york-county-sues-purdue-jj-over-opioid-marketing-2017-5
297.0,5/16/2017 5:36:10 PM,BRIEF-Livanova announces Thad Huston as chief financial officer (JNJ),Reuters,http://www.businessinsider.com/r-brief-livanova-announces-thad-huston-as-chief-financial-officer-2017-5
298.0,5/17/2017 1:26:03 AM,"U.S. FDA warns of foot, leg amputations with J&J diabetes drug (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-us-fda-warns-of-foot-leg-amputations-with-jj-diabetes-drug-2017-5
299.0,5/17/2017 12:44:00 PM,Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting,PR Newswire,/news/stocks/johnson-&-johnson-showcases-strong-pipeline-of-transformational-medicines-at-its-pharmaceutical-business-review-meeting-683092
300.0,5/17/2017 1:16:07 PM,BRIEF-J&J says expects more than 10 new products to launch or file for regulatory approval by 2021 (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-expects-more-than-10-new-products-to-launch-or-file-for-regulatory-approval-by-2021-2017-5
301.0,5/17/2017 4:18:55 PM,The world's largest drugmaker thinks it has 11 billion-dollar drugs in the pipeline ‚Äî here's what they treat (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-blockbuster-drug-potentials-by-2021-2017-5
302.0,5/18/2017 12:20:07 PM,Johnson & Johnson offers EU concessions over Actelion deal (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-offers-eu-concessions-over-actelion-deal-2017-5
303.0,5/18/2017 5:10:09 PM,"EU mergers and takeovers (May 18) (JNJ, IJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-18-2017-5
304.0,5/19/2017 2:30:05 AM,"For millions of Chinese with rare diseases, some relief in sight (CELG, BMY, JNJ, SHP, SAN, PFE, MRK, SAPL, ALXN)",Reuters,http://www.businessinsider.com/r-for-millions-of-chinese-with-rare-diseases-some-relief-in-sight-2017-5
305.0,5/19/2017 7:12:03 AM,"Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy (JNJ, AMGN)",Reuters,http://www.businessinsider.com/r-janssen-files-suit-in-us-to-block-sale-of-samsung-bioepis-remicade-copy-2017-5
306.0,5/19/2017 8:36:03 PM,"EU mergers and takeovers (May 19) (SAF, 600115, EDF, 8058, 521, C14, BX, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-19-2017-5
307.0,5/22/2017 4:36:02 PM,"Cross-border M&A between U.S. and European firms at 10 year high (HUN, ULVR, UNA, JNJ, AKZA, PPG, RB., MJN)",Reuters,http://www.businessinsider.com/r-cross-border-ma-between-us-and-european-firms-at-10-year-high-2017-5
308.0,5/23/2017 12:52:02 PM,"UPDATE 1-UK competition watchdog accuses Merck of obstructing biosimilars (MRK, 068270, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-uk-competition-watchdog-accuses-merck-of-obstructing-biosimilars-2017-5
309.0,5/23/2017 7:50:05 PM,"EU mergers and takeovers (May 23) (9101, 9104, 9107, FTI, LIN, RDSA, EDF, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 521, C14, BX)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-23-2017-5
310.0,5/24/2017 7:26:05 PM,J&J settles drug manufacturing probe by U.S. states for $33 million (JNJ),Reuters,http://www.businessinsider.com/r-jj-settles-drug-manufacturing-probe-by-us-states-for-33-million-2017-5
311.0,5/24/2017 8:24:05 PM,UPDATE 1-J&J settles drug manufacturing probe by U.S. states for $33 mln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-settles-drug-manufacturing-probe-by-us-states-for-33-mln-2017-5
312.0,5/25/2017 11:32:16 AM,Biotech Stocks Facing FDA Decision In June ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-june-1002042040
313.0,5/30/2017 11:30:07 AM,"Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5
314.0,5/30/2017 11:30:07 AM,"RPT-Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5
315.0,5/30/2017 1:36:07 PM,BRIEF-Protagonist Therapeutics signs deal with J&J to develop bowel drug (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-signs-deal-with-jj-to-develop-bowel-drug-2017-5
316.0,5/30/2017 2:12:06 PM,BRIEF-Protagonist Therapeutics says will be responsible for conduct of Phase 1 clinical trial for PTG-200 (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-says-will-be-responsible-for-conduct-of-phase-1-clinical-trial-for-ptg-200-2017-5
317.0,5/30/2017 3:14:05 PM,US STOCKS-Wall St set to open lower as investors digest data (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-investors-digest-data-2017-5
318.0,5/30/2017 4:30:08 PM,"US STOCKS-Wall St opens slightly lower as investors digest data (JNJ, ATW, ESV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-slightly-lower-as-investors-digest-data-2017-5
319.0,5/31/2017 3:58:05 PM,"US STOCKS-Wall St flat as oil offsets gains in tech, healthcare (JNJ, EXAS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-oil-offsets-gains-in-tech-healthcare-2017-5
320.0,5/31/2017 5:48:06 PM,"Ohio is suing 5 drug companies over the opioid crisis (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-ohio-sues-five-drug-companies-over-opioid-crisis-2017-5
321.0,5/31/2017 6:40:25 PM,"EU mergers and takeovers (May 31) (GE, BHI, 9984, FIG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 2317, RDSA, 521, C14, BX, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-31-2017-5
322.0,6/1/2017 7:12:03 AM,"PRESS DIGEST - Wall Street Journal - June 1 (GS, JNJ, TEVA, AGN, ENDP)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---june-1-2017-6
323.0,6/1/2017 4:56:05 PM,"EU mergers and takeovers (June 1) (HLDX, GS, UG, GM, BNP, GLE, DG, DUFN, MQG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, FIG, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-1-2017-6
324.0,6/1/2017 10:12:08 PM,"BRIEF-‚ÄçJanssen Sciences Ireland UC -VIIV Healthcare made regulatory submissions to EMA,FDA for dolutegravir and rilpivirine‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-sciences-ireland-uc--viiv-healthcare-made-regulatory-submissions-to-emafda-for-dolutegravir-and-rilpivirine-2017-6
325.0,6/2/2017 12:01:23 PM,State Sues Big Pharma For Opioid Carnage ,RTTNews,/news/stocks/state-sues-big-pharma-for-opioid-carnage-1002062739
326.0,6/3/2017 1:46:06 PM,Study shows early Zytiga use improves prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-study-shows-early-zytiga-use-improves-prostate-cancer-survival-2017-6
327.0,6/3/2017 10:24:05 PM,UPDATE 1-Early use of J&J's Zytiga extends prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-update-1-early-use-of-jjs-zytiga-extends-prostate-cancer-survival-2017-6
328.0,6/6/2017 1:18:08 AM,"MOVES-Credit Suisse hires Rapkin for healthcare investment banking (JPM, JNJ, FRE, AKRX, UNH, HCA, DVA)",Reuters,http://www.businessinsider.com/r-moves-credit-suisse-hires-rapkin-for-healthcare-investment-banking-2017-6
329.0,6/8/2017 1:30:03 AM,"Trump FBI nominee's corporate legal work could exclude him from some probes (JNJ, T, DBK, CVS, GM, WFC, GSK, 7312, LMT)",Reuters,http://www.businessinsider.com/r-trump-fbi-nominees-corporate-legal-work-could-exclude-him-from-some-probes-2017-6
330.0,6/8/2017 10:06:03 AM,"Actelion antibiotic misses mark on one study, hits it on another (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-antibiotic-misses-mark-on-one-study-hits-it-on-another-2017-6
331.0,6/8/2017 1:20:08 PM,"EU mergers and takeovers (June 8) (RTO, DD, FMC, BNP, CBK, SAZ, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, GLE,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-8-2017-6
332.0,6/8/2017 11:32:08 PM,"UPDATE 1-U.S. FDA asks Endo to withdraw Opana ER opioid; shares fall (ENDP, TEVA, JNJ, AGN)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-asks-endo-to-withdraw-opana-er-opioid-shares-fall-2017-6
333.0,6/9/2017 1:32:05 PM,EU approves J&J purchase of Actelion subject to conditions (JNJ),Reuters,http://www.businessinsider.com/r-eu-approves-jj-purchase-of-actelion-subject-to-conditions-2017-6
334.0,6/9/2017 4:58:05 PM,BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment (JNJ),Reuters,http://www.businessinsider.com/r-brief-clinicaltrialsgov-says-janssens-study-of-niraparib-suspends-recruitment-2017-6
335.0,6/9/2017 5:30:00 PM,"Johnson & Johnson Announces Expected Settlement of Actelion Tender Offer on June 16, 2017",PR Newswire,/news/stocks/johnson-johnson-announces-expected-settlement-of-actelion-tender-offer-on-june-16-2017-1002082475
336.0,6/9/2017 5:58:05 PM,Johnson & Johnson expects to complete of Actelion offer on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-expects-to-complete-of-actelion-offer-on-june-16-2017-6
337.0,6/9/2017 6:28:05 PM,UPDATE 1-Johnson & Johnson expects to complete Actelion purchase on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-expects-to-complete-actelion-purchase-on-june-16-2017-6
338.0,6/9/2017 6:52:03 PM,"BRIEF-J&J Spokesperson says study enrollment in Niraparib is on temporary hold, anticipates re-opening enrollment soon ‚Äç‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-spokesperson-says-study-enrollment-in-niraparib-is-on-temporary-hold-anticipates-re-opening-enrollment-soon--2017-6
339.0,6/9/2017 6:52:03 PM,"EU mergers and takeovers (June 9) (JNJ, GS, RF, FMC, DD, EDF, QCOM, NXPI, IJ, RHI, MAGG3, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, BNP, GLE, DG, DUFN,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-9-2017-6
340.0,6/9/2017 8:34:05 PM,"BRIEF-Johnson & Johnson says expects settlement of Actelion tender offer on June 16, 2017 (JNJ)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-expects-settlement-of-actelion-tender-offer-on-june-16-2017-2017-6
341.0,6/12/2017 12:54:05 PM,BRIEF-Tesaro says Janssen updated clinicaltrials.gov website to reflect janssen had placed temporary enrollment hold in the galahad ‚Äç‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-tesaro-says-janssen-updated-clinicaltrialsgov-website-to-reflect-janssen-had-placed-temporary-enrollment-hold-in-the-galahad--2017-6
342.0,6/12/2017 1:48:04 PM,"BRIEF-Qualcomm announces agreement with Lifescan Inc (QCOM, JNJ)",Reuters,http://www.businessinsider.com/r-brief-qualcomm-announces-agreement-with-lifescan-inc-2017-6
343.0,6/12/2017 5:08:03 PM,"BRIEF-Metlife names Susan Podlogar Chief Human Resources Officer (MET, JNJ)",Reuters,http://www.businessinsider.com/r-brief-metlife-names-susan-podlogar-chief-human-resources-officer-2017-6
344.0,6/12/2017 11:12:05 PM,"Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6
345.0,6/12/2017 11:52:03 PM,"UPDATE 1-Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6
346.0,6/13/2017 12:30:07 AM,"J&J diabetes drug shows heart benefit in large safety study (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-jj-diabetes-drug-shows-heart-benefit-in-large-safety-study-2017-6
347.0,6/13/2017 3:15:13 AM,J&J And Bayer Win Second Trial On Xarelto Bleeding Risks ,RTTNews,/news/stocks/j-j-and-bayer-win-second-trial-on-xarelto-bleeding-risks-1002087149
348.0,6/13/2017 3:26:08 PM,BRIEF-Pulmatrix licenses novel drug candidates from Respivert (JNJ),Reuters,http://www.businessinsider.com/r-brief-pulmatrix-licenses-novel-drug-candidates-from-respivert-2017-6
349.0,6/14/2017 1:18:03 PM,Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6
350.0,6/14/2017 1:18:03 PM,"BRIEF-Janssen says Phase 3 data shows anti-TNF Alpha Simponi Aria significantly improved arthritis, skin manifestations (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-says-phase-3-data-shows-anti-tnf-alpha-simponi-aria-significantly-improved-arthritis-skin-manifestations-2017-6
351.0,6/14/2017 1:28:06 PM,"BRIEF-J&J says Pimodivir alone or in combination with oseltamivir demonstrated a significant reduction in viral load in adults with Influenza A (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-brief-jj-says-pimodivir-alone-or-in-combination-with-oseltamivir-demonstrated-a-significant-reduction-in-viral-load-in-adults-with-influenza-a-2017-6
352.0,6/14/2017 1:48:06 PM,"UPDATE 1-Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-update-1-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6
353.0,6/14/2017 2:34:07 PM,BRIEF-Johnson & Johnson says are working with medical University of South Carolina (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-are-working-with-medical-university-of-south-carolina-2017-6
354.0,6/14/2017 4:10:07 PM,"US STOCKS-Wall St flat as banks fall after weak data; Fed eyed (JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-banks-fall-after-weak-data-fed-eyed-2017-6
355.0,6/14/2017 5:32:03 PM,"US STOCKS-Weak data weighs on bank stocks; Fed rate decision looms (XOM, CVX, JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-data-weighs-on-bank-stocks-fed-rate-decision-looms-2017-6
356.0,6/14/2017 6:44:14 PM,BRIEF-Janssen presents long term phase 3 efficacy and safety data of Sirukumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-presents-long-term-phase-3-efficacy-and-safety-data-of-sirukumab-2017-6
357.0,6/14/2017 6:58:05 PM,"US STOCKS-Oil drop, weak data weigh on Wall St; Fed move looms (XOM, CVX, JNJ, ALXN, BIIB, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-oil-drop-weak-data-weigh-on-wall-st-fed-move-looms-2017-6
358.0,6/14/2017 10:46:04 PM,BRIEF-Minerva Neurosciences enters amendment to co-development and license agreement with Janssen Pharmaceutica NV (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-enters-amendment-to-co-development-and-license-agreement-with-janssen-pharmaceutica-nv-2017-6
359.0,6/15/2017 1:04:03 AM,"Google bets on European biotech drugs, backs new fund (GSK, SAN, JNJ, AAPL, MSFT, GEN)",Reuters,http://www.businessinsider.com/r-google-bets-on-european-biotech-drugs-backs-new-fund-2017-6
360.0,6/15/2017 8:08:03 PM,"U.S. state attorneys general probe opioid drug companies (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-us-state-attorneys-general-probe-opioid-drug-companies-2017-6
361.0,6/16/2017 7:10:19 AM,Johnson & Johnson Closes Acquisition Of Actelion ,RTTNews,/news/stocks/johnson-johnson-closes-acquisition-of-actelion-1002098255
362.0,6/16/2017 9:38:05 AM,Actelion spin-off Idorsia makes market debut at 10 Sfr per share (JNJ),Reuters,http://www.businessinsider.com/r-actelion-spin-off-idorsia-makes-market-debut-at-10-sfr-per-share-2017-6
363.0,6/16/2017 7:54:06 PM,"BRIEF-Genmab says U.S. FDA approves darzalex in combination with pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-us-fda-approves-darzalex-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma-2017-6
364.0,6/20/2017 2:00:00 PM,"Douglas Wallace, Ph.D., Wins 2017 Dr. Paul Janssen Award for Biomedical Research",PR Newswire,/news/stocks/douglas-wallace-ph-d-wins-2017-dr-paul-janssen-award-for-biomedical-research-1002107304
365.0,6/20/2017 4:42:05 PM,"Exxon, BP support Republican elders' climate proposal (XOM, RDSA, FP, GM, JNJ, PEP, BP.)",Reuters,http://www.businessinsider.com/r-exxon-bp-support-republican-elders-climate-proposal-2017-6
366.0,6/20/2017 10:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1002109462
367.0,6/21/2017 1:18:03 AM,"U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6
368.0,6/21/2017 1:10:09 PM,"RPT-U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-rpt-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6
369.0,6/21/2017 4:00:00 PM,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,PR Newswire,/news/stocks/s-p-500-buybacks-fall-17-5-year-over-year-to-133-1-billion-for-q1-2017-1002112472
370.0,6/21/2017 4:02:05 PM,"US STOCKS-Wall St slightly higher on healthcare; oil steadies (UNH, JNJ, ADBE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-higher-on-healthcare-oil-steadies-2017-6
371.0,6/21/2017 4:12:07 PM,"Missouri attorney general sues opioid manufacturers (JNJ, ENDP)",Reuters,http://www.businessinsider.com/r-missouri-attorney-general-sues-opioid-manufacturers-2017-6
372.0,6/21/2017 5:30:03 PM,"UPDATE 1-Missouri attorney general sues opioid manufacturers (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-missouri-attorney-general-sues-opioid-manufacturers-2017-6
373.0,6/22/2017 2:04:00 PM,Johnson & Johnson Releases 2016 Health for Humanity Report,PR Newswire,/news/stocks/johnson-johnson-releases-2016-health-for-humanity-report-1002115911
374.0,6/22/2017 5:42:03 PM,"US STOCKS-Gains in healthcare stocks lift Wall Street (UNH, JNJ, GILD, ACN)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-healthcare-stocks-lift-wall-street-2017-6
375.0,6/22/2017 7:18:05 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (UNH, JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6
376.0,6/22/2017 9:10:08 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6
377.0,6/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-pfizer-merck-abbvie-and-johnson-johnson-1002123019
378.0,6/28/2017 2:54:03 PM,BRIEF-FDA grants priority review of Xarelto SNDA to reduce risk of recurrent VTE (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-grants-priority-review-of-xarelto-snda-to-reduce-risk-of-recurrent-vte-2017-6
379.0,6/29/2017 4:52:03 PM,BRIEF-Depuy Synthes announces U.S. Launch of Viper and Expedium Fenestrated Screw Systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-announces-us-launch-of-viper-and-expedium-fenestrated-screw-systems-2017-6
380.0,6/29/2017 6:26:06 PM,"U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6
381.0,6/29/2017 10:00:03 PM,"UPDATE 1-U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-update-1-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6
382.0,7/3/2017 8:24:06 AM,"RPT-Big pharma turns to AI to speed drug discovery, GSK signs deal (GSK, MRK, JNJ, SAN, PFE)",Reuters,http://www.businessinsider.com/r-rpt-big-pharma-turns-to-ai-to-speed-drug-discovery-gsk-signs-deal-2017-7
383.0,7/4/2017 11:38:03 AM,Australian class action suit filed against Johnson & Johnson over pelvic mesh (JNJ),Reuters,http://www.businessinsider.com/r-australian-class-action-suit-filed-against-johnson--johnson-over-pelvic-mesh-2017-7
384.0,7/6/2017 4:36:05 PM,"Robot wars: knee surgery marks new battleground for companies (SYK, SN., ISRG, JNJ)",Reuters,http://www.businessinsider.com/r-robot-wars-knee-surgery-marks-new-battleground-for-companies-2017-7
385.0,7/7/2017 12:48:03 AM,BRIEF-Capricor Therapeutics retains full rights to CAP-1002 as Janssen Biotech decides not to exercise option (JNJ),Reuters,http://www.businessinsider.com/r-brief-capricor-therapeutics-retains-full-rights-to-cap-1002-as-janssen-biotech-decides-not-to-exercise-option-2017-7
386.0,7/8/2017 8:38:00 AM,Commercial Hydrogen Announces New Board Member,PR Newswire,/news/stocks/commercial-hydrogen-announces-new-board-member-1001831570
387.0,7/10/2017 5:40:03 PM,"US STOCKS-Gains in technology stocks prop up Wall St (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-technology-stocks-prop-up-wall-st-2017-7
388.0,7/10/2017 6:52:03 PM,"US STOCKS- Wall St up as technology shares hold gains (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, AMZN, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks--wall-st-up-as-technology-shares-hold-gains-2017-7
389.0,7/10/2017 10:04:08 PM,"Arena's heart-lung drug meets main goal in mid-stage study (ARNA, JNJ, 4523)",Reuters,http://www.businessinsider.com/r-arenas-heart-lung-drug-meets-main-goal-in-mid-stage-study-2017-7
390.0,7/10/2017 10:46:11 PM,"Here‚Äôs how much the 10 largest pharmaceutical companies spend on R&D (PFE, AMGN, NVS, ROG, MRK, SNY, JNJ, GILD, GSK, ABBV)",Business Insider,http://www.businessinsider.com/largest-pharmaceutical-companies-by-prescription-sales-and-rd-2017-7
391.0,7/11/2017 1:40:07 AM,"FBI director nominee Wray earned $9.2 million in law practice last year (WFC, JNJ, HIL, STI, AAPL, WMT, XOM)",Reuters,http://www.businessinsider.com/r-fbi-director-nominee-wray-earned-92-million-in-law-practice-last-year-2017-7
392.0,7/11/2017 7:34:05 AM,"Sanofi to buy vaccines biotech group Protein Sciences (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-sanofi-to-buy-vaccines-biotech-group-protein-sciences-2017-7
393.0,7/13/2017 5:30:08 PM,"US STOCKS-Wall St flat as focus shifts to quarterly earnings (AMZN, MCD, JNJ, CELG, JPM, WFC, C, TGT, WMT, COST, YNDX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-focus-shifts-to-quarterly-earnings-2017-7
394.0,7/13/2017 10:18:06 PM,BRIEF-Janssen announces FDA approval of Tremfya (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-tremfya-2017-7
395.0,7/14/2017 4:00:31 AM,FDA Oks Janssen' Tremfya To Treat Moderate To Severe Plaque Psoriasis ,RTTNews,/news/stocks/fda-oks-janssen-tremfya-to-treat-moderate-to-severe-plaque-psoriasis-1002173036
396.0,7/14/2017 11:42:03 AM,"BRIEF-Morphosys CEO sees 5 months of guselkumab royalties this year (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-ceo-sees-5-months-of-guselkumab-royalties-this-year-2017-7
397.0,7/14/2017 1:48:03 PM,"Novartis stocks drug cabinet with ""Big-3"" arthritis blockbusters (AMGN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-novartis-stocks-drug-cabinet-with-big-3-arthritis-blockbusters-2017-7
398.0,7/14/2017 7:01:00 PM,"Affinion Group, Inc. to Hold Informational Call to Discuss Results for the Quarter Ended June 30, 2017",PR Newswire,/news/stocks/affinion-group-inc-to-hold-informational-call-to-discuss-results-for-the-quarter-ended-june-30-2017-1001855621
399.0,7/17/2017 1:26:05 PM,"US STOCKS-Futures little changed ahead of big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-little-changed-ahead-of-big-earnings-2017-7
400.0,7/17/2017 2:52:11 PM,"US STOCKS-Wall St set to open flat in run-up to big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-in-run-up-to-big-earnings-2017-7
401.0,7/17/2017 3:54:09 PM,"US STOCKS-Wall St opens flat as investors await big earnings (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-flat-as-investors-await-big-earnings-2017-7
402.0,7/17/2017 5:12:03 PM,"US STOCKS-Wall St holds steady as investors await big earnings (MSFT, IBM, JNJ, NFLX, AAPL, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-holds-steady-as-investors-await-big-earnings-2017-7
403.0,7/17/2017 7:02:03 PM,"US STOCKS-Wall St slightly up as earnings season picks up pace (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-up-as-earnings-season-picks-up-pace-2017-7
404.0,7/17/2017 7:08:08 PM,BRIEF-J&J sets quarterly cash dividend of $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-084-per-share-2017-7
405.0,7/18/2017 12:46:20 PM,Johnson & Johnson Q2 Earnings Rise 3%,RTTNews,/news/stocks/johnson-johnson-q2-earnings-rise-3-1002181984
406.0,7/18/2017 1:06:13 PM,BRIEF-Johnson & Johnson Q2 earnings per share $1.40 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q2-earnings-per-share-140-2017-7
407.0,7/18/2017 1:06:13 PM,J&J reports dip in quarterly profit (JNJ),Reuters,http://www.businessinsider.com/r-jj-reports-dip-in-quarterly-profit-2017-7
408.0,7/18/2017 1:19:46 PM,Genmab To Receive Royalties On DARZALEX Sales From Janssen Biotech - Quick Facts ,RTTNews,/news/stocks/genmab-to-receive-royalties-on-darzalex-sales-from-janssen-biotech-quick-facts-1002182141
409.0,7/18/2017 1:22:08 PM,UPDATE 1-J&J raises 2017 profit forecast; Q2 earnings beat Street (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-raises-2017-profit-forecast-q2-earnings-beat-street-2017-7
410.0,7/18/2017 1:22:08 PM,"US STOCKS-Futures flat as investors gauge big companies' earnings (UNH, JNJ, IBM, UAL, NFLX, BAC, JPM, WFC, C, HOG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-gauge-big-companies-earnings-2017-7
411.0,7/18/2017 1:36:13 PM,"Johnson & Johnson Q2 Profit Down, But Adj. EPS Tops View; Lifts 2017 Outlook ",RTTNews,/news/stocks/johnson-johnson-q2-profit-down-but-adj-eps-tops-view-lifts-2017-outlook-1002182245
412.0,7/18/2017 3:08:04 PM,"US STOCKS-Wall St set to open lower on tepid earnings, policy gridlock (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-on-tepid-earnings-policy-gridlock-2017-7
413.0,7/18/2017 3:52:08 PM,"US STOCKS-Wall St opens lower on dull earnings, healthcare logjam (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-lower-on-dull-earnings-healthcare-logjam-2017-7
414.0,7/18/2017 10:58:03 PM,"US STOCKS-Nasdaq hits record on Netflix boost; Dow dragged by Goldman (GS, NFLX, JNJ, HOG, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-hits-record-on-netflix-boost-dow-dragged-by-goldman-2017-7
415.0,7/19/2017 11:58:08 AM,"UPDATE 1-China adds blockbuster drugs to insurance list after price cuts (CELG, JNJ, AZN, NOVO )",Reuters,http://www.businessinsider.com/r-update-1-china-adds-blockbuster-drugs-to-insurance-list-after-price-cuts-2017-7
416.0,7/21/2017 1:28:05 PM,BRIEF-EU Medicines Agency recommends approval J&J unit's Symtuza drug for HIV (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-recommends-approval-jj-units-symtuza-drug-for-hiv-2017-7
417.0,7/21/2017 1:48:03 PM,Janssen-Cilag's HIV drug gets EU regulatory panel's nod (JNJ),Reuters,http://www.businessinsider.com/r-janssen-cilags-hiv-drug-gets-eu-regulatory-panels-nod-2017-7
418.0,7/24/2017 10:28:08 AM,BRIEF-Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-encouraging-first-in-human-clinical-data-for-investigational-hiv-preventive-vaccine-2017-7
419.0,7/24/2017 10:28:09 AM,"HIV fight advances with new drug cocktails, fresh vaccine hopes (GILD, GSK, MRK, JNJ)",Reuters,http://www.businessinsider.com/r-hiv-fight-advances-with-new-drug-cocktails-fresh-vaccine-hopes-2017-7
420.0,7/24/2017 2:02:05 PM,"Samsung Bioepis launches U.S. sales of Remicade biosmiliar (JNJ, PFE, AZN)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-launches-us-sales-of-remicade-biosmiliar-2017-7
421.0,7/24/2017 5:40:07 PM,"US STOCKS-S&P, Dow lower as Johnson & Johnson drags (JNJ, AMZN, HAL, CALM, WBMD, KKR)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-johnson--johnson-drags-2017-7
422.0,7/24/2017 6:34:03 PM,"GLOBAL MARKETS-U.S. dollar, bond yields climb, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-climb-with-focus-on-fed-2017-7
423.0,7/24/2017 7:04:03 PM,"UPDATE 1-Merck, Samsung Bioepis launch discounted U.S. Remicade alternative (MRK, JNJ, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-merck-samsung-bioepis-launch-discounted-us-remicade-alternative-2017-7
424.0,7/24/2017 7:08:03 PM,"US STOCKS-S&P, Dow lower as J&J drags; Nasdaq hits record (JNJ, HAL, CALM, HIBB, DKS, FL, FINL, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-jj-drags-nasdaq-hits-record-2017-7
425.0,7/24/2017 9:18:08 PM,"GLOBAL MARKETS-U.S. dollar, bond yields edge up, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-edge-up-with-focus-on-fed-2017-7
426.0,7/24/2017 10:32:03 PM,"US STOCKS-Nasdaq, tech shine as earnings pick up; Dow, S&P lag (NFLX, AMZN, JNJ, HAL, HIBB, DKS, FL, FINL)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-tech-shine-as-earnings-pick-up-dow-sp-lag-2017-7
427.0,7/25/2017 6:40:05 AM,"PRESS DIGEST- Wall Street Journal - July 25 (005930, JNJ, DAI, BKS)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---july-25-2017-7
428.0,7/25/2017 2:58:03 PM,BRIEF-Janssen announces Phase 3 pivotal study results for darunavir-based complete treatment regimen (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-phase-3-pivotal-study-results-for-darunavir-based-complete-treatment-regimen-2017-7
429.0,7/25/2017 8:38:00 PM,"Report: More than 15,000 Adverse Events Linked to Xarelto in 2016",PR Newswire,/news/stocks/report-more-than-15-000-adverse-events-linked-to-xarelto-in-2016-1002203317
430.0,7/27/2017 10:54:03 AM,"UPDATE 1-Bavarian expands J&J deal to HIV and hepatitis B vaccines, shares jump (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-expands-jj-deal-to-hiv-and-hepatitis-b-vaccines-shares-jump-2017-7
431.0,7/27/2017 5:22:06 PM,"US STOCKS-Wall St adds to record rally on strong earnings (VZ, AMGN, JNJ, CELG, UPS, AMZN, INTC, SBUX, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-adds-to-record-rally-on-strong-earnings-2017-7
432.0,7/27/2017 7:14:08 PM,"US STOCKS-Wall St trims gains as tech stocks weigh (AAPL, VZ, AMZN, INTC, AMGN, JNJ, CELG, UPS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-trims-gains-as-tech-stocks-weigh-2017-7
433.0,7/27/2017 7:42:05 PM,"U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7
434.0,7/27/2017 9:12:08 PM,"UPDATE 1-U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7
435.0,7/28/2017 2:24:06 PM,"UPDATE 1-AbbVie's profit beats on robust Humira demand (AMGN, CHRS, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbvies-profit-beats-on-robust-humira-demand-2017-7
436.0,7/31/2017 2:42:03 PM,J&J arthritis drug sirukumab raises safety concerns - FDA staff (JNJ),Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-sirukumab-raises-safety-concerns---fda-staff-2017-7
437.0,7/31/2017 3:00:04 PM,"UPDATE 1-J&J arthritis drug sirukumab raises safety concerns -FDA staff (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-jj-arthritis-drug-sirukumab-raises-safety-concerns--fda-staff-2017-7
438.0,8/2/2017 9:52:03 PM,U.S. FDA panel votes against approval of J&J arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-panel-votes-against-approval-of-jj-arthritis-drug-2017-8
439.0,8/3/2017 6:48:01 AM,"FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps ",RTTNews,/news/stocks/fda-panel-snubs-jnj-chmp-seeks-more-data-from-pbyi-tbph-on-watch-agrx-slumps-1002228543
440.0,8/4/2017 8:17:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-barclays-global-consumer-staples-conference-552971
441.0,8/4/2017 8:28:00 PM,Johnson & Johnson to Participate in the 2017 Wells Fargo 12th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-wells-fargo-12th-annual-healthcare-conference-1001938540
442.0,8/4/2017 10:57:08 PM,"Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8
443.0,8/6/2017 7:02:03 PM,"RPT-Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-rpt-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8
444.0,8/7/2017 3:32:06 PM,BRIEF-DePuy Synthes collaborates with Medical Enterprises Distribution to co-market ME1000 (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-collaborates-with-medical-enterprises-distribution-to-co-market-me1000-2017-8
445.0,8/8/2017 9:02:03 PM,"US STOCKS-Wall Street clings to gains with tech leading (AAPL, JNJ, WFC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-clings-to-gains-with-tech-leading-2017-8
446.0,8/9/2017 8:17:03 PM,"BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8
447.0,8/10/2017 7:42:03 AM,"RPT-BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8
448.0,8/10/2017 12:15:00 PM,"Technical Snapshots for These Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/technical-snapshots-for-these-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002247897
449.0,8/10/2017 2:02:03 PM,"How AI robots hunt new drugs for crippling nerve disease (IBM, GSK, JNJ, SAN, MRK, MSFT)",Reuters,http://www.businessinsider.com/r-how-ai-robots-hunt-new-drugs-for-crippling-nerve-disease-2017-8
450.0,8/10/2017 7:42:05 PM,"BUZZ- DJI: From hot to not (BA, AAPL, GS, MCD, JNJ, KO, UKX)",Reuters,http://www.businessinsider.com/r-buzz--dji-from-hot-to-not-2017-8
451.0,8/14/2017 2:27:08 PM,BRIEF-Cerecor Inc Q2 loss per share $0.14 (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerecor-inc-q2-loss-per-share-014-2017-8
452.0,8/14/2017 3:47:00 PM,Johnson & Johnson to Participate in 2017 Morgan Stanley Global Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-2017-morgan-stanley-global-health-care-conference-1002255625
453.0,8/16/2017 3:12:06 PM,India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-india-introduces-price-controls-for-knee-implants-2017-8
454.0,8/16/2017 5:57:05 PM,UPDATE 1-India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-india-introduces-price-controls-for-knee-implants-2017-8
455.0,8/16/2017 7:42:10 PM,BRIEF-J&J says leaving White House manufacturing council (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-leaving-white-house-manufacturing-council-2017-8
456.0,8/18/2017 11:37:17 PM,"Bayer, J&J win third U.S. trial over Xarelto bleeding risk (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-third-us-trial-over-xarelto-bleeding-risk-2017-8
457.0,8/21/2017 7:52:16 PM,J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8
458.0,8/21/2017 8:22:10 PM,UPDATE 1-J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8
459.0,8/21/2017 11:59:52 PM,JNJ To Pay Dearly For Talc-cancer Connection ,RTTNews,/news/stocks/jnj-to-pay-dearly-for-talc-cancer-connection-1002273437
460.0,8/22/2017 7:22:03 AM,"PRESS DIGEST-New York Times business news - Aug 22 (VZ, S, T, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest-new-york-times-business-news---aug-22-2017-8
461.0,8/24/2017 7:42:03 AM,"Swiss stocks - Factors to watch on Aug 24 (PFE, JNJ, VONN, SPSN, IMPN, KOMN, WARN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-aug-24-2017-8
462.0,8/24/2017 5:12:03 PM,"CORRECTED-Florida set to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-florida-set-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8
463.0,8/24/2017 10:22:16 PM,BRIEF-Protagonist Therapeutics announces closing of Janssen license (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-announces-closing-of-janssen-license-2017-8
464.0,8/24/2017 11:07:15 PM,"UPDATE 1-Florida to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-florida-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8
465.0,8/25/2017 3:52:03 AM,"Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8
466.0,8/25/2017 7:02:04 AM,"UPDATE 1-Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8
467.0,8/25/2017 1:07:03 PM,"Bavarian Nordic says first milestone payment under new J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-bavarian-nordic-says-first-milestone-payment-under-new-jj-deal-could-be-in-2019-2017-8
468.0,8/25/2017 1:57:03 PM,"UPDATE 1-Bavarian Nordic says first milestone payment under J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-nordic-says-first-milestone-payment-under-jj-deal-could-be-in-2019-2017-8
469.0,8/25/2017 2:42:05 PM,BRIEF-Minerva Neurosciences announces European Commission approval of amendment of MIN-202 agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-announces-european-commission-approval-of-amendment-of-min-202-agreement-with-janssen-2017-8
470.0,8/25/2017 5:27:11 PM,Florida Execution Using New Anesthetic Drug Turns Controversial ,RTTNews,/news/stocks/florida-execution-using-new-anesthetic-drug-turns-controversial-1002285787
471.0,8/27/2017 11:27:08 AM,"Bayer, J&J in frame for bigger anti-clotting market opportunity (BAYN, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-jj-in-frame-for-bigger-anti-clotting-market-opportunity-2017-8
472.0,8/29/2017 2:23:52 PM,Biotech Stocks Facing FDA Decision In September ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-1002291346
473.0,8/30/2017 3:42:03 PM,"BUZZ- DJI tight range nears end (, , BA, AAPL, MCD, IBM, GS, UKX, KO, JNJ)",Reuters,http://www.businessinsider.com/r-buzz--dji-tight-range-nears-end-2017-8
474.0,8/31/2017 10:57:08 PM,BRIEF-Macrogenics announces termination of duvortuxizumab collaboration (JNJ),Reuters,http://www.businessinsider.com/r-brief-macrogenics-announces-termination-of-duvortuxizumab-collaboration-2017-8
475.0,9/5/2017 3:05:00 PM,National Awards Program Seeking North Carolina's Top Youth Volunteers Of 2018,PR Newswire,/news/stocks/national-awards-program-seeking-north-carolina-s-top-youth-volunteers-of-2018-1001630845
476.0,9/7/2017 9:22:14 PM,"New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9
477.0,9/7/2017 10:02:12 PM,"UPDATE 1-New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9
478.0,9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9
479.0,9/11/2017 8:04:00 AM,Johnson & Johnson Consumer Inc. Debuts New Scientific Data at the European Academy of Dermatology and Venerology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-debuts-new-scientific-data-at-the-european-academy-of-dermatology-and-venerology-annual-meeting-1002356606
480.0,9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9
481.0,9/11/2017 10:07:03 AM,"BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-termination-of-worldwide-collaboration-for-hepatitis-c-with-janssen-2017-9
482.0,9/11/2017 12:03:25 PM,Medivir Stock Down As Janssen To Discontinue Development Of JNJ-4178 ,RTTNews,/news/stocks/medivir-stock-down-as-janssen-to-discontinue-development-of-jnj-4178-1002357446
483.0,9/11/2017 1:52:35 PM,Integra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical ,RTTNews,/news/stocks/integra-lifesciences-to-sell-certain-neurosurgery-assets-to-natus-medical-1002357885
484.0,9/13/2017 12:25:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002365439
485.0,9/13/2017 3:00:00 PM,Johnson & Johnson Launches Dr. Paul Janssen Project to Catalyze and Convene Champions of Science Across Generations and Geographies,PR Newswire,/news/stocks/johnson-johnson-launches-dr-paul-janssen-project-to-catalyze-and-convene-champions-of-science-across-generations-and-geographies-1002366163
486.0,9/14/2017 10:02:03 AM,"Astra's Farxiga results may open up type 1 diabetes opportunity (AZN, LLY, JNJ)",Reuters,http://www.businessinsider.com/r-astras-farxiga-results-may-open-up-type-1-diabetes-opportunity-2017-9
487.0,9/14/2017 5:32:03 PM,"UPDATE 3-Pfizer, Astellas prostate cancer drug promising in late-stage trial (PFE, 4503, JNJ)",Reuters,http://www.businessinsider.com/r-update-3-pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-2017-9
488.0,9/14/2017 10:32:16 PM,BRIEF-Janssen submits supplemental New Drug Application to U.S. FDA for Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-us-fda-for-zytiga-2017-9
489.0,9/14/2017 11:15:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-&-johnson-to-host-investor-conference-call-on-third-quarter-results-675144
490.0,9/15/2017 1:57:03 PM,BRIEF-EU Medicines Agency publishes recommendations for Sept 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-publishes-recommendations-for-sept-2017-2017-9
491.0,9/15/2017 2:07:03 PM,European panel recommends approval of J&J's psoriasis drug (JNJ),Reuters,http://www.businessinsider.com/r-european-panel-recommends-approval-of-jjs-psoriasis-drug-2017-9
492.0,9/15/2017 2:12:03 PM,"Samsung Bioepis wins EU endorsement for first Herceptin copy (MYL, BIOCON, 068270, AMGN, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-wins-eu-endorsement-for-first-herceptin-copy-2017-9
493.0,9/15/2017 2:42:10 PM,"UPDATE 1-European panel backs Janssen's psoriasis drug (JNJ, MOR)",Reuters,http://www.businessinsider.com/r-update-1-european-panel-backs-janssens-psoriasis-drug-2017-9
494.0,9/18/2017 4:00:00 PM,"Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion",PR Newswire,/news/stocks/q2-2017-s-p-500-buybacks-fall-9-8-from-q1-to-120-1-billion-1002379146
495.0,9/19/2017 6:42:09 PM,"BRIEF-NY A.G. Schneiderman, coalition of AGs expand investigation into opioid crisis (AGN, ENDP, JNJ, TEVA, ABC, CAH, MCK)",Reuters,http://www.businessinsider.com/r-brief-ny-ag-schneiderman-coalition-of-ags-expand-investigation-into-opioid-crisis-2017-9
496.0,9/20/2017 3:22:17 PM,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra ,RTTNews,/news/stocks/pfe-claims-j-j-engaged-in-unlawful-conduct-to-stifle-competition-from-inflectra-1002387484
497.0,9/20/2017 3:42:03 PM,"BRIEF-‚ÄçPfizer files lawsuit against Johnson & Johnson‚Äã (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-files-lawsuit-against-johnson--johnson-2017-9
498.0,9/20/2017 3:47:03 PM,"Pfizer sues Johnson & Johnson over Remicade biosimilar (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-pfizer-sues-johnson--johnson-over-remicade-biosimilar-2017-9
499.0,9/20/2017 4:22:03 PM,"UPDATE 1-Pfizer files suit against J&J over Remicade contracts (PFE, JNJ, UNH, AET, CI)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-files-suit-against-jj-over-remicade-contracts-2017-9
500.0,9/21/2017 7:01:37 AM,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ ",RTTNews,/news/stocks/fda-nod-for-abmd-aeri-faces-fda-panel-in-oct-ipci-put-on-notice-pfe-sues-jnj-1002392403
501.0,9/21/2017 7:02:03 AM,"PRESS DIGEST - Wall Street Journal - Sept 21 (2498, 6502, AAPL, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---sept-21-2017-9
502.0,9/21/2017 1:52:03 PM,BRIEF-Provention Bio announces licensing agreements with Janssen for two clinical-stage immunology assets (JNJ),Reuters,http://www.businessinsider.com/r-brief-provention-bio-announces-licensing-agreements-with-janssen-for-two-clinical-stage-immunology-assets-2017-9
503.0,9/21/2017 3:07:03 PM,"YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-your-money-three-tips-for-smart-dividend-etf-plays-2017-9
504.0,9/22/2017 12:12:14 AM,"RPT-YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-rpt-your-money-three-tips-for-smart-dividend-etf-plays-2017-9
505.0,9/22/2017 10:37:21 PM,U.S. FDA rejects J&J's arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-rejects-jjs-arthritis-drug-2017-9
506.0,9/22/2017 11:02:07 PM,"UPDATE 1-U.S. FDA declines to approve J&J arthritis drug (JNJ, SAN, REGN, LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-declines-to-approve-jj-arthritis-drug-2017-9
507.0,9/26/2017 11:52:12 PM,"U.S. picks companies to help make rules for advanced personal health monitors (AAPL, DXCM, 005930, JNJ)",Reuters,http://www.businessinsider.com/r-us-picks-companies-to-help-make-rules-for-advanced-personal-health-monitors-2017-9
508.0,9/27/2017 5:27:06 PM,"FTC allows Integra to buy J&J‚Äôs Codman neuro business, with conditions (IART, JNJ)",Reuters,http://www.businessinsider.com/r-ftc-allows-integra-to-buy-jjs-codman-neuro-business-with-conditions-2017-9
509.0,9/27/2017 6:02:03 PM,"UPDATE 1-U.S. FTC approves Integra purchase of J&J‚Äôs Codman business (IART, JNJ, BABY)",Reuters,http://www.businessinsider.com/r-update-1-us-ftc-approves-integra-purchase-of-jjs-codman-business-2017-9
510.0,9/28/2017 7:52:12 PM,"UPDATE 1-Washington state sues opioid manufacturer Purdue Pharma (TEVA, JNJ, ENDP, AGN)",Reuters,http://www.businessinsider.com/r-update-1-washington-state-sues-opioid-manufacturer-purdue-pharma-2017-9
511.0,9/28/2017 8:27:17 PM,"UPDATE 1-Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR, QDEL, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9
512.0,9/29/2017 1:52:13 PM,Biotech Stocks Facing FDA Decision In October ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-october-1002845284
513.0,9/29/2017 2:07:03 PM,"Merck to stop development of hepatitis C treatments (MRK, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-merck-to-stop-development-of-hepatitis-c-treatments-2017-9
514.0,9/29/2017 6:22:03 PM,"US invests $170 million in late-stage Ebola vaccines, drugs (MRK, JNJ, REGN)",Reuters,http://www.businessinsider.com/r-us-invests-170-million-in-late-stage-ebola-vaccines-drugs-2017-9
515.0,10/2/2017 2:22:03 PM,BRIEF-Janssen submits supplemental new drug application to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-fda-2017-10
516.0,10/2/2017 5:52:06 PM,"US STOCKS-Wall Street hits record high on boost from tech, healthcare (JNJ, GILD, MSFT, INTC, XOM, CVX, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-hits-record-high-on-boost-from-tech-healthcare-2017-10
517.0,10/2/2017 7:22:05 PM,"US STOCKS-S&P, Dow at record highs as financials, healthcare climb (JNJ, GILD, JPM, C, XOM, GM, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-at-record-highs-as-financials-healthcare-climb-2017-10
518.0,10/2/2017 10:01:00 PM,Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation,PR Newswire,/news/stocks/johnson-johnson-announces-completion-of-codman-neurosurgery-divestiture-to-integra-lifesciences-holding-corporation-1002055951
519.0,10/5/2017 1:22:03 PM,"BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-brief-jj-diabetes-care-company-animas-to-close-operations-and-exit-insulin-pump-market-2017-10
520.0,10/5/2017 2:37:03 PM,"J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10
521.0,10/5/2017 2:57:05 PM,"UPDATE 1-J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-update-1-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10
522.0,10/5/2017 10:27:14 PM,"BRIEF-Bayer's Navigate Esus study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayers-navigate-esus-study-halted-early-2017-10
523.0,10/6/2017 7:02:03 AM,"INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10
524.0,10/6/2017 7:37:03 AM,"RPT-INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10
525.0,10/6/2017 7:52:03 AM,"Bayer says Phase III Xarelto study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-says-phase-iii-xarelto-study-halted-early-2017-10
526.0,10/6/2017 9:57:08 AM,"BRIEF-Bayer keeps forecast for peak Xarelto annual sales (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-keeps-forecast-for-peak-xarelto-annual-sales-2017-10
527.0,10/6/2017 10:52:03 AM,"UPDATE 1-Bayer sticks by Xarelto sales estimate despite study setback (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-sticks-by-xarelto-sales-estimate-despite-study-setback-2017-10
528.0,10/11/2017 3:42:03 PM,BRIEF-Janssen submits NDA for Apalutamide(ARN-509) to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-nda-for-apalutamidearn-509-to-fda-2017-10
529.0,10/11/2017 4:07:03 PM,"US STOCKS-Wall St treads water; financials drop ahead of reports (KR, JPM, C, GE, JNJ, MU)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-treads-water-financials-drop-ahead-of-reports-2017-10
530.0,10/11/2017 5:42:04 PM,"US STOCKS-Wall St flat; financials drop ahead of earnings (JPM, C, WMT, CL, GE, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-financials-drop-ahead-of-earnings-2017-10
531.0,10/11/2017 6:19:38 PM,Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies ,RTTNews,/news/stocks/johnson-johnson-posting-notable-gain-after-upgrade-by-jefferies-1003846253
532.0,10/11/2017 7:12:08 PM,"US STOCKS-Dow inches up to record-high on gains in J&J, Wal-Mart (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-inches-up-to-record-high-on-gains-in-jj-wal-mart-2017-10
533.0,10/11/2017 9:47:03 PM,"US STOCKS-Wall St ticks higher with eyes on earnings (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-with-eyes-on-earnings-2017-10
534.0,10/11/2017 10:47:07 PM,"US STOCKS-Wall St ticks higher to record close; eyes on earnings, Fed (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-to-record-close-eyes-on-earnings-fed-2017-10
535.0,10/12/2017 4:12:03 PM,"NIH partners 11 drugmakers to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-nih-partners-11-drugmakers-to-accelerate-cancer-therapy-research-2017-10
536.0,10/12/2017 4:40:00 PM,Treasure Investments Corporation Releases Scripophily and Americana Currency Collections for Auctions,PR Newswire,/news/stocks/treasure-investments-corporation-releases-scripophily-and-americana-currency-collections-for-auctions-1001755642
537.0,10/12/2017 6:27:06 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10
538.0,10/12/2017 10:12:15 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10
539.0,10/13/2017 2:07:11 PM,"BRIEF-EU Medicines Agency provides recommendations for October 2017 (AZN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-provides-recommendations-for-october-2017-2017-10
540.0,10/13/2017 5:42:07 PM,BRIEF-CHMP issues positive opinion on Janssen‚Äôs ZYTIGA (JNJ),Reuters,http://www.businessinsider.com/r-brief-chmp-issues-positive-opinion-on-janssens-zytiga-2017-10
541.0,10/13/2017 10:27:08 PM,BRIEF-Johnson & Johnson says FDA approves Stelara for adolescents with moderate to severe plaque psoriasis (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approves-stelara-for-adolescents-with-moderate-to-severe-plaque-psoriasis-2017-10
542.0,10/13/2017 11:07:07 PM,J&J psoriasis drug gets expanded U.S. approval for teens (JNJ),Reuters,http://www.businessinsider.com/r-jj-psoriasis-drug-gets-expanded-us-approval-for-teens-2017-10
543.0,10/16/2017 9:07:13 PM,BRIEF-Cerveau Technologies announces research collaboration agreement with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerveau-technologies-announces-research-collaboration-agreement-with-janssen-pharmaceuticals-2017-10
544.0,10/17/2017 12:40:00 PM,Johnson & Johnson Reports 2017 Third-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-third-quarter-results-1004608091
545.0,10/17/2017 12:46:47 PM,Johnson & Johnson Q3 Income Rises 11%,RTTNews,/news/stocks/johnson-johnson-q3-income-rises-11-1004608117
546.0,10/17/2017 1:14:17 PM,Johnson & Johnson Lifts FY17 Forecast As Q3 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-lifts-fy17-forecast-as-q3-results-top-estimates-1004611195
547.0,10/17/2017 1:27:08 PM,"UPDATE 1-Pharma business, Actelion buy drive J&J's profit beat (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pharma-business-actelion-buy-drive-jjs-profit-beat-2017-10
548.0,10/17/2017 1:37:15 PM,"US STOCKS-Futures flat as investors assess earnings from big names (MS, GS, JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-assess-earnings-from-big-names-2017-10
549.0,10/17/2017 3:02:08 PM,"US STOCKS-Wall St set to open flat as big bank results fail to cheer (JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-as-big-bank-results-fail-to-cheer-2017-10
550.0,10/17/2017 3:22:18 PM,"J&J's Puerto Rico plants running, can't rule out shortages (JNJ)",Reuters,http://www.businessinsider.com/r-jjs-puerto-rico-plants-running-cant-rule-out-shortages-2017-10
551.0,10/17/2017 4:17:03 PM,"US STOCKS-Wall St flat as losses in financials offset healthcare gains (GS, MS, UNH, JNJ, AAPL, BA, BBD., NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-losses-in-financials-offset-healthcare-gains-2017-10
552.0,10/17/2017 5:47:03 PM,"US STOCKS-Dow breaches 23,000-mark for the first time (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-breaches-23000-mark-for-the-first-time-2017-10
553.0,10/17/2017 7:02:03 PM,J&J wins reversal of $72 million verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-wins-reversal-of-72-million-verdict-over-talc-cancer-risks-2017-10
554.0,10/17/2017 7:07:03 PM,"US STOCKS-Dow tops 23,000-mark for the first time on strong earnings (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-tops-23000-mark-for-the-first-time-on-strong-earnings-2017-10
555.0,10/17/2017 8:12:08 PM,UPDATE 1-J&J wins reversal of $72 mln verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-reversal-of-72-mln-verdict-over-talc-cancer-risks-2017-10
556.0,10/17/2017 9:37:03 PM,"US STOCKS-Dow hits 23,000-mark, then backs off (GS, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-hits-23000-mark-then-backs-off-2017-10
557.0,10/17/2017 10:47:04 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10
558.0,10/17/2017 11:37:03 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10
559.0,10/18/2017 12:22:03 AM,"US STOCKS-Dow pierces 23,000 but ends below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-ends-below-milestone-2017-10
560.0,10/18/2017 5:56:27 AM,Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict ,RTTNews,/news/stocks/johnson-johnson-wins-reversal-of-first-st-louis-talc-cancer-verdict-1004718217
561.0,10/18/2017 3:02:03 PM,BRIEF-Trovagene's PCM-075 demonstrates Synergy with Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-trovagenes-pcm-075-demonstrates-synergy-with-zytiga-2017-10
562.0,10/19/2017 12:27:18 PM,BRIEF-‚ÄçJohnson & Johnson Medical GmbH to acquire Surgical Process Institute‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-medical-gmbh-to-acquire-surgical-process-institute-2017-10
563.0,10/19/2017 12:50:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2017-1004893120
564.0,10/19/2017 1:22:07 PM,BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-arcturus-therapeutics-to-collaborate-with-johnson--johnson-2017-10
565.0,10/20/2017 10:32:08 PM,BRIEF-Janssen receives two FDA approvals for SIMPONI ARIA for treatment of active psoriatic arthritis (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-two-fda-approvals-for-simponi-aria-for-treatment-of-active-psoriatic-arthritis-2017-10
566.0,10/21/2017 2:12:19 AM,California judge tosses $417 mln talc cancer verdict against J&J (JNJ),Reuters,http://www.businessinsider.com/r-california-judge-tosses-417-mln-talc-cancer-verdict-against-jj-2017-10
567.0,10/22/2017 4:34:33 AM,California Court Overturns $417 Mln Verdict Linking J&J Baby Powder With Cancer ,RTTNews,/news/stocks/california-court-overturns-417-mln-verdict-linking-j-j-baby-powder-with-cancer-1005201613
568.0,10/23/2017 4:17:03 PM,"UPDATE 1-Smith & Nephew to buy Rotation Medical for up to $210 mln (SN., SYK, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-smith--nephew-to-buy-rotation-medical-for-up-to-210-mln-2017-10
569.0,10/23/2017 7:22:03 PM,"US STOCKS-Losses in GE keep Wall St in check (GE, AAPL, INTC, JNJ, CELG, SLB, HAL, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-losses-in-ge-keep-wall-st-in-check-2017-10
570.0,10/24/2017 4:07:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BAC, JPM, GM, WHR, BIIB, CNC, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10
571.0,10/24/2017 5:42:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BIIB, CNC, JNJ, JPM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10
572.0,10/24/2017 7:02:06 PM,"US STOCKS-Dow rallies on strong earnings from 3M, Caterpillar (MMM, CAT, MCD, BIIB, CNC, JNJ, BAC, JPM, GM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-rallies-on-strong-earnings-from-3m-caterpillar-2017-10
573.0,10/25/2017 2:12:15 PM,BRIEF-Janssen Pharmaceutica says Phase 3 Amber study achieved its primary endpoint‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceutica-says-phase-3-amber-study-achieved-its-primary-endpoint-2017-10
574.0,10/25/2017 2:37:12 PM,"UPDATE 1-Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria (BAX, MRK, JNJ, PFE, GSK, MDT, DEPO, AMGN, BMY, LLY, AZN)",Reuters,http://www.businessinsider.com/r-update-1-baxter-expects-70-mln-hit-to-4th-qtr-sales-from-hurricane-maria-2017-10
575.0,10/25/2017 5:27:00 PM,Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-26th-annual-credit-suisse-health-care-conference-1005589294
576.0,10/25/2017 8:11:01 PM,Judge Overturns Verdict In J&J Baby Powder Verdict ,RTTNews,/news/stocks/judge-overturns-verdict-in-j-j-baby-powder-verdict-1005604075
577.0,10/30/2017 12:02:08 PM,"Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10
578.0,10/30/2017 12:52:15 PM,BRIEF-J&J's Janssen announces Imbruvica as the first approved treatment for chronic graft-versus-host disease granted by Health Canada priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-janssen-announces-imbruvica-as-the-first-approved-treatment-for-chronic-graft-versus-host-disease-granted-by-health-canada-priority-review-2017-10
579.0,10/30/2017 1:32:07 PM,BRIEF-Johnson & Johnson says FDA approved 10 mg dose of Xarelto for reducing continued risk for recurrent venous thromboembolism‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approved-10-mg-dose-of-xarelto-for-reducing-continued-risk-for-recurrent-venous-thromboembolism-2017-10
580.0,10/30/2017 2:52:12 PM,"UPDATE 1-Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10
581.0,10/31/2017 1:27:08 PM,"BRIEF-Geron announces fast track designation grant for imetelstat (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-announces-fast-track-designation-grant-for-imetelstat-2017-10
582.0,10/31/2017 1:47:19 PM,"BRIEF-Halozyme - ‚ÄçJanssen Biotech initiated first phase 3 clinical trial evaluating subcutaneous delivery of Darzalex (HALO, JNJ)",Reuters,http://www.businessinsider.com/r-brief-halozyme---janssen-biotech-initiated-first-phase-3-clinical-trial-evaluating-subcutaneous-delivery-of-darzalex-2017-10
583.0,11/2/2017 7:02:03 PM,"U.S. Congress to hold hearing on Allergan tribal patent deal (AGN, JNJ, MYL)",Reuters,http://www.businessinsider.com/r-us-congress-to-hold-hearing-on-allergan-tribal-patent-deal-2017-11
584.0,11/5/2017 12:37:03 AM,"J&J's Stelara shows promise against lupus in study (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-jjs-stelara-shows-promise-against-lupus-in-study-2017-11
585.0,11/6/2017 10:42:03 AM,"Bayer in bid to broaden use of anti-clotting drug Xarelto (BAYN, JNJ, MON, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-in-bid-to-broaden-use-of-anti-clotting-drug-xarelto-2017-11
586.0,11/6/2017 2:47:03 PM,BRIEF-J&J's Stelara shows positive results in treatment of systemic lupus erythematosus in phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-stelara-shows-positive-results-in-treatment-of-systemic-lupus-erythematosus-in-phase-2-trial-2017-11
587.0,11/8/2017 4:27:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; stable outlook,Moodys,/news/bonds/johnson-amp-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-stable-outlook-1007303842
588.0,11/13/2017 11:07:03 AM,BRIEF-Zymeworks announces license agreement with Johnson & Johnson Innovation (JNJ),Reuters,http://www.businessinsider.com/r-brief-zymeworks-announces-license-agreement-with-johnson--johnson-innovation-2017-11
589.0,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872498
590.0,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872494
591.0,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-&-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-586831
592.0,11/13/2017 2:27:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007874103
593.0,11/15/2017 2:12:03 PM,BRIEF-Jannsen Inc says‚Äç Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-jannsen-inc-says-health-canada-has-approved-tremfya-for-treatment-of-adult-moderate-to-severe-plaque-psoriasis-2017-11
594.0,11/15/2017 5:52:03 PM,"Astellas faces U.S. probe over patient assistance charity support (4503, PFE, JNJ, UTHR, GILD, VRX, CELG)",Reuters,http://www.businessinsider.com/r-astellas-faces-us-probe-over-patient-assistance-charity-support-2017-11
595.0,11/20/2017 4:32:03 PM,BRIEF-‚ÄçJanssen-Cilag says European Commission approves expanded use of Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-cilag-says-european-commission-approves-expanded-use-of-zytiga-2017-11
596.0,11/20/2017 6:47:00 PM,Johnson & Johnson to Participate in the Citi 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-citi-2017-global-healthcare-conference-520043
597.0,11/21/2017 3:02:03 PM,"J&J multiple myeloma drug succeeds in first-line combination study (JNJ, 4502, CELG)",Reuters,http://www.businessinsider.com/r-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11
598.0,11/21/2017 3:52:03 PM,BRIEF-Janssen seeks expanded use of Darzalex from EMA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-seeks-expanded-use-of-darzalex-from-ema-2017-11
599.0,11/21/2017 6:37:03 PM,"UPDATE 1-J&J multiple myeloma drug succeeds in first-line combination study (JNJ, GEN, 4502, CELG)",Reuters,http://www.businessinsider.com/r-update-1-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11
600.0,11/21/2017 9:12:05 PM,"U.S. FDA approves first two-drug HIV regimen (GSK, 4507, GILD, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-approves-first-two-drug-hiv-regimen-2017-11
601.0,11/22/2017 12:22:03 AM,"UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK (GSK, PFE, 4507, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-first-two-drug-hiv-regimen-from-gsk-2017-11
602.0,11/22/2017 12:32:03 AM,BRIEF-Janssen announces FDA approval of Juluca for the treatment of HIV-1 infection (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-juluca-for-the-treatment-of-hiv-1-infection-2017-11
603.0,11/28/2017 1:07:03 PM,"New ETF joins fight against sexual harassment in workplace (AAPL, MSFT, JNJ)",Reuters,http://www.businessinsider.com/r-new-etf-joins-fight-against-sexual-harassment-in-workplace-2017-11
604.0,11/29/2017 8:12:03 PM,"U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11
605.0,11/29/2017 9:17:05 PM,"UPDATE 1-U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11
606.0,11/29/2017 9:52:04 PM,"BRIEF-Genmab Achieves $20 Million Milestone In Daratumumab Collaboration With Janssen (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-achieves-20-million-milestone-in-daratumumab-collaboration-with-janssen-2017-11
607.0,11/30/2017 8:07:03 AM,Hopes for HIV vaccine buoyed by start of second big trial (JNJ),Reuters,http://www.businessinsider.com/r-hopes-for-hiv-vaccine-buoyed-by-start-of-second-big-trial-2017-11
608.0,11/30/2017 11:07:05 AM,"UPDATE 1-New vaccine, long-acting drug trials buoy hopes in HIV fight (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-new-vaccine-long-acting-drug-trials-buoy-hopes-in-hiv-fight-2017-11
609.0,11/30/2017 4:08:00 PM,Moody's: Pharma manufacturers and distributors face rising risks related to US opioid crisis,Moodys,/news/bonds/moody-s-pharma-manufacturers-and-distributors-face-rising-risks-related-to-us-opioid-crisis-1010065274
610.0,11/30/2017 4:22:03 PM,"BRIEF-Moody's Says Pharma Manufacturers, Distributors Face Rising Risks Related To U.S. Opioid Crisis (ENDP, JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-brief-moodys-says-pharma-manufacturers-distributors-face-rising-risks-related-to-us-opioid-crisis-2017-11
611.0,11/30/2017 9:34:00 PM,Johnson & Johnson to Participate in the BMO Capital Markets Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-bmo-capital-markets-healthcare-conference-552620
612.0,12/4/2017 9:07:03 AM,Idorsia to get $230 mln from J&J in latest hypertension deal (JNJ),Reuters,http://www.businessinsider.com/r-idorsia-to-get-230-mln-from-jj-in-latest-hypertension-deal-2017-12
613.0,12/5/2017 8:07:04 AM,"BRIEF-Morphosys Says Licensee Janssen Receives Approval For Tremfya In Canada (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-says-licensee-janssen-receives-approval-for-tremfya-in-canada-2017-12
614.0,12/5/2017 2:52:04 PM,BRIEF-Imbruvica Plus Rituximab Phase 3 Innovate Trial In Rare Waldenstr√∂m's Macroglobulinemia Met Primary Endpoint (JNJ),Reuters,http://www.businessinsider.com/r-brief-imbruvica-plus-rituximab-phase-3-innovate-trial-in-rare-waldenstrms-macroglobulinemia-met-primary-endpoint-2017-12
615.0,12/5/2017 7:02:03 PM,"Jury orders Bayer, J&J to pay $29 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-jury-orders-bayer-jj-to-pay-29-million-in-xarelto-lawsuit-2017-12
616.0,12/5/2017 8:37:04 PM,"UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-jury-orders-bayer-jj-to-pay-28-million-in-xarelto-lawsuit-2017-12
617.0,12/6/2017 2:12:09 PM,"BRIEF-Genomic Health Announces Research Collaboration with Janssen Pharma (GHDX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genomic-health-announces-research-collaboration-with-janssen-pharma-2017-12
618.0,12/7/2017 6:47:04 PM,BRIEF-J&J considers sale of anti-dandruff shampoo Nizoral - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-considers-sale-of-anti-dandruff-shampoo-nizoral---bloomberg-2017-12
619.0,12/10/2017 4:32:03 PM,"'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study (JNJ, CELG, GILD)",Reuters,http://www.businessinsider.com/r-unheard-of-responses-to-bluebird-car-t-therapy-seen-in-myeloma-study-2017-12
620.0,12/14/2017 1:02:03 AM,"Bumper crop of new drugs fails to lift big pharma R&D returns (BION, NOVO , PFE, SAN, GSK, JNJ, AZN, MRK, LLY, BMY, 4502, AMGN, BIIB, CELG, GILD)",Reuters,http://www.businessinsider.com/r-bumper-crop-of-new-drugs-fails-to-lift-big-pharma-rd-returns-2017-12
621.0,12/14/2017 7:22:05 PM,"US STOCKS-S&P, Dow flat as healthcare losses offset by tech, media gains (DIS, NFLX, CMCSA, JNJ, VZ, T, CTL)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-flat-as-healthcare-losses-offset-by-tech-media-gains-2017-12
622.0,12/14/2017 9:12:03 PM,"US STOCKS-Wall St falls as investors fret about tax bill passage (DIS, NFLX, CMCSA, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-investors-fret-about-tax-bill-passage-2017-12
623.0,12/15/2017 2:22:03 AM,"UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-2017-12
624.0,12/19/2017 2:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1011641653
625.0,12/19/2017 2:30:00 PM,Johnson & Johnson to Participate in 36th Annual JP Morgan Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-36th-annual-jp-morgan-health-care-conference-1011641907
626.0,12/19/2017 9:32:03 PM,"FDA medical device proposal may skirt the law - legal experts (AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-fda-medical-device-proposal-may-skirt-the-law---legal-experts-2017-12
627.0,12/20/2017 9:57:05 AM,Johnson & Johnson fined 25 mln euros by French competition watchdog (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-fined-25-mln-euros-by-french-competition-watchdog-2017-12
628.0,12/20/2017 11:42:06 AM,"UPDATE 1-France fines J&J 25 mln euros over painkilller patch (JNJ, TEVA, SAN)",Reuters,http://www.businessinsider.com/r-update-1-france-fines-jj-25-mln-euros-over-painkilller-patch-2017-12
629.0,12/20/2017 9:52:03 PM,"UPDATE 1-New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-adds-insys-mallinckrodt-to-opioid-epidemic-lawsuit-2017-12
630.0,12/20/2017 10:17:04 PM,"BRIEF-U.S. Fda Approves New Diabetes Drug From Merck And Pfizer (MRK, PFE, JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12
631.0,12/20/2017 10:27:06 PM,"U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12
632.0,12/20/2017 10:42:03 PM,"UPDATE 1-U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12
633.0,12/21/2017 1:22:04 PM,Indian minister writes to Modi urging price caps on 20 medical devices (JNJ),Reuters,http://www.businessinsider.com/r-indian-minister-writes-to-modi-urging-price-caps-on-20-medical-devices-2017-12
634.0,12/21/2017 11:37:03 PM,BRIEF-Janssen Enters Collaboration And License Agreement With China's Legend Biotech To Develop CAR-T Cancer Therapy (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-enters-collaboration-and-license-agreement-with-chinas-legend-biotech-to-develop-car-t-cancer-therapy-2017-12
635.0,12/22/2017 1:02:03 AM,"BRIEF-Genscript Biotech Says US, Ireland Units ‚Äç& Janssen Biotech Enter Collaboration & License Agreement ‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-genscript-biotech-says-us-ireland-units--janssen-biotech-enter-collaboration--license-agreement--2017-12
636.0,12/27/2017 4:22:03 PM,"US STOCKS-Wall St little changed; oil drop weighs on energy shares (COP, CVX, NVDA, AAPL, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-little-changed-oil-drop-weighs-on-energy-shares-2017-12
637.0,12/27/2017 5:42:08 PM,"US STOCKS-Tech, healthcare stocks prop up Wall Street (AAPL, COP, CVX, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-healthcare-stocks-prop-up-wall-street-2017-12
638.0,12/27/2017 7:07:03 PM,"US STOCKS-Healthcare, tech stocks prop up Wall Street (MSFT, AAPL, CXO, DVN, UNH, JNJ, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-healthcare-tech-stocks-prop-up-wall-street-2017-12
639.0,1/2/2018 12:45:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2018-1002302613
640.0,1/2/2018 12:52:03 PM,BRIEF-Johnson & Johnson Declares Cash Dividend For Q1 2018 Of $0.84 Per Share On Co's Common Stock (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-declares-cash-dividend-for-q1-2018-of-084-per-share-on-cos-common-stock-2018-1
641.0,1/2/2018 2:22:04 PM,BRIEF-Syros Announces Clinical Supply Agreement With Janssen To Evaluate SY-1425 (JNJ),Reuters,http://www.businessinsider.com/r-brief-syros-announces-clinical-supply-agreement-with-janssen-to-evaluate-sy-1425-2018-1
642.0,1/2/2018 8:12:05 PM,FDA issues recall on J&J heart device (JNJ),Reuters,http://www.businessinsider.com/r-fda-issues-recall-on-jj-heart-device-2018-1
643.0,1/2/2018 8:27:14 PM,BRIEF-FDA Issues Class I Recall Of Reprocessed Agilis Steerable Introducer Sheath By Sterilmed (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-issues-class-i-recall-of-reprocessed-agilis-steerable-introducer-sheath-by-sterilmed-2018-1
644.0,1/3/2018 2:32:03 PM,BRIEF-Landmark Schizophrenia Data Receive FDA Approval For Inclusion In Invega Sustenna (Paliperidone Palmitate) Label (JNJ),Reuters,http://www.businessinsider.com/r-brief-landmark-schizophrenia-data-receive-fda-approval-for-inclusion-in-invega-sustenna-paliperidone-palmitate-label-2018-1
645.0,1/3/2018 9:00:00 PM,Dr. Paul Janssen Award for Biomedical Research Issues 2018 Call for Nominations to Celebrate Champions of Science,PR Newswire,/news/stocks/dr-paul-janssen-award-for-biomedical-research-issues-2018-call-for-nominations-to-celebrate-champions-of-science-1012444286
646.0,1/7/2018 3:50:22 PM,New Drugs Approved In December ,RTTNews,/news/stocks/new-drugs-approved-in-december-1012620046
647.0,1/9/2018 3:38:00 AM,Small Business Funding Solutions: What to Do Differently in 2018,PR Newswire,/news/stocks/small-business-funding-solutions-what-to-do-differently-in-2018-1001655459
648.0,1/9/2018 3:11:00 PM,Moody's: US pharmaceutical companies' cash holdings set to decline under new tax law,Moodys,/news/bonds/moody-s-us-pharmaceutical-companies-cash-holdings-set-to-decline-under-new-tax-law-1012731176
649.0,1/17/2018 9:03:00 PM,"Ortho-Clinical Diagnostics SA -- Moody's affirms Ortho-Clinical's ratings, outlook revised to stable",Moodys,/news/bonds/ortho-clinical-diagnostics-sa-moody-s-affirms-ortho-clinical-s-ratings-outlook-revised-to-stable-1013174029
650.0,1/23/2018 9:13:41 AM,"Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ) ",RTTNews,/news/stocks/earnings-in-focus-jan-23-ful-ati-jnj-pg-vz-1013685346
651.0,1/23/2018 12:40:00 PM,Johnson & Johnson Reports 2017 Fourth-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2017-fourth-quarter-results--694806
652.0,1/23/2018 12:45:25 PM,Johnson & Johnson Q4 Earnings Rise 10%,RTTNews,/news/stocks/johnson-johnson-q4-earnings-rise-10-1013703855
653.0,1/23/2018 1:27:38 PM,Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-sees-fy18-profit-above-view-1013707581
654.0,1/23/2018 6:01:00 PM,Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018,PR Newswire,/news/stocks/forty-of-the-nation-s-most-promising-young-scientists-named-finalists-in-regeneron-science-talent-search-2018-1001688777
655.0,1/25/2018 5:59:00 PM,Bayer Shares the Risk with Cotton Farmers,PR Newswire,/news/stocks/bayer-shares-the-risk-with-cotton-farmers-703862
656.0,1/31/2018 8:18:00 PM,Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-leerink-partners-7th-annual-global-healthcare-conference-1014710803
657.0,2/1/2018 2:30:00 PM,MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene,PR Newswire,/news/stocks/meiragtx-receives-rare-pediatric-disease-designation-for-a002-for-the-treatment-of-achromatopsia-due-to-mutations-in-the-cngb3-gene-1001718908
658.0,2/7/2018 4:58:00 PM,Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-rbc-capital-markets-2018-global-healthcare-conference-1015054422
659.0,2/8/2018 2:30:00 PM,Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio,PR Newswire,/news/stocks/janssen-and-johnson-johnson-to-provide-webcast-presentation-on-phase-3-data-for-apalutamide-and-the-janssen-prostate-cancer-strategy-and-portfolio-1015121273
660.0,2/8/2018 4:10:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ)",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-announces-investigation-of-johnson-johnson-jnj-1015127765
661.0,2/8/2018 5:41:00 PM,Johnson & Johnson to Participate in the 2018 CAGNY Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-cagny-conference-1015133630
662.0,2/9/2018 6:48:07 AM,"FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress ",RTTNews,/news/stocks/fda-nod-for-jnj-cori-awaits-results-in-q2-mdgl-s-hefh-data-fails-to-impress-1015183062
663.0,2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222120
664.0,2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222116
665.0,2/16/2018 4:03:00 PM,Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-presents-new-scientific-research-at-2018-american-academy-of-dermatology-annual-meeting-1016029591
666.0,2/20/2018 2:53:00 AM,J&J Reportedly Explores Sale Of $2 Bln Sterilization Division ,RTTNews,/news/stocks/j-j-reportedly-explores-sale-of-2-bln-sterilization-division-1016384446
667.0,2/20/2018 10:43:00 PM,Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-cowen-38th-annual-healthcare-conference-1016490049
668.0,2/23/2018 3:00:00 PM,"Milliman: Public pension funding improves by $60 billion, funded ratio climbs to 73.1% in 2017 Q4",PR Newswire,/news/stocks/milliman-public-pension-funding-improves-by-60-billion-funded-ratio-climbs-to-73-1-in-2017-q4-1001785596
669.0,3/5/2018 3:22:13 PM,New Drugs Approved In February ,RTTNews,/news/stocks/new-drugs-approved-in-february-1018015655
670.0,3/6/2018 8:52:00 PM,Johnson & Johnson to Participate in Barclays Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-healthcare-conference-1018169448
671.0,3/8/2018 10:33:00 PM,"Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials",PR Newswire,/news/stocks/judge-s-order-sets-1-200-xarelto-product-liability-lawsuits-for-separate-jury-trials-1018455278
672.0,3/13/2018 6:59:00 PM,"Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc.",PR Newswire,/news/stocks/lifshitz-miller-llp-announces-investigation-of-8point3-energy-partners-lp-grandpoint-capital-inc-hardinge-inc-johnson-johnson-ljm-funds-management-ltd-nationstar-mortgage-holdings-inc-1002161243
673.0,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849153
674.0,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849140
675.0,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849144
676.0,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849145
677.0,3/16/2018 12:38:52 PM,J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln ,RTTNews,/news/stocks/j-j-gets-binding-offer-from-platinum-equity-to-buy-lifescan-unit-for-2-1-bln-1018849187
678.0,3/19/2018 5:25:00 PM,Syracuse Creative Agency Expands into Southern Tier,PR Newswire,/news/stocks/syracuse-creative-agency-expands-into-southern-tier-1002179054
679.0,3/20/2018 2:24:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1018945975
680.0,3/20/2018 9:15:00 PM,Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson,PR Newswire,/news/stocks/dominic-j-caruso-to-retire-as-chief-financial-officer-of-johnson-johnson-1018958892
681.0,4/3/2018 1:54:24 PM,Will These Drugs Reach Blockbuster Status? ,RTTNews,/news/stocks/will-these-drugs-reach-blockbuster-status-1020339832
682.0,4/6/2018 6:24:53 AM,"J&J, Imerys Ordered To Pay $37 Mln In Case Over Talc Cancer Risks ",RTTNews,/news/stocks/j-j-imerys-ordered-to-pay-37-mln-in-case-over-talc-cancer-risks-1020647379
683.0,4/10/2018 10:15:00 PM,Horizon Technology Finance Announces Renewal of Credit Facility,PR Newswire,/news/stocks/horizon-technology-finance-announces-renewal-of-credit-facility-564055
684.0,4/11/2018 2:53:47 AM,FDA Approves First Contact Lens With Light-adaptive Technology ,RTTNews,/news/stocks/fda-approves-first-contact-lens-with-light-adaptive-technology-1021112699
685.0,4/17/2018 12:40:00 PM,Johnson & Johnson Reports 2018 First-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2018-first-quarter-results--1001599660
686.0,4/17/2018 12:50:28 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1021431007
687.0,4/17/2018 1:02:11 PM,Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions ,RTTNews,/news/stocks/johnson-johnson-increases-sales-guidance-plans-supply-chain-actions-1021431726
688.0,4/18/2018 12:41:00 AM,FreeBackgroundCheck.org Announces Members Area Upgrades,PR Newswire,/news/stocks/freebackgroundcheck-org-announces-members-area-upgrades-1001600515
689.0,4/24/2018 2:00:00 PM,Unison Reports Fast Company Growth Supported by Strategic Hires and New Market Expansion,PR Newswire,/news/stocks/unison-reports-fast-company-growth-supported-by-strategic-hires-and-new-market-expansion-1001957720
690.0,4/24/2018 10:01:00 PM,Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-deutsche-bank-43rd-annual-health-care-conference-1022160611
691.0,4/26/2018 4:26:00 PM,Johnson & Johnson Announces Dividend Increase of 7.1%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-7-1-1022412658
692.0,4/28/2018 5:35:58 AM,Biotech Stocks Facing FDA Decision In May ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-may-1022627793
693.0,4/30/2018 2:47:38 PM,Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918 ,RTTNews,/news/stocks/cytori-updates-on-us-manufacturing-and-eu-approval-plans-for-ati-0918-1022889295
694.0,5/2/2018 6:00:00 PM,Johnson & Johnson to Host Consumer and Medical Devices Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-consumer-and-medical-devices-business-review-1001658284
695.0,5/3/2018 7:18:00 PM,Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-2018-ubs-global-health-care-conference-657014
696.0,5/5/2018 2:00:00 PM,New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression,PR Newswire,/news/stocks/new-phase-3-data-show-esketamine-nasal-spray-demonstrated-rapid-improvements-in-depressive-symptoms-in-patients-with-treatment-resistant-depression-1023481483
697.0,5/5/2018 2:09:03 PM,A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift (JNJ),Business Insider,http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-5
698.0,5/7/2018 10:53:00 PM,LifeScan Global Corporation -- Moody's assigns B2 CFR to LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b2-cfr-to-lifescan-global-corporation-1023685176
699.0,5/8/2018 7:47:04 AM,"It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug. ",RTTNews,/news/stocks/it-s-raining-fda-approvals-mson-muscling-up-rdhl-to-report-data-in-aug-1023720441
700.0,5/29/2018 4:15:14 AM,Juries Weigh Cases Over Alleged Harms Of Johnson & Johnson Baby Powder ,RTTNews,/news/stocks/juries-weigh-cases-over-alleged-harms-of-johnson-johnson-baby-powder-1025660907
701.0,5/29/2018 4:53:00 PM,Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-goldman-sachs-39th-annual-global-healthcare-conference-1025725224
702.0,6/1/2018 9:05:50 AM,"Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg ",RTTNews,/news/stocks/celgene-appoints-j-j-s-david-elkins-as-evp-cfo-succeeding-peter-kellogg-1026083080
703.0,6/5/2018 2:00:00 PM,Johnson & Johnson Announces Progress Toward Health for Humanity Goals,PR Newswire,/news/stocks/johnson-johnson-announces-progress-toward-health-for-humanity-goals-1026560176
704.0,6/6/2018 10:46:00 PM,Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP),PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-fortive-corporation-to-acquire-advanced-sterilization-products-asp-1026756589
705.0,6/6/2018 11:07:28 PM,Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln ,RTTNews,/news/stocks/fortive-offers-to-buy-j-j-s-advance-sterilization-product-biz-for-2-8-bln-1026757669
706.0,6/7/2018 4:07:00 PM,ISG Awarded IT Services Contract by State of Texas,PR Newswire,/news/stocks/isg-awarded-it-services-contract-by-state-of-texas-1001772800
707.0,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886164
708.0,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886155
709.0,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886154
710.0,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1002095213
711.0,6/12/2018 10:19:22 PM,Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln ,RTTNews,/news/stocks/johnson-johnson-accepts-platinum-equity-s-offer-to-buy-lifescan-for-2-1-bln-1026886960
712.0,6/15/2018 2:30:00 AM,"Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.",PR Newswire,/news/stocks/kyros-law-is-investigating-claims-on-behalf-of-invokana-users-1-100-invokana-lawsuits-alleging-diabetic-ketoacidosis-kidney-injury-amputations-and-heart-complications-filed-1027052699
713.0,6/15/2018 11:00:00 PM,LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1,Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-global-s-term-loan-b-rating-to-b2-from-b1-1027141162
714.0,6/18/2018 2:27:00 PM,FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio,PR Newswire,/news/stocks/fda-approves-the-next-generation-of-customized-lasik-treatment-with-idesign-refractive-studio-1027167302
715.0,6/18/2018 2:39:34 PM,Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-vision-fda-approves-idesign-refractive-studio-quick-facts-1027167394
716.0,6/19/2018 11:09:23 AM,Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For ¬£60 Mln; Stock Up ,RTTNews,/news/stocks/alliance-pharma-to-buy-rights-to-j-j-s-nizoral-in-apac-for-60-mln-stock-up-1027192834
717.0,6/19/2018 4:04:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1027202865
718.0,6/28/2018 11:23:31 AM,STADA Buys EMEA Rights To J&J's Medicated Anti-dandruff Shampoo Nizoral ,RTTNews,/news/stocks/stada-buys-emea-rights-to-j-j-s-medicated-anti-dandruff-shampoo-nizoral-1027325596
719.0,7/13/2018 3:19:58 AM,J&J Ordered To Pay $4.69 Bln In Baby Powder Case ,RTTNews,/news/stocks/j-j-ordered-to-pay-4-69-bln-in-baby-powder-case-1027364374
720.0,7/13/2018 12:51:07 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, JNJ, T, JPM, WFC, C)",Business Insider,http://www.businessinsider.com/stock-market-news-opening-bell-july-13-2018-2018-7
721.0,7/13/2018 5:01:00 PM,Johnson & Johnson -- Moody's: Talc award against J&J is credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-talc-award-against-j-j-is-credit-negative-1027366484
722.0,7/13/2018 9:33:56 PM,Johnson & Johnson Posting Notable Loss But Well Off Lows ,RTTNews,/news/stocks/johnson-johnson-posting-notable-loss-but-well-off-lows-1027367008
723.0,7/16/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-q2-earnings-preview-1027369916
724.0,7/17/2018 12:52:30 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1027373268
725.0,7/17/2018 12:56:53 PM,Johnson & Johnson Updates FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-updates-fy18-outlook-quick-facts-1027373283
726.0,7/17/2018 10:49:00 PM,"MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc.",Moodys,/news/bonds/medplast-holdings-inc-moody-s-assigns-b2-cfr-to-medplast-holdings-inc-1027375790
727.0,9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053
728.0,10/2/2018 6:20:14 AM,Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity ,RTTNews,/news/stocks/johnson-johnson-closes-sale-of-lifescan-business-to-platinum-equity-1027581261
729.0,10/4/2018 9:19:00 AM,"Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US",Moodys,/news/bonds/moody-s-biosimilars-a-growing-challenge-biotech-drugs-with-european-market-developing-more-quickly-than-the-us-1027589140
730.0,10/4/2018 2:21:26 PM,Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen ,RTTNews,/news/stocks/arrowhead-enters-3-7-bln-license-and-collaboration-deals-with-janssen-1027590345
731.0,10/15/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-quarter-earnings-preview-q3-1027616785
732.0,10/16/2018 12:46:13 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1027620272
733.0,10/16/2018 1:08:25 PM,Johnson & Johnson Boosts FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy18-outlook-quick-facts-1027620458
734.0,10/23/2018 9:38:23 AM,Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In ¬•230 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-remaining-stake-in-japan-s-ci-z-in-230-bln-deal-1027642569
735.0,12/13/2018 3:48:06 AM,J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases ,RTTNews,/news/stocks/j-j-reportedly-willing-to-pay-400-million-plus-in-hip-device-cases-1027804575
736.0,12/14/2018 6:24:50 AM,Janssen's Daratumumab SNDA In Japan Triggers $2 Mln Milestone Payment To Genmab ,RTTNews,/news/stocks/janssen-s-daratumumab-snda-in-japan-triggers-2-mln-milestone-payment-to-genmab-1027808788
737.0,12/14/2018 5:12:11 PM,Johnson & Johnson tumbles after report says it knew for decades that its baby powder contained asbestos (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-asbestos-sinks-stock-2018-12-1027810884
738.0,12/14/2018 6:31:57 PM,J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder ,RTTNews,/news/stocks/j-j-posting-steep-loss-on-reported-knowledge-of-asbestos-in-baby-powder-1027811132
739.0,12/14/2018 7:00:05 PM,"Almost $40 billion has been erased from Johnson & Johnson's market value, but JPMorgan says the selling is overdone (JNJ)",Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-sell-off-an-overreaction-jpmorgan-2018-12-1027811184
740.0,12/14/2018 7:11:05 PM,Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-down-8-on-report-of-asbestos-in-baby-powder-1027811213
741.0,12/18/2018 1:30:18 AM,"Johnson & Johnson Authorizes $5 Billion Buyback, Reaffirms FY Guidance ",RTTNews,/news/stocks/johnson-johnson-authorizes-5-billion-buyback-reaffirms-fy-guidance-1027815688
742.0,1/11/2019 1:18:23 PM,Johnson & Johnson Issues Update On Offer For Ci:z Holdings - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-issues-update-on-offer-for-ci-z-holdings-quick-facts-1027861865
743.0,1/18/2019 4:01:31 PM,"J&J, Apple To Collaborate In Research Study Involving Apple Watch ",RTTNews,/news/stocks/j-j-apple-to-collaborate-in-research-study-involving-apple-watch-1027879765
744.0,1/21/2019 3:01:26 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-quarter-earnings-preview-q4-1027882798
745.0,1/22/2019 12:44:25 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1027885249
746.0,1/22/2019 1:40:53 PM,Johnson & Johnson Q4 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-1027885557
747.0,1/22/2019 2:36:04 PM,Johnson & Johnson is sliding after guidance comes up short (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-revenue-profit-earnings-stock-price-2019-1-1027885862
748.0,1/23/2019 4:14:01 AM,J&J Reaches $120 Mln Settlement With 46 Attorneys General Over Hip Implants ,RTTNews,/news/stocks/j-j-reaches-120-mln-settlement-with-46-attorneys-general-over-hip-implants-1027887817
749.0,2/5/2019 2:30:56 AM,J&J Reportedly Agrees To Resolve Most Pinnacle Hip-Device Lawsuits ,RTTNews,/news/stocks/j-j-reportedly-agrees-to-resolve-most-pinnacle-hip-device-lawsuits-1027922794
750.0,2/5/2019 4:52:00 PM,Johnson & Johnson -- Moody's -  Talc-related lawsuits could increase risk to Johnson & Johnson‚Äôs strong credit profile,Moodys,/news/bonds/johnson-johnson-moody-s-talc-related-lawsuits-could-increase-risk-to-johnson-johnson-s-strong-credit-profile-1027926321
751.0,2/12/2019 8:51:06 PM,A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval (JNJ),Business Insider,https://www.businessinsider.com/new-depression-drug-esketamine-jnj-fda-closer-approval-2019-1
752.0,2/13/2019 3:21:04 PM,Johnson & Johnson is buying a Silicon Valley surgical-robotics startup for $3.4 billion (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-acquires-auris-health-surgical-robots-for-34-billion-2019-2
753.0,2/13/2019 3:26:18 PM,J&J's Ethicon Agrees To Acquire Auris Health For About $3.4 Billion In Cash ,RTTNews,/news/stocks/j-j-s-ethicon-agrees-to-acquire-auris-health-for-about-3-4-billion-in-cash-1027949736
754.0,2/15/2019 10:07:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1027957857
755.0,2/21/2019 2:39:04 PM,Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-subpoena-doj-sec-queries-stock-falls-2019-2-1027972093
756.0,2/27/2019 4:51:26 AM,Biotech Stocks Facing FDA Decision In March ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-1027987182
757.0,3/6/2019 2:03:05 AM,"Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential (JNJ)",Business Insider,https://www.businessinsider.com/esketamine-depression-drug-approved-fda-johnson-johnson-antidepressant-2019-2
758.0,3/6/2019 3:01:45 AM,FDA Okays Janssen's Nasal Spray Medication For Treatment-resistant Depression ,RTTNews,/news/stocks/fda-okays-janssen-s-nasal-spray-medication-for-treatment-resistant-depression-1028007062
759.0,3/8/2019 6:36:06 PM,"Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years",Business Insider,https://www.businessinsider.com/dispensed-weekly-healthcare-newsletter-march-8-2019-3
760.0,3/14/2019 9:25:14 PM,Johnson & Johnson Ordered To Pay $29 Mln In Latest Talcum Cancer Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-29-mln-in-latest-talcum-cancer-case-1028032239
761.0,3/22/2019 6:02:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028050916
762.0,3/25/2019 11:44:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028055051
763.0,3/25/2019 7:41:59 PM,"Bayer, Johnson & Johnson To Pay $775 Mln To Settle Xarelto Lawsuits ",RTTNews,/news/stocks/bayer-johnson-johnson-to-pay-775-mln-to-settle-xarelto-lawsuits-1028056729
764.0,4/4/2019 5:16:01 AM,10 Best Selling Drugs Of 2018 ,RTTNews,/news/stocks/10-best-selling-drugs-of-2018-1028084412
765.0,4/15/2019 3:01:27 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-price-q1-earnings-preview-1028110928
766.0,4/16/2019 12:49:25 PM,Johnson & Johnson Q1 adjusted earnings of $2.10 per share,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-of-2-10-per-share-1028113977
767.0,4/16/2019 3:15:04 PM,Johnson & Johnson's net earnings dropped 14% in the first-quarter (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-q1-earnings-shares-rise-after-earnings-beat-2019-4-1028115029
768.0,5/1/2019 8:39:00 PM,Jabil Inc. -- Moody's upgrades Jabil to Baa3; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-upgrades-jabil-to-baa3-outlook-stable-1028159025
769.0,5/9/2019 5:06:55 AM,"Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln ",RTTNews,/news/stocks/takeda-to-sell-dry-eye-drug-surgical-patch-to-novartis-j-j-for-up-to-5-7-bln-1028184178
770.0,5/15/2019 12:58:12 PM,J&J Plans To Execute All Levers Of Capital Allocation Strategy ,RTTNews,/news/stocks/j-j-plans-to-execute-all-levers-of-capital-allocation-strategy-1028202651
771.0,6/3/2019 10:51:00 PM,"Moody's  ‚Äì Ability to absorb opioid-related lawsuits will vary widely among drug makers, distributors",Moodys,/news/bonds/moody-s-ability-to-absorb-opioid-related-lawsuits-will-vary-widely-among-drug-makers-distributors-1028250300
772.0,6/12/2019 8:22:08 PM,Dow Jones Today: Stocks Are Spinning Their Wheels,InvestorPlace,/news/stocks/dow-jones-today-stocks-are-spinning-their-wheels-1028275487
773.0,6/20/2019 6:48:34 PM,5 Boring Stocks to Buy This Summer,InvestorPlace,/news/stocks/5-boring-stocks-to-buy-this-summer-1028296950
774.0,6/24/2019 3:04:56 PM,How Chinese Culture Could Affect the Future of 3M Stock,InvestorPlace,/news/stocks/chinese-culture-future-3m-stock-1028303878
775.0,6/24/2019 10:31:00 PM,LifeScan Global Corporation -- Moody's announces completion of a periodic review of ratings of LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-lifescan-global-corporation-1028303411
776.0,6/25/2019 4:46:38 PM,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs-1028307938
777.0,6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925
778.0,6/27/2019 1:10:05 PM,"Microsoft Stock Is Overvalued, but Still a Solid Long-Term Bet",InvestorPlace,/news/stocks/microsoft-stock-long-term-bet-1028315914
779.0,7/10/2019 5:55:21 PM,Is Shopify Stock Getting Ahead of Its Fundamentals?,InvestorPlace,/news/stocks/is-shopify-stock-getting-ahead-of-its-fundamentals-1028344461
780.0,7/12/2019 7:34:31 PM,Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation,InvestorPlace,/news/stocks/johnson-johnson-baby-powder-news-jnj-stock-1028350343
781.0,7/12/2019 7:39:04 PM,J&J tumbles amid reports the DOJ launched a criminal investigation into whether it lied about its baby powder's cancer risks (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-price-reaction-reported-doj-investigation-baby-powder-2019-7-1028349902
782.0,7/12/2019 7:46:29 PM,4 Healthcare Stocks That Are Feeling Sick ¬†,InvestorPlace,/news/stocks/4-healthcare-stocks-that-are-feeling-sick-1028350342
783.0,7/12/2019 8:16:12 PM,"4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB",InvestorPlace,/news/stocks/4-top-stock-trades-for-mondayjnj-sq-ilmn-acb-1028350340
784.0,7/12/2019 8:31:29 PM,Dow Jones Today: A Fantastic Friday,InvestorPlace,/news/stocks/dow-jones-today-a-fantastic-friday-1028350337
785.0,7/13/2019 3:41:26 PM,Johnson & Johnson Stock Sinks As U.S. Probes Baby Powder ,RTTNews,/news/stocks/johnson-johnson-stock-sinks-as-u-s-probes-baby-powder-1028350459
786.0,7/15/2019 1:11:14 PM,Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results,InvestorPlace,/news/stocks/johnson-johnson-stock-facing-negative-catalysts-ahead-of-q2-results-1028354769
787.0,7/15/2019 1:24:12 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Ford and Square",InvestorPlace,/news/stocks/mondays-vital-data-options-trading-johnson-johnson-ford-and-square-1028354768
788.0,7/15/2019 3:01:21 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-q2-earnings-preview-1028352611
789.0,7/15/2019 8:22:50 PM,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday",InvestorPlace,/news/stocks/dow-jones-today-china-earnings-anticipation-stall-stocks-on-monday-1028354735
790.0,7/16/2019 12:46:35 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1028355756
791.0,7/16/2019 12:57:32 PM,Johnson & Johnson Boosts FY19 Sales Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-sales-outlook-quick-facts-1028355784
792.0,7/16/2019 5:17:49 PM,"Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance",InvestorPlace,/news/stocks/johnson-johnson-earnings-beat-estimates-jnj-stock-down-1028358971
793.0,7/16/2019 7:18:20 PM,"5 Top Stock Trades for Wednesday: JNJ, WFC, UBER, APRN, ROKU",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-jnj-wfc-uber-aprn-roku-1028358956
794.0,7/16/2019 7:35:06 PM,Judge To Weigh $17 Bln Opioid Case Against Johnson & Johnson ,RTTNews,/news/stocks/judge-to-weigh-17-bln-opioid-case-against-johnson-johnson-1028357861
795.0,7/16/2019 8:17:35 PM,Dow Jones Today: Earnings Disappointments,InvestorPlace,/news/stocks/dow-jones-today-earnings-disappointments-1028358952
796.0,7/17/2019 4:18:52 PM,These 6 SPDR ETFs and Amazon Tell Me the Rally Is Over,InvestorPlace,/news/stocks/these-6-spdr-etfs-and-amazon-tell-me-the-rally-is-over-1028363024
797.0,7/22/2019 6:55:40 PM,5 Dow Jones Stocks to Sell Before the Market Slumps,InvestorPlace,/news/stocks/5-dow-jones-stocks-to-sell-before-the-market-slumps-1028374199
798.0,7/23/2019 3:14:49 PM,Opioid Crisis: Trials As Well As Tribulations ,RTTNews,/news/stocks/opioid-crisis-trials-as-well-as-tribulations-1028376600
799.0,7/24/2019 1:29:03 PM,Johnson & Johnson Could Turn Around After its Strong Earnings,InvestorPlace,/news/stocks/johnson-johnson-could-turn-around-after-strong-earnings-1028383028
800.0,7/24/2019 1:51:29 PM,Is Johnson & Johnson Stock Losing Its Shine?,InvestorPlace,/news/stocks/is-johnson-johnson-stock-losing-its-shine-1028383025
801.0,7/26/2019 7:55:03 AM,Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal ,RTTNews,/news/stocks/janssen-s-late-stage-study-on-relapsing-multiple-sclerosis-meets-primary-goal-1028387423
802.0,7/26/2019 1:47:39 PM,Janssen Gets CHMP Positive Opinion For Stelara - Quick Facts ,RTTNews,/news/stocks/janssen-gets-chmp-positive-opinion-for-stelara-quick-facts-1028388259
803.0,7/29/2019 12:26:47 PM,Why Johnson & Johnson Stock Isn‚Äôt a Buy‚Ä¶ Yet,InvestorPlace,/news/stocks/why-johnson-johnson-stock-isnt-a-buy-yet-1028395885
804.0,7/29/2019 7:52:04 PM,"5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-shop-nflx-jnj-1028395850
805.0,8/5/2019 8:35:43 PM,Stock Market Today: Time to Hope for ‚ÄòTurnaround Tuesday‚Äô,InvestorPlace,/news/stocks/stock-market-today-time-to-hope-for-turnaround-tuesday-1028419252
806.0,8/14/2019 11:10:21 AM,JNJ Stock Is a Way Better Investment Than Bonds or CDs,InvestorPlace,/news/stocks/jnj-stock-is-a-way-better-investment-than-bonds-or-cds-1028447984
807.0,8/15/2019 4:05:03 PM,3 Stocks to Buy on Almost Any Dip,InvestorPlace,/news/stocks/3-stocks-to-buy-on-almost-any-dip-1028451497
808.0,8/16/2019 6:35:00 PM,Jabil Inc. -- Moody's assigns Prime-3 short term rating to Jabil's new $1.8 billion commercial paper program,Moodys,/news/bonds/jabil-inc-moody-s-assigns-prime-3-short-term-rating-to-jabil-s-new-1-8-billion-commercial-paper-program-1028453311
809.0,8/20/2019 7:11:01 PM,"3 Healthcare Stocks to Trade: UNH, JNJ and PFE",InvestorPlace,/news/stocks/3-healthcare-stocks-to-trade-unh-jnj-and-pfe-1028461453
810.0,8/21/2019 1:43:28 PM,"Johnson & Johnson Stock Is a Gamble, but an Interesting One",InvestorPlace,/news/stocks/johnson-johnson-stock-is-a-gamble-but-an-interesting-one-1028464947
811.0,8/22/2019 8:29:08 PM,"Stock Market Today: Boeing Takes Flight, Manufacturing Slumps",InvestorPlace,/news/stocks/stock-market-today-boeing-takes-flight-manufacturing-slumps-1028468412
812.0,8/23/2019 6:37:40 PM,Will Lawsuits Sink Johnson & Johnson Stock?,InvestorPlace,/news/stocks/lawsuits-jnj-stock-probably-not-1028470702
813.0,8/26/2019 12:47:29 PM,Biotech Stocks Facing FDA Decision In September 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-2019-1028472695
814.0,8/26/2019 8:26:00 PM,Dow Jones Today: The Return of Trade Optimism,InvestorPlace,/news/stocks/the-dow-jones-industrial-surged-monday-amid-nice-trade-chatter-1028475023
815.0,8/26/2019 8:34:50 PM,"Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks",InvestorPlace,/news/stocks/stock-market-today-biotech-in-focus-trade-talks-steady-stocks-1028475022
816.0,8/26/2019 11:57:28 PM,Johnson & Johnson Ordered To Pay $572 Million For Oklahoma Opioid Crisis ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-572-million-for-oklahoma-opioid-crisis-1028474595
817.0,8/27/2019 1:18:47 PM,J2 Global Unit Acquires BabyCenter From Johnson & Johnson - Quick Facts ,RTTNews,/news/stocks/j2-global-unit-acquires-babycenter-from-johnson-johnson-quick-facts-1028476166
818.0,8/27/2019 3:18:05 PM,J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-572-million-opioid-crisis-settlement-stock-price-2019-8
819.0,8/27/2019 4:40:22 PM,J&J Opioid Ruling 2019: 13 Things to Know,InvestorPlace,/news/stocks/jj-opioid-ruling-2019-13-things-to-know-1028478913
820.0,8/27/2019 5:12:04 PM,The $572 million fine Johnson & Johnson has to pay for its role in the opioid epidemic is only 4% of its annual profit (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-judgement-small-part-of-2018-profit-2019-8
821.0,8/27/2019 8:12:28 PM,"5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-cmg-sbux-jnj-1028478901
822.0,8/27/2019 8:13:44 PM,"Dow Jones Today: Not Much Activity, But That‚Äôs OK",InvestorPlace,/news/stocks/dow-stocks-were-mostly-sluggish-today-and-thats-alright-1028478900
823.0,8/28/2019 5:26:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's affirms J&J at Aaa; revises outlook to negative,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-affirms-j-j-at-aaa-revises-outlook-to-negative-1028481456
824.0,8/30/2019 3:37:52 PM,3 Large-Cap Stocks to Sell in September,InvestorPlace,/news/stocks/3-large-cap-stocks-sell-september-1028488909
825.0,8/30/2019 5:43:28 PM,It‚Äôs Time to Short Johnson & Johnson Stock,InvestorPlace,/news/stocks/its-time-to-short-johnson-johnson-stock-1028488901
826.0,9/4/2019 3:35:01 PM,EU Okays Expanded Use Of Janssen's STELARA ,RTTNews,/news/stocks/eu-okays-expanded-use-of-janssen-s-stelara-1028498117
827.0,9/5/2019 8:16:39 PM,"Dow Jones Today: Finally, Some Relief on the Trade Front",InvestorPlace,/news/stocks/dow-stocks-were-boosted-by-some-good-news-on-the-trade-front-1028504009
828.0,9/10/2019 2:55:17 PM,10 Healthcare Stocks to Buy Despite the Headlines,InvestorPlace,/news/stocks/10-healthcare-stocks-to-buy-despite-the-headlines-1028514931
829.0,9/16/2019 9:48:58 AM,OxyContin Maker Purdue Pharma Files For Bankruptcy Protection ,RTTNews,/news/stocks/oxycontin-maker-purdue-pharma-files-for-bankruptcy-protection-1028525612
830.0,9/18/2019 10:40:19 AM,"JNJ Stock Is Undervalued, but Not Compelling Given These Headwinds",InvestorPlace,/news/stocks/jnj-stock-undervalued-not-compelling-headwinds-1028536192
831.0,9/19/2019 4:10:24 PM,Buy This If You Like Johnson & Johnson Stock But Hate the Lawsuits ¬†,InvestorPlace,/news/stocks/buy-this-if-you-like-johnson-johnson-stock-but-hate-the-lawsuits-1028539745
832.0,9/20/2019 12:44:35 PM,There‚Äôs a Lot More Trouble Looming for JNJ Stock Than You Might Think,InvestorPlace,/news/stocks/damage-johnson-and-johnson-1028542274
833.0,9/20/2019 3:58:30 PM,3 Dow Stocks That Could Keep Going Lower,InvestorPlace,/news/stocks/3-dow-stocks-that-could-keep-going-lower-mmm-wba-jnj-1028542254
834.0,9/20/2019 7:17:16 PM,Should Johnson & Johnson Investors Worry About Opioid Lawsuits?,InvestorPlace,/news/stocks/should-johnson-johnson-investors-worry-about-opioid-lawsuits-1028542244
835.0,9/23/2019 7:25:20 PM,Long-Term Investors Should Consider Buying SHOP Stock Near $250,InvestorPlace,/news/stocks/long-term-investors-should-consider-buying-shop-stock-near-250-1028546632
836.0,9/24/2019 1:58:02 PM,Why Contrarians May Want to Take a Look at JNJ Stock,InvestorPlace,/news/stocks/why-contrarians-may-want-to-take-a-look-at-jnj-stock-1028550815
837.0,9/24/2019 5:57:56 PM,6 Dow Jones Industrial Average Stocks to Buy Right Now,InvestorPlace,/news/stocks/6-dow-jones-industrial-average-stocks-to-buy-right-now-1028550791
838.0,9/26/2019 2:47:18 PM,Don‚Äôt Ignore the Johnson and Johnson Pharmaceutical Pipeline,InvestorPlace,/news/stocks/johnson-johnson-drug-pipeline-underappreciated-1028558195
839.0,9/27/2019 10:27:19 AM,Should You Buy Johnson & Johnson Stock in October?,InvestorPlace,/news/stocks/should-you-buy-johnson-johnson-stock-in-october-1028560688
840.0,9/27/2019 7:34:40 PM,7 Big Biotech Stocks to Watch,InvestorPlace,/news/stocks/7-big-biotech-stocks-to-watch-1028560645
841.0,9/30/2019 5:20:47 PM,Can Johnson and Johnson Stock Overcome Opiod Implications?,InvestorPlace,/news/stocks/can-johnson-and-johnson-stock-overcome-opiod-implications-1028565214
842.0,10/1/2019 11:44:44 AM,Johnson & Johnson Can Overcome Its Legal Issues,InvestorPlace,/news/stocks/legal-issues-problem-johnson-johnson-stock-1028569362
843.0,10/1/2019 2:24:43 PM,Negative Press Presents a Buying Opportunity with JNJ Stock,InvestorPlace,/news/stocks/negative-press-opportunity-jnj-stock-1028569347
844.0,10/1/2019 5:27:02 PM,Microsoft Stock Is Still a Good Pick for One Type of Investor,InvestorPlace,/news/stocks/valuations-msft-serve-investor-well-1028569331
845.0,10/2/2019 3:21:33 AM,J&J Settles With Two Ohio Counties Ahead Of Upcoming Opioid Trial ,RTTNews,/news/stocks/j-j-settles-with-two-ohio-counties-ahead-of-upcoming-opioid-trial-1028569091
846.0,10/2/2019 5:42:04 PM,"Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial (JNJ)",Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jumps-on-opioid-lawsuit-settlement-2019-10
847.0,10/2/2019 8:11:19 PM,Stock Market Today: October Rolls in With a Bang,InvestorPlace,/news/stocks/stock-market-today-october-rolls-in-with-a-bang-1028572822
848.0,10/2/2019 8:12:57 PM,"Dow Jones Today: Houston, We‚Äôve Got a Growth Problem",InvestorPlace,/news/stocks/more-slack-data-points-stung-the-dow-jones-today-1028572821
849.0,10/3/2019 12:45:55 PM,3 Reasons Why Johnson and Johnson Stock Will Get Back on Track,InvestorPlace,/news/stocks/3-reasons-johnson-and-johnson-jnj-will-rally-1028575957
850.0,10/3/2019 1:57:00 PM,3 Things Investors Should Know About the Opioid Lawsuits Against Johnson & Johnson,InvestorPlace,/news/stocks/jnj-stock-opioid-lawsuits-1028575952
851.0,10/7/2019 6:51:22 PM,Why Johnson & Johnson Stock Is Not a Screaming Buy,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-not-screaming-buy-1028581887
852.0,10/9/2019 3:55:12 AM,J&J Ordered To Pay $8 Bln In Case Over Male Breast Growth On Anti-psychotic Drug ,RTTNews,/news/stocks/j-j-ordered-to-pay-8-bln-in-case-over-male-breast-growth-on-anti-psychotic-drug-1028585334
853.0,10/9/2019 3:57:05 PM,J&J slides after jury orders it to pay $8 billion in male breast-growth case (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/jnj-stock-price-falls-risperdal-male-breast-growth-jury-decision-2019-10-1028587229
854.0,10/9/2019 6:22:30 PM,Jury: JNJ Must Pay $8 Billion Over Male Breast Growth Tied to Risperdal Drug,InvestorPlace,/news/stocks/jnj-must-pay-8-billion-in-risperdal-lawsuit-1028588698
855.0,10/9/2019 8:07:10 PM,Stock Market Today: Johnson & Johnson Gets Served Again,InvestorPlace,/news/stocks/stock-market-today-jnj-gets-served-again-1028588690
856.0,10/9/2019 9:40:00 PM,Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk,Moodys,/news/bonds/johnson-johnson-moody-s-risperdal-verdict-adds-to-j-j-s-litigation-risk-1028588177
857.0,10/11/2019 4:03:26 PM,Johnson & Johnson Stock Has Limited Upside,InvestorPlace,/news/stocks/johnson-and-johnson-stock-mixed-bag-limited-upside-1028594594
858.0,10/11/2019 8:17:27 PM,Stock Market Today: Let‚Äôs Make a Deal,InvestorPlace,/news/stocks/stock-market-today-lets-make-a-deal-1028594574
859.0,10/14/2019 3:01:15 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-q3-quarterly-earnings-preview-stock-1028596463
860.0,10/14/2019 4:51:27 PM,Should Investors Buy Shopify Stock After Its Recent Decline?,InvestorPlace,/news/stocks/should-investors-buy-shopify-stock-after-its-recent-decline-1028597930
861.0,10/14/2019 7:59:43 PM,Johnson and Johnson Stock Still Significantly Undervalued,InvestorPlace,/news/stocks/johnson-stock-significantly-undervalued-1028597917
862.0,10/14/2019 8:26:33 PM,Stock Market Today: Stocks Hit Snooze Ahead of Earnings,InvestorPlace,/news/stocks/stock-market-today-stocks-hit-snooze-ahead-of-earnings-1028597915
863.0,10/15/2019 6:30:00 AM,Johnson & Johnson to Host Earnings Call,Accesswire,/news/stocks/johnson-johnson-to-host-earnings-call-1028602062
864.0,10/15/2019 7:41:02 AM,"RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today ",RTTNews,/news/stocks/reta-surges-on-trial-data-rvnc-on-track-all-eyes-on-rlmd-today-1028598042
865.0,10/15/2019 12:50:05 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1028598775
866.0,10/15/2019 1:00:00 PM,Johnson & Johnson Boosts FY19 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-outlook-quick-facts-1028598788
867.0,10/15/2019 3:53:53 PM,"Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts",InvestorPlace,/news/stocks/johnson-johnson-stock-has-good-numbers-but-bad-verdicts-1028601982
868.0,10/15/2019 8:16:30 PM,Stock Market Today: Bring on the Earnings¬†,InvestorPlace,/news/stocks/stock-market-today-bring-on-the-earnings-1028601963
869.0,10/15/2019 8:33:27 PM,Dow Jones Today: Earnings Boosts Across the Board,InvestorPlace,/news/stocks/dow-jones-today-earnings-boosts-across-the-board-1028601962
870.0,10/16/2019 4:26:00 AM,Major Drug Distributors In Talks To Settle Opioid Litigation For $18 Bln : WSJ ,RTTNews,/news/stocks/major-drug-distributors-in-talks-to-settle-opioid-litigation-for-18-bln-wsj-1028601751
871.0,10/16/2019 2:16:08 PM,Missouri Appeals Court Reverses $110 Mln Talc Verdict Against J&J ,RTTNews,/news/stocks/missouri-appeals-court-reverses-110-mln-talc-verdict-against-j-j-1028603481
872.0,10/18/2019 1:35:01 PM,"J&J Offers $4 Bln, Teva $15 Bln To Settle Opioid Claims Ahead Of Trial ",RTTNews,/news/stocks/j-j-offers-4-bln-teva-15-bln-to-settle-opioid-claims-ahead-of-trial-1028610613
873.0,10/18/2019 2:55:44 PM,Johnson & Johnson Consumer Recalls Single Lot Of Baby Powder In U.S. ,RTTNews,/news/stocks/johnson-johnson-consumer-recalls-single-lot-of-baby-powder-in-u-s-1028610926
874.0,10/18/2019 3:03:31 PM,Trade Johnson and Johnson Stock to New Highs,InvestorPlace,/news/stocks/trade-johnson-and-johnson-stock-to-new-highs-1028611576
875.0,10/18/2019 3:30:03 PM,3 Earnings Reports to Watch Next Week,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-earnings-calendar-1028224242
876.0,10/18/2019 3:39:03 PM,Johnson & Johnson recalled a batch of baby powder after a test found asbestos. The company says the product is safe. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-jnj-baby-powder-recall-asbestos-in-talc-2019-10
877.0,10/18/2019 7:59:28 PM,"5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP",InvestorPlace,/news/stocks/5-top-stock-trades-for-monday-ba-msft-jnj-snap-axp-1028612006
878.0,10/18/2019 8:07:43 PM,Stock Market Today: High-Growth Hiccup Causes Worries,InvestorPlace,/news/stocks/stock-market-today-high-growth-hiccup-causes-worries-1028612005
879.0,10/18/2019 8:22:05 PM,"Dow Jones Today: Not Upbeat, But Not Too Downbeat",InvestorPlace,/news/stocks/dow-jones-today-not-upbeat-but-not-too-downbeat-1028612172
880.0,10/21/2019 1:20:59 PM,Case Closed: Johnson and Johnson Stock Is a Short,InvestorPlace,/news/stocks/case-closed-johnson-and-johnson-stock-is-a-short-1028615525
881.0,10/21/2019 1:25:49 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Coca-Cola and Boeing",InvestorPlace,/news/stocks/mondays-vital-data-johnson-johnson-coca-cola-and-boeing-1028615524
882.0,10/22/2019 11:24:06 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Adobe, and Applied Materials",InvestorPlace,/news/stocks/3-big-stock-charts-tuesday-johnson-johnson-adobe-applied-materials-1028618545
883.0,10/22/2019 12:20:31 PM,Litigation Dip Is a Buying Opportunity for Johnson and Johnson Stock,InvestorPlace,/news/stocks/buy-the-litigation-dip-in-jnj-stock-1028619588
884.0,10/22/2019 5:50:49 PM,7 Safe Stocks to Buy and Hold Through 2020,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-and-hold-through-2020-1028620495
885.0,10/22/2019 6:58:47 PM,Splunk Stock Could Hit New 2019 Lows,InvestorPlace,/news/stocks/splunk-stock-could-hit-new-2019-lows-1028620786
886.0,10/23/2019 12:04:34 PM,Trade of the Day: Johnson and Johnson Stock‚Äôs Dip Is Signal for the Bulls,InvestorPlace,/news/stocks/trade-of-the-day-johnson-and-johnson-stocks-dip-is-signal-for-the-bulls-1028622955
887.0,10/23/2019 6:24:39 PM,2 Sells and 1 Buy in Opioid Stocks,InvestorPlace,/news/stocks/2-sells-and-1-buy-in-opioid-stocks-1028624856
888.0,10/24/2019 8:00:00 PM,Johnson & Johnson -- Moody's: J&J's proposed opioid agreement credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-s-proposed-opioid-agreement-credit-negative-1028629001
889.0,10/25/2019 11:10:52 AM,Investors Should Short JNJ Stock and Buy Boeing Stock,InvestorPlace,/news/stocks/investors-should-short-jnj-stock-buy-boeing-stock-1028631236
890.0,10/28/2019 6:00:19 PM,Can Johnson and Johnson Survive this Latest Controversy?,InvestorPlace,/news/stocks/can-johnson-and-johnson-survive-this-latest-controversy-1028636605
891.0,10/29/2019 5:28:44 PM,7 Dividend Stocks That Could Struggle to Continue Payout Hikes,InvestorPlace,/news/stocks/7-dividend-stocks-payout-hikes-1028641102
892.0,10/29/2019 8:31:06 PM,Dow Jones Today: Struggling at the Highs,InvestorPlace,/news/stocks/merck-and-pfizer-boosted-the-dow-jones-today-thanks-to-upped-guidance-1028641490
893.0,10/30/2019 2:56:02 PM,Johnson & Johnson Says New Tests Found No Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-says-new-tests-found-no-asbestos-in-baby-powder-1028644202
894.0,10/30/2019 7:45:08 PM,"4 Top Stock Trades for Thursday: FB, JNJ, EA,¬†AMD",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-fb-jnj-ea-amd-1028645841
895.0,10/30/2019 8:21:32 PM,Stock Market Today: Fed Cuts Rates as Stocks Hit Record Highs,InvestorPlace,/news/stocks/stock-market-today-fed-cuts-rates-as-stocks-hit-record-highs-1028645840
896.0,10/30/2019 8:24:41 PM,Dow Jones Today: Another Tepid Reaction to a Fed Rate Cut,InvestorPlace,/news/stocks/the-fed-provided-a-modest-assist-to-the-dow-jones-today-1028645839
897.0,10/31/2019 10:12:04 PM,Ethicon Recalls ECHELON FLEX ENDOPATH Staplers ,RTTNews,/news/stocks/ethicon-recalls-echelon-flex-endopath-staplers-1028650012
898.0,11/5/2019 5:56:46 PM,Consider Purchasing Microsoft Stock While It Is Still a Buy,InvestorPlace,/news/stocks/consider-purchasing-microsoft-stock-buy-1028661616
899.0,11/12/2019 4:56:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1028681878
900.0,11/13/2019 3:35:57 PM,Should Investors Buy Pfizer Stock Before Next Year‚Äôs Huge Shake Up?,InvestorPlace,/news/stocks/should-investors-buy-pfizer-stock-before-next-years-huge-shake-up-1028686378
901.0,11/13/2019 7:34:42 PM,Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?,InvestorPlace,/news/stocks/should-investors-add-johnson-johnson-stock-to-their-shopping-lists-1028686949
902.0,11/18/2019 4:39:09 PM,9 Tantalizing Dividend Stocks for 2020,InvestorPlace,/news/stocks/9-tantalizing-dividend-stocks-for-2020-1028697526
903.0,11/19/2019 3:04:26 PM,"Rebounding Teva Stock Could Climb Higher, But Risks Remain",InvestorPlace,/news/stocks/rebounding-teva-stock-climb-higher-but-risks-remain-1028700876
904.0,11/19/2019 3:24:11 PM,Reduced Opioid Payout Is No Reason to Buy Johnson and Johnson Stock,InvestorPlace,/news/stocks/payout-buy-johnson-and-johnson-stock-1028701422
905.0,11/20/2019 9:22:07 PM,Stock Market Today: Is It Time to Get Worried?¬†,InvestorPlace,/news/stocks/stock-market-today-is-it-time-to-get-worried-1028706167
906.0,11/20/2019 9:32:09 PM,Dow Jones Today: Investors Desperate for a Trade Deal,InvestorPlace,/news/stocks/dow-jones-today-investors-desperate-for-a-trade-deal-1028706165
907.0,11/21/2019 4:31:08 PM,J&J Subsidiary Ethicon Loses Class Action Suit In Australia ,RTTNews,/news/stocks/j-j-subsidiary-ethicon-loses-class-action-suit-in-australia-1028708636
908.0,11/22/2019 9:31:54 PM,"Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow",InvestorPlace,/news/stocks/dow-jones-today-trade-progress-pushes-stocks-healthcare-helps-dow-1028712595
909.0,11/26/2019 3:44:36 PM,7 Unsteady Stocks Investors Should Consider Selling Before 2020,InvestorPlace,/news/stocks/7-stocks-to-sell-investors-selling-2020-1028719195
910.0,12/4/2019 9:36:35 PM,Dow Jones Today: A Trade Redemption Story,InvestorPlace,/news/stocks/dow-jones-today-a-trade-redemption-story-1028738868
911.0,12/5/2019 9:29:26 PM,Dow Jones Today: Trade Influenced Stocks More Than Impeachment News,InvestorPlace,/news/stocks/dow-jones-today-trade-influenced-stocks-more-than-impeachment-news-1028742731
912.0,12/6/2019 2:06:42 PM,10 Stocks That Should Be Every Young Investor‚Äôs First Choice,InvestorPlace,/news/stocks/10-stocks-that-should-be-every-young-investors-first-choice-1028326562
913.0,12/9/2019 3:55:21 AM,Janssen To Buy Investigational Bermekimab From XBiotech ,RTTNews,/news/stocks/janssen-to-buy-investigational-bermekimab-from-xbiotech-1028745938
914.0,12/12/2019 1:09:45 PM,9 Best Dividend Stocks to Buy for Every Investor,InvestorPlace,/news/stocks/best-dividend-stocks-buy-every-investment-strategy-1028237147
915.0,12/17/2019 9:25:49 PM,Stock Market Today: Roku‚Äôs CFO Stepping Down; Buy Microsoft?,InvestorPlace,/news/stocks/stock-market-today-roku-cfo-buy-microsoft-stock-1028770587
916.0,12/17/2019 9:32:10 PM,Dow Jones Today: Stocks Continue Building Momentum,InvestorPlace,/news/stocks/dow-jones-today-stocks-continue-building-momentum-1028770586
917.0,12/19/2019 7:03:33 PM,Why Microsoft Stock Might Take a Pause in 2020,InvestorPlace,/news/stocks/why-microsoft-stock-might-take-a-pause-in-2020-1028777014
918.0,12/19/2019 9:23:44 PM,Dow Jones Today: The Great Melt Up Continues,InvestorPlace,/news/stocks/stocks-advanced-again-as-some-surprises-lifted-the-dow-jones-today-1028777572
919.0,12/20/2019 12:58:16 PM,Johnson & Johnson To Acquire Remaining Stake In Verb Surgical - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-remaining-stake-in-verb-surgical-quick-facts-1028778683
920.0,12/20/2019 4:09:49 PM,7 Best Vanguard ETFs for 2020,InvestorPlace,/news/stocks/7-best-vanguard-etfs-2020-1028779761
921.0,12/20/2019 6:50:00 PM,"LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR",Moodys,/news/bonds/lifescan-global-corporation-moody-s-revises-lifescan-s-outlook-to-negative-affirms-b2-cfr-1028779871
922.0,12/23/2019 11:40:50 AM,"After Moving Higher, Apple May Stop Bearing Fruit While It Corrects",InvestorPlace,/news/stocks/moving-higher-apple-stock-corrects-1028782105
923.0,12/26/2019 10:01:54 AM,Embattled TEVA Has Made Headlines for All of the Wrong Reasons,InvestorPlace,/news/stocks/embattled-teva-has-made-headlines-for-all-of-the-wrong-reasons-1028785016
924.0,1/3/2020 12:40:18 PM,Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock,InvestorPlace,/news/stocks/future-looks-bleak-teva-stock-1028793227
925.0,1/3/2020 6:38:44 PM,"After Lackluster 2019, Pfizer Stock Could Rebound in 2020",InvestorPlace,/news/stocks/after-lackluster-2019-pfizer-stock-could-rebound-in-2020-1028793896
926.0,1/6/2020 5:18:24 PM,7 Investing Resolutions to Follow in 2020,InvestorPlace,/news/stocks/7-investing-resolutions-to-follow-in-2020-1028797249
927.0,1/6/2020 7:03:48 PM,A 2019 Review of Dow Jones Stocks (And What 2020 May Bring),InvestorPlace,/news/stocks/a-2019-review-of-dow-jones-stocks-and-what-2020-may-bring-1028797244
928.0,1/7/2020 4:27:34 PM,Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability,InvestorPlace,/news/stocks/johnson-johnson-stock-serious-legal-liability-1028800497
929.0,1/7/2020 9:35:58 PM,Dow Jones Today: Middle East Focus Factors Into The Equation Again,InvestorPlace,/news/stocks/boeing-supported-the-dow-jones-today-as-a-most-of-the-index-dropped-1028801231
930.0,1/8/2020 2:47:00 PM,The Diagnosis for Teva Stock Still Looks Grim,InvestorPlace,/news/stocks/the-diagnosis-for-teva-stock-still-looks-grim-1028803509
931.0,1/8/2020 5:33:00 PM,"Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable",Moodys,/news/bonds/jabil-inc-moody-s-rates-jabil-s-new-notes-baa3-outlook-stable-1028803822
932.0,1/8/2020 6:03:01 PM,Scandal-Ridden Teva Pharmaceutical Is Fishing for a Bottom,InvestorPlace,/news/stocks/scandals-opioid-teva-stock-fishing-bottom-1028804210
933.0,1/10/2020 4:51:43 PM,3 Biotech Stocks to Bank on for Buyouts in 2020,InvestorPlace,/news/stocks/3-biotech-stocks-buyouts-2020-1028809868
934.0,1/10/2020 5:08:08 PM,7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-or-sell-as-pricing-pressures-mount-1028809866
935.0,1/10/2020 5:18:36 PM,Should Investors Buy Johnson & Johnson Stock Prior to Earnings?,InvestorPlace,/news/stocks/should-investors-buy-johnson-johnson-stock-prior-to-earnings-1028810096
936.0,1/13/2020 9:21:57 PM,Dow Jones Today: Tech Lifts Stocks as Trade Deal Signing Nears,InvestorPlace,/news/stocks/dow-jones-today-tech-lifts-stocks-as-trade-deal-signing-nears-1028814122
937.0,1/14/2020 7:02:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1028817171
938.0,1/15/2020 4:37:07 PM,Pfizer Stock Offers Good Value to Patient Investors,InvestorPlace,/news/stocks/pfizer-stock-offers-good-value-investors-1028820483
939.0,1/21/2020 9:24:41 PM,Dow Jones Today: China Virus Provides an Excuse for Sellers to Sell,InvestorPlace,/news/stocks/dow-jones-today-china-virus-provides-an-excuse-for-sellers-to-sell-1028834066
940.0,1/22/2020 12:35:41 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1028835192
941.0,1/22/2020 1:32:43 PM,Johnson & Johnson Q4 Profit Beats Estimates; Adj. Operational Sales Up 3.4% ,RTTNews,/news/stocks/johnson-johnson-q4-profit-beats-estimates-adj-operational-sales-up-3-4-1028835473
942.0,1/22/2020 5:20:08 PM,Johnson & Johnson Stock Will Continue To Rally Into 2020,InvestorPlace,/news/stocks/jnj-stock-will-continue-to-rally-into-2020-1028837164
943.0,1/22/2020 8:16:02 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower on Q4 Results,InvestorPlace,/news/stocks/johnson-johnson-earnings-drop-jnj-stock-1028837410
944.0,1/22/2020 9:16:11 PM,Stock Market Today: Apple‚Äôs New iPhone; Tesla at $100 Billion,InvestorPlace,/news/stocks/stock-market-today-apples-new-iphone-tesla-at-100-billion-1028837680
945.0,1/22/2020 9:16:44 PM,Dow Jones Today: Stocks Still Rise Despite Mixed Bag With Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-still-rise-despite-mixed-bag-with-earnings-1028837679
946.0,1/27/2020 9:26:45 PM,Stock Market Today: Beyond Meat Grows Partnerships; Coronavirus Cure?,InvestorPlace,/news/stocks/stock-market-today-beyond-meat-grows-partnerships-coronavirus-cure-1028848288
947.0,1/27/2020 9:29:18 PM,"Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks",InvestorPlace,/news/stocks/defensives-lead-the-dow-jones-today-but-not-much-else-worked-1028848287
948.0,1/28/2020 5:42:09 PM,J&J CEO Alex Gorsky testifies that he trusted internal experts as the company remains embroiled in legal disputes over baby powder (JNJ),Business Insider,https://www.businessinsider.com/jj-ceo-alex-gorsky-baby-powder-claims-trusted-internal-experts-2020-1
949.0,1/29/2020 1:27:00 PM,Did Investors Miss Their Chance with Shopify Stock?,InvestorPlace,/news/stocks/did-investors-miss-chance-shopify-stock-1028855888
950.0,1/30/2020 4:40:54 PM,How Disease Outbreaks Affect Stock Prices,InvestorPlace,/news/stocks/how-disease-outbreaks-affect-stock-prices-1028860905
951.0,1/31/2020 3:57:33 AM,Johnson & Johnson Ordered To Pay $344 Mln In California Pelvic Mesh Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-344-mln-in-california-pelvic-mesh-case-1028861914
952.0,2/4/2020 12:30:56 PM,Johnson & Johnson Stock Looks Like a Safe Place to Hide Out,InvestorPlace,/news/stocks/jnj-stock-looks-safe-place-hide-1028871756
953.0,2/5/2020 4:43:16 PM,Coronavirus cases remain modest in U.S.,Seeking Alpha,https://seekingalpha.com/news/3538634-coronavirus-cases-remain-modest-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral
954.0,2/6/2020 1:13:09 PM,Why Johnson & Johnson Is Deceptively Boring,InvestorPlace,/news/stocks/why-jnj-stock-is-deceptively-boring-1028881947
955.0,2/6/2020 10:59:27 PM,Johnson & Johnson told to pay $750M in New Jersey talc case,Seeking Alpha,https://seekingalpha.com/news/3539564-johnson-johnson-told-to-pay-750m-in-new-jersey-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral
956.0,2/7/2020 1:19:14 PM,Can JNJ Stock Keep on Its Current Growth Track?,InvestorPlace,/news/stocks/can-jnj-stock-keep-growing-1028885182
957.0,2/7/2020 2:47:42 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3539712-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral
958.0,2/7/2020 4:30:20 PM,Coronavirus cases inch up in U.S. but still very light,Seeking Alpha,https://seekingalpha.com/news/3539753-coronavirus-cases-inch-up-in-u-s-still-light?utm_source=markets.businessinsider.com&utm_medium=referral
959.0,2/7/2020 6:53:04 PM,Johnson & Johnson Ordered To Pay $750 Mln In New Jersey Baby Powder Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-750-mln-in-new-jersey-baby-powder-case-1028885636
960.0,2/7/2020 7:09:24 PM,With Alibaba Stock the Waiting Is the Hardest Part,InvestorPlace,/news/stocks/with-alibaba-stock-the-waiting-is-the-hardest-part-1028885754
961.0,2/10/2020 8:35:52 PM,"Coronavirus outbreak continues to spread, still largely restricted to Hubei province",Seeking Alpha,https://seekingalpha.com/news/3540190-coronavirus-outbreak-continues-to-spread-still-largely-restricted-to-hubei-province?utm_source=markets.businessinsider.com&utm_medium=referral
962.0,2/11/2020 3:59:54 PM,7 Low-Volatility Stocks to Buy In Jittery Times,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-in-jittery-times-1028894771
963.0,2/13/2020 10:01:01 AM,Is the Bad News Already Baked into Boeing Stock? Maybe,InvestorPlace,/news/stocks/boeing-stock-appears-to-be-on-the-mend-and-may-be-a-tepid-buy-here-1028902147
964.0,2/13/2020 7:25:33 PM,3 Dow Jones Industrial Average Stocks to Sell,InvestorPlace,/news/stocks/3-dow-jones-industrial-average-stocks-to-sell-1028904779
965.0,2/13/2020 9:23:53 PM,Dow Jones Today: Coronavirus Controversy Reemerges,InvestorPlace,/news/stocks/dow-jones-today-coronavirus-controversy-reemerges-1028905225
966.0,2/14/2020 12:14:37 PM,J&J's Stelara shows positive action in late-stage Crohn's study,Seeking Alpha,https://seekingalpha.com/news/3542140-j-and-js-stelara-shows-positive-action-in-late-stage-crohns-study?utm_source=markets.businessinsider.com&utm_medium=referral
967.0,2/14/2020 9:20:40 PM,Dow Jones Today: A Day for Safe Havens,InvestorPlace,/news/stocks/dow-jones-today-a-day-for-safe-havens-1028908217
968.0,2/18/2020 12:57:08 PM,Opioid-related payouts to less than expected - NYT,Seeking Alpha,https://seekingalpha.com/news/3542632-opioid-related-payouts-to-less-expected-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
969.0,2/19/2020 4:55:25 PM,Molecular Templates up 8% on ETB advancement,Seeking Alpha,https://seekingalpha.com/news/3543320-molecular-templates-up-8-on-etb-advancement?utm_source=markets.businessinsider.com&utm_medium=referral
970.0,2/21/2020 2:32:53 PM,Dems attack Trump over stalled efforts to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3544481-dems-attack-trump-over-stalled-efforts-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral
971.0,2/24/2020 4:18:27 PM,3 Healthcare Stocks to Buy This Year,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-this-year-1028932507
972.0,2/27/2020 2:36:23 PM,Fighting The Deadly Coronavirus ,RTTNews,/news/stocks/fighting-the-deadly-coronavirus-1028945765
973.0,3/2/2020 4:32:41 PM,J&J gene therapy nabs accelerated review status in Europe for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3547547-j-and-j-gene-therapy-nabs-accelerated-review-status-in-europe-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral
974.0,3/2/2020 5:51:53 PM,FDA OKs Sanofi drug for previously treated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3547590-fda-oks-sanofi-drug-for-previously-treated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
975.0,3/3/2020 12:01:05 AM,"J&J should separate CEO and chairman roles, shareholder says",Seeking Alpha,https://seekingalpha.com/news/3547836-j-and-j-should-separate-ceo-and-chairman-roles-shareholder-says?utm_source=markets.businessinsider.com&utm_medium=referral
976.0,3/3/2020 6:42:24 PM,"Coronavirus plays - vaccines, drugs & infection control products",Seeking Alpha,https://seekingalpha.com/news/3548189-coronavirus-plays-vaccines-drugs-infection-control-products?utm_source=markets.businessinsider.com&utm_medium=referral
977.0,3/3/2020 9:31:46 PM,Dow Jones Today: Misery Returns as Fed Cuts Fail to Save the Day,InvestorPlace,/news/stocks/dow-jones-today-misery-returns-as-fed-cuts-fail-to-save-the-day-1028961702
978.0,3/4/2020 1:50:04 PM,5 ETFs That Will Help Lower Your Taxes,InvestorPlace,/news/stocks/5-etfs-that-will-help-lower-your-taxes-1028628623
979.0,3/4/2020 4:22:38 PM,8 Stocks to Buy in March for a Coronavirus Rebound,InvestorPlace,/news/stocks/8-stocks-to-buy-in-march-for-a-coronavirus-rebound-1028965222
980.0,3/4/2020 9:15:44 PM,"Dow Jones Today: Primary Results, Stimulus Speculation Prove Potent",InvestorPlace,/news/stocks/dow-jones-today-primary-results-stimulus-speculation-prove-potent-1028966188
981.0,3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral
982.0,3/9/2020 2:43:27 PM,ViiV Healthcare reports positive data on less-frequent dosing of HIV regimen,Seeking Alpha,https://seekingalpha.com/news/3549766-viiv-healthcare-reports-positive-data-on-less-frequent-dosing-of-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral
983.0,3/9/2020 8:31:49 PM,Biotech Stocks: Coronavirus Response Shows How Far We‚Äôve Come ‚Ä¶,InvestorPlace,/news/stocks/biotech-stocks-coronavirus-response-how-far-we-have-come-1028978308
984.0,3/10/2020 2:29:46 PM,Its Powerful Pipeline Shows Pfizer Stock Is Undervalued by 15%,InvestorPlace,/news/stocks/pfe-stock-is-undervalued-by-at-least-15-1028981675
985.0,3/10/2020 3:30:36 PM,9 Recession-Proof Stocks to Disinfect the Coronavirus,InvestorPlace,/news/stocks/9-recession-proof-stocks-to-disinfect-the-coronavirus-1028982558
986.0,3/11/2020 4:06:44 PM,MMM Is a Free Cash Flow Giant Poised to Do Well This Year,InvestorPlace,/news/stocks/mmm-stock-free-cash-flow-giant-1028986979
987.0,3/12/2020 12:07:00 PM,"Moody's ‚Äì More opioid settlements likely in 2020, with mainly negative credit impact for defendants",Moodys,/news/bonds/moody-s-more-opioid-settlements-likely-in-2020-with-mainly-negative-credit-impact-for-defendants-1028989071
988.0,3/12/2020 3:27:26 PM,3 Stocks to Buy That Will Dodge Any Volatile Market,InvestorPlace,/news/stocks/3-stocks-to-buy-that-will-dodge-any-volatile-market-1028990968
989.0,3/13/2020 2:00:29 PM,J&J launches COVID-19 vaccine program,Seeking Alpha,https://seekingalpha.com/news/3551589-j-and-j-launches-covidminus-19-vaccine-program?utm_source=markets.businessinsider.com&utm_medium=referral
990.0,3/13/2020 3:00:51 PM,J&J Collaborates With BIDMC To Accelerate COVID-19 Vaccine Development ,RTTNews,/news/stocks/j-j-collaborates-with-bidmc-to-accelerate-covid-19-vaccine-development-1028994178
991.0,3/13/2020 5:57:01 PM,There‚Äôs Still Time To Buy the Dip in Shopify Stock,InvestorPlace,/news/stocks/theres-still-time-to-buy-the-dip-in-shopify-stock-1028995279
992.0,3/16/2020 11:14:02 AM,U.S. stocks set to gap down at open,Seeking Alpha,https://seekingalpha.com/news/3551922-u-s-stocks-set-to-gap-down-open?utm_source=markets.businessinsider.com&utm_medium=referral
993.0,3/16/2020 2:58:00 PM,Darunavir unlikely to be effective against COVID-19 - J&J,Seeking Alpha,https://seekingalpha.com/news/3552069-darunavir-unlikely-to-be-effective-against-covidminus-19-j-and-j?utm_source=markets.businessinsider.com&utm_medium=referral
994.0,3/16/2020 3:17:06 PM,10 Do‚Äôs and Don‚Äôts for Avoiding the Coronavirus,InvestorPlace,/news/stocks/10-dos-and-donts-for-avoiding-the-coronavirus-1029000781
995.0,3/16/2020 4:02:41 PM,7 Dividend Stocks to Watch for Stable Income,InvestorPlace,/news/stocks/7-dividend-stocks-to-watch-for-stable-income-1029000778
996.0,3/17/2020 11:34:20 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, J.M. Smucker, and Zscaler",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-j-m-smucker-and-zscaler-1029004002
997.0,3/17/2020 1:22:25 PM,Use Johnson & Johnson for Quick Income,InvestorPlace,/news/stocks/use-johnson-johnson-for-quick-income-1029004683
998.0,3/17/2020 4:34:34 PM,J&J Says No Proof To Support Use Of Darunavir For COVID-19 ,RTTNews,/news/stocks/j-j-says-no-proof-to-support-use-of-darunavir-for-covid-19-1029004811
999.0,3/19/2020 6:16:38 AM,"FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study ",RTTNews,/news/stocks/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-1029011073
1000.0,3/19/2020 5:00:38 PM,Profit-taking pressures Moderna after Hahn comments on vaccine timeline,Seeking Alpha,https://seekingalpha.com/news/3553448-profit-taking-pressures-moderna-after-hahn-comments-on-vaccine-timeline?utm_source=markets.businessinsider.com&utm_medium=referral
1001.0,3/20/2020 11:40:07 AM,"TSLA Stock Didn‚Äôt Catch an Unlucky Break, Its Luck Just Ran Out",InvestorPlace,/news/stocks/tsla-stock-luck-ran-out-1029017044
1002.0,3/20/2020 3:23:46 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3553839-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral
1003.0,3/23/2020 5:14:44 PM,Why Shopify Stock Is a Buy on This Pullback,InvestorPlace,/news/stocks/why-shopify-stock-is-a-buy-on-this-pullback-1029024220
1004.0,3/24/2020 12:58:32 PM,J&J finance chief warns on reliability of guidance amid Covid-19 outbreak,Seeking Alpha,https://seekingalpha.com/news/3554647-j-and-j-finance-chief-warns-on-reliability-of-guidance-amid-covidminus-19-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral
1005.0,3/27/2020 2:19:32 PM,CHMP thumbs up for label extensions in Europe,Seeking Alpha,https://seekingalpha.com/news/3555893-chmp-thumbs-up-for-label-extensions-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral
1006.0,3/30/2020 11:31:28 AM,J&J picks lead Covid-19 vaccine candidate; shares up 4% premarket,Seeking Alpha,https://seekingalpha.com/news/3556197-j-and-j-picks-lead-covidminus-19-vaccine-candidate-shares-up-4-premarket?utm_source=markets.businessinsider.com&utm_medium=referral
1007.0,3/30/2020 1:58:25 PM,Johnson & Johnson Identifies Lead COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/johnson-johnson-identifies-lead-covid-19-vaccine-candidate-1029044192
1008.0,3/30/2020 3:15:04 PM,"J&J just sped up the timeline for its coronavirus vaccine, and said it could be ready for emergency use early next year (JNJ)",Business Insider,https://www.businessinsider.com/jj-coronavirus-vaccine-research-timeline-and-emergency-use-2020-3
1009.0,3/30/2020 3:38:45 PM,7 Stocks to Buy for a Dovish Federal Reserve,InvestorPlace,/news/stocks/7-stocks-to-buy-dovish-federal-reserve-1029045589
1010.0,3/30/2020 7:03:03 PM,Johnson & Johnson News: JNJ Stock Jumps 8% on Coronavirus Vaccine Hopes,InvestorPlace,/news/stocks/johnson-johnson-news-coronavirus-vaccine-jnj-stock-up-1029046271
1011.0,3/30/2020 8:00:15 PM,Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnsonjohnson-stock-price-gains-coronavirus-vaccine-timeline-human-testing-september-2020-3-1029045913
1012.0,3/30/2020 8:16:47 PM,Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?,InvestorPlace,/news/stocks/stock-market-today-healthcare-stocks-leads-the-way-buy-zoom-1029046564
1013.0,3/30/2020 8:42:07 PM,"Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks",InvestorPlace,/news/stocks/dow-jones-today-healthcare-help-hopes-worst-may-be-over-lift-stocks-1029046563
1014.0,3/31/2020 6:03:52 AM,"AMRN Loses Legal Fight, AKRO Awaits Big Day, JNJ's Covid-19 Vaccine Study In Sep ",RTTNews,/news/stocks/amrn-loses-legal-fight-akro-awaits-big-day-jnj-s-covid-19-vaccine-study-in-sep-1029046989
1015.0,3/31/2020 11:32:18 AM,"3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals-1029048681
1016.0,3/31/2020 7:33:07 PM,'Like warp speed': J&J's top scientist told us how the pharma giant plans to rapidly test a potential coronavirus vaccine and pump out 1 billion doses (JNJ),Premium,/news/stocks/jj-coronavirus-vaccine-interview-timetable-testing-manufacturing-2020-3
1017.0,4/1/2020 11:50:43 AM,7 Biotech Stocks to Buy That Could Beat the Coronavirus,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-that-could-beat-the-coronavirus-1028882437
1018.0,4/1/2020 2:24:14 PM,Any COVID-19 Vaccine Upside Already Is Built Into MRNA Stock,InvestorPlace,/news/stocks/covid-19-upside-built-into-mrna-stock-1029055594
1019.0,4/1/2020 3:04:17 PM,Avoid Buying General Electric Despite Upside Potential,InvestorPlace,/news/stocks/avoid-buying-ge-stock-despite-upside-potential-1029055588
1020.0,4/1/2020 8:49:52 PM,J&J postpones medical device review,Seeking Alpha,https://seekingalpha.com/news/3557541-j-and-j-postpones-medical-device-review?utm_source=markets.businessinsider.com&utm_medium=referral
1021.0,4/2/2020 8:20:35 PM,Dow Jones Today: Stocks Backflip as Unemployment Picture Darkens,InvestorPlace,/news/stocks/dow-jones-today-stocks-backflip-as-unemployment-picture-darkens-1029060946
1022.0,4/2/2020 9:00:17 PM,Fate Therapeutics up 23% after-hours on J&J cell therapy deal,Seeking Alpha,https://seekingalpha.com/news/3558035-fate-therapeutics-up-23-after-hours-on-j-and-j-cell-therapy-deal?utm_source=markets.businessinsider.com&utm_medium=referral
1023.0,4/3/2020 4:37:17 AM,"Fate Therapeutics Seals Deal With JNJ For Cancer Immunotherapies, Stock Jumps ",RTTNews,/news/stocks/fate-therapeutics-seals-deal-with-jnj-for-cancer-immunotherapies-stock-jumps-1029061143
1024.0,4/6/2020 2:38:38 PM,Healthcare firms pile on initiatives as COVID-19 pandemic advances,Seeking Alpha,https://seekingalpha.com/news/3558642-healthcare-firms-pile-on-initiatives-covidminus-19-pandemic-advances?utm_source=markets.businessinsider.com&utm_medium=referral
1025.0,4/6/2020 6:26:48 PM,Moderna Emerges as Coronavirus Vaccine Leader,InvestorPlace,/news/stocks/moderna-is-soaring-on-covid-19-hopes-but-those-hopes-are-risky-1029069273
1026.0,4/8/2020 3:30:48 PM,"Amazon, Nike and Goldfish big winners in teen survey",Seeking Alpha,https://seekingalpha.com/news/3559378-amazon-nike-and-goldfish-big-winners-in-teen-survey?utm_source=markets.businessinsider.com&utm_medium=referral
1027.0,4/8/2020 6:59:50 PM,Piper Sandler Survey: Top Teen Brands for Spring 2020,InvestorPlace,/news/stocks/top-teen-brands-for-spring-2020-1029077615
1028.0,4/9/2020 5:20:58 PM,Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks,InvestorPlace,/news/stocks/dividend-investors-should-buy-jnj-stock-on-pullbacks-1029081336
1029.0,4/10/2020 7:25:11 PM,J&J drops deal for Takeda's TachoSil surgical patch,Seeking Alpha,https://seekingalpha.com/news/3559944-j-and-j-drops-deal-for-takedas-tachosil-surgical-patch?utm_source=markets.businessinsider.com&utm_medium=referral
1030.0,4/13/2020 3:01:20 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q1-1029085741
1031.0,4/13/2020 4:07:20 PM,"INO Stock May Fade After the Virus, but It Could Rocket to $20 First",InvestorPlace,/news/stocks/ino-stock-could-rocket-20-1029086362
1032.0,4/13/2020 8:23:31 PM,Stock Market Today: Amazon Hiring Spree; Disney Turmoil?,InvestorPlace,/news/stocks/stock-market-today-amazon-hiring-spree-disney-turmoil-1029087117
1033.0,4/13/2020 8:42:28 PM,Dow Jones Today: Stocks Decline Anticipating Q1 Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-decline-anticipating-q1-earnings-1029087115
1034.0,4/13/2020 9:30:21 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3560221-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
1035.0,4/13/2020 9:30:48 PM,Johnson & Johnson Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3560239-johnson-and-amp-johnson-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
1036.0,4/14/2020 11:19:02 AM,J&J delivers strong Q1 but lowers guidance amid COVID-19 headwinds,Seeking Alpha,https://seekingalpha.com/news/3560398-j-and-j-delivers-strong-q1-lowers-guidance-amid-covidminus-19-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral
1037.0,4/14/2020 12:36:30 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1029088737
1038.0,4/14/2020 1:25:39 PM,J&J Q1 Results Top Estimates; Cuts 2020 Outlook Due To COVID-19 Impact ,RTTNews,/news/stocks/j-j-q1-results-top-estimates-cuts-2020-outlook-due-to-covid-19-impact-1029088933
1039.0,4/14/2020 6:38:47 PM,Johnson & Johnson Earnings: JNJ Stock Jumps 5% on Strong Q1,InvestorPlace,/news/stocks/johnson-johnson-earnings-boost-jnj-stock-up-1029091260
1040.0,4/14/2020 8:46:49 PM,Stock Market Today: Earnings Season Begins; Chesapeake Reverse Split,InvestorPlace,/news/stocks/stock-market-today-earnings-season-begins-chesapeake-reverse-split-1029091585
1041.0,4/14/2020 8:49:16 PM,"5 Top Stock Trades for Wednesday: BAC, GS, JNJ, SPCE, SHOP",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-bac-gs-jnj-spce-shop-1029091584
1042.0,4/14/2020 11:03:00 PM,Johnson & Johnson -- Moody's: Coronavirus will temporarily pressure J&J's earnings,Moodys,/news/bonds/johnson-johnson-moody-s-coronavirus-will-temporarily-pressure-j-j-s-earnings-1029091502
1043.0,4/15/2020 11:40:35 AM,"2 Pros, 2 Cons for Investing in Moderna as It Develops Coronavirus Vaccine",InvestorPlace,/news/stocks/mrna-stock-and-coronavirus-vaccine-1029093779
1044.0,4/15/2020 11:48:29 AM,"3 Big Stock Charts for Wednesday: Apple, Paypal, and Johnson & Johnson",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-apple-paypal-and-johnson-johnson-1029093778
1045.0,4/15/2020 3:13:45 PM,RemeGen candidate Fast Track'd for lupus,Seeking Alpha,https://seekingalpha.com/news/3560931-remegen-candidate-fast-trackd-for-lupus?utm_source=markets.businessinsider.com&utm_medium=referral
1046.0,4/15/2020 4:48:31 PM,5 Stocks to Buy For Big Gains On CARES Act Stimulus,InvestorPlace,/news/stocks/5-stocks-to-buy-for-big-gains-on-cares-act-stimulus-1029095722
1047.0,4/15/2020 7:22:26 PM,Johnson & Johnson Stock Is Your Shelter From the Storm,InvestorPlace,/news/stocks/jnj-stock-shelter-from-storm-coronavirus-1029096024
1048.0,4/16/2020 3:19:42 PM,10 Best Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/10-best-stocks-to-buy-and-hold-forever-1028240913
1049.0,4/20/2020 1:46:26 PM,"Trading at 52-Week Highs, LLY Stock Is Already Priced to Perfection",InvestorPlace,/news/stocks/hold-off-overvalued-lly-stock-1029107790
1050.0,4/20/2020 6:09:37 PM,Money flow spikes in COVID-19 vaccine players amid rush for early data,Seeking Alpha,https://seekingalpha.com/news/3562210-money-flow-spikes-in-covidminus-19-vaccine-players-amid-rush-for-early-data?utm_source=markets.businessinsider.com&utm_medium=referral
1051.0,4/21/2020 7:56:51 PM,FDA OK new use of AbbVie's Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3562765-fda-ok-new-use-of-abbvies-imbruvica?utm_source=markets.businessinsider.com&utm_medium=referral
1052.0,4/22/2020 11:38:49 AM,BofA likes Johnson & Johnson in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3562964-bofa-likes-johnson-johnson-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral
1053.0,4/23/2020 11:30:59 AM,Moderna Faces Tough Threats in the Short and Long Term,InvestorPlace,/news/stocks/moderna-faces-tough-threats-in-the-short-and-long-term-1029122410
1054.0,4/23/2020 10:53:28 PM,"Big universities, others to return $350M of PPP loans: coronavirus briefing",Seeking Alpha,https://seekingalpha.com/news/3564009-big-universities-others-to-return-350m-of-ppp-loans-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral
1055.0,4/24/2020 3:20:52 AM,J&J to partner with Emergent Bio on coronavirus vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3564016-j-and-j-to-partner-emergent-bio-on-coronavirus-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
1056.0,4/24/2020 5:05:19 AM,J&J To Expand Manufacturing Capabilities For COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/j-j-to-expand-manufacturing-capabilities-for-covid-19-vaccine-candidate-1029125206
1057.0,4/24/2020 7:43:19 AM,"SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch ",RTTNews,/news/stocks/sava-gets-funding-for-ad-drug-jnj-hits-all-time-high-enz-on-watch-1029125551
1058.0,4/24/2020 1:26:36 PM,J&J files U.S. applications for expanded use of IV golimumab,Seeking Alpha,https://seekingalpha.com/news/3564182-j-and-j-files-u-s-applications-for-expanded-use-of-iv-golimumab?utm_source=markets.businessinsider.com&utm_medium=referral
1059.0,4/24/2020 8:14:04 PM,Stock Market Today: Facebook vs. Zoom; AT&T CEO Leaves,InvestorPlace,/news/stocks/stock-market-today-facebook-vs-zoom-att-ceo-leaves-1029128556
1060.0,4/27/2020 8:35:40 AM,Heartburn meds for COVID-19? NY is trying it,Seeking Alpha,https://seekingalpha.com/news/3564475-heartburn-meds-for-covidminus-19-ny-is-trying?utm_source=markets.businessinsider.com&utm_medium=referral
1061.0,4/27/2020 10:10:49 AM,J&J files application in Japan for subcutaneous formulation of Darzalex,Seeking Alpha,https://seekingalpha.com/news/3564504-j-and-j-files-application-in-japan-for-subcutaneous-formulation-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral
1062.0,4/27/2020 1:52:56 PM,Don‚Äôt Let Negative Data Dissuade You from Gilead Sciences,InvestorPlace,/news/stocks/dont-let-negative-data-dissuade-you-from-gilead-sciences-1029133468
1063.0,4/27/2020 7:16:56 PM,J&J must face talc lawsuits - New Jersey court,Seeking Alpha,https://seekingalpha.com/news/3564835-j-and-j-must-face-talc-lawsuits-new-jersey-court?utm_source=markets.businessinsider.com&utm_medium=referral
1064.0,4/27/2020 7:52:32 PM,How to Invest With Deflation on the Horizon,InvestorPlace,/news/stocks/how-to-invest-with-deflation-on-horizon-1029134529
1065.0,4/28/2020 9:01:07 AM,The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors,InvestorPlace,/news/stocks/the-abbvie-buyout-is-not-a-sure-thing-for-allergan-stock-investors-1029137151
1066.0,4/28/2020 11:28:34 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-merck-and-bristol-myers-squibb-1029137983
1067.0,4/28/2020 11:32:55 AM,Wells softens view on Edwards Lifesciences in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3565181-wells-softens-view-on-edwards-lifesciences-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral
1068.0,4/28/2020 11:44:49 AM,UBS heads to sidelines on J&J after big rally,Seeking Alpha,https://seekingalpha.com/news/3565191-ubs-heads-to-sidelines-on-j-and-j-after-big-rally?utm_source=markets.businessinsider.com&utm_medium=referral
1069.0,4/28/2020 12:51:00 PM,9 Healthcare Stocks to Buy Even After the Coronavirus Fades,InvestorPlace,/news/stocks/9-healthcare-stocks-buy-even-after-coronavirus-1029139171
1070.0,4/28/2020 4:56:14 PM,"Pfizer to make ""hundreds of millions"" doses of COVID-19 vaccine next year - CEO",Seeking Alpha,https://seekingalpha.com/news/3565400-pfizer-to-make-hundreds-of-millions-doses-of-covidminus-19-vaccine-next-year-ceo?utm_source=markets.businessinsider.com&utm_medium=referral
1071.0,4/28/2020 9:37:18 PM,9 Stocks to Buy to Weather the Recession,InvestorPlace,/news/stocks/9-stocks-to-buy-to-weather-the-recession-1029055060
1072.0,4/29/2020 12:51:50 AM,COVID-19 vaccine could be ready for emergency use by fall,Seeking Alpha,https://seekingalpha.com/news/3565740-covidminus-19-vaccine-be-ready-for-emergency-use-fall?utm_source=markets.businessinsider.com&utm_medium=referral
1073.0,4/29/2020 6:00:46 PM,What Lies Ahead for Vaccine Development and INO Stock in May?,InvestorPlace,/news/stocks/what-lies-ahead-for-vaccine-development-and-ino-stock-in-may-1029146509
1074.0,4/30/2020 10:00:55 AM,"Moderna Stock Is Near Highs, But Faces Risk",InvestorPlace,/news/stocks/moderna-stock-is-near-highs-but-faces-risk-1029149020
1075.0,5/1/2020 2:58:48 AM,Shot Roster: COVID-19 Vaccines In Human Trials ,RTTNews,/news/stocks/shot-roster-covid-19-vaccines-in-human-trials-1029154136
1076.0,5/1/2020 2:27:51 PM,10 Dow Jones Stocks to Keep Your Portfolio Afloat,InvestorPlace,/news/stocks/10-dow-jones-stocks-to-keep-your-portfolio-afloat-1029155699
1077.0,5/1/2020 6:41:32 PM,FDA OKs subcutaneous version of J&J's Darzalex,Seeking Alpha,https://seekingalpha.com/news/3567772-fda-oks-subcutaneous-version-of-j-and-js-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral
1078.0,5/4/2020 12:55:21 PM,iBio Stock Is Too Risky,InvestorPlace,/news/stocks/ibio-is-in-the-coronavirus-vaccine-mix-but-its-still-risky-1029160950
1079.0,5/5/2020 6:18:48 PM,3 Healthcare Stocks Popping Off Support,InvestorPlace,/news/stocks/3-healthcare-stocks-popping-off-support-1029167820
1080.0,5/5/2020 8:35:00 PM,"LifeScan Global Corporation -- Moody's downgrades LifeScan's CFR to B3, stable outlook",Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-s-cfr-to-b3-stable-outlook-1029167567
1081.0,5/7/2020 8:42:45 PM,Dow Jones Today: Jobless Claims Soar But Stocks Do Too,InvestorPlace,/news/stocks/tech-lifted-the-dow-jones-today-as-nasdaq-goes-green-on-the-year-1029180374
1082.0,5/11/2020 5:59:24 PM,7 Winning Stocks and 3 Losing Stocks to Watch Right Now,InvestorPlace,/news/stocks/winning-stocks-losing-stocks-watch-right-now-coronavirus-1029188685
1083.0,5/12/2020 12:38:10 PM,7 Dividend Stocks That You Can Still Bank On,InvestorPlace,/news/stocks/7-dividend-stocks-that-you-can-still-bank-on-1029192814
1084.0,5/13/2020 1:45:18 PM,7 Tech Industry Dividend Stocks for Growth and Income,InvestorPlace,/news/stocks/7-tech-industry-dividend-stocks-1028478920
1085.0,5/13/2020 3:05:47 PM,FDA accepts Arbor Pharma application for ADHD med AR19,Seeking Alpha,https://seekingalpha.com/news/3573965-fda-accepts-arbor-pharma-application-for-adhd-med-ar19?utm_source=markets.businessinsider.com&utm_medium=referral
1086.0,5/14/2020 8:10:17 PM,Halozyme bags $15M milestone from J&J under Enhanze license,Seeking Alpha,https://seekingalpha.com/news/3574681-halozyme-bags-15m-milestone-from-j-and-j-under-enhanze-license?utm_source=markets.businessinsider.com&utm_medium=referral
1087.0,5/18/2020 1:13:47 PM,"If You‚Äôre Bullish on the Internet, Be Bullish on Shopify Stock",InvestorPlace,/news/stocks/if-youre-bullish-on-the-internet-be-bullish-on-shopify-stock-1029211448
1088.0,5/18/2020 8:30:31 PM,Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher,InvestorPlace,/news/stocks/dow-jones-today-vaccine-news-and-fed-talk-powered-markets-higher-1029212694
1089.0,5/19/2020 9:09:36 PM,Does Moderna Stock‚Äôs Rally Hold Up Under the Microscope?,InvestorPlace,/news/stocks/mrna-stock-rally-microscope-coronavirus-vaccine-1029217325
1090.0,5/20/2020 4:32:25 AM,Johnson & Johnson To Stop Selling Talc-based Baby Powder In North America ,RTTNews,/news/stocks/johnson-johnson-to-stop-selling-talc-based-baby-powder-in-north-america-1029217492
1091.0,5/20/2020 8:58:59 PM,Dow Jones Today: Pent Up Demand and Reopening in Sight,InvestorPlace,/news/stocks/dow-jones-today-pent-up-demand-and-reopening-in-sight-1029221833
1092.0,5/21/2020 9:16:53 AM,The Virus Vaccine Race is Fueling Moderna Stock to New Highs,InvestorPlace,/news/stocks/the-virus-vaccine-race-is-fueling-moderna-stock-to-new-highs-1029222715
1093.0,5/21/2020 1:54:41 PM,7 Dow Jones Stocks to Buy With Fortress-Like Balance Sheets,InvestorPlace,/news/stocks/7-dow-jones-stocks-to-buy-with-fortress-like-balance-sheets-1029223935
1094.0,5/21/2020 3:00:43 PM,The Rewards Outweigh the Risks for Moderna Stock,InvestorPlace,/news/stocks/the-rewards-outweigh-the-risks-for-moderna-stock-1029224348
1095.0,5/27/2020 11:48:12 AM,Why Did Lincoln Park Capital Just Buy a Million Shares of iBio Stock?,InvestorPlace,/news/stocks/why-lincoln-park-capital-bought-million-shares-ibio-stock-1029237335
1096.0,5/29/2020 11:34:37 AM,European advisory group backs J&J Ebola vaccine regimen,Seeking Alpha,https://seekingalpha.com/news/3578594-european-advisory-group-backs-j-and-j-ebola-vaccine-regimen?utm_source=markets.businessinsider.com&utm_medium=referral
1097.0,5/29/2020 3:33:21 PM,J&J Gets Positive CHMP Opinion For Investigational Preventive Ebola Vaccine Regimen ,RTTNews,/news/stocks/j-j-gets-positive-chmp-opinion-for-investigational-preventive-ebola-vaccine-regimen-1029263538
1098.0,5/29/2020 4:34:10 PM,"'99%' chance Covid-19 vaccine will be effective, Sinovac claims",Seeking Alpha,https://seekingalpha.com/news/3578690-99-percent-chance-covidminus-19-vaccine-will-be-effective-sinovac-claims?utm_source=markets.businessinsider.com&utm_medium=referral
1099.0,6/2/2020 11:35:10 AM,Sanofi's isatuximab OK'd in Europe for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3579477-sanofis-isatuximab-okd-in-europe-for-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1100.0,6/2/2020 1:16:22 PM,The Best 5 Stocks to Buy on the Next Dip,InvestorPlace,/news/stocks/5-stocks-to-buy-next-dip-1029273033
1101.0,6/4/2020 6:37:03 AM,"List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps  On MISSION ",RTTNews,/news/stocks/list-of-operation-warp-speed-finalists-sava-to-reassess-ad-study-results-kzr-jumps-on-mission-1029279089
1102.0,6/5/2020 1:52:42 PM,China in thick of race for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3580791-china-in-thick-of-race-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1103.0,6/8/2020 4:08:25 PM,Inovio Slumps as Its Setbacks Pile Up,InvestorPlace,/news/stocks/inovio-slumps-as-its-setbacks-pile-up-1029289728
1104.0,6/8/2020 4:14:39 PM,The Odds For Long Shot Inovio Stock Just Got Longer,InvestorPlace,/news/stocks/the-odds-for-long-shot-ino-stock-just-got-longer-1029290046
1105.0,6/9/2020 3:10:56 PM,Aggressive Investors Can Do Much Better Than Merck Stock,InvestorPlace,/news/stocks/aggressive-investors-better-mrk-stock-1029293865
1106.0,6/9/2020 3:49:54 PM,7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-buy-coronavirus-gains-1029293862
1107.0,6/10/2020 1:54:15 PM,Johnson & Johnson accelerates start of COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3581918-johnson-johnson-accelerates-start-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1108.0,6/10/2020 3:19:36 PM,Three key studies of COVID-19 vaccines to launch in summer,Seeking Alpha,https://seekingalpha.com/news/3581971-three-key-studies-of-covidminus-19-vaccines-to-launch-in-summer?utm_source=markets.businessinsider.com&utm_medium=referral
1109.0,6/10/2020 4:04:48 PM,Johnson & Johnson To Begin First-in-human Trial Of COVID-19 Vaccine Candidate In July ,RTTNews,/news/stocks/johnson-johnson-to-begin-first-in-human-trial-of-covid-19-vaccine-candidate-in-july-1029297243
1110.0,6/11/2020 3:22:25 PM,Momentum mover candidates on a down market day,Seeking Alpha,https://seekingalpha.com/news/3582348-momentum-mover-candidates-on-down-market-day?utm_source=markets.businessinsider.com&utm_medium=referral
1111.0,6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the COVID-19 recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covidminus-19-recession?utm_source=markets.businessinsider.com&utm_medium=referral
1112.0,6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the covid recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covid-recession?utm_source=markets.businessinsider.com&utm_medium=referral
1113.0,6/15/2020 9:49:26 AM,Janssen: Long-term Trial Shows TREMFYA As Efficacious Therapy In Plaque Psoriasis ,RTTNews,/news/stocks/janssen-long-term-trial-shows-tremfya-as-efficacious-therapy-in-plaque-psoriasis-1029307015
1114.0,6/15/2020 1:37:36 PM,Band-Aid To Launch Black And Brown Bandages For Diverse Skin ,RTTNews,/news/stocks/band-aid-to-launch-black-and-brown-bandages-for-diverse-skin-1029307775
1115.0,6/15/2020 4:56:24 PM,5 Cheap Growth Stocks With Attractive Dividend Yields,InvestorPlace,/news/stocks/5-cheap-growth-stocks-attractive-dividend-yields-1029309729
1116.0,6/16/2020 5:49:43 PM,Pfizer and Merck's diabetes med Steglatro shows mixed results in cardiovascular outcomes study,Seeking Alpha,https://seekingalpha.com/news/3583523-pfizer-and-mercks-diabetes-med-steglatro-shows-mixed-results-in-cardiovascular-outcomes-study?utm_source=markets.businessinsider.com&utm_medium=referral
1117.0,6/18/2020 10:16:36 AM,"3 Pros, 3 Cons For Buying iBio Stock Right Now",InvestorPlace,/news/stocks/3-pros-cons-of-buying-ibio-stock-right-now-1029321599
1118.0,6/18/2020 2:08:10 PM,Stay Safe on the Sidelines With Inovio Stock,InvestorPlace,/news/stocks/pandemic-fading-hold-off-ino-stock-1029322421
1119.0,6/18/2020 4:05:39 PM,10 Robotics Stocks on the Technological Cutting Edge,InvestorPlace,/news/stocks/10-robotics-stocks-cutting-edge-1029322986
1120.0,6/18/2020 6:06:48 PM,3 Reasons Clorox Stock Is a Buy Right Now,InvestorPlace,/news/stocks/3-reasons-clorox-clx-stock-is-a-buy-right-now-1029323448
1121.0,6/18/2020 6:07:14 PM,3 Dow Jones Companies to Buy as Markets Get Volatile,InvestorPlace,/news/stocks/3-dow-jones-companies-to-buy-as-markets-get-volatile-1029323447
1122.0,6/22/2020 12:00:59 PM,Ride Out the Choppy Seas and Buy Royal Caribbean,InvestorPlace,/news/stocks/ride-out-the-choppy-seas-and-buy-royal-caribbean-rcl-stock-1029329112
1123.0,6/23/2020 9:15:26 PM,J&J Damages Cut By More Than Half In Talcum Powder Cancer Suit ,RTTNews,/news/stocks/j-j-damages-cut-by-more-than-half-in-talcum-powder-cancer-suit-1029335440
1124.0,6/26/2020 2:16:18 AM,10 Recession-Proof Stocks to Weather the Storm,InvestorPlace,/news/stocks/10-stocks-to-buy-to-weather-the-recession-1029173355
1125.0,6/26/2020 1:59:03 PM,Alibaba Stock Won‚Äôt Be Left Behind Smaller Rivals Forever,InvestorPlace,/news/stocks/alibaba-stock-wont-be-left-behind-smaller-rivals-forever-1029346118
1126.0,6/30/2020 3:56:56 AM,9 All-Around Dividend Stocks to Tough It Out,InvestorPlace,/news/stocks/best-dividend-stocks-to-buy-for-every-investor-1028788633
1127.0,6/30/2020 2:47:33 PM,3 Reasons to Buy the Ad Boycott Dip in FB Stock,InvestorPlace,/news/stocks/3-reasons-buy-ad-boycott-dip-fb-stock-1029355526
1128.0,7/2/2020 2:04:27 PM,Buy Opko Stock For Two Ways to Play the Ongoing Pandemic,InvestorPlace,/news/stocks/buy-opko-stock-for-two-ways-to-play-the-ongoing-pandemic-1029363124
1129.0,7/2/2020 5:02:06 PM,"Keep an Eye on Royalty Pharma Stock, 2020‚Äôs Biggest IPO",InvestorPlace,/news/stocks/keep-eye-rprx-stock-2020-1029363917
1130.0,7/6/2020 10:40:08 AM,Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years,InvestorPlace,/news/stocks/rprx-stock-is-likely-to-reach-new-highs-coming-years-1029368649
1131.0,7/6/2020 1:07:37 PM,Emergent Signs 5-yr Manufacturing Deal For Johnson & Johnson's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/emergent-signs-5-yr-manufacturing-deal-for-johnson-johnson-s-covid-19-vaccine-candidate-1029368443
1132.0,7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965
1133.0,7/6/2020 6:43:12 PM,Moderna Stock Has a Bright Future After the Coronavirus,InvestorPlace,/news/stocks/moderna-mrna-stock-coronavirus-vaccine-drug-discovery-1029370223
1134.0,7/6/2020 7:05:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new senior notes,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-senior-notes-1029369827
1135.0,7/10/2020 5:10:55 PM,INO Stock Could Receive Operation Warp Speed Funding Soon,InvestorPlace,/news/stocks/ino-stock-could-receive-operation-warp-speed-funding-soon-1029384591
1136.0,7/10/2020 7:19:51 PM,A Safer Way to Play IBio Stock Could Spread Like the Coronavirus¬†,InvestorPlace,/news/stocks/a-safer-way-to-play-ibio-stock-could-spread-like-the-coronavirus-1029384769
1137.0,7/14/2020 1:13:14 PM,"With Earnings in Sight, Johnson & Johnson Stock Looks Perfectly Healthy",InvestorPlace,/news/stocks/with-earnings-in-sight-jnj-stock-looks-perfectly-healthy-1029392989
1138.0,7/14/2020 1:19:36 PM,Quick Income from a Put Write on Johnson & Johnson,InvestorPlace,/news/stocks/quick-income-from-a-put-write-on-johnson-johnson-1029392988
1139.0,7/15/2020 3:01:26 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q2-1029397198
1140.0,7/16/2020 12:44:01 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1029400773
1141.0,7/16/2020 12:59:11 PM,Johnson & Johnson Boosts FY20 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy20-outlook-quick-facts-1029400798
1142.0,7/16/2020 6:28:20 PM,JNJ Stock: 4 Things to Know About Johnson & Johnson Q2 Earnings,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-q2-earnings-1029403303
1143.0,7/17/2020 1:55:45 PM,3 Best Long-Term Stocks to Set and Forget,InvestorPlace,/news/stocks/the-best-long-term-stocks-feature-growth-and-lower-volatility-1029405444
1144.0,7/21/2020 5:25:42 PM,4 Top Blue-Chip Stocks for Peace of Mind,InvestorPlace,/news/stocks/4-top-blue-chip-stocks-for-peace-of-mind-1029416248
1145.0,7/22/2020 12:27:19 PM,The Curtain Is Coming Down on Inovio Pharmaceuticals‚Äô Vaccine Candidate,InvestorPlace,/news/stocks/curtain-coming-down-on-ino-stock-1029420801
1146.0,7/22/2020 1:54:28 PM,Sell Overpriced Novavax Stock While You Still Can,InvestorPlace,/news/stocks/why-you-should-sell-nvax-stock-while-you-still-can-1029420794
1147.0,7/23/2020 10:31:35 AM,History and Competition Suggest Caution Toward Inovio Stock,InvestorPlace,/news/stocks/history-competition-caution-ino-stock-1029424603
1148.0,7/27/2020 1:25:18 PM,iBio Stock Has Tripled in a Few Weeks. Here‚Äôs What‚Äôs Next,InvestorPlace,/news/stocks/ibio-stock-tripled-now-what-1029434265
1149.0,7/28/2020 2:07:24 PM,Sintx Joins List of Highly Speculative Covid-19 Plays,InvestorPlace,/news/stocks/sintx-technologies-stock-speculative-covid-19-play-1029439555
1150.0,7/29/2020 3:53:42 PM,5 Dental Stocks to Buy For Big Smiles As Coronavirus Fears Ease,InvestorPlace,/news/stocks/5-dental-stocks-to-buy-for-big-smiles-as-coronavirus-fears-ease-1029446842
1151.0,7/30/2020 11:26:46 AM,Buy Exxon Stock at $44 Before It Recovers,InvestorPlace,/news/stocks/xom-stock-exxon-mobil-recover-soon-1029451792
1152.0,7/30/2020 11:58:29 AM,J&J's Single Dose COVID-19 Vaccine Candidate Shows Robust Protection In Pre-clinical Studies ,RTTNews,/news/stocks/j-j-s-single-dose-covid-19-vaccine-candidate-shows-robust-protection-in-pre-clinical-studies-1029449823
1153.0,7/30/2020 12:14:19 PM,A More Sustainable Business Model Doesn‚Äôt Make iBio Stock Less Risky,InvestorPlace,/news/stocks/sustainable-business-model-ibio-stock-risky-1029451784
1154.0,8/3/2020 2:54:47 PM,5 Healthcare Stocks for Good (Portfolio) Health,InvestorPlace,/news/stocks/5-healthcare-stocks-for-good-portfolio-health-1029462755
1155.0,8/4/2020 3:55:00 PM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029467707
1156.0,8/4/2020 5:08:35 PM,Don‚Äôt Count on Inovio To Deliver a Covid-19 Vaccine,InvestorPlace,/news/stocks/dont-count-on-inovio-pharmaceuticals-ino-stock-covid-19-vaccine-1029478836
1157.0,8/5/2020 4:21:00 AM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029469394
1158.0,8/5/2020 2:48:51 PM,Janssen Pharma Enters Deal With U.S. Government On 100 Mln Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/janssen-pharma-enters-deal-with-u-s-government-on-100-mln-doses-of-covid-19-vaccine-1029472652
1159.0,8/6/2020 12:10:24 PM,"As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet",InvestorPlace,/news/stocks/vaccine-looks-likely-mrna-stock-still-is-a-good-bet-1029478835
1160.0,8/6/2020 1:38:49 PM,The Best Dividend Stocks to Buy in 9 Sectors,InvestorPlace,/news/stocks/the-best-dividend-stocks-to-buy-in-9-sectors-1029478830
1161.0,8/6/2020 5:51:20 PM,5 Biotech Stocks That Offer Long-Term Growth and Value,InvestorPlace,/news/stocks/5-biotech-stocks-that-offer-long-term-growth-and-value-1029479695
1162.0,8/7/2020 9:09:38 PM,The Top 7 Blue-Chip Stocks for the Rest of 2020,InvestorPlace,/news/stocks/the-top-7-blue-chip-stocks-for-the-rest-of-2020-1029497294
1163.0,8/12/2020 5:59:57 AM,U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/u-s-reaches-deal-with-moderna-for-100-million-doses-of-covid-19-vaccine-1029494061
1164.0,8/12/2020 3:25:00 PM,The 10 Top Stocks to Buy and Hold Into 2021,InvestorPlace,/news/stocks/the-10-top-stocks-to-buy-and-hold-into-2021-1029497764
1165.0,8/12/2020 7:30:33 PM,7 of the Best Index Funds to Buy on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-index-funds-to-buy-on-the-market-today-1029498343
1166.0,8/14/2020 4:38:20 PM,10 Nasdaq Stocks to Buy and Hold for the Long Haul,InvestorPlace,/news/stocks/10-nasdaq-stocks-to-buy-and-hold-for-the-long-haul-1029505887
1167.0,8/19/2020 12:46:56 PM,Johnson & Johnson To Acquire Momenta Pharmaceuticals - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-momenta-pharmaceuticals-quick-facts-1029516037
1168.0,8/19/2020 2:39:01 PM,Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover,Business Insider,https://www.businessinsider.com/momenta-pharmaceuticals-stock-price-johnson-johnson-acquisition-deal-autoimmune-drugs-2020-8
1169.0,8/19/2020 5:26:00 PM,Johnson & Johnson -- Moody's affirms J&J's Aaa rating; negative outlook,Moodys,/news/bonds/johnson-johnson-moody-s-affirms-j-j-s-aaa-rating-negative-outlook-1029517573
1170.0,8/19/2020 5:29:31 PM,Buying iBio As a Vaccine Winner Is a Waste of Money,InvestorPlace,/news/stocks/ibio-stock-is-a-waste-of-money-as-covid-19-vaccine-winner-1029518046
1171.0,8/19/2020 6:46:01 PM,Momenta Pharmaceuticals News: MNTA Stock Rockets 69% on JNJ Deal,InvestorPlace,/news/stocks/momenta-pharmaceuticals-news-sends-mnta-stock-soaring-1029518297
1172.0,8/20/2020 8:43:27 AM,"JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch ",RTTNews,/news/stocks/jnj-acquires-mnta-fda-strikes-down-bmrn-s-gene-therapy-blrx-s-genesis-on-track-tptx-on-watch-1029519157
1173.0,8/20/2020 6:17:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; outlook negative,Moodys,/news/bonds/johnson-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-outlook-negative-1029521758
1174.0,8/21/2020 5:34:04 AM,Amgen : FDA Approves New KYPROLIS For Multiple Myeloma ,RTTNews,/news/stocks/amgen-fda-approves-new-kyprolis-for-multiple-myeloma-1029522678
1175.0,8/21/2020 10:31:25 AM,There Are Still Too Many Risks In iBio Stock,InvestorPlace,/news/stocks/still-too-many-risks-ibio-stock-1029523762
1176.0,8/21/2020 3:31:12 PM,Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma,InvestorPlace,/news/stocks/lly-stock-still-looks-like-best-buy-large-cap-pharma-1029524567
1177.0,8/21/2020 4:04:40 PM,7 Safe Stocks to Buy That Can Shrug Off the Growing Volatility,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-that-can-shrug-off-the-growing-volatility-1029524563
1178.0,8/24/2020 11:19:04 PM,20 Stable Stocks to Buy If You‚Äôre Still Betting on America to Thrive,InvestorPlace,/news/stocks/20-stocks-to-buy-if-youre-betting-on-america-1029203418
1179.0,8/25/2020 7:05:31 PM,"Inovio Stock Is a Sideshow, Not a Serious Investment",InvestorPlace,/news/stocks/inovio-stock-is-a-sideshow-not-a-serious-investment-1029533338
1180.0,8/26/2020 11:16:15 AM,Buyout Excitement Is Already Priced Into Momenta Pharmaceuticals,InvestorPlace,/news/stocks/buyout-excitement-is-already-priced-into-momenta-pharmaceuticals-stock-1029535445
1181.0,8/26/2020 12:04:28 PM,3 Key Questions to Ask Before Buying Novavax,InvestorPlace,/news/stocks/3-key-questions-before-buying-nvax-stock-1029535441
1182.0,8/26/2020 7:42:20 PM,CureVac Is a Bet on a Safe and Effective Vaccine,InvestorPlace,/news/stocks/curevac-stock-bet-on-covid-19-vaccine-could-produce-68-percent-roi-1029537603
1183.0,8/26/2020 9:30:05 PM,30 Dividend Stocks to Buy Now for 20 Years of Income Growth,InvestorPlace,/news/stocks/30-dividend-stocks-to-buy-for-20-years-of-income-growth-1029537832
1184.0,8/27/2020 11:35:20 AM,"After a 30% Surge, Is It Time to Buy iBio Stock Again?¬†",InvestorPlace,/news/stocks/after-a-30-surge-is-it-time-to-buy-ibio-stock-again-1029539794
1185.0,8/28/2020 2:10:18 PM,7 Companies That Should Split Their Stocks,InvestorPlace,/news/stocks/7-companies-should-have-stock-splits-following-apple-tesla-1029544430
1186.0,8/31/2020 6:18:04 PM,Why Johnson & Johnson Remains a Risky Bet,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-remains-a-risky-bet-despite-its-financial-condition-1029549615
1187.0,8/31/2020 11:44:00 PM,Jabil Inc. -- Moody's affirms Jabil's Baa3 senior unsecured rating; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-affirms-jabil-s-baa3-senior-unsecured-rating-outlook-stable-1029549821
1188.0,9/2/2020 11:30:52 AM,Bet on Wild Swings in the Market With the SPXL ETF,InvestorPlace,/news/stocks/bet-on-wild-swings-in-the-market-with-spxl-stock-1029555951
1189.0,9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234
1190.0,9/2/2020 2:36:56 PM,"At This Point, iBioPharma Is a Flash in the Pandemic",InvestorPlace,/news/stocks/at-this-point-ibio-stock-is-a-flash-in-the-pandemic-1029557232
1191.0,9/3/2020 12:54:31 PM,10 Blue-Chip Stocks Ideal for Any Investor,InvestorPlace,/news/stocks/10-blue-chip-stocks-ideal-for-any-investor-1029560529
1192.0,9/4/2020 11:10:20 PM,COVID-19 vaccine developers prepare joint pledge on safety - WSJ,Seeking Alpha,https://seekingalpha.com/news/3611895-covidminus-19-vaccine-developers-prepare-joint-pledge-on-safety-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
1193.0,9/7/2020 6:19:22 PM,Trump considers 'decoupling' U.S. from China,Seeking Alpha,https://seekingalpha.com/news/3611949-trump-considers-decoupling-u-s-from-china?utm_source=markets.businessinsider.com&utm_medium=referral
1194.0,9/8/2020 3:33:54 AM,EC OKs expanded use of J&J's Imbruvica + Rituximab for leukemia,Seeking Alpha,https://seekingalpha.com/news/3611954-ec-oks-expanded-use-of-j-and-js-imbruvica-rituximab-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral
1195.0,9/9/2020 2:36:39 PM,The Top 7 Healthcare Stocks You Should Be Watching,InvestorPlace,/news/stocks/the-top-7-healthcare-stocks-you-should-be-watching-1029355520
1196.0,9/10/2020 11:42:10 AM,"As Its Vaccine Dreams Fade, Inovio Stock Will Keep Retreating",InvestorPlace,/news/stocks/ino-stock-retreating-vaccine-1029577589
1197.0,9/10/2020 1:15:35 PM,"Carnival Is Not Going Bankrupt, But Only Risk-Tolerant Investors Should Buy CCL Stock",InvestorPlace,/news/stocks/go-long-on-ccl-stock-if-you-can-stomach-a-bit-of-risk-1029578640
1198.0,9/14/2020 5:13:03 PM,7 Coronavirus Vaccine Stocks to Watch as Approval Nears,InvestorPlace,/news/stocks/7-coronavirus-vaccine-stocks-watch-approval-hopefully-nears-1029587809
1199.0,9/17/2020 2:51:41 PM,6 Dividend Stocks To Buy For Stable Yield And Growth Potential,InvestorPlace,/news/stocks/6-dividend-stocks-to-buy-for-stable-yield-and-growth-potential-1029599920
1200.0,9/18/2020 9:31:13 AM,20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening,InvestorPlace,/news/stocks/20-20-genesystems-stock-leveraging-ai-for-more-accurate-cancer-screening-1029601945
1201.0,9/18/2020 1:51:10 PM,Why Novartis‚Äô Absence From the Covid-19 Vaccine Race Is a Benefit,InvestorPlace,/news/stocks/novartis-stock-absence-covid-19-vaccine-race-benefit-1029602941
1202.0,9/18/2020 3:04:05 PM,6 Long-Term Stocks to See You Through the Bad Times,InvestorPlace,/news/stocks/6-long-term-stocks-to-see-you-through-the-bad-times-1029603332
1203.0,9/18/2020 3:24:21 PM,"Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses ",RTTNews,/news/stocks/europe-signs-deal-with-sanofi-gsk-to-secure-up-to-300-mln-covid-19-vaccine-doses-1029602745
1204.0,9/21/2020 6:21:15 PM,Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare,Business Insider,https://www.businessinsider.com/healthcare-stock-prices-ruth-bader-ginsburg-death-obamacare-uncertainty-insurance-2020-9
1205.0,9/21/2020 6:28:06 PM,Compass Pathways IPO: 5 Things for Potential CMPS Investors to Know,InvestorPlace,/news/stocks/compass-pathways-ipo-5-things-for-potential-cmps-investors-to-know-1029608581
1206.0,9/22/2020 5:19:01 PM,"Keep An Eye On Novavax, But Keep Your Money In Your Pocket",InvestorPlace,/news/stocks/keep-an-eye-on-novavax-nvax-stock-but-keep-your-money-in-your-pocket-1029612589
1207.0,9/23/2020 12:05:31 PM,There Simply Isn‚Äôt Enough Good News for iBio,InvestorPlace,/news/stocks/simply-not-enough-good-news-ibio-stock-1029615057
1208.0,9/23/2020 1:00:21 PM,JNJ Initiates Pivotal Global Phase 3 Clinical Trial Of Janssen's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/jnj-initiates-pivotal-global-phase-3-clinical-trial-of-janssen-s-covid-19-vaccine-candidate-1029614548
1209.0,9/23/2020 1:06:52 PM,Johnson & Johnson News: JNJ Stock Pops on Late-Stage Vaccine Trials,InvestorPlace,/news/stocks/johnson-johnson-news-jnj-stock-pops-on-late-stage-vaccine-trials-1029615936
1210.0,9/23/2020 5:08:22 PM,Aggressive Investors Have No Excuse for Not Owning Moderna,InvestorPlace,/news/stocks/aggressive-investors-have-no-excuse-for-not-owning-moderna-mrna-stock-at-this-stage-of-the-game-cseo-1029616770
1211.0,9/23/2020 8:57:04 PM,"4 Top Stock Trades for Thursday: NKE, CHWY, JNJ, WORK",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-nke-chwy-jnj-work-1029617227
1212.0,9/24/2020 7:21:39 AM,"JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch ",RTTNews,/news/stocks/jnj-begins-phase-3-covid-19-vaccine-trial-another-headstone-in-alzheimer-s-graveyard-pfe-on-watch-1029617682
1213.0,9/24/2020 10:10:57 AM,7 of the Best Penny Stocks to Buy Now,InvestorPlace,/news/stocks/7-of-the-best-penny-stocks-to-buy-now-1029330493
1214.0,9/25/2020 9:16:35 AM,Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock,InvestorPlace,/news/stocks/bmy-stock-worth-46-percent-more-based-on-history-and-comps-1029623231
1215.0,9/25/2020 5:00:08 PM,NVAX Stock: Novavax Rallies After Entering Phase 3 Vaccine Trials,InvestorPlace,/news/stocks/nvax-stock-novavax-rallies-after-entering-phase-3-vaccine-trials-1029623831
1216.0,9/28/2020 12:40:39 PM,Inovio Stock Still Has Real Promise Despite Faltering in Vaccine Race,InvestorPlace,/news/stocks/ino-stock-promising-despite-vaccine-race-1029627233
1217.0,9/29/2020 2:48:42 PM,Deep Diving the Complex Narrative Behind Novavax,InvestorPlace,/news/stocks/deep-diving-complex-narrative-nvax-stock-novavax-cseo-1029632023
1218.0,9/29/2020 6:52:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1029632178
1219.0,9/30/2020 12:55:36 PM,The 7 Best 401k Investments to Enrich Your Retirement,InvestorPlace,/news/stocks/the-7-best-401k-investments-to-enrich-your-retirement-1029635832
1220.0,10/1/2020 5:00:25 AM,Novavax Gains With Start of Phase 3 Vaccine Trial,InvestorPlace,/news/stocks/nvax-stock-gains-with-phase-3-trial-1029641338
1221.0,10/2/2020 12:09:03 PM,"If You‚Äôre Not a Speculator, You Should Avoid iBio",InvestorPlace,/news/stocks/if-youre-not-a-speculator-you-should-avoid-ibio-1029643897
1222.0,10/2/2020 4:12:40 PM,The Real Value in Novavax Goes Beyond the Coronavirus,InvestorPlace,/news/stocks/influenza-vaccine-gives-nvax-stock-value-cseo-1029645075
1223.0,10/2/2020 5:01:29 PM,iBio Is a Pure Spec Play That Remains a Day Trader‚Äôs Delight,InvestorPlace,/news/stocks/ibio-stock-is-a-pure-spec-play-that-remains-a-day-traders-delight-1029645068
1224.0,10/5/2020 1:00:54 PM,7 Sizzling Hot Stocks to Buy Now Amid Even Hotter Politics,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-amid-even-hotter-politics-1029648698
1225.0,10/5/2020 2:24:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648147
1226.0,10/5/2020 2:25:32 PM,This Is Why I‚Äôd Still Avoid IBio for Now,InvestorPlace,/news/stocks/this-is-why-id-still-avoid-vaccine-stock-ibio-for-now-cseo-1029649209
1227.0,10/5/2020 2:41:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648241
1228.0,10/5/2020 5:43:41 PM,Moderna Is Ready To Rally After 2-Month Market Correction,InvestorPlace,/news/stocks/moderna-mrna-stock-is-ready-to-rally-after-2-month-market-correction-1029649495
1229.0,10/5/2020 6:28:38 PM,Investors Should Proceed With Caution in Sorrento Stock,InvestorPlace,/news/stocks/investors-should-proceed-with-caution-in-sorrento-stock-1029662225
1230.0,10/6/2020 2:12:30 PM,FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements,Seeking Alpha,https://seekingalpha.com/news/3620151-fda-ad-com-this-month-to-clarify-covidminus-19-vaccine-authorization-requirements?utm_source=markets.businessinsider.com&utm_medium=referral
1231.0,10/6/2020 2:15:27 PM,J&J's Biosense Webster gets FDA nod for ablation catheter for atrial fibrillation,Seeking Alpha,https://seekingalpha.com/news/3620137-j-and-js-biosense-webster-gets-fda-nod-for-ablation-catheter-for-atrial-fibrillation?utm_source=markets.businessinsider.com&utm_medium=referral
1232.0,10/6/2020 2:44:51 PM,The 7 Best New Stocks From 2020 to Buy Now,InvestorPlace,/news/stocks/the-7-best-new-stocks-from-2020-to-buy-now-1029653691
1233.0,10/6/2020 3:22:31 PM,"Psychedelics the ""next big thing"" in treating mental health disorders",Seeking Alpha,https://seekingalpha.com/news/3619871-psychedelics-next-big-thing-in-treating-mental-health-disorders?utm_source=markets.businessinsider.com&utm_medium=referral
1234.0,10/6/2020 6:12:37 PM,The Deep Price Pullback Is Your Signal to Buy Novavax,InvestorPlace,/news/stocks/the-deep-price-pullback-is-your-signal-to-buy-nvax-stock-1029654462
1235.0,10/6/2020 6:36:01 PM,Get Out of IBIO Stock Before It‚Äôs Too Late,InvestorPlace,/news/stocks/get-out-of-ibio-stock-before-its-too-late-cseo-1029658676
1236.0,10/6/2020 9:13:19 PM,7 High-Growth Value Stocks for a Post-Pandemic Future,InvestorPlace,/news/stocks/7-value-stocks-to-buy-post-pandemic-future-1029654705
1237.0,10/7/2020 9:31:16 AM,5 Blue-chip Stocks to Buy on a Discount to Fortify Portfolios,InvestorPlace,/news/stocks/wmt-pfe-jpm-ko-jnj-5-blue-chip-stocks-to-buy-1029656064
1238.0,10/7/2020 12:28:15 PM,Inovio Pharmaceuticals Does Not Need Any More Misfortune,InvestorPlace,/news/stocks/ino-stock-needs-change-fortunes-1029657681
1239.0,10/7/2020 2:11:17 PM,Does Sorrento Therapeutics Meet the ‚ÄòSAD‚Äô Criteria for Vaccines?,InvestorPlace,/news/stocks/does-srne-stock-meet-sad-criteria-for-covid-vaccines-1029657676
1240.0,10/7/2020 4:27:48 PM,7 Biotech Stocks To Buy For Profit From The Vaccine Crunch,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-for-profit-from-the-vaccine-crunch-1029658673
1241.0,10/8/2020 11:28:38 AM,Spinal Elements to issue 7.7M shares in IPO at $13-$15 per share,Seeking Alpha,https://seekingalpha.com/news/3620718-spinal-elements-to-issue-7_7m-shares-in-ipo-13-15-per-share?utm_source=markets.businessinsider.com&utm_medium=referral
1242.0,10/8/2020 11:55:08 AM,The Risk-to-Reward Proposition for Sorrento Has Gone Bad,InvestorPlace,/news/stocks/the-risk-to-reward-proposition-for-sorrento-therapeutics-srne-stock-has-gone-negative-1029661288
1243.0,10/8/2020 12:04:17 PM,J&J to supply up to 400M doses of COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3620741-j-and-j-to-supply-up-to-400m-doses-of-covidminus-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral
1244.0,10/8/2020 2:10:04 PM,Johnson & Johnson: European Commission Approves Agreement To Supply COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-european-commission-approves-agreement-to-supply-covid-19-vaccine-1029661273
1245.0,10/9/2020 10:45:57 AM,7 Index Funds to Hold Through Thick and Thin,InvestorPlace,/news/stocks/7-index-funds-to-hold-through-thick-and-thin-1029665545
1246.0,10/9/2020 12:13:20 PM,7 Stocks You Can Buy to Help Save the Planet,InvestorPlace,/news/stocks/esg-investing-7-stocks-buy-help-save-the-planet-environment-1029621059
1247.0,10/9/2020 7:00:01 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3621193-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1248.0,10/12/2020 8:38:11 AM,Janssen reports long-term results from late-stage IM-UNITI study in inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/3621286-janssen-reports-long-term-results-from-late-stage-im-uniti-study-in-inflammatory-bowel?utm_source=markets.businessinsider.com&utm_medium=referral
1249.0,10/12/2020 10:48:20 AM,Head of Operation Warp Speed sees emergency authorization vaccine request around Thanksgiving,Seeking Alpha,https://seekingalpha.com/news/3621297-head-of-operation-warp-speed-sees-emergency-authorization-vaccine-request-around-thanksgiving?utm_source=markets.businessinsider.com&utm_medium=referral
1250.0,10/12/2020 3:01:20 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1029669986
1251.0,10/12/2020 3:35:50 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3621436-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
1252.0,10/12/2020 5:12:04 PM,Johnson & Johnson Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3621474-johnson-johnson-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
1253.0,10/12/2020 7:06:31 PM,Novavax Is Incredibly Risky but Worth a Small Allocation,InvestorPlace,/news/stocks/nvax-stock-is-incredibly-risky-but-worth-a-small-allocation-1029671346
1254.0,10/12/2020 8:17:47 PM,Q3 earnings ringing in; FactSet sees drop in earnings across sectors,Seeking Alpha,https://seekingalpha.com/news/3621517-q3-earnings-ringing-in-factset-sees-drop-in-earnings-across-sectors?utm_source=markets.businessinsider.com&utm_medium=referral
1255.0,10/12/2020 8:58:31 PM,7 Highly Rated Pharmaceutical Stocks for Q4,InvestorPlace,/news/stocks/7-highly-rated-pharmaceutical-stocks-for-q4-1029679826
1256.0,10/12/2020 11:30:42 PM,Johnson & Johnson sued over Auris Health payouts,Seeking Alpha,https://seekingalpha.com/news/3621554-johnson-johnson-sued-over-auris-health-payouts?utm_source=markets.businessinsider.com&utm_medium=referral
1257.0,10/13/2020 2:33:03 AM,J&J vaccine study paused due to unexplained illness in participant,Seeking Alpha,https://seekingalpha.com/news/3621557-j-and-j-vaccine-study-paused-due-to-unexplained-illness-in-participant?utm_source=markets.businessinsider.com&utm_medium=referral
1258.0,10/13/2020 5:14:47 AM,J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness ,RTTNews,/news/stocks/j-j-pauses-late-stage-covid-19-vaccine-trial-on-unexplained-illness-1029671663
1259.0,10/13/2020 8:32:35 AM,First case of COVID-19 reinfection confirmed in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral
1260.0,10/13/2020 10:41:23 AM,"Johnson & Johnson beats on earnings, raises FY20 guidance",Seeking Alpha,https://seekingalpha.com/news/3621594-johnson-johnson-beats-on-earnings-raises-fy20-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
1261.0,10/13/2020 11:12:02 AM,J&J Darzalex sales up 44%; FY20 outlook raise tops consensus,Seeking Alpha,https://seekingalpha.com/news/3621605-j-and-j-darzalex-sales-up-44-fy20-outlook-raise-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
1262.0,10/13/2020 12:44:27 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1029673178
1263.0,10/13/2020 1:26:14 PM,Johnson & Johnson Q3 Results Top Estimates; Boosts FY20 Outlook ,RTTNews,/news/stocks/johnson-johnson-q3-results-top-estimates-boosts-fy20-outlook-1029673428
1264.0,10/13/2020 2:57:02 PM,Johnson & Johnson falls despite earnings beat after pausing COVID-19 vaccine trial over 'unexplained illness',Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jnj-earnings-covid19-vaccine-illness-2020-10
1265.0,10/13/2020 3:35:23 PM,Novavax Stock Stalemate Is About to Catch Fire,InvestorPlace,/news/stocks/nvax-stock-stalemate-is-about-to-catch-fire-1029675475
1266.0,10/13/2020 3:37:22 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower as Vaccine Trial Pause Overshadows Q3 Beat,InvestorPlace,/news/stocks/johnson-johnson-earnings-jnj-stock-ticks-lower-as-vaccine-trial-pause-overshadows-q3-beat-1029675474
1267.0,10/13/2020 4:30:12 PM,Inovio Stock Is a Great Long Setup for an Overreaction Trade,InvestorPlace,/news/stocks/ino-stock-is-a-great-long-setup-for-an-overreaction-trade-1029675876
1268.0,10/14/2020 8:31:39 AM,"LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS ",RTTNews,/news/stocks/lly-pauses-covid-19-antibody-trial-jnj-boosts-annual-outlook-double-whammy-for-goss-1029677498
1269.0,10/14/2020 1:03:22 PM,Health care holding up despite COVID setbacks: At the Open,Seeking Alpha,https://seekingalpha.com/news/3622071-health-care-holding-up-despite-covid-setbacks-open?utm_source=markets.businessinsider.com&utm_medium=referral
1270.0,10/15/2020 11:30:19 PM,9 Stocks to Buy for a Wild Ride in October,InvestorPlace,/news/stocks/9-stocks-to-buy-for-a-wild-ride-in-july-1029381606
1271.0,10/16/2020 11:58:35 AM,Biden Town Hall: 4 Key Investing Takeaways,InvestorPlace,/news/stocks/biden-town-hall-4-key-investing-takeaways-1029688135
1272.0,10/16/2020 1:03:00 PM,7 Short-Term Stocks to Make a Quick Buck,InvestorPlace,/news/stocks/7-short-term-stocks-to-buy-for-quick-buck-1029688757
1273.0,10/16/2020 2:37:50 PM,GSK Says Viiv Healthcare Gets Positive CHMP Opinion For Long-acting HIV Regimen ,RTTNews,/news/stocks/gsk-says-viiv-healthcare-gets-positive-chmp-opinion-for-long-acting-hiv-regimen-1029688318
1274.0,10/16/2020 5:53:26 PM,Can Cytonics Pivot Successfully to Covid-19 Therapeutics?,InvestorPlace,/news/stocks/cytonics-stock-pivot-coronavirus-therapeutics-1029689508
1275.0,10/16/2020 5:53:36 PM,Novavax Stock Looks Volatile As Vaccine Enthusiasm Wanes,InvestorPlace,/news/stocks/nvax-stock-looks-volatile-as-vaccine-enthusiasm-wanes-1029689507
1276.0,10/16/2020 7:30:50 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3622976-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1277.0,10/19/2020 4:58:50 PM,Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets,Seeking Alpha,https://seekingalpha.com/news/3623326-pfizer-and-moderna-pivotal-studies-on-covidminus-19-vaccines-near-enrollment-targets?utm_source=markets.businessinsider.com&utm_medium=referral
1278.0,10/19/2020 5:25:37 PM,Why the FDA‚Äôs Inquiry of Inovio Is More Critical Than You Think,InvestorPlace,/news/stocks/why-fda-inquiry-very-critical-ino-stock-1029694935
1279.0,10/19/2020 5:50:56 PM,The Low-Hanging Fruit for Covid-19 Vaccines Is Gone for iBio,InvestorPlace,/news/stocks/ibio-stock-no-more-low-hanging-fruit-1029694932
1280.0,10/20/2020 7:18:42 AM,Moderna not far behind Pfizer on vaccine emergency authorization,Seeking Alpha,https://seekingalpha.com/news/3623490-moderna-not-far-behind-pfizer-on-vaccine-emergency-authorization?utm_source=markets.businessinsider.com&utm_medium=referral
1281.0,10/21/2020 2:10:42 PM,OxyContin maker Purdue Pharma to plead guilty to three criminal charges,Seeking Alpha,https://seekingalpha.com/news/3624251-oxycontin-maker-purdue-pharma-to-plead-guilty-to-three-criminal-charges?utm_source=markets.businessinsider.com&utm_medium=referral
1282.0,10/21/2020 4:35:08 PM,"While Risky, Sorrento Therapeutics Has Many Options to Win",InvestorPlace,/news/stocks/while-risky-sorrento-therapeutics-has-many-options-to-win-1029706542
1283.0,10/21/2020 5:43:16 PM,FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3624369-fda-ad-com-tomorrow-on-development-authorization-of-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1284.0,10/21/2020 7:49:40 PM,Key U.S. COVID-19 vaccine trials set to resume,Seeking Alpha,https://seekingalpha.com/news/3624430-key-u-s-covidminus-19-vaccine-trials-set-to-resume?utm_source=markets.businessinsider.com&utm_medium=referral
1285.0,10/21/2020 7:50:43 PM,Sorrento Therapeutics Is a Vaccine Movie That Investors Have Already Seen,InvestorPlace,/news/stocks/lack-of-covid-19-focus-could-hinder-srne-stock-1029706960
1286.0,10/21/2020 9:05:18 PM,J&J's daratumumab extends survival in first-line multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3624549-j-and-js-daratumumab-extends-survival-in-first-line-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1287.0,10/22/2020 5:31:38 PM,Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?,InvestorPlace,/news/stocks/is-it-too-late-for-novavax-to-profit-from-a-covid-19-vaccine-1029712056
1288.0,10/22/2020 6:08:42 PM,Time Is Running Out on Inovio as Other Vaccine Candidates Advance,InvestorPlace,/news/stocks/time-is-running-out-on-ino-stock-as-other-vaccine-candidates-advance-1029712050
1289.0,10/22/2020 6:21:39 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3624985-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
1290.0,10/23/2020 3:25:03 PM,FDA getting cold feet on EUA nod for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3625386-fda-getting-cold-feet-on-eua-nod-for-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1291.0,10/23/2020 6:23:01 PM,Can Novavax Stock Overcome Growing Vaccine Distrust?,InvestorPlace,/news/stocks/novavax-nvax-stock-not-a-win-on-astrazeneca-blunder-1029716054
1292.0,10/23/2020 10:11:16 PM,J&J to resume pivotal study of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3625481-j-and-j-to-resume-pivotal-study-of-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1293.0,10/26/2020 10:41:53 AM,"Fauci Says Covid Vaccine's Safety, Efficacy Will Be Known By Dec ",RTTNews,/news/stocks/fauci-says-covid-vaccine-s-safety-efficacy-will-be-known-by-dec-1029719925
1294.0,10/26/2020 5:03:44 PM,3 Blue Chip Stocks to Buy for Safe Dividends,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-safe-dividends-1029722331
1295.0,10/27/2020 1:34:57 PM,7 Cheap Index Funds for the Careful Investor,InvestorPlace,/news/stocks/7-cheap-index-funds-to-buy-for-the-careful-investor-1029728195
1296.0,10/27/2020 9:10:05 PM,Don‚Äôt Be Fazed by the Recent Market Volatility,InvestorPlace,/news/stocks/why-im-not-fazed-by-the-recent-market-volatility-1029729497
1297.0,10/28/2020 11:52:24 AM,Vaccine Hopeful Novavax Could Be Worth a Shot,InvestorPlace,/news/stocks/vaccine-hopeful-novavax-could-be-worth-a-shot-1029734122
1298.0,10/28/2020 4:39:57 PM,"U.S. COVID-19 cases on the rise, key vaccine data expected in November",Seeking Alpha,https://seekingalpha.com/news/3627364-u-s-covidminus-19-cases-on-rise-key-vaccine-data-expected-in-november?utm_source=markets.businessinsider.com&utm_medium=referral
1299.0,10/29/2020 11:53:30 AM,IBIO Stock Remains a Speculative Biopharma Play,InvestorPlace,/news/stocks/ibio-stock-remains-a-speculative-biopharma-play-1029741060
1300.0,10/29/2020 4:46:15 PM,Why Palantir May Be a Solid Covid-19 Play,InvestorPlace,/news/stocks/why-palantir-may-be-a-solid-covid-19-play-1029742932
1301.0,10/30/2020 10:44:17 AM,"Protagonist Therapeutics, Janssen advance oral IL-23 receptor antagonists program",Seeking Alpha,https://seekingalpha.com/news/3628947-protagonist-therapeutics-janssen-advance-oral-ilminus-23-receptor-antagonists-program?utm_source=markets.businessinsider.com&utm_medium=referral
1302.0,10/30/2020 3:21:03 PM,Regeneron : IDMC Recommends To Hold Enrollment In Hospitalized High Risk COVID-19 Patients ,RTTNews,/news/stocks/regeneron-idmc-recommends-to-hold-enrollment-in-hospitalized-high-risk-covid-19-patients-1029746946
1303.0,10/30/2020 6:43:02 PM,J&J to test coronavirus vaccine in youngsters,Seeking Alpha,https://seekingalpha.com/news/3629207-j-and-j-to-test-coronavirus-vaccine-in-youngsters?utm_source=markets.businessinsider.com&utm_medium=referral
1304.0,10/31/2020 6:00:00 AM,"Vaccine developers take varied approaches to COVID-19, next-gen platforms may not be better than more traditional technologies",Seeking Alpha,https://seekingalpha.com/news/3629098-vaccine-developers-take-varied-approaches-to-covidminus-19-next-gen-platforms-may-not-be?utm_source=markets.businessinsider.com&utm_medium=referral
1305.0,11/2/2020 12:14:11 PM,J&J files U.S. application for twice yearly dosing of schizophrenia med,Seeking Alpha,https://seekingalpha.com/news/3629520-j-and-j-files-u-s-application-for-twice-yearly-dosing-of-schizophrenia-med?utm_source=markets.businessinsider.com&utm_medium=referral
1306.0,11/2/2020 1:14:27 PM,A Lot of News Isn‚Äôt Necessarily Good News for Sorrento Therapeutics,InvestorPlace,/news/stocks/lot-news-good-news-srne-stock-1029754095
1307.0,11/2/2020 4:11:03 PM,5 Industries Biden Would Destroy as President,InvestorPlace,/news/stocks/election-stocks-sell-5-industries-threatened-biden-victory-1029754646
1308.0,11/2/2020 8:19:18 PM,7 Hot Stocks¬†To Buy With Mega-Cap Status,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-with-mega-cap-status-1029755365
1309.0,11/3/2020 1:04:10 PM,Sorrento Therapeutics Is Charming But Read the Label,InvestorPlace,/news/stocks/srne-stock-charming-but-read-label-1029758584
1310.0,11/3/2020 6:32:00 PM,Brazil on board with resumption of J&J COVID-19 vaccine study,Seeking Alpha,https://seekingalpha.com/news/3630627-brazil-on-board-resumption-of-j-and-j-covidminus-19-vaccine-study?utm_source=markets.businessinsider.com&utm_medium=referral
1311.0,11/3/2020 8:13:53 PM,J&J strikes out with appeal of $2.1B talc judgement in Missouri,Seeking Alpha,https://seekingalpha.com/news/3630709-j-and-j-strikes-out-appeal-of-2_1b-talc-judgement-in-missouri?utm_source=markets.businessinsider.com&utm_medium=referral
1312.0,11/5/2020 2:46:54 PM,India races ahead with COVID-19 vaccine as AstraZeneca deliveries lag,Seeking Alpha,https://seekingalpha.com/news/3632254-india-races-ahead-covidminus-19-vaccine-astrazeneca-deliveries-lag?utm_source=markets.businessinsider.com&utm_medium=referral
1313.0,11/5/2020 8:06:56 PM,Cytonics: Invest In A Startup That‚Äôs Targeting Osteoarthritis,InvestorPlace,/news/stocks/cytonics-invest-in-a-startup-thats-targeting-osteoarthritis-1029772608
1314.0,11/6/2020 1:49:30 PM,J&J to host device update November 19,Seeking Alpha,https://seekingalpha.com/news/3633158-j-and-j-to-host-device-update-november-19?utm_source=markets.businessinsider.com&utm_medium=referral
1315.0,11/6/2020 3:34:01 PM,Drug wholesalers and J&J agree to tentative $26B deal to settle opioid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3633211-drug-wholesalers-and-j-and-j-agree-to-tentative-26b-deal-to-settle-opioid-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral
1316.0,11/7/2020 5:30:00 AM,Biogen's long and winding road in Alzheimer's hits wall,Seeking Alpha,https://seekingalpha.com/news/3633230-biogens-long-and-winding-road-in-alzheimers-hits-wall?utm_source=markets.businessinsider.com&utm_medium=referral
1317.0,11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301
1318.0,11/9/2020 12:07:49 PM,"Pfizer/BioNTech COVID-19 vaccine 90% effective, U.S. EUA application expected this month",Seeking Alpha,https://seekingalpha.com/news/3633509-pfizer-biontech-covidminus-19-vaccine-90-effective-u-s-eua-application-expected-this-month?utm_source=markets.businessinsider.com&utm_medium=referral
1319.0,11/9/2020 6:32:14 PM,Don‚Äôt Expect Massive Short-Term Gains in Novavax Stock Right Now,InvestorPlace,/news/stocks/dont-expect-massive-short-term-gains-in-novavax-nvax-stock-1029783007
1320.0,11/9/2020 6:52:11 PM,"Despite Ethical Issues, Palantir Is a Can‚Äôt-Miss Opportunity",InvestorPlace,/news/stocks/despite-ethical-issues-pltr-stock-is-a-cant-miss-opportunity-1029783005
1321.0,11/9/2020 8:30:43 PM,3 Dividend Stocks With Super-Safe Payouts,InvestorPlace,/news/stocks/3-dividend-stocks-with-super-safe-payouts-jnj-1029783354
1322.0,11/10/2020 1:02:00 PM,Novavax Steals Some of Pfizer‚Äôs Thunder With Fast Track Designation,InvestorPlace,/news/stocks/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation-1029786505
1323.0,11/10/2020 7:24:22 PM,7 Dividend Stocks To Buy For Post-Election Volatility,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-post-election-volatility-1029789073
1324.0,11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408
1325.0,11/11/2020 4:50:34 PM,7 Biotech Penny Stocks Worth a Gamble,InvestorPlace,/news/stocks/7-biotech-stocks-to-gamble-with-1029793010
1326.0,11/11/2020 6:40:36 PM,Good News for Society Isn‚Äôt Necessarily So for Slack Stock,InvestorPlace,/news/stocks/good-news-for-society-is-not-great-for-slack-stock-1029793372
1327.0,11/12/2020 9:49:16 AM,"Amid cold-storage hurdle, Sanofi and J&J may beat logistical challenges",Seeking Alpha,https://seekingalpha.com/news/3635295-amid-cold-storage-hurdle-sanofi-and-j-and-j-may-beat-logistical-challenges?utm_source=markets.businessinsider.com&utm_medium=referral
1328.0,11/12/2020 12:22:36 PM,J&J files applications for subcutaneous Darzalex in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3635397-j-and-j-files-applications-for-subcutaneous-darzalex-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1329.0,11/12/2020 6:48:30 PM,Emergent BioSolutions in focus on upcoming 60 Minutes episode,Seeking Alpha,https://seekingalpha.com/news/3635657-emergent-biosolutions-in-focus-on-upcoming-60-minutes-episode?utm_source=markets.businessinsider.com&utm_medium=referral
1330.0,11/13/2020 4:29:50 PM,Acceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studies,Seeking Alpha,https://seekingalpha.com/news/3636208-accelerons-sotatercept-shows-positive-action-in-mid-stage-pulmonary-arterial-hypertension?utm_source=markets.businessinsider.com&utm_medium=referral
1331.0,11/13/2020 6:05:40 PM,7 Value Stocks That Could Make You the Next Warren Buffett,InvestorPlace,/news/stocks/7-value-stocks-that-could-make-you-the-next-warren-buffett-1029802378
1332.0,11/13/2020 8:00:17 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3636251-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1333.0,11/14/2020 5:00:41 PM,"J&J, U.S. Expand Agreement To Support Next Phase Of COVID-19 Vaccine R&D ",RTTNews,/news/stocks/j-j-u-s-expand-agreement-to-support-next-phase-of-covid-19-vaccine-r-d-1029803409
1334.0,11/15/2020 5:29:46 PM,J&J expands partnership with HHS in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3636401-j-and-j-expands-partnership-hhs-in-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1335.0,11/16/2020 8:45:14 AM,COVID-19 Vaccines - The Blues And Ease Of Cold Storage ,RTTNews,/news/stocks/covid-19-vaccines-the-blues-and-ease-of-cold-storage-1029804652
1336.0,11/16/2020 12:20:35 PM,"Moderna shares jump 12% as COVID-19 vaccine shows 94.5% efficacy, expects EUA submission shortly",Seeking Alpha,https://seekingalpha.com/news/3636472-moderna-shares-jump-12-covidminus-19-vaccine-shows-94_5-efficacy-expects-eua-submission?utm_source=markets.businessinsider.com&utm_medium=referral
1337.0,11/16/2020 12:49:36 PM,"Moderna's COVID-19 vaccine candidate has longer shelf life, to remain stable at 2¬∞ to 8¬∞C",Seeking Alpha,https://seekingalpha.com/news/3636496-modernas-covidminus-19-vaccine-candidate-longer-shelf-life-to-remain-stable-2-to-8-c?utm_source=markets.businessinsider.com&utm_medium=referral
1338.0,11/16/2020 4:00:50 PM,7 Vanguard Funds With Ultra Low Expenses,InvestorPlace,/news/stocks/7-vanguard-funds-with-ultra-low-expenses-1029807476
1339.0,11/17/2020 7:55:22 AM,J&J tests new two-dose regimen for COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3636937-j-and-j-tests-new-two-dose-regimen-for-covidminus-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
1340.0,11/17/2020 8:10:16 AM,"ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective ",RTTNews,/news/stocks/admp-snubbed-again-fda-delay-s-decision-on-bmy-s-liso-cel-mrna-s-covid-19-vaccine-94-5-effective-1029809234
1341.0,11/17/2020 11:45:38 AM,Is messenger RNA technology in COVID-19 a new tool to success?,Seeking Alpha,https://seekingalpha.com/news/3636976-is-messenger-rna-technology-in-covidminus-19-new-tool-to-success?utm_source=markets.businessinsider.com&utm_medium=referral
1342.0,11/17/2020 3:10:41 PM,7 Pharmaceutical Stocks to Buy for 2021 and Beyond¬†,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond-1029811903
1343.0,11/17/2020 7:36:43 PM,Sell Novavax Stock After Its Huge Gain,InvestorPlace,/news/stocks/sell-novavax-stock-after-its-huge-gain-1029813268
1344.0,11/17/2020 9:22:53 PM,J&J expects data for U.S. authorization of COVID-19 vaccine by February - Reuters,Seeking Alpha,https://seekingalpha.com/news/3637280-j-and-j-expects-data-for-u-s-authorization-of-covidminus-19-vaccine-february-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1345.0,11/19/2020 10:01:06 AM,5 Index Funds That Belong In Any Portfolio Seeking Diversification,InvestorPlace,/news/stocks/5-index-funds-vfiax-vgt-vti-swppx-gold-that-help-you-sleep-soundly-1029819756
1346.0,11/19/2020 10:02:20 AM,FDA plans early advisory meetings in December to discuss COVID-19 vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3637799-fda-plans-early-advisory-meetings-in-december-to-discuss-covidminus-19-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral
1347.0,11/19/2020 6:40:32 PM,CDC warns against Thanksgiving travel amid COVID spike,Seeking Alpha,https://seekingalpha.com/news/3638052-cdc-warns-against-thanksgiving-travel-amid-covid-spike?utm_source=markets.businessinsider.com&utm_medium=referral
1348.0,11/20/2020 7:59:23 AM,"EU may approve BioNtech, Moderna vaccines in December, could pay $10B for doses",Seeking Alpha,https://seekingalpha.com/news/3638224-eu-may-approve-biontech-moderna-vaccines-in-december-pay-10b-for-doses?utm_source=markets.businessinsider.com&utm_medium=referral
1349.0,11/20/2020 1:02:28 PM,Inovio Gets the Go-Ahead But It‚Äôs Probably Too Late,InvestorPlace,/news/stocks/ino-stock-gets-go-ahead-but-probably-too-late-1029824918
1350.0,11/20/2020 5:50:42 PM,7 Hot Stocks to Buy Before 2021 Ushers in Change,InvestorPlace,/news/stocks/7-of-the-hot-stocks-to-buy-before-2021-ushers-in-change-1029826116
1351.0,11/22/2020 2:12:08 PM,Vaccine access and distribution a big topic at G20,Seeking Alpha,https://seekingalpha.com/news/3638524-vaccine-access-and-distribution-big-topic-g20?utm_source=markets.businessinsider.com&utm_medium=referral
1352.0,11/23/2020 8:02:44 AM,"All eyes on AstraZeneca-Oxford shot after strong Pfizer, Moderna results",Seeking Alpha,https://seekingalpha.com/news/3638538-all-eyes-on-astrazeneca-oxford-shot-after-strong-pfizer-moderna-results?utm_source=markets.businessinsider.com&utm_medium=referral
1353.0,11/23/2020 5:40:46 PM,Slack Shares Might Start to Slack Off,InvestorPlace,/news/stocks/slack-stock-shares-might-start-to-slack-off-1029831155
1354.0,11/23/2020 7:17:19 PM,Johnson & Johnson sized up favorably after positive medical devices update,Seeking Alpha,https://seekingalpha.com/news/3638793-johnson-johnson-sized-up-favorably-after-positive-medical-devices-update?utm_source=markets.businessinsider.com&utm_medium=referral
1355.0,11/24/2020 2:50:06 PM,Johnson & Johnson Is an Excellent Dividend Growth Stock,InvestorPlace,/news/stocks/johnson-johnson-is-an-excellent-dividend-1029834845
1356.0,11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here‚Äôs Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075
1357.0,11/25/2020 8:49:37 AM,Purdue Pharma pleads guilty to criminal opioid crisis charges,Seeking Alpha,https://seekingalpha.com/news/3639300-purdue-pharma-pleads-guilty-to-criminal-opioid-crisis-charges?utm_source=markets.businessinsider.com&utm_medium=referral
1358.0,11/25/2020 6:06:07 PM,Overlook Novavax at the Risk of Incurring an Opportunity Cost,InvestorPlace,/news/stocks/overlook-nvax-stock-at-your-own-risk-1029839833
1359.0,11/25/2020 8:47:28 PM,AstraZeneca skids another 2% as confusion remains over vaccine,Seeking Alpha,https://seekingalpha.com/news/3639522-astrazeneca-skids-another-2-confusion-remains-over-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1360.0,11/30/2020 11:55:00 AM,"The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered",InvestorPlace,/news/stocks/ibio-stock-presents-investors-with-key-question-1029848699
1361.0,12/2/2020 1:15:24 PM,Just Say No to Inovio Pharmaceuticals Stock,InvestorPlace,/news/stocks/just-say-no-to-inovio-pharmaceuticals-stock-1029858306
1362.0,12/2/2020 1:46:56 PM,J&J acquires rights to gene therapy for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3640789-j-and-j-acquires-rights-to-gene-therapy-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral
1363.0,12/2/2020 1:49:15 PM,Kinnate Biopharma increases IPO size by 25% to $213M,Seeking Alpha,https://seekingalpha.com/news/3640795-kinnate-biopharma-increases-ipo-size-25-to-213m?utm_source=markets.businessinsider.com&utm_medium=referral
1364.0,12/3/2020 6:37:33 AM,"BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK ",RTTNews,/news/stocks/bcrx-awaits-fda-decision-jnj-on-watch-pfizer-biontech-s-covid-19-vaccine-gets-green-light-in-uk-1029860123
1365.0,12/3/2020 8:55:24 AM,U.S. could immunize one-third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-one-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral
1366.0,12/3/2020 8:55:24 AM,U.S. could immunize third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral
1367.0,12/3/2020 10:16:13 AM,7 Undervalued Stocks to Snap Up Today,InvestorPlace,/news/stocks/undervalued-stocks-are-out-there-including-some-familiar-names-1029860944
1368.0,12/3/2020 12:12:52 PM,J&J files U.S. application for bispecific antibody for type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/3641279-j-and-j-files-u-s-application-for-bispecific-antibody-for-type-of-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral
1369.0,12/3/2020 12:20:28 PM,J&J sells ex-U.S. rights to transdermal contraceptive patch to Gedeon Richter,Seeking Alpha,https://seekingalpha.com/news/3641284-j-and-j-sells-ex-u-s-rights-to-transdermal-contraceptive-patch-to-gedeon-richter?utm_source=markets.businessinsider.com&utm_medium=referral
1370.0,12/3/2020 6:53:40 PM,3 Dividend Stocks for Big Total Returns in 2021,InvestorPlace,/news/stocks/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt-1029863076
1371.0,12/4/2020 6:32:46 AM,"FDA Nod For BCRX - Decision In Japan, Europe Next, ENLV Soars On COVID Trial Data, STRO Abuzz ",RTTNews,/news/stocks/fda-nod-for-bcrx-decision-in-japan-europe-next-enlv-soars-on-covid-trial-data-stro-abuzz-1029863959
1372.0,12/4/2020 12:55:11 PM,Sell-siders bullish on Moderna COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3641671-sell-siders-bullish-on-moderna-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1373.0,12/4/2020 6:26:02 PM,J&J's daratumumab shows clinical benefit in multiple myeloma study,Seeking Alpha,https://seekingalpha.com/news/3641796-j-and-js-daratumumab-shows-clinical-benefit-in-multiple-myeloma-study?utm_source=markets.businessinsider.com&utm_medium=referral
1374.0,12/7/2020 10:52:00 AM,Moody's - Outlook for global pharmaceutical industry revised to positive as COVID-19 vaccines and treatments boost earnings,Moodys,/news/bonds/moody-s-outlook-for-global-pharmaceutical-industry-revised-to-positive-as-covid-19-vaccines-and-treatments-boost-earnings-1029868484
1375.0,12/7/2020 5:20:23 PM,Johnson & Johnson sees positive data from pair of multiple myeloma approaches at ASH,Seeking Alpha,https://seekingalpha.com/news/3642175-johnson-johnson-sees-positive-data-from-pair-of-multiple-myeloma-approaches-ash?utm_source=markets.businessinsider.com&utm_medium=referral
1376.0,12/8/2020 8:41:39 AM,U.K. rolls out COVID-19 vaccine to public - report,Seeking Alpha,https://seekingalpha.com/news/3642355-u-k-rolls-out-covidminus-19-vaccine-to-public-report?utm_source=markets.businessinsider.com&utm_medium=referral
1377.0,12/8/2020 7:03:42 PM,7 Blue-Chip Stocks You Can Trust,InvestorPlace,/news/stocks/blue-chip-stocks-7-blue-chip-stocks-you-can-trust-1029874779
1378.0,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca for vaccine delivery, inoculation expected by mid 2021 - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-for-vaccine-delivery-inoculation-expected-mid-2021-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1379.0,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca shots to vaccinate Americans",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-shots-to-vaccinate-americans?utm_source=markets.businessinsider.com&utm_medium=referral
1380.0,12/9/2020 3:30:11 PM,Investment Breakdown: The Best Stock in Each Sector of the Market,InvestorPlace,/news/stocks/breakdown-the-best-stock-in-each-sector-of-the-market-1029878480
1381.0,12/10/2020 10:01:49 AM,7 Cheap Stocks Under $20 To Buy That Span Industries,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-now-under-20-to-buy-that-span-industry-doyu-znga-arcc-hbi-veco-pdce-bcov-1029880669
1382.0,12/11/2020 1:15:04 PM,Janssen: CHMP Recommends Expanded Use Of SPRAVATO - Quick Facts ,RTTNews,/news/stocks/janssen-chmp-recommends-expanded-use-of-spravato-quick-facts-1029885074
1383.0,12/12/2020 11:05:53 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643900-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1384.0,12/12/2020 11:06:41 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643901-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1385.0,12/14/2020 11:55:50 AM,Novavax Far From Finished In the Race for a Vaccine,InvestorPlace,/news/stocks/novavax-far-from-finished-in-the-race-for-a-vaccine-nvax-stock-1029889699
1386.0,12/14/2020 5:48:04 PM,8 Retirement Stocks You Can Rely On,InvestorPlace,/news/stocks/8-retirement-investments-you-can-rely-on-1029891268
1387.0,12/15/2020 6:35:20 AM,First COVID-19 shot given in U.S. as roll-out begins - WSJ,Seeking Alpha,https://seekingalpha.com/news/3644277-first-covidminus-19-shot-given-in-u-s-roll-out-begins-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
1388.0,12/15/2020 2:16:41 PM,7 Value Stocks Ready for Rotation,InvestorPlace,/news/stocks/7-value-stocks-ready-for-rotation-1029894555
1389.0,12/15/2020 2:49:15 PM,Veracyte broadens the collaboration with JNJ in early cancer detection,Seeking Alpha,https://seekingalpha.com/news/3644460-veracyte-broadens-collaboration-jnj-in-early-cancer-detection?utm_source=markets.businessinsider.com&utm_medium=referral
1390.0,12/15/2020 3:56:35 PM,7 Undervalued Stocks That You Shouldn‚Äôt Pass On,InvestorPlace,/news/stocks/7-undervalued-stocks-that-you-shouldnt-pass-on-1029895193
1391.0,12/15/2020 4:01:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1029894522
1392.0,12/16/2020 8:59:10 AM,American public to get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-american-public-to-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral
1393.0,12/16/2020 8:59:10 AM,Most of American public may get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-of-american-public-may-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral
1394.0,12/16/2020 10:47:45 AM,Micro-cap oncology biotech Scopus Biopharma prices downsized $2.75M IPO,Seeking Alpha,https://seekingalpha.com/news/3644762-micro-cap-oncology-biotech-scopus-biopharma-prices-downsized-2_75m-ipo?utm_source=markets.businessinsider.com&utm_medium=referral
1395.0,12/17/2020 12:49:50 PM,"The Vaccine Race Is Far From Over, And That‚Äôs Good News for Novavax",InvestorPlace,/news/stocks/vaccine-race-far-from-over-good-news-for-nvax-stock-1029902118
1396.0,12/17/2020 6:51:04 PM,7 Long-Term Stocks for Buffett-Like Investors,InvestorPlace,/news/stocks/7-long-term-stocks-for-buffett-like-investors-1029904001
1397.0,12/18/2020 4:23:05 AM,J&J says late-stage COVID vaccine trial fully enrolled,Seeking Alpha,https://seekingalpha.com/news/3645594-j-and-j-says-late-stage-covid-vaccine-trial-fully-enrolled?utm_source=markets.businessinsider.com&utm_medium=referral
1398.0,12/18/2020 11:33:08 AM,EU set to rollout COVID-19 vaccine from December 27 - NYT,Seeking Alpha,https://seekingalpha.com/news/3645629-eu-set-to-rollout-covidminus-19-vaccine-from-december-27-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1399.0,12/18/2020 4:21:54 PM,7 of the Best Dividend Aristocrats on the Market¬†,InvestorPlace,/news/stocks/7-of-the-best-stocks-with-dividends-to-own-dividend-aristocrats-1029907361
1400.0,12/21/2020 9:13:37 AM,GSK: ViiV Healthcare's Vocabria Gets EU Approval To Be Used With Janssen's Rekambys And Edurant ,RTTNews,/news/stocks/gsk-viiv-healthcare-s-vocabria-gets-eu-approval-to-be-used-with-janssen-s-rekambys-and-edurant-1029909538
1401.0,12/21/2020 10:07:08 AM,"ViiV, Janssen's cabotegravir + rilpivirine wins marketing approval in Europe for HIV treatment",Seeking Alpha,https://seekingalpha.com/news/3646055-viiv-janssens-cabotegravir-rilpivirine-wins-marketing-approval-in-europe-for-hiv-treatment?utm_source=markets.businessinsider.com&utm_medium=referral
1402.0,12/21/2020 8:00:47 PM,"Janssen, begins rolling submission of marketing application for BCMA Car-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3646305-janssen-begins-rolling-submission-of-marketing-application-for-bcma-car-t-therapy-in-multiple?utm_source=markets.businessinsider.com&utm_medium=referral
1403.0,12/22/2020 12:32:35 AM,"'Pennies: Going In Raw' Hosts Hugh Henne, Dan Deity Join Benzinga's Power Hour",Benzinga,/news/stocks/pennies-going-in-raw-hosts-hugh-henne-dan-deity-join-benzinga-s-power-hour-1029912354
1404.0,12/22/2020 10:00:56 AM,Will vaccines work against the U.K. coronavirus variant?,Seeking Alpha,https://seekingalpha.com/news/3646502-will-vaccines-work-against-u-k-coronavirus-variant?utm_source=markets.businessinsider.com&utm_medium=referral
1405.0,12/22/2020 12:55:04 PM,Health Canada OK's JNJ unit Janssen's Darzalex combination regimen in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3646563-health-canada-oks-jnj-unit-janssens-darzalex-combination-regimen-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1406.0,12/22/2020 4:34:09 PM,Veracyte and Bayer collaborate in precision oncology; shares jump +17%,Seeking Alpha,https://seekingalpha.com/news/3646727-veracyte-and-bayer-collaborate-in-precision-oncology-shares-jumpplus-17?utm_source=markets.businessinsider.com&utm_medium=referral
1407.0,12/22/2020 5:09:32 PM,4 Dividend Stocks to Help You Prepare for Retirement,InvestorPlace,/news/stocks/4-stocks-with-dividend-to-help-you-prepare-for-retirement-kn-qdf-stor-wba-1029914787
1408.0,12/23/2020 3:49:06 PM,The 12 Best Stocks to Buy for a Whole New Year of Returns in 2021,InvestorPlace,/news/stocks/12-best-stocks-to-buy-for-a-whole-new-year-of-returns-in-2021-1029866334
1409.0,12/28/2020 11:35:55 AM,"As Vaccine Excitement Fades, Buy the Pullback in Pfizer",InvestorPlace,/news/stocks/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock-1029921274
1410.0,12/29/2020 12:53:33 PM,EMA says AstraZeneca/Oxford COVID-19 jab unfit for January approval,Seeking Alpha,https://seekingalpha.com/news/3647663-ema-says-astrazeneca-oxford-covidminus-19-jab-unfit-for-january-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1411.0,12/29/2020 5:47:41 PM,Is Now a Good Time to Buy Moderna Stock?,InvestorPlace,/news/stocks/is-now-a-good-time-to-buy-moderna-stock-1029923962
1412.0,12/30/2020 10:01:36 AM,7 Great Index Funds To Help Investors Minimize Risk in a Volatile World,InvestorPlace,/news/stocks/7-great-index-funds-to-help-investors-minimize-risk-in-a-volatile-world-1029924929
1413.0,12/31/2020 3:16:42 PM,8 Dental Stocks If You Want to Clean Up,InvestorPlace,/news/stocks/8-dental-stocks-to-buy-if-you-want-to-clean-up-1029927337
1414.0,12/31/2020 7:19:38 PM,Why Pfizer is the Cheapest Coronavirus Vaccine Play,InvestorPlace,/news/stocks/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine-1029927517
1415.0,12/31/2020 9:34:42 PM,COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021,Seeking Alpha,https://seekingalpha.com/news/3648143-covidminus-19-vaccine-makers-looking-back-on-2020-seeking-insights-for-2021?utm_source=markets.businessinsider.com&utm_medium=referral
1416.0,1/1/2021 1:07:48 PM,Israel leads world in COVID vaccinations per capita,Seeking Alpha,https://seekingalpha.com/news/3648167-israel-leads-world-in-covid-vaccinations-per-capita?utm_source=markets.businessinsider.com&utm_medium=referral
1417.0,1/4/2021 1:32:36 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3648294-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
1418.0,1/5/2021 7:36:32 PM,7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible,InvestorPlace,/news/stocks/7-coronavirus-stocks-to-buy-to-make-mass-vaccination-possible-1029935369
1419.0,1/6/2021 1:30:57 PM,"The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-aerpio-reviews-strategic-options-hologic-goes-shopping-1029936895
1420.0,1/7/2021 2:20:50 PM,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-curevac-covid-19-vaccine-deal-argenx-out-licenses-neuromuscular-disorder-drug-xencor-s-oncology-collaboration-1029940542
1421.0,1/8/2021 11:02:18 AM,Oncology Biotech company Cullinan Management prices upsized IPO above expected range,Seeking Alpha,https://seekingalpha.com/news/3649849-oncology-biotech-company-cullinan-management-prices-upsized-ipo-above-expected-range?utm_source=markets.businessinsider.com&utm_medium=referral
1422.0,1/8/2021 12:06:38 PM,EU secures 300M more doses of Pfizer-BioNTech jab,Seeking Alpha,https://seekingalpha.com/news/3649872-eu-secures-300m-doses-of-pfizer-biontech-jab?utm_source=markets.businessinsider.com&utm_medium=referral
1423.0,1/8/2021 1:25:06 PM,"The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-sarepta-gene-therapy-study-readout-novavax-vaccine-supply-deal-2-ipos-1029943328
1424.0,1/8/2021 3:41:14 PM,"As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade",InvestorPlace,/news/stocks/bull-case-mrna-stock-beginning-to-fade-1029944159
1425.0,1/8/2021 5:44:30 PM,SPY Stock Is Headed Higher Over Time,InvestorPlace,/news/stocks/spy-stock-is-headed-higher-over-time-1029944373
1426.0,1/11/2021 12:56:47 PM,JNJ‚Äôs single-dose COVID-19 vaccine viewed favorably by analysts,Seeking Alpha,https://seekingalpha.com/news/3650208-jnj-s-single-dose-covidminus-19-vaccine-viewed-favorably-analysts?utm_source=markets.businessinsider.com&utm_medium=referral
1427.0,1/11/2021 3:32:35 PM,NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening,InvestorPlace,/news/stocks/nvax-stock-is-worth-a-small-position-but-vaccine-race-is-tightening-1029956501
1428.0,1/11/2021 4:19:50 PM,Stocks That Hit 52-Week Highs On Monday,Benzinga,/news/stocks/stocks-that-hit-52-week-highs-on-monday-1029956096
1429.0,1/11/2021 4:59:22 PM,The Top 7 Pharmaceutical Stocks for the Next 10 Years¬†,InvestorPlace,/news/stocks/the-top-7-pharmaceutical-stocks-for-the-next-10-years-1029956488
1430.0,1/11/2021 6:22:46 PM,Novavax executives sold $46M worth company shares in 2020 ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3650426-novavax-executives-sold-46m-worth-company-shares-in-2020-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1431.0,1/11/2021 8:36:50 PM,8 Value Stocks That Could Perform Surprisingly Well In 2021,InvestorPlace,/news/stocks/8-value-stocks-that-could-perform-surprisingly-well-in-2021-1029957111
1432.0,1/12/2021 1:49:49 PM,South Korea nears deal to buy Novavax COVID-19 Vaccines - report,Seeking Alpha,https://seekingalpha.com/news/3650682-south-korea-nears-deal-to-buy-novavax-covidminus-19-vaccines-report?utm_source=markets.businessinsider.com&utm_medium=referral
1433.0,1/12/2021 2:15:54 PM,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",Benzinga,/news/stocks/the-daily-biotech-pulse-gsk-vir-to-start-covid-19-antibody-study-novartis-in-licenses-beigene-s-cancer-drug-earnings-preannouncements-continue-1029959657
1434.0,1/12/2021 7:05:42 PM,The 7 Best Startups You Can Buy on SeedInvest Right Now,InvestorPlace,/news/stocks/the-7-best-startups-you-can-buy-on-seedinvest-right-now-invest-in-startups-1029798071
1435.0,1/12/2021 10:22:17 PM,JNJ's COVID-19 jab could receive emergency approval by next month: Official,Seeking Alpha,https://seekingalpha.com/news/3650838-jnjs-covidminus-19-jab-receive-emergency-approval-next-month-official?utm_source=markets.businessinsider.com&utm_medium=referral
1436.0,1/13/2021 1:25:58 PM,Johnson & Johnson's Imbruvica combo OK'd in Canada in CLL setting,Seeking Alpha,https://seekingalpha.com/news/3651021-johnson-johnsons-imbruvica-combo-okd-in-canada-in-cll-setting?utm_source=markets.businessinsider.com&utm_medium=referral
1437.0,1/13/2021 1:35:02 PM,ESSA Pharma and Janssen to test combo treatments in prostate cancer setting,Seeking Alpha,https://seekingalpha.com/news/3651023-essa-pharma-and-janssen-to-test-combo-treatments-in-prostate-cancer-setting?utm_source=markets.businessinsider.com&utm_medium=referral
1438.0,1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1439.0,1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT (Updated)",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt-updated?utm_source=markets.businessinsider.com&utm_medium=referral
1440.0,1/13/2021 7:51:59 PM,7 Pharmaceutical Stocks With Exciting Plans for 2021,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-with-exciting-plans-for-2021-1029966098
1441.0,1/13/2021 10:47:43 PM,JNJ‚Äôs COVID-19 vaccine data published in Medical Journal,Seeking Alpha,https://seekingalpha.com/news/3651315-jnj-s-covidminus-19-vaccine-data-published-in-medical-journal?utm_source=markets.businessinsider.com&utm_medium=referral
1442.0,1/14/2021 10:41:17 AM,"5 Stocks To Watch For January 14, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-january-14-2021-1029967453
1443.0,1/14/2021 11:15:53 AM,"Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated ",RTTNews,/news/stocks/johnson-johnson-s-covid-19-vaccine-safe-well-tolerated-1029967588
1444.0,1/14/2021 12:09:08 PM,"A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Jobless Claims, Fed's Powell Speech",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mostly-higher-ahead-of-jobless-claims-fed-s-powell-speech-1029967735
1445.0,1/14/2021 1:56:59 PM,"The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates",Benzinga,/news/stocks/the-daily-biotech-pulse-alexion-pauses-covid-19-study-nantkwest-readout-organogenesis-jumps-on-guidance-trial-updates-1029968277
1446.0,1/14/2021 5:59:22 PM,7 Great Index Funds To Buy With Super Low Fees,InvestorPlace,/news/stocks/7-great-index-funds-with-super-low-fees-1029970330
1447.0,1/14/2021 8:34:12 PM,Invitae teams up with healthcare giants to develop MRD detection panel,Seeking Alpha,https://seekingalpha.com/news/3651590-invitae-teams-up-healthcare-giants-to-develop-mrd-detection-panel?utm_source=markets.businessinsider.com&utm_medium=referral
1448.0,1/14/2021 9:32:48 PM,Netflix Stock Remains Well Ahead of the Competition,InvestorPlace,/news/stocks/netflix-nflx-stock-remains-well-ahead-of-the-competition-1029971027
1449.0,1/15/2021 1:32:12 PM,"The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges",Benzinga,/news/stocks/the-daily-biotech-pulse-dbv-s-positive-fda-feedback-pfizer-s-cancer-drug-gets-label-expansion-applied-dna-covid-testing-volume-surges-1029972538
1450.0,1/15/2021 8:01:15 PM,Genmab's therapy for AL amyloidosis receives FDA approval,Seeking Alpha,https://seekingalpha.com/news/3651950-genmabs-therapy-for-al-amyloidosis-receives-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1451.0,1/19/2021 4:50:45 PM,"Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today",Benzinga,/news/stocks/why-aclaris-tenax-gritstone-merus-minerva-and-celyad-are-rallying-today-1029982313
1452.0,1/19/2021 8:27:33 PM,B.Riley downgrades Arcturus on 'broken narrative' for its ARCT-021 COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3652405-briley-downgrades-arcturus-on-broken-narrative-for-its-arct-021-covid-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
1453.0,1/19/2021 8:48:27 PM,The 7 Best Stocks To Buy In The Dow Jones¬†Today,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-in-the-dow-jones-today-1029983307
1454.0,1/20/2021 1:32:35 PM,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-greenlights-merck-s-heart-failure-drug-histogen-hit-with-clinical-hold-aptorum-gets-nod-for-commencing-human-study-1029985849
1455.0,1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247
1456.0,1/20/2021 4:03:11 PM,9 Beginner Stocks for First-Time Investors,InvestorPlace,/news/stocks/9-beginner-stocks-for-first-time-investors-to-buy-1029987242
1457.0,1/20/2021 4:52:55 PM,Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today,InvestorPlace,/news/stocks/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock-1029987235
1458.0,1/21/2021 7:32:45 AM,"Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy",Seeking Alpha,https://seekingalpha.com/news/3652974-addex-janssen-pharma-on-go-with-phase-2a-study-of-jnj-40411813-adx71149-in-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral
1459.0,1/21/2021 2:05:24 PM,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-addex-jumps-on-positive-data-for-out-licensed-drug-covid-19-vaccine-developer-inovio-announces-150m-follow-on-offering-boston-scientific-goes-shopping-1029990203
1460.0,1/21/2021 2:59:40 PM,Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Today,InvestorPlace,/news/stocks/epilepsy-drug-news-why-addex-therapeutics-adxn-stock-is-soaring-today-1029991037
1461.0,1/22/2021 4:51:44 AM,FDA OK's Janssen's HIV drug combo Cabenuva,Seeking Alpha,https://seekingalpha.com/news/3653426-fda-oks-janssens-hiv-drug-combo-cabenuva?utm_source=markets.businessinsider.com&utm_medium=referral
1462.0,1/22/2021 9:20:13 AM,Why is the U.S. vaccine rollout taking longer than expected?,Seeking Alpha,https://seekingalpha.com/news/3653444-why-is-us-vaccine-rollout-taking-longer-than-expected?utm_source=markets.businessinsider.com&utm_medium=referral
1463.0,1/22/2021 1:22:34 PM,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",Benzinga,/news/stocks/the-daily-biotech-pulse-fluidigm-s-saliva-based-covid-test-approved-in-europe-china-backs-amarin-s-vascepa-1029993832
1464.0,1/22/2021 10:13:36 PM,The Best 4 Pharmaceutical Stocks to Buy in Any Climate,InvestorPlace,/news/stocks/the-best-4-pharmaceutical-stocks-to-buy-in-any-climate-1030014921
1465.0,1/22/2021 10:36:45 PM,"'Halftime Report' Picks For January 22: Apple, KLA And More",Benzinga,/news/stocks/halftime-report-picks-for-january-22-apple-kla-and-more-1029995458
1466.0,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049
1467.0,1/24/2021 3:01:22 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-earnings-preview-stock-1029996631
1468.0,1/24/2021 3:46:36 PM,COVID vaccines for kids? Trials are underway,Seeking Alpha,https://seekingalpha.com/news/3653738-covid-vaccines-for-kids-trials-are-underway?utm_source=markets.businessinsider.com&utm_medium=referral
1469.0,1/25/2021 3:43:35 PM,5 Biden-Friendly Warren Buffett Stocks to Load Up On,InvestorPlace,/news/stocks/5-biden-friendly-warren-buffett-stocks-to-load-up-on-ko-gm-jnj-tmus-mco-1030000374
1470.0,1/25/2021 6:19:43 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3654000-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
1471.0,1/25/2021 6:27:17 PM,Johnson & Johnson Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654012-johnson-amp-johnson-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
1472.0,1/25/2021 10:21:16 PM,"4 Top Stock Trades for Tuesday: GME, CLX, JNJ, MCD",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-gme-clx-jnj-mcd-1030001230
1473.0,1/26/2021 11:00:58 AM,Can GameStop Short Squeeze Bring Down The Market? What The Experts Are Saying,Benzinga,/news/stocks/can-gamestop-short-squeeze-bring-down-the-market-what-the-experts-are-saying-1030003051
1474.0,1/26/2021 11:44:00 AM,"Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus",Seeking Alpha,https://seekingalpha.com/news/3654230-johnson-amp-johnson-eps-beats-by-003-beats-on-revenue-guides-fy21-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
1475.0,1/26/2021 12:11:30 PM,"J&J tops Q4 forecast, guides FY2021 outlook above consensus",Seeking Alpha,https://seekingalpha.com/news/3654249-jj-tops-q4-forecast-guides-fy2021-outlook-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
1476.0,1/26/2021 12:46:16 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1030003402
1477.0,1/26/2021 12:59:52 PM,Johnson & Johnson Projects 2021 Adjusted Operational EPS Growth Of 16.4% - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-projects-2021-adjusted-operational-eps-growth-of-16-4-quick-facts-1030003424
1478.0,1/26/2021 1:53:45 PM,MeiraGTx's AAV-CNGA3 Fast Track'd in U.S. for inherited retinal disease,Seeking Alpha,https://seekingalpha.com/news/3654336-meiragtxs-aav-cnga3-fast-trackd-in-us-for-inherited-retinal-disease?utm_source=markets.businessinsider.com&utm_medium=referral
1479.0,1/26/2021 2:07:40 PM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-misses-j-j-beats-in-big-pharma-earnings-vaccine-developer-curevac-taps-equity-market-1030004007
1480.0,1/26/2021 4:16:59 PM,"Johnson & Johnson expects to release COVID-19 vaccine results next week, CFO tells CNBC",Seeking Alpha,https://seekingalpha.com/news/3654321-johnson-johnson-expects-to-release-covid-19-vaccine-results-next-week-cfo-tells-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral
1481.0,1/26/2021 5:38:19 PM,JNJ earnings release brightens U.S. biopharma outlook - BofA,Seeking Alpha,https://seekingalpha.com/news/3654484-jnj-earnings-release-brightens-us-biopharma-outlook-bofa?utm_source=markets.businessinsider.com&utm_medium=referral
1482.0,1/27/2021 8:56:46 AM,"AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch ",RTTNews,/news/stocks/agio-s-activate-t-hits-goals-edsa-catches-eye-jnj-provides-rosy-outlook-vxrt-on-watch-1030008289
1483.0,1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241
1484.0,1/27/2021 2:15:11 PM,"As It Hits $100M In Assets Under Management, XOUT Proves Exclusion Matters",Benzinga,/news/etf/as-it-hits-100m-in-assets-under-management-xout-proves-exclusion-matters-1030009668
1485.0,1/27/2021 2:19:05 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030009667
1486.0,1/27/2021 2:41:14 PM,First Psychedelics ETF Debuts On NEO Exchange,Benzinga,/news/stocks/first-psychedelics-etf-debuts-on-neo-exchange-1030009809
1487.0,1/27/2021 3:52:54 PM,"Johnson & Johnson could have 'tens of millions' of COVID-19 doses by end of February, Gottlieb says",Seeking Alpha,https://seekingalpha.com/news/3654948-johnson-johnson-could-have-tens-of-millions-of-covid-19-doses-by-end-of-march-gottlieb-says?utm_source=markets.businessinsider.com&utm_medium=referral
1488.0,1/27/2021 6:43:34 PM,7 Reliable Index Funds To Set And Forget For The Long Term,InvestorPlace,/news/stocks/7-reliable-index-funds-to-set-and-forget-for-the-long-term-1030011503
1489.0,1/28/2021 5:03:51 PM,How to Ride the Covid-19 Bull with Moderna,InvestorPlace,/news/stocks/how-to-ride-covid-19-bull-moderna-stock-1030016518
1490.0,1/29/2021 12:02:52 AM,"Major pharma set for strong 2021, and trading at a 35% discount to market - J.P. Morgan",Seeking Alpha,https://seekingalpha.com/news/3655985-major-pharma-set-for-strong-2021-and-trading-at-a-35-discount-to-market-jp-morgan?utm_source=markets.businessinsider.com&utm_medium=referral
1491.0,1/29/2021 10:20:35 AM,"Once approved, J&J to initiate U.S. supply of COVID-19 vaccine with 2M doses - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3656030-once-approved-jj-to-initiate-us-supply-of-covid-19-vaccine-with-2m-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1492.0,1/29/2021 1:16:24 PM,Johnson & Johnson COVID-19 vaccine 66% effective in global trial,Seeking Alpha,https://seekingalpha.com/news/3656132-johnson-johnson-covid-19-vaccine-66-effective-in-global-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1493.0,1/29/2021 1:46:43 PM,"Moderna, BioNTech, Pfizer surge after JNJ COVID-19 vaccine data",Seeking Alpha,https://seekingalpha.com/news/3656159-moderna-biontech-pfizer-surge-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral
1494.0,1/29/2021 1:53:34 PM,NVAX Stock: Why Novavax Shares Are Shooting Higher Today,InvestorPlace,/news/stocks/nvax-stock-why-novavax-shares-are-shooting-higher-today-1030020363
1495.0,1/29/2021 2:19:28 PM,Inovio climbs in premarket after JNJ COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3656197-inovio-climbs-in-premarket-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral
1496.0,1/29/2021 2:31:10 PM,"J&J COVID-19 Vaccine Shows Complete Protection Against Hospitalization, 28 Days Post-vaccination ",RTTNews,/news/stocks/j-j-covid-19-vaccine-shows-complete-protection-against-hospitalization-28-days-post-vaccination-1030019893
1497.0,1/29/2021 3:33:02 PM,Dow slides 200 points on concerns of retail investors' speculative trading,Business Insider,https://www.businessinsider.com/stock-market-news-today-indexes-reddit-trader-speculation-vaccine-data-2021-1
1498.0,1/29/2021 6:19:49 PM,JNJ COVID-19 vaccine will be a key contributor to normalcy ‚Äì BofA,Seeking Alpha,https://seekingalpha.com/news/3656303-jnj-covid-19-vaccine-will-be-key-contributor-for-normalcy-bofa?utm_source=markets.businessinsider.com&utm_medium=referral
1499.0,1/29/2021 8:30:31 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3656322-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1500.0,1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250
1501.0,1/31/2021 2:31:04 PM,Don‚Äôt Overlook These 3 Dividend Kings,InvestorPlace,/news/stocks/dont-overlook-these-3-dividend-kings-1030023138
1502.0,2/1/2021 1:05:13 PM,"Moderna cut to underperform at BofA, with sales estimates 'unrealistic'",Seeking Alpha,https://seekingalpha.com/news/3656554-moderna-downgraded-to-underperform-at-bofa-citing-valuation?utm_source=markets.businessinsider.com&utm_medium=referral
1503.0,2/1/2021 3:09:27 PM,CanSino to further advance late-stage trial for COVID-19 shot after interim analysis,Seeking Alpha,https://seekingalpha.com/news/3656650-cansino-to-further-advance-late-stage-trial-for-covid-19-shot-after-interim-analysis?utm_source=markets.businessinsider.com&utm_medium=referral
1504.0,2/1/2021 4:40:03 PM,7 Blue Chip Stocks to Help Prepare For Your Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-help-prepare-your-retirement-1030028811
1505.0,2/1/2021 6:29:28 PM,Moderna Analyst: Unrealistic COVID-19 Vaccine Expectations Create Unfavorable Setup,Benzinga,/news/stocks/moderna-analyst-unrealistic-covid-19-vaccine-expectations-create-unfavorable-setup-1030028936
1506.0,2/2/2021 9:58:12 AM,"Dosing underway in Janssen, Exonate's study of EXN 407 in diabetic macular oedema",Seeking Alpha,https://seekingalpha.com/news/3657037-dosing-underway-in-janssen-exonates-study-of-exn-407-in-diabetic-macular-oedema?utm_source=markets.businessinsider.com&utm_medium=referral
1507.0,2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-jnj-sjm-por-bokf-iff-o-avgo-cmcsa-1030034395
1508.0,2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-1030033865
1509.0,2/2/2021 4:22:56 PM,7 Stocks to Buy for the Long Run,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-long-run-1030034388
1510.0,2/2/2021 9:11:16 PM,JNJ receives FDA approval for monofocal intraocular lens,Seeking Alpha,https://seekingalpha.com/news/3657456-jnj-receives-fda-approval-for-monofocal-intraocular-lens?utm_source=markets.businessinsider.com&utm_medium=referral
1511.0,2/3/2021 10:16:07 AM,Read the Label Carefully Before Gambling on Ocugen Stock,InvestorPlace,/news/stocks/read-label-carefully-ocgn-stock-1030037523
1512.0,2/4/2021 12:52:45 PM,"Sana prices upsized IPO at $25, above the expected range, trades today",Seeking Alpha,https://seekingalpha.com/news/3658334-sana-prices-upsized-ipo-at-25-above-the-expected-range-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral
1513.0,2/4/2021 10:55:26 PM,Johnson & Johnson applies for emergency use OK for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3658893-johnson-johnson-applies-for-emergency-use-ok-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1514.0,2/5/2021 2:55:57 AM,J&J Seeks FDA Emergency Authorization For World's First Single-dose Covid-19 Vaccine ,RTTNews,/news/stocks/j-j-seeks-fda-emergency-authorization-for-world-s-first-single-dose-covid-19-vaccine-1030046218
1515.0,2/5/2021 8:38:02 AM,"JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track ",RTTNews,/news/stocks/jnj-single-shot-covid-19-vaccine-at-fda-altar-kpti-expands-xpovio-s-footprint-otlk-on-track-1030047435
1516.0,2/5/2021 10:23:40 AM,"8 Stocks To Watch For February 5, 2021",Benzinga,/news/stocks/8-stocks-to-watch-for-february-5-2021-1030047675
1517.0,2/5/2021 11:13:17 AM,Bolt Biotherapeutics raises $230M in IPO,Seeking Alpha,https://seekingalpha.com/news/3658964-bolt-biotherapeutics-raises-230m-in-ipo?utm_source=markets.businessinsider.com&utm_medium=referral
1518.0,2/5/2021 11:58:38 AM,"Cell therapy biotech Vor Biopharma prices upsized IPO at $18/share, trades today",Seeking Alpha,https://seekingalpha.com/news/3658982-cell-therapy-biotech-vor-biopharma-prices-upsized-ipo-at-18share-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral
1519.0,2/5/2021 1:44:38 PM,"The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-covid-19-vaccine-approval-zimmer-biomet-s-spin-off-ipo-deluge-hits-street-1030048263
1520.0,2/5/2021 7:23:28 PM,3 Downtrodden Stocks to Buy as the Crowds Return,InvestorPlace,/news/stocks/3-downtrodden-stocks-to-buy-as-the-crowds-return-1030049778
1521.0,2/9/2021 12:16:24 PM,JNJ‚Äôs Erleada yields positive data in late-stage trial for prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3659881-jnjs-erleada-yields-positive-data-in-late-stage-trial-for-prostate-cancer?utm_source=markets.businessinsider.com&utm_medium=referral
1522.0,2/9/2021 1:50:53 PM,7 Blue-Chip Stocks With Gains and Pedigree,InvestorPlace,/news/stocks/7-blue-chip-stocks-with-gains-and-pedigree-1030061482
1523.0,2/9/2021 6:27:58 PM,7 Safe Stocks for Reddit‚Äôs WSB Bull Gang,InvestorPlace,/news/stocks/7-safe-stocks-for-reddits-wsb-bull-gang-rkt-ibm-baba-mmm-jnj-ko-net-1030062358
1524.0,2/10/2021 7:56:54 AM,"South Africa to discontinue AstraZeneca vaccine, will give J&J shots",Seeking Alpha,https://seekingalpha.com/news/3660358-south-africa-to-discontinue-astrazeneca-vaccine-will-give-jj-shots?utm_source=markets.businessinsider.com&utm_medium=referral
1525.0,2/10/2021 9:02:19 AM,Expect annual COVID shots for the next several years - Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3660361-expect-annual-covid-shots-for-the-next-several-years-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral
1526.0,2/10/2021 6:10:49 PM,PhaseBio shares spike 22% in afternoon trading,Seeking Alpha,https://seekingalpha.com/news/3660706-phasebio-shares-spike-22-in-afternoon-trading?utm_source=markets.businessinsider.com&utm_medium=referral
1527.0,2/10/2021 8:45:02 PM,JNJ cloud transition leads BTIG to raise Model N to buy,Seeking Alpha,https://seekingalpha.com/news/3660770-jnj-cloud-transition-leads-btig-to-raise-model-n-to-buy?utm_source=markets.businessinsider.com&utm_medium=referral
1528.0,2/11/2021 1:40:41 PM,AC Immune and JNJ‚Äôs Alzheimer‚Äôs jab succeeds in early-stage study,Seeking Alpha,https://seekingalpha.com/news/3661202-ac-immune-and-jnjs-alzheimers-jab-succeeds-in-early-stage-study?utm_source=markets.businessinsider.com&utm_medium=referral
1529.0,2/11/2021 2:16:05 PM,AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally,Benzinga,/news/stocks/ac-immune-s-alzheimer-s-vaccine-candidate-elicit-response-in-early-stage-study-shares-rally-1030072705
1530.0,2/11/2021 3:14:41 PM,ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today,InvestorPlace,/news/stocks/aciu-stock-why-ac-immune-shares-are-rocketing-higher-today-1030073976
1531.0,2/11/2021 5:11:17 PM,Cardiff Oncology's Onvansertib Combo Associated With Two-Fold Increase Disease Control Rate In Prostate Cancer Study,Benzinga,/news/stocks/cardiff-oncology-s-onvansertib-combo-associated-with-two-fold-increase-disease-control-rate-in-prostate-cancer-study-1030073754
1532.0,2/11/2021 5:25:26 PM,COVID-19 vaccination to cover 75% of U.S. adults by mid-summer: Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/3661304-covid-19-vaccination-to-cover-three-quarters-of-us-adults-by-summer-morgan-stanley?utm_source=markets.businessinsider.com&utm_medium=referral
1533.0,2/11/2021 8:57:13 PM,Biden to announce a deal for another 200M doses of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3661377-biden-to-announce-a-deal-for-another-200m-doses-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1534.0,2/13/2021 9:00:00 PM,"Pharmas engaged in Alzheimer's, the 'holy grail' of drug development",Seeking Alpha,https://seekingalpha.com/news/3661766-pharmas-engaged-in-alzheimers-the-holy-grail-of-drug-development?utm_source=markets.businessinsider.com&utm_medium=referral
1535.0,2/15/2021 12:42:46 PM,South Africa gives green light to J&J's vaccine implementation study,Seeking Alpha,https://seekingalpha.com/news/3661980-south-africa-gives-green-light-to-jjs-vaccine-implementation-study?utm_source=markets.businessinsider.com&utm_medium=referral
1536.0,2/16/2021 3:18:43 PM,Novavax U.S. trial enrollment for COVID-19 shot is nearing completion: CEO,Seeking Alpha,https://seekingalpha.com/news/3662269-novavax-us-trial-enrollment-for-covid-19-shot-is-nearing-completion-ceo?utm_source=markets.businessinsider.com&utm_medium=referral
1537.0,2/16/2021 6:07:34 PM,JNJ files for conditional approval for COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3662377-jnj-seeks-conditional-approval-for-covid-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral
1538.0,2/17/2021 7:56:35 PM,7 Blue-Chip Stocks That Aren‚Äôt a Gamble,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-arent-a-gamble-1030094166
1539.0,2/18/2021 11:45:43 AM,COVID-19 vaccine developers to benefit from supply constraints and uneven distribution,Seeking Alpha,https://seekingalpha.com/news/3663356-covid-19-vaccine-developers-to-benefit-from-supply-constraints-and-uneven-distribution?utm_source=markets.businessinsider.com&utm_medium=referral
1540.0,2/18/2021 2:23:25 PM,Here's Why High Dividend Stocks Remain An Attractive Choice,Benzinga,/news/stocks/here-s-why-high-dividend-stocks-remain-an-attractive-choice-1030097073
1541.0,2/18/2021 7:55:46 PM,NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19,InvestorPlace,/news/stocks/nvax-stock-most-undervalued-vaccine-maker-endemic-covid-19-1030099038
1542.0,2/19/2021 12:59:04 PM,JNJ seeks WHO emergency use nod for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3663893-jnj-seeks-who-emergency-use-nod-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1543.0,2/19/2021 2:02:36 PM,Johnson & Johnson Seeks Emergency WHO Nod For Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-seeks-emergency-who-nod-for-single-dose-covid-19-vaccine-1030101439
1544.0,2/20/2021 3:36:28 PM,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-j-j-vaccine-adcom-meeting-sarepta-fda-decision-and-plenty-of-earnings-1030104010
1545.0,2/21/2021 4:18:07 AM,A new model shows U.S. could reach COVID-19 herd immunity by July,Seeking Alpha,https://seekingalpha.com/news/3664177-a-new-model-shows-us-could-reach-covid-19-herd-immunity-by-july?utm_source=markets.businessinsider.com&utm_medium=referral
1546.0,2/22/2021 11:32:32 AM,Sanofi to support JNJ in manufacturing of COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3664218-sanofi-to-support-jnj-in-manufacturing-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
1547.0,2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral
1548.0,2/23/2021 2:25:13 AM,"J&J sets aside $3.9B for talc verdict, settlements",Seeking Alpha,https://seekingalpha.com/news/3664687-jj-sets-aside-39b-for-talc-verdict-settlements?utm_source=markets.businessinsider.com&utm_medium=referral
1549.0,2/23/2021 3:38:06 AM,"Johnson & Johnson Sets Aside $3.9 Bln For Baby Powder Verdict, Settlements ",RTTNews,/news/stocks/johnson-johnson-sets-aside-3-9-bln-for-baby-powder-verdict-settlements-1030109923
1550.0,2/23/2021 5:41:49 PM,Johnson & Johnson plans 20M COVID-19 vaccine doses by end of March,Seeking Alpha,https://seekingalpha.com/news/3665028-johnson-johnson-plans-20m-covid-19-vaccine-doses-by-end-of-march?utm_source=markets.businessinsider.com&utm_medium=referral
1551.0,2/23/2021 7:02:29 PM,Why You Should Keep Your Distance from Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-stay-your-distance-from-ocugen-1030114797
1552.0,2/24/2021 1:17:19 PM,RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today,InvestorPlace,/news/stocks/rlftf-why-little-known-relief-therapeutics-is-climbing-today-brpa-stock-1030119085
1553.0,2/24/2021 1:44:53 PM,FDA staff finds J&J COVID vaccine effective ahead of review,Seeking Alpha,https://seekingalpha.com/news/3665494-jnj-covid-19-vaccine-fda-releases-briefing-documents-ahead-of-review?utm_source=markets.businessinsider.com&utm_medium=referral
1554.0,2/24/2021 3:03:19 PM,What Will the Stock Market Do Today? 4 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-big-stories-rfltf-stock-wkhs-stock-fsr-stock-1030119078
1555.0,2/24/2021 4:08:48 PM,"United Airlines, Royal Caribbean lead travel and leisure stocks higher",Seeking Alpha,https://seekingalpha.com/news/3665590-united-airlines-royal-caribbean-lead-travel-and-leisure-stocks-higher?utm_source=markets.businessinsider.com&utm_medium=referral
1556.0,2/24/2021 5:52:47 PM,"Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today",InvestorPlace,/news/stocks/airline-stocks-2-big-reasons-aal-dal-and-ual-stock-are-soaring-today-1030119942
1557.0,2/24/2021 7:57:21 PM,ABNB Stock: Why Airbnb Is Booking Big Gains Today,InvestorPlace,/news/stocks/abnb-stock-why-airbnb-is-booking-big-gains-today-q4-earnings-1030120277
1558.0,2/25/2021 7:29:12 AM,Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-vaccine-safe-and-effective-fda-1030121922
1559.0,2/25/2021 3:22:19 PM,5 Surefire Stocks If the Market Crashes,InvestorPlace,/news/stocks/5-surefire-stocks-if-the-market-crash-1030125308
1560.0,2/26/2021 12:00:07 PM,J&J‚Äôs COVID-19 vaccine set to undergo FDA review; EU review set for early March,Seeking Alpha,https://seekingalpha.com/news/3667041-jjs-covid-19-vaccine-set-to-undergo-fda-review-eu-review-set-for-early-march?utm_source=markets.businessinsider.com&utm_medium=referral
1561.0,2/26/2021 2:16:52 PM,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",Benzinga,/news/stocks/the-daily-biotech-pulse-adcom-test-awaits-j-j-s-covid-19-vaccine-lilly-to-supply-additional-antibody-therapy-doses-to-us-regulatory-setback-for-tricida-1030129439
1562.0,2/26/2021 3:20:06 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-hmbl-tsnp-stock-tsnpd-jnj-abnb-stock-1030130462
1563.0,2/26/2021 10:10:23 PM,Johnson & Johnson rises as COVID-19 vaccine clears FDA panel vote,Seeking Alpha,https://seekingalpha.com/news/3667371-johnson-johnson-rises-as-covid-19-vaccine-clears-fda-panel-vote?utm_source=markets.businessinsider.com&utm_medium=referral
1564.0,2/27/2021 3:53:56 PM,FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine ,RTTNews,/news/stocks/fda-says-rapidly-works-toward-emergency-use-approval-of-j-j-s-single-shot-covid-19-vaccine-1030131785
1565.0,2/27/2021 11:21:57 PM,Johnson & Johnson COVID-19 vaccine wins FDA's emergency-use approval,Seeking Alpha,https://seekingalpha.com/news/3667403-johnson-johnson-covid-19-vaccine-wins-fdas-emergency-use-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1566.0,2/28/2021 3:04:59 AM,JNJ to deliver fewer COVID-19 vaccine doses amid production problems: FT,Seeking Alpha,https://seekingalpha.com/news/3667406-jnj-to-deliver-fewer-covid-19-vaccine-doses-amid-production-problems-ft?utm_source=markets.businessinsider.com&utm_medium=referral
1567.0,2/28/2021 5:52:51 AM,FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/fda-authorizes-emergency-use-of-johnson-johnson-s-single-dose-covid-19-vaccine-1030131930
1568.0,3/1/2021 6:05:10 AM,CDC recommends JNJ's single-shot COVID-19 vaccine in U.S.,Seeking Alpha,https://seekingalpha.com/news/3667418-cdc-recommends-jnjs-first-single-shot-covid-19-vaccine-in-us?utm_source=markets.businessinsider.com&utm_medium=referral
1569.0,3/1/2021 11:51:19 AM,JNJ COVID-19 vaccine distribution started: McKesson,Seeking Alpha,https://seekingalpha.com/news/3667462-jnj-covid-19-vaccine-distribution-started-mckesson?utm_source=markets.businessinsider.com&utm_medium=referral
1570.0,3/1/2021 12:02:57 PM,A Peek Into The Markets: US Stock Futures Rise; J&J Secures Emergency Authorization for Covid-19 Vaccine,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-rise-j-j-secures-emergency-authorization-for-covid-19-vaccine-1030134387
1571.0,3/1/2021 1:58:08 PM,"Here's Why Apple, Microsoft, Disney, Plug Power Are Moving",Benzinga,/news/stocks/here-s-why-apple-microsoft-disney-plug-power-are-moving-1030134973
1572.0,3/1/2021 3:16:25 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-warren-buffett-bitcoin-nio-stock-doge-ccl-sos-1030136574
1573.0,3/1/2021 4:13:09 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Receives FDA Approval For COVID-19 Vaccine,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-receives-fda-approval-for-covid-19-vaccine-1030136012
1574.0,3/1/2021 5:02:52 PM,"What's Moving The Market Monday? US, Asian Stocks Higher, Europe Stocks Lower",Benzinga,/news/stocks/what-s-moving-the-market-monday-us-asian-stocks-higher-europe-stocks-lower-1030136260
1575.0,3/1/2021 6:16:55 PM,Mid-Day Market Update: Dow Jumps Over 600 Points; CorMedix Shares Plummet,Benzinga,/news/stocks/mid-day-market-update-dow-jumps-over-600-points-cormedix-shares-plummet-1030136675
1576.0,3/1/2021 7:11:23 PM,7 Value Stocks Ready for the Next 10 Years,InvestorPlace,/news/stocks/7-value-stocks-ready-for-the-next-10-years-1030136985
1577.0,3/1/2021 8:37:10 PM,Mid-Afternoon Market Update: Crud Oil Down Over 1%; Morphic Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-crud-oil-down-over-1-morphic-shares-spike-higher-1030137126
1578.0,3/1/2021 10:11:05 PM,3 Penny Stocks To Buy According To Top Stock Market Analysts,Benzinga,/news/stocks/3-penny-stocks-to-buy-according-to-top-stock-market-analysts-1030137366
1579.0,3/1/2021 10:59:00 PM,Johnson & Johnson -- Moody's: J&J vaccine emergency authorization is credit positive,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-vaccine-emergency-authorization-is-credit-positive-1030137651
1580.0,3/2/2021 1:21:01 PM,Merck to help Johnson & Johnson in COVID-19 vaccine production,Seeking Alpha,https://seekingalpha.com/news/3668226-merck-to-help-johnson-johnson-in-covid-19-vaccine-production?utm_source=markets.businessinsider.com&utm_medium=referral
1581.0,3/2/2021 3:00:28 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-warren-wealth-tax-gme-rkt-stock-1030141280
1582.0,3/2/2021 10:01:45 PM,Merck to receive $269 million for production of COVID-19 vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3668535-merck-to-receive-269-million-for-production-of-covid-19-vaccines-and-drugs?utm_source=markets.businessinsider.com&utm_medium=referral
1583.0,3/2/2021 10:11:13 PM,"Texas, Mississippi roll back mask mandates, pandemic business restrictions",Seeking Alpha,https://seekingalpha.com/news/3668542-texas-mississippi-roll-back-mask-mandates-pandemic-business-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral
1584.0,3/3/2021 1:46:17 PM,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-kempharm-adhd-drug-gets-the-nod-medicinova-shelves-vaccine-study-1030144928
1585.0,3/3/2021 2:31:53 PM,7 Blue-Chip Stocks That May Be Perfect For Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-may-be-perfect-for-retirement-1030146050
1586.0,3/3/2021 4:18:10 PM,7 Stocks for Any Retiree to Consider,InvestorPlace,/news/stocks/7-stocks-for-any-retiree-to-consider-1030146542
1587.0,3/3/2021 4:31:27 PM,JNJ takes its talc verdict battle to U.S. Supreme Court,Seeking Alpha,https://seekingalpha.com/news/3668841-jnj-takes-its-talc-verdict-battle-to-supreme-court?utm_source=markets.businessinsider.com&utm_medium=referral
1588.0,3/3/2021 5:02:46 PM,"U.S. government to provide $100M to Merck, J&J to double COVID-19 vaccine output",Seeking Alpha,https://seekingalpha.com/news/3668862-us-government-to-provide-100m-to-merck-johnson-and-johnson-to-double-covid-19-vaccine-output?utm_source=markets.businessinsider.com&utm_medium=referral
1589.0,3/3/2021 8:12:22 PM,JNJ cut to hold at CFRA citing reopening trade and lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/3669029-jnj-cut-to-hold-at-cfra-citing-reopening-trade-and-lack-of-catalysts?utm_source=markets.businessinsider.com&utm_medium=referral
1590.0,3/4/2021 1:50:49 PM,Big Tech and non-tech valuations may be closer than they appear: At the Open,Seeking Alpha,https://seekingalpha.com/news/3669326-big-tech-and-non-tech-valuations?utm_source=markets.businessinsider.com&utm_medium=referral
1591.0,3/4/2021 5:45:36 PM,Avoid Johnson & Johnson Shares Like the Plague,InvestorPlace,/news/stocks/jnj-stock-avoid-johnson-johnson-shares-like-the-plague-1030152096
1592.0,3/4/2021 7:38:08 PM,Johnson & Johnson Is One of the Best Healthcare Plays on the Market,InvestorPlace,/news/stocks/jnj-stock-is-one-of-the-best-healthcare-on-the-market-1030152430
1593.0,3/5/2021 2:29:28 PM,JNJ receives Health Canada approval for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3669924-jnj-receives-health-canada-approval-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1594.0,3/5/2021 3:27:45 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-oil-stocks-opec-gme-reddit-ipo-1030155707
1595.0,3/5/2021 4:50:37 PM,7 Mega-Cap Stocks Standing Above the Fray,InvestorPlace,/news/stocks/7-mega-cap-stocks-standing-above-the-fray-1030155694
1596.0,3/5/2021 8:15:12 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3669995-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1597.0,3/5/2021 8:55:23 PM,Carnival Is Climbing Too High Too Fast,InvestorPlace,/news/stocks/ccl-stock-moving-too-high-too-fast-1030156156
1598.0,3/8/2021 11:15:46 AM,Is Ocugen Worth $18 or Just a Couple of Bucks?,InvestorPlace,/news/stocks/is-ocgn-stock-worth-18-or-just-a-couple-of-bucks-1030159343
1599.0,3/8/2021 4:25:05 PM,Sell Inovio While You Still Can,InvestorPlace,/news/stocks/sell-ino-stock-while-you-still-can-1030160441
1600.0,3/8/2021 5:51:34 PM,"Biden event with J&J, Merck moved over Emergent controversy - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3670344-biden-event-with-jj-merck-moved-over-emergent-controversy-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1601.0,3/8/2021 8:58:27 PM,Johnson & Johnson Is a Stock to Buy and Hold Forever,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-is-a-stock-to-buy-and-hold-forever-1030161050
1602.0,3/9/2021 4:03:06 PM,Supply issues may impact J&J EU COVID-19 vaccine supply goal - Reuters,Seeking Alpha,https://seekingalpha.com/news/3670757-supply-issues-may-impact-johnson-and-johnson-q2-eu-covid-19-vaccine-supply-goal-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1603.0,3/9/2021 9:42:55 PM,Market Recap: The Real Driver Behind Today‚Äôs Strength,InvestorPlace,/news/stocks/market-recap-the-real-driver-behind-tuesday-market-strength-1030166121
1604.0,3/10/2021 12:38:38 PM,Pfizer/BioNTech to supply extra 4M vaccine doses to EU to tackle virus border clusters,Seeking Alpha,https://seekingalpha.com/news/3671111-pfizerbiontech-to-supply-extra-4m-vaccine-doses-to-eu-to-tackle-virus-border-clusters?utm_source=markets.businessinsider.com&utm_medium=referral
1605.0,3/10/2021 2:58:14 PM,Biden to order 100 million additional J&J COVID-19 vaccine doses - NBC News,Seeking Alpha,https://seekingalpha.com/news/3671220-biden-to-order-100-million-additional-jj-covid-19-vaccine-doses-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral
1606.0,3/11/2021 12:51:15 PM,More Doses Of Johnson & Johnson's Covid-19 Vaccine For US ,RTTNews,/news/stocks/more-doses-of-johnson-johnson-s-covid-19-vaccine-for-us-1030172649
1607.0,3/11/2021 1:28:47 PM,JNJ‚Äôs COVID-19 vaccine recommended for European approval,Seeking Alpha,https://seekingalpha.com/news/3671687-jnjs-covid-19-vaccine-recommended-for-european-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1608.0,3/11/2021 4:22:47 PM,Johnson & Johnson' Single-dose COVID-19 Vaccine Recommended For Use In EU ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-19-vaccine-recommended-for-use-in-eu-1030174234
1609.0,3/11/2021 4:46:06 PM,J&J's COVID-19 vaccine gets European Commission conditional marketing authorization,Seeking Alpha,https://seekingalpha.com/news/3671830-jjs-covid-19-vaccine-gets-european-commission-conditional-marketing-authorization?utm_source=markets.businessinsider.com&utm_medium=referral
1610.0,3/11/2021 9:05:27 PM,Why UAL Stock Will Continue to Fly High,InvestorPlace,/news/stocks/ual-stock-why-united-airlines-will-continue-to-fly-high-1030175430
1611.0,3/11/2021 9:08:32 PM,JNJ to produce up to 3 billion COVID-19 vaccine doses in 2022,Seeking Alpha,https://seekingalpha.com/news/3671942-jnj-to-produce-up-to-3-billion-covid-19-vaccine-doses-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral
1612.0,3/11/2021 9:44:40 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-cpng-stock-ocgn-stock-stimulus-1030175736
1613.0,3/12/2021 3:27:50 AM,Johnson & Johnson's Single-dose COVID-19 Vaccine Gets Conditional Marketing Authorization In EU ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-gets-conditional-marketing-authorization-in-eu-1030175963
1614.0,3/12/2021 9:30:53 AM,Biden says all U.S. adults to be eligible for vaccines by May 1,Seeking Alpha,https://seekingalpha.com/news/3672131-biden-says-all-us-adults-to-be-eligible-for-vaccines-by-may-1?utm_source=markets.businessinsider.com&utm_medium=referral
1615.0,3/12/2021 10:01:15 AM,7 of the Best Value Stocks on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-value-stocks-on-the-market-today-1030177716
1616.0,3/12/2021 11:17:58 AM,Novavax (NVAX) shares continue to climb after robust COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3672149-novavax-nvax-shares-continue-to-climb-on-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral
1617.0,3/12/2021 3:07:40 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ride-stock-nvax-stock-infrastructure-nflx-1030179712
1618.0,3/12/2021 4:40:51 PM,WHO authorizes Johnson & Johnson vaccine for emergency use worldwide,Seeking Alpha,https://seekingalpha.com/news/3672319-who-authorizes-johnson-johnson-vaccine-for-emergency-use-worldwide?utm_source=markets.businessinsider.com&utm_medium=referral
1619.0,3/12/2021 4:43:05 PM,7 Healthcare Stocks to Buy and Hold for the Long Term,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-and-hold-for-the-long-term-1030180655
1620.0,3/12/2021 6:28:30 PM,Johnson & Johnson's Single-Shot COVID Vaccine Issued Emergency Use Listing By WHO ,RTTNews,/news/stocks/johnson-johnson-s-single-shot-covid-vaccine-issued-emergency-use-listing-by-who-1030180848
1621.0,3/12/2021 10:06:30 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-vaccines-nvax-wkhs-ride-stock-chpt-stock-nfts-1030182966
1622.0,3/14/2021 5:40:20 AM,"Big Pharma is pushing back the pandemic, but its stocks are cheap - Barron's",Seeking Alpha,https://seekingalpha.com/news/3672437-big-pharma-is-pushing-back-the-pandemic-but-its-stocks-are-cheap-barrons?utm_source=markets.businessinsider.com&utm_medium=referral
1623.0,3/15/2021 10:16:28 AM,Ocugen Needs Pieces To Fall Into Place Before It‚Äôs a Solid Vaccine Play,InvestorPlace,/news/stocks/ocgn-stock-is-purely-a-speculative-covid-19-vaccine-play-1030203068
1624.0,3/15/2021 12:02:14 PM,Takeda to support manufacturing of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3672551-takeda-to-support-manufacturing-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1625.0,3/15/2021 12:24:06 PM,The Top Reason to Consider iBio Stock in the Long Term,InvestorPlace,/news/stocks/the-top-reason-to-consider-ibio-stock-in-the-long-term-1030204312
1626.0,3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599
1627.0,3/15/2021 6:18:28 PM,Sell Ocugen Stock Now Before It Sinks Even Further,InvestorPlace,/news/stocks/sell-ocgn-stock-now-before-it-sinks-even-further-1030207527
1628.0,3/15/2021 6:19:30 PM,Ocugen plans to sell 100M doses of COVID-19 vaccine in U.S. in 2021 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3672781-ocugen-plans-to-sell-100m-doses-of-covid-19-vaccine-in-us-in-2021-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1629.0,3/15/2021 6:59:36 PM,OCGN Stock: Red-Hot Ocugen Eyes U.S. Vaccine Launch in Q2,InvestorPlace,/news/stocks/ocgn-stock-red-hot-ocugen-eyes-u-s-vaccine-launch-in-q2-1030207522
1630.0,3/15/2021 8:12:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-ocgn-stock-sndl-ccl-aal-tlry-amc-stock-1030208455
1631.0,3/16/2021 10:41:48 AM,J&J's Tremfya shows efficacy in psoriatic arthritis study through two years,Seeking Alpha,https://seekingalpha.com/news/3672990-jnjs-jnj-tremfya-shows-efficacy-in-late-stage-psoriatic-arthritis-study?utm_source=markets.businessinsider.com&utm_medium=referral
1632.0,3/16/2021 1:17:20 PM,"The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fulgent-nabs-cdc-contract-enzo-rallies-solid-biosciences-releases-gene-therapy-data-moderna-begins-pediatric-vaccine-study-1030214585
1633.0,3/16/2021 2:35:36 PM,Investing in Moderna Has Little Upside At This Point,InvestorPlace,/news/stocks/investing-in-mrna-stock-has-little-upside-at-this-point-1030215865
1634.0,3/17/2021 3:55:14 PM,7 Growth Stocks With Compelling Stories,InvestorPlace,/news/stocks/7-growth-stocks-with-compelling-stories-1030220806
1635.0,3/18/2021 6:28:52 PM,Microvision Isn‚Äôt the Second Coming,InvestorPlace,/news/stocks/microvision-mvis-stock-isnt-the-second-coming-1030225541
1636.0,3/19/2021 12:35:38 PM,FDA approves Johnson & Johnson's multiple sclerosis drug ponesimod,Seeking Alpha,https://seekingalpha.com/news/3674381-fda-approves-johnson-johnson-multiple-sclerosis-drug-ponvory-ponesimod?utm_source=markets.businessinsider.com&utm_medium=referral
1637.0,3/19/2021 1:42:55 PM,Ocugen Stock Is Not One to Trust With Nest Egg Funds,InvestorPlace,/news/stocks/ocgn-stock-ocugen-not-one-to-trust-with-nest-egg-funds-1030228419
1638.0,3/22/2021 11:47:30 AM,AstraZeneca COVID-19 shot shows 79% efficacy; shares rise 2.5%,Seeking Alpha,https://seekingalpha.com/news/3674697-moderna-and-biontech-lower-after-astrazeneca-releases-us-trial-data-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
1639.0,3/22/2021 2:16:56 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ev-stocks-cciv-stock-gme-stock-sprt-1030232941
1640.0,3/23/2021 1:02:44 PM,3 Key Reasons to Be Bullish on Airbnb Stock,InvestorPlace,/news/stocks/3-key-reasons-to-be-bullish-on-airbnb-stock-1030236613
1641.0,3/23/2021 3:55:22 PM,Ocugen Looks Very Dicey at Current Levels,InvestorPlace,/news/stocks/ocugen-ocgn-stock-looks-very-dicey-at-current-levels-1030237828
1642.0,3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral
1643.0,3/23/2021 6:34:36 PM,JNJ COVID-19 vaccine deliveries to rise as Catalent facility in Indiana gets FDA nod,Seeking Alpha,https://seekingalpha.com/news/3675408-jnj-covid-19-vaccine-deliveries-to-rise-as-catalent-facility-in-indiana-gets-fda-nod?utm_source=markets.businessinsider.com&utm_medium=referral
1644.0,3/24/2021 9:23:46 AM,EU set to curb COVID-19 vaccine export to U.K. - Reuters,Seeking Alpha,https://seekingalpha.com/news/3675539-eu-set-to-curb-covid-19-vaccines-export-to-uk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1645.0,3/24/2021 7:25:44 PM,7 Value Stocks Everyone Is Ignoring,InvestorPlace,/news/stocks/7-value-stocks-everyone-is-ignoring-1030242954
1646.0,3/25/2021 11:40:48 AM,"Ocugen Stock Has Way More Downside, Even After This Deep Correction",InvestorPlace,/news/stocks/ocgn-stock-more-downside-deep-correction-1030245902
1647.0,3/25/2021 3:55:26 PM,Biden to announce new vaccine goal of 200M shots - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676327-biden-to-announce-new-vaccine-goal-of-200m-shots-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral
1648.0,3/26/2021 12:48:45 PM,J&J's multiple sclerosis drug Ponvory receives positive CHMP opinion,Seeking Alpha,https://seekingalpha.com/news/3676745-johnson-johnson-multiple-sclerosis-drug-ponvory-receives-positive-chmp-opinion?utm_source=markets.businessinsider.com&utm_medium=referral
1649.0,3/26/2021 2:02:46 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-gme-stock-nio-stock-wework-ipo-1030250431
1650.0,3/26/2021 3:53:41 PM,Is Approval Even Enough for Ocugen Stock?,InvestorPlace,/news/stocks/for-ocgn-stock-question-whether-approval-enough-1030250787
1651.0,3/26/2021 6:30:51 PM,9 First Stocks a New Investor Should Buy,InvestorPlace,/news/stocks/9-first-stocks-new-investor-should-buy-1030251108
1652.0,3/26/2021 9:17:45 PM,White House considers lifting IP protections for vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676977-white-house-considers-lifting-ip-protections-for-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral
1653.0,3/28/2021 6:12:53 AM,Barron's touts 10 stocks to build retirement income stream,Seeking Alpha,https://seekingalpha.com/news/3677018-barrons-touts-10-stocks-to-build-retirement-income-stream?utm_source=markets.businessinsider.com&utm_medium=referral
1654.0,3/29/2021 8:15:24 AM,JNJ to supply up to 400M doses of COVID-19 vaccine to Africa,Seeking Alpha,https://seekingalpha.com/news/3677033-jnj-to-supply-up-to-400m-doses-of-covid-19-vaccine-to-africa?utm_source=markets.businessinsider.com&utm_medium=referral
1655.0,3/29/2021 10:57:30 AM,Johnson & Johnson To Supply Up To 400 Mln Doses Of COVID-19 Vaccine Candidate To Africa ,RTTNews,/news/stocks/johnson-johnson-to-supply-up-to-400-mln-doses-of-covid-19-vaccine-candidate-to-africa-1030253605
1656.0,3/29/2021 4:33:06 PM,J&J will begin delivering vaccine to Europe on April 19 - AFP,Seeking Alpha,https://seekingalpha.com/news/3677266-johnson-johnson-will-begin-delivering-vaccine-to-europe-on-april-19-afp?utm_source=markets.businessinsider.com&utm_medium=referral
1657.0,3/29/2021 6:09:45 PM,Ocugen Stock Will Continue to Climb in Anticipation of Vaccine Launch,InvestorPlace,/news/stocks/ocgn-stock-will-continue-to-climb-in-run-up-to-vaccine-launch-1030255859
1658.0,3/29/2021 11:56:24 PM,7 Reddit Penny Stocks That Are Moving Higher,InvestorPlace,/news/stocks/7-reddit-penny-stocks-that-are-moving-higher-1030265510
1659.0,3/31/2021 4:52:56 PM,10 Great Dividend Stocks Under $25,InvestorPlace,/news/stocks/10-great-dividend-stocks-under-25-1030265503
1660.0,3/31/2021 9:57:53 PM,"Manufacturing snafu ruins 15M J&J vaccine doses, delays shipments - New York Times",Seeking Alpha,https://seekingalpha.com/news/3678350-manufacturing-snafu-ruins-15m-johnson-johnson-vaccine-doses-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral
1661.0,4/1/2021 4:30:26 AM,Johnson & Johnson Says COVID-19 Vaccine Batch Fails To Meet Quality Standards ,RTTNews,/news/stocks/johnson-johnson-says-covid-19-vaccine-batch-fails-to-meet-quality-standards-1030266860
1662.0,4/1/2021 1:32:55 PM,Johnson & Johnson: Ride Out the Tech Selloff with this Dividend King,InvestorPlace,/news/stocks/johnson-johnson-ride-out-the-tech-selloff-with-this-dividend-king-1030269518
1663.0,4/1/2021 2:12:16 PM,Emergent‚Äôs plant implicated in vaccine mix-up had issues cited by FDA in 2020: AP,Seeking Alpha,https://seekingalpha.com/news/3678593-emergents-plant-implicated-in-vaccine-mix-up-had-issues-even-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral
1664.0,4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707
1665.0,4/1/2021 6:33:23 PM,Expect American Airlines Stock to Take Off by Summer as Bookings Soar,InvestorPlace,/news/stocks/aal-stock-expect-american-airlines-stock-take-off-bookings-soar-1030270705
1666.0,4/1/2021 7:51:27 PM,General Electric Will Surge if Spending Plan Goes Through,InvestorPlace,/news/stocks/ge-stock-will-surge-if-spending-plan-goes-through-1030270693
1667.0,4/2/2021 3:15:15 PM,7 Robinhood Stocks Even Billionaires Want in Their Portfolios,InvestorPlace,/news/stocks/7-robinhood-stocks-even-billionaires-want-in-their-portfolios-1030272181
1668.0,4/2/2021 4:06:09 PM,American Airlines Stock May Lose More Altitude,InvestorPlace,/news/stocks/american-airlines-stock-may-lose-more-altitude-1030272174
1669.0,4/4/2021 1:12:36 AM,Tailwinds for air lines as CDC updates travel guidance,Seeking Alpha,https://seekingalpha.com/news/3679001-tailwinds-for-air-lines-as-cdc-updates-travel-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
1670.0,4/4/2021 1:15:45 AM,Johnson & Johnson inoculates adolescents in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3679003-johnson-johnson-inoculates-adolescents-in-covid-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1671.0,4/4/2021 3:47:01 AM,HHS puts J&J in charge of Emergent BioSolutions plant behind vaccine foul-up - NYT,Seeking Alpha,https://seekingalpha.com/news/3679006-hhs-puts-johnson-johnson-in-charge-of-emergent-biosolutions-plant-behind-vaccine-foul-up-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1672.0,4/5/2021 4:06:46 AM,Emergent Bio receives modified task order for expansion of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3679014-emergent-bio-receives-modified-task-order-for-expansion-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1673.0,4/5/2021 12:28:40 PM,Cidara shares gain 15% on antiviral conjugates development deal with Janssen,Seeking Alpha,https://seekingalpha.com/news/3679090-cidara-shares-gain-15-on-antiviral-conjugates-development-deal-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral
1674.0,4/5/2021 1:26:05 PM,"Janssen Pharma Gets Worldwide Rights To Cidara's CD388, Other Influenza Antiviral Conjugates ",RTTNews,/news/stocks/janssen-pharma-gets-worldwide-rights-to-cidara-s-cd388-other-influenza-antiviral-conjugates-1030273393
1675.0,4/5/2021 2:27:00 PM,3 Consumer Staples Stocks Rising From the Ashes,InvestorPlace,/news/stocks/3-consumer-staples-stocks-rising-from-the-ashes-1030274336
1676.0,4/5/2021 3:10:04 PM,The 7 Best Startups You Can Buy on Republic Right Now,InvestorPlace,/news/stocks/the-7-best-startups-to-invest-in-on-republic-right-now-1029859065
1677.0,4/5/2021 7:28:00 PM,3 Reasons Why the General Electric Comeback Is Real,InvestorPlace,/news/stocks/ge-stock-3-reasons-why-the-general-electric-comeback-is-real-1030274740
1678.0,4/6/2021 8:58:28 AM,Fauci says government won't mandate vaccine passports,Seeking Alpha,https://seekingalpha.com/news/3679359-fauci-says-government-wont-mandate-vaccine-passports?utm_source=markets.businessinsider.com&utm_medium=referral
1679.0,4/6/2021 9:32:45 AM,EU may reach herd immunity by July 14: Commissioner Thierry Breton,Seeking Alpha,https://seekingalpha.com/news/3679363-eu-may-reach-herd-immunity-by-july-14-commissioner-thierry-breton?utm_source=markets.businessinsider.com&utm_medium=referral
1680.0,4/6/2021 2:03:27 PM,8 Retirement Stocks to Buy for Any Market Conditions,InvestorPlace,/news/stocks/8-retirement-stocks-to-buy-for-any-market-conditions-1030277583
1681.0,4/6/2021 3:50:56 PM,7 Cheap Stocks That Won‚Äôt Be on Discount for Long,InvestorPlace,/news/stocks/7-cheap-stocks-that-wont-be-on-discount-for-long-linc-jd-cto-intu-bgfv-eqc-gsk-1030278180
1682.0,4/6/2021 5:01:57 PM,Emergent plant at center of vaccine troubles had issues in the past - NYT,Seeking Alpha,https://seekingalpha.com/news/3679596-emergent-plant-at-center-of-vaccine-troubles-had-issues-in-the-past-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1683.0,4/6/2021 5:58:49 PM,Dividend payment net changes nearly doubled to $18B in Q1,Seeking Alpha,https://seekingalpha.com/news/3679618-sp-dow-jones-indices-dividend-payments-increases-18b-doubled-qq-growth?utm_source=markets.businessinsider.com&utm_medium=referral
1684.0,4/7/2021 10:03:19 AM,JNJ inks deal to manufacture contact lenses for myopia in children,Seeking Alpha,https://seekingalpha.com/news/3679721-jnj-inks-deal-to-manufacture-contact-lenses-for-myopia-in-children?utm_source=markets.businessinsider.com&utm_medium=referral
1685.0,4/7/2021 3:23:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new note offering,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-note-offering-1030281672
1686.0,4/7/2021 6:19:30 PM,7 Great ETFs to Buy Now for Momentum Going Into Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-going-into-q2-1030283106
1687.0,4/8/2021 11:02:36 AM,AstraZeneca vaccine woes could derail global vaccination drive,Seeking Alpha,https://seekingalpha.com/news/3680226-astrazeneca-vaccine-woes-could-derail-global-vaccination-drive?utm_source=markets.businessinsider.com&utm_medium=referral
1688.0,4/8/2021 11:49:26 AM,Ocugen Stock Is an Excellent Day Trade as Long as You Get Out in Time,InvestorPlace,/news/stocks/ocgn-stock-excellent-day-trade-get-out-in-time-1030285246
1689.0,4/8/2021 12:15:35 PM,The 7 Best Startups You Can Buy on StartEngine Right Now,InvestorPlace,/news/stocks/the-7-best-equity-crowdfunding-startups-you-can-buy-on-startengine-right-now-1029812989
1690.0,4/8/2021 5:49:44 PM,States will begin to feel J&J vaccine pinch with 86% decline in doses next week,Seeking Alpha,https://seekingalpha.com/news/3680469-states-will-begin-to-feel-johnson-johnson-vaccine-pinch-with-86-decline-in-doses-next-week?utm_source=markets.businessinsider.com&utm_medium=referral
1691.0,4/8/2021 6:43:55 PM,Johnson & Johnson adverse reaction prompts closure of Colorado COVID-19 vaccine site,Seeking Alpha,https://seekingalpha.com/news/3680484-jnj-covid-19-shot-closes-vaccine-site-in-colorado?utm_source=markets.businessinsider.com&utm_medium=referral
1692.0,4/8/2021 10:17:48 PM,Colorado Covid Vaccination Center Shuts Early Due To 11 Adverse Reaction Cases ,RTTNews,/news/stocks/colorado-covid-vaccination-center-shuts-early-due-to-11-adverse-reaction-cases-1030287409
1693.0,4/9/2021 2:03:56 PM,Johnson & Johnson‚Äôs COVID-19 shot under review in EU over blood clots,Seeking Alpha,https://seekingalpha.com/news/3680703-johnson-johnsons-covid-19-shot-under-review-in-eu-over-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral
1694.0,4/9/2021 2:34:02 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-nio-stock-ppi-1030289838
1695.0,4/9/2021 3:59:20 PM,7 Dividend Stocks With 50 Years of Dividend Increases,InvestorPlace,/news/stocks/7-dividend-stocks-with-50-years-of-dividend-increases-1030289825
1696.0,4/9/2021 4:53:25 PM,7 Excellent Index Funds With Juicy Dividends for Income Investors,InvestorPlace,/news/stocks/7-excellent-index-funds-with-juicy-dividends-for-income-investors-1030290105
1697.0,4/9/2021 8:44:17 PM,JNJ to begin India trial for its COVID-19 vaccine soon,Seeking Alpha,https://seekingalpha.com/news/3680816-jnj-to-begin-trials-for-its-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral
1698.0,4/9/2021 9:35:25 PM,Consumer products' Honest Company files for initial public offering,Seeking Alpha,https://seekingalpha.com/news/3680823-consumer-products-honest-company-files-for-initial-public-offering?utm_source=markets.businessinsider.com&utm_medium=referral
1699.0,4/10/2021 1:00:15 PM,WOOF Stock: 3 Reasons To Befriend This Recent IPO,InvestorPlace,/news/stocks/woof-stock-3-reasons-to-befriend-this-recent-ipo-1030290873
1700.0,4/12/2021 5:02:08 PM,Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks,InvestorPlace,/news/stocks/vaccine-passport-potential-could-boost-these-7-pharmaceutical-stocks-1030295137
1701.0,4/12/2021 5:13:09 PM,Pulmatrix slips 15% after J&J terminates license agreement,Seeking Alpha,https://seekingalpha.com/news/3681040-pulmatrix-slips-15-after-johnson-johnson-terminates-license-agreement?utm_source=markets.businessinsider.com&utm_medium=referral
1702.0,4/13/2021 11:10:19 AM,JNJ down after CDC halts the use of its COVID-19 vaccine (Updated),Seeking Alpha,https://seekingalpha.com/news/3681245-jnj-is-down-after-cdc-halts-the-use-of-its-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1703.0,4/13/2021 1:28:12 PM,JNJ‚Äôs safety issues lead to gains in other COVID-19 vaccine makers,Seeking Alpha,https://seekingalpha.com/news/3681341-bntx-stock-is-up-after-jnj-safety-issues?utm_source=markets.businessinsider.com&utm_medium=referral
1704.0,4/13/2021 1:37:37 PM,JNJ to delay COVID-19 vaccine rollout in Europe,Seeking Alpha,https://seekingalpha.com/news/3681350-johnson-johnson-issues-statement-on-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral
1705.0,4/13/2021 1:56:46 PM,Moderna says its vaccine not associated with blood clots; shares up 9%,Seeking Alpha,https://seekingalpha.com/news/3681363-moderna-says-its-vaccine-not-associated-with-blood-clots-shares-up-9?utm_source=markets.businessinsider.com&utm_medium=referral
1706.0,4/13/2021 1:59:51 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-jnj-stock-fda-agc-stock-1030299170
1707.0,4/13/2021 2:09:54 PM,White House: J&J pause won't significantly impact vaccination efforts (updated),Seeking Alpha,https://seekingalpha.com/news/3681370-white-house-jj-pause-wont-significantly-impact-vaccination-efforts?utm_source=markets.businessinsider.com&utm_medium=referral
1708.0,4/13/2021 2:16:36 PM,"The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-leadership-transition-at-amarin-vaccine-setback-for-j-j-fda-nod-for-label-expansion-of-roche-s-asthma-drug-1030298345
1709.0,4/13/2021 2:48:21 PM,FDA Halts Use Of Johnson & Johnson's COVID-19 Vaccine Over Blood Clot Issues - Quick Facts ,RTTNews,/news/stocks/fda-halts-use-of-johnson-johnson-s-covid-19-vaccine-over-blood-clot-issues-quick-facts-1030298526
1710.0,4/13/2021 3:35:08 PM,JNJ COVID-19 vaccine pause could be a ‚Äúmatter of days‚Äù: FDA,Seeking Alpha,https://seekingalpha.com/news/3681414-jnj-covid-19-vaccine-pause-could-be-a-matter-of-days-fda?utm_source=markets.businessinsider.com&utm_medium=referral
1711.0,4/13/2021 3:36:03 PM,US stocks trade mixed as investors digest March inflation surge and J&J vaccine pause,Business Insider,/news/stocks/stock-market-news-today-march-inflation-data-jnj-vaccine-pause-2021-4
1712.0,4/13/2021 7:36:42 PM,JNJ COVID-19 vaccine use halted in South Africa,Seeking Alpha,https://seekingalpha.com/news/3681494-jnj-covid-19-vaccine-use-halted-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral
1713.0,4/13/2021 8:45:55 PM,FDA Halts Johnson & Johnson's Covid-19 Vaccine Over Clotting Issues ,RTTNews,/news/stocks/fda-halts-johnson-johnson-s-covid-19-vaccine-over-clotting-issues-1030300274
1714.0,4/13/2021 8:50:02 PM,Pfizer CEO Alfred Bourla says Pfizer ramping production of COVID-19 vaccine (updated),Seeking Alpha,https://seekingalpha.com/news/3681539-ceo-bourla-says-pfizer-ramping-up-production-of-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1715.0,4/13/2021 10:03:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-xrp-doge-eth-btc-coinbase-ipo-1030300678
1716.0,4/14/2021 11:58:27 AM,Denmark to halt the use of AstraZeneca‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3681666-denmark-to-halt-the-use-of-astrazenecas-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
1717.0,4/14/2021 12:47:21 PM,Pfizer to raise second-quarter EU vaccine deliveries by 25%,Seeking Alpha,https://seekingalpha.com/news/3681700-pfizer-to-raise-second-quarter-eu-vaccine-delivery-target-by-25?utm_source=markets.businessinsider.com&utm_medium=referral
1718.0,4/14/2021 1:50:12 PM,EMA expediting review of J&J vaccine amid blood clot cases,Seeking Alpha,https://seekingalpha.com/news/3681740-ema-expediting-review-of-johnson-johnson-vaccine-amid-blood-clot-cases?utm_source=markets.businessinsider.com&utm_medium=referral
1719.0,4/14/2021 1:51:00 PM,"The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-cfo-departs-zai-lab-inks-cancer-drug-collaboration-fda-nod-for-gilead-1030303096
1720.0,4/14/2021 5:08:08 PM,JNJ to exclude pregnant women in vaccine trial in South Africa; Other trials remain paused,Seeking Alpha,https://seekingalpha.com/news/3681818-jnj-to-exclude-pregnant-women-in-vaccine-trial-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral
1721.0,4/14/2021 8:26:22 PM,Widening 'moat' for mRNA vaccines will benefit Moderna - Jefferies,Seeking Alpha,https://seekingalpha.com/news/3681898-widening-moat-for-mrna-vaccines-will-benefit-moderna-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral
1722.0,4/14/2021 9:13:43 PM,JNJ and AstraZeneca suffer setback for COVID-19 vaccine deals in Europe,Seeking Alpha,https://seekingalpha.com/news/3681930-jnj-and-astrazeneca-suffer-set-back-for-covid-19-vaccine-deals-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral
1723.0,4/14/2021 11:10:49 PM,EMA Says Johnson & Johnson's COVID-19 Vaccine's Benefits Outweigh Side Effects ,RTTNews,/news/stocks/ema-says-johnson-johnson-s-covid-19-vaccine-s-benefits-outweigh-side-effects-1030305558
1724.0,4/14/2021 11:53:30 PM,CDC panel postpones vote on J&J shot as it probes blood clots,Seeking Alpha,https://seekingalpha.com/news/3681948-cdc-panel-postpones-vote-on-jj-shot-as-it-probes-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral
1725.0,4/15/2021 12:56:11 PM,"JNJ‚Äôs COVID-19 vaccine woes to benefit mRNA based developers, Needham sizes up telehealth rivals; and more in today‚Äôs analyst action",Seeking Alpha,https://seekingalpha.com/news/3682121-jnjs-covid-19-vaccine-woes-to-benefit-mrna-based-developers?utm_source=markets.businessinsider.com&utm_medium=referral
1726.0,4/15/2021 1:49:24 PM,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-shelves-2-covid-19-studies-bristol-myers-squibb-gets-european-regulatory-nod-inspiremd-s-reverse-split-1030307762
1727.0,4/15/2021 3:43:38 PM,JNJ COVID-19 vaccine use could involve specific guidelines: Cantor,Seeking Alpha,https://seekingalpha.com/news/3682236-jnj-covid-19-vaccine-use-could-involve-specific-guidelines-cantor?utm_source=markets.businessinsider.com&utm_medium=referral
1728.0,4/15/2021 9:11:56 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogecoin-price-predictions-qs-stock-1030310657
1729.0,4/16/2021 11:43:41 AM,"J&J asked Pfizer, Moderna to help investigate blood clots but declined - WSJ",Seeking Alpha,https://seekingalpha.com/news/3682520-johnson-johnson-asked-pfizer-moderna-to-help-investigate-blood-clots-but-declined-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
1730.0,4/16/2021 12:12:56 PM,Janssen showcases nipocalimab data in generalized myasthenia gravis at AAN 2021,Seeking Alpha,https://seekingalpha.com/news/3682544-janssen-showcases-nipocalimab-data-in-generalized-myasthenia-gravis-at-aan-2021?utm_source=markets.businessinsider.com&utm_medium=referral
1731.0,4/16/2021 5:52:05 PM,7 Reddit Penny Stocks to Buy for a Biotech Boom,InvestorPlace,/news/stocks/7-reddit-penny-stocks-buy-biotech-boom-1030313550
1732.0,4/16/2021 6:22:10 PM,No evidence to support link between vaccine and blood clots -- J&J researchers,Seeking Alpha,https://seekingalpha.com/news/3682683-no-evidence-to-support-link-between-vaccine-and-blood-clots-johnson-johnson-researchers?utm_source=markets.businessinsider.com&utm_medium=referral
1733.0,4/16/2021 6:46:59 PM,"Moderna, Pfizer vaccine allocations to rise next week as J&J shot suspended",Seeking Alpha,https://seekingalpha.com/news/3682688-moderna-pfizer-vaccine-allocations-to-rise-next-week-as-johnson-johnson-shot-suspended?utm_source=markets.businessinsider.com&utm_medium=referral
1734.0,4/16/2021 7:30:09 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3682690-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
1735.0,4/17/2021 3:25:15 PM,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-johnson-johnson-biogen-earnings-neurology-conference-and-ipos-1030314413
1736.0,4/18/2021 2:08:03 AM,South African regulator recommends lifting ban on JNJ‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3682764-south-african-regulator-recommends-lifting-ban-on-jnjs-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
1737.0,4/18/2021 3:01:24 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q1-earnings-preview-1030315086
1738.0,4/18/2021 3:56:30 PM,Fauci expects J&J vaccinations to resume later this week,Seeking Alpha,https://seekingalpha.com/news/3682773-fauci-expects-jj-vaccinations-to-resume-later-this-week?utm_source=markets.businessinsider.com&utm_medium=referral
1739.0,4/18/2021 6:22:14 PM,"Barron's Latest Picks And Pans: Amazon, Coinbase, Disney, Johnson & Johnson And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-amazon-coinbase-disney-johnson-johnson-and-more-1030315209
1740.0,4/19/2021 10:45:46 AM,Drugmakers go on trial for opioid epidemic in California,Seeking Alpha,https://seekingalpha.com/news/3682811-drugmakers-go-on-trial-for-opioid-epidemic-in-california?utm_source=markets.businessinsider.com&utm_medium=referral
1741.0,4/19/2021 11:58:02 AM,JNJ's Darzalex combo regimen OK'd in Canada for rare blood cell disorder,Seeking Alpha,https://seekingalpha.com/news/3682852-jnjs-darzalex-combo-regimen-okd-in-canada-for-rare-blood-cell-disorder?utm_source=markets.businessinsider.com&utm_medium=referral
1742.0,4/19/2021 1:45:06 PM,J&J vaccine was paused because of concerns over treating blood clots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3682959-johnson-johnson-vaccine-was-paused-because-of-concerns-over-treating-blood-clots-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
1743.0,4/19/2021 3:08:56 PM,Decision On Resuming Johnson & Johnson Vaccine Expected This Week ,RTTNews,/news/stocks/decision-on-resuming-johnson-johnson-vaccine-expected-this-week-1030318065
1744.0,4/19/2021 4:03:07 PM,Moderna and BioNTech slide as Fauci predicts resumption of JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3683037-moderna-and-biontech-slides-as-fauci-predicts-resumption-of-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral
1745.0,4/19/2021 4:21:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3683044-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
1746.0,4/19/2021 6:06:36 PM,Johnson & Johnson Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683084-johnson-johnson-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
1747.0,4/19/2021 8:30:30 PM,JNJ will not pursue regulatory submission based on prostate cancer study,Seeking Alpha,https://seekingalpha.com/news/3683157-jnj-will-not-pursue-regulatory-submission-based-on-prostate-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral
1748.0,4/19/2021 9:07:19 PM,Emergent Bio hurt by second steepest drop for the year as FDA inspects manufacturing site,Seeking Alpha,https://seekingalpha.com/news/3683186-emergent-bio-drops-as-fda-inspects-manufacturing-site?utm_source=markets.businessinsider.com&utm_medium=referral
1749.0,4/19/2021 9:28:14 PM,What Did the Stock Market Do today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogeday-next-big-crypto-safemoon-1030319772
1750.0,4/20/2021 9:47:09 AM,EMA to issue advice on JNJ COVID shot later today,Seeking Alpha,https://seekingalpha.com/news/3683236-ema-to-issue-advice-on-jnj-covid-shot-later-today?utm_source=markets.businessinsider.com&utm_medium=referral
1751.0,4/20/2021 10:31:14 AM,"Johnson & Johnson EPS beats by $0.24, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3683261-johnson-and-amp-johnson-eps-beats-0_24-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
1752.0,4/20/2021 10:48:23 AM,Johnson & Johnson hikes dividend by 5% to $1.06 per share,Seeking Alpha,https://seekingalpha.com/news/3683259-johnson--johnson-hikes-dividend-by-5-to-106-per-share?utm_source=markets.businessinsider.com&utm_medium=referral
1753.0,4/20/2021 11:11:51 AM,JNJ raises 2021 guidance and quarterly dividend after Q1 earnings beat consensus,Seeking Alpha,https://seekingalpha.com/news/3683290-jnj-raises-2021-guidance-and-quarterly-dividend-after-q1-earnings-beat-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
1754.0,4/20/2021 12:35:10 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1030322014
1755.0,4/20/2021 1:43:16 PM,Johnson & Johnson Q1 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q1-results-top-estimates-1030322385
1756.0,4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640
1757.0,4/20/2021 2:35:07 PM,JNJ COVID-19 vaccine: European Medicines Agency highlights positive benefit-risk,Seeking Alpha,https://seekingalpha.com/news/3683459-jnj-covid-19-vaccine-ema-highlights-positive-benefit-risk?utm_source=markets.businessinsider.com&utm_medium=referral
1758.0,4/20/2021 3:29:30 PM,Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology,Benzinga,/news/stocks/remote-monitoring-telemedicine-company-sees-spiked-growth-of-products-and-technology-1030323571
1759.0,4/20/2021 3:41:41 PM,"JNJ reiterates positive benefit/risk profile of COVID-19 vaccine as CDC probes a ""handful"" of more cases of adverse events",Seeking Alpha,https://seekingalpha.com/news/3683496-jnj-reiterates-positive-benefitrisk-profile-of-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1760.0,4/20/2021 4:06:58 PM,J&J to resume vaccine rollout in Europe following EMA review (updated),Seeking Alpha,https://seekingalpha.com/news/3683506-johnson-johnson-to-resume-vaccine-rollout-in-europe-following-ema-review?utm_source=markets.businessinsider.com&utm_medium=referral
1761.0,4/20/2021 4:27:10 PM,Ocugen‚Äôs Outlook Is Still Very Bleak,InvestorPlace,/news/stocks/ocgn-stock-outlook-is-still-very-bleak-1030324938
1762.0,4/20/2021 8:00:03 PM,EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks ,RTTNews,/news/stocks/ema-says-j-j-covid-vaccine-s-benefits-outweigh-rare-blood-clot-risks-1030324875
1763.0,4/20/2021 9:07:08 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-airline-stocks-cruise-stocks-1030325540
1764.0,4/20/2021 9:16:20 PM,"5 Top Stock Trades for Wednesday: UAL, JNJ, PG, KSU, IBM",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-ual-jnj-pg-ksu-ibm-1030325539
1765.0,4/21/2021 9:48:47 AM,JNJ's VERITAS Vision System secures FDA clearance and CE mark,Seeking Alpha,https://seekingalpha.com/news/3683786-jnjs-veritas-vision-system-secures-fda-clearance-and-ce-mark?utm_source=markets.businessinsider.com&utm_medium=referral
1766.0,4/21/2021 12:25:48 PM,OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-huge-covaxin-news-sending-ocugen-climbing-today-1030329624
1767.0,4/21/2021 12:48:26 PM,COVID-19 vaccine supply to exceed demand in the coming weeks - report,Seeking Alpha,https://seekingalpha.com/news/3683891-vaccine-supply-to-exceed-demand-in-the-coming-weeks-report?utm_source=markets.businessinsider.com&utm_medium=referral
1768.0,4/21/2021 1:19:39 PM,Weekly record for new COVID-19 cases set - WHO,Seeking Alpha,https://seekingalpha.com/news/3683937-weekly-record-for-new-covid-19-cases-set-who?utm_source=markets.businessinsider.com&utm_medium=referral
1769.0,4/21/2021 1:55:40 PM,FDA finds multiple deficiencies in inspection of troubled Emergent Biosolutions plant,Seeking Alpha,https://seekingalpha.com/news/3683956-fda-finds-multiple-deficiencies-in-inspection-of-troubled-emergent-biosolutions-plant?utm_source=markets.businessinsider.com&utm_medium=referral
1770.0,4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral
1771.0,4/21/2021 3:09:49 PM,JNJ reiterates commitment to US COVID-19 vaccine deliveries after FDA inspection of Emergent facility,Seeking Alpha,https://seekingalpha.com/news/3684009-jnj-reiterates-commitment-to-us-covid-19-vaccine-deliveries-after-fda-inspection?utm_source=markets.businessinsider.com&utm_medium=referral
1772.0,4/21/2021 3:59:50 PM,"EU not taking up options on additional AstraZeneca, J&J vaccines - Reuters",Seeking Alpha,https://seekingalpha.com/news/3684028-eu-not-taking-up-options-on-additional-astrazeneca-johnson-johnson-vaccines-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1773.0,4/21/2021 6:41:11 PM,Pressure mounting on Biden administration to waive COVID-19 vaccine patents,Seeking Alpha,https://seekingalpha.com/news/3684145-pressure-mounting-on-biden-administration-to-waive-covid-19-vaccine-patents?utm_source=markets.businessinsider.com&utm_medium=referral
1774.0,4/22/2021 11:18:17 AM,Pfizer in talks with India to supply COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3684453-pfizer-in-talks-with-india-to-supply-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1775.0,4/22/2021 1:04:23 PM,JNJ COVID-19 vaccine: South Africa to resume rollout,Seeking Alpha,https://seekingalpha.com/news/3684563-jnj-covid-19-vaccine-south-africa-to-resume-rollout?utm_source=markets.businessinsider.com&utm_medium=referral
1776.0,4/22/2021 4:47:42 PM,J&J vaccine found effective against COVID-19 variants,Seeking Alpha,https://seekingalpha.com/news/3684700-johnson-johnson-vaccine-found-effective-against-covid-19-variants?utm_source=markets.businessinsider.com&utm_medium=referral
1777.0,4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral
1778.0,4/23/2021 10:36:21 AM,Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July,Benzinga,/news/stocks/johnson-johnson-covid-19-vaccine-could-make-its-way-to-india-by-july-1030337765
1779.0,4/23/2021 10:51:14 AM,India plans to import JNJ's COVID-19 vaccine by July end,Seeking Alpha,https://seekingalpha.com/news/3684994-india-plans-to-import-jnjs-covid-19-vaccine-by-july-end?utm_source=markets.businessinsider.com&utm_medium=referral
1780.0,4/23/2021 11:39:04 AM,JNJ COVID-19 vaccine heads for U.S. review today,Seeking Alpha,https://seekingalpha.com/news/3685021-jnj-covid-19-vaccine-heads-for-us-review-today?utm_source=markets.businessinsider.com&utm_medium=referral
1781.0,4/23/2021 12:06:48 PM,EU finalizes deal for 1.8B doses of Pfizer-BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3685044-eu-finalizes-deal-for-18b-doses-of-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1782.0,4/23/2021 2:21:54 PM,"GameStop, AMC, Penny And Crypto Stocks: Top Q1 Trends For Millennials And Gen Z",Benzinga,/news/stocks/gamestop-amc-penny-and-crypto-stocks-top-q1-trends-for-millennials-and-gen-z-1030338567
1783.0,4/23/2021 2:41:58 PM,OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen,InvestorPlace,/news/stocks/ocgn-stock-the-big-covaxin-news-that-prompted-40-gains-in-ocugen-1030339413
1784.0,4/23/2021 3:00:27 PM,7 Great ETFs to Buy to Ride Out Rough Seas,InvestorPlace,/news/stocks/7-great-etfs-to-buy-to-ride-out-rough-seas-1030339410
1785.0,4/23/2021 3:01:05 PM,8 Dividend Stocks Increasing Payouts in 2021,InvestorPlace,/news/stocks/8-dividend-stocks-increasing-payouts-in-2021-1030339409
1786.0,4/23/2021 4:16:04 PM,Blood clot cases linked to J&J vaccine rises to 15 - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685169-blood-clot-cases-linked-to-johnson-johnson-vaccine-rises-to-15-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1787.0,4/23/2021 6:45:05 PM,Ocugen Looks Less Interesting With Each Passing Shot,InvestorPlace,/news/stocks/ocgn-stock-looks-less-compelling-as-vaccines-increase-1030339903
1788.0,4/23/2021 8:55:44 PM,CDC advisory committee votes to recommend J&J vaccine with warning (updated),Seeking Alpha,https://seekingalpha.com/news/3685278-cdc-advisory-committee-votes-to-recommend-johnson-johnson-vaccine-following-pause?utm_source=markets.businessinsider.com&utm_medium=referral
1789.0,4/23/2021 9:21:35 PM,J&J rekindling plan to sell breast implant division Mentor - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685283-jj-rekindling-plan-to-sell-breast-implant-division-mentor-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1790.0,4/23/2021 11:27:24 PM,FDA and CDC lift J&J vaccine pause (updated),Seeking Alpha,https://seekingalpha.com/news/3685295-fda-and-cdc-lift-jj-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral
1791.0,4/24/2021 3:24:00 PM,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-25-may-1-fda-decisions-for-sol-gel-protalix-bio-ardelyx-1030340692
1792.0,4/24/2021 8:00:00 PM,"What might be behind blood clot risk with AstraZeneca, J&J vaccines?",Seeking Alpha,https://seekingalpha.com/news/3685297-what-might-be-behind-blood-clot-risk-with-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1793.0,4/25/2021 5:17:06 AM,Ocugen-partnered COVID-19 vaccine shows efficacy against new variant behind India‚Äôs second wave,Seeking Alpha,https://seekingalpha.com/news/3685312-ocugen-partnered-covid-19-vaccine-shows-efficacy-against-new-variant-in-india?utm_source=markets.businessinsider.com&utm_medium=referral
1794.0,4/26/2021 6:26:26 AM,FDA Lifts Pause On Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-lifts-pause-on-johnson-johnson-s-covid-19-vaccine-1030342587
1795.0,4/26/2021 7:21:45 AM,World pledges medical aid to India amid surging COVID-19 infections,Seeking Alpha,https://seekingalpha.com/news/3685321-world-pledges-medical-aid-to-india-amid-surging-new-infections?utm_source=markets.businessinsider.com&utm_medium=referral
1796.0,4/26/2021 12:04:06 PM,Most Americans hesitant about getting J&J vaccine - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3685398-most-americans-hesitant-about-getting-johnson-johnson-vaccine-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral
1797.0,4/26/2021 12:08:37 PM,A Peek Into The Markets: US Stock Futures Mixed; Tesla Earnings In Focus,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-tesla-earnings-in-focus-1030344568
1798.0,4/26/2021 12:25:52 PM,OCGN Stock: The White House News That Has Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-white-house-news-that-has-ocugen-climbing-today-1030346247
1799.0,4/26/2021 2:38:14 PM,J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director ,RTTNews,/news/stocks/j-j-vaccine-holds-lower-side-effect-risks-than-aspirin-nih-director-1030345359
1800.0,4/26/2021 3:00:47 PM,Decline in new COVID-19 cases could last despite a slowdown in vaccine rollout: Experts,Seeking Alpha,https://seekingalpha.com/news/3685540-decline-in-new-covid-19-cases-could-last-despite-a-slowdown-in-vaccine-rollout-experts?utm_source=markets.businessinsider.com&utm_medium=referral
1801.0,4/26/2021 3:18:33 PM,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,Benzinga,/news/stocks/sanofi-steps-in-for-fill-finish-200m-doses-of-moderna-s-covid-19-vaccine-1030346045
1802.0,4/26/2021 4:51:43 PM,Over 9 million doses ready to go into arms as states resume JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3685595-over-9-million-doses-ready-to-go-into-arms-as-states-resume-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral
1803.0,4/26/2021 5:39:37 PM,7 Undervalued Stocks to Buy Before the Bounce,InvestorPlace,/news/stocks/7-undervalued-stocks-to-buy-before-the-bounce-1030347104
1804.0,4/26/2021 6:22:32 PM,7 Blue-Chip Stocks Everyone Should Watch,InvestorPlace,/news/stocks/7-blue-chip-stocks-everyone-should-watch-1030347421
1805.0,4/27/2021 1:18:05 PM,Health Canada OKs Johnson & Johnson Vision's daily disposable contact lens,Seeking Alpha,https://seekingalpha.com/news/3686091-health-canada-oks-johnson-johnson-visions-daily-disposable-contact-lens?utm_source=markets.businessinsider.com&utm_medium=referral
1806.0,4/27/2021 2:21:20 PM,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,Benzinga,/news/stocks/us-to-share-up-to-60m-astrazeneca-covid-19-vaccine-doses-1030351378
1807.0,4/27/2021 3:45:31 PM,Two more blood clot cases reported with J&J vaccine - Reuters,Seeking Alpha,https://seekingalpha.com/news/3686185-two-more-blood-clot-cases-reported-with-johnson-johnson-vaccine-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1808.0,4/27/2021 4:54:02 PM,CDC updates guidance on mask wearing for people fully vaccinated against COVID-19,Seeking Alpha,https://seekingalpha.com/news/3686236-cdc-updates-guidance-on-mask-wearing-for-people-fully-vaccinated-against-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
1809.0,4/28/2021 12:34:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354437
1810.0,4/28/2021 12:38:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354444
1811.0,4/28/2021 10:00:30 AM,A Couple Of Shots in the Arm for Ocugen Stock,InvestorPlace,/news/stocks/a-couple-of-shots-in-the-arm-for-ocugen-stock-1030356996
1812.0,4/28/2021 2:29:03 PM,7 Pharmaceutical Stocks With Dividends in Hand,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-dividends-in-hand-1030359387
1813.0,4/28/2021 4:15:19 PM,10 Low-Volatility Safe Stocks to Buy Now,InvestorPlace,/news/stocks/10-low-volatility-safe-stocks-to-buy-now-1030359712
1814.0,4/28/2021 5:46:21 PM,"California reports nearly 1,400 COVID-19 cases in fully vaccinated people",Seeking Alpha,https://seekingalpha.com/news/3687105-california-records-about-1400-covid-19-cases-in-fully-vaccinated-people?utm_source=markets.businessinsider.com&utm_medium=referral
1815.0,4/28/2021 6:02:51 PM,7 Great ETFs to Buy for Dividend-Hungry Investors,InvestorPlace,/news/stocks/7-great-etfs-to-buy-for-dividend-hungry-investors-1030359697
1816.0,4/28/2021 8:23:40 PM,Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?,Benzinga,/news/stocks/time100-most-influential-companies-what-61-publicly-traded-companies-are-on-the-inaugural-list-1030359837
1817.0,4/29/2021 10:00:37 AM,7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-valuation-plus-solid-dividends-1030363716
1818.0,4/29/2021 7:06:03 PM,Emergent awaiting FDA OK to release 60M J&J vaccine doses - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3688108-emergent-awaiting-fda-ok-to-release-60m-johnson-johnson-vaccine-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1819.0,4/30/2021 10:10:55 AM,Janssen files CAR-T therapy cilta-del application for multiple myeloma in Europe,Seeking Alpha,https://seekingalpha.com/news/3688490-janssen-files-car-t-therapy-cilta-del-application-for-multiple-myeloma-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral
1820.0,4/30/2021 4:46:11 PM,"CDC allocating J&J vaccine again, but still at low numbers",Seeking Alpha,https://seekingalpha.com/news/3688786-cdc-allocating-johnson-johnson-vaccine-again-but-still-at-low-numbers?utm_source=markets.businessinsider.com&utm_medium=referral
1821.0,4/30/2021 8:30:28 PM,More than 30% of U.S. population fully vaccinated - CDC,Seeking Alpha,https://seekingalpha.com/news/3688921-more-than-30-of-us-population-fully-vaccinated-cdc?utm_source=markets.businessinsider.com&utm_medium=referral
1822.0,5/2/2021 7:17:07 PM,"To waive COVID vaccine patents, or not, that is the question",Seeking Alpha,https://seekingalpha.com/news/3689015-to-waive-covid-vaccine-patents-or-not-that-is-the-question?utm_source=markets.businessinsider.com&utm_medium=referral
1823.0,5/3/2021 10:00:27 AM,"Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use",InvestorPlace,/news/stocks/ocgn-stock-remains-gamble-covaxin-news-notwithstanding-1030377582
1824.0,5/3/2021 11:58:45 AM,"If You Have Ocugen Stock, Now‚Äôs the Time to Take Profits",InvestorPlace,/news/stocks/ocgn-stock-why-you-should-take-profit-1030378125
1825.0,5/3/2021 3:03:10 PM,Wells Fargo debuts riskier 'Signature Picks' portfolio with four megacaps featured,Seeking Alpha,https://seekingalpha.com/news/3689265-wells-fargo-debuts-riskier-signature-picks-with-four-megacaps-featured?utm_source=markets.businessinsider.com&utm_medium=referral
1826.0,5/3/2021 3:40:55 PM,JNJ‚Äôs COVID-19 vaccine left out in Danish vaccine rollout,Seeking Alpha,https://seekingalpha.com/news/3689298-jnjs-covid-19-vaccine-left-out-in-danish-vaccine-rollout?utm_source=markets.businessinsider.com&utm_medium=referral
1827.0,5/3/2021 8:11:11 PM,U.S. COVID-19 vaccine demand dips as vaccination rate climbs,Seeking Alpha,https://seekingalpha.com/news/3689695-us-covid-19-vaccine-demand-dips-as-vaccination-rate-climbs?utm_source=markets.businessinsider.com&utm_medium=referral
1828.0,5/3/2021 9:45:39 PM,FDA set to OK Pfizer vaccine for adolescents next week - New York Times,Seeking Alpha,https://seekingalpha.com/news/3689831-fda-set-to-ok-pfizer-vaccine-for-adolescents-next-week-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral
1829.0,5/4/2021 3:25:18 PM,8 Blue-Chip Stocks With Strong Earnings,InvestorPlace,/news/stocks/eight-blue-chip-stocks-strong-earnings-1030385989
1830.0,5/4/2021 3:40:26 PM,Shares of major drug makers in focus as House committees hold hearings on drug pricing bill,Seeking Alpha,https://seekingalpha.com/news/3690229-shares-of-major-drug-makers-in-focus-as-house-committees-hold-hearings-on-drug-pricing-bill?utm_source=markets.businessinsider.com&utm_medium=referral
1831.0,5/4/2021 7:09:14 PM,"Biden says vaccination effort will focus on adolescents, hesitant adults (updated)",Seeking Alpha,https://seekingalpha.com/news/3690452-biden-says-vaccination-effort-will-focus-on-adolescents-hesitant-adults?utm_source=markets.businessinsider.com&utm_medium=referral
1832.0,5/5/2021 7:35:46 PM,COVID-19 vaccine makers in the red as U.S. to back waiver of IP protections,Seeking Alpha,https://seekingalpha.com/news/3691449-covid-19-vaccine-makers-in-the-red-as-us-to-back-waiver-of-vaccine-ip-protections?utm_source=markets.businessinsider.com&utm_medium=referral
1833.0,5/6/2021 1:42:10 PM,"Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action",Seeking Alpha,https://seekingalpha.com/news/3692234-weighing-in-on-vaccine-patent-waivers-alcon-and-ultragenyx-upgraded-at-citi-and-more-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral
1834.0,5/6/2021 2:10:44 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ocgn-stock-space-stocks-btc-brphf-1030397159
1835.0,5/6/2021 4:03:03 PM,7 Safe Stocks You Can Leave to Your Children,InvestorPlace,/news/stocks/7-safe-stocks-you-can-leave-your-children-1030397799
1836.0,5/6/2021 4:39:42 PM,Germany's Merkel opposed to lifting IP protections on vaccines -- Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3692395-germany-merkel-opposed-to-lifting-ip-protections-on-vaccines-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1837.0,5/6/2021 7:43:04 PM,Emergent-produced J&J vaccine distribution paused in several countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3692464-emergent-produced-johnson-johnson-vaccine-distribution-paused-in-several-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1838.0,5/6/2021 8:41:26 PM,5 Cheap Growth Stocks for Q2 2021,InvestorPlace,/news/stocks/5-cheap-growth-stocks-for-q2-2021-1030399122
1839.0,5/7/2021 6:59:18 AM,"JNJ's Tecnis Synergy and Tecnis Synergy Toric II IOLs OK'd in U.S., Canada",Seeking Alpha,https://seekingalpha.com/news/3692955-jnjs-tecnis-synergy-and-tecnis-synergy-toric-ii-iols-okd-in-us-canada?utm_source=markets.businessinsider.com&utm_medium=referral
1840.0,5/11/2021 6:48:00 PM,States won‚Äôt receive JNJ COVID-19 vaccine deliveries next week: Politico,Seeking Alpha,https://seekingalpha.com/news/3694765-states-wont-receive-jnj-covid-19-vaccine-deliveries-next-week-politico?utm_source=markets.businessinsider.com&utm_medium=referral
1841.0,5/12/2021 12:55:50 PM,FDA OKs Johnson & Johnson Vision's Acuvue Abiliti Overnight lenses for myopia,Seeking Alpha,https://seekingalpha.com/news/3695232-fda-oks-johnson-johnson-visions-acuvue-abiliti-overnight-lenses-for-myopia?utm_source=markets.businessinsider.com&utm_medium=referral
1842.0,5/12/2021 12:59:21 PM,Emergent says it is making improvements to troubled Baltimore vaccine plant,Seeking Alpha,https://seekingalpha.com/news/3695230-emergent-says-it-is-making-improvements-to-troubled-baltimore-vaccine-plant?utm_source=markets.businessinsider.com&utm_medium=referral
1843.0,5/12/2021 2:23:33 PM,Emergent executives to testify before House coronavirus panel next week,Seeking Alpha,https://seekingalpha.com/news/3695305-emergent-executives-to-testify-before-house-coronavirus-panel-next-week?utm_source=markets.businessinsider.com&utm_medium=referral
1844.0,5/12/2021 3:26:19 PM,Ethereum (ETH) Price Predictions: Why Some Analysts Think ETH Will Hit $20K in 2025,InvestorPlace,/news/stocks/ethereum-eth-price-predictions-why-some-analysts-see-20k-in-2025-1030422216
1845.0,5/13/2021 1:05:22 PM,Blood clot risk from J&J vaccine 40 times less than dying from COVID,Seeking Alpha,https://seekingalpha.com/news/3695918-blood-clot-risk-from-johnson-johnson-vaccine-40-times-less-than-dying-from-covid?utm_source=markets.businessinsider.com&utm_medium=referral
1846.0,5/13/2021 2:23:31 PM,Ocugen Has a Longer Road To Paying off Than People Think,InvestorPlace,/news/stocks/confusing-trading-leaves-ocgn-stock-interesting-1030426929
1847.0,5/13/2021 6:41:24 PM,The 7 Best Stocks and Cryptos to Buy in May,InvestorPlace,/news/stocks/the-7-best-stocks-and-cryptos-to-buy-in-may-1030427551
1848.0,5/14/2021 3:38:44 PM,It Won‚Äôt Take Much for Vaxart Stock to Pop Once Again,InvestorPlace,/news/stocks/vxrt-stock-wont-make-much-to-pop-once-again-1030431453
1849.0,5/14/2021 5:38:17 PM,J&J vaccines to Latin America could expire before they are fully deployed - FT,Seeking Alpha,https://seekingalpha.com/news/3696723-johnson-johnson-vaccines-to-latin-america-could-expire-before-they-are-fully-deployed-ft?utm_source=markets.businessinsider.com&utm_medium=referral
1850.0,5/17/2021 4:35:49 AM,Janssen Pharma's Xarelto + aspirin significantly reduces total ischemic events in peripheral artery disease,Seeking Alpha,https://seekingalpha.com/news/3696894-janssen-pharmas-xarelto-aspirin-significantly-reduces-total-ischemic-events-in-peripheral-artery-disease?utm_source=markets.businessinsider.com&utm_medium=referral
1851.0,5/17/2021 11:28:54 AM,AC Immune expands Phase 1b/2a phospho-Tau Alzheimer‚Äôs vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3696962-ac-immune-expands-phase-1b2a-phospho-tau-alzheimers-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral
1852.0,5/17/2021 2:36:18 PM,Supreme Court rejects J&J $70M Risperdal award appeal,Seeking Alpha,https://seekingalpha.com/news/3697202-supreme-court-rejects-jj-70m-risperdal-award-appeal?utm_source=markets.businessinsider.com&utm_medium=referral
1853.0,5/17/2021 3:55:02 PM,AC Immune Provides Update On Alzheimer's Disease Vaccine Candidate,Benzinga,/news/stocks/ac-immune-provides-update-on-alzheimer-s-disease-vaccine-candidate-1030437016
1854.0,5/17/2021 4:12:11 PM,JNJ to cut vaccine shipments to EU by half this week,Seeking Alpha,https://seekingalpha.com/news/3697248-jnj-to-cut-vaccine-shipments-to-eu-by-half-this-week?utm_source=markets.businessinsider.com&utm_medium=referral
1855.0,5/17/2021 5:28:00 PM,U.S. to ship additional 20M vaccine doses abroad in June,Seeking Alpha,https://seekingalpha.com/news/3697271-us-to-ship-additional-20m-vaccine-doses-abroad-abroad-in-june?utm_source=markets.businessinsider.com&utm_medium=referral
1856.0,5/17/2021 6:45:29 PM,7 ETFs To Buy if You Want To Try To Outperform Cathie Wood,InvestorPlace,/news/stocks/7-etfs-to-buy-if-you-want-to-try-to-outperform-cathie-wood-1030438262
1857.0,5/18/2021 5:14:32 PM,JNJ confirms it is working with Indian company to manufacture COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3697906-jnj-confirms-it-is-working-with-indian-company-to-manufacture-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1858.0,5/18/2021 7:54:31 PM,Why Zomedica Doesn‚Äôt Need Reddit,InvestorPlace,/news/stocks/zom-stock-why-zomedica-doesnt-need-reddit-1030443399
1859.0,5/19/2021 7:16:02 AM,"AstraZeneca/Oxford's third booster shot induces ""high antibody response"", study shows",Seeking Alpha,https://seekingalpha.com/news/3698071-astrazenecaoxfords-third-booster-shot-induces-high-antibody-response-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral
1860.0,5/19/2021 9:01:32 AM,7 Best Biotech Stocks To Buy in 2021 as Innovation Takes Center Stage,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-as-innovation-takes-center-stage-1030445426
1861.0,5/19/2021 1:09:13 PM,India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters,Benzinga,/news/stocks/india-s-biological-e-to-make-johnson-johnson-s-covid-19-shots-reuters-1030445754
1862.0,5/19/2021 2:03:56 PM,House report finds Emergent execs given bonuses despite failing to deliver vaccines,Seeking Alpha,https://seekingalpha.com/news/3698231-house-report-details-relationships-with-emergent-and-members-of-congress?utm_source=markets.businessinsider.com&utm_medium=referral
1863.0,5/19/2021 3:24:10 PM,Senate Republicans ask Biden to walk back support of waiving vaccine IP protection,Seeking Alpha,https://seekingalpha.com/news/3698273-senate-republicans-ask-biden-to-walk-back-support-of-waiving-vaccine-ip-protection?utm_source=markets.businessinsider.com&utm_medium=referral
1864.0,5/19/2021 7:04:34 PM,Stay On The Sidelines With Ocugen Stock,InvestorPlace,/news/stocks/stay-on-the-sidelines-with-ocgn-stock-1030455829
1865.0,5/20/2021 2:12:01 PM,"Merck downgraded to hold at Argus, Allogene upped at Truist, and more in today's analyst action",Seeking Alpha,https://seekingalpha.com/news/3698655-merck-downgraded-to-hold-at-argus-allogene-upped-at-truist-and-more-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral
1866.0,5/20/2021 5:51:41 PM,JNJ highlights potential of IMBRUVICA as a first-line treatment for leukemia,Seeking Alpha,https://seekingalpha.com/news/3698811-jnj-highlights-potential-of-imbruvica-as-a-first-line-treatment-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral
1867.0,5/20/2021 6:16:48 PM,Moderna Holds the Key to the Future of mRNA Vaccines,InvestorPlace,/news/stocks/mrna-stock-holds-the-key-to-the-future-of-vaccines-1030452921
1868.0,5/20/2021 6:44:51 PM,Legend Biotech spikes on EMA acceptance of marketing application for cilta-cel,Seeking Alpha,https://seekingalpha.com/news/3698833-legend-biotech-spikes-on-ema-acceptance-of-marketing-application-for-cilta-cel?utm_source=markets.businessinsider.com&utm_medium=referral
1869.0,5/21/2021 12:36:52 PM,Gavi to purchase 200M J&J vaccine doses for poorer countries,Seeking Alpha,https://seekingalpha.com/news/3699079-gavi-to-purchase-200m-johnson-johnson-vaccine-doses-for-poorer-countries?utm_source=markets.businessinsider.com&utm_medium=referral
1870.0,5/21/2021 1:30:02 PM,EMA advisory group backs Janssen's Darzalex for AL amyloidosis and multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3699117-ema-advisory-group-backs-janssens-darzalex-for-al-amyloidosis-and-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1871.0,5/21/2021 2:04:27 PM,"Pfizer, Moderna, and J&J pledge more shots for poorer countries - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3699127-pfizer-moderna-and-johnson-johnson-pledge-more-shots-for-poorer-countries-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
1872.0,5/21/2021 3:02:52 PM,JNJ wins positive opinion in Europe for expanded use of DARZALEX,Seeking Alpha,https://seekingalpha.com/news/3699162-jnj-wins-positive-opinion-in-europe-for-expanded-use-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral
1873.0,5/21/2021 4:29:21 PM,Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze ,RTTNews,/news/stocks/janssen-gets-two-positive-chmp-opinions-for-darzalex-subcutaneous-formulation-utilizing-enhanze-1030455493
1874.0,5/21/2021 6:37:07 PM,FDA approves J&J's Rybrevant as targeted therapy for NSCLC patient subset,Seeking Alpha,https://seekingalpha.com/news/3699217-fda-approves-johnson-johnson-rybrevant-as-targeted-therapy-for-nsclc-patient-subset?utm_source=markets.businessinsider.com&utm_medium=referral
1875.0,5/22/2021 2:16:04 PM,"'Halftime Report' Traders Share Their Thoughts On Target, Home Depot And More",Benzinga,/news/stocks/halftime-report-traders-share-their-thoughts-on-target-home-depot-and-more-1030456782
1876.0,5/24/2021 4:51:31 AM,Janssen presents Stelara data from late-stage Seavue study in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3699311-janssen-presents-stelara-data-from-late-stage-seavue-study-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral
1877.0,5/24/2021 6:27:23 AM,Johnson & Johnson seeks COVID-19 vaccine approval in Japan - Reuters,Seeking Alpha,https://seekingalpha.com/news/3699315-johnson-johnson-seeks-covid-19-vaccine-approval-in-japan-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1878.0,5/24/2021 6:31:26 PM,3 Healthcare Stocks to Buy as the Sector Breaks Out,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-sector-breaks-out-1030459870
1879.0,5/25/2021 6:02:06 PM,EU targets more than a billion COVID-19 vaccine doses by September,Seeking Alpha,https://seekingalpha.com/news/3699985-eu-targets-more-than-a-billion-covid-19-vaccine-doses-by-september?utm_source=markets.businessinsider.com&utm_medium=referral
1880.0,5/25/2021 7:46:23 PM,"With a Stumbling Track Record, All Signs Say Stay Away from Novavax",InvestorPlace,/news/stocks/nvax-stock-stumbling-track-record-all-signs-say-stay-away-1030464342
1881.0,5/26/2021 11:10:09 AM,FDA is set to decline new emergency use authorizations for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3700199-fda-is-set-to-decline-new-emergency-use-authorizations-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1882.0,5/26/2021 2:02:40 PM,Belgium suspends J&J COVID-19 jab for people under 41 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3700331-belgium-suspends-jj-covid-19-jab-for-people-under-41-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1883.0,5/26/2021 3:49:59 PM,7 Top Dividend Stocks Trading at a Discount Worth Snapping Up,InvestorPlace,/news/stocks/7-top-dividend-stocks-trading-discount-worth-snapping-up-1030468041
1884.0,5/26/2021 5:13:23 PM,7 Defensive ETFs to Protect Yourself From the Tech Sell-Off,InvestorPlace,/news/stocks/7-defensive-etfs-to-protect-yourself-from-the-tech-sell-off-1030468425
1885.0,5/26/2021 6:21:23 PM,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,Benzinga,/news/stocks/fda-may-not-review-new-covid-19-vaccine-emergency-use-requests-1030468148
1886.0,5/26/2021 9:41:26 PM,FDA grants J&J multiple myeloma treatment cilta-cel priority review,Seeking Alpha,https://seekingalpha.com/news/3700574-fda-grants-johnson-johnson-multiple-myeloma-treatment-cilta-cel-priority-review?utm_source=markets.businessinsider.com&utm_medium=referral
1887.0,5/27/2021 8:41:14 AM,Here's What Is Going On With Ocugen (OCGN) Stock,Benzinga,/news/stocks/here-s-what-is-going-on-with-ocugen-ocgn-stock-1030469868
1888.0,5/27/2021 2:23:09 PM,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-vir-glaxosmithkline-covid-19-antibody-treatment-approved-zosano-spikes-on-long-term-migraine-drug-data-decision-day-for-eton-2-ipos-1030471204
1889.0,5/27/2021 4:22:40 PM,J&J may miss June vaccine supply target for EU - Dutch broadcaster,Seeking Alpha,https://seekingalpha.com/news/3700892-johnson-johnson-may-miss-june-vaccine-supply-target-for-eu-dutch-broadcaster?utm_source=markets.businessinsider.com&utm_medium=referral
1890.0,5/27/2021 9:27:56 PM,"COVID-19 vaccines from Pfizer/BioNTech, JNJ and Moderna set for India entry as India clears hurdles",Seeking Alpha,https://seekingalpha.com/news/3701056-covid-19-vaccines-from-pfizerbiontech-jnj-and-moderna-set-for-india-entry?utm_source=markets.businessinsider.com&utm_medium=referral
1891.0,5/28/2021 3:59:49 AM,"J&J, FDA close to deal allowing release of vaccine from troubled Emergent plant - WSJ",Seeking Alpha,https://seekingalpha.com/news/3701095-johnson-johnson-fda-close-to-deal-allowing-release-of-vaccine-from-troubled-emergent-plant-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
1892.0,5/28/2021 12:02:35 PM,Johnson & Johnson COVID-19 vaccine wins UK approval (updated),Seeking Alpha,https://seekingalpha.com/news/3701176-johnson-johnson-covid-19-vaccine-wins-uk-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1893.0,5/28/2021 2:01:46 PM,Biden's goal of 70% Covid vaccination by summer may be in reach - NYT,Seeking Alpha,https://seekingalpha.com/news/3701240-bidens-goal-of-70-covid-vaccination-by-summer-may-be-in-reach-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1894.0,5/28/2021 3:00:13 PM,Johnson & Johnson's Single Dose COVID-19 Vaccine Approved In U.K. ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-approved-in-u-k-1030475349
1895.0,5/30/2021 3:54:17 AM,Companies can require employees to get COVID-19 shot: EEOC,Seeking Alpha,https://seekingalpha.com/news/3701444-companies-can-require-employees-to-get-covid-19-shot-eeoc?utm_source=markets.businessinsider.com&utm_medium=referral
1896.0,5/31/2021 7:21:08 PM,JNJ‚Äôs delay in meeting COVID-19 vaccine delivery targets only temporary: EU,Seeking Alpha,https://seekingalpha.com/news/3701477-jnjs-delay-in-meeting-covid-19-vaccine-delivery-targets-only-temporary-eu?utm_source=markets.businessinsider.com&utm_medium=referral
1897.0,6/1/2021 11:04:05 AM,JNJ to hear from Supreme Court regarding $2 billion talc verdict,Seeking Alpha,https://seekingalpha.com/news/3701563-jnj-to-hear-from-supreme-court-regarding-2-billion-talc-verdict?utm_source=markets.businessinsider.com&utm_medium=referral
1898.0,6/1/2021 1:53:05 PM,Johnson & Johnson slips as supreme court rejects appeal in talc case,Seeking Alpha,https://seekingalpha.com/news/3701717-johnson-johnson-slips-as-supreme-court-rejects-appeal-in-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral
1899.0,6/1/2021 7:18:38 PM,7 Best Stocks To Buy To Hedge Against A Potential Downturn,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-hedge-against-a-potential-downturn-1030484539
1900.0,6/1/2021 10:41:40 PM,Supreme Court Dismisses J&J Appeal Against The $2bln Fine ,RTTNews,/news/stocks/supreme-court-dismisses-j-j-appeal-against-the-2bln-fine-1030484758
1901.0,6/1/2021 11:31:09 PM,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-june-pdufa-dates-1030484849
1902.0,6/2/2021 9:37:50 AM,European countries roll out digital Covid certificate to ease travel - NYT,Seeking Alpha,https://seekingalpha.com/news/3702175-european-countries-roll-out-digital-covid-certificate-to-ease-travel-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1903.0,6/2/2021 10:37:13 AM,NIH begins study to evaluate mix-and-match COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3702194-nih-begins-study-to-evaluate-mix-and-match-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
1904.0,6/2/2021 4:35:00 PM,Johnson & Johnson -- Moody's: Denial of J&J's talc verdict appeal highlights litigation exposures,Moodys,/news/bonds/johnson-johnson-moody-s-denial-of-j-j-s-talc-verdict-appeal-highlights-litigation-exposures-1030487991
1905.0,6/2/2021 8:03:14 PM,AstraZeneca in talks to shift COVID-19 vaccine production from Emergent-owned facility,Seeking Alpha,https://seekingalpha.com/news/3702588-astrazeneca-in-talks-to-shift-covid-19-vaccine-production-from-emergent-owned-facility?utm_source=markets.businessinsider.com&utm_medium=referral
1906.0,6/3/2021 8:06:03 AM,Low-income nations secure additional $2.4B to boost access to COVID-19 vaccines - NYT,Seeking Alpha,https://seekingalpha.com/news/3702752-low-income-nations-secures-additional-24b-to-boost-access-to-covid-19-vaccines-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1907.0,6/3/2021 3:48:24 PM,4 Best Defensive ETFs to Protect Your Portfolio,InvestorPlace,/news/stocks/4-best-defensive-etfs-to-protect-your-portfolio-1030492368
1908.0,6/3/2021 5:29:36 PM,I Would Hope Inovio Isn‚Äôt Attracting ANY Serious Money,InvestorPlace,/news/stocks/i-would-hope-inovio-and-ino-stock-isnt-attracting-any-serious-money-1030492714
1909.0,6/4/2021 7:20:52 PM,"Despite Setbacks, the Future Remains Bright for Novavax Stock",InvestorPlace,/news/stocks/despite-setbacks-the-future-remains-bright-for-novavax-stock-1030496514
1910.0,6/7/2021 7:06:19 AM,Argenx to regain global rights to cusatuzumab from Janssen Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3703535-argenx-to-regain-global-rights-to-cusatuzumab-from-janssen-pharmaceuticals?utm_source=markets.businessinsider.com&utm_medium=referral
1911.0,6/7/2021 7:43:19 AM,Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag ,RTTNews,/news/stocks/argenx-to-regain-global-rights-to-anti-cd70-antibody-cusatuzumab-from-janssen-s-cilag-1030498269
1912.0,6/7/2021 8:31:19 AM,"Addex, Janssen initiate Phase 2 study of ADX71149 for epilepsy",Seeking Alpha,https://seekingalpha.com/news/3703540-addex-janssen-initiate-phase-2-study-of-adx71149-for-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral
1913.0,6/7/2021 10:37:17 AM,U.S. to weigh COVID-19 shots for children as vaccination drive reaches milestone,Seeking Alpha,https://seekingalpha.com/news/3703562-us-to-weigh-covid-19-shots-for-children-as-vaccination-drive-reaches-milestone?utm_source=markets.businessinsider.com&utm_medium=referral
1914.0,6/7/2021 8:41:33 PM,JNJ faces steep decline in demand for COVID-19 shot in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3703903-jnj-faces-steep-decline-in-demand-for-covid-19-shot-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral
1915.0,6/8/2021 3:18:10 PM,"Could Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?",Seeking Alpha,https://seekingalpha.com/news/3704152-could-lilly-donanemab-others-for-alzheimers-get-a-boost-from-biogen-approval?utm_source=markets.businessinsider.com&utm_medium=referral
1916.0,6/8/2021 5:44:00 PM,There‚Äôs Good Reason to Believe Novavax Will Rise Soon,InvestorPlace,/news/stocks/theres-good-reason-to-believe-nvax-stock-will-rise-soon-1030505029
1917.0,6/8/2021 8:13:34 PM,JNJ COVID-19 vaccines left unused in U.S.: states urged to seek longer shelf life,Seeking Alpha,https://seekingalpha.com/news/3704323-jnj-covid-19-vaccines-left-unused-in-us-states-urged-to-seek-longer-shelf-life?utm_source=markets.businessinsider.com&utm_medium=referral
1918.0,6/9/2021 9:35:12 AM,CDC relaxes COVID-19 travel recommendations to over 100 countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3704419-the-cdc-relaxes-covid-19-travel-recommendations-to-over-100-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1919.0,6/9/2021 10:36:44 AM,J&J COVID-19 vaccines at risk of going waste due to expiry in June - NYT,Seeking Alpha,https://seekingalpha.com/news/3704430-jj-covid-19-vaccines-at-risk-of-going-waste-due-to-expiry-in-june-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1920.0,6/9/2021 2:30:00 PM,"Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities",PR Newswire,/news/stocks/johnson-johnson-releases-2020-health-for-humanity-report-highlighting-performance-and-progress-on-environmental-social-and-governance-priorities-1030507524
1921.0,6/9/2021 4:59:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1030508454
1922.0,6/9/2021 7:43:27 PM,"Roivant's Datavant, Ciox Health To Merge In $7B Deal",Benzinga,/news/stocks/roivant-s-datavant-ciox-health-to-merge-in-7b-deal-1030508950
1923.0,6/9/2021 8:08:33 PM,JNJ CEO sees need for COVID-19 booster vaccines with annual flu shots for several years,Seeking Alpha,https://seekingalpha.com/news/3704764-jnj-ceo-sees-need-for-covid-19-booster-vaccines-with-annual-flu-shots-for-several-years?utm_source=markets.businessinsider.com&utm_medium=referral
1924.0,6/10/2021 9:48:41 AM,WTO to initiate vaccine supply negotiations amid patent waiver conflict for Covid drugs - Reuters,Seeking Alpha,https://seekingalpha.com/news/3704887-wto-to-initiate-vaccine-supply-negotiations-on-june-17-amid-patent-waiver-conflict-for-covid-drugs-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1925.0,6/10/2021 10:56:35 AM,JNJ COVID-19 vaccine: EU to donate extra doses,Seeking Alpha,https://seekingalpha.com/news/3704904-jnj-covid-19-vaccine-eu-to-donate-extra-doses?utm_source=markets.businessinsider.com&utm_medium=referral
1926.0,6/10/2021 3:52:38 PM,JNJ COVID-19 vaccine: shelf life extended by one-and-a-half months,Seeking Alpha,https://seekingalpha.com/news/3705103-jnj-covid-19-vaccine-shelf-life-extended-by-one-and-a-half-months?utm_source=markets.businessinsider.com&utm_medium=referral
1927.0,6/10/2021 4:15:23 PM,Anti-Meme Stocks: 7 Value Stock Picks for Common Sense Investors,InvestorPlace,/news/stocks/anti-meme-stocks-7-value-stock-picks-for-common-sense-investors-1030513268
1928.0,6/11/2021 3:16:57 PM,JNJ will need to trash 60M COVID doses from Emergent plant but can distribute 10M (updated),Seeking Alpha,https://seekingalpha.com/news/3705686-johnson-johnson-will-need-to-discard-60m-covid-doses-made-at-emergent-plant-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1929.0,6/14/2021 8:26:35 AM,JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study,Seeking Alpha,https://seekingalpha.com/news/3705857-jnjabbvies-imbruvicavenclexta-show-promising-progression-free-survival-in-blood-cancer?utm_source=markets.businessinsider.com&utm_medium=referral
1930.0,6/14/2021 8:55:09 AM,JNJ's DARZALEX combo regime shows significant overall survival benefits in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3705858-jnjs-darzalex-combo-regime-shows-significant-overall-survival-benefits-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
1931.0,6/14/2021 11:11:05 AM,G7 leaders pledge 1B coronavirus vaccines for developing countries,Seeking Alpha,https://seekingalpha.com/news/3705892-g7-leaders-pledge-1b-coronavirus-vaccines-for-developing-countries?utm_source=markets.businessinsider.com&utm_medium=referral
1932.0,6/14/2021 5:43:07 PM,"Seeking vaccination boost, NYC launches $100 referral bonus program for organizations",Seeking Alpha,https://seekingalpha.com/news/3706113-seeking-vaccination-boost-nyc-launches-100-referral-bonus-program-for-organizations?utm_source=markets.businessinsider.com&utm_medium=referral
1933.0,6/14/2021 6:11:12 PM,Rivals in the red after Novavax posted strong efficacy data for its COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3706122-rivals-in-the-red-after-novavax-posted-strong-efficacy-data-for-its-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
1934.0,6/15/2021 2:25:26 PM,Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects,InvestorPlace,/news/stocks/hold-mrk-stock-for-solid-dividend-and-covid-19-treatment-prospects-1030525034
1935.0,6/15/2021 4:32:32 PM,"Cramer Weighs In On Johnson & Johnson, ViacomCBS And More",Benzinga,/news/stocks/cramer-weighs-in-on-johnson-johnson-viacomcbs-and-more-1030524603
1936.0,6/15/2021 5:15:32 PM,"US, EU aim to vaccinate two-thirds of world's population against COVID by end of 2022",Seeking Alpha,https://seekingalpha.com/news/3706544-us-eu-aim-to-vaccinate-two-thirds-of-worlds-population-against-covid-by-end-of-2022?utm_source=markets.businessinsider.com&utm_medium=referral
1937.0,6/16/2021 1:50:34 AM,Another 14M J&J vaccine doses from Emergent plant authorized by FDA - Reuters,Seeking Alpha,https://seekingalpha.com/news/3706719-another-14m-johnson-johnson-vaccine-doses-from-emergent-plant-authorized-by-fda-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1938.0,6/16/2021 11:04:42 AM,JNJ to miss second quarter target for COVID-19 vaccine deliveries: EU,Seeking Alpha,https://seekingalpha.com/news/3706772-jnj-to-miss-second-quarter-target-for-covid-19-vaccine-deliveries-eu?utm_source=markets.businessinsider.com&utm_medium=referral
1939.0,6/16/2021 12:13:20 PM,It‚Äôs Time to Admit Defeat and Dump Ocugen Stock as a Covid Play,InvestorPlace,/news/stocks/ocgn-stock-is-no-covid-play-1030528088
1940.0,6/16/2021 4:00:34 PM,Is There Still Upside Potential for Novavax Stock?,InvestorPlace,/news/stocks/is-there-still-upside-potential-for-novavax-stock-1030529164
1941.0,6/17/2021 4:40:21 AM,BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant - Barron's,Seeking Alpha,https://seekingalpha.com/news/3707136-biontech-ceo-sahin-warns-of-possible-covid-resurgence-from-delta-variant-barrons?utm_source=markets.businessinsider.com&utm_medium=referral
1942.0,6/17/2021 3:02:39 PM,7 Penny Stocks Under a Penny That Are Worth a Look,InvestorPlace,/news/stocks/7-penny-stocks-under-a-penny-that-are-worth-a-look-1030532972
1943.0,6/17/2021 9:13:38 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-bitcoin-ride-stock-cvac-stock-1030533935
1944.0,6/19/2021 6:38:00 PM,"The Facebook trade is crowded, but Apple isn't; here's the global list: Alpha Tactics",Seeking Alpha,https://seekingalpha.com/news/3707855-facebook-is-crowded-but-apple-isnt-global-list?utm_source=markets.businessinsider.com&utm_medium=referral
1945.0,6/21/2021 8:39:43 AM,CDC warns Delta variant could become dominant in U.S. this summer,Seeking Alpha,https://seekingalpha.com/news/3707964-cdc-warns-delta-variant-could-become-dominant-in-us-this-summer-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral
1946.0,6/21/2021 10:00:50 AM,Novavax Is a Long-Term Buy for the Continuing Pandemic,InvestorPlace,/news/stocks/nvax-stock-is-a-long-term-buy-for-the-continuing-pandemic-1030538420
1947.0,6/21/2021 6:20:08 PM,China reaches a milestone in COVID-19 vaccination with 1 billion shots,Seeking Alpha,https://seekingalpha.com/news/3708387-china-reaches-a-milestone-in-covid-19-vaccination-with-1-billion-shots?utm_source=markets.businessinsider.com&utm_medium=referral
1948.0,6/22/2021 4:58:56 PM,White House to fall short of July 4 Covid vaccination goal - NBC,Seeking Alpha,https://seekingalpha.com/news/3708788-white-house-to-say-us-could-miss-fourth-of-july-goal-in-covid-19-vaccination-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral
1949.0,6/23/2021 6:54:00 AM,Fauci says Delta variant greatest threat to U.S. efforts to eradicate COVID-19,Seeking Alpha,https://seekingalpha.com/news/3708985-fauci-says-delta-variant-greatest-threat-to-united-states-efforts-to-eradicate-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
1950.0,6/23/2021 3:13:30 PM,J&J Janssen division submits Xarelto NDA for blood clots in children,Seeking Alpha,https://seekingalpha.com/news/3709231-johnson-johnson-janssen-division-submits-xarelto-nda-for-blood-clots-in-children?utm_source=markets.businessinsider.com&utm_medium=referral
1951.0,6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404
1952.0,6/24/2021 9:45:14 AM,NIH commences COVID-19 vaccine trial in pregnant women - Reuters,Seeking Alpha,https://seekingalpha.com/news/3709428-nih-commences-covid-19-vaccine-trial-in-pregnant-women-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1953.0,6/24/2021 10:06:34 AM,U.S. to supply 3M doses on J&J's COVID-19 vaccine to Brazil,Seeking Alpha,https://seekingalpha.com/news/3709435-us-to-supply-3m-doses-on-jjs-covid-19-vaccine-to-brazil?utm_source=markets.businessinsider.com&utm_medium=referral
1954.0,6/24/2021 4:35:43 PM,CDC and WHO weigh in on need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3709736-cdc-and-who-weigh-in-on-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
1955.0,6/25/2021 1:25:02 PM,"Denmark to continuing banning J&J, AstraZeneca vaccines",Seeking Alpha,https://seekingalpha.com/news/3710130-denmark-to-continuing-banning-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
1956.0,6/26/2021 3:19:47 PM,J&J to stop selling opioid meds as part of $230M settlement with New York,Seeking Alpha,https://seekingalpha.com/news/3710315-johnson-johnson-to-stop-selling-opioid-meds-as-part-of-230m-settlement-with-new-york?utm_source=markets.businessinsider.com&utm_medium=referral
1957.0,6/26/2021 4:49:24 PM,Johnson & Johnson Agrees To Settle New York Opioid Lawsuit : Reports ,RTTNews,/news/stocks/johnson-johnson-agrees-to-settle-new-york-opioid-lawsuit-reports-1030556564
1958.0,6/27/2021 1:06:49 AM,JNJ COVID-19 vaccine and risks from delta variant: experts are already taking booster shots,Seeking Alpha,https://seekingalpha.com/news/3710324-jnj-covid-19-vaccine-and-risks-from-delta-variant-experts-are-already-taking-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
1959.0,6/28/2021 10:49:54 AM,"5 Stocks To Watch For June 28, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-june-28-2021-1030557819
1960.0,6/28/2021 12:09:06 PM,A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-crude-oil-edges-lower-1030558050
1961.0,6/28/2021 12:44:18 PM,"Pfizer, Moderna mRNA vaccines may result in long-lasting immunity: Study",Seeking Alpha,https://seekingalpha.com/news/3710450-pfizer-moderna-mrna-vaccines-may-result-in-long-lasting-immunity-study?utm_source=markets.businessinsider.com&utm_medium=referral
1962.0,6/28/2021 1:18:54 PM,Gates med research CEO transitioning to head vaccines at J&J - Endpoints,Seeking Alpha,https://seekingalpha.com/news/3710491-gates-med-research-ceo-transitioning-to-head-vaccines-role-at-johnson-johnson--endpoints?utm_source=markets.businessinsider.com&utm_medium=referral
1963.0,6/28/2021 5:07:04 PM,JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst,Benzinga,/news/stocks/jnj-s-260m-settlement-could-serve-as-global-opioid-deal-template-analyst-1030559635
1964.0,6/29/2021 9:14:34 AM,"Amid surge in Delta variant, nations impose new restrictions to curb infections",Seeking Alpha,https://seekingalpha.com/news/3710809-amid-surge-in-delta-variant-nations-impose-new-restrictions-to-curb-infections?utm_source=markets.businessinsider.com&utm_medium=referral
1965.0,6/29/2021 4:30:14 PM,"Jury trial against drugmakers, drug distributors over opioids begins in N.Y. (updated)",Seeking Alpha,https://seekingalpha.com/news/3711050-jury-trial-against-drugmakers-drug-distributors-over-opioids-begins-in-ny?utm_source=markets.businessinsider.com&utm_medium=referral
1966.0,6/29/2021 5:23:41 PM,JNJ COVID-19 shot shows efficacy against variants in lab-based study: NIH,Seeking Alpha,https://seekingalpha.com/news/3711063-jnj-covid-19-shot-shows-efficacy-against-variants-in-lab-based-study-nih?utm_source=markets.businessinsider.com&utm_medium=referral
1967.0,6/29/2021 9:24:57 PM,"New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid",Benzinga,/news/stocks/new-york-takes-drugmakers-drug-retailers-to-legal-trial-over-opioid-1030564453
1968.0,6/30/2021 2:51:57 PM,Thailand to purchase 5M Moderna COVID vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3711425-thailand-to-purchase-5m-moderna-covid-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral
1969.0,6/30/2021 8:05:08 PM,World Bank to boost financing available for COVID vaccine purchases to $20B,Seeking Alpha,https://seekingalpha.com/news/3711572-world-bank-to-boost-financing-available-for-covid-vaccine-purchase-to-20b?utm_source=markets.businessinsider.com&utm_medium=referral
1970.0,6/30/2021 8:27:54 PM,Sell Ocugen Stock Before the Other Shoe Finally Drops,InvestorPlace,/news/stocks/ocgn-stock-sell-ocugen-before-other-shoe-finally-drops-1030569105
1971.0,7/1/2021 3:35:29 AM,J&J COVID vaccine may protect against Delta variant - US Surgeon General,Seeking Alpha,https://seekingalpha.com/news/3711660-jj-covid-vaccine-may-protect-against-delta-variant-us-surgeon-general?utm_source=markets.businessinsider.com&utm_medium=referral
1972.0,7/1/2021 10:51:13 AM,U.K. COVID-19 cases reach the highest since January as Delta variant becomes dominant,Seeking Alpha,https://seekingalpha.com/news/3711713-uk-covid-19-cases-reach-the-highest-since-january-as-delta-variant-becomes-dominant?utm_source=markets.businessinsider.com&utm_medium=referral
1973.0,7/1/2021 9:16:41 PM,WHO chief urges every nation to vaccinate at least 10% of population by September,Seeking Alpha,https://seekingalpha.com/news/3712248-who-chief-urges-every-nation-to-vaccinate-at-least-10-of-population-by-september?utm_source=markets.businessinsider.com&utm_medium=referral
1974.0,7/2/2021 1:59:00 AM,Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response,PR Newswire,/news/stocks/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity-against-delta-variant-and-long-lasting-durability-of-response-1030573808
1975.0,7/2/2021 3:12:05 AM,J&J Says Data Shows Its Single-shot COVID-19 Vaccine Effective Against Delta And Other Variants ,RTTNews,/news/stocks/j-j-says-data-shows-its-single-shot-covid-19-vaccine-effective-against-delta-and-other-variants-1030573838
1976.0,7/2/2021 11:34:30 AM,COVAX urges all governments for equal recognition of COVID-19 vaccines for travel,Seeking Alpha,https://seekingalpha.com/news/3712318-covax-urges-all-governments-for-equal-recognition-of-covid-19-vaccines-for-travel?utm_source=markets.businessinsider.com&utm_medium=referral
1977.0,7/2/2021 1:14:04 PM,"Gottlleb says OK for vaccinated Americans gather with friends, family for July 4 - CNBC",Seeking Alpha,https://seekingalpha.com/news/3712370-gottlleb-says-ok-for-vaccinated-americans-gather-with-friends-family-for-july-4-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral
1978.0,7/2/2021 1:58:09 PM,COVID-19 response teams being deployed across U.S. to combat Delta variant,Seeking Alpha,https://seekingalpha.com/news/3712399-covid-19-response-teams-being-deployed-across-us-to-combat-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral
1979.0,7/2/2021 4:25:53 PM,"Biden not concerned about major COVID outbreak, but wants to see more vaccinations",Seeking Alpha,https://seekingalpha.com/news/3712520-biden-not-concerned-about-major-covid-outbreak-but-wants-to-see-more-vaccinations?utm_source=markets.businessinsider.com&utm_medium=referral
1980.0,7/2/2021 7:33:18 PM,JNJ COVID-19 vaccine snafu at Emergent plant: FDA clears another batch of doses,Seeking Alpha,https://seekingalpha.com/news/3712668-jnj-covid-19-vaccine-snafu-at-emergent-plant-fda-clears-another-batch-of-doses?utm_source=markets.businessinsider.com&utm_medium=referral
1981.0,7/4/2021 1:14:17 AM,Scientists not alarmed by deaths due to COVID-19 Delta variant among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3712735-deaths-due-to-covid-19-delta-variant-among-fully-vaccinated-scientists-are-not-alarmed?utm_source=markets.businessinsider.com&utm_medium=referral
1982.0,7/5/2021 10:00:22 AM,NVAX Stock Is Not For The Faint Of Heart,InvestorPlace,/news/stocks/nvax-stock-is-not-for-the-faint-of-heart-1030578313
1983.0,7/6/2021 6:29:48 AM,Israel sees decrease in Pfizer vaccine effectiveness against COVID-19 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3712766-israel-sees-decrease-in-pfizer-vaccine-effectiveness-against-covid-19-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
1984.0,7/6/2021 10:00:14 AM,"Ocugen Has Had a Good Run, but the Math Says It‚Äôs Over",InvestorPlace,/news/stocks/ocgn-stock-has-had-good-run-but-math-says-its-over-1030581139
1985.0,7/6/2021 10:01:16 AM,7 Safe Harbor Stocks To Buy Ahead of the Potential Volatility,InvestorPlace,/news/stocks/7-safe-harbor-stocks-to-buy-ahead-potential-volatility-1030581134
1986.0,7/6/2021 5:53:53 PM,JNJ to deliver nearly 40M of additional COVID-19 vaccine doses to EU,Seeking Alpha,https://seekingalpha.com/news/3713042-jnj-to-deliver-nearly-40m-of-additional-covid-19-vaccine-doses-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral
1987.0,7/6/2021 7:56:28 PM,"Biden ramping up vaccination efforts, focusing on adolescents, pediatricians, and workplaces",Seeking Alpha,https://seekingalpha.com/news/3713077-biden-ramping-up-vaccination-efforts-focusing-on-adolescents-pediatricians-and-workplaces?utm_source=markets.businessinsider.com&utm_medium=referral
1988.0,7/7/2021 4:31:44 AM,New Zealand OK's use of J&J COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3713159-new-zealand-oks-use-of-jj-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
1989.0,7/7/2021 7:47:11 AM,"U.K. Health secretary warns daily COVID-19 cases could reach 100,000",Seeking Alpha,https://seekingalpha.com/news/3713163-uk-health-secretary-warns-daily-covid-19-cases-could-reach-100000?utm_source=markets.businessinsider.com&utm_medium=referral
1990.0,7/7/2021 10:49:38 AM,Mid-size pharmaceutical firms lead bigger rivals in acquisitions this year,Seeking Alpha,https://seekingalpha.com/news/3713185-mid-size-pharmaceutical-firms-lead-bigger-rivals-in-acquisitions-this-year?utm_source=markets.businessinsider.com&utm_medium=referral
1991.0,7/7/2021 5:13:09 PM,Latest CDC data show COVID-19 Delta variant is now dominant in U.S.,Seeking Alpha,https://seekingalpha.com/news/3713403-latest-cdc-data-show-covid-19-delta-variant-is-now-dominant-in-us?utm_source=markets.businessinsider.com&utm_medium=referral
1992.0,7/8/2021 12:09:05 PM,Vor Biopharma teams up with Janssen Biotech to develop leukemia therapy,Seeking Alpha,https://seekingalpha.com/news/3713574-vor-biopharma-teams-up-with-janssen-biotech-to-develop-leukemia-therapy?utm_source=markets.businessinsider.com&utm_medium=referral
1993.0,7/8/2021 2:42:54 PM,Fifteen states reach agreement with Purdue over bankruptcy plan - NYT,Seeking Alpha,https://seekingalpha.com/news/3713666-fifteen-states-reach-agreement-with-purdue-over-bankruptcy-plan-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
1994.0,7/8/2021 2:52:13 PM,Global COVID-19 death toll surpasses 4M,Seeking Alpha,https://seekingalpha.com/news/3713684-global-covid-19-death-roll-surpasses-4m?utm_source=markets.businessinsider.com&utm_medium=referral
1995.0,7/8/2021 3:28:49 PM,"Vor Biopharma, Janssen Team Up To Develop Combination Therapies For Acute Myeloid Leukemia",Benzinga,/news/stocks/vor-biopharma-janssen-team-up-to-develop-combination-therapies-for-acute-myeloid-leukemia-1030589987
1996.0,7/8/2021 4:27:00 PM,Stay Away From Low-Growth Organon,InvestorPlace,/news/stocks/low-growth-weak-catalysts-ogn-stock-unattractive-1030590811
1997.0,7/8/2021 5:56:17 PM,Scientists weigh in on reimplementation of COVID-19 restrictions in under-vaccinated areas,Seeking Alpha,https://seekingalpha.com/news/3713742-scientists-weigh-in-on-reimplementation-of-covid-19-restrictions-in-under-vaccinated-areas?utm_source=markets.businessinsider.com&utm_medium=referral
1998.0,7/8/2021 7:38:27 PM,"House Oversight report says pharmas spend more on buybacks, dividends than R&D",Seeking Alpha,https://seekingalpha.com/news/3713778-house-oversight-report-says-pharmas-spend-more-on-buybacks-dividends-than-research-development?utm_source=markets.businessinsider.com&utm_medium=referral
1999.0,7/9/2021 11:35:41 AM,CDC and FDA: No need for COVID-19 booster shots at this time for fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3713918-cdc-and-fda-there-is-no-need-for-covid-19-booster-shots-at-this-time-for-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral
2000.0,7/9/2021 12:40:27 PM,EMA finds link possible between heart inflammation and mRNA COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3713951-ema-finds-link-possible-between-heart-inflammation-and-mrna-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2001.0,7/9/2021 2:00:00 PM,Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats,PR Newswire,/news/stocks/johnson-johnson-launches-network-of-global-health-discovery-centers-that-aim-to-speed-up-science-and-tackle-pandemic-threats-1030592893
2002.0,7/9/2021 2:58:08 PM,7 Travel Stocks to Sell if the Delta Variant Slows the Reopening Rally,InvestorPlace,/news/stocks/7-travel-stocks-to-sell-if-delta-variant-slows-reopening-rally-1030593455
2003.0,7/9/2021 3:42:37 PM,JNJ posts encouraging three-year data for STELARA in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3714032-jnj-posts-encouraging-three-year-data-for-stelara-in-ulcerative-colitis?utm_source=markets.businessinsider.com&utm_medium=referral
2004.0,7/9/2021 4:02:14 PM,Watch Out for a Selloff in Vaxart Stock,InvestorPlace,/news/stocks/watch-out-for-a-selloff-in-vaxart-stock-1030593691
2005.0,7/9/2021 4:53:01 PM,CDC updates guidance for schools recommending indoor masking for unvaccinated children and teachers,Seeking Alpha,https://seekingalpha.com/news/3714051-cdc-updates-guidance-for-schools-recommending-indoor-masking-for-unvaccinated-children-and-teachers?utm_source=markets.businessinsider.com&utm_medium=referral
2006.0,7/10/2021 10:51:53 PM,Alector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rally,Seeking Alpha,https://seekingalpha.com/news/3714135-alector-leads-weekly-healthcare-gainers-gene-editing-stocks-fall-after-intellia-driven-rally?utm_source=markets.businessinsider.com&utm_medium=referral
2007.0,7/11/2021 2:29:21 AM,"New daily COVID-19 cases exceed 48,000 in U.S., highest since May",Seeking Alpha,https://seekingalpha.com/news/3714138-new-daily-covid-19-cases-exceed-48000-in-us-highest-since-may?utm_source=markets.businessinsider.com&utm_medium=referral
2008.0,7/12/2021 10:50:13 AM,"Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says",Seeking Alpha,https://seekingalpha.com/news/3714180-chinese-covid-19-shots-have-nearly-70-efficacy-against-delta-variant-scientist-says?utm_source=markets.businessinsider.com&utm_medium=referral
2009.0,7/12/2021 12:24:53 PM,FDA approves Janssen's Darzalex Faspro combo in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3714230-fda-approves-janssens-darzalex-faspro-combo-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
2010.0,7/12/2021 6:01:46 PM,JNJ vaccine linked to new side effect; FDA to add warning to indicate risk,Seeking Alpha,https://seekingalpha.com/news/3714421-jnj-vaccine-linked-to-new-side-effect-cdc?utm_source=markets.businessinsider.com&utm_medium=referral
2011.0,7/12/2021 6:29:48 PM,"France to require health pass for bars, cafes, attractions and travel",Seeking Alpha,https://seekingalpha.com/news/3714430-france-to-require-health-pass-for-bars-cafes-attractions-and-travel?utm_source=markets.businessinsider.com&utm_medium=referral
2012.0,7/12/2021 9:38:05 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-spce-stock-johnson-and-johnson-1030598854
2013.0,7/12/2021 11:36:14 PM,J&J's Covid Vaccine Linked To Rare Neurological Condition; FDA Might Issue Warning ,RTTNews,/news/stocks/j-j-s-covid-vaccine-linked-to-rare-neurological-condition-fda-might-issue-warning-1030598846
2014.0,7/13/2021 11:17:08 AM,New warning added to Johnson & Johnson COVID-19 shot to reflect risk of rare side effect,Seeking Alpha,https://seekingalpha.com/news/3714604-new-warning-added-to-jnj-covid-19-shot-to-reflect-risk-of-rare-side-effect?utm_source=markets.businessinsider.com&utm_medium=referral
2015.0,7/13/2021 11:44:01 AM,"JNJ, AstraZeneca explore modifications for COVID-19 shots to address clotting risk: WSJ",Seeking Alpha,https://seekingalpha.com/news/3714620-jnj-astrazeneca-explore-modifications-to-covid-19-shots-to-address-clotting-risk-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
2016.0,7/13/2021 2:05:06 PM,"The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data",Benzinga,/news/stocks/the-daily-biotech-pulse-equillium-issues-positive-regulatory-update-biogen-in-licenses-multiple-sclerosis-drug-aridis-releases-covid-19-antibody-cocktail-data-1030601329
2017.0,7/13/2021 3:32:41 PM,"J&J, AstraZeneca Exploring Fixes To Rare Blood Clots Linked To Their Vaccines: WSJ ",RTTNews,/news/stocks/j-j-astrazeneca-exploring-fixes-to-rare-blood-clots-linked-to-their-vaccines-wsj-1030602027
2018.0,7/13/2021 5:18:16 PM,More data needed on potential side effects of COVID-19 booster shots: CDC official,Seeking Alpha,https://seekingalpha.com/news/3714823-more-data-needed-on-potential-side-effects-of-covid-19-booster-shots-cdc-official?utm_source=markets.businessinsider.com&utm_medium=referral
2019.0,7/14/2021 2:07:15 PM,7 Stocks to Buy if You‚Äôre Worried About the Pandemic Like Warren Buffett,InvestorPlace,/news/stocks/7-stocks-to-buy-if-worried-like-warren-buffett-about-pandemic-1030607187
2020.0,7/14/2021 5:08:48 PM,"Europe adds warnings on Pfizer, Moderna COVID-19 shots to reflect risk of heart inflammation",Seeking Alpha,https://seekingalpha.com/news/3715227-europe-adds-warnings-on-pfizer-moderna-covid-19-shots-to-reflect-risk-of-heart-inflammation?utm_source=markets.businessinsider.com&utm_medium=referral
2021.0,7/14/2021 6:00:21 PM,EMA says too early to determine if COVID booster shots will be needed,Seeking Alpha,https://seekingalpha.com/news/3715240-ema-says-too-early-to-determine-if-covid-booster-shots-will-be-needed?utm_source=markets.businessinsider.com&utm_medium=referral
2022.0,7/14/2021 9:30:12 PM,JNJ to recall certain NEUTROGENA and AVEENO sunscreen products citing carcinogen,Seeking Alpha,https://seekingalpha.com/news/3715331-jnj-to-recall-certain-neutrogena-and-aveeno-sunscreen-products-citing-carcinogen?utm_source=markets.businessinsider.com&utm_medium=referral
2023.0,7/14/2021 11:00:00 PM,Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA¬Æ and AVEENO¬Æ Aerosol Sunscreen Products Due to the Presence of Benzene,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-issues-voluntary-recall-of-specific-neutrogena-and-aveeno-aerosol-sunscreen-products-due-to-the-presence-of-benzene-1030608381
2024.0,7/15/2021 12:45:34 AM,Johnson & Johnson Recalls Certain Sunscreen Products Due To Benzene Presence ,RTTNews,/news/stocks/johnson-johnson-recalls-certain-sunscreen-products-due-to-benzene-presence-1030608536
2025.0,7/15/2021 1:34:43 PM,CDC to discuss need for COVID-19 booster doses in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3715544-cdc-to-discuss-need-for-covid-19-booster-doses-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral
2026.0,7/15/2021 2:07:56 PM,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-sinks-on-data-j-j-recalls-sunscreen-products-fibrogen-awaits-adcom-verdict-3-ipos-1030610817
2027.0,7/15/2021 4:00:51 PM,CVS Health pulls two sunburn products citing cancer-causing agent,Seeking Alpha,https://seekingalpha.com/news/3715639-cvs-health-pulls-two-sunburn-products?utm_source=markets.businessinsider.com&utm_medium=referral
2028.0,7/15/2021 8:35:26 PM,Medtech firm HeartFlow agrees to $2.4B SPAC merger with Longview Acquisition Corp. II,Seeking Alpha,https://seekingalpha.com/news/3715766-heartflow-agrees-to-spac-merger-with-longview-acquisition-corp-ii?utm_source=markets.businessinsider.com&utm_medium=referral
2029.0,7/16/2021 2:17:21 PM,MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500,InvestorPlace,/news/stocks/mrna-stock-10-things-to-know-about-moderna-as-it-gets-ready-to-join-the-sp-500-1030615504
2030.0,7/16/2021 4:10:20 PM,7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-to-juice-your-portfolio-yield-1030615780
2031.0,7/16/2021 8:21:41 PM,FDA now investigating cause of benzene contamination in J&J sunscreens,Seeking Alpha,https://seekingalpha.com/news/3716107-fda-now-investigating-cause-of-benzene-contamination-in-jj-sunscreens?utm_source=markets.businessinsider.com&utm_medium=referral
2032.0,7/17/2021 8:00:00 PM,"Interest in ""shroom stocks"" rises as investors see potential of psychedelics as therapy",Seeking Alpha,https://seekingalpha.com/news/3716128-interest-in-shroom-stocks-rises-as-investors-see-potential-of-psychedelics-as-therapy?utm_source=markets.businessinsider.com&utm_medium=referral
2033.0,7/18/2021 4:25:56 PM,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-earnings-kickstart-with-j-j-and-biogen-albireo-awaits-fda-decisions-more-ipos-1030617574
2034.0,7/19/2021 3:56:18 AM,J&J may put talc liabilities into new business that files bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3716153-jj-may-put-talc-liabilities-into-new-business-that-files-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2035.0,7/19/2021 5:25:57 AM,Johnson & Johnson Considering Plan To Put Talc Liabilities Into Bankruptcy : Report ,RTTNews,/news/stocks/johnson-johnson-considering-plan-to-put-talc-liabilities-into-bankruptcy-report-1030617774
2036.0,7/19/2021 3:01:28 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q2-quarterly-earnings-preview-stock-1030620368
2037.0,7/19/2021 4:39:12 PM,"Johnson & Johnson declares $1.06 dividend, stock yields 2.6%",Seeking Alpha,https://seekingalpha.com/news/3716448-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
2038.0,7/19/2021 6:35:00 PM,Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2021-1030621320
2039.0,7/19/2021 8:21:37 PM,60% of people admitted to hospitals due to COVID-19 are unvaccinated - U.K. chief scientific adviser,Seeking Alpha,https://seekingalpha.com/news/3716576-60-of-people-admitted-to-hospitals-due-to-covid-19-are-unvaccinated-uk-chief-scientific-adviser?utm_source=markets.businessinsider.com&utm_medium=referral
2040.0,7/20/2021 2:20:32 AM,"U.S. is said to near $26B opioid settlement with drug distributors, J&J",Seeking Alpha,https://seekingalpha.com/news/3716659-us-is-said-to-near-26b-opioid-settlement-with-drug-distributors-jj?utm_source=markets.businessinsider.com&utm_medium=referral
2041.0,7/20/2021 1:15:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3716864-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
2042.0,7/20/2021 4:08:50 PM,COVID-19 Delta variant now accounts for 83% of new cases - CDC Director,Seeking Alpha,https://seekingalpha.com/news/3716985-covid-19-delta-variant-now-accounts-for-83-of-new-cases-cdc-director?utm_source=markets.businessinsider.com&utm_medium=referral
2043.0,7/20/2021 4:10:18 PM,Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims ,RTTNews,/news/stocks/three-drug-distributors-to-pay-up-to-1-18-bln-to-settle-new-york-opioid-claims-1030625917
2044.0,7/20/2021 5:06:36 PM,"JNJ, drug distributors favored on Street as they near $26B opioid settlement with U.S.",Seeking Alpha,https://seekingalpha.com/news/3717024-jnj-drug-distributors-favored-on-street-as-they-near-26b-opioid-settlement-with-us?utm_source=markets.businessinsider.com&utm_medium=referral
2045.0,7/20/2021 8:52:56 PM,7 Top Defensive Stocks To Buy For Q2 Earnings Season,InvestorPlace,/news/stocks/7-top-defensive-stocks-to-buy-for-q2-earnings-season-1030627206
2046.0,7/21/2021 10:31:17 AM,"Johnson & Johnson EPS beats by $0.19, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3717239-johnson-and-johnson-eps-beats-0_19-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
2047.0,7/21/2021 11:16:44 AM,Johnson & Johnson boosts 2021 guidance after Q2 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3717274-johnson-johnson-boosts-2021-guidance-after-q2-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral
2048.0,7/21/2021 12:25:00 PM,Johnson & Johnson Reports Q2 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q2-2021-results-1030629526
2049.0,7/21/2021 12:34:47 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1030629548
2050.0,7/21/2021 1:08:46 PM,Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-raises-fy21-view-above-market-as-q2-results-top-estimates-1030629771
2051.0,7/21/2021 1:52:07 PM,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-novartis-report-solid-results-chembio-soars-on-covid-test-order-lumos-signals-clinical-trial-delay-1030629917
2052.0,7/21/2021 5:58:30 PM,U.S life expectancy cut by a year and a half in 2020 due to COVID-19,Seeking Alpha,https://seekingalpha.com/news/3717587-us-life-expectancy-cut-by-a-year-and-a-half-in-2020-due-to-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
2053.0,7/21/2021 8:47:49 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-10-1030632297
2054.0,7/21/2021 9:43:35 PM,"4 Top Stock Trades for Thursday: SQ, JNJ, KO, CMG",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-sq-jnj-ko-cmg-1030632487
2055.0,7/21/2021 11:44:50 PM,"Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal ",RTTNews,/news/stocks/johnson-johnson-drug-distributors-settle-26-bln-opioid-deal-1030632399
2056.0,7/23/2021 12:18:20 PM,Johnson & Johnson's VERITAS Vision System available globally,Seeking Alpha,https://seekingalpha.com/news/3718535-johnson-johnsons-veritas-vision-system-available-globally?utm_source=markets.businessinsider.com&utm_medium=referral
2057.0,7/23/2021 4:16:35 PM,"Snap, Twitter Earnings Impress, Potentially Setting Table For Facebook Next Week",Benzinga,/news/stocks/snap-twitter-earnings-impress-potentially-setting-table-for-facebook-next-week-1030639365
2058.0,7/23/2021 5:57:32 PM,"Pfizer/BioNTech COVID-19 shot is 39% effective with prevalence of Delta variant, Israel says",Seeking Alpha,https://seekingalpha.com/news/3718702-pfizerbiontech-covid-19-shot-is-39-effective-with-prevalence-of-delta-variant-israel-says?utm_source=markets.businessinsider.com&utm_medium=referral
2059.0,7/23/2021 8:17:00 PM,Johnson & Johnson -- Moody's: J&J opioid settlement adds financial leverage but reduces uncertainty,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-opioid-settlement-adds-financial-leverage-but-reduces-uncertainty-1030639924
2060.0,7/25/2021 3:14:39 AM,COVID-19 cases are rising in every U.S. state amid vaccine hesitancy,Seeking Alpha,https://seekingalpha.com/news/3718822-covid-19-cases-are-rising-in-every-us-state-amid-vaccine-hesitancy?utm_source=markets.businessinsider.com&utm_medium=referral
2061.0,7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744
2062.0,7/26/2021 10:00:41 AM,3 Blue-Chip Dividend Stocks for a Bear Market,InvestorPlace,/news/stocks/3-blue-chip-dividend-stocks-for-a-bear-market-1030643974
2063.0,7/26/2021 10:00:58 AM,Novavax Stock May Not Get the Delta Varient Bump Investors Need,InvestorPlace,/news/stocks/novavax-stock-may-not-get-the-delta-varient-bump-investors-need-1030643966
2064.0,7/26/2021 11:21:36 AM,Biden officials contemplate the need of COVID-19 booster shots in vulnerable Americans,Seeking Alpha,https://seekingalpha.com/news/3718902-biden-officials-contemplate-the-need-of-covid-19-booster-shots-in-vulnerable-americans?utm_source=markets.businessinsider.com&utm_medium=referral
2065.0,7/26/2021 8:42:19 PM,Data from Israel suggest impact of vaccines on severe COVID-19 despite uptick in cases,Seeking Alpha,https://seekingalpha.com/news/3719325-data-from-israel-highlight-impact-of-vaccines-on-severe-covid-19-despite-uptick-in-cases?utm_source=markets.businessinsider.com&utm_medium=referral
2066.0,7/27/2021 10:45:49 AM,"Vaccine mandates announced in NYC, California and Department of Veterans Affairs",Seeking Alpha,https://seekingalpha.com/news/3719480-vaccine-mandates-announced-in-nyc-california-and-department-of-veterans-affairs?utm_source=markets.businessinsider.com&utm_medium=referral
2067.0,7/27/2021 2:05:24 PM,Israel to offer COVID-19 vaccines to at-risk children - Jerusalem Post,Seeking Alpha,https://seekingalpha.com/news/3719701-israel-to-offer-covid-19-vaccines-to-at-risk-children-jerusalem-post?utm_source=markets.businessinsider.com&utm_medium=referral
2068.0,7/27/2021 6:23:20 PM,7 Cheap Value Stocks to Buy for August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-1030652138
2069.0,7/27/2021 7:52:39 PM,CDC recommends masks in public spaces in areas with substantial and high COVID-19 transmission,Seeking Alpha,https://seekingalpha.com/news/3719958-cdc-mandates-masks-in-public-spaces-in-areas-with-substantial-high-covid-19-transmission?utm_source=markets.businessinsider.com&utm_medium=referral
2070.0,7/27/2021 8:09:11 PM,U.S. is weighing vaccine mandates for all federal employees,Seeking Alpha,https://seekingalpha.com/news/3719984-us-is-weighing-vaccine-mandates-for-all-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral
2071.0,7/27/2021 10:10:00 PM,Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-virtual-wells-fargo-healthcare-conference-1030652364
2072.0,7/28/2021 6:10:09 PM,White House tells federal agencies to mandate masks indoors in high COVID areas - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720745-white-house-tells-federal-agencies-to-mandate-masks-indoors-in-high-covid-areas-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2073.0,7/28/2021 8:12:09 PM,J&J asked by U.S. House subcommittee to provide info on plans to put talc liabilities into bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720863-j-asked-by-us-house-subcommittee-to-provide-info-on-plans-to-put-talc-liabilities-into-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2074.0,7/29/2021 5:28:16 AM,FDA Extends Shelf-life Of Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-extends-shelf-life-of-johnson-johnson-s-covid-19-vaccine-1030659292
2075.0,7/29/2021 10:46:54 AM,Emergent to restart COVID-19 vaccine production at Baltimore Plant,Seeking Alpha,https://seekingalpha.com/news/3721278-emergent-to-restart-covid-19-vaccine-production-at-baltimore-plant?utm_source=markets.businessinsider.com&utm_medium=referral
2076.0,7/29/2021 5:14:00 PM,"Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney",PR Newswire,/news/stocks/women-cancer-victims-opposed-to-johnson-johnson-s-texas-two-step-bankruptcy-ploy-urge-passage-of-reforms-introduced-by-warren-durbin-nadler-blumenthal-and-maloney-1030663440
2077.0,7/29/2021 5:14:59 PM,AstraZeneca and J&J are yet to see need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3721739-astrazeneca-and-jj-are-yet-to-see-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2078.0,7/29/2021 8:38:54 PM,7 Best ETFs To Buy Now if You‚Äôre Looking for Safety,InvestorPlace,/news/stocks/7-best-etfs-to-buy-now-for-safety-1030664554
2079.0,7/30/2021 8:12:18 AM,Is a third COVID-19 vaccine dose necessary? What you need to know about boosters,Seeking Alpha,https://seekingalpha.com/news/3722140-is-a-third-covid-19-vaccine-dose-necessary-what-you-need-to-know-about-boosters?utm_source=markets.businessinsider.com&utm_medium=referral
2080.0,7/30/2021 11:00:10 AM,"COVID-19 Delta variant is as contagious as chickenpox, CDC report says - NYT",Seeking Alpha,https://seekingalpha.com/news/3722207-covid-19-delta-variant-is-as-contagious-as-chickenpox-cdc-report-says-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
2081.0,7/30/2021 12:43:53 PM,FDA OKs Janssen Pharma's Uptravi for intravenous use in adults with PAH,Seeking Alpha,https://seekingalpha.com/news/3722343-fda-oks-janssen-pharmas-uptravi-for-intravenous-use-in-adults-with-pah?utm_source=markets.businessinsider.com&utm_medium=referral
2082.0,7/30/2021 1:53:58 PM,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylam-s-clinical-collaboration-4-ipos-1030667906
2083.0,7/30/2021 2:23:34 PM,"Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?",Benzinga,/news/stocks/elon-musk-jeff-bezos-richard-branson-which-market-leaders-will-make-up-the-cannabis-industry-space-race-1030668073
2084.0,7/30/2021 5:29:08 PM,Johnson & Johnson agrees to delay bankruptcy plan for talc liabilities,Seeking Alpha,https://seekingalpha.com/news/3722555-johnson-johnson-agrees-to-delay-bankruptcy-plan-for-talc-liabilities?utm_source=markets.businessinsider.com&utm_medium=referral
2085.0,7/30/2021 6:30:04 PM,Fully vaccinated people made up 74% of cases in a COVID-19 outbreak in Massachusetts - CDC,Seeking Alpha,https://seekingalpha.com/news/3722589-fully-vaccinated-people-made-up-74-of-cases-in-a-covid-19-outbreak-in-massachusetts-cdc?utm_source=markets.businessinsider.com&utm_medium=referral
2086.0,8/2/2021 8:06:26 AM,U.S. lockdown unlikely despite surge in Covid cases: Fauci,Seeking Alpha,https://seekingalpha.com/news/3722777-us-lockdown-unlikely-despite-surge-in-covid-cases-fauci?utm_source=markets.businessinsider.com&utm_medium=referral
2087.0,8/2/2021 10:14:30 AM,J&J pulls back proposal for expedited COVID-19 vaccine approval in India,Seeking Alpha,https://seekingalpha.com/news/3722794-jj-pulls-back-proposal-for-expedited-covid-19-vaccine-approval-in-india?utm_source=markets.businessinsider.com&utm_medium=referral
2088.0,8/2/2021 11:31:33 AM,"CDC reports over 6,000 COVID-19 hospitalizations in U.S. among fully vaccinated",Seeking Alpha,https://seekingalpha.com/news/3722831-cdc-reports-over-6000-covid-19-hospitalizations-in-us-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral
2089.0,8/2/2021 3:33:59 PM,"Pfizer, Moderna raise COVID-19 vaccine prices in the EU",Seeking Alpha,https://seekingalpha.com/news/3723066-pfizer-moderna-raise-covid-19-vaccine-prices-in-the-eu?utm_source=markets.businessinsider.com&utm_medium=referral
2090.0,8/2/2021 3:54:58 PM,"Throw in The Towel, Ocugen Stock is Not Coming Back",InvestorPlace,/news/stocks/ocgn-stock-throw-in-towel-not-coming-back-1030677286
2091.0,8/3/2021 11:12:27 AM,Britain and Germany to offer COVID-19 booster shots; U.S. seeks more data,Seeking Alpha,https://seekingalpha.com/news/3723709-britain-and-germany-to-offer-covid-19-booster-shots-us-waits-for-more-data?utm_source=markets.businessinsider.com&utm_medium=referral
2092.0,8/3/2021 2:50:39 PM,"DeBlasio: NYC requiring vaccination proof for restaurants, gyms, and entertainment venues",Seeking Alpha,https://seekingalpha.com/news/3723960-deblasio-nyc-requiring-vaccination-proof-for-restaurants-gyms-and-entertainment-venues?utm_source=markets.businessinsider.com&utm_medium=referral
2093.0,8/3/2021 5:01:31 PM,7 Cheap Value Stocks To Buy For August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-2-1030684926
2094.0,8/4/2021 9:19:16 AM,Final FDA approval for Pfizer's COVID-19 vaccine expected by early September,Seeking Alpha,https://seekingalpha.com/news/3724672-final-fda-approval-for-pfizers-covid-19-vaccine-expected-by-early-september?utm_source=markets.businessinsider.com&utm_medium=referral
2095.0,8/4/2021 1:52:10 PM,"The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-s-positive-readout-nrx-strikes-r-d-collaboration-with-mannkind-cerus-invitae-jump-on-earnings-1030688766
2096.0,8/4/2021 2:37:31 PM,WHO calls for COVID vaccine booster moratorium so poorer countries can get shots,Seeking Alpha,https://seekingalpha.com/news/3724983-who-calls-for-covid-booster-moratorium-so-poorer-countries-can-get-shots-wapo?utm_source=markets.businessinsider.com&utm_medium=referral
2097.0,8/4/2021 5:08:27 PM,7 Stocks to Buy for Responsibility and Sustainability,InvestorPlace,/news/stocks/7-stocks-to-buy-for-responsibility-and-sustainability-1030690642
2098.0,8/4/2021 6:29:01 PM,"Pfizer, Moderna COVID-19 shots offered in San Francisco to Johnson & Johnson vaccine recipients",Seeking Alpha,https://seekingalpha.com/news/3725234-pfizer-moderna-covid-19-shots-offered-in-san-francisco-to-johnson-johnson-vaccine-recipients?utm_source=markets.businessinsider.com&utm_medium=referral
2099.0,8/5/2021 9:48:09 AM,Global COVID-19 cases top 200M as Delta variant rages,Seeking Alpha,https://seekingalpha.com/news/3725762-global-covid-19-cases-top-200m-as-delta-variant-rages?utm_source=markets.businessinsider.com&utm_medium=referral
2100.0,8/5/2021 2:07:56 PM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-positive-keytruda-readout-moderna-slips-despite-q2-beat-bayer-to-buy-vividion-for-up-to-2b-glycomimetics-gets-new-ceo-1030695873
2101.0,8/5/2021 6:08:03 PM,Fauci warns COVID-19 variants more severe than delta could emerge,Seeking Alpha,https://seekingalpha.com/news/3726300-fauci-warns-covid-19-variants-more-severe-than-delta-could-emerge?utm_source=markets.businessinsider.com&utm_medium=referral
2102.0,8/6/2021 10:31:15 AM,Johnson & Johnson COVID-19 shot offers 71% protection when Delta variant dominates - Study,Seeking Alpha,https://seekingalpha.com/news/3726850-johnson-johnson-covid-19-shot-offers-71-protection-when-delta-variant-dominates-study?utm_source=markets.businessinsider.com&utm_medium=referral
2103.0,8/6/2021 10:48:30 AM,Johnson & Johnson seeks emergency use approval of COVID-19 vaccine in India,Seeking Alpha,https://seekingalpha.com/news/3726866-johnson-johnson-seeks-emergency-use-approval-of-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral
2104.0,8/6/2021 3:49:09 PM,"Despite Novavax‚Äôs Challenges, NVAX Stock Could Still Pop",InvestorPlace,/news/stocks/nvax-stock-despite-challenges-could-still-pop-from-here-1030702070
2105.0,8/6/2021 5:32:31 PM,Latest CDC report shows a slight uptick in COVID-19 cases among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3727132-latest-cdc-report-shows-a-slight-uptick-in-covid-19-cases-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral
2106.0,8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral
2107.0,8/8/2021 7:11:35 PM,India Approves Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/india-approves-johnson-johnson-s-single-dose-covid-19-vaccine-1030704408
2108.0,8/8/2021 9:35:13 PM,Fauci hopes FDA will give full approval for COVID-19 vaccine in next few weeks,Seeking Alpha,https://seekingalpha.com/news/3727253-fauci-hopes-fda-will-give-full-approval-for-covid-19--vaccine-in-next-few-weeks?utm_source=markets.businessinsider.com&utm_medium=referral
2109.0,8/9/2021 6:04:30 AM,Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey,Seeking Alpha,https://seekingalpha.com/news/3727278-pfizer-vaccine-booster-shot-has-similar-side-effects-to-2nd-dose-israeli-survey?utm_source=markets.businessinsider.com&utm_medium=referral
2110.0,8/9/2021 3:07:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-consumer-staples-virtual-conference-1030708907
2111.0,8/9/2021 3:17:59 PM,Why These Biotech Stocks Are Soaring,InvestorPlace,/news/stocks/why-these-biotech-stocks-are-soaring-1030710695
2112.0,8/10/2021 8:14:31 AM,Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time,Seeking Alpha,https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time?utm_source=markets.businessinsider.com&utm_medium=referral
2113.0,8/10/2021 12:57:28 PM,COVID-19 during pregnancy associated with higher risk of preterm birth: U.S. Study,Seeking Alpha,https://seekingalpha.com/news/3728176-covid-19-during-pregnancy-associated-with-higher-risk-of-preterm-birth-us-study?utm_source=markets.businessinsider.com&utm_medium=referral
2114.0,8/10/2021 8:40:24 PM,Dr. Scott Gottlieb says current COVID-19 surge could be the ‚Äúfinal wave‚Äù in U.S.,Seeking Alpha,https://seekingalpha.com/news/3728500-dr-scott-gottlieb-says-current-covid-19-surge-could-be-the-final-wave-in-us?utm_source=markets.businessinsider.com&utm_medium=referral
2115.0,8/11/2021 10:00:50 AM,Novavax Is Looking More Like a Bet Worth Taking,InvestorPlace,/news/stocks/nvax-stock-is-looking-more-like-a-bet-worth-taking-1030717837
2116.0,8/11/2021 4:57:52 PM,7 Biotech Stocks to Buy Amid the Delta Variant‚Äôs Onslaught,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-amid-rising-covid-19-cases-1030719978
2117.0,8/11/2021 6:30:41 PM,7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn,InvestorPlace,/news/stocks/7-best-bear-market-stocks-to-buy-now-in-preparation-for-a-downturn-1030720182
2118.0,8/12/2021 11:01:31 AM,AstraZeneca COVID-19 shot did not lead to new cases of rare clots after age restrictions - study,Seeking Alpha,https://seekingalpha.com/news/3729425-astrazeneca-covid-19-shot-did-not-lead-to-new-cases-of-rare-clots-after-age-restrictions-study?utm_source=markets.businessinsider.com&utm_medium=referral
2119.0,8/12/2021 3:14:00 PM,Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-1030724612
2120.0,8/12/2021 4:07:52 PM,CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag,Benzinga,/news/stocks/cytosorbents-antithrombotic-removal-system-scores-second-fda-breakthrough-device-tag-1030724927
2121.0,8/12/2021 11:18:53 PM,Why This Fundamentally Superior Biotech Is Soaring,InvestorPlace,/news/stocks/why-this-fundamentally-superior-biotech-is-soaring-1030735292
2122.0,8/13/2021 10:07:10 AM,Pfizer/BioNTech and Moderna win FDA nod for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3730157-pfizerbiontech-and-moderna-win-fda-nod-in-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2123.0,8/13/2021 1:43:02 PM,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-vaccine-produces-durable-response-against-variants-fda-approves-jazz-s-sleep-disorder-drug-dermata-ipo-1030728962
2124.0,8/13/2021 7:43:28 PM,Novavax: Bronze Medal May Be Good Enough in COVID Race,InvestorPlace,/news/stocks/nvax-stock-bronze-medal-may-be-good-enough-in-covid-race-1030730157
2125.0,8/13/2021 9:01:38 PM,"Pfizer, Moderna to enjoy first mover advantage as COVID-19 expected to become endemic",Seeking Alpha,https://seekingalpha.com/news/3730492-pfizer-moderna-to-enjoy-first-mover-advantage-as-covid-19-expected-to-become-endemic?utm_source=markets.businessinsider.com&utm_medium=referral
2126.0,8/15/2021 2:52:53 AM,Plans underway in U.S. to widen access to COVID-19 boosters as early as fall - NYT,Seeking Alpha,https://seekingalpha.com/news/3730532-plans-underway-in-us-to-widen-access-to-covid-19-boosters-as-early-as-fall-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
2127.0,8/16/2021 6:35:52 AM,Texas Supreme Court temporarily halts local mask mandates,Seeking Alpha,https://seekingalpha.com/news/3730569-texas-supreme-court-temporarily-halts-local-mask-mandates?utm_source=markets.businessinsider.com&utm_medium=referral
2128.0,8/17/2021 2:28:53 PM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-reorganizes-business-units-in-neuroscience-focus-helius-medical-spikes-on-breakthrough-designation-ra-medical-sells-dermatology-business-1030738023
2129.0,8/18/2021 2:06:17 AM,COVID-19 Delta variant is linked to higher risk of hospitalizations - WHO,Seeking Alpha,https://seekingalpha.com/news/3731680-covid-19-delta-variant-is-linked-to-higher-risk-of-hospitalizations-who?utm_source=markets.businessinsider.com&utm_medium=referral
2130.0,8/18/2021 7:35:29 AM,Los Angeles to require masks at large outdoor events,Seeking Alpha,https://seekingalpha.com/news/3731693-los-angeles-to-require-masks-at-large-outdoor-events-us-transport-mask-mandate-extended?utm_source=markets.businessinsider.com&utm_medium=referral
2131.0,8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574
2132.0,8/18/2021 2:28:03 PM,Pfizer's third COVID-19 shot 86% effective in people over 60: Israeli healthcare provider,Seeking Alpha,https://seekingalpha.com/news/3731878-pfizers-third-covid-19-shot-86-effective-in-people-over-60s-israeli-healthcare-provider?utm_source=markets.businessinsider.com&utm_medium=referral
2133.0,8/19/2021 8:18:01 AM,Biden administration to require nursing home workers get COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3732117-biden-administration-to-require-nursing-home-workers-get-covid-19-vaccine-amid-delta-surge?utm_source=markets.businessinsider.com&utm_medium=referral
2134.0,8/19/2021 11:14:21 AM,Biden's booster shots recommendation questioned by some health experts,Seeking Alpha,https://seekingalpha.com/news/3732172-bidens-booster-shots-recommendation-causes-distress-among-scientists-and-health-experts?utm_source=markets.businessinsider.com&utm_medium=referral
2135.0,8/19/2021 11:18:00 PM,"Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022",PR Newswire,/news/stocks/alex-gorsky-to-serve-as-executive-chairman-and-transition-role-of-chief-executive-officer-of-johnson-johnson-to-joaquin-duato-effective-january-3-2022-1030747372
2136.0,8/20/2021 2:14:06 AM,Acting FDA head Woodcock ruled out as permanent nominee - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3732564-acting-fda-head-woodcock-ruled-out-as-permanent-nominee-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
2137.0,8/20/2021 5:00:34 AM,Alex Gorsky To Step Down As J&J's CEO And Joaquin Duato To Take Over CEO Role ,RTTNews,/news/stocks/alex-gorsky-to-step-down-as-j-j-s-ceo-and-joaquin-duato-to-take-over-ceo-role-1030747568
2138.0,8/20/2021 8:52:08 AM,Texas Supreme Court to temporarily keep school mask mandates in place,Seeking Alpha,https://seekingalpha.com/news/3732584-texas-supreme-court-to-temporarily-keep-school-mask-mandates-in-place?utm_source=markets.businessinsider.com&utm_medium=referral
2139.0,8/20/2021 1:45:43 PM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-announces-ceo-transition-fibrogen-s-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data-1030748705
2140.0,8/20/2021 1:54:10 PM,"Israel expands COVID-19 booster shot eligibility to people over 40, teachers",Seeking Alpha,https://seekingalpha.com/news/3732705-israel-expands-covid-19-booster-shot-eligibility-to-people-over-40-teachers?utm_source=markets.businessinsider.com&utm_medium=referral
2141.0,8/20/2021 3:22:23 PM,"Novavax Stock Could Remain a Winner, Despite its ‚ÄòAlso Ran‚Äô Status",InvestorPlace,/news/stocks/nvax-stock-could-remain-winner-despite-also-ran-status-1030749369
2142.0,8/20/2021 8:36:39 PM,"What Did the Stock Market Do Today, Aug. 20? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-13-2-2-1030749919
2143.0,8/20/2021 9:30:57 PM,Pfizer/BioNTech COVID-19 vaccine set to win full FDA approval on Monday - NYT,Seeking Alpha,https://seekingalpha.com/news/3732860-pfizerbiontech-covid-19-vaccine-set-to-win-full-fda-approval-on-monday-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
2144.0,8/22/2021 1:58:42 AM,Pfizer/BioNTech COVID-19 vaccine protection dropped faster than AstraZeneca‚Äôs - study,Seeking Alpha,https://seekingalpha.com/news/3732884-pfizerbiontech-covid-19-vaccine-protection-dropped-faster-than-astrazenecas-study?utm_source=markets.businessinsider.com&utm_medium=referral
2145.0,8/22/2021 3:01:25 PM,"The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-cara-fda-decision-ascendis-earnings-aileron-data-presentation-and-more-1030750711
2146.0,8/23/2021 8:45:22 PM,COVID-19 vaccine mandates in NYC schools and Pentagon after FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733298-covid-19-vaccine-mandates-in-nyc-schools-and-pentagon-after-full-fda-approval-for-pfizerbiontech-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2147.0,8/24/2021 11:17:10 AM,Biden calls on companies to require COVID-19 vaccines after Pfizer's FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733404-biden-calls-on-companies-to-require-covid-19-vaccines-after-pfizers-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral
2148.0,8/24/2021 12:06:50 PM,Theravance draws downgrade and target cuts after setback in ulcerative colitis trial,Seeking Alpha,https://seekingalpha.com/news/3733435-theravance-draws-downgrade-and-target-cuts-after-setback-in-ulcerative-colitis-trial?utm_source=markets.businessinsider.com&utm_medium=referral
2149.0,8/24/2021 12:16:48 PM,Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study,Benzinga,/news/stocks/theravance-stock-plunges-as-jak-inhibitor-flops-ulcerative-colitis-study-1030754399
2150.0,8/24/2021 10:05:03 PM,Why BioNTech Is the Better Biotech Buy,InvestorPlace,/news/stocks/why-biontech-is-the-better-biotech-buy-1030759223
2151.0,8/24/2021 11:40:00 PM,Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan,PR Newswire,/news/stocks/ovarian-cancer-victims-ask-court-to-block-johnson-johnson-s-texas-two-step-bankruptcy-plan-1030756167
2152.0,8/25/2021 10:45:43 AM,COVID-19 vaccine protection wanes within six months: U.K. study,Seeking Alpha,https://seekingalpha.com/news/3733837-covid-19-vaccine-protection-wanes-with-six-months-uk-study?utm_source=markets.businessinsider.com&utm_medium=referral
2153.0,8/25/2021 12:45:00 PM,Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-data-to-support-boosting-its-single-shot-covid-19-vaccine-1030757202
2154.0,8/25/2021 1:38:31 PM,J&J COVID-19 Vaccine Booster Dose Rapidly Boosted Spike-binding Antibodies ,RTTNews,/news/stocks/j-j-covid-19-vaccine-booster-dose-rapidly-boosted-spike-binding-antibodies-1030757361
2155.0,8/25/2021 4:08:19 PM,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-with-huge-upside-1030758448
2156.0,8/25/2021 4:33:06 PM,Pfizer/BioNTech start rolling submission for FDA approval of booster COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3734101-pfizerbiontech-start-rolling-submission-for-fda-approval-of-booster-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2157.0,8/26/2021 9:17:50 AM,Risk of heart inflammation higher after COVID-19 than post vaccination: Study,Seeking Alpha,https://seekingalpha.com/news/3734298-risk-of-heart-inflammation-higher-after-covid-19-than-post-vaccination-study?utm_source=markets.businessinsider.com&utm_medium=referral
2158.0,8/26/2021 3:15:00 PM,Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cantor-virtual-global-healthcare-conference-1030760955
2159.0,8/26/2021 6:03:01 PM,"Illinois Gov. Pritzker issues vaccine, masks requirement in healthcare settings, schools",Seeking Alpha,https://seekingalpha.com/news/3734594-illinois-gov-pritzker-issues-vaccine-masks-requirement-in-healthcare-settings-schools?utm_source=markets.businessinsider.com&utm_medium=referral
2160.0,8/26/2021 10:30:00 PM,"Johnson & Johnson Seeks Global Nominees for Award Geared at Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design",PR Newswire,/news/stocks/johnson-johnson-seeks-global-nominees-for-award-geared-at-female-researchers-working-in-science-technology-engineering-math-manufacturing-and-design-1030762105
2161.0,8/27/2021 10:00:26 AM,Longshot Covid Play Vaxart Stock Is Too Risky at These Prices,InvestorPlace,/news/stocks/longshot-covid-play-vxrt-stock-is-too-risky-at-these-prices-1030763261
2162.0,8/27/2021 10:30:00 AM,7 Safe Stocks To Buy for an Increasingly Unstable World,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-for-an-increasingly-unstable-world-1030763320
2163.0,8/27/2021 10:55:26 AM,"Singapore nears target of inoculating 80% of population, rolls out COVID-19 test kits",Seeking Alpha,https://seekingalpha.com/news/3734757-singapore-nears-target-of-inoculating-80-of-population-rolls-out-covid-19-test-kits?utm_source=markets.businessinsider.com&utm_medium=referral
2164.0,8/27/2021 1:35:25 PM,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-morphosys-incyte-snag-european-nod-immutep-granted-chinese-patent-bolt-biotherapeutics-strike-oncology-collaboration-1030763431
2165.0,8/27/2021 2:45:49 PM,3 Top-Quality Dividend Stocks for a Secure Retirement,InvestorPlace,/news/stocks/3-top-quality-dividend-stocks-for-a-secure-retirement-1030763866
2166.0,8/30/2021 8:54:01 AM,Fauci says COVID-19 vaccine mandates in school 'a good idea',Seeking Alpha,https://seekingalpha.com/news/3735055-fauci-says-covid-19-vaccine-mandates-in-school-a-good-idea?utm_source=markets.businessinsider.com&utm_medium=referral
2167.0,8/30/2021 1:43:57 PM,Novavax Looks Like a Good Stock to Trade,InvestorPlace,/news/stocks/novavax-looks-like-a-good-stock-to-trade-1030767134
2168.0,8/31/2021 12:45:00 PM,Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa,PR Newswire,/news/stocks/johnson-johnson-and-global-partners-announce-results-from-phase-2b-imbokodo-hiv-vaccine-clinical-trial-in-young-women-in-sub-saharan-africa-1030769172
2169.0,8/31/2021 1:13:54 PM,Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study ,RTTNews,/news/stocks/johnson-johnson-hiv-vaccine-candidate-fails-to-provide-protection-to-discontinue-imbokodo-study-1030769299
2170.0,8/31/2021 5:41:24 PM,7 Dividend Aristocrat Stocks to Buy in September for Gains and Stability,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-to-buy-in-september-for-gains-and-stability-1030770935
2171.0,8/31/2021 7:03:00 PM,Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict,PR Newswire,/news/stocks/outcry-continues-to-grow-for-johnson-johnson-to-resolve-talc-cancer-claims-after-latest-jury-verdict-1030770850
2172.0,8/31/2021 7:28:37 PM,"7 Stocks To Watch For Tech, Fintech and Inflation Catalysts",InvestorPlace,/news/stocks/7-stocks-to-watch-for-tech-fintech-and-inflation-catalysts-1030771062
2173.0,8/31/2021 8:25:48 PM,"Novo Nordisk, Pfizer lead monthly gainers among large-cap pharma; Elanco, Amgen trail",Seeking Alpha,https://seekingalpha.com/news/3735840-novo-nordisk-pfizer-lead-monthly-gainers-among-large-cap-pharma-elanco-amgen-trail?utm_source=markets.businessinsider.com&utm_medium=referral
2174.0,9/1/2021 10:07:34 AM,"Pennsylvania Gov. Tom Wolf issues mask requirements for schools, child care centers",Seeking Alpha,https://seekingalpha.com/news/3735929-pennsylvania-gov-tom-wolf-issues-mask-requirements-for-schools-child-care-centers?utm_source=markets.businessinsider.com&utm_medium=referral
2175.0,9/1/2021 2:56:51 PM,FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts ,RTTNews,/news/stocks/fda-ok-s-janssen-pharmaceutical-s-invega-hafyera-to-treat-adults-with-schizophrenia-quick-facts-1030773101
2176.0,9/1/2021 4:43:35 PM,WHO warns of a new COVID-19 variant with potential to evade vaccine-driven immunity,Seeking Alpha,https://seekingalpha.com/news/3736184-who-warns-of-a-new-covid-19-variant-with-potential-to-evade-vaccine-driven-immunity?utm_source=markets.businessinsider.com&utm_medium=referral
2177.0,9/2/2021 9:06:04 AM,FDA advisory panel to discuss Pfizer's booster shot application on Sept. 17,Seeking Alpha,https://seekingalpha.com/news/3736545-fda-advisory-panel-to-discuss-pfizers-booster-shot-application-on-sept-17?utm_source=markets.businessinsider.com&utm_medium=referral
2178.0,9/2/2021 10:44:38 AM,Risk of long COVID reduces by 50% in fully vaccinated people: Study,Seeking Alpha,https://seekingalpha.com/news/3736578-risk-of-long-covid-reduces-by-50-in-fully-vaccinated-people-study?utm_source=markets.businessinsider.com&utm_medium=referral
2179.0,9/2/2021 3:25:30 PM,Moderna COVID-19 booster strategy triggers debate on dose level,Seeking Alpha,https://seekingalpha.com/news/3736801-moderna-covid-19-booster-strategy-leads-to-mixed-views-on-dose-level?utm_source=markets.businessinsider.com&utm_medium=referral
2180.0,9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In¬†,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655
2181.0,9/2/2021 8:16:10 PM,Fauci says COVID-19 full vaccine regimen is unlikely to exceed three shots,Seeking Alpha,https://seekingalpha.com/news/3736990-fauci-says-covid-19-full-vaccine-regimen-is-unlikely-to-exceed-three-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2182.0,9/2/2021 10:07:00 PM,"Battle Against Johnson & Johnson ""Texas Two-Step"" Ploy Moves to New Jersey",PR Newswire,/news/stocks/battle-against-johnson-johnson-texas-two-step-ploy-moves-to-new-jersey-1030777921
2183.0,9/7/2021 4:02:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-7-2021-1030784466
2184.0,9/8/2021 10:00:31 AM,Vaxart Stock Is One Vaccine Also-Ran Worth Another Look,InvestorPlace,/news/stocks/vxrt-stock-is-one-vaccine-also-ran-worth-another-look-1030786409
2185.0,9/8/2021 10:59:23 AM,"WHO says coronavirus is ‚Äúhere to stay‚Äù, elimination unlikely",Seeking Alpha,https://seekingalpha.com/news/3737810-who-says-coronavirus-is-here-to-stay-elimination-unlikely?utm_source=markets.businessinsider.com&utm_medium=referral
2186.0,9/8/2021 11:28:20 AM,"Fed's Kaplan traded millions of dollars in stocks in 2020, including megacaps - WSJ",Seeking Alpha,https://seekingalpha.com/news/3737825-dallas-fed-president-robert-kaplan-traded-millions-in-stocks-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral
2187.0,9/8/2021 11:39:46 AM,Pfizer chief scientist rejects criticism on COVID-19 booster push; defends jab‚Äôs potency,Seeking Alpha,https://seekingalpha.com/news/3737836-pfizer-chief-scientist-rejects-criticism-on-covid-19-booster-push-defends-jabs-potency?utm_source=markets.businessinsider.com&utm_medium=referral
2188.0,9/8/2021 4:25:03 PM,7 Busted Biotech Stocks Due for a Rebound,InvestorPlace,/news/stocks/7-busted-biotech-stocks-due-for-a-rebound-1030787940
2189.0,9/8/2021 4:37:46 PM,WHO chief urges richer nations to halt COVID-19 booster shot rollouts till end of the year,Seeking Alpha,https://seekingalpha.com/news/3738021-who-chief-urges-richer-nations-to-halt-covid-19-booster-shot-rollouts-till-end-of-the-year?utm_source=markets.businessinsider.com&utm_medium=referral
2190.0,9/10/2021 1:31:21 PM,Endo Shares Move Higher On Settlement Of New York State Opioid Cases,Benzinga,/news/stocks/endo-shares-move-higher-on-settlement-of-new-york-state-opioid-cases-1030792398
2191.0,9/14/2021 12:30:00 AM,Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases,PR Newswire,/news/stocks/johnson-johnson-ebola-vaccine-regimen-demonstrated-robust-and-durable-immune-response-in-adults-and-children-in-data-published-in-the-lancet-infectious-diseases-1030796874
2192.0,9/14/2021 4:41:59 AM,Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response ,RTTNews,/news/stocks/johnson-johnson-ebola-vaccine-data-shows-strong-immune-response-1030796943
2193.0,9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122
2194.0,9/14/2021 8:42:17 PM,Novavax Has More Room to Run as the Vaccination Push Carries On,InvestorPlace,/news/stocks/nvax-stock-more-room-to-run-as-vaccination-push-carries-on-1030799785
2195.0,9/14/2021 9:28:13 PM,7 Great Stocks to Buy for an Income-Rich Retirement,InvestorPlace,/news/stocks/7-great-stocks-to-buy-for-an-income-rich-retirement-1030799872
2196.0,9/15/2021 8:51:37 PM,7 Great Dividend Stocks To Buy In September For Insulation from Volatility,InvestorPlace,/news/stocks/7-great-dividend-stocks-to-buy-in-september-for-insulation-from-volatility-1030803003
2197.0,9/16/2021 8:41:05 PM,"With the European Union Buying Doses, Novavax Has Plenty of Upside Left",InvestorPlace,/news/stocks/with-european-union-buying-doses-nvax-stock-plenty-upside-left-1030805836
2198.0,9/16/2021 11:54:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results-1030805914
2199.0,9/17/2021 7:40:14 PM,3 Value Dividend Stocks for High Total Returns,InvestorPlace,/news/stocks/3-value-dividend-stocks-for-high-total-returns-1030807937
2200.0,9/19/2021 3:46:51 PM,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-19-25-incyte-verrica-fda-decisions-and-conference-presentations-in-the-spotlight-1030808489
2201.0,9/20/2021 10:00:23 AM,It‚Äôs OK to Sell the News on Ocugen and Covaxin,InvestorPlace,/news/stocks/sell-the-news-on-ocgn-stock-1030809323
2202.0,9/20/2021 12:21:15 PM,Mauna Kea in pact with Lung Cancer Initiative at Johnson & Johnson for biopsy guidance tool,Seeking Alpha,https://seekingalpha.com/news/3741122-mauna-kea-in-pact-with-lung-cancer-initiative-at-johnson-johnson-in-lung-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral
2203.0,9/20/2021 8:11:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810876
2204.0,9/20/2021 8:24:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810940
2205.0,9/20/2021 9:41:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030811057
2206.0,9/21/2021 7:30:37 AM,Fauci says COVID-19 vaccine for kids ages 5 to 11 could be available before Halloween,Seeking Alpha,https://seekingalpha.com/news/3741645-covid-19-vaccine-for-kids-ages-5-to-11-could-be-available-before-halloween?utm_source=markets.businessinsider.com&utm_medium=referral
2207.0,9/21/2021 12:30:00 PM,Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.,PR Newswire,/news/stocks/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s-1030812150
2208.0,9/21/2021 1:08:01 PM,AC Immune granted U.S. patent covering Alzheimer's Disease candidate,Seeking Alpha,https://seekingalpha.com/news/3741817-ac-immune-granted-us-patent-covering-alzheimers-disease-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
2209.0,9/21/2021 1:18:50 PM,J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection ,RTTNews,/news/stocks/j-j-real-world-data-confirms-efficacy-of-vaccine-in-the-u-s-booster-shows-94-protection-1030812309
2210.0,9/21/2021 2:12:37 PM,"India to decline Pfizer/BioNTech, Moderna COVID-19 shots amid local supplies - Reuters",Seeking Alpha,https://seekingalpha.com/news/3741869-india-to-decline-pfizerbiontech-moderna-covid-19-shots-amid-local-supplies-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2211.0,9/21/2021 2:20:50 PM,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",Benzinga,/news/stocks/the-daily-biotech-pulse-aprea-jumps-on-esmo-presentation-verrica-sinks-on-regulatory-setback-aerie-ceo-quits-j-j-touts-positive-covid-19-booster-shot-data-1030812654
2212.0,9/21/2021 8:40:12 PM,7 Stocks to Buy Following Vaccine Victories,InvestorPlace,/news/stocks/7-stocks-to-buy-following-vaccine-victories-1030814227
2213.0,9/22/2021 4:12:01 PM,"After Today's Fed Meeting, Investors Are Stuck With Contradictory Reports On Evergrande And The Debt Ceiling",Benzinga,/news/stocks/after-today-s-fed-meeting-investors-are-stuck-with-contradictory-reports-on-evergrande-and-the-debt-ceiling-1030816331
2214.0,9/22/2021 5:51:34 PM,Is Ketamine A Psychedelic? Depends On Who You Ask,Benzinga,/news/stocks/is-ketamine-a-psychedelic-depends-on-who-you-ask-1030816611
2215.0,9/23/2021 2:55:26 PM,7 Robinhood Stocks to Buy for Newbie Investors,InvestorPlace,/news/stocks/7-robinhood-stocks-to-buy-for-newbie-investors-1030819480
2216.0,9/23/2021 4:19:45 PM,7 High-Yield Dividend Stocks That Will Please Any Income Lover,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-please-any-income-lover-1030819743
2217.0,9/23/2021 6:50:44 PM,10 Oversold Stocks to Buy for the Final Quarter,InvestorPlace,/news/stocks/10-oversold-stocks-to-buy-for-the-final-quarter-1030820052
2218.0,9/25/2021 6:58:09 PM,"Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-healthcare-roundtable-picks-dividend-aristocrats-and-more-1030823039
2219.0,9/27/2021 4:22:37 PM,Novavax and the Changing Covid-19 Vaccine Game,InvestorPlace,/news/stocks/nvax-stock-and-the-changing-covid-vaccine-game-1030830062
2220.0,9/28/2021 1:00:00 PM,Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes,PR Newswire,/news/stocks/johnson-johnson-celebrates-covid-19-vaccine-science-superheroes-1030827585
2221.0,9/28/2021 7:30:23 PM,7 Biotech Stocks Entering the Golden Boom Phase,InvestorPlace,/news/stocks/7-biotech-stocks-entering-the-golden-boom-phase-1030829968
2222.0,9/30/2021 11:13:47 AM,Meet members of the 2021 IPO class: Healthcare - 1,Seeking Alpha,https://seekingalpha.com/news/3746473-meet-members-of-the-2021-ipo-class-healthcare-1?utm_source=markets.businessinsider.com&utm_medium=referral
2223.0,9/30/2021 11:17:26 AM,Meet members of the 2021 IPO class: Healthcare - 2,Seeking Alpha,https://seekingalpha.com/news/3746475-meet-members-of-the-2021-ipo-class-healthcare-2?utm_source=markets.businessinsider.com&utm_medium=referral
2224.0,10/1/2021 11:14:01 AM,Pharmacy chains to face first U.S. legal trial related to opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3746868-pharmacy-chains-to-face-first-us-legal-trial-on-opioid-crisis?utm_source=markets.businessinsider.com&utm_medium=referral
2225.0,10/1/2021 2:30:32 PM,Merck data for coronavirus pill pressures developers of antibody therapies,Seeking Alpha,https://seekingalpha.com/news/3747028-merck-data-for-coronavirus-pill-pressure-developers-of-antibody-therapies?utm_source=markets.businessinsider.com&utm_medium=referral
2226.0,10/3/2021 2:13:12 AM,Moderna COVID-19 shot linked to higher rates of heart inflammation - Canada,Seeking Alpha,https://seekingalpha.com/news/3747415-moderna-covid-19-shot-linked-to-higher-rates-of-heart-inflammation-canada?utm_source=markets.businessinsider.com&utm_medium=referral
2227.0,10/4/2021 1:00:15 PM,Merck extends gains after data for COVID-19 pill as vaccine makers retreat,Seeking Alpha,https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat?utm_source=markets.businessinsider.com&utm_medium=referral
2228.0,10/4/2021 2:21:35 PM,Teva pulls over 2.5M vials of U.S. made drugs after FDA concerns on contamination,Seeking Alpha,https://seekingalpha.com/news/3748104-teva-pulls-over-25m-vials-of-us-made-drugs-after-fda-concerns-on-contamination?utm_source=markets.businessinsider.com&utm_medium=referral
2229.0,10/4/2021 4:27:19 PM,"JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody",Benzinga,/news/stocks/jnj-xencor-sign-1-3b-licensing-deal-for-b-cell-malignancies-targeted-bispecific-antibody-1030841141
2230.0,10/4/2021 5:53:01 PM,It‚Äôs Time To Drop Ocugen Stock While You Still Can,InvestorPlace,/news/stocks/its-time-to-drop-ocugen-ocgn-stock-while-you-still-can-1030841717
2231.0,10/5/2021 5:05:51 AM,Pfizer/BioNTech's COVID-19 vaccine efficacy wanes after 6 months: Study,Seeking Alpha,https://seekingalpha.com/news/3748432-pfizers-covid-19-vaccine-90-effective-in-preventing-hospitalizations-study?utm_source=markets.businessinsider.com&utm_medium=referral
2232.0,10/5/2021 12:30:00 PM,Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-submission-of-emergency-use-authorization-amendment-to-the-u-s-fda-to-support-booster-of-its-single-shot-covid-19-vaccine-1030843189
2233.0,10/5/2021 12:57:45 PM,Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-submits-data-to-fda-to-support-booster-of-single-shot-covid-19-vaccine-1030843243
2234.0,10/5/2021 2:01:45 PM,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-booster-dose-authorization-gemini-restructures-strata-skin-cfo-departs-kaleido-reports-positive-readout-1030843466
2235.0,10/5/2021 5:16:48 PM,Merck‚Äôs Good News Doesn‚Äôt End the Bullish Story for Novavax,InvestorPlace,/news/stocks/mercks-good-news-doesnt-end-the-bullish-story-for-novavax-1030844852
2236.0,10/6/2021 5:00:00 PM,Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature,PR Newswire,/news/stocks/janssen-announces-novel-mechanism-of-action-that-shows-promise-against-dengue-in-data-published-in-nature-1030847834
2237.0,10/6/2021 5:58:57 PM,Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst,Benzinga,/news/stocks/merck-s-oral-covid-19-treatment-could-be-game-changer-bofa-analyst-1030848005
2238.0,10/6/2021 8:08:19 PM,Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue ,RTTNews,/news/stocks/janssen-pharmaceuticals-new-early-stage-compound-shows-promise-against-dengue-1030848355
2239.0,10/8/2021 11:44:04 AM,Novavax Stock Looks Interesting as the World Still Needs Vaccines,InvestorPlace,/news/stocks/novavax-stock-looks-interesting-as-the-world-still-needs-vaccines-1030852726
2240.0,10/8/2021 3:43:24 PM,7 Defensive Stocks to Buy and Forget About In Times of Volatility,InvestorPlace,/news/stocks/7-defensive-stocks-to-buy-and-forget-about-in-times-of-volatility-1030853320
2241.0,10/8/2021 6:30:13 PM,"Catalyst Watch for next week: JPMorgan leads out big bank earnings; eyes on Plug Power, Alibaba and HubSpot",Seeking Alpha,https://seekingalpha.com/news/3751002-catalyst-watch-for-next-week-jpmorgan-leads-out-big-bank-earnings-eyes-on-plug-power-alibaba-and-hubspot?utm_source=markets.businessinsider.com&utm_medium=referral
2242.0,10/11/2021 10:45:00 PM,Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-credit-suisse-30th-annual-healthcare-conference-1030857049
2243.0,10/12/2021 10:00:08 AM,"Novavax Stock Will Find Its Bottom, But Probably not Soon",InvestorPlace,/news/stocks/nvax-stock-will-find-its-bottom-but-probably-not-soon-1030858438
2244.0,10/12/2021 10:00:43 AM,Don‚Äôt Buy Too Much Into the WHO Hype Surrounding Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-dont-buy-too-much-into-the-who-hype-1030858436
2245.0,10/12/2021 12:45:00 PM,"Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire,  Effective December 31, 2021",PR Newswire,/news/stocks/dr-paul-stoffels-vice-chairman-of-the-executive-committee-and-chief-scientific-officer-of-johnson-johnson-to-retire-effective-december-31-2021-1030858511
2246.0,10/12/2021 2:12:28 PM,WHO recommends an additional COVID-19 vaccine for immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3752012-who-recommends-an-additional-covid-19-vaccine-for-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral
2247.0,10/12/2021 10:15:00 PM,Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations,PR Newswire,/news/stocks/johnson-johnson-announces-jessica-moore-as-vice-president-of-investor-relations-1030860395
2248.0,10/13/2021 12:45:00 PM,Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals,PR Newswire,/news/stocks/johnson-johnson-to-host-business-review-highlighting-pharmaceuticals-1030862351
2249.0,10/14/2021 7:19:45 PM,Moderna gains with unanimous AdCom backing for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3752981-moderna-gains-with-unanimous-adcom-backing-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2250.0,10/14/2021 7:48:29 PM,FDA Panel Convenes To Discuss Requirement Of Moderna Vaccine Booster Shots ,RTTNews,/news/stocks/fda-panel-convenes-to-discuss-requirement-of-moderna-vaccine-booster-shots-1030867537
2251.0,10/14/2021 11:55:00 PM,Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims,PR Newswire,/news/stocks/johnson-johnson-takes-steps-to-equitably-resolve-all-current-and-future-talc-claims-1030867970
2252.0,10/15/2021 4:38:00 AM,Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme,PR Newswire,/news/stocks/johnson-johnson-ovarian-cancer-victims-vow-fight-to-stop-j-j-s-bankruptcy-scheme-1030868065
2253.0,10/15/2021 1:44:03 PM,"The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-booster-shot-gets-fda-panel-backing-decision-day-for-avadel-silence-therapeutics-strikes-licensing-deal-mink-ipo-1030869318
2254.0,10/15/2021 2:43:00 PM,"Johnson & Johnson -- Moody's: J&J talc costs are credit negative, but channeling injunction process will reduce uncertainty",Moodys,/news/bonds/johnson-johnson-moody-s-j-j-talc-costs-are-credit-negative-but-channeling-injunction-process-will-reduce-uncertainty-1030869543
2255.0,10/15/2021 4:45:33 PM,Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings,Benzinga,/news/stocks/health-care-sector-appears-to-be-a-drag-on-positive-unitedhealth-earnings-1030869859
2256.0,10/15/2021 10:11:00 PM,Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-unanimously-recommended-for-emergency-use-authorization-by-u-s-fda-advisory-committee-1030870403
2257.0,10/15/2021 10:47:45 PM,FDA Panel Unanimously Recommends J&J Covid Booster Shot ,RTTNews,/news/stocks/fda-panel-unanimously-recommends-j-j-covid-booster-shot-1030870461
2258.0,10/17/2021 3:01:19 PM,Here's what to expect from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-1030871254
2259.0,10/18/2021 1:34:17 PM,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-18-23-j-j-biogen-kickstart-big-pharma-earnings-regeneron-sanofi-roche-await-fda-decisions-and-ipos-1030873336
2260.0,10/18/2021 2:58:07 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3754116-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
2261.0,10/18/2021 3:47:21 PM,MeiraGTx climbs to a 52-week high after positive mention on Barron‚Äôs,Seeking Alpha,https://seekingalpha.com/news/3754135-meiragtx-climbs-to-a-52-week-high-after-positive-mention-on-barrons?utm_source=markets.businessinsider.com&utm_medium=referral
2262.0,10/18/2021 4:46:00 PM,"LifeScan Global Corporation -- Moody's assigns B3 rating to LifeScan's proposed first lien term loan and secured notes, Ba3 to proposed super-priority revolver",Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b3-rating-to-lifescan-s-proposed-first-lien-term-loan-and-secured-notes-ba3-to-proposed-super-priority-revolver-1030874192
2263.0,10/19/2021 10:41:12 AM,"5 Stocks To Watch For October 19, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-october-19-2021-1030876483
2264.0,10/19/2021 12:25:00 PM,Johnson & Johnson Reports Q3 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q3-2021-results-1030876705
2265.0,10/19/2021 12:29:15 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1030876709
2266.0,10/19/2021 12:58:49 PM,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-ahead-of-earnings-reports-1030876820
2267.0,10/19/2021 1:28:38 PM,Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market ,RTTNews,/news/stocks/johnson-johnson-q3-earnings-top-estimates-lifts-fy21-view-above-market-1030876942
2268.0,10/19/2021 2:23:01 PM,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",Benzinga,/news/stocks/the-daily-biotech-pulse-entasis-dermata-spike-higher-on-positive-readouts-j-j-q3-eps-beats-estimates-wave-life-sciences-regains-right-to-cns-portfolio-1030877269
2269.0,10/19/2021 2:33:19 PM,Will FDA Allow 'mix And Match' Of Covid Booster Shots? ,RTTNews,/news/stocks/will-fda-allow-mix-and-match-of-covid-booster-shots-1030877340
2270.0,10/19/2021 4:08:55 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-boosts-fy21-guidance-1030878014
2271.0,10/19/2021 4:32:45 PM,Lower Than Expected Housing Starts and Building Permits Could Be Problems for Homebuilders,Benzinga,/news/stocks/lower-than-expected-housing-starts-and-building-permits-could-be-problems-for-homebuilders-1030878068
2272.0,10/19/2021 6:10:09 PM,Abbott Laboratories Q3 earnings preview and review,Seeking Alpha,https://seekingalpha.com/news/3755153-abbott-laboratories-q3-earnings-preview-and-review?utm_source=markets.businessinsider.com&utm_medium=referral
2273.0,10/19/2021 6:11:39 PM,Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-silver-surges-3-galera-therapeutics-shares-plunge-1030878384
2274.0,10/19/2021 8:35:47 PM,Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-surges-over-100-points-harmony-biosciences-shares-spike-higher-1030878699
2275.0,10/19/2021 9:10:23 PM,3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat,Benzinga,/news/stocks/3-biopharma-stocks-to-watch-following-johnson-johnson-s-earnings-beat-1030878749
2276.0,10/20/2021 12:45:09 PM,"28 Stocks To Benefit From Inflation, According To Jim Cramer",Benzinga,/news/stocks/28-stocks-to-benefit-from-inflation-according-to-jim-cramer-1030881145
2277.0,10/20/2021 4:51:39 PM,"Thinking About Buying Stock In Qualcomm, Microsoft, Micron, Johnson & Johnson Or BP?",Benzinga,/news/stocks/thinking-about-buying-stock-in-qualcomm-microsoft-micron-johnson-johnson-or-bp-1030882415
2278.0,10/21/2021 12:38:00 AM,Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-authorized-for-emergency-use-by-u-s-fda-1030883560
2279.0,10/21/2021 3:51:48 AM,FDA Authorizes Johnson & Johnson And Moderna Booster Shots ,RTTNews,/news/stocks/fda-authorizes-johnson-johnson-and-moderna-booster-shots-1030883612
2280.0,10/21/2021 10:42:29 AM,Pfizer/BioNTech COVID vaccine 'highly effective' against Delta variant in Israel study-Reuters,Seeking Alpha,https://seekingalpha.com/news/3755955-pfizerbiontech-covid-vaccine-highly-effective-against-delta-variant-in-israel-study-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2281.0,10/21/2021 11:02:39 AM,Pfizer/BioNTech post promising data from late-stage COVID-19 booster study,Seeking Alpha,https://seekingalpha.com/news/3755971-pfizerbiontech-post-promising-data-from-late-stage-covid-19-booster-study?utm_source=markets.businessinsider.com&utm_medium=referral
2282.0,10/21/2021 12:49:12 PM,Moderna leads COVID-19 vaccine makers as Piper Sandler favors its booster shot,Seeking Alpha,https://seekingalpha.com/news/3756089-moderna-leads-covid-19-vaccine-makers-as-piper-sandler-favors-its-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2283.0,10/21/2021 2:05:16 PM,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-authorizes-moderna-j-j-booster-shots-regulatory-approvals-for-bristol-myers-squibb-sanofi-regeneron-ventyx-ipo-1030885538
2284.0,10/21/2021 3:22:09 PM,UK says rare nerve disorder possible side effect of AstraZeneca COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3756200-uk-says-rare-nerve-disorder-possible-side-effect-of-astrazeneca-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
2285.0,10/21/2021 4:48:37 PM,7 Safe Stocks to Own to Hedge Against Inflation,InvestorPlace,/news/stocks/7-safe-stocks-to-own-to-hedge-against-inflation-1030886760
2286.0,10/21/2021 5:40:58 PM,EU to issue decision on Moderna COVID-19 booster shot next week,Seeking Alpha,https://seekingalpha.com/news/3756271-eu-to-issue-decision-on-moderna-booster-shot-next-week?utm_source=markets.businessinsider.com&utm_medium=referral
2287.0,10/21/2021 6:27:10 PM,Sight Sciences shares up 11% after releasing data on TearCare system,Seeking Alpha,https://seekingalpha.com/news/3756283-sights-sciences-shares-up-11-after-releasing-data-on-tearcare-system?utm_source=markets.businessinsider.com&utm_medium=referral
2288.0,10/21/2021 8:38:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2021-1030886959
2289.0,10/22/2021 1:48:00 AM,U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines,PR Newswire,/news/stocks/u-s-cdc-advisory-committee-unanimously-recommends-johnson-johnson-covid-19-vaccine-as-a-booster-for-all-eligible-individuals-who-receive-authorized-covid-19-vaccines-1030887453
2290.0,10/22/2021 3:18:16 AM,CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot ,RTTNews,/news/stocks/cdc-panel-backs-johnson-johnson-covid-19-booster-shot-1030887480
2291.0,10/22/2021 1:39:28 PM,Moderna and Johnson & Johnson COVID booster shots now available at Walgreens stores,Seeking Alpha,https://seekingalpha.com/news/3756635-moderna-and-johnson-johnson-covid-booster-shots-now-available-at-walgreens-stores?utm_source=markets.businessinsider.com&utm_medium=referral
2292.0,10/22/2021 3:01:56 PM,7 of the Best Dividend Stocks for Passive Income,InvestorPlace,/news/stocks/7-of-the-best-dividend-stocks-for-passive-income-1030889458
2293.0,10/22/2021 4:02:03 PM,Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. ,RTTNews,/news/stocks/walgreens-offers-moderna-and-johnson-johnson-covid-19-vaccine-booster-shots-in-u-s-1030889295
2294.0,10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741
2295.0,10/25/2021 5:10:05 PM,EMA committee says Moderna boosters can be used in those 18 and over,Seeking Alpha,https://seekingalpha.com/news/3757582-ema-committee-says-moderna-boosters-can-be-used-in-those-18-and-over?utm_source=markets.businessinsider.com&utm_medium=referral
2296.0,10/25/2021 7:20:44 PM,"Novavax is Now a Riskier Play, but Still One to Keep Your Eye On",InvestorPlace,/news/stocks/nvax-stock-is-now-a-riskier-play-but-still-one-to-keep-your-eye-on-1030896008
2297.0,10/27/2021 2:19:00 PM,Teva Pharmaceutical Finance Netherlands II BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharmaceutical-finance-netherlands-ii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905015
2298.0,10/27/2021 2:44:00 PM,Teva Pharma Finance Netherlands III BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharma-finance-netherlands-iii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905145
2299.0,10/28/2021 11:24:41 AM,"GlaxoSmithKline, Pfizer owned ViiV says EU greenlighted a simpler HIV regimen",Seeking Alpha,https://seekingalpha.com/news/3759886-glaxosmithkline-pfizer-owned-viiv-says-eu-greenlighted-a-simpler-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral
2300.0,10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260
2301.0,10/28/2021 9:56:30 PM,"FDA Restricts Sale, Approves New Labeling Of Breast Implants",Benzinga,/news/stocks/fda-restricts-sale-approves-new-labeling-of-breast-implants-1030911878
2302.0,10/29/2021 2:14:43 PM,Aurinia Pharma may be worth $45-$53/share in a potential sale - analyst,Seeking Alpha,https://seekingalpha.com/news/3760897-aurinia-pharma-may-be-worth-45-53share-in-a-potential-sale-analyst?utm_source=markets.businessinsider.com&utm_medium=referral
2303.0,10/29/2021 7:00:57 PM,"Catalyst watch for next week: FOMC and OPEC meetings, Beyond Meat hits McDonald's stores and more eyes on crypto",Seeking Alpha,https://seekingalpha.com/news/3760981-catalyst-watch-for-next-week-fomc-and-opec-meetings-beyond-meat-hits-mcdonalds-stores-and-more-eyes-on-crypto?utm_source=markets.businessinsider.com&utm_medium=referral
2304.0,11/1/2021 10:00:10 AM,"Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated",InvestorPlace,/news/stocks/novavax-stock-rises-as-uk-covid-vax-okay-sought-other-growth-anticipated-1030920758
2305.0,11/1/2021 2:01:23 PM,Aurinia Pharma drops after GlaxoSmithKline denies report on potential bid,Seeking Alpha,https://seekingalpha.com/news/3761428-aurinia-pharma-drops-after-glaxosmithkline-denies-report-on-potential-bid?utm_source=markets.businessinsider.com&utm_medium=referral
2306.0,11/2/2021 10:57:42 AM,"Teva, Endo among firms beating $50B opioid case in California in an industry first",Seeking Alpha,https://seekingalpha.com/news/3762662-teva-endo-among-firms-beating-50b-opioid-case-in-california-in-an-industry-first?utm_source=markets.businessinsider.com&utm_medium=referral
2307.0,11/2/2021 12:21:00 PM,California Judge Rules For Drugmakers In Major Opioid Litigation,Benzinga,/news/stocks/california-judge-rules-for-drugmakers-in-major-opioid-litigation-1030925651
2308.0,11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781
2309.0,11/2/2021 3:30:16 PM,Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-november-pdufa-dates-1030927142
2310.0,11/2/2021 4:11:31 PM,Ocugen hits six-month high ahead of key WHO meeting on partner‚Äôs COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3763060-ocgn-stock-hits-six-month-high-ahead-of-key-who-meeting-on-partners-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
2311.0,11/2/2021 6:03:40 PM,7 Stocks to Set Your Sights on as the ‚ÄòHyperinflation‚Äô Debate Stirs Up,InvestorPlace,/news/stocks/7-stocks-to-set-your-sights-on-as-the-hyperinflation-debate-stirs-up-1030927812
2312.0,11/2/2021 10:00:48 PM,Darzalex sales royalties help propel Halozyme Therapeutics to Q3 2021 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3763536-darzalex-sales-royalties-help-propel-halozyme-therapeutics-to-q3-2021-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral
2313.0,11/4/2021 1:00:58 PM,Moderna drags COVID-19 vaccine developers lower after slashing outlook,Seeking Alpha,https://seekingalpha.com/news/3765159-moderna-drags-covid-19-vaccine-developers-lower-after-slashing-outlook?utm_source=markets.businessinsider.com&utm_medium=referral
2314.0,11/4/2021 4:56:43 PM,7 Safe Stocks that are Immune from China‚Äôs Market Volatility,InvestorPlace,/news/stocks/7-safe-stocks-that-are-immune-from-chinas-market-volatility-1030938455
2315.0,11/4/2021 5:27:37 PM,7 Stocks to Buy to Hone in on Ray Dalio‚Äôs Reliable Favorites,InvestorPlace,/news/stocks/7-stocks-to-buy-to-hone-in-on-ray-dalio-reliable-favorites-1030938626
2316.0,11/4/2021 6:27:12 PM,This Are The 5 Largest European Stocks,Benzinga,/news/stocks/this-are-the-5-largest-european-stocks-1030938555
2317.0,11/4/2021 6:40:59 PM,Novavax Looks Primed and Ready for a Vaccine Comeback,InvestorPlace,/news/stocks/nvax-stock-looks-primed-and-ready-for-a-vaccine-comeback-1030938703
2318.0,11/5/2021 3:44:57 AM,Emergent shares fall 15% after U.S. government ends vaccine contract early,Seeking Alpha,https://seekingalpha.com/news/3765897-emergent-shares-fall-15-after-us-government-ends-vaccine-contract-early?utm_source=markets.businessinsider.com&utm_medium=referral
2319.0,11/5/2021 10:00:00 AM,The Novavax Rebound Is Just Warming Up,InvestorPlace,/news/stocks/nvax-stock-rebound-is-just-warming-up-1030942042
2320.0,11/5/2021 11:10:23 AM,Pfizer data on COVID-19 pill pressures rival Merck and vaccine developers,Seeking Alpha,https://seekingalpha.com/news/3766005-pfizer-data-on-covid-19-pill-pressure-rival-merck-and-vaccine-developers?utm_source=markets.businessinsider.com&utm_medium=referral
2321.0,11/5/2021 8:38:57 PM,Emergent Biosolutions granted FDA clearance for two more COVID-19 vaccine batches,Seeking Alpha,https://seekingalpha.com/news/3766453-emergent-biosolutions-granted-fda-clearance-for-two-more-covid-19-vaccine-batches?utm_source=markets.businessinsider.com&utm_medium=referral
2322.0,11/5/2021 9:24:38 PM,See Why Emergent BioSolutions Stock Plunged 37% On Friday?,Benzinga,/news/stocks/see-why-emergent-biosolutions-stock-plunged-37-on-friday-1030943698
2323.0,11/8/2021 9:52:49 PM,Alkermes slips as Johnson & Johnson moves to end licensing pact,Seeking Alpha,https://seekingalpha.com/news/3767304-alkermes-slips-as-johnson-johnson-moves-to-end-licensing-pact?utm_source=markets.businessinsider.com&utm_medium=referral
2324.0,11/9/2021 11:00:39 AM,7 Stocks to Buy That Could Be the Next Trillion-Dollar Company¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-that-could-be-the-next-trillion-dollar-company-1030952970
2325.0,11/9/2021 2:13:10 PM,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",Benzinga,/news/stocks/the-daily-biotech-pulse-double-dose-of-positive-tidings-for-merck-alkermes-slips-on-partial-termination-of-j-j-licensing-deal-amgen-migraine-drug-data-1030953661
2326.0,11/9/2021 6:14:33 PM,Oklahoma Supreme Court overturns $465M opioid judgment against J&J - Reuters,Seeking Alpha,https://seekingalpha.com/news/3767931-oklahoma-supreme-court-overturns-465m-opioid-judgment-against-johnson-johnson-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2327.0,11/9/2021 8:32:11 PM,OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today,InvestorPlace,/news/stocks/ocgn-stock-alert-the-earnings-news-that-has-ocugen-slipping-today-1030955404
2328.0,11/9/2021 10:30:00 PM,Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards,PR Newswire,/news/stocks/johnson-johnson-endows-research-america-outstanding-achievement-in-public-health-awards-1030955761
2329.0,11/10/2021 4:58:57 PM,7 Defensive Stocks To Add Portfolio Stability in the Fourth Quarter,InvestorPlace,/news/stocks/7-defensive-stocks-to-add-portfolio-stability-in-fourth-quarter-1030960556
2330.0,11/10/2021 7:35:31 PM,Johnson & Johnson wins court ruling on request to halt tens of thousands of talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3768884-johnson-johnson-wins-court-ruling-on-request-to-halt-tens-of-thousands-of-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral
2331.0,11/10/2021 10:32:01 PM,J&J agrees to provide its COVID vaccine through COVAX Humanitarian Buffer,Seeking Alpha,https://seekingalpha.com/news/3769224-johnson-johnson-agrees-to-provide-its-covid-vaccine-through-covax-humanitarian-buffer?utm_source=markets.businessinsider.com&utm_medium=referral
2332.0,11/10/2021 11:14:00 PM,Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer,PR Newswire,/news/stocks/johnson-johnson-enters-into-agreement-to-provide-its-single-shot-covid-19-vaccine-for-the-world-s-most-vulnerable-people-through-novel-humanitarian-buffer-1030961668
2333.0,11/12/2021 11:29:03 AM,Johnson & Johnson stock jumps on report it will split into two public companies,Seeking Alpha,https://seekingalpha.com/news/3769919-johnson-johnson-stock-jumps-on-report-it-will-split-into-two-public-companies?utm_source=markets.businessinsider.com&utm_medium=referral
2334.0,11/12/2021 12:30:00 PM,"Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business",PR Newswire,/news/stocks/johnson-johnson-announces-plans-to-accelerate-innovation-serve-patients-and-consumers-and-unlock-value-through-intent-to-separate-consumer-health-business-1030969511
2335.0,11/12/2021 1:25:01 PM,J&J Plans To Form Separate Consumer Health Company ,RTTNews,/news/stocks/j-j-plans-to-form-separate-consumer-health-company-1030969749
2336.0,11/12/2021 1:40:21 PM,"The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-to-spin-off-consumer-health-business-astrazeneca-earnings-embattled-emergent-to-buy-back-shares-1030969817
2337.0,11/12/2021 3:11:19 PM,JNJ Split: 10 Things for Investors to Know About Johnson & Johnson‚Äôs Breakup Plans,InvestorPlace,/news/stocks/jnj-split-10-things-for-investors-to-know-about-johnson-johnsons-breakup-plans-1030970444
2338.0,11/12/2021 3:27:10 PM,Johnson & Johnson gains as analysts cheer consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3770123-johnson-johnson-gains-as-analysts-cheer-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral
2339.0,11/12/2021 3:48:16 PM,SNDL Stock: The Good News That Has Cannabis Play Sundial Growers Heading Higher Today,InvestorPlace,/news/stocks/sndl-stock-the-good-news-that-has-cannabis-play-sundial-growers-heading-higher-today-1030970565
2340.0,11/12/2021 5:45:42 PM,Biden nominates former commissioner Robert Califf to head FDA,Seeking Alpha,https://seekingalpha.com/news/3770181-biden-nominates-former-commissioner-robert-califf-to-head-fda?utm_source=markets.businessinsider.com&utm_medium=referral
2341.0,11/12/2021 8:00:04 PM,"Catalyst watch for next week: Lucid earnings volatility and big events for Qualcomm, ADP, Teladoc and Palo Alto Networks",Seeking Alpha,https://seekingalpha.com/news/3770226-catalyst-watch-for-next-week-lucid-earnings-volatility-and-big-events-for-qualcomm-adp-teladoc-and-palo-alto-networks?utm_source=markets.businessinsider.com&utm_medium=referral
2342.0,11/13/2021 3:00:00 PM,Tech Roundup: Disney+ Day leads a week highlighted by streaming TV,Seeking Alpha,https://seekingalpha.com/news/3770330-tech-roundup-disney-day-leads-a-week-highlighted-by-streaming-tv?utm_source=markets.businessinsider.com&utm_medium=referral
2343.0,11/14/2021 3:57:21 PM,"The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-nov-14-nov-20-biomarin-fda-decision-tapering-earnings-news-flow-conference-presentations-and-more-1030972118
2344.0,11/15/2021 8:06:40 PM,Arrowhead posts mid-stage data for hep B candidate advanced by Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3770859-arrowhead-posts-mid-stage-data-for-hep-b-candidate-advanced-by-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral
2345.0,11/16/2021 2:04:33 PM,Pfizer moves to allow cheaper COVID-19 pills sending shares of rivals lower,Seeking Alpha,https://seekingalpha.com/news/3771400-pfizer-moves-to-allow-cheaper-covid-19-pills-sending-shares-of-rivals-lower?utm_source=markets.businessinsider.com&utm_medium=referral
2346.0,11/17/2021 2:17:11 PM,"Arrowhead, Janssen's JNJ-75220795 in development for NASH",Seeking Alpha,https://seekingalpha.com/news/3771913-arrowhead-janssens-jnj-75220795-in-development-for-nash?utm_source=markets.businessinsider.com&utm_medium=referral
2347.0,11/18/2021 2:33:44 PM,J&J expects to file for 14 new drugs by 2025 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3772449-johnson-johnson-janssen-expects-to-file-for-14-new-drugs-by-2025-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2348.0,11/19/2021 11:29:05 AM,7 Dividend Stocks to Buy for 2022 and Hold Forever,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-2022-and-hold-forever-1030881013
2349.0,11/19/2021 3:34:38 PM,3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio,InvestorPlace,/news/stocks/3-recent-spin-off-stocks-worth-a-spot-in-your-portfolio-1030991913
2350.0,11/22/2021 11:00:16 AM,7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation,InvestorPlace,/news/stocks/7-stocks-to-buy-for-their-resistance-to-the-6-2-monthly-inflation-1030994239
2351.0,11/23/2021 8:16:33 PM,Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst,Benzinga,/news/stocks/pfizer-s-covid-19-franchise-could-push-revenue-past-100b-in-2022-analyst-1030999039
2352.0,11/24/2021 8:29:48 AM,Philogen collaborates with Janssen Biotech to discover small molecule therapeutics,Seeking Alpha,https://seekingalpha.com/news/3774089-philogen-collaborates-with-janssen-biotech-to-discover-small-molecule-therapeutics?utm_source=markets.businessinsider.com&utm_medium=referral
2353.0,11/24/2021 11:18:46 AM,EU health agency considers COVID-19 vaccine booster shots for all adults - Reuters,Seeking Alpha,https://seekingalpha.com/news/3774171-eu-health-agency-considers-covid-19-vaccine-booster-shots-for-all-adults-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2354.0,11/24/2021 12:52:00 PM,Health Canada approves JNJ's COVID-19 vaccine in people 18 years of age and above,Seeking Alpha,https://seekingalpha.com/news/3774209-health-canada-approves-jnjs-covid-19-vaccine-in-people-18-years-of-age-and-above?utm_source=markets.businessinsider.com&utm_medium=referral
2355.0,11/24/2021 2:37:59 PM,Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts ,RTTNews,/news/stocks/health-canada-approves-johnson-johnson-covid-19-vaccine-quick-facts-1031000995
2356.0,11/26/2021 7:30:01 AM,New COVID-19 variant detected in South Africa prompts renewed travel restrictions,Seeking Alpha,https://seekingalpha.com/news/3774462-new-covid-19-variant-detected-in-south-africa-prompts-renewed-travel-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral
2357.0,11/26/2021 2:05:34 PM,WHO meets today as new COVID variant poised to become new threat,Seeking Alpha,https://seekingalpha.com/news/3774583-who-meets-today-as-new-covid-variant-poised-to-become-new-threat?utm_source=markets.businessinsider.com&utm_medium=referral
2358.0,11/26/2021 2:19:14 PM,U.S. must study data before deciding on travel ban over new COVID-19 variant: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774591-us-must-study-data-before-deciding-on-travel-ban-over-new-covid-19-variant-fauci?utm_source=markets.businessinsider.com&utm_medium=referral
2359.0,11/26/2021 2:26:32 PM,Most J&J COVID vaccine recipients switch to another shot for booster - WSJ,Seeking Alpha,https://seekingalpha.com/news/3774595-most-johnson-johnson-covid-vaccine-recipients-switch-to-another-shot-for-booster-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
2360.0,11/27/2021 6:52:48 PM,Meme stocks and megacaps make UBS list of most and least crowded trades: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3773977-meme-stocks-and-megacaps-make-ubs-list-of-most-and-least-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral
2361.0,11/28/2021 12:10:44 AM,New COVID-19 variant found in U.K. and Germany; Israel shuts borders for foreigners,Seeking Alpha,https://seekingalpha.com/news/3774702-new-covid-19-variant-found-in-uk-and-germany-israel-shuts-borders-for-foreigners?utm_source=markets.businessinsider.com&utm_medium=referral
2362.0,11/28/2021 1:16:20 PM,Moderna says new vaccine for Omicron could be ready for early next year,Seeking Alpha,https://seekingalpha.com/news/3774708-moderna-says-new-vaccine-for-omicron-could-be-ready-for-early-next-year?utm_source=markets.businessinsider.com&utm_medium=referral
2363.0,11/29/2021 7:34:54 AM,"Japan, Morocco ban foreign travelers as Omicron spreads; new cases reported in Netherlands, Canada, Australia",Seeking Alpha,https://seekingalpha.com/news/3774719-japan-morocco-bans-foreign-travelers-as-omicron-spreads-new-cases-reported-in-netherlands-canada-australia?utm_source=markets.businessinsider.com&utm_medium=referral
2364.0,11/29/2021 8:45:39 AM,U.S. readies fight against Omicron variant but too soon for lockdowns: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774720-us-readies-fight-against-omicron-variant-but-too-soon-for-lockdowns-fauci?utm_source=markets.businessinsider.com&utm_medium=referral
2365.0,11/29/2021 12:56:03 PM,Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant,Benzinga,/news/stocks/novavax-working-on-new-covid-19-vaccine-to-combat-omicron-variant-1031008391
2366.0,11/29/2021 2:35:56 PM,"Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed ",RTTNews,/news/stocks/vaccine-makers-investigate-new-covid-variant-to-adapt-shots-if-needed-1031008838
2367.0,11/29/2021 4:44:03 PM,J&J researching Omicron-specific COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3774973-johnson-johnson-researching-omicron-specific-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
2368.0,11/29/2021 6:19:36 PM,5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market,InvestorPlace,/news/stocks/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market-1031009824
2369.0,11/29/2021 7:15:07 PM,Biden to direct regulators to use ‚Äòfastest process available‚Äù to clear vaccines against Omicron,Seeking Alpha,https://seekingalpha.com/news/3775031-biden-to-direct-regulators-to-use-fastest-process-available-to-clear-vaccines-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral
2370.0,11/29/2021 9:31:27 PM,"Amid Omicron, CDC now says everyone 18 and older should get COVID booster shot",Seeking Alpha,https://seekingalpha.com/news/3775092-amid-omicron-cdc-now-says-everyone-18-and-older-should-get-covid-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2371.0,11/30/2021 3:06:35 AM,CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns ,RTTNews,/news/stocks/cdc-strengthens-booster-recommendation-for-all-adults-due-to-omicron-variant-concerns-1031010292
2372.0,11/30/2021 8:47:49 AM,England to impose mask mandates to curb spread of Omicron - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775168-england-to-impose-mask-mandates-to-curb-spread-omicron-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2373.0,11/30/2021 10:55:45 AM,EU expects to approve shot against Omicron in 3-4 months,Seeking Alpha,https://seekingalpha.com/news/3775204-eu-expects-to-approve-shot-against-omicron-in-3-4-months?utm_source=markets.businessinsider.com&utm_medium=referral
2374.0,11/30/2021 4:17:16 PM,"FDA working with other agencies, private industry on potential impact from Omicron",Seeking Alpha,https://seekingalpha.com/news/3775445-fda-working-with-other-agencies-private-industry-on-potential-impact-from-omicron?utm_source=markets.businessinsider.com&utm_medium=referral
2375.0,11/30/2021 7:29:27 PM,7 Drug Stocks to Buy Now While They‚Äôre Still on Sale,InvestorPlace,/news/stocks/7-drug-stocks-to-buy-now-while-theyre-still-on-sale-1031013701
2376.0,11/30/2021 7:47:10 PM,Street analysts have mixed views on Omicron impact on COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3775526-street-analysts-have-mixed-views-on-omicron-impact-on-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2377.0,11/30/2021 10:49:08 PM,Have the Markets Overreacted to Omicron?,InvestorPlace,/news/stocks/have-the-markets-overreacted-to-omicron-1031017944
2378.0,12/1/2021 8:15:42 AM,South African disease expert says Omicron variant could outweigh Delta - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775645-south-african-disease-expert-says-omicron-variant-could-outweigh-delta-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2379.0,12/1/2021 5:20:42 PM,"Johnson & Johnson, Amgen win FDA approval for drug combo targeting multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3775966-johnson-johnson-amgen-win-fda-approval-for-drug-combo-targeting-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
2380.0,12/1/2021 7:48:03 PM,VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down,InvestorPlace,/news/stocks/vxrt-stock-other-vaccine-stocks-are-gaining-but-jim-cramer-just-sent-vaxart-down-1031017418
2381.0,12/2/2021 4:36:02 AM,Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment ,RTTNews,/news/stocks/amgen-fda-approves-kyprolis-combination-regimen-for-multiple-myeloma-treatment-1031017923
2382.0,12/2/2021 2:32:57 PM,3 Sickly Covid Stocks to Buy as Omicron Gets Around,InvestorPlace,/news/stocks/3-sickly-covid-stocks-to-buy-1031020211
2383.0,12/2/2021 4:06:41 PM,Aurinia Pharmaceuticals gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3776494-aurinia-pharmaceuticals-gains-on-takeover-speculation?utm_source=markets.businessinsider.com&utm_medium=referral
2384.0,12/2/2021 8:09:52 PM,Scientists find reason behind rare blood clots linked to AstraZeneca COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3776636-scientists-find-reason-behind-rare-blood-clots-linked-to-astrazeneca-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2385.0,12/2/2021 9:00:37 PM,More Omicron cases found in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3776657-more-omicron-cases-found-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral
2386.0,12/2/2021 9:38:52 PM,Protagonist chooses candidate to advance into phase 2 in collaboration with Janssen,Seeking Alpha,https://seekingalpha.com/news/3776679-protagonist-chooses-candidate-to-advance-into-phase-2-in-collaboration-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral
2387.0,12/3/2021 1:33:09 PM,J&J's Tremfya shows durable response in psoriatric arthritis in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/3776881-johnson-johnson-tremfya-shows-durable-response-in-psoriatric-arthritis-in-late-stage-trial?utm_source=markets.businessinsider.com&utm_medium=referral
2388.0,12/3/2021 1:40:11 PM,"The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering",Benzinga,/news/stocks/the-daily-biotech-pulse-protagonist-pulls-plug-on-phase-1-asset-xenon-aces-mid-stage-epilepsy-study-esperion-prices-offering-1031022833
2389.0,12/3/2021 3:23:59 PM,"Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate",Benzinga,/news/stocks/protagonist-to-go-ahead-with-oral-peptide-pn-235-discontinues-phase-1-candidate-1031023141
2390.0,12/3/2021 4:15:06 PM,WHO says no evidence yet Omicron requires adjustments to existing COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3776979-who-says-no-evidence-yet-omicron-requires-adjustments-to-existing-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2391.0,12/3/2021 7:02:42 PM,House Oversight Committee schedules Dec. 9 hearing on prescription drug prices,Seeking Alpha,https://seekingalpha.com/news/3777032-house-oversight-committee-schedules-dec-9-hearing-on-prescription-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral
2392.0,12/4/2021 1:24:00 AM,Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021,PR Newswire,/news/stocks/janssen-to-showcase-progress-on-respiratory-syncytial-virus-rsv-vaccine-candidate-at-eswi-2021-1031024126
2393.0,12/5/2021 11:03:00 PM,"Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses",PR Newswire,/news/stocks/johnson-johnson-covid-19-booster-administered-six-months-after-two-dose-regimen-of-bnt162b2-shows-substantial-increase-in-antibody-and-t-cell-responses-1031024672
2394.0,12/6/2021 2:43:14 AM,Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses ,RTTNews,/news/stocks/johnson-johnson-says-its-covid-19-booster-shows-increase-in-antibody-and-t-cell-responses-1031024711
2395.0,12/6/2021 7:02:43 AM,"J&J's COVID-19 booster shot shows increase in antibody, T-cell responses",Seeking Alpha,https://seekingalpha.com/news/3777145-jjs-covid-19-booster-shot-shows-increase-in-antibody-t-cell-responses?utm_source=markets.businessinsider.com&utm_medium=referral
2396.0,12/6/2021 10:59:57 AM,U.S. prepares to fast-track authorization of Omicron COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3777176-us-prepares-to-fast-track-authorization-of-omicron-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2397.0,12/6/2021 2:19:00 PM,NDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulators,Seeking Alpha,https://seekingalpha.com/news/3777264-nda-for-johnson-johnson-cilta-cel-for-multiple-myeloma-submitted-to-japanese-regulators?utm_source=markets.businessinsider.com&utm_medium=referral
2398.0,12/6/2021 8:50:20 PM,Biden calls on Senate to pass legislation to tackle 'outrageously expensive' drug prices,Seeking Alpha,https://seekingalpha.com/news/3777526-biden-call-on-senate-to-pass-legislation-to-tackle-outrageously-expensive-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral
2399.0,12/7/2021 8:37:17 AM,New York City to impose vaccine mandate for all private employees,Seeking Alpha,https://seekingalpha.com/news/3777604-new-york-city-to-impose-vaccine-mandate-for-all-private-employees?utm_source=markets.businessinsider.com&utm_medium=referral
2400.0,12/7/2021 11:00:16 AM,7 Stocks to Watch as the Omicron Variant Becomes the Market‚Äôs New Wildcard,InvestorPlace,/news/stocks/7-stocks-to-watch-as-the-omicron-variant-becomes-the-markets-new-wildcard-1031028496
2401.0,12/7/2021 12:09:33 PM,Johnson & Johnson‚Äôs respiratory syncytial virus candidate shows 80% efficacy,Seeking Alpha,https://seekingalpha.com/news/3777661-johnson-johnsons-respiratory-syncytial-virus-candidate-shows-80-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral
2402.0,12/7/2021 3:44:01 PM,Legend Biotech rises on filing of marketing application for CAR-T therapy in Japan,Seeking Alpha,https://seekingalpha.com/news/3777831-legend-biotech-rises-on-filing-of-marketing-application-for-car-t-therapy-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral
2403.0,12/8/2021 12:01:40 PM,"Pfizer, BioNTech say three vaccine doses neutralize Omicron in early lab tests",Seeking Alpha,https://seekingalpha.com/news/3778159-pfizer-biontech-lower-after-early-data-on-omicrons-impact-on-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2404.0,12/8/2021 8:14:45 PM,U.S. COVID-19 cases rise amid vaccine milestone,Seeking Alpha,https://seekingalpha.com/news/3778424-us-covid-19-cases-rise-despite-vaccine-milestone?utm_source=markets.businessinsider.com&utm_medium=referral
2405.0,12/8/2021 9:34:06 PM,N.Y. judge issues temporary restraining order on NYC public sector vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3778474-ny-judge-issues-temporary-restraining-order-on-nyc-public-sector-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral
2406.0,12/9/2021 12:30:00 PM,Johnson & Johnson Appoints Senior Leaders to Executive Committee,PR Newswire,/news/stocks/johnson-johnson-appoints-senior-leaders-to-executive-committee-1031034957
2407.0,12/9/2021 2:53:01 PM,Johnson & Johnson makes new Executive Committee appointments,Seeking Alpha,https://seekingalpha.com/news/3778742-johnson-johnson-makes-new-executive-committee-appointments?utm_source=markets.businessinsider.com&utm_medium=referral
2408.0,12/9/2021 10:52:49 PM,WHO advisory panel recommends J&J COVID vaccine booster,Seeking Alpha,https://seekingalpha.com/news/3778989-who-advisory-panel-recommends-johnson-johnson-covid-vaccine-booster?utm_source=markets.businessinsider.com&utm_medium=referral
2409.0,12/9/2021 11:00:00 PM,World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster,PR Newswire,/news/stocks/world-health-organization-strategic-advisory-group-of-experts-sage-interim-recommendation-supports-use-of-johnson-johnson-covid-19-vaccine-as-a-booster-1031037203
2410.0,12/10/2021 11:00:33 AM,Why You Should Buy Moderna Stock at Every Dip,InvestorPlace,/news/stocks/why-you-should-buy-mrna-stock-at-every-dip-1031038543
2411.0,12/10/2021 7:08:46 PM,3 Healthcare Stocks for Long-Term Dividend Growth,InvestorPlace,/news/stocks/3-healthcare-stocks-for-long-term-dividend-growth-1031039566
2412.0,12/10/2021 7:39:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1031039532
2413.0,12/10/2021 10:17:58 PM,FDA advisor: Real-world data on current vaccines will determine if Omicron shots needed,Seeking Alpha,https://seekingalpha.com/news/3779324-fda-advisor-real-world-data-on-current-vaccines-will-determine-if-omicron-covbid-shots-needed?utm_source=markets.businessinsider.com&utm_medium=referral
2414.0,12/13/2021 7:32:25 PM,Why does Pfizer's $6.7B acquisition of Arena Pharmaceuticals make sense? Etrasimod,Seeking Alpha,https://seekingalpha.com/news/3779629-why-does-pfizer-67b-acquisition-of-arena-pharmaceuticals-make-sense-etrasimod?utm_source=markets.businessinsider.com&utm_medium=referral
2415.0,12/13/2021 8:15:41 PM,Supreme Court blocks challenge to N.Y. COVID mandate for healthcare workers (updated),Seeking Alpha,https://seekingalpha.com/news/3779642-supreme-court-blocks-challenge-to-ny-covid-vaccine-mandate-for-health-workers?utm_source=markets.businessinsider.com&utm_medium=referral
2416.0,12/13/2021 11:24:29 PM,J&J Talcum Powder Woes Continue As SC Declines To Hear The Company ,RTTNews,/news/stocks/j-j-talcum-powder-woes-continue-as-sc-declines-to-hear-the-company-1031042458
2417.0,12/14/2021 11:34:08 AM,Johnson & Johnson COVID-19 vaccine study in South Africa finds no Omicron deaths,Seeking Alpha,https://seekingalpha.com/news/3779804-johnson-johnson-covid-19-vaccine-study-in-south-africa-finds-no-omicron-deaths?utm_source=markets.businessinsider.com&utm_medium=referral
2418.0,12/14/2021 7:27:38 PM,"10 Stocks to Buy if You Have $5,000 in Starter Money",InvestorPlace,/news/stocks/10-stocks-to-buy-if-you-have-5000-dollars-in-starter-money-1031044495
2419.0,12/14/2021 8:04:38 PM,WHO chief says there is a ‚Äúsmall decline‚Äù in effectiveness of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3780074-who-chief-says-there-is-a-small-decline-in-effectiveness-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2420.0,12/15/2021 11:19:35 AM,EMA recommends Johnson & Johnson COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3780235-ema-recommends-johnson-johnson-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2421.0,12/15/2021 12:53:33 PM,EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults ,RTTNews,/news/stocks/ema-recommends-covid-19-vaccine-janssen-booster-shot-for-adults-1031046724
2422.0,12/15/2021 1:34:01 PM,Study finds COVID booster shots significantly increase Omicron neutralization,Seeking Alpha,https://seekingalpha.com/news/3780324-study-finds-covid-booster-shots-significantly-increase-omicron-neutralization?utm_source=markets.businessinsider.com&utm_medium=referral
2423.0,12/15/2021 2:32:00 PM,Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-positive-chmp-opinion-for-a-booster-shot-of-its-covid-19-vaccine-1031047251
2424.0,12/15/2021 2:46:14 PM,Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-receives-positive-chmp-opinion-for-booster-shot-of-covid-19-vaccine-1031047303
2425.0,12/15/2021 5:27:38 PM,3 Consumer Staples Stocks to Buy for Safety,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-buy-for-safety-1031048130
2426.0,12/16/2021 5:53:14 PM,Legend now up 4% following ADS offering pricing after initially falling,Seeking Alpha,https://seekingalpha.com/news/3780935-legend-now-up-4-following-ads-offering-pricing-after-initially-falling?utm_source=markets.businessinsider.com&utm_medium=referral
2427.0,12/16/2021 11:12:30 PM,J&J says its COVID vaccine remains crucial after CDC advisors vote in favor of mRNA shots,Seeking Alpha,https://seekingalpha.com/news/3781137-jj-says-its-covid-vaccine-remains-crucial-after-cdc-advisors-vote-in-favor-of-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2428.0,12/17/2021 3:33:12 AM,"CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots ",RTTNews,/news/stocks/cdc-recommends-pfizer-moderna-covid-19-vaccines-over-j-j-due-to-rare-blood-clots-1031051886
2429.0,12/17/2021 9:47:05 AM,Biden warns unvaccinated against Omicron; asks Supreme Court to unblock vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3781179-biden-warns-unvaccinated-against-omicron-asks-supreme-court-to-lift-covid-19-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral
2430.0,12/17/2021 11:47:41 AM,"Pfizer/BioNTech, Moderna COVID-19 shots get CDC backing ahead of J&J‚Äôs",Seeking Alpha,https://seekingalpha.com/news/3781205-pfizerbiontech-moderna-covid-19-shots-get-cdc-backing-ahead-of-jjs?utm_source=markets.businessinsider.com&utm_medium=referral
2431.0,12/17/2021 4:17:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-17-2021-1031053650
2432.0,12/17/2021 10:15:36 PM,"The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More",Benzinga,/news/stocks/the-week-in-cannabis-pfizer-visa-730m+-in-financings-malta-eu-columbia-care-medmen-uruguay-and-more-1031054254
2433.0,12/20/2021 8:43:28 AM,U.S. appeals court revives Biden administration‚Äôs COVID-19 vaccine mandate for businesses,Seeking Alpha,https://seekingalpha.com/news/3781502-us-appeals-court-revives-biden-administrations-covid-19-vaccine-mandate-for-businesses?utm_source=markets.businessinsider.com&utm_medium=referral
2434.0,12/20/2021 12:00:05 PM,Moderna leads COVID-19 vaccine makers after booster data on Omicron,Seeking Alpha,https://seekingalpha.com/news/3781536-moderna-leads-covid-19-vaccine-makers-after-booster-data-on-omicron?utm_source=markets.businessinsider.com&utm_medium=referral
2435.0,12/21/2021 12:00:59 PM,"Meta hits UBS list of most crowded trades, most megacaps still uncrowded: At the Open",Seeking Alpha,https://seekingalpha.com/news/3781908-meta-hits-ubs-list-of-most-crowded-trades-most-megacaps-still-uncrowded?utm_source=markets.businessinsider.com&utm_medium=referral
2436.0,12/21/2021 2:11:20 PM,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",Benzinga,/news/stocks/the-daily-biotech-pulse-aldeyra-sinks-on-dry-eye-disease-readout-sanofi-goes-shopping-regulatory-setback-for-aquestive-aridis-touts-pan-coronavirus-antibody-cocktail-1031059051
2437.0,12/21/2021 3:50:16 PM,DYAI: Jumpin' Janssen Jamboree,Benzinga,/news/stocks/dyai-jumpin-janssen-jamboree-1031059462
2438.0,12/21/2021 5:35:05 PM,Johnson & Johnson nabs two additional pediatric indications for Xarelto,Seeking Alpha,https://seekingalpha.com/news/3782424-johnson-johnson-nabs-two-additional-pediatric-indications-for-xarelto?utm_source=markets.businessinsider.com&utm_medium=referral
2439.0,12/21/2021 6:33:44 PM,EMA: Data shows COVID boosters protect against Omicron; altering shots not yet needed,Seeking Alpha,https://seekingalpha.com/news/3782462-ema-data-shows-covid-boosters-protect-against-omicron-altering-shots-not-yet-needed?utm_source=markets.businessinsider.com&utm_medium=referral
2440.0,12/21/2021 8:19:03 PM,Biden says country 'not going back to March 2020' in terms of COVID closures (updated),Seeking Alpha,https://seekingalpha.com/news/3782480-biden-says-country-not-going-back-to-march-2020-in-terms-of-covid-closures?utm_source=markets.businessinsider.com&utm_medium=referral
2441.0,12/21/2021 9:25:59 PM,"AstraZeneca, Oxford start work on Omicron-specific COVID vaccine - FT",Seeking Alpha,https://seekingalpha.com/news/3782496-astrazeneca-oxford-start-work-on-omicron-specific-covid-vaccine-ft?utm_source=markets.businessinsider.com&utm_medium=referral
2442.0,12/22/2021 6:07:58 PM,Study finds mRNA vaccine boosters significantly increase protection against Omicron,Seeking Alpha,https://seekingalpha.com/news/3782789-study-finds-mrna-covid-vaccine-boosters-significantly-increase-protection-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral
2443.0,12/23/2021 8:00:14 AM,Janssen terminates izencitinib deal with Theravance Biopharma,Seeking Alpha,https://seekingalpha.com/news/3782899-janssen-terminates-izencitinib-deal-with-theravance-biopharma?utm_source=markets.businessinsider.com&utm_medium=referral
2444.0,12/23/2021 12:27:47 PM,Top 10 Blockbuster Drugs In 2021 ,RTTNews,/news/stocks/top-10-blockbuster-drugs-in-2021-1031063755
2445.0,12/23/2021 1:13:05 PM,South Africa approves J&J's COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3782987-south-africa-approves-jjs-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2446.0,12/23/2021 3:07:25 PM,Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table,Benzinga,/news/stocks/corporate-cannabis-takeover-assessing-5-big-industries-already-at-the-table-1031064194
2447.0,12/23/2021 8:53:48 PM,Endo to pay $63M to settle Texas opioid claims,Seeking Alpha,https://seekingalpha.com/news/3783297-endo-to-pay-63m-to-settle-texas-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral
2448.0,12/27/2021 8:18:53 AM,Global COVID-19 cases break records as Omicron variant spreads,Seeking Alpha,https://seekingalpha.com/news/3783344-global-covid-19-cases-break-records-as-omicron-variant-spreads?utm_source=markets.businessinsider.com&utm_medium=referral
2449.0,12/27/2021 5:32:41 PM,Number of daily COVID-19 cases now on par when Delta variant was surging,Seeking Alpha,https://seekingalpha.com/news/3783469-number-of-daily-covid-19-cases-now-on-par-when-delta-variant-was-surging?utm_source=markets.businessinsider.com&utm_medium=referral
2450.0,12/27/2021 8:11:30 PM,"If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-one-year-ago-here-s-how-much-you-d-have-now-1031067341
2451.0,12/28/2021 9:55:54 AM,New York expands COVID-19 testing as cases continue to rise,Seeking Alpha,https://seekingalpha.com/news/3783547-new-york-expands-covid-19-testing-as-cases-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral
2452.0,12/28/2021 11:36:01 AM,Omicron enhances neutralizing immunity against Delta variant: South Africa study,Seeking Alpha,https://seekingalpha.com/news/3783567-omicron-enhances-neutralizing-immunity-against-delta-variant-south-africa-study?utm_source=markets.businessinsider.com&utm_medium=referral
2453.0,12/29/2021 9:38:52 AM,NYC schools to ramp up testing to limit classroom closures - NYT,Seeking Alpha,https://seekingalpha.com/news/3783823-nyc-schools-to-ramp-up-testing-to-limit-classroom-closures-nyt?utm_source=markets.businessinsider.com&utm_medium=referral
2454.0,12/29/2021 1:29:24 PM,Johnson & Johnson seeks FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3783872-johnson-johnson-seeks-fda-approval-for-multiple-myeloma-therapy?utm_source=markets.businessinsider.com&utm_medium=referral
2455.0,12/29/2021 2:50:46 PM,COVID-19 cases 7-day moving average reaches level not seen since January,Seeking Alpha,https://seekingalpha.com/news/3783910-covid-19-cases-7-day-moving-average-reaches-level-not-seen-since-january?utm_source=markets.businessinsider.com&utm_medium=referral
2456.0,12/30/2021 9:11:05 AM,J&J COVID-19 booster dose slashes Omicron hospital stay: South African study,Seeking Alpha,https://seekingalpha.com/news/3784064-jj-covid-19-booster-dose-slashes-omicron-hospital-stay-south-african-study?utm_source=markets.businessinsider.com&utm_medium=referral
2457.0,12/30/2021 9:52:37 AM,Omicron COVID surge could peak in U.S. by January end: Fauci,Seeking Alpha,https://seekingalpha.com/news/3784080-omicron-covid-surge-could-peak-in-us-by-january-end-fauci?utm_source=markets.businessinsider.com&utm_medium=referral
2458.0,12/30/2021 12:30:00 PM,Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-demonstrates-85-percent-effectiveness-against-hospitalization-in-south-africa-when-omicron-was-dominant-1031071002
2459.0,12/30/2021 1:11:18 PM,"J&J's COVID-19 Booster Shot 85% Effective Against Hospitalization, In South Africa Phase 3 Study ",RTTNews,/news/stocks/j-j-s-covid-19-booster-shot-85-effective-against-hospitalization-in-south-africa-phase-3-study-1031071067
2460.0,1/2/2022 5:00:00 PM,Can COVID-19 vaccine makers stellar 2021 continue in 2022?,Seeking Alpha,https://seekingalpha.com/news/3784267-can-covid-19-vaccine-makers-stellar-2021-continue-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral
2461.0,1/3/2022 11:00:54 AM,Some Investors Should Buy Novavax Stock on the Dip,InvestorPlace,/news/stocks/some-investors-should-buy-nvax-stock-on-the-dip-1031073881
2462.0,1/3/2022 4:19:37 PM,Theravance up 9% on 3x higher than normal volume,Seeking Alpha,https://seekingalpha.com/news/3784627-theravance-up-10-on-3x-higher-than-normal-volume?utm_source=markets.businessinsider.com&utm_medium=referral
2463.0,1/3/2022 8:55:57 PM,States siding with McKinsey to block local governments' opioid cases,Seeking Alpha,https://seekingalpha.com/news/3784696-states-siding-with-mckinsey-to-block-local-governments-opioid-cases?utm_source=markets.businessinsider.com&utm_medium=referral
2464.0,1/4/2022 8:42:50 AM,U.S. schools delay openings amid COVID-19 surge driven by Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3784800-us-schools-delay-openings-amid-covid-19-surge-driven-by-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral
2465.0,1/4/2022 1:34:30 PM,Johnson & Johnson declares $1.06 dividend,Seeking Alpha,https://seekingalpha.com/news/3784864-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
2466.0,1/4/2022 2:00:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2022-1031076008
2467.0,1/4/2022 4:02:18 PM,CDC backs use of a third Pfizer/BioNTech COVID-19 shot for certain children,Seeking Alpha,https://seekingalpha.com/news/3785056-cdc-backs-use-of-a-third-pfizerbiontech-covid-19-shot-for-certain-children?utm_source=markets.businessinsider.com&utm_medium=referral
2468.0,1/4/2022 5:07:32 PM,"Store Capital falls as CNBC commentator sells shares, buys Carlyle Group, recommends Viper Energy (update)",Seeking Alpha,https://seekingalpha.com/news/3785136-store-capital-falls-after-cnbc-commentator-sells-shares-buys-carlyle-group?utm_source=markets.businessinsider.com&utm_medium=referral
2469.0,1/4/2022 8:59:04 PM,Biden says vaccinated people shouldn't be 'alarmed' by COVID-19,Seeking Alpha,https://seekingalpha.com/news/3785196-biden-says-vaccinated-people-shouldnt-be-alarmed-by-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
2470.0,1/5/2022 1:22:15 PM,"Nevada joins Johnson & Johnson, drug distributors $26B opioid settlement",Seeking Alpha,https://seekingalpha.com/news/3785354-johnson-johnson-drug-distributors-win-nevada-for-26b-opioid-deal?utm_source=markets.businessinsider.com&utm_medium=referral
2471.0,1/5/2022 7:49:53 PM,Global M&A deals annual volume reach highest level since 2008: Willis Towers,Seeking Alpha,https://seekingalpha.com/news/3785549-global-ma-deals-annual-volume-reach-highest-level-since-2008-willis-towers?utm_source=markets.businessinsider.com&utm_medium=referral
2472.0,1/5/2022 9:41:23 PM,"J&J Janssen unit, SRI International to collaborate on drug discovery using AI",Seeking Alpha,https://seekingalpha.com/news/3785625-johnson-johnson-janssen-unit-sri-international-to-collaborate-drug-discovery-using-ai?utm_source=markets.businessinsider.com&utm_medium=referral
2473.0,1/6/2022 12:33:59 PM,7 Best Stocks to Buy to Kick Off the New Year,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-kick-off-new-year-1031081283
2474.0,1/6/2022 12:38:01 PM,"Meta, Netflix move up list of crowded trades, even as funds dump tech: At the Open",Seeking Alpha,https://seekingalpha.com/news/3785535-meta-netflix-move-up-the-list-of-ubs-most-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral
2475.0,1/6/2022 10:03:32 PM,"J&J touts data on durable protection of COVID shot against infections, hospitalization",Seeking Alpha,https://seekingalpha.com/news/3786033-johnson-johnson-touts-data-on-durable-protection-of-covid-shot-against-infections-hospitalization?utm_source=markets.businessinsider.com&utm_medium=referral
2476.0,1/6/2022 10:10:00 PM,"Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States",PR Newswire,/news/stocks/real-world-evidence-shows-johnson-johnson-covid-19-vaccine-demonstrates-durable-protection-against-breakthrough-infection-hospitalization-and-intensive-care-unit-admission-in-the-united-states-1031082512
2477.0,1/7/2022 4:07:19 AM,Johnson & Johnson Vaccine Protects Up To Six Months Against COVID-19 Breakthrough Infections ,RTTNews,/news/stocks/johnson-johnson-vaccine-protects-up-to-six-months-against-covid-19-breakthrough-infections-1031082696
2478.0,1/7/2022 5:59:39 PM,Some Supreme Court justices take issue with Biden vaccine mandates,Seeking Alpha,https://seekingalpha.com/news/3786332-some-supreme-court-justices-take-issue-with-biden-vaccine-mandates?utm_source=markets.businessinsider.com&utm_medium=referral
2479.0,1/7/2022 6:17:06 PM,Biden administration to ask Congress for more COVID funding - WaPo,Seeking Alpha,https://seekingalpha.com/news/3786338-biden-administration-to-ask-congress-for-more-covid-funding?utm_source=markets.businessinsider.com&utm_medium=referral
2480.0,1/7/2022 6:34:48 PM,Judge allows Purdue to immediately appeal bankruptcy settlement rejection,Seeking Alpha,https://seekingalpha.com/news/3786345-judge-gives-purdue-right-to-immediately-appeal-bankruptcy-opioid-settlement-rejection?utm_source=markets.businessinsider.com&utm_medium=referral
2481.0,1/11/2022 11:10:02 AM,U.S. COVID-19 hospitalizations surpass last winter record as Omicron surges,Seeking Alpha,https://seekingalpha.com/news/3786959-us-covid-19-hospitalizations-surpass-last-winter-record-as-omicron-surges?utm_source=markets.businessinsider.com&utm_medium=referral
2482.0,1/11/2022 8:46:55 PM,FDA mandates warning of risk of blood clotting disorder with J&J COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3787247-fda-mandates-warning-of-risk-of-blood-clotting-disorder-with-jj-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
2483.0,1/12/2022 4:57:30 PM,Theravance Biopharma continues slide; down another 12% today,Seeking Alpha,https://seekingalpha.com/news/3787576-theravance-biosciences-continues-slide-down-another-12-today?utm_source=markets.businessinsider.com&utm_medium=referral
2484.0,1/13/2022 8:52:18 AM,Calls grow to treat COVID like an 'endemic' illness,Seeking Alpha,https://seekingalpha.com/news/3787737-calls-grow-to-treat-covid-like-an-endemic-illness?utm_source=markets.businessinsider.com&utm_medium=referral
2485.0,1/13/2022 6:43:38 PM,FDA document outlines testing of cosmetics containing talc for asbestos,Seeking Alpha,https://seekingalpha.com/news/3788023-fda-document-outlines-testing-of-cosmetics-containing-talc-for-asbestos?utm_source=markets.businessinsider.com&utm_medium=referral
2486.0,1/13/2022 7:42:56 PM,"Supreme Court blocks COVID vaccine mandate for businesses, but OK for healthcare workers",Seeking Alpha,https://seekingalpha.com/news/3788042-supreme-court-blocks-covid-vaccine-mandate-for-businesses-but-ok-for-healthcare-workers?utm_source=markets.businessinsider.com&utm_medium=referral
2487.0,1/14/2022 5:24:27 PM,What To Expect When Johnson & Johnson Unveils Q4 Performance This Month,Benzinga,/news/stocks/what-to-expect-when-johnson-johnson-unveils-q4-performance-this-month-1031103799
2488.0,1/14/2022 5:48:39 PM,AstraZeneca COVID-19 vaccine linked to rare spinal condition - European regulator,Seeking Alpha,https://seekingalpha.com/news/3788370-astrazeneca-covid-19-vaccine-linked-to-rare-spinal-condition-european-regulator?utm_source=markets.businessinsider.com&utm_medium=referral
2489.0,1/14/2022 6:18:54 PM,Johnson & Johnson set to hear bankruptcy ruling for talc claims by Feb. 28,Seeking Alpha,https://seekingalpha.com/news/3788379-johnson-johnson-set-to-hear-bankruptcy-ruling-for-talc-claims-by-feb-28?utm_source=markets.businessinsider.com&utm_medium=referral
2490.0,1/14/2022 8:35:57 PM,Novavax Still Has Not Received an FDA EUA as the Market Waits,InvestorPlace,/news/stocks/nvax-stock-could-be-a-buy-here-before-the-fda-eua-for-its-vaccine-1031104155
2491.0,1/20/2022 3:10:01 PM,CDC study finds prior infection provides better immunity against COVID than vaccines,Seeking Alpha,https://seekingalpha.com/news/3789643-cdc-report-finds-prior-infection-provides-better-immunity-against-covid-than-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral
2492.0,1/20/2022 8:33:40 PM,7 Bull Market Stocks to Buy for a Continued Run Higher in 2022¬†,InvestorPlace,/news/stocks/7-bull-market-stocks-to-buy-for-a-continued-run-higher-in-2022-1031117463
2493.0,1/21/2022 7:04:31 PM,Judge blocks Biden mandate requiring COVID vaccination for federal employees,Seeking Alpha,https://seekingalpha.com/news/3790408-judge-blocks-biden-mandate-requiring-covid-vaccination-for-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral
2494.0,1/21/2022 7:42:11 PM,Worldwide Adoption of Novavax Vaccines Makes It a Winner,InvestorPlace,/news/stocks/worldwide-adoption-of-nvax-stock-vaccines-makes-it-a-winner-1031119838
2495.0,1/24/2022 3:41:46 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3790744-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
2496.0,1/24/2022 4:25:26 PM,"AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine",Seeking Alpha,https://seekingalpha.com/news/3790763-astrazeneca-pfizer-biontech-or-jj-shots-found-to-boost-effect-of-sinovac-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral
2497.0,1/24/2022 5:07:29 PM,"Omicron blunts rise in vaccine sales for 2022, health analytics firm says",Seeking Alpha,https://seekingalpha.com/news/3790796-omicron-blunts-rise-in-vaccine-sales-for-2022-health-analytics-firm-says?utm_source=markets.businessinsider.com&utm_medium=referral
2498.0,1/24/2022 5:58:07 PM,All eyes on J&J Q4 results with new CEO and plans of company split,Seeking Alpha,https://seekingalpha.com/news/3790850-all-eyes-on-jj-q4-results-with-new-ceo-and-plans-of-company-split?utm_source=markets.businessinsider.com&utm_medium=referral
2499.0,1/25/2022 8:16:59 AM,New York judge blocks statewide mask mandate - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791053-new-york-judge-blocks-statewide-mask-mandate-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2500.0,1/25/2022 11:31:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M",Seeking Alpha,https://seekingalpha.com/news/3791095-johnson-and-johnson-non-gaap-eps-of-2_13-beats-0_01-revenue-of-24_8b-misses-490m?utm_source=markets.businessinsider.com&utm_medium=referral
2501.0,1/25/2022 12:17:12 PM,Johnson & Johnson down 2% on top-line miss; FY22 guidance tops consensus,Seeking Alpha,https://seekingalpha.com/news/3791124-johnson-johnson-down-2-on-top-line-miss-fy22-guidance-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
2502.0,1/25/2022 12:25:00 PM,Johnson & Johnson Reports Q4 and Full-Year 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q4-and-full-year-2021-results-1031125670
2503.0,1/25/2022 12:30:17 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1031125675
2504.0,1/25/2022 12:59:24 PM,Johnson & Johnson Projects 2022 Adj. Operational EPS Growth Of 9.2% ,RTTNews,/news/stocks/johnson-johnson-projects-2022-adj-operational-eps-growth-of-9-2-1031125779
2505.0,1/25/2022 1:46:12 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-starts-omicron-specific-vaccine-study-j-j-misses-on-topline-sierra-oncology-reports-positive-data-1031126033
2506.0,1/25/2022 2:21:16 PM,Genmab announces Darzalex 2021 sales rise 43.8% Y/Y,Seeking Alpha,https://seekingalpha.com/news/3791243-genmab-announces-darzalex-2021-sales-rise-438-yy?utm_source=markets.businessinsider.com&utm_medium=referral
2507.0,1/25/2022 2:26:33 PM,"Stocks to Watch Tuesday: What‚Äôs Moving VZ, JNJ, GE, IBM and MMM Today",InvestorPlace,/news/stocks/stocks-to-watch-tuesday-whats-moving-vz-jnj-ge-ibm-and-mmm-today-1031126757
2508.0,1/25/2022 3:01:13 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1031126392
2509.0,1/25/2022 4:05:21 PM,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views,Benzinga,/news/stocks/mid-morning-market-update-markets-open-lower-johnson-johnson-sales-miss-views-1031126925
2510.0,1/25/2022 5:21:17 PM,OSHA withdraws private employee vaccine mandate following Supreme Court ruling,Seeking Alpha,https://seekingalpha.com/news/3791386-osha-withdraws-private-employee-vaccine-mandate-following-supreme-court-ruling?utm_source=markets.businessinsider.com&utm_medium=referral
2511.0,1/25/2022 6:14:35 PM,Mid-Day Market Update: Nasdaq Tumbles 300 Points; Sierra Oncology Shares Jump,Benzinga,/news/stocks/mid-day-market-update-nasdaq-tumbles-300-points-sierra-oncology-shares-jump-1031127368
2512.0,1/25/2022 6:50:12 PM,Biopharmas need to personalize engagement in competitive oncology landscape - Accenture,Seeking Alpha,https://seekingalpha.com/news/3791441-biopharmas-need-to-personalize-engagement-in-competitive-oncology-landscape-accenture?utm_source=markets.businessinsider.com&utm_medium=referral
2513.0,1/25/2022 8:30:27 PM,Mid-Afternoon Market Update: Dow Turns Higher; General Electric Shares Slide,Benzinga,/news/stocks/mid-afternoon-market-update-dow-turns-higher-general-electric-shares-slide-1031127641
2514.0,1/25/2022 9:07:36 PM,Uncertain Market Conditions And Good News Make Novavax A Cautious Buy,InvestorPlace,/news/stocks/uncertain-market-conditions-and-good-news-make-novavax-a-cautious-buy-1031127797
2515.0,1/25/2022 10:11:19 PM,"4 Top Stock Trades for Wednesday: S&P 500, XOM, DOGE, JNJ",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-sp-500-xom-doge-jnj-1031127979
2516.0,1/26/2022 5:59:16 AM,New York mask mandate temporarily restored by Appeals Court judge - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791615-new-york-mask-mandate-temporarily-restored-by-appeals-court-judge-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2517.0,1/26/2022 1:36:25 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1031130439
2518.0,1/26/2022 3:51:12 PM,Denmark and Austria become latest European countries to lift COVID restrictions,Seeking Alpha,https://seekingalpha.com/news/3791864-denmark-and-austria-become-latest-european-countries-to-lift-covid-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral
2519.0,1/26/2022 9:09:20 PM,Galapagos ropes in former J&J science chief Paul Stoffels as CEO,Seeking Alpha,https://seekingalpha.com/news/3792070-galapagos-ropes-in-paul-stoffels-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral
2520.0,1/27/2022 7:48:36 AM,Two-thirds of Omicron COVID cases are reinfections: English study,Seeking Alpha,https://seekingalpha.com/news/3792249-two-thirds-of-omicron-covid-cases-are-reinfections-english-study?utm_source=markets.businessinsider.com&utm_medium=referral
2521.0,1/27/2022 11:47:08 AM,Most U.S. local governments join opioid deal with J&J and drug distributors,Seeking Alpha,https://seekingalpha.com/news/3792302-most-us-local-governments-join-opioid-deal-with-jj-and-drug-distributors?utm_source=markets.businessinsider.com&utm_medium=referral
2522.0,1/27/2022 1:57:50 PM,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-appoints-j-j-exec-as-ceo-aridis-gets-funding-for-antiviral-treatment-moderna-starts-omicron-specific-booster-study-1031135162
2523.0,1/27/2022 2:01:54 PM,MeiraGTx secures $30M milestone from Janssen under gene therapies collaboration,Seeking Alpha,https://seekingalpha.com/news/3792460-meiragtx-secures-30m-milestone-from-janssen-under-gene-therapies-collaboration?utm_source=markets.businessinsider.com&utm_medium=referral
2524.0,1/27/2022 3:56:38 PM,Galapagos at a six-month high after naming former J&J science chief as CEO,Seeking Alpha,https://seekingalpha.com/news/3792569-galapagos-at-a-six-month-high-after-naming-former-jj-science-chief-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral
2525.0,1/27/2022 7:04:30 PM,"Inflation - what have we learned from earnings so far, and which stocks could benefit",Seeking Alpha,https://seekingalpha.com/news/3792652-inflation-what-have-we-learned-from-earnings-so-far-and-who-could-benefit?utm_source=markets.businessinsider.com&utm_medium=referral
2526.0,1/27/2022 11:28:00 PM,Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-citi-s-2022-virtual-healthcare-conference-1031137355
2527.0,1/28/2022 7:00:54 AM,COVID-19 boosters give 95% protection from death due to Omicron in people over 50: UKHSA,Seeking Alpha,https://seekingalpha.com/news/3792885-covid-19-boosters-gives-95-protection-from-death-due-to-omicron-in-people-over-50-ukhsa?utm_source=markets.businessinsider.com&utm_medium=referral
2528.0,1/28/2022 8:40:11 AM,CDC study finds third dose of COVID-19 vaccine reduce risk of hospitalizations in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3792890-cdc-study-finds-third-dose-of-covid-19-vaccine-reduce-risk-of-hospitalizations-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral
2529.0,1/28/2022 5:05:31 PM,Novavax Could Be the Biggest Bargain in the Market Right Now,InvestorPlace,/news/stocks/nvax-stock-could-be-biggest-bargain-in-the-market-right-now-1031140035
2530.0,1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625
2531.0,1/29/2022 9:00:00 PM,"Vaccines to dominate pharma sales this year, but Bristol could have most best-sellers",Seeking Alpha,https://seekingalpha.com/news/3793190-vaccines-to-have-highest-pharma-sales-this-year-but-bristol-could-have-most-best-sellers?utm_source=markets.businessinsider.com&utm_medium=referral
2532.0,1/31/2022 11:40:24 AM,"Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target",Benzinga,/news/stocks/kaleido-halts-upcoming-phase-2-copd-trial-piper-sandler-cuts-price-target-1031143668
2533.0,1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306
2534.0,2/1/2022 11:00:48 AM,7 Stocks to Watch in This Current Earnings Season,InvestorPlace,/news/stocks/7-stocks-to-watch-in-this-current-earnings-season-aal-sq-nvax-panw-pins-tgt-wday-1031148366
2535.0,2/1/2022 2:23:56 PM,ViiV Healthcare announces FDA approval of two-month dosing of Cabenuva for HIV,Seeking Alpha,https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv?utm_source=markets.businessinsider.com&utm_medium=referral
2536.0,2/1/2022 3:29:20 PM,WHO: Omicron subvariant BA.2 not more severe than original variant,Seeking Alpha,https://seekingalpha.com/news/3794130-who-omicron-subvariant-ba2-not-more-severe-than-original-variant?utm_source=markets.businessinsider.com&utm_medium=referral
2537.0,2/1/2022 4:51:04 PM,WHO warns on lifting COVID curbs quickly as many countries have not reached Omicron peak,Seeking Alpha,https://seekingalpha.com/news/3794208-who-warns-on-lifting-covid-curbs-as-many-countries-have-not-reached-omicron-peak?utm_source=markets.businessinsider.com&utm_medium=referral
2538.0,2/1/2022 5:39:58 PM,"Johnson & Johnson, drug distributors in $590M deal with U.S. tribes to settle opioid claims",Seeking Alpha,https://seekingalpha.com/news/3794268-johnson-johnson-drug-distributors-in-590m-deal-with-us-tribes-to-settle-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral
2539.0,2/2/2022 4:35:37 PM,GOOG vs. GOOGL: Everything You Need to Know About the Google Stock Split,InvestorPlace,/news/stocks/goog-googl-stock-split-google-stock-split-1030992513
2540.0,2/2/2022 9:13:21 PM,"Avoid Novavax for Now, Until the Picture Clears Up",InvestorPlace,/news/stocks/avoid-novavax-for-now-until-the-picture-clears-up-1031155602
2541.0,2/2/2022 11:22:25 PM,J&J to record $610M impairment charge from terminating development of therapy,Seeking Alpha,https://seekingalpha.com/news/3795276-johnson-johnson-to-record-610m-impairment-charge-from-terminating-development-of-therapy?utm_source=markets.businessinsider.com&utm_medium=referral
2542.0,2/3/2022 2:07:09 PM,Johnson & Johnson‚Äôs Jannsen unit in pact with Mersana for antibody-drug conjugates,Seeking Alpha,https://seekingalpha.com/news/3795540-johnson-johnsons-jannsen-unit-in-pact-with-mersana-for-antibody-drug-conjugates?utm_source=markets.businessinsider.com&utm_medium=referral
2543.0,2/3/2022 2:13:03 PM,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",Benzinga,/news/stocks/the-daily-biotech-pulse-big-pharma-earnings-prove-lackluster-mersana-inks-1b-adc-r-d-deal-syros-gets-orphan-drug-designation-1031158702
2544.0,2/3/2022 7:39:45 PM,Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets,Benzinga,/news/stocks/janssen-inks-over-1b-pact-for-mersana-s-adc-technology-in-three-targets-1031160035
2545.0,2/4/2022 9:34:01 PM,"J&J hatched plan, ""Project Plato,"" to stem payouts in talc lawsuits: Reuters",Seeking Alpha,https://seekingalpha.com/news/3796255-johnson-johnson-hatched-plan-project-plato-to-stem-payouts-in-talc-lawsuits-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2546.0,2/7/2022 3:20:50 PM,"Teva in $225 million opioid deal with Texas, Attorney General says",Seeking Alpha,https://seekingalpha.com/news/3796575-teva-in-225-million-opioid-deal-with-texas-attorney-general-says?utm_source=markets.businessinsider.com&utm_medium=referral
2547.0,2/7/2022 10:51:00 PM,Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cowen-42nd-annual-health-care-virtual-conference-1031168722
2548.0,2/8/2022 4:10:30 PM,J&J shut production of COVID vaccine at only plant making usable batches - NY Times,Seeking Alpha,https://seekingalpha.com/news/3797306-johnson-johnson-shut-production-of-covid-vaccine-at-only-plant-making-usable-batches-ny-times?utm_source=markets.businessinsider.com&utm_medium=referral
2549.0,2/8/2022 7:58:13 PM,Take a Leap Into Novavax Stock After Vaccine Sales Start,InvestorPlace,/news/stocks/take-a-leap-into-nvax-stock-after-vaccine-sales-start-1031173149
2550.0,2/8/2022 9:18:39 PM,"J&J Stops Production Of Its COVID-19 Vaccine, Says NYT ",RTTNews,/news/stocks/j-j-stops-production-of-its-covid-19-vaccine-says-nyt-1031173174
2551.0,2/9/2022 10:28:00 PM,Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-raymond-james-43rd-annual-institutional-investors-conference-1031178736
2552.0,2/10/2022 11:48:15 AM,Teva eyes up to $3.6 billion to settle opioid claims - Reuters,Seeking Alpha,https://seekingalpha.com/news/3798416-teva-stock-lower-as-company-eyes-up-to-36-billion-to-settle-opioid-claims-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2553.0,2/10/2022 4:14:05 PM,J&J single-shot COVID vaccine has only ~53% efficacy based on final analysis,Seeking Alpha,https://seekingalpha.com/news/3798678-johnson-johnson-single-shot-vaccine-covid-has-only-53-efficacy-based-on-final-analysis?utm_source=markets.businessinsider.com&utm_medium=referral
2554.0,2/11/2022 9:50:14 AM,Purdue's Sacklers mulling to add extra $1B in opioid settlement - Bloomberg News,Seeking Alpha,https://seekingalpha.com/news/3799037-purdues-sacklers-mulling-to-add-extra-1b-in-opioid-settlement-bloomberg-news?utm_source=markets.businessinsider.com&utm_medium=referral
2555.0,2/11/2022 1:52:42 PM,Legend Biotech hits two milestones under its deal with Janssen for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3799161-jnj-stock-down-as-legend-biotech-wins-milestones-under-car-t-deal?utm_source=markets.businessinsider.com&utm_medium=referral
2556.0,2/11/2022 8:00:38 PM,"Catalyst watch for next week: Spotlight on Nvidia, Intel, 3M, Mattel and Stablecoins",Seeking Alpha,https://seekingalpha.com/news/3799300-catalyst-watch-for-next-week-spotlight-on-nvidia-intel-3m-mattel-and-stablecoins?utm_source=markets.businessinsider.com&utm_medium=referral
2557.0,2/12/2022 9:00:00 PM,Cassava Sciences citizen petition saga shines light on alleged abuse of FDA program,Seeking Alpha,https://seekingalpha.com/news/3799281-cassava-sciences-citizen-petition-saga-shines-light-on-alleged-abuse-of-fda-program?utm_source=markets.businessinsider.com&utm_medium=referral
2558.0,2/14/2022 11:00:23 AM,7 Defensive Growth Stocks to Buy for February,InvestorPlace,/news/stocks/7-defensive-growth-stocks-to-buy-for-february-1031191037
2559.0,2/14/2022 1:31:39 PM,Cidara announces FDA acceptance of its request to study the flu candidate,Seeking Alpha,https://seekingalpha.com/news/3799514-cidara-announces-fda-acceptance-of-its-request-to-study-the-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
2560.0,2/14/2022 3:22:44 PM,COVID-19 vaccine makers decline after delay for FDA decision on vaccines for kids,Seeking Alpha,https://seekingalpha.com/news/3799593-covid-19-vaccine-makers-decline-after-delay-for-fda-decision-on-vaccines-for-kids?utm_source=markets.businessinsider.com&utm_medium=referral
2561.0,2/14/2022 7:29:44 PM,7 Dividend Aristocrats That Could Outpace This Volatile Market,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-could-outpace-this-volatile-market-1031192576
2562.0,2/15/2022 2:14:27 PM,J&J says bankruptcy is best way to resolve talc claims in trial,Seeking Alpha,https://seekingalpha.com/news/3800089-johnson-johnson-says-bankruptcy-is-best-way-to-resolve-talc-claims-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral
2563.0,2/15/2022 8:06:26 PM,The Best Russell 2000 Stocks to Buy Before they Rebound,InvestorPlace,/news/stocks/the-best-russell-2000-stocks-to-buy-before-they-rebound-1031197231
2564.0,2/15/2022 8:54:13 PM,AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial,Benzinga,/news/stocks/ac-immune-janssen-partnered-alzheimer-s-vaccine-shows-tau-specific-antibodies-in-early-stage-trial-1031197200
2565.0,2/15/2022 10:30:00 PM,"Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors",PR Newswire,/news/stocks/johnson-johnson-names-darius-adamczyk-chairman-and-chief-executive-officer-of-honeywell-to-its-board-of-directors-1031197406
2566.0,2/16/2022 10:57:17 AM,AstraZeneca COVID vaccine short shelf life complicates roll out in poor nations - Reuters,Seeking Alpha,https://seekingalpha.com/news/3800550-astrazeneca-covid-vaccine-short-shelf-life-complicates-roll-out-in-poor-nations-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
2567.0,2/16/2022 3:39:01 PM,3 Desirable Drug Stocks With Very Promising Pipelines,InvestorPlace,/news/stocks/3-desirable-drug-stocks-with-very-promising-pipelines-1031201417
2568.0,2/16/2022 6:31:52 PM,Johnson & Johnson's talc cases bankruptcy strategy attacked by Sen. Durbin,Seeking Alpha,https://seekingalpha.com/news/3800910-johnson-johnson-talc-cases-bankruptcy-strategy-attacked-by-sen-durbin?utm_source=markets.businessinsider.com&utm_medium=referral
2569.0,2/16/2022 6:57:55 PM,Novavax Stock Is at Risk Despite Positive Poll Results,InvestorPlace,/news/stocks/nvax-stock-is-at-risk-despite-positive-poll-results-1031201978
2570.0,2/17/2022 12:40:36 PM,"DaVita study suggests J&J, Pfizer/BioNTech COVID vaccines at parity for kidney patients",Seeking Alpha,https://seekingalpha.com/news/3801363-davita-study-suggests-jj-pfizerbiontech-covid-vaccines-at-parity-for-kidney-patients?utm_source=markets.businessinsider.com&utm_medium=referral
2571.0,2/17/2022 12:57:47 PM,Johnson & Johnson‚Äôs Janssen unit and Remix Therapeutics strikes deal valued at up to $1B,Seeking Alpha,https://seekingalpha.com/news/3801376-johnson-johnsons-janssen-unit-and-remix-therapeutics-strikes-deal-valued-at-up-to-1b?utm_source=markets.businessinsider.com&utm_medium=referral
2572.0,2/17/2022 2:00:05 PM,"The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-unit-announces-research-collaboration-with-remix-regencell-touts-covid-data-decision-day-for-agios-1031204785
2573.0,2/17/2022 3:07:36 PM,J&J says it may raise $2B settlement offer for talc cases - WSJ,Seeking Alpha,https://seekingalpha.com/news/3801476-johnson-johnson-says-it-may-raise-2b-settlement-offer-for-talc-cases-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
2574.0,2/18/2022 9:46:54 AM,GSK pauses trials of RSV vaccine in pregnant women,Seeking Alpha,https://seekingalpha.com/news/3801834-gsk-pauses-trials-of-rsv-vaccine-in-pregnant-women?utm_source=markets.businessinsider.com&utm_medium=referral
2575.0,2/18/2022 4:03:41 PM,Ocugen Stock Is a Fairy Tale in Need of a Happy Ending,InvestorPlace,/news/stocks/ocgn-stock-is-a-fairy-tale-in-need-of-a-happy-ending-1031209187
2576.0,2/18/2022 4:14:58 PM,7 Low Volatility Stocks to Buy to Escape Wild Market Swings,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-to-escape-the-wild-market-swings-1031209185
2577.0,2/18/2022 4:19:05 PM,Johnson & Johnson‚Äôs Janssen unit posts 48-week data for Tremfya in Crohn‚Äôs disease,Seeking Alpha,https://seekingalpha.com/news/3801991-johnson-johnsons-janssen-unit-posts-48-week-data-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral
2578.0,2/22/2022 6:53:11 PM,J&J argues plaintiffs' attorneys don't support talc bankruptcy plan over more money,Seeking Alpha,https://seekingalpha.com/news/3802738-johnson-johnson-argues-plaintiffs-attorneys-dont-support-talc-bankruptcy-plan-over-more-money?utm_source=markets.businessinsider.com&utm_medium=referral
2579.0,2/23/2022 8:29:25 PM,How might a Sanofi-GSK COVID vaccine compete against mRNA shots?,Seeking Alpha,https://seekingalpha.com/news/3804505-how-might-a-sanofi-gsk-covid-vaccine-compete-against-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2580.0,2/25/2022 2:17:56 PM,Johnson & Johnson to pay $5B as part of landmark opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3805932-johnson-johnson-to-pay-5b-as-part-of-landmark-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral
2581.0,2/25/2022 4:46:48 PM,Healthcare leads a rally in S&P 500 amid hopes of Russia - Ukraine talks,Seeking Alpha,https://seekingalpha.com/news/3806014-healthcare-leads-a-rally-in-sp-500-amid-hopes-of-russia-ukraine-talks?utm_source=markets.businessinsider.com&utm_medium=referral
2582.0,2/25/2022 4:56:18 PM,Johnson & Johnson given go-ahead for bankruptcy strategy on talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3806018-johnson-johnson-given-go-ahead-for-bankruptcy-strategy-on-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral
2583.0,2/25/2022 11:47:08 PM,J&J Bankruptcy Ploy Upheld By NJ Court ,RTTNews,/news/stocks/j-j-bankruptcy-ploy-upheld-by-nj-court-1031233558
2584.0,2/27/2022 3:26:47 PM,"The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-27-march-5-earnings-multiple-regulatory-decisions-take-the-spotlight-1031235310
2585.0,3/1/2022 12:22:00 PM,"Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease",PR Newswire,/news/stocks/pathalys-pharma-inc-launches-with-mission-to-address-high-priority-needs-in-chronic-kidney-disease-1031242156
2586.0,3/1/2022 1:51:14 PM,"The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution",Benzinga,/news/stocks/the-daily-biotech-pulse-legend-biotech-cti-biopharma-receive-fda-approvals-abbvie-announces-delay-in-skyrizi-review-editas-gains-on-crispr-patent-resolution-1031242590
2587.0,3/2/2022 2:01:03 PM,J&J Acuvue Theravision with Ketotifen contact lens gets FDA nod to prevent eye itch,Seeking Alpha,https://seekingalpha.com/news/3808423-jj-acuvue-theravision-with-ketotifen-contact-lens-gets-fda-nod-to-prevent-eye-itch?utm_source=markets.businessinsider.com&utm_medium=referral
2588.0,3/2/2022 5:02:09 PM,White House COVID pandemic plan aims to ease return to normalcy,Seeking Alpha,https://seekingalpha.com/news/3808551-white-house-covid-pandemic-plan-aims-to-ease-return-to-normalcy?utm_source=markets.businessinsider.com&utm_medium=referral
2589.0,3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946
2590.0,3/3/2022 3:57:17 PM,U.S. to share government-backed COVID-19 tech with WHO - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3809199-us-to-share-government-backed-covid-19-tech-with-who-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral
2591.0,3/3/2022 6:10:33 PM,7 Funds to Buy to Sidestep the Stock Market Volatility,InvestorPlace,/news/stocks/7-funds-to-buy-to-sidestep-the-stock-market-volatility-1031252665
2592.0,3/3/2022 7:24:40 PM,"Purdue Pharma, Sacklers reach new $6B opioid settlement with states",Seeking Alpha,https://seekingalpha.com/news/3809272-purdue-pharma-sacklers-reach-new-6b-opioid-settlement-with-states?utm_source=markets.businessinsider.com&utm_medium=referral
2593.0,3/4/2022 1:48:11 PM,Humanigen gains as CEO more than doubles stake,Seeking Alpha,https://seekingalpha.com/news/3809582-hgen-stock-gains-as-ceo-more-than-doubles-stake?utm_source=markets.businessinsider.com&utm_medium=referral
2594.0,3/4/2022 2:09:47 PM,90% of U.S. counties experiencing low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3809592-90-of-us-counties-experiencing-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral
2595.0,3/4/2022 4:31:07 PM,"New York City to lift indoor vaccine mandate, school mask requirement on Monday",Seeking Alpha,https://seekingalpha.com/news/3809678-new-york-city-to-lift-indoor-vaccine-mandate-school-mask-requirement-on-monday?utm_source=markets.businessinsider.com&utm_medium=referral
2596.0,3/6/2022 12:16:50 PM,Johnson & Johnson is in talks for biotech deals in China - FT,Seeking Alpha,https://seekingalpha.com/news/3809928-johnson-johnson-is-in-talks-for-biotech-deals-in-china-ft?utm_source=markets.businessinsider.com&utm_medium=referral
2597.0,3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral
2598.0,3/8/2022 4:26:46 PM,Johnson & Johnson inks deal with Aspen as COVID-19 vaccine makers focus on Africa,Seeking Alpha,https://seekingalpha.com/news/3810690-johnson-johnson-inks-deal-with-aspen-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2599.0,3/8/2022 8:58:16 PM,Mediators appointed in J&J bankruptcy talc case to determine amount of trust fund,Seeking Alpha,https://seekingalpha.com/news/3810788-mediators-appointed-in-johnson-johnson-bankruptcy-talc-case-to-determine-amount-of-trust-fund?utm_source=markets.businessinsider.com&utm_medium=referral
2600.0,3/9/2022 1:52:45 PM,"The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-begins-late-stage-pediatric-covid-pill-study-midatech-and-j-j-unit-expand-r-d-collaboration-abbvie-alvotech-settle-humira-dispute-1031266063
2601.0,3/9/2022 3:37:30 PM,DoJ bankruptcy arm raises concerns with potential Purdue opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3811173-doj-bankruptcy-arm-raises-concerns-with-potential-purdue-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral
2602.0,3/10/2022 12:35:12 PM,7 Drug Stocks to Consider After the Viatris Plunge,InvestorPlace,/news/stocks/7-drug-stocks-to-consider-after-the-viatris-plunge-abbv-bmy-gsk-vtrs-jnj-teva-pfe-nvs-mrk-1031269941
2603.0,3/10/2022 5:10:40 PM,J&J extends R&D collaboration with Midatech Pharma on second molecule,Seeking Alpha,https://seekingalpha.com/news/3812267-johnson-johnson-extends-research-development-collaboration-with-midatech-pharma-on-second-molecule?utm_source=markets.businessinsider.com&utm_medium=referral
2604.0,3/10/2022 7:41:24 PM,Is Roblox Stock a Game Bulls Want to Play?,InvestorPlace,/news/stocks/is-roblox-stock-a-game-bulls-want-to-play-1031271555
2605.0,3/11/2022 3:25:40 PM,More than 98% of U.S. in areas with low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3812745-more-than-98-of-us-in-areas-with-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral
2606.0,3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral
2607.0,3/14/2022 2:50:43 PM,"Vaccine makers on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-vaccine-makers-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral
2608.0,3/14/2022 3:10:39 PM,"Moderna, BioNTech on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-moderna-biontech-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral
2609.0,3/14/2022 3:49:29 PM,"J&J, drug distributors draw lawmaker scrutiny over tax benefits linked to opioid deals",Seeking Alpha,https://seekingalpha.com/news/3813166-jj-drug-distributors-draw-lawmaker-scrutiny-on-tax-benefits-for-opioid-deals?utm_source=markets.businessinsider.com&utm_medium=referral
2610.0,3/15/2022 1:20:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1031281088
2611.0,3/16/2022 2:29:24 PM,JNJ's DePuy Synthes adds 2 products to ATTUNE knee restoration portfolio,Seeking Alpha,https://seekingalpha.com/news/3814128-jnjs-unit-depuy-synthes-adds-new-technologies-to-attune-knee-restoration-portfolio?utm_source=markets.businessinsider.com&utm_medium=referral
2612.0,3/16/2022 4:05:40 PM,J&J downgraded to market perform at Bernstein on 'uphill battle' for Janssen,Seeking Alpha,https://seekingalpha.com/news/3814195-johnson-johnson-downgraded-to-market-perform-at-bernstein-on-uphill-battle-for-janssen?utm_source=markets.businessinsider.com&utm_medium=referral
2613.0,3/16/2022 4:07:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-16-2022-1031285835
2614.0,3/16/2022 4:08:51 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031285834
2615.0,3/16/2022 4:15:15 PM,Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today,InvestorPlace,/news/stocks/wednesday-top-stock-news-8-analyst-upgrades-and-downgrades-today-1031286037
2616.0,3/16/2022 4:47:17 PM,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,Benzinga,/news/stocks/protagonist-therapeutics-earns-25m-milestone-payment-from-janssen-biotech-1031285958
2617.0,3/16/2022 5:30:02 PM,Genmab upgraded at UBS; says ‚Äúmost of the pipeline is for free‚Äù,Seeking Alpha,https://seekingalpha.com/news/3814233-genmab-upgraded-at-ubs-says-most-of-the-pipeline-is-for-free?utm_source=markets.businessinsider.com&utm_medium=referral
2618.0,3/16/2022 6:03:19 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031286197
2619.0,3/17/2022 5:58:59 PM,AstraZeneca ready to drop plans for U.S. regulatory approval of COVID-19 shot - FT,Seeking Alpha,https://seekingalpha.com/news/3814697-astrazeneca-to-drop-plans-for-us-regulatory-approval-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2620.0,3/18/2022 11:59:11 AM,7 Stagflation Stocks to Buy to Combat Slow Growth and Inflation,InvestorPlace,/news/stocks/7-stagflation-stocks-to-buy-to-combat-slow-growth-and-inflation-1031291619
2621.0,3/21/2022 1:40:24 PM,FDA to hold AdCom meeting on COVID-19 booster shots next month,Seeking Alpha,https://seekingalpha.com/news/3815361-pfx-bntx-mrna-stocks-gain-on-adcom-meeting-on-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2622.0,3/22/2022 4:53:13 PM,COVID Omicron subvariant BA.2 accounts for growing share of new cases in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3816112-covid-omicron-subvariant-ba2-accounts-for-growing-share-of-new-cases-in-the-us-cdc?utm_source=markets.businessinsider.com&utm_medium=referral
2623.0,3/22/2022 11:06:45 PM,7 Reddit Stocks Likely to Withstand Any Recession in 2022,InvestorPlace,/news/stocks/7-reddit-stocks-likely-to-withstand-any-recession-in-2022-1031299733
2624.0,3/23/2022 8:25:14 AM,U.S. weighs fourth booster as BA.2 subvariant threatens next COVID wave,Seeking Alpha,https://seekingalpha.com/news/3816282-us-weighs-fourth-booster-as-ba2-subvariant-threatens-next-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral
2625.0,3/23/2022 12:43:16 PM,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-positive-ulcerative-colitis-study-data-novavax-covid-shot-authorized-for-adolescents-in-india-argenx-stock-sale-1031301077
2626.0,3/23/2022 5:36:32 PM,White House mulls fourth COVID-19 shot for older Americans - Politico,Seeking Alpha,https://seekingalpha.com/news/3816601-white-house-mulls-fourth-covid-19-shot-for-older-americans-politico?utm_source=markets.businessinsider.com&utm_medium=referral
2627.0,3/25/2022 3:29:01 AM,ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva ,RTTNews,/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584
2628.0,3/25/2022 7:00:23 PM,"Catalyst watch: Tesla deliveries, XPeng earnings, Five Below event and Netflix at the Oscars",Seeking Alpha,https://seekingalpha.com/news/3817588-catalyst-watch-for-next-week-tesla-deliveries-xpeng-earnings-and-netflix-at-the-oscars?utm_source=markets.businessinsider.com&utm_medium=referral
2629.0,3/29/2022 2:53:29 PM,J&J to suspend supply of personal care products in Russia,Seeking Alpha,https://seekingalpha.com/news/3818471-jj-to-suspend-supply-of-personal-care-products-in-russia?utm_source=markets.businessinsider.com&utm_medium=referral
2630.0,3/29/2022 7:55:34 PM,Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated),Seeking Alpha,https://seekingalpha.com/news/3818472-pfizerbiontech-and-moderna-granted-fda-ok-for-second-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral
2631.0,3/29/2022 8:11:57 PM,"Ukraine War Update: European ETFs rise, U.S. agriculture stocks fall amid peace talks",Seeking Alpha,https://seekingalpha.com/news/3818236-ukraine-war-update?utm_source=markets.businessinsider.com&utm_medium=referral
2632.0,3/30/2022 10:23:32 AM,Novavax Stock Is a Bet on Interest From Unvaccinated People,InvestorPlace,/news/stocks/novavax-stock-is-a-bet-on-interest-from-unvaccinated-people-1031318249
2633.0,3/30/2022 1:46:42 PM,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-s-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on-positive-covid-antibody-data-amylyx-awaits-adcom-verdict-1031318540
2634.0,3/30/2022 9:38:30 PM,"CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report",Benzinga,/news/stocks/cvs-health-teva-settle-florida-state-s-opioid-related-claims-report-1031320117
2635.0,3/31/2022 1:53:04 PM,Cidara doses first group in phase 1 trial of CD388 for treating/preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3819296-cidara-therapeutics-doses-first-cohort-of-volunteers-in-phase-1-trial-of-antiviral-cd388?utm_source=markets.businessinsider.com&utm_medium=referral
2636.0,4/1/2022 10:37:35 AM,World's 1st COVID human challenge trial suggests spread of virus not correlated to symptoms,Seeking Alpha,https://seekingalpha.com/news/3819725-worlds-1st-covid-human-challenge-trial-suggests-spread-of-virus-not-correlated-to-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral
2637.0,4/1/2022 12:56:59 PM,Cidara gains on dosing milestone in early-stage trial for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3819826-cdtx-stock-gains-on-dosing-milestone-in-early-stage-trial-for-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral
2638.0,4/1/2022 8:02:24 PM,How to Approach Trading Downtrodden Novavax Today,InvestorPlace,/news/stocks/how-to-approach-trading-downtrodden-novavax-nvax-stock-today-1031327433
2639.0,4/1/2022 10:00:43 PM,3 Low-Risk Mutual Funds to Buy for Volatile Times,InvestorPlace,/news/stocks/3-low-risk-mutual-funds-to-buy-for-volatile-times-1031327542
2640.0,4/3/2022 4:19:55 PM,"10 Investor Questions About COVID-19, Answered",Benzinga,/news/stocks/10-investor-questions-about-covid-19-answered-1031328140
2641.0,4/4/2022 11:01:54 AM,DYAI: 2021 Results,Benzinga,/news/stocks/dyai-2021-results-1031329197
2642.0,4/4/2022 12:23:32 PM,Johnson & Johnson's Rybrevant gets conditional approval in Canada for lung cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3820309-johnson-johnsons-rybrevant-gets-conditional-approval-in-canada-for-lung-cancer-subtype?utm_source=markets.businessinsider.com&utm_medium=referral
2643.0,4/4/2022 9:00:38 PM,Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated),Seeking Alpha,https://seekingalpha.com/news/3820489-lawmakers-set-to-announce-10-billion-additional-funding-for-us-covid-response?utm_source=markets.businessinsider.com&utm_medium=referral
2644.0,4/4/2022 9:09:14 PM,"West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters",Benzinga,/news/stocks/west-virginia-says-j-j-teva-abbvie-caused-tsunami-of-opioid-addiction-reuters-1031331125
2645.0,4/4/2022 9:17:18 PM,Moderna CEO predicts many people will eventually get annual COVID shots,Seeking Alpha,https://seekingalpha.com/news/3820563-moderna-ceo-predicts-many-people-will-eventually-get-annual-covid-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2646.0,4/5/2022 3:32:39 PM,3 Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/3-vanguard-etfs-to-buy-now-1031333971
2647.0,4/5/2022 9:37:56 PM,MindMed Appoints Francois Lilienthal As New CCO,Benzinga,/news/stocks/mindmed-appoints-francois-lilienthal-as-new-cco-1031334555
2648.0,4/6/2022 4:44:05 PM,Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection,InvestorPlace,/news/stocks/is-nvax-stock-a-buy-at-52-week-low-skip-the-novavax-portfolio-injection-1031337591
2649.0,4/6/2022 5:57:27 PM,Royalty Pharma upgraded at Morgan Stanley on valuation,Seeking Alpha,https://seekingalpha.com/news/3821323-rprx-stock-gains-on-morgan-stanley-upgrade?utm_source=markets.businessinsider.com&utm_medium=referral
2650.0,4/7/2022 1:37:39 PM,Dear Biotech Investors: Novavax‚Äôs Comparable Vaccine Matters,InvestorPlace,/news/stocks/nvax-stock-dear-biotech-investors-novavaxs-comparable-vaccine-matters-1031340330
2651.0,4/7/2022 10:30:00 PM,Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bofa-securities-2022-healthcare-conference-1031341306
2652.0,4/8/2022 1:52:26 PM,"The Daily Biotech Pulse: Evotec Earns $16M Milestone Payment, Genmab Hit With Adverse Tribunal Ruling, Quidel Announces Above-Consensus Q1 Revenues And More",Benzinga,/news/stocks/the-daily-biotech-pulse-evotec-earns-16m-milestone-payment-genmab-hit-with-adverse-tribunal-ruling-quidel-announces-above-consensus-q1-revenues-and-more-1031342792
2653.0,4/10/2022 1:39:55 PM,Demand for COVID-19 shots falls amid reluctance to boosters,Seeking Alpha,https://seekingalpha.com/news/3822183-demand-for-covid-19-shots-drop-amid-reluctance-to-boosters?utm_source=markets.businessinsider.com&utm_medium=referral
2654.0,4/11/2022 11:48:55 AM,Goldman screens companies with best and worst pricing power into earnings season,Seeking Alpha,https://seekingalpha.com/news/3822185-godlman-screens-companies-with-best-and-worst-pricing-power-into-earnings-season?utm_source=markets.businessinsider.com&utm_medium=referral
2655.0,4/11/2022 2:25:59 PM,Beigene's Brukinsa bests Imbruvica in overall response in leukemia trial,Seeking Alpha,https://seekingalpha.com/news/3822346-beigene-brukinsa-bests-imbruvica-in-overall-response-in-leukemia-trial?utm_source=markets.businessinsider.com&utm_medium=referral
2656.0,4/13/2022 9:59:35 PM,J&J Ordered To Pay $302 Mln Penalty For Wrong Pelvic Mesh Implant Ads ,RTTNews,/news/stocks/j-j-ordered-to-pay-302-mln-penalty-for-wrong-pelvic-mesh-implant-ads-1031354675
2657.0,4/14/2022 3:13:06 PM,What 6 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-johnson-johnson-1031356974
2658.0,4/14/2022 9:18:41 PM,7 Earnings Reports to Watch the Week of April 18,InvestorPlace,/news/stocks/7-earnings-reports-to-watch-the-week-of-april-18-1031358951
2659.0,4/14/2022 9:27:57 PM,Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings,Benzinga,/news/stocks/raymond-james-thinks-med-tech-investors-are-somewhat-paralyzed-ahead-of-q1-earnings-1031357902
2660.0,4/17/2022 4:00:26 PM,Pfizer draws skeptics amid concerns over outlook for COVID-related sales,Seeking Alpha,https://seekingalpha.com/news/3823672-pfe-stock-in-focus-amid-concerns-over-outlook-for-covid-related-sales?utm_source=markets.businessinsider.com&utm_medium=referral
2661.0,4/17/2022 8:31:32 PM,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-17-april-23-j-j-abbott-earnings-adcom-test-for-tg-therapeutics-and-more-1031359853
2662.0,4/18/2022 12:54:24 AM,Johnson & Johnson COVID-19 shot holds its ground amid breakthrough cases,Seeking Alpha,https://seekingalpha.com/news/3823676-johnson-johnson-covid-19-shot-holds-its-ground-amid-breakthrough-cases?utm_source=markets.businessinsider.com&utm_medium=referral
2663.0,4/18/2022 11:59:23 AM,Eli Lilly expects $165 million in charges related to in-process R&D projects,Seeking Alpha,https://seekingalpha.com/news/3823792-eli-lilly-to-recognize-165-million-in-charges-related-to-in-process-rd-projects?utm_source=markets.businessinsider.com&utm_medium=referral
2664.0,4/18/2022 1:42:17 PM,Johnson & Johnson to pay $99M to resolve opioid suits with West Virginia,Seeking Alpha,https://seekingalpha.com/news/3823864-johnson-johnson-to-pay-99m-to-resolve-opioid-suits-with-west-virginia?utm_source=markets.businessinsider.com&utm_medium=referral
2665.0,4/18/2022 2:45:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3823892-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
2666.0,4/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1031361015
2667.0,4/18/2022 4:54:52 PM,J&J to report Q1 result amid lingering pandemic headwinds,Seeking Alpha,https://seekingalpha.com/news/3823909-jj-to-report-q1-result-amid-lingering-pandemic-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral
2668.0,4/18/2022 8:27:58 PM,Amgen's biosimilar candidate to Stelara shows no clinically meaningful differences in study,Seeking Alpha,https://seekingalpha.com/news/3824066-amgens-biosimilar-candidate-to-stelara-shows-no-clinically-meaningful-differences-in-study?utm_source=markets.businessinsider.com&utm_medium=referral
2669.0,4/19/2022 10:02:33 AM,"5 Stocks To Watch For April 19, 2022",Benzinga,/news/stocks/5-stocks-to-watch-for-april-19-2022-1031363148
2670.0,4/19/2022 10:26:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M",Seeking Alpha,https://seekingalpha.com/news/3824178-johnson-amp-johnson-non-gaap-eps-of-267-beats-by-010-revenue-of-234b-misses-by-210m-reaffirms-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
2671.0,4/19/2022 10:26:18 AM,Johnson & Johnson raises dividend by 6.6% to $1.13,Seeking Alpha,https://seekingalpha.com/news/3824174-johnson-and-johnson-declares-1_13-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
2672.0,4/19/2022 11:13:13 AM,A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-ahead-of-earnings-1031363262
2673.0,4/19/2022 11:17:54 AM,Moderna says its first bivalent booster vaccine outperformed current COVID-19 booster,Seeking Alpha,https://seekingalpha.com/news/3824200-moderna-says-first-bivalent-booster-shot-trumped-current-covid-19-booster?utm_source=markets.businessinsider.com&utm_medium=referral
2674.0,4/19/2022 11:27:48 AM,"J&J stock rises on Q1 earnings beat; lowers adjusted EPS outlook, suspends COVID vaccine guidance",Seeking Alpha,https://seekingalpha.com/news/3824205-jj-stock-dips-on-q1-revenue-miss-lowers-adjusted-eps-outlook-suspends-covid-vaccine-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
2675.0,4/19/2022 12:20:00 PM,Johnson & Johnson Announces Dividend Increase of 6.6%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-6-6-1031363386
2676.0,4/19/2022 12:25:00 PM,Johnson & Johnson Reports Q1 2022 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q1-2022-results-1031363397
2677.0,4/19/2022 12:30:45 PM,"Johnson & Johnson Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q1-profit-decreases-but-beats-estimates-1031363436
2678.0,4/19/2022 12:53:40 PM,Johnson & Johnson Suspends Guidance On Its COVID-19 Vaccine Sales ,RTTNews,/news/stocks/johnson-johnson-suspends-guidance-on-its-covid-19-vaccine-sales-1031363479
2679.0,4/19/2022 1:55:40 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 19",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-april-19-1031363748
2680.0,4/19/2022 2:29:32 PM,Why Is Johnson & Johnson (JNJ) Stock in Focus Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-in-focus-today-1031364592
2681.0,4/19/2022 2:57:17 PM,Why Is ToughBuilt Industries (TBLT) Stock Up 65% Today?,InvestorPlace,/news/stocks/why-is-toughbuilt-industries-tblt-stock-up-65-today-1031364637
2682.0,4/19/2022 3:05:03 PM,"The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-acquires-checkmate-pharma-moderna-s-bivalent-booster-covid-19-vaccine-update-priority-review-for-astrazeneca-s-enhertu-1031364260
2683.0,4/19/2022 3:19:35 PM,AbbVie falls as partner Johnson & Johnson cites pressure on Imbruvica sales,Seeking Alpha,https://seekingalpha.com/news/3824338-abbv-stock-falls-as-johnson--johnson-as-imbruvica-sales-drop?utm_source=markets.businessinsider.com&utm_medium=referral
2684.0,4/19/2022 3:32:59 PM,"Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More",Benzinga,/news/stocks/benzinga-s-daily-brief-on-trending-tickers-for-april-19-2022-plug-power-twitter-cassava-sciences-and-more-1031364340
2685.0,4/19/2022 4:59:32 PM,Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-dow-jumps-400-points-1031364642
2686.0,4/19/2022 5:21:14 PM,Johnson & Johnson‚Äôs MedTech performance rallies industry,Seeking Alpha,https://seekingalpha.com/news/3824408-johnson-johnsons-medtech-performance-rallies-industry?utm_source=markets.businessinsider.com&utm_medium=referral
2687.0,4/19/2022 6:37:08 PM,Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher,Benzinga,/news/stocks/mid-day-market-update-crud-oil-down-over-5-checkmate-pharmaceuticals-shares-spike-higher-1031364910
2688.0,4/19/2022 8:41:10 PM,Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-surges-200-points-dentsply-sirona-shares-plunge-1031365143
2689.0,4/20/2022 9:03:27 AM,"Alabama reaches $276M settlement with J&J, McKesson, Endo over opioid claims - Waff",Seeking Alpha,https://seekingalpha.com/news/3824600-alabama-reaches-276m-settlement-with-jj-mckesson-endo-over-opioid-claims-waff?utm_source=markets.businessinsider.com&utm_medium=referral
2690.0,4/20/2022 5:03:06 PM,Bank of America is cautious on life sciences companies ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/3824851-bank-of-america-is-cautious-on-life-sciences-companies-ahead-of-earnings?utm_source=markets.businessinsider.com&utm_medium=referral
2691.0,4/20/2022 6:42:37 PM,Novavax has plunged amid falling demand for COVID vaccines. Is it time to buy?,Seeking Alpha,https://seekingalpha.com/news/3824544-novavax-has-plunged-amid-falling-demand-for-covid-vaccines-is-it-time-to-buy-pandemic?utm_source=markets.businessinsider.com&utm_medium=referral
2692.0,4/20/2022 9:51:56 PM,"JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters",Benzinga,/news/stocks/jnj-mckesson-endo-settle-275m-opioid-claims-with-alabama-reuters-1031369258
2693.0,4/20/2022 10:30:00 PM,Johnson & Johnson to Participate in the UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-ubs-global-healthcare-conference-1031369405
2694.0,4/22/2022 4:58:09 PM,Intuitive Surgical sheds over 10% most in over two years despite earnings beat,Seeking Alpha,https://seekingalpha.com/news/3825875-isrg-stock-plunges-despite-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral
2695.0,4/25/2022 1:30:00 PM,"Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)",PR Newswire,/news/stocks/johnson-johnson-launches-next-satellite-center-for-global-health-discovery-at-holistic-drug-discovery-and-development-centre-university-of-cape-town-focused-on-antimicrobial-resistance-amr-1031379719
2696.0,4/25/2022 10:11:22 PM,"San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters",Benzinga,/news/stocks/san-francisco-to-start-opioid-epidemic-trial-against-teva-walgreen-reuters-1031381415
2697.0,4/26/2022 10:16:16 AM,3 Dividend Stocks for Value Investors Seeking Regular Income,InvestorPlace,/news/stocks/dividend-stocks-investors-seeking-income-1031384022
2698.0,4/26/2022 12:06:10 PM,Novavax price target lowered at B. Riley amid demand uncertainty for COVID-19 shots,Seeking Alpha,https://seekingalpha.com/news/3826692-nvax-stock-lower-as-b-riley-cuts-target-amid-uncertainty-for-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral
2699.0,4/28/2022 10:15:22 AM,7 Long-Term Stocks to Buy for a Robust Retirement,InvestorPlace,/news/stocks/long-term-stocks-7-to-buy-for-a-robust-retirement-1031396460
2700.0,4/28/2022 2:13:40 PM,J&J seeks approval of Zytiga/Zejula combination for prostate cancer to EMA,Seeking Alpha,https://seekingalpha.com/news/3828664-johnson-johnson-janssen-seeks-approval-of-zytiga-zejula-combination-for-prostate-cancer-to-ema?utm_source=markets.businessinsider.com&utm_medium=referral
2701.0,4/29/2022 9:05:06 PM,Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements,Benzinga,/news/stocks/emergent-biosolutions-suspends-cdmo-guidance-as-it-awaits-clarity-on-covid-19-vaccine-requirements-1031403521
2702.0,5/2/2022 9:34:31 AM,J&J stockholders reject proposal to discontinue global sales of baby powder,Seeking Alpha,https://seekingalpha.com/news/3829831-jj-stockholders-reject-proposal-to-discontinue-global-sales-of-baby-powder?utm_source=markets.businessinsider.com&utm_medium=referral
2703.0,5/2/2022 3:56:44 PM,First COVID-19 vaccine plant in Africa at risk of closure with no orders,Seeking Alpha,https://seekingalpha.com/news/3830207-aspen-covid-19-vaccine-plant-at-risk-of-closure-with-no-orders?utm_source=markets.businessinsider.com&utm_medium=referral
2704.0,5/2/2022 7:55:14 PM,It Pays to Be Greedy,InvestorPlace,/news/stocks/it-pays-to-be-greedy-1031410830
2705.0,5/2/2022 10:30:00 PM,Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bernstein-38th-annual-strategic-decisions-conference-1031410351
2706.0,5/3/2022 11:32:50 PM,3 Mighty Mutual Funds to Buy for Q2,InvestorPlace,/news/stocks/3-mighty-mutual-funds-to-buy-for-q2-1031415970
2707.0,5/5/2022 10:39:18 AM,What ETF Is Best? 7 Great Funds to Consider.,InvestorPlace,/news/stocks/what-etf-is-best-7-great-funds-to-consider-1031424937
2708.0,5/5/2022 11:33:44 AM,J&J files suit against drug-benefit provider over use of copay assistance program - WSJ,Seeking Alpha,https://seekingalpha.com/news/3833202-jj-files-suit-against-drug-benefit-provider-over-use-of-copay-assistance-program-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
2709.0,5/5/2022 5:46:53 PM,COVID-19 Omicron variant is as severe as previous variants - study,Seeking Alpha,https://seekingalpha.com/news/3833571-covid-19-omicron-variant-is-as-severe-as-previous-variants-study?utm_source=markets.businessinsider.com&utm_medium=referral
2710.0,5/5/2022 9:49:27 PM,FDA limits use of J&J COVID-19 vaccine due to risk of blood clot,Seeking Alpha,https://seekingalpha.com/news/3834009-fda-limits-use-of-jj-covid-19-vaccine-due-to-risk-of-blood-clot?utm_source=markets.businessinsider.com&utm_medium=referral
2711.0,5/6/2022 5:24:20 AM,FDA Limits Use Of Johnson & Johnson COVID-19 Vaccine Due To Blood Clot Risk ,RTTNews,/news/stocks/fda-limits-use-of-johnson-johnson-covid-19-vaccine-due-to-blood-clot-risk-1031428218
2712.0,5/6/2022 2:50:26 PM,"Cramer Gives His Opinion On CoreCivic, SGHC And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-corecivic-sghc-and-more-1031430970
2713.0,5/6/2022 2:54:29 PM,"The Daily Biotech Pulse: Limited Use Of JNJ's COVID-19 Shot, Myovant-Pfizer's Relugolix Application Delayed, Gain Therapeutics' Parkinson's Data",Benzinga,/news/stocks/the-daily-biotech-pulse-limited-use-of-jnj-s-covid-19-shot-myovant-pfizer-s-relugolix-application-delayed-gain-therapeutics-parkinson-s-data-1031431013
2714.0,5/9/2022 11:10:25 AM,4 Blue-Chip Stocks to Buy for May 2022,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-buy-for-may-2022-1031436095
2715.0,5/10/2022 4:20:07 PM,More Emergent BioSolutions produced COVID vaccines destroyed than previously reported,Seeking Alpha,https://seekingalpha.com/news/3836074-more-emergent-biosolutions-produced-covid-vaccines-destroyed-than-previously-reported?utm_source=markets.businessinsider.com&utm_medium=referral
2716.0,5/11/2022 11:17:13 AM,Johnson & Johnson appoints CEO and CFO for consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3836685-johnson-johnson-appoints-ceo-and-cfo-for-new-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral
2717.0,5/11/2022 12:30:00 PM,Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company,PR Newswire,/news/stocks/johnson-johnson-appoints-thibaut-mongon-as-ceo-designate-of-planned-new-consumer-health-company-1031447377
2718.0,5/11/2022 12:53:04 PM,"Johnson & Johnson Names CEO, CFO Designates Of New Consumer Health Company ",RTTNews,/news/stocks/johnson-johnson-names-ceo-cfo-designates-of-new-consumer-health-company-1031447454
2719.0,5/11/2022 2:19:09 PM,Novanta raised to Outperform at William Blair on valuation,Seeking Alpha,https://seekingalpha.com/news/3836853-novt-stock-gains-after-first-bullish-view-on-wall-street?utm_source=markets.businessinsider.com&utm_medium=referral
2720.0,5/11/2022 10:06:01 PM,Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco,Benzinga,/news/stocks/almost-400m-covid-19-vaccine-doses-lost-due-to-emergent-s-baltimore-plant-fiasco-1031449913
2721.0,5/12/2022 2:14:54 PM,Federal flags to fly at half-staff to mark one million COVID deaths,Seeking Alpha,https://seekingalpha.com/news/3837849-federal-flags-to-fly-at-half-staff-to-mark-one-million-covid-deaths?utm_source=markets.businessinsider.com&utm_medium=referral
2722.0,5/12/2022 9:36:40 PM,Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock,Benzinga,/news/stocks/read-why-hc-wainwright-lowered-price-target-on-this-small-biotech-stock-1031455130
2723.0,5/12/2022 10:30:00 PM,Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-goldman-sachs-43rd-annual-global-healthcare-conference-1031455370
2724.0,5/14/2022 10:00:15 AM,Johnson & Johnson Stock: A Rare Bright Spot in the Market,InvestorPlace,/news/stocks/jnj-stock-a-rare-bright-spot-in-the-market-1031459931
2725.0,5/16/2022 3:55:45 PM,"Dalio's Bridgewater invests in Berkshire Hathaway, exits Tesla in Q1",Seeking Alpha,https://seekingalpha.com/news/3839310-dalios-bridgewater-invests-in-berkshire-hathaway-exits-tesla-in-q1?utm_source=markets.businessinsider.com&utm_medium=referral
2726.0,5/16/2022 8:24:57 PM,Inflation May Have Peaked: What to Do Now,InvestorPlace,/news/stocks/inflation-may-have-peaked-what-to-do-now-1031466390
2727.0,5/16/2022 9:02:02 PM,"Investing Mistakes Were Made on Wall Street, and Now Opportunity Abounds",InvestorPlace,/news/stocks/investing-mistakes-were-made-on-wall-street-and-now-opportunity-abounds-1031466055
2728.0,5/17/2022 11:26:03 AM,"J&J, BARDA program gives a spot to Australian antiviral nasal spray developer ENA Respiratory",Seeking Alpha,https://seekingalpha.com/news/3839858-jj-barda-program-gives-a-spot-to-australian-antiviral-nasal-spray-developer-ena-respiratory?utm_source=markets.businessinsider.com&utm_medium=referral
2729.0,5/17/2022 4:42:38 PM,New York City reaches ‚Äúhigh‚Äù COVID alert level; indoor masking urged,Seeking Alpha,https://seekingalpha.com/news/3840091-new-york-city-reaches-high-covid-alert-level-indoor-masking-urged?utm_source=markets.businessinsider.com&utm_medium=referral
2730.0,5/17/2022 5:15:04 PM,8 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/8-analysts-have-this-to-say-about-johnson-johnson-1031469249
2731.0,5/18/2022 10:00:43 PM,5 Stocks to Buy for the Coming Recession,InvestorPlace,/news/stocks/5-stocks-to-buy-for-the-coming-recession-1031473821
2732.0,5/19/2022 12:43:36 AM,Sector Rotation And 9 Stocks To Watch During A Recession,Benzinga,/news/stocks/sector-rotation-and-9-stocks-to-watch-during-a-recession-1031473832
2733.0,5/19/2022 2:34:59 PM,J&J touts Tremfya in-vitro studies differentiating it from AbbVie's Skyrizi,Seeking Alpha,https://seekingalpha.com/news/3840978-johnson-johnson-janssen-touts-tremfya-in-vitro-studies-as-differentiating-it-from-abbvie-skyrizi?utm_source=markets.businessinsider.com&utm_medium=referral
2734.0,5/20/2022 1:32:01 PM,ImmixBio surges on mice data for lead candidate in connective tissue cancer,Seeking Alpha,https://seekingalpha.com/news/3841363-immx-stock-soars-on-mice-data-for-lead-candidate-in-connective-tissue-cancer?utm_source=markets.businessinsider.com&utm_medium=referral
2735.0,5/20/2022 3:02:43 PM,ImmixBio: IMX-110 Shows Improved Survival In Connective Tissue Cancer Soft Tissue Sarcoma Mice Study ,RTTNews,/news/stocks/immixbio-imx-110-shows-improved-survival-in-connective-tissue-cancer-soft-tissue-sarcoma-mice-study-1031478642
2736.0,5/20/2022 6:19:05 PM,Is Johnson & Johnson a buy amid rising COVID cases and a shift towards defensive stocks?,Seeking Alpha,https://seekingalpha.com/news/3841381-covid-cases-rise-healthcare-defends-against-downturns-so-is-johnson-johnson-a-buy?utm_source=markets.businessinsider.com&utm_medium=referral
2737.0,5/23/2022 6:31:20 PM,"Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch",Benzinga,/news/etf/amid-monkeypox-outbreak-this-3x-leveraged-etf-provides-exposure-to-health-sector-what-to-watch-1031482614
2738.0,5/24/2022 1:29:05 PM,COVID-19 sales boom for vaccine and drug makers might be over - analysts,Seeking Alpha,https://seekingalpha.com/news/3842211-covid-19-sales-boom-for-vaccine-and-drug-makers-might-be-over?utm_source=markets.businessinsider.com&utm_medium=referral
2739.0,5/24/2022 1:36:13 PM,Alvotech's biosimilar candidate AVT04 shows therapeutic equivalence to J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/3842220-alvotechs-biosimilar-candidate-avt04-shows-therapeutic-equivalence-to-jjs-stelara?utm_source=markets.businessinsider.com&utm_medium=referral
2740.0,5/24/2022 8:22:39 PM,"4 Top Stock Trades for Wednesday: FB, JNJ, CCL, NCLH",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-fb-jnj-ccl-nclh-1031486514
2741.0,5/24/2022 9:56:54 PM,J&J's Janssen presents new data at Digestive Disease Week for Tremfya in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3842456-jjs-janssen-presents-new-data-at-digestive-disease-week-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral
2742.0,5/25/2022 7:57:03 PM,"Long COVID risk drops only slightly after vaccination, large study shows",Seeking Alpha,https://seekingalpha.com/news/3842802-long-covid-risk-drops-only-slightly-after-vaccination-large-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral
2743.0,5/27/2022 3:31:11 PM,"Boston Scientific upgraded to buy at Needham on new products, potential M&A target",Seeking Alpha,https://seekingalpha.com/news/3843519-boston-scientific-upgraded-to-buy-at-needham-on-new-products-potential-ma-target?utm_source=markets.businessinsider.com&utm_medium=referral
2744.0,5/31/2022 2:49:12 PM,7 Safe Dividend Stocks With High Yields to Buy Now,InvestorPlace,/news/stocks/7-safe-dividend-stocks-with-high-yields-to-buy-now-1031498852
2745.0,5/31/2022 6:12:38 PM,3 Stocks to Buy if You Think a Recession is Imminent,InvestorPlace,/news/stocks/3-stocks-to-buy-if-you-think-a-recession-is-imminent-1031499549
2746.0,6/1/2022 10:15:24 AM,3 Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-before-they-boom-1031501085
2747.0,6/1/2022 1:18:29 PM,7 Stocks to Buy to Avoid Being Mauled by a Bear Market,InvestorPlace,/news/stocks/7-stocks-to-buy-to-avoid-being-mauled-by-a-bear-market-1031502160
2748.0,6/1/2022 1:51:49 PM,Johnson & Johnson's Tremfya demonstrates long-term benefit in psoriatric arthritis,Seeking Alpha,https://seekingalpha.com/news/3844409-johnson-johnson-janssen-tremfya-demonstrates-long-term-benefit-in-psoriatric-arthritis?utm_source=markets.businessinsider.com&utm_medium=referral
2749.0,6/1/2022 1:52:13 PM,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,Benzinga,/news/stocks/pfizer-to-quit-gsk-s-consumer-health-jv-following-its-spin-off-1031501411
2750.0,6/1/2022 4:13:50 PM,Legend Biotech clinical hold on CAR-T lymphoma candidate lifted by FDA,Seeking Alpha,https://seekingalpha.com/news/3844471-legend-biotech-clinical-hold-on-car-t-lymphoma-candidate-lifted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral
2751.0,6/2/2022 4:25:53 PM,Johnson & Johnson arthritis drug leads to clinical improvement in hospitalized COVID-19,Seeking Alpha,https://seekingalpha.com/news/3845099-johnson-johnson-arthritis-drug-leads-to-clinical-improvement-in-hospitalized-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
2752.0,6/2/2022 9:00:50 PM,3 Value Stocks That Could 2x in a Recession,InvestorPlace,/news/stocks/3-value-stocks-that-could-2x-in-a-recession-1031506774
2753.0,6/3/2022 3:19:26 PM,"J&J/AbbVie's Imbruvica 'significantly' cuts risk of disease progression in rare lymphoma, in trial",Seeking Alpha,https://seekingalpha.com/news/3845546-jjabbvies-imbruvica-significantly-cuts-risk-of-disease-progression-in-rare-lymphoma-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral
2754.0,6/6/2022 10:48:57 AM,Curis gains over 20% as majority of patients respond to blood cancer drug,Seeking Alpha,https://seekingalpha.com/news/3845814-cris-stock-gains-as-majority-of-patients-respond-to-blood-cancer-drug?utm_source=markets.businessinsider.com&utm_medium=referral
2755.0,6/6/2022 2:57:39 PM,Jim Cramer Prefers This Oil Stock Over Occidental Petroleum,Benzinga,/news/stocks/jim-cramer-prefers-this-oil-stock-over-occidental-petroleum-1031510963
2756.0,6/6/2022 3:27:21 PM,J&J's Carvykti demonstrates durable response in heavily pretreated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3845973-johnson-johnson-carvykti-demonstrates-durable-response-in-heavily-pretreated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral
2757.0,6/6/2022 4:14:08 PM,"Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More",Benzinga,/news/stocks/benzinga-s-premarket-brief-on-trending-tickers-amazon-alibaba-didi-solaredge-and-more-1031511219
2758.0,6/6/2022 4:55:31 PM,"Johnson & Johnson breached vaccine contract, Emergent says",Seeking Alpha,https://seekingalpha.com/news/3846012-ebs-stock-slips-after-announcing-johnson--johnson-breached-vaccine-contract?utm_source=markets.businessinsider.com&utm_medium=referral
2759.0,6/6/2022 5:20:10 PM,Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract,Benzinga,/news/stocks/emergent-bio-says-johnson-johnson-breached-covid-19-vaccine-contract-1031511342
2760.0,6/7/2022 1:35:11 PM,J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement,Benzinga,/news/stocks/j-j-serves-notice-to-emergent-for-terminating-covid-19-shot-contract-as-two-accuse-each-other-of-breach-of-agreement-1031513069
2761.0,6/7/2022 2:07:41 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, June 7",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-june-7-1031513234
2762.0,6/7/2022 4:24:00 PM,Johnson & Johnson posts interim data for cancer drug to indicate 29% overall response,Seeking Alpha,https://seekingalpha.com/news/3846371-jnj-posts-interim-data-for-cancer-drug-to-indicate-29-overall-response?utm_source=markets.businessinsider.com&utm_medium=referral
2763.0,6/8/2022 10:29:23 AM,7 Dividend Stocks to Buy for a Rich Retirement,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-rich-retirement-mcd-wmt-cat-jnj-gpc-adp-ko-1031515667
2764.0,6/8/2022 2:00:00 PM,Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments,PR Newswire,/news/stocks/johnson-johnson-releases-2021-health-for-humanity-report-highlighting-performance-on-esg-priorities-and-progress-against-public-commitments-1031516039
2765.0,6/8/2022 3:06:22 PM,NVAX Stock Price Predictions: Where Will Novavax Go From Here?,InvestorPlace,/news/stocks/nvax-stock-price-predictions-where-will-novavax-go-from-here-1031516951
2766.0,6/9/2022 11:48:19 AM,Novavax slips amid concerns over delay for FDA decision on COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3847111-nvax-stock-slips-amid-concerns-over-delay-for-fda-decision-on-covid-19-shot?utm_source=businessinsider&utm_medium=referral
2767.0,6/9/2022 10:10:03 PM,Genmab seeks $405M award under new arbitration with J&J over cancer drug,Seeking Alpha,https://seekingalpha.com/news/3847542-genmab-seeks-405m-award-under-new-arbitration-with-jj-over-cancer-drug?utm_source=businessinsider&utm_medium=referral
2768.0,6/10/2022 2:57:48 PM,7 Great ETFs to Buy Now for Momentum in Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-in-q2-1031522477
2769.0,6/13/2022 5:16:00 PM,EU public health agency warns of probable increase in COVID cases in coming weeks,Seeking Alpha,https://seekingalpha.com/news/3848128-eu-public-health-agency-warns-of-probable-increase-in-covid-cases-in-coming-weeks?utm_source=businessinsider&utm_medium=referral
2770.0,6/14/2022 1:28:36 PM,Bristol Myers tops S&P 500 with largest intangible adjustment in 2021,Seeking Alpha,https://seekingalpha.com/news/3848429-bristol-myers-tops-sp-500-with-largest-intangible-adjustment-in-2021?utm_source=businessinsider&utm_medium=referral
2771.0,6/14/2022 1:57:38 PM,Wells Fargo unveils its recession stock portfolio,Seeking Alpha,https://seekingalpha.com/news/3848418-wells-fargo-unveils-its-recession-stock-portfolio?utm_source=businessinsider&utm_medium=referral
2772.0,6/14/2022 6:37:16 PM,"Newer, more contagious Omicron subvariants gaining traction in U.S.",Seeking Alpha,https://seekingalpha.com/news/3848543-newer-more-contagious-omicron-subvariants-gaining-traction-in-us?utm_source=businessinsider&utm_medium=referral
2773.0,6/14/2022 6:47:03 PM,"Klobuchar, Porter want investigation into Bristol-Myers Squibb, Pfizer, Janssen price hikes",Seeking Alpha,https://seekingalpha.com/news/3848541-klobuchar-porter-want-investigation-bristol-myers-squibb-pfizer-janssen-price-hikes-stat?utm_source=businessinsider&utm_medium=referral
2774.0,6/15/2022 10:31:43 AM,3 Super-Safe Dividend Stocks to Buy,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-fdx-jnj-low-1031530085
2775.0,6/15/2022 6:58:44 PM,Dr. Fauci tests positive for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3848965-dr-fauci-tests-positive-for-covid-19?utm_source=businessinsider&utm_medium=referral
2776.0,6/17/2022 7:00:44 PM,"Catalyst watch: FedEx earnings, Revlon drama and huge Polestar SPAC deal goes to a vote",Seeking Alpha,https://seekingalpha.com/news/3849682-catalyst-watch-fedex-earnings-revlon-drama-and-huge-polestar-spac-deal-goes-to-a-vote?utm_source=businessinsider&utm_medium=referral
2777.0,6/17/2022 8:24:28 PM,Legend Biotech Shares Move Higher After Bullish BMO Pitch,Benzinga,/news/stocks/legend-biotech-shares-move-higher-after-bullish-bmo-pitch-1031536189
2778.0,6/20/2022 10:00:07 AM,"7 Stocks to Buy If You Have $1,000 to Invest",InvestorPlace,/news/stocks/7-stocks-to-buy-if-you-have-1000-to-invest-1031537752
2779.0,6/21/2022 2:00:00 AM,Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research,PR Newswire,/news/stocks/johnson-johnson-opens-first-satellite-center-for-global-health-discovery-in-asia-pacific-at-duke-nus-to-advance-dengue-research-1031538632
2780.0,6/21/2022 3:18:22 AM,J&J Opens Satellite Center For Global Health Discovery In Asia Pacific To Advance Dengue Research ,RTTNews,/news/stocks/j-j-opens-satellite-center-for-global-health-discovery-in-asia-pacific-to-advance-dengue-research-1031538650
2781.0,6/21/2022 2:45:52 PM,"A '70s style recession would push S&P 500 to 2,525 - SocGen",Seeking Alpha,https://seekingalpha.com/news/3850076-a-70s-style-recession-would-push-sp-500-to-2525-socgen?utm_source=businessinsider&utm_medium=referral
2782.0,6/22/2022 11:12:49 AM,Bear Market 2022: Is There Anything Left to Invest In?,InvestorPlace,/news/stocks/bear-market-2022-is-there-anything-left-to-invest-in-1031542804
2783.0,6/22/2022 12:15:20 PM,Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money,InvestorPlace,/news/stocks/economic-hurricane-ahead-7-profitable-places-to-hide-your-money-1031543188
2784.0,6/23/2022 10:46:58 AM,7 Retirement Stocks to Buy After Age 30,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-after-age-30-v-deo-ecl-amt-nke-mmm-jnj-1031545576
2785.0,6/23/2022 9:03:48 PM,Why Did HC Wainwright Downgrade Addex Therapeutics,Benzinga,/news/stocks/why-did-hc-wainwright-downgrade-addex-therapeutics-1031547234
2786.0,6/24/2022 10:46:13 AM,7 Large-Cap Stocks to Buy After the Next Big Correction,InvestorPlace,/news/stocks/7-large-cap-stocks-to-buy-after-the-next-big-correction-ko-tsla-intc-jnj-cvx-cost-cd-1031548398
2787.0,6/24/2022 2:01:11 PM,EMA panel recommends extending indication for J&J's blood cancer medicine Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3851592-ema-panel-recommends-extending-indication-for-jjs-blood-cancer-medicine-imbruvica?utm_source=businessinsider&utm_medium=referral
2788.0,6/28/2022 9:08:38 AM,"AmerisourceBergen, McKesson, Cardinal to pay Oklahoma $250M to resolve opioid claims",Seeking Alpha,https://seekingalpha.com/news/3852297-amerisourcebergen-mckesson-cardinal-to-pay-oklahoma-250m-to-resolve-opioid-claims?utm_source=businessinsider&utm_medium=referral
2789.0,6/28/2022 1:42:09 PM,"Enovis initiated at Argus with a hold citing EPS growth, competition",Seeking Alpha,https://seekingalpha.com/news/3852453-enovis-initiated-at-argus-with-a-hold-citing-eps-growth-competition?utm_source=businessinsider&utm_medium=referral
2790.0,6/28/2022 8:28:42 PM,MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial,Benzinga,/news/stocks/meiragtx-posts-encouraging-gene-therapy-data-from-eye-disorder-trial-1031555651
2791.0,6/29/2022 10:30:13 AM,Novavax Stock Is in Prime Position For Speculation,InvestorPlace,/news/stocks/nvax-stock-is-in-prime-position-for-speculation-1031557041
2792.0,6/29/2022 1:55:26 PM,J&J multiple myeloma candidate for talquetamab granted Breakthrough Therapy Designation,Seeking Alpha,https://seekingalpha.com/news/3852832-johnson-johnson-janssen-multiple-myeloma-candidate-for-talquetamab-granted-breakthrough-therapy-designation?utm_source=businessinsider&utm_medium=referral
2793.0,6/30/2022 2:41:30 PM,FDA requests manufacturers to update vaccines for latest Omicron subvariants,Seeking Alpha,https://seekingalpha.com/news/3853297-fda-requests-manufacturers-to-update-vaccines-for-latest-omicron-subvariants?utm_source=businessinsider&utm_medium=referral
2794.0,7/1/2022 4:34:01 PM,What Companies Will Pay for Abortion Travel?,InvestorPlace,/news/stocks/what-companies-will-pay-for-abortion-travel-1031563754
2795.0,7/1/2022 10:45:50 PM,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",Benzinga,/news/etf/only-8-of-the-30-dow-jones-stocks-were-positive-in-the-first-half-of-2022-chevron-leads-but-who-else-was-up-1031564229
2796.0,7/2/2022 6:00:00 PM,"As amyloid-targeting therapies for Alzheimer's fail, where might success lie?",Seeking Alpha,https://seekingalpha.com/news/3853361-as-amyloid-targeting-therapies-for-alzheimers-fail-where-might-success-lie?utm_source=businessinsider&utm_medium=referral
2797.0,7/5/2022 9:47:06 AM,US judge rules in favor of drug distributors in West Virginia county opioid suit - AP,Seeking Alpha,https://seekingalpha.com/news/3854023-us-judge-rules-in-favor-of-drug-distributors-in-west-virginia-county-opioid-suit-ap?utm_source=businessinsider&utm_medium=referral
2798.0,7/5/2022 3:25:45 PM,Geron extends winning streak to reach 52-week high,Seeking Alpha,https://seekingalpha.com/news/3854229-gern-stock-extends-wining-streak-to-reach-52-week-high?utm_source=businessinsider&utm_medium=referral
2799.0,7/8/2022 2:42:25 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031575494
2800.0,7/8/2022 2:58:24 PM,EMA looking into neurodevelopmental risks associated with J&J's seizure med Topamax,Seeking Alpha,https://seekingalpha.com/news/3855388-ema-looking-into-neurodevelopmental-risks-associated-with-johnson-jonhson-seizure-med-topamax?utm_source=businessinsider&utm_medium=referral
2801.0,7/11/2022 10:25:17 AM,EU recommends second COVID boosters for ages 60-79,Seeking Alpha,https://seekingalpha.com/news/3855582-eu-recommends-second-covid-boosters-for-ages-60-79?utm_source=businessinsider&utm_medium=referral
2802.0,7/14/2022 2:40:41 PM,What Is Going on With Novavax (NVAX) Stock Today?,InvestorPlace,/news/stocks/what-is-going-on-with-novavax-nvax-stock-today-2-1031588212
2803.0,7/14/2022 11:40:15 PM,7 Best S&P 500 Stocks to Buy in July,InvestorPlace,/news/stocks/best-sp-500-stocks-1031588965
2804.0,7/15/2022 12:15:59 PM,7 Best Long-Term Dividend Stocks to Buy Right Now,InvestorPlace,/news/stocks/best-long-term-dividend-stocks-1031590160
2805.0,7/18/2022 10:57:31 AM,Top sticky stocks most immune to big earnings misses and beats,Seeking Alpha,https://seekingalpha.com/news/3857382-top-sticky-stocks-most-immune-to-big-earnings-misses-and-beats?utm_source=businessinsider&utm_medium=referral
2806.0,7/18/2022 2:31:54 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3857597-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
2807.0,7/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q2-earnings-preview-1031594009
2808.0,7/18/2022 4:34:51 PM,J&J to report Q2 results amid several macro factors that threaten to diminish near-term growth,Seeking Alpha,https://seekingalpha.com/news/3857655-jj-to-report-q2-result-amid-several-macro-factors-that-threaten-to-diminish-near-term-growth?utm_source=businessinsider&utm_medium=referral
2809.0,7/18/2022 6:58:43 PM,Top pharma lobby says R&D spending reached a peak in 2021,Seeking Alpha,https://seekingalpha.com/news/3857699-top-pharma-lobby-says-rd-spending-reached-a-peak-in-2021?utm_source=businessinsider&utm_medium=referral
2810.0,7/19/2022 9:36:04 AM,"Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/netflix-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031596292
2811.0,7/19/2022 10:26:44 AM,"Johnson & Johnson beats on earnings, maintains FY22 Adj. op. EPS and op. sales, cuts FY22 revenue and Adj. EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3857915-johnson-amp-johnson-non-gaap-eps-of-259-beats-by-004-revenue-of-24b-beats-by-180m-cuts-fy22-guidance?utm_source=businessinsider&utm_medium=referral
2812.0,7/19/2022 11:00:27 AM,Johnson & Johnson cuts 2022 guidance as MedTech underperforms in 2Q,Seeking Alpha,https://seekingalpha.com/news/3857931-jnj-stock-slips-as-company-cuts-2022-guidance?utm_source=businessinsider&utm_medium=referral
2813.0,7/19/2022 11:05:42 AM,Genmab reports Q2 worldwide net sales of DARZALEX $1.99B,Seeking Alpha,https://seekingalpha.com/news/3857936-genmab-reports-q2-worldwide-net-sales-of-darzalex-199b?utm_source=businessinsider&utm_medium=referral
2814.0,7/19/2022 12:06:34 PM,"US Stock Futures Higher Ahead of J&J, Netflix Earnings",Benzinga,/news/stocks/us-stock-futures-higher-ahead-of-j-j-netflix-earnings-1031596560
2815.0,7/19/2022 12:35:43 PM,"Johnson & Johnson Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1031596637
2816.0,7/19/2022 3:12:33 PM,"The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-tentatively-approves-avadel-s-narcolepsy-drug-european-approval-broadens-astrazeneca-s-enhertu-in-breast-cancer-pharma-giants-earnings-1031597418
2817.0,7/19/2022 6:18:59 PM,Dow Surges 500 Points; Johnson & Johnson Lowers Guidance,Benzinga,/news/stocks/dow-surges-500-points-johnson-johnson-lowers-guidance-1031598024
2818.0,7/19/2022 7:06:34 PM,2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today,InvestorPlace,/news/stocks/2-big-reasons-novavax-nvax-stock-is-shooting-higher-today-1031598337
2819.0,7/19/2022 8:19:52 PM,Johnson & Johnson executive chairman elected to JPMorgan Chase board,Seeking Alpha,https://seekingalpha.com/news/3858273-johnson-johnson-executive-chairman-elected-to-jpmorgan-chase-board?utm_source=businessinsider&utm_medium=referral
2820.0,7/19/2022 8:30:26 PM,Nasdaq Rises More Than 300 Points; Crude Oil Moves Higher,Benzinga,/news/stocks/nasdaq-rises-more-than-300-points-crude-oil-moves-higher-1031598272
2821.0,7/20/2022 10:30:37 AM,7 Best Stocks for College Graduates,InvestorPlace,/news/stocks/best-stocks-for-college-graduates-1031600455
2822.0,7/20/2022 1:41:28 PM,The Valens Company Nominates Independent Director To Board Of Directors,Benzinga,/news/stocks/the-valens-company-nominates-independent-director-to-board-of-directors-1031600634
2823.0,7/20/2022 1:46:13 PM,JP Morgan Calls For Coca-Cola to $70: Here Are 4 Other Price Target Changes for Wednesday,Benzinga,/news/stocks/jp-morgan-calls-for-coca-cola-to-70-here-are-4-other-price-target-changes-for-wednesday-1031600653
2824.0,7/20/2022 4:18:23 PM,Arcellx named new buy at Canaccord Genuity on multiple myeloma candidate,Seeking Alpha,https://seekingalpha.com/news/3858614-arcellx-named-new-buy-at-canaccord-genuity-on-multiple-myeloma-candidate?utm_source=businessinsider&utm_medium=referral
2825.0,7/20/2022 6:02:48 PM,4 Analysts Takeaways From Johnson & Johnson's Quarterly Results: What Investors Need To Know,Benzinga,/news/stocks/4-analysts-takeaways-from-johnson-johnson-s-quarterly-results-what-investors-need-to-know-1031601822
2826.0,7/22/2022 12:26:47 PM,J&J gets EMA panel nod for conditional approval of Tecvayli for blood cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3859583-jj-gets-ema-panel-nod-for-conditional-approval-of-tecvayli-for-blood-cancer-subtype?utm_source=businessinsider&utm_medium=referral
2827.0,7/22/2022 1:49:29 PM,7 Seriously Undervalued Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/undervalued-retirement-stocks-1031607886
2828.0,7/23/2022 8:15:00 PM,"Drug pricing legislation will affect biopharma revenue, but impact is manageable - RBC",Seeking Alpha,https://seekingalpha.com/news/3859761-drug-pricing-legislation-will-affect-biopharma-revenue-but-impact-is-manageable-rbc?utm_source=businessinsider&utm_medium=referral
2829.0,7/24/2022 4:00:31 PM,"Pfizer, Moderna to see sales decline for COVID shots before recovery",Seeking Alpha,https://seekingalpha.com/news/3859843-pfizer-moderna-to-see-sales-decline-for-covid-shots-before-recovery?utm_source=businessinsider&utm_medium=referral
2830.0,7/25/2022 6:35:07 PM,Follow Nancy Pelosi and Watch These 8 Stocks That Lawmakers Are Buying,InvestorPlace,/news/stocks/follow-nancy-pelosi-and-watch-these-8-stocks-that-lawmakers-are-buying-1031612506
2831.0,7/26/2022 3:17:27 PM,JNJ Stock Alert: What to Know as Johnson & Johnson Releases Clinical Trial Data,InvestorPlace,/news/stocks/jnj-stock-alert-what-to-know-as-johnson-johnson-releases-clinical-trial-data-1031616136
2832.0,7/27/2022 2:06:05 AM,"Teva Pharmaceutical in $4.35B opioid settlement with states, Native American tribes",Seeking Alpha,https://seekingalpha.com/news/3861061-teva-pharmaceutical-in-435-opioid-settlement-with-states-native-american-tribes?utm_source=businessinsider&utm_medium=referral
2833.0,7/27/2022 11:10:39 AM,7 Large-Cap Stocks to Buy on the Dip,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-on-the-dip-1031619962
2834.0,7/27/2022 2:05:04 PM,"Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2",Benzinga,/news/stocks/jim-cramer-says-this-stock-costs-about-3-but-if-you-wait-long-enough-you-can-buy-it-for-2-1031620221
2835.0,7/28/2022 4:37:49 PM,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",Benzinga,/news/stocks/daily-biotech-pulse-gsk-s-kidney-disease-drug-approved-for-children-tonix-pharma-to-launch-monkeypox-vaccine-study-in-kenya-positive-effect-of-cyclerion-s-schizophrenia-candidate-1031626482
2836.0,7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral
2837.0,7/29/2022 1:50:18 AM,Biden administration mulls updated booster rollout in September ‚Äì NYT,Seeking Alpha,https://seekingalpha.com/news/3862940-biden-administration-mulls-updated-booster-rollout-in-september-nyt?utm_source=businessinsider&utm_medium=referral
2838.0,7/31/2022 3:21:24 PM,Biotech Investors: August's Key PDUFA Catalysts You Must Know,Benzinga,/news/stocks/biotech-investors-august-s-key-pdufa-catalysts-you-must-know-1031631857
2839.0,8/1/2022 5:12:52 PM,Johnson & Johnson unit‚Äôs arthritis injection now indicated for children in U.S.,Seeking Alpha,https://seekingalpha.com/news/3863900-johnson-johnson-units-arthritis-injection-now-indicated-for-children-in-us?utm_source=businessinsider&utm_medium=referral
2840.0,8/1/2022 8:04:35 PM,Is Vanguard Dividend Appreciation ETF (VIG) A Strong ETF Right Now?,Benzinga,/news/stocks/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now-1031636436
2841.0,8/1/2022 11:23:06 PM,Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss,Seeking Alpha,https://seekingalpha.com/news/3864300-emergent-biosolutions-misses-on-top-and-bottom-lines-as-it-swings-to-quarterly-loss?utm_source=businessinsider&utm_medium=referral
2842.0,8/2/2022 7:50:15 PM,"Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus",Benzinga,/news/stocks/emergent-biosolutions-posts-q2-loss-on-lower-sales-q3-forecasts-below-consensus-1031641002
2843.0,8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161
2844.0,8/9/2022 11:00:11 AM,3 Dividend Stocks to Buy to Beat Runaway Inflation,InvestorPlace,/news/stocks/dividend-stocks-to-buy-to-beat-runaway-inflation-1031665050
2845.0,8/9/2022 1:35:38 PM,Why Is Novavax (NVAX) Stock Plunging 30%?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-plunging-30-1031666251
2846.0,8/9/2022 3:00:47 PM,HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson ,RTTNews,/news/stocks/hca-healthcare-signs-strategic-collaboration-with-johnson-johnson-1031665887
2847.0,8/10/2022 4:36:56 PM,The 3 Best Sectors for a Bear Market,InvestorPlace,/news/stocks/the-3-best-sectors-for-a-bear-market-1031671637
2848.0,8/10/2022 8:02:05 PM,Johnson & Johnson partner Aspen risks closure of COVID vaccine plant as orders dry up,Seeking Alpha,https://seekingalpha.com/news/3870976-jj-partner-aspen-risks-closure-of-covid-vaccine-plant-as-orders-dry-up?utm_source=businessinsider&utm_medium=referral
2849.0,8/11/2022 7:26:06 PM,CDC eases COVID guidance for unvaccinated people,Seeking Alpha,https://seekingalpha.com/news/3871779-cdc-eases-covid-guidance-for-unvaccinated-people?utm_source=businessinsider&utm_medium=referral
2850.0,8/11/2022 9:22:02 PM,"J&J, Merck, Regeneron most exposed to Medicare drug price negotiation - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3871983-johnson-johnson-merck-regeneron-most-exposed-to-medicare-drug-price-negotiation-bloomberg?utm_source=businessinsider&utm_medium=referral
2851.0,8/11/2022 9:23:05 PM,Johnson & Johnson to end sales of talc-based baby powder globally in 2023,Seeking Alpha,https://seekingalpha.com/news/3872014-johnson--johnson-to-stop-selling-talc-based-baby-powder-globally-in-2023?utm_source=businessinsider&utm_medium=referral
2852.0,8/12/2022 9:10:44 AM,Johnson & Johnson To Discontinue Talc-based Baby Powder ,RTTNews,/news/stocks/johnson-johnson-to-discontinue-talc-based-baby-powder-1031679050
2853.0,8/12/2022 1:28:51 PM,Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant,Seeking Alpha,https://seekingalpha.com/news/3872367-additional-135m-covid-19-vaccine-doses-destroyed-at-emergent-biosolutions-baltimore-plant?utm_source=businessinsider&utm_medium=referral
2854.0,8/12/2022 10:45:00 PM,"Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science",PR Newswire,/news/stocks/johnson-johnson-ends-global-sales-of-cancer-causing-baby-powder-amid-increased-scrutiny-from-consumer-litigation-science-1031680779
2855.0,8/14/2022 5:48:06 PM,Analysts rule out major industry impact from drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3872629-analysts-rule-out-major-industry-impact-from-drug-pricing-negotiations?utm_source=businessinsider&utm_medium=referral
2856.0,8/15/2022 2:41:21 PM,Emergent ticks lower after FDA warning on Baltimore facility,Seeking Alpha,https://seekingalpha.com/news/3872985-emergent-ticks-lower-after-fda-warning-on-baltimore-facility?utm_source=businessinsider&utm_medium=referral
2857.0,8/16/2022 8:20:19 AM,AstraZeneca/Merck's Lynparza gets FDA priority review to treat prostate cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3873395-astrazenecamercks-lynparza-gets-fda-priority-review-to-treat-prostate-cancer-subtype?utm_source=businessinsider&utm_medium=referral
2858.0,8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall ‚Äì Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral
2859.0,8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral
2860.0,8/18/2022 4:59:56 PM,7 Stocks That Win When the Fed Hikes Interest Rates,InvestorPlace,/news/stocks/7-stocks-that-win-when-the-fed-hikes-interest-rates-1031693784
2861.0,8/19/2022 12:31:52 PM,"HHS sets Aug. 30 meeting as costs for COVID products to shift to payors, individuals ‚Äì WSJ",Seeking Alpha,https://seekingalpha.com/news/3875015-hhs-sets-aug-meeting-as-covid-products-head-for-commercialization-wsj?utm_source=businessinsider&utm_medium=referral
2862.0,8/19/2022 2:17:52 PM,Johnson & Johnson goes ex-dividend on Monday,Seeking Alpha,https://seekingalpha.com/news/3875073-johnson--johnson-goes-ex-dividend-on-monday?utm_source=businessinsider&utm_medium=referral
2863.0,8/22/2022 11:22:03 AM,Johnson & Johnson to use Texas bankruptcy plan to fight two states‚Äô talc cases,Seeking Alpha,https://seekingalpha.com/news/3875309-johnson-johnson-to-use-texas-bankruptcy-plan-to-fight-two-states-talc-cases?utm_source=businessinsider&utm_medium=referral
2864.0,8/22/2022 2:28:02 PM,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday,...",Benzinga,/news/stocks/benzinga-before-the-bell-apple-employees-resist-calls-for-return-to-office-tesla-about-to-hike-fsd-prices-again-mgm-china-injects-594m-into-macau-unit-and-other-top-financial-stories-monday-august-22-1031697874
2865.0,8/24/2022 10:53:47 AM,JNJ adds former CVS CEO as non-executive chair of new consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3876108-jnj-adds-former-cvs-ceo-non-executive-chair-new-consumer-spinoff?utm_source=businessinsider&utm_medium=referral
2866.0,8/24/2022 12:16:25 PM,Pfizer said to have had bidding war with Johnson & Johnson for Global Blood,Seeking Alpha,https://seekingalpha.com/news/3876151-pfizer-said-to-have-had-bidding-war-with-johnson-johnson-for-global-blood?utm_source=businessinsider&utm_medium=referral
2867.0,8/24/2022 2:40:20 PM,Johnson & Johnson Names Larry Merlo Chair Designate Of Planned New Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-names-larry-merlo-chair-designate-of-planned-new-consumer-health-company-1031703127
2868.0,8/24/2022 4:30:36 PM,Congressman wants DoJ update on Johnson & Johnson talc powder investigation,Seeking Alpha,https://seekingalpha.com/news/3876289-congressman-wants-doj-update-on-johnson-johnson-talc-powder-investigation?utm_source=businessinsider&utm_medium=referral
2869.0,8/24/2022 7:45:18 PM,Billionaire Steven Cohen Just Made a Big Bet on Minerva Neurosciences (NERV) Stock,InvestorPlace,/news/stocks/billionaire-steven-cohen-just-made-a-big-bet-on-minerva-neurosciences-nerv-stock-1031704192
2870.0,8/25/2022 12:53:45 AM,Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-wednesday-s-biotech-catalysts---end-of-the-day-summary-1031704410
2871.0,8/25/2022 3:48:30 AM,Ligand : Janssen's Tecvayli Gets Conditional Approval In Europe For R/R Multiple Myeloma Treatment ,RTTNews,/news/stocks/ligand-janssen-s-tecvayli-gets-conditional-approval-in-europe-for-r-r-multiple-myeloma-treatment-1031704454
2872.0,8/25/2022 9:38:03 AM,"AbbVie, J&J Imbruvica gets FDA nod to treat graft-versus-host disease in kids",Seeking Alpha,https://seekingalpha.com/news/3876504-abbvie-jj-imbruvica-gets-fda-nod-to-treat-graft-versus-host-disease-in-kids?utm_source=businessinsider&utm_medium=referral
2873.0,8/25/2022 11:12:25 AM,Pfizer posts 86% efficacy for respiratory syncytial virus vaccine,Seeking Alpha,https://seekingalpha.com/news/3876550-pfizer-posts-efficacy-for-respiratory-syncytial-virus-vaccine?utm_source=businessinsider&utm_medium=referral
2874.0,8/25/2022 4:32:25 PM,Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients,Benzinga,/news/stocks/janssen-scores-conditional-approval-for-multiple-myeloma-treatment-in-pretreated-patients-1031706261
2875.0,8/28/2022 4:00:00 PM,Pfizer eyes $10B-plus market for RSV vaccines with two-prong approach,Seeking Alpha,https://seekingalpha.com/news/3877243-pfizer-eyes-10b-plus-market-for-rsv-vaccines-with-pandemic-era-model?utm_source=businessinsider&utm_medium=referral
2876.0,8/29/2022 4:44:50 PM,"Bristol-Myers falls 5%, most in two years, after mid-stage data for blood thinner",Seeking Alpha,https://seekingalpha.com/news/3877518-bmy-stock-falls-after-mid-stage-data-for-blood-thinner?utm_source=businessinsider&utm_medium=referral
2877.0,8/31/2022 3:41:46 PM,Pfizer snatches first chief marketing officer from Google's Verily,Seeking Alpha,https://seekingalpha.com/news/3878965-pfizer-snatches-first-chief-marketing-officer-from-googles-verily?utm_source=businessinsider&utm_medium=referral
2878.0,8/31/2022 8:52:36 PM,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",Benzinga,/news/stocks/bluebird-bio-seeks-back-to-back-nods-go-or-no-go-for-revance-s-botox-rival-amylyx-twin-hurdles-and-more-september-s-key-pdufa-catalysts-biotech-investors-must-know-1031717312
2879.0,9/1/2022 2:49:57 PM,Johnson & Johnson to pay $40.5M over opioid claims in New Hampshire,Seeking Alpha,https://seekingalpha.com/news/3879416-johnson-johnson-to-pay-405m-over-opioid-claims-in-new-hampshire?utm_source=businessinsider&utm_medium=referral
2880.0,9/2/2022 1:10:56 PM,EMA committee starts review of use of epileptic seizures drug topiramate in pregnancy,Seeking Alpha,https://seekingalpha.com/news/3879806-ema-committee-starts-review-of-use-of-epileptic-seizures-drug-topiramate-in-pregnancy?utm_source=businessinsider&utm_medium=referral
2881.0,9/4/2022 1:18:40 PM,"M&A may be a tailwind for biotech sector into end of year, analyst says",Seeking Alpha,https://seekingalpha.com/news/3880197-ma-may-be-a-tailwind-for-biotech-sector-into-end-of-year-analyst-says?utm_source=businessinsider&utm_medium=referral
2882.0,9/6/2022 7:12:48 AM,The 7 Best Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/the-best-vanguard-etfs-1028807655
2883.0,9/6/2022 6:00:50 PM,6 Safe Stocks to Buy in September 2022,InvestorPlace,/news/stocks/best-safe-stocks-1031561144
2884.0,9/6/2022 6:55:35 PM,7 Dow Stocks With Superior Fundamentals,InvestorPlace,/news/stocks/7-dow-stocks-with-superior-fundamentals-1031727239
2885.0,9/8/2022 2:48:04 PM,Shockwave Medical gains on vague takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3881275-shockwave-medical-gains-on-vague-takeover-speculation?utm_source=businessinsider&utm_medium=referral
2886.0,9/8/2022 9:01:53 PM,"FDA warns about skin cancer, various lymphomas in scar tissue around breast implants",Seeking Alpha,https://seekingalpha.com/news/3881442-fda-warns-about-skin-cancer-various-lymphomas-in-scar-tissue-around-breast-implants?utm_source=businessinsider&utm_medium=referral
2887.0,9/9/2022 5:30:31 AM,The 3 Best Funds for Retirees,InvestorPlace,/news/stocks/best-funds-for-retirees-1031611261
2888.0,9/11/2022 11:03:19 PM,7 Blue-Chip Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-before-bull-market-returns-1031630381
2889.0,9/12/2022 9:05:45 AM,J&J reaches A$300M settlement in pelvic mesh implant class lawsuits in Australia,Seeking Alpha,https://seekingalpha.com/news/3881885-jj-reaches-a300m-settlement-in-pelvic-mesh-implant-class-lawsuits-in-australia?utm_source=businessinsider&utm_medium=referral
2890.0,9/12/2022 12:36:04 PM,Shine Justice Agrees To Settle Australian J&J/Ethicon Mesh Class Actions ,RTTNews,/news/stocks/shine-justice-agrees-to-settle-australian-j-j-ethicon-mesh-class-actions-1031736803
2891.0,9/12/2022 11:05:24 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031738400
2892.0,9/13/2022 3:49:07 PM,Cidara begins dosing of antiviral CD388 in trial for preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3882393-cidara-begins-dosing-in-study-of-antiviral-cd388-for-preventing-influenza?utm_source=businessinsider&utm_medium=referral
2893.0,9/13/2022 3:50:55 PM,3 Best Index Funds to Buy Now,InvestorPlace,/news/stocks/best-index-funds-1031567253
2894.0,9/14/2022 10:48:58 AM,J&J plans $5B stock buyback program; affirms FY22 outlook,Seeking Alpha,https://seekingalpha.com/news/3882616-jj-plans-5b-stock-buyback-program-affirms-fy22-outlook?utm_source=businessinsider&utm_medium=referral
2895.0,9/14/2022 12:52:45 PM,Johnson & Johnson Reaffirms FY22 Outlook; Authorizes Up To $5 Bln Share Buyback ,RTTNews,/news/stocks/johnson-johnson-reaffirms-fy22-outlook-authorizes-up-to-5-bln-share-buyback-1031742257
2896.0,9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral
2897.0,9/14/2022 8:24:39 PM,7 Dividend Stocks to Buy and Hold Forever¬†,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-hold-forever-2-1031743860
2898.0,9/15/2022 1:20:48 AM,The 3 Best Mutual Funds to Buy in September,InvestorPlace,/news/stocks/best-mutual-funds-1031587594
2899.0,9/17/2022 8:00:18 PM,"BioNTech, Moderna, Pfizer led biopharma revenue growth from 2020-2021",Seeking Alpha,https://seekingalpha.com/news/3883566-biontech-moderna-pfizer-led-biopharma-revenue-growth-from-2020-2021?utm_source=businessinsider&utm_medium=referral
2900.0,9/19/2022 7:00:53 PM,COVID-19 vaccine makers fall as Biden says pandemic is over (update),Seeking Alpha,https://seekingalpha.com/news/3883793-mrna-stock-lead-selloff-covid-vaccine-makers-biden-says-pandemic-over?utm_source=businessinsider&utm_medium=referral
2901.0,9/20/2022 3:00:49 PM,Ethicon To Source Eastman Renew Materials For Medical Device Sterile-barrier Packaging ,RTTNews,/news/stocks/ethicon-to-source-eastman-renew-materials-for-medical-device-sterile-barrier-packaging-1031753633
2902.0,9/21/2022 4:20:56 PM,Want To Invest Like The World's Largest Hedge Fund? 2 High Yielders That Are Recession Proof,Benzinga,/news/stocks/want-to-invest-like-the-world-s-largest-hedge-fund-2-high-yielders-that-are-recession-proof-1031756914
2903.0,9/22/2022 11:00:14 AM,7 Safe Havens All Investors Should Have Exposure to in 2022,InvestorPlace,/news/stocks/7-safe-havens-for-investors-to-have-exposure-to-in-2022-1031758874
2904.0,9/22/2022 3:21:17 PM,Gracell Biotechnologies initiated at buy at Citi citing its autologous CAR-T platform,Seeking Alpha,https://seekingalpha.com/news/3885329-gracell-biotechnologies-initiated-at-buy-at-citi-citing-its-autologous-car-t-platform?utm_source=businessinsider&utm_medium=referral
2905.0,9/22/2022 3:55:15 PM,"WHO chief reiterates belief that COVID-19 pandemic end near, says work still needed",Seeking Alpha,https://seekingalpha.com/news/3885339-who-chief-reiterates-belief-that-covid-19-pandemic-end-near-says-work-still-needed?utm_source=businessinsider&utm_medium=referral
2906.0,9/22/2022 7:25:05 PM,Healthcare outperforms S&P 500 as large cap pharma rebounds,Seeking Alpha,https://seekingalpha.com/news/3885399-healthcare-outperforms-sp-500-as-large-cap-pharma-rebounds?utm_source=businessinsider&utm_medium=referral
2907.0,9/23/2022 7:37:13 AM,NervGen Pharma appoints Bill Radvak as interim CEO,Seeking Alpha,https://seekingalpha.com/news/3885493-nervgen-pharma-appoints-bill-radvak-as-interim-ceo?utm_source=businessinsider&utm_medium=referral
2908.0,9/23/2022 11:08:24 AM,Biden administration allocates $1.5B to address U.S. opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3885562-biden-administration-allocates-15b-to-address-us-opioid-crisis?utm_source=businessinsider&utm_medium=referral
2909.0,9/23/2022 6:25:08 PM,7 Investments to FIRE Up a Fat Stash and Retire Early,InvestorPlace,/news/stocks/7-investments-for-fatfire-movement-1031762591
2910.0,9/25/2022 6:00:00 PM,The prostate cancer therapy market will soar. Here are the companies that could benefit.,Seeking Alpha,https://seekingalpha.com/news/3885824-the-prostate-cancer-therapy-market-will-soar-here-are-the-companies-that-could-benefit?utm_source=businessinsider&utm_medium=referral
2911.0,9/26/2022 11:29:08 AM,7 Stocks to Buy Before They Crush Q3 Earnings,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-crush-q3-earnings-1031764320
2912.0,9/26/2022 4:16:19 PM,3 Dividend Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-before-the-bull-market-returns-1031765258
2913.0,9/27/2022 11:15:11 AM,The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031766644
2914.0,9/27/2022 2:29:31 PM,Legend Biotech wins approval of Carvykti for multiple myeloma in Japan,Seeking Alpha,https://seekingalpha.com/news/3886395-legend-biotech-wins-approval-of-carvykti-for-multiple-myeloma-in-japan?utm_source=businessinsider&utm_medium=referral
2915.0,9/27/2022 6:32:56 PM,Investors are pouring money into healthcare and other defensive sectors as market tanks,Seeking Alpha,https://seekingalpha.com/news/3886489-investors-are-pouring-money-into-healthcare-stocks-and-other-defensive-stocks-as-market-tanks?utm_source=businessinsider&utm_medium=referral
2916.0,9/27/2022 6:50:42 PM,7 Dow Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768144
2917.0,9/27/2022 11:13:29 PM,3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768461
2918.0,9/28/2022 12:03:25 PM,Johnson & Johnson names consumer health spinoff 'Kenvue',Seeking Alpha,https://seekingalpha.com/news/3886683-johnson-johnson-names-consumer-health-spinoff-kenvue?utm_source=businessinsider&utm_medium=referral
2919.0,9/28/2022 1:44:40 PM,Johnson & Johnson wins FDA OK to expand use of myopia lenses,Seeking Alpha,https://seekingalpha.com/news/3886748-johnson-johnson-wins-fda-ok-to-expand-use-of-myopia-lenses?utm_source=businessinsider&utm_medium=referral
2920.0,9/28/2022 2:06:53 PM,Johnson & Johnson Unveils Kenvue Brand Name For Planned Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-unveils-kenvue-brand-name-for-planned-consumer-health-company-1031769895
2921.0,9/28/2022 3:21:40 PM,5 Little-Known Dividend Kings,InvestorPlace,/news/stocks/5-little-known-dividend-kings-1031770642
2922.0,9/28/2022 10:01:13 PM,"Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data",Seeking Alpha,https://seekingalpha.com/news/3886925-many-alzheimers-drug-developers-close-significantly-higher-thanks-to-biogen-eisai-data?utm_source=businessinsider&utm_medium=referral
2923.0,9/28/2022 10:45:22 PM,Aligos Therapeutics files court response and counterclaims to J&J's allegations of theft,Seeking Alpha,https://seekingalpha.com/news/3886939-aligos-therapeutics-files-court-response-and-counterclaims-to-jjs-allegations-of-theft?utm_source=businessinsider&utm_medium=referral
2924.0,9/29/2022 12:09:01 PM,The 3 Best Dividend Stocks to Buy for Retirement,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-to-buy-for-retirement-1031772709
2925.0,9/29/2022 8:36:50 PM,"Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say",Benzinga,/news/stocks/immunovant-s-new-candidate-provides-some-strategic-flexibility-clarity-analysts-say-1031773948
2926.0,10/2/2022 2:30:26 PM,7 S&P 500 Stocks to Sell Before They Die,InvestorPlace,/news/stocks/7-sp-500-stocks-to-sell-before-they-die-1031779874
2927.0,10/3/2022 10:14:22 AM,"Svante P√§√§bo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral
2928.0,10/3/2022 12:33:53 PM,Clovis stock rises 10% as Rubraca shows survival benefit in prostate cancer in confirmatory trial,Seeking Alpha,https://seekingalpha.com/news/3887902-clovis-stock-rises-as-rubraca-shows-survival-benefit-in-prostate-cancer-in-confirmatory-trial?utm_source=businessinsider&utm_medium=referral
2929.0,10/3/2022 11:56:59 PM,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint ‚Äî It's Very Short,Benzinga,/news/etf/the-short-list-of-dow-jones-stocks-that-are-actually-up-this-year-hint-‚Äî-it-s-very-short-1031780150
2930.0,10/4/2022 11:04:52 AM,7 Recession-Proof Stocks to Buy in October¬†,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-in-october-1031781197
2931.0,10/5/2022 4:25:31 PM,Bankruptcy judge temporarily prevents two states from suing J&J over talc safety,Seeking Alpha,https://seekingalpha.com/news/3888954-bankruptcy-judge-temporarily-prevents-two-states-from-suing-johnson-johnson-over-talc-safety?utm_source=businessinsider&utm_medium=referral
2932.0,10/5/2022 7:05:49 PM,Ray Dalio Is Stepping Down. Here Are His Top 5 Stock Bets.,InvestorPlace,/news/stocks/ray-dalio-is-stepping-down-here-are-his-top-5-stock-bets-1031785604
2933.0,10/6/2022 11:26:50 AM,7 Dividend Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/7-dividend-stocks-that-are-too-cheap-to-ignore-1031787020
2934.0,10/6/2022 6:34:41 PM,Want to Bet Against Jim Cramer? Short These 10 Stocks.,InvestorPlace,/news/stocks/want-to-bet-against-jim-cramer-short-these-10-stocks-1031788455
2935.0,10/7/2022 5:40:40 PM,Former J&J executive is tipped to become Biogen CEO ‚Äì Stat News,Seeking Alpha,https://seekingalpha.com/news/3889747-former-jj-executive-is-tipped-to-become-biogen-ceo-stat-news?utm_source=businessinsider&utm_medium=referral
2936.0,10/7/2022 6:02:20 PM,U.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries,Seeking Alpha,https://seekingalpha.com/news/3889752-us-report-says-covid-vaccines-led-to-over-300k-fewer-deaths-among-medicare-beneficiaries?utm_source=businessinsider&utm_medium=referral
2937.0,10/7/2022 9:46:21 PM,"JNJ, MDT: Are Their ~3% Dividend Yields Worth It?",TipRanks,/news/stocks/jnj-mdt-are-their-~3-dividend-yields-worth-it-1031790938
2938.0,10/10/2022 10:30:32 AM,This Is the Best Time to Buy These 7 Long-Term Blue-Chip Stocks,InvestorPlace,/news/stocks/this-is-the-best-time-to-buy-these-7-long-term-blue-chip-stocks-1031792717
2939.0,10/10/2022 3:21:50 PM,Johnson & Johnson highlights long-term effect of ulcerative colitis therapy,Seeking Alpha,https://seekingalpha.com/news/3890049-johnson-johnson-highlights-long-term-effect-of-ulcerative-colitis-therapy?utm_source=businessinsider&utm_medium=referral
2940.0,10/10/2022 5:35:12 PM,"J&J says Tremfya, Simponi combination effective for ulcerative colitis",Seeking Alpha,https://seekingalpha.com/news/3890091-johnson-johnson-says-tremfya-simponi-combination-effective-for-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral
2941.0,10/10/2022 6:09:22 PM,GOP senators introduce bill to undo Medicare prescription drug negotiation,Seeking Alpha,https://seekingalpha.com/news/3890099-gop-senators-introduce-bill-to-undo-medicare-prescription-drug-negotiation?utm_source=businessinsider&utm_medium=referral
2942.0,10/12/2022 11:57:47 AM,BeiGene Brukinsa shows better survival benefit vs Imbruvica in blood cancer patients in trial,Seeking Alpha,https://seekingalpha.com/news/3890655-beigene-brukinsa-shows-better-survival-benefit-vs-imbruvica-in-blood-cancer-patients-in-trial?utm_source=businessinsider&utm_medium=referral
2943.0,10/12/2022 7:07:29 PM,What 7 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-7-analyst-ratings-have-to-say-about-johnson-johnson-1031800562
2944.0,10/12/2022 8:19:14 PM,Analyst Casts Doubts On Merus' Lung Candidate Safety Profile,Benzinga,/news/stocks/analyst-casts-doubts-on-merus-lung-candidate-safety-profile-1031800674
2945.0,10/13/2022 8:43:29 AM,GSK RSV vaccine for older adults shows 94.1% efficacy in severe disease in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3890968-gsk-rsv-vaccine-for-older-adults-shows-941-efficacy-in-severe-disease-in-phase-3-trial?utm_source=businessinsider&utm_medium=referral
2946.0,10/13/2022 10:07:43 AM,J&J's Biosense launches Heliostar balloon ablation catheter in Europe,Seeking Alpha,https://seekingalpha.com/news/3890979-jjs-biosense-launches-heliostar-balloon-ablation-catheter-in-europe?utm_source=businessinsider&utm_medium=referral
2947.0,10/13/2022 5:28:57 PM,BeiGene upgraded to buy at Guggenheim on improved confidence in Brukinsa potential,Seeking Alpha,https://seekingalpha.com/news/3891157-beigene-upgraded-to-buy-at-guggenheim-on-improved-confidence-in-brukinsa-potential?utm_source=businessinsider&utm_medium=referral
2948.0,10/13/2022 9:46:53 PM,3 Dow Stocks to Buy if You Are Feeling Greedy,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-if-you-are-feeling-greedy-1031804612
2949.0,10/14/2022 3:55:21 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031804731
2950.0,10/14/2022 12:24:33 PM,Biden to sign Executive Order tasking HHS to find additional ways to lower drug costs,Seeking Alpha,https://seekingalpha.com/news/3891387-biden-to-sign-executive-order-tasking-hhs-to-find-additional-ways-to-lower-drug-costs-medicare?utm_source=businessinsider&utm_medium=referral
2951.0,10/14/2022 5:10:04 PM,"Earnings week ahead: Tesla, Netflix, Johnson & Johnson, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3891460-earnings-week-ahead-tesla-netflix-johnson-johnson-att-and-more?utm_source=businessinsider&utm_medium=referral
2952.0,10/14/2022 6:30:00 PM,"Catalyst Watch: Tesla, Netflix, Fisker, TechCrunch Disrupt and Paris Motor Show headline big week",Seeking Alpha,https://seekingalpha.com/news/3891159-catalyst-watch-tesla-netflix-techcrunch-disrupt-and-paris-motor-show-headline-big-week?utm_source=businessinsider&utm_medium=referral
2953.0,10/17/2022 9:05:30 AM,Bill & Melinda Gates Foundation commits $1.2B to end polio,Seeking Alpha,https://seekingalpha.com/news/3891702-bill-melinda-gates-foundation-commit-12b-to-end-polio?utm_source=businessinsider&utm_medium=referral
2954.0,10/17/2022 2:43:09 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3891864-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
2955.0,10/17/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q3-1031810009
2956.0,10/17/2022 4:15:31 PM,Johnson & Johnson to report Q3 earnings amid macro concerns on guidance,Seeking Alpha,https://seekingalpha.com/news/3891898-johnson-johnson-to-report-q3-earnings-amid-macro-concerns-on-guidance?utm_source=businessinsider&utm_medium=referral
2957.0,10/18/2022 10:03:45 AM,"Goldman Sachs, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/goldman-sachs-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031812521
2958.0,10/18/2022 10:27:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M",Seeking Alpha,https://seekingalpha.com/news/3892097-johnson-and-johnson-non-gaap-eps-of-2_55-beats-0_06-revenue-of-23_8b-beats-360m?utm_source=businessinsider&utm_medium=referral
2959.0,10/18/2022 11:07:24 AM,Johnson & Johnson lowers 2022 guidance amid inflationary and forex impact,Seeking Alpha,https://seekingalpha.com/news/3892112-johnson-johnson-lowers-2022-guidance-amid-inflationary-and-forex-impact?utm_source=businessinsider&utm_medium=referral
2960.0,10/18/2022 12:04:15 PM,"US Stock Futures Surge Following Monday's Rally; Goldman Sachs, Johnson & Johnson Earnings In Focus",Benzinga,/news/stocks/us-stock-futures-surge-following-monday-s-rally-goldman-sachs-johnson-johnson-earnings-in-focus-1031812722
2961.0,10/18/2022 12:34:33 PM,"Johnson & Johnson Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q3-profit-increases-beats-estimates-1031812774
2962.0,10/18/2022 1:10:43 PM,Johnson & Johnson Q3 Profit Beats Estimates; Adj. Operational Sales Up 8.2%; Increases Guidance ,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-adj-operational-sales-up-8-2-increases-guidance-1031812929
2963.0,10/18/2022 1:15:02 PM,"US Stocks' Momentum Set To Continue Tuesday As Nasdaq Futures Lead Rally ‚Äî Tesla, Goldman, J&J, United Airlines In Focus",Benzinga,/news/stocks/us-stocks-momentum-set-to-continue-tuesday-as-nasdaq-futures-lead-rally-‚Äî-tesla-goldman-j-j-united-airlines-in-focus-1031812959
2964.0,10/18/2022 1:37:18 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-1031813799
2965.0,10/18/2022 1:38:42 PM,"AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session",Benzinga,/news/stocks/aveo-pharmaceuticals-akouos-and-some-other-big-stocks-moving-higher-in-today-s-pre-market-session-1031813041
2966.0,10/18/2022 1:58:42 PM,CANO Stock Jumps Despite Rumors CVS Is Walking Away From Cano Health Acquisition,InvestorPlace,/news/stocks/cano-stock-jumps-despite-rumors-cvs-is-walking-away-from-cano-health-acquisition-1031813930
2967.0,10/18/2022 2:30:39 PM,"Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18",Benzinga,/news/stocks/complete-exit-for-exxon-from-russia-microsoft-s-layoffs-another-setback-for-boeing-s-potential-737-max-7-approval-visa-mastercard-under-ftc-probe-top-stories-tuesday-oct-18-1031813286
2968.0,10/18/2022 4:09:22 PM,Johnson & Johnson weighs job cuts ahead of consumer health spinoff,Seeking Alpha,https://seekingalpha.com/news/3892300-johnson-johnson-weighs-job-cuts-ahead-of-consumer-health-spinoff?utm_source=businessinsider&utm_medium=referral
2969.0,10/18/2022 6:03:51 PM,Colgate gains after activist Third Point takes stake (update),Seeking Alpha,https://seekingalpha.com/news/3892236-colgate-gains-on-report-activist-third-point-takes-stake-in-colgate?utm_source=businessinsider&utm_medium=referral
2970.0,10/18/2022 7:52:05 PM,Legend Biotech climbs as analysts probe JNJ Q3 results to estimate Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/3892388-legn-stock-climbs-as-analysts-parse-jnj-q3-to-estimate-carvykti-sales?utm_source=businessinsider&utm_medium=referral
2971.0,10/19/2022 12:25:40 PM,Johnson & Johnson (NYSE:JNJ) Eyes Job Cuts as Macro Pressures Persist,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-eyes-job-cuts-as-macro-pressures-persist-1031817309
2972.0,10/19/2022 12:35:55 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1031817392
2973.0,10/19/2022 12:40:36 PM,"Analysts Conflicted on These Healthcare Names: Amarin (AMRN), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-amarin-amrn-johnson-johnson-jnj-and-unitedhealth-unh-1031817383
2974.0,10/19/2022 2:56:15 PM,Goldman Sachs To $410? Plus Credit Suisse Predicts $272 For McDonald's,Benzinga,/news/stocks/goldman-sachs-to-410-plus-credit-suisse-predicts-272-for-mcdonald-s-1031817530
2975.0,10/19/2022 4:32:05 PM,"Analysts Are Neutral on These Healthcare Stocks: Intuitive Surgical (ISRG), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-intuitive-surgical-isrg-johnson-johnson-jnj-1031818361
2976.0,10/19/2022 5:52:27 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-best-blue-chip-stocks-to-buy-now-1031818533
2977.0,10/20/2022 12:26:56 PM,J&J's Teligen system gets FDA clearance for use in spinal surgeries,Seeking Alpha,https://seekingalpha.com/news/3893113-jjs-teligen-system-gets-fda-clearance-for-use-in-spinal-surgeries?utm_source=businessinsider&utm_medium=referral
2978.0,10/20/2022 1:36:54 PM,AbbVie to acquire DJS Antibodies for $255M to bolster immunology pipeline,Seeking Alpha,https://seekingalpha.com/news/3893196-abbvie-to-acquire-djs-antibodies-for-255m-to-bolster-immunology-pipeline?utm_source=businessinsider&utm_medium=referral
2979.0,10/20/2022 5:19:54 PM,Prescription drugs make up a rising share of Medicare spending ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3893317-prescription-drugs-account-for-a-rising-chunk-of-medicare-spending-study?utm_source=businessinsider&utm_medium=referral
2980.0,10/20/2022 5:52:21 PM,CDC panel recommends adding COVID-19 vaccines to regular immunizations,Seeking Alpha,https://seekingalpha.com/news/3893337-cdc-panel-recommends-adding-covid-19-vaccines-to-regular-immunizations?utm_source=businessinsider&utm_medium=referral
2981.0,10/20/2022 9:34:45 PM,Johnson & Johnson bags $244M defense logistics contract,Seeking Alpha,https://seekingalpha.com/news/3893508-johnson-johnson-bags-244m-defense-logistics-contract?utm_source=businessinsider&utm_medium=referral
2982.0,10/21/2022 1:15:41 AM,Credit Suisse Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/credit-suisse-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1031822861
2983.0,10/21/2022 5:56:11 PM,"Talks begin with pharma, health insurers over negotiating drug prices for Medicare",Seeking Alpha,https://seekingalpha.com/news/3893788-talks-begin-with-pharma-health-insurers-over-negotiating-drug-prices-for-medicare?utm_source=businessinsider&utm_medium=referral
2984.0,10/22/2022 8:00:00 PM,"J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market",Seeking Alpha,https://seekingalpha.com/news/3893816-johnson-johnson-alkermes-abbvie-others-set-to-benefit-from-expanding-schizophrenia-drug-market?utm_source=businessinsider&utm_medium=referral
2985.0,10/23/2022 4:00:00 PM,"Pfizer, Moderna bank on price hikes, updated shots to retain COVID vaccine duopoly",Seeking Alpha,https://seekingalpha.com/news/3893783-pfizer-moderna-bank-on-price-hikes-updated-shots-to-win-covid-vaccine-duopoly?utm_source=businessinsider&utm_medium=referral
2986.0,10/24/2022 1:58:47 PM,"'Right Now I Don't Want To Back Away From It,' Jim Cramer Says About This Stock Down Only 8% This Year",Benzinga,/news/stocks/right-now-i-don-t-want-to-back-away-from-it-jim-cramer-says-about-this-stock-down-only-8-this-year-1031828185
2987.0,10/25/2022 7:01:39 PM,Updated COVID boosters did not outperform original COVID vaccines ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3895008-updated-covid-boosters-did-not-outperform-original-covid-vaccines-study?utm_source=businessinsider&utm_medium=referral
2988.0,10/25/2022 8:01:58 PM,Johnson & Johnson wins FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3895052-johnson-johnson-wins-fda-approval-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral
2989.0,10/27/2022 6:06:16 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031841991
2990.0,10/27/2022 8:37:46 PM,"Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock",Benzinga,/news/stocks/analyst-sees-market-potential-for-arcellx-multiple-myeloma-candidate-sees-50-upside-in-stock-1031844903
2991.0,10/29/2022 10:19:32 AM,"Constructing a Stock Portfolio ‚Äî What to Consider, What to Avoid",TipRanks,/news/stocks/constructing-a-stock-portfolio-‚Äî-what-to-consider-what-to-avoid-1031849725
2992.0,10/29/2022 8:00:00 PM,"With medical devices market expected to soar, here are companies set to benefit the most",Seeking Alpha,https://seekingalpha.com/news/3897411-with-medical-devices-market-expected-to-soar-here-are-companies-set-to-benefit-the-most?utm_source=businessinsider&utm_medium=referral
2993.0,10/31/2022 11:15:50 AM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-bear-market-stocks-to-buy-now-1031853131
2994.0,10/31/2022 12:14:49 PM,ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset,Seeking Alpha,https://seekingalpha.com/news/3897672-epix-stock-drops-after-johnson--johnson-setback-for-prostrate-cancer-drug?utm_source=businessinsider&utm_medium=referral
2995.0,10/31/2022 12:37:03 PM,Sonnet stock soars 16% on collaboration with J&J for 3 drug compounds,Seeking Alpha,https://seekingalpha.com/news/3897688-sonnet-stock-soars-16-on-collaboration-with-jj-for-3-drug-compounds?utm_source=businessinsider&utm_medium=referral
2996.0,10/31/2022 4:28:38 PM,7 Blue-Chip Stocks Set to Soar From 52-Week Lows,InvestorPlace,/news/stocks/7-blue-chip-stocks-set-to-soar-from-52-week-lows-1031854441
2997.0,10/31/2022 6:30:10 PM,Why Is Sonnet BioTherapeutics (SONN) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-sonnet-biotherapeutics-sonn-stock-up-100-today-1031854886
2998.0,11/1/2022 4:31:30 AM,7 Cash-Rich Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/7-cash-rich-dividend-stocks-to-buy-now-1031855561
2999.0,11/1/2022 11:54:21 AM,Abiomed climbs 52% on $380/ share buyout deal with Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3898357-abmd-stock-surges-on-buyout-deal-with-johnson--johnson?utm_source=businessinsider&utm_medium=referral
3000.0,11/1/2022 12:37:04 PM,Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market ,RTTNews,/news/stocks/abiomed-to-be-bought-by-johnson-johnson-in-16-6-bln-deal-stock-surges-in-pre-market-1031857889
3001.0,11/1/2022 1:42:21 PM,Why Is Abiomed (ABMD) Stock Up 50% Today?,InvestorPlace,/news/stocks/why-is-abiomed-abmd-stock-up-50-today-1031858696
3002.0,11/1/2022 1:47:55 PM,Johnson & Johnson said to have approached Abiomed,Seeking Alpha,https://seekingalpha.com/news/3898558-johnson-johnson-said-to-have-approached-abiomed?utm_source=businessinsider&utm_medium=referral
3003.0,11/1/2022 5:26:53 PM,Legend Biotech initiated at outperform at Cowen on strength of Carvykti,Seeking Alpha,https://seekingalpha.com/news/3898764-legend-biotech-initiated-at-outperform-at-cowen-on-strength-of-carvykti?utm_source=businessinsider&utm_medium=referral
3004.0,11/1/2022 5:51:17 PM,Abiomed unlikely to see higher bid given size of J&J premium - analyst,Seeking Alpha,https://seekingalpha.com/news/3898849-abiomed-unlikely-to-see-higher-bid-given-size-of-jj-premium-analyst?utm_source=businessinsider&utm_medium=referral
3005.0,11/1/2022 9:28:16 PM,What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal,Benzinga,/news/etf/what-to-watch-in-the-s-p-biotech-etf-after-johnson-johnson-s-16-6b-abiomed-deal-1031860263
3006.0,11/2/2022 12:25:29 AM,Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.,InvestorPlace,/news/stocks/hurry-7-pitiful-nasdaq-stocks-to-sell-before-2022-ends-1031860759
3007.0,11/3/2022 1:06:27 PM,Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It',Benzinga,/news/stocks/cramer-s-take-on-this-stock-that-s-down-53-year-to-date-i-think-long-term-i-don-t-want-to-own-it-1031870171
3008.0,11/3/2022 4:30:26 PM,"Cancer drugs launch prices soaring, straining Medicare, report finds",Seeking Alpha,https://seekingalpha.com/news/3901117-cancer-drugs-launch-prices-soaring-straining-medicare-report-finds?utm_source=businessinsider&utm_medium=referral
3009.0,11/3/2022 7:34:14 PM,Why Is Provention Biosciences (PRVB) Stock Up 25% Today?,InvestorPlace,/news/stocks/why-is-provention-biosciences-prvb-stock-up-25-today-1031872165
3010.0,11/4/2022 5:30:43 PM,"Catalyst watch: CPI downtick, election ripples, Disney and Rivian earnings, Roblox conference call",Seeking Alpha,https://seekingalpha.com/news/3902134-catalyst-watch-cpi-downtick-election-ripples-disney-and-rivian-earnings-roblox-conference-call?utm_source=businessinsider&utm_medium=referral
3011.0,11/6/2022 2:00:31 PM,"M&A investors have tough, unexpected week with Rogers deal termination, Albertsons dividend",Seeking Alpha,https://seekingalpha.com/news/3902379-ma-investors-have-tough-unexpected-week-with-rogers-deal-termination-albertsons-dividend?utm_source=businessinsider&utm_medium=referral
3012.0,11/6/2022 5:00:24 PM,"Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report",Seeking Alpha,https://seekingalpha.com/news/3902378-off-patent-drugs-make-up-91-of-prescriptions-18-of-spending?utm_source=businessinsider&utm_medium=referral
3013.0,11/7/2022 2:05:19 PM,"Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'",Benzinga,/news/stocks/cramer-on-this-stock-up-138-year-to-date-santa-can-t-afford-that-coal-it-s-going-up-too-much-1031881232
3014.0,11/7/2022 8:42:12 PM,Former J&J exec no longer seen as frontrunner for Biogen CEO position  - STAT,Seeking Alpha,https://seekingalpha.com/news/3902997-former-johnson-johnson-exec-no-longer-seen-as-frontrunner-for-biogen-ceo-position-stat?utm_source=businessinsider&utm_medium=referral
3015.0,11/8/2022 5:50:15 AM,"PFE, JNJ, or CVS: Which Healthcare Stock is a ‚ÄúStrong Buy‚Äù for Wall Street Pros?",TipRanks,/news/stocks/pfe-jnj-or-cvs-which-healthcare-stock-is-a-strong-buy-for-wall-street-pros-1031885165
3016.0,11/8/2022 7:04:04 PM,The 7 Best Pharma Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-pharma-stocks-to-buy-now-1031893081
3017.0,11/8/2022 8:37:59 PM,Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?,Benzinga,/news/stocks/election-day-is-here-which-politicians-are-profiting-or-losing-on-stocks-1031888216
3018.0,11/9/2022 7:19:11 PM,"'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target",Benzinga,/news/stocks/waiting-game-continues-in-emergent-biosolutions-analysts-cut-price-target-1031893444
3019.0,11/11/2022 5:12:10 PM,J&J analysis: Early Tremfya efficacy in psoriatic arthritis can predict long-term response,Seeking Alpha,https://seekingalpha.com/news/3906562-johnson-johnson-analysis-early-tremfya-efficacy-in-psoriatric-arthritis-can-predict-long-term-response?utm_source=businessinsider&utm_medium=referral
3020.0,11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral
3021.0,11/11/2022 11:34:31 PM,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",Benzinga,/news/etf/these-2-dividend-paying-etfs-have-a-track-record-for-increasing-payments-can-help-diversify-against-industry-risk-1031905724
3022.0,11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral
3023.0,11/15/2022 2:37:53 AM,The Top Dividend Stocks to Prepare for Retirement ‚Äì And How to Choose Them,TipRanks,/news/stocks/the-top-dividend-stocks-to-prepare-for-retirement-‚Äì-and-how-to-choose-them-1031912167
3024.0,11/16/2022 9:52:53 AM,"GSK tops Access to Medicine Index, to invest ¬£100M for initiatives in low income countries",Seeking Alpha,https://seekingalpha.com/news/3908464-gsk-tops-access-to-medicine-index-to-invest-100m-for-initiatives-in-low-income-countries?utm_source=businessinsider&utm_medium=referral
3025.0,11/18/2022 5:03:50 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031925789
3026.0,11/18/2022 5:58:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-18-2022-1031925925
3027.0,11/18/2022 6:01:11 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1031925921
3028.0,11/18/2022 8:01:50 PM,7 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-johnson-johnson-1031926149
3029.0,11/18/2022 8:54:31 PM,Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock,Benzinga,/news/stocks/analyst-expects-derisking-required-ahead-of-patent-expiry-for-this-large-pharma-medtech-stock-1031926255
3030.0,11/21/2022 2:02:22 PM,7 Must-Own Safe Havens as Market Selloff Accelerates,InvestorPlace,/news/stocks/7-must-own-safe-havens-as-market-selloff-accelerates-1031928733
3031.0,11/30/2022 3:54:10 PM,Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?,InvestorPlace,/news/stocks/why-is-horizon-therapeutics-hznp-stock-up-30-today-1031945358
3032.0,11/30/2022 7:52:36 PM,Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout,Benzinga,/news/stocks/analyst-forecasts-101-117-share-offer-price-for-horizon-therapeutics-buyout-1031946005
3033.0,12/1/2022 2:42:14 AM,J&J Elects Its CEO Joaquin Duato To Assume Additional Position Of Chairman ,RTTNews,/news/stocks/j-j-elects-its-ceo-joaquin-duato-to-assume-additional-position-of-chairman-1031946511
3034.0,12/5/2022 4:30:33 PM,Why Is Yumanity Therapeutics (YMTX) Stock Up Today?,InvestorPlace,/news/stocks/why-is-yumanity-therapeutics-ymtx-stock-up-today-1031953540
3035.0,12/5/2022 8:22:27 PM,7 Iron-Clad Stocks That Will Resist the Market Turmoil,InvestorPlace,/news/stocks/7-iron-clad-stocks-that-will-resist-the-market-turmoil-1031953891
3036.0,12/6/2022 4:25:35 PM,Morgan Stanley Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1031956250
3037.0,12/8/2022 1:43:23 PM,Abiomed ticks higher after HSR waiting period for Johnson & Johnson sale expires,Seeking Alpha,https://seekingalpha.com/news/3915276-abiomed-ticks-higher-after-hsr-waiting-period-for-johnson-johnson-sale-expires?utm_source=businessinsider&utm_medium=referral
3038.0,12/8/2022 7:28:13 PM,"Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims",Benzinga,/news/stocks/gracell-biotech-stock-has-over-100-upside-on-next-gen-car-t-platforms-analyst-claims-1031961324
3039.0,12/8/2022 7:28:42 PM,EU wants to delay medical device law amid supply challenges - Reuters,Seeking Alpha,https://seekingalpha.com/news/3915442-eu-wants-to-delay-medical-device-law-amid-supply-challenges-reuters?utm_source=businessinsider&utm_medium=referral
3040.0,12/9/2022 6:56:26 PM,The 7 Best Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-1031665405
3041.0,12/11/2022 7:24:02 PM,Amgen said in advanced talks to buy Horizon Therapeutics for well over $20B - WSJ,Seeking Alpha,https://seekingalpha.com/news/3915954-amgen-said-in-advanced-talks-to-buy-horizon-therapeutics-wsj?utm_source=businessinsider&utm_medium=referral
3042.0,12/12/2022 2:19:47 AM,Sanofi Says Doesn't Intend To Make Offer For Horizon; But Amgen Reportedly In Advanced Talks ,RTTNews,/news/stocks/sanofi-says-doesn-t-intend-to-make-offer-for-horizon-but-amgen-reportedly-in-advanced-talks-1031964257
3043.0,12/12/2022 11:40:45 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Surgery Partners (SGRY) and Reata Pharmaceuticals (RETA)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-surgery-partners-sgry-and-reata-pharmaceuticals-reta-1031965110
3044.0,12/12/2022 2:47:43 PM,Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal,InvestorPlace,/news/stocks/horizon-therapeutics-hznp-stock-pops-on-huge-amgen-deal-1031967131
3045.0,12/12/2022 3:03:26 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031965423
3046.0,12/12/2022 5:34:15 PM,Allogene down 11% following downgrade to underperform at BofA,Seeking Alpha,https://seekingalpha.com/news/3916226-allogene-down-11-downgraded-to-underperform-at-bofa-on-lack-of-catalysts-competitiveness-concerns?utm_source=businessinsider&utm_medium=referral
3047.0,12/13/2022 6:50:12 PM,BeiGene says Brukinsa bests J&J's Imbruvica in progression-free survival for leukemia,Seeking Alpha,https://seekingalpha.com/news/3916643-beigene-says-brukinsa-bests-johnson-johnson-imbruvica-in-progression-free-survival-for-leukemia?utm_source=businessinsider&utm_medium=referral
3048.0,12/13/2022 7:53:05 PM,The 7 Best Investment Funds to Navigate a Possible Recession,InvestorPlace,/news/stocks/the-7-best-investment-funds-to-navigate-possible-recession-1031970170
3049.0,12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral
3050.0,12/14/2022 7:02:53 PM,Colorado becomes fourth state to ask feds to import drugs from Canada,Seeking Alpha,https://seekingalpha.com/news/3917055-colorado-becomes-fourth-state-to-ask-feds-to-import-drugs-from-canada?utm_source=businessinsider&utm_medium=referral
3051.0,12/15/2022 9:34:46 AM,FDA extends review of AstraZeneca/Merck's Lynparza's expanded use in prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3917418-fda-extends-review-of-astrazenecamercks-lynparzas-expanded-use-in-prostate-cancer?utm_source=businessinsider&utm_medium=referral
3052.0,12/15/2022 11:08:17 AM,"J&J, Merck Ebola vaccines show lasting antibody response in kids, adults in trials",Seeking Alpha,https://seekingalpha.com/news/3917434-jj-merck-ebola-vaccines-show-lasting-antibody-response-in-kids-and-adults-in-trials?utm_source=businessinsider&utm_medium=referral
3053.0,12/16/2022 11:25:27 AM,7 Top-Rated Large-Cap Stocks to Buy and Hold,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-and-hold-1031827937
3054.0,12/16/2022 4:46:26 PM,FDA sets January meeting to consider further updates to COVID shots,Seeking Alpha,https://seekingalpha.com/news/3918097-fda-sets-january-meeting-to-consider-further-updates-to-covid-shots?utm_source=businessinsider&utm_medium=referral
3055.0,12/16/2022 6:04:34 PM,Time to start nibbling at stocks; 'this is not all gloom and doom' - Hightower's Stephanie Link,Seeking Alpha,https://seekingalpha.com/news/3918108-hightowers-stephanie-link-markets-will-sky-rocket-when-fed-will-pivot-but-not-very-soon?utm_source=businessinsider&utm_medium=referral
3056.0,12/18/2022 9:34:20 PM,The 7 Best Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/best-retirement-stocks-1031562793
3057.0,12/19/2022 10:41:09 PM,"Abiomed leaving S&P 500, replaced by Steel Dynamics",Seeking Alpha,https://seekingalpha.com/news/3918757-abiomed-leaving-sp-500-replaced-by-steel-dynamics?utm_source=businessinsider&utm_medium=referral
3058.0,12/20/2022 12:35:00 AM,Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400,PR Newswire,/news/stocks/steel-dynamics-set-to-join-s-p-500-super-micro-computer-to-join-s-p-midcap-400-1031981302
3059.0,12/20/2022 1:30:49 AM,Steel Dynamics To Replace Abiomed In S&P 500 ,RTTNews,/news/stocks/steel-dynamics-to-replace-abiomed-in-s-p-500-1031981329
3060.0,12/20/2022 3:12:22 PM,"CVS, Walgreens limiting purchases of children's pain relief meds on high demand",Seeking Alpha,https://seekingalpha.com/news/3918953-cvs-walgreens-limiting-purchases-of-childrens-pain-relief-meds-on-high-demand?utm_source=businessinsider&utm_medium=referral
3061.0,12/20/2022 5:00:22 PM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/best-bear-market-stocks-1031573318
3062.0,12/21/2022 7:00:40 PM,7 Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/dividend-stocks-to-buy-and-hold-1031557866
3063.0,12/22/2022 7:44:36 AM,Johnson & Johnson (NYSE:JNJ): This Dividend King is an Appealing Retirement Stock,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-this-dividend-king-is-an-appealing-retirement-stock-1031986408
3064.0,12/22/2022 2:28:07 PM,Johnson & Johnson closes Abiomed acquisition,Seeking Alpha,https://seekingalpha.com/news/3919803-jnj-stock-dips-closes-abiomed-acquisition?utm_source=businessinsider&utm_medium=referral
3065.0,12/23/2022 4:51:10 PM,Immune-evasive Omicron subvariant XBB rapidly gaining ground in U.S.,Seeking Alpha,https://seekingalpha.com/news/3920398-immune-evasive-omicron-subvariant-xbb-rapidly-gaining-ground-in-us?utm_source=businessinsider&utm_medium=referral
3066.0,12/23/2022 8:21:12 PM,"Tax-loss selling, window dressing will likely ruin Santa Claus rally - DCLA's Sarat Sethi",Seeking Alpha,https://seekingalpha.com/news/3920543-fed-spooks-santa-claus-rally-dclas-sarat-sethi?utm_source=businessinsider&utm_medium=referral
3067.0,12/24/2022 6:17:58 PM,"Barron's Top Weekend Stock Picks: Costco, Johnson & Johnson, And How Tesla Could Become A Value Stock",Benzinga,/news/stocks/barron-s-top-weekend-stock-picks-costco-johnson-johnson-and-how-tesla-could-become-a-value-stock-1031989835
3068.0,12/26/2022 12:05:59 PM,The 7 Best Warren Buffett Stocks to Buy,InvestorPlace,/news/stocks/best-warren-buffett-stocks-1031570894
3069.0,12/30/2022 5:45:22 PM,Merck is best performing large U.S. pharma of 2022,Seeking Alpha,https://seekingalpha.com/news/3921306-merck-is-best-performing-large-us-pharma-of-2022?utm_source=businessinsider&utm_medium=referral
3070.0,12/30/2022 6:19:49 PM,Omicron subvariant XBB becomes dominant COVID strain in U.S.,Seeking Alpha,https://seekingalpha.com/news/3921324-omicron-subvariant-xbb-becomes-dominant-covid-strain-in-us?utm_source=businessinsider&utm_medium=referral
3071.0,12/31/2022 3:00:00 PM,"Align, Invitae among healthcare stocks SA contributors correctly said to avoid in 2022",Seeking Alpha,https://seekingalpha.com/news/3920820-align-invitae-among-health-names-sa-contributors-correctly-said-to-avoid-in-2022?utm_source=businessinsider&utm_medium=referral
3072.0,1/2/2023 11:33:02 AM,7 Stocks for Beginners to Buy Now,InvestorPlace,/news/stocks/best-stocks-for-beginners-1031607349
3073.0,1/3/2023 9:24:44 AM,"J&J, Legend Biotech's Carvykti for multiple myeloma gets review in China",Seeking Alpha,https://seekingalpha.com/news/3921428-jj-legend-biotechs-carvykti-for-multiple-myeloma-gets-review-in-china?utm_source=businessinsider&utm_medium=referral
3074.0,1/3/2023 7:20:31 PM,7 Must-Buy Dividend Stocks for Your January Buy List,InvestorPlace,/news/stocks/7-must-buy-dividend-stocks-for-your-january-buy-list-1031998516
3075.0,1/3/2023 7:43:16 PM,Immunovant gains as Wells Fargo names as a top SMID cap biotech pick,Seeking Alpha,https://seekingalpha.com/news/3921686-imvt-stock-gains-wells-fargo-names-top-smid-cap-biotech-pick?utm_source=businessinsider&utm_medium=referral
3076.0,1/4/2023 5:30:15 PM,The 10 Best Dividend Stocks of All Time¬†,InvestorPlace,/news/stocks/best-dividend-stocks-of-all-time-1031596593
3077.0,1/4/2023 6:55:55 PM,7 Safe Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/safe-stocks-to-buy-and-hold-1031612420
3078.0,1/4/2023 11:34:40 PM,J&J consumer health spinout Kenvue files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/3922164-jj-consumer-health-spinout-kenvue-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral
3079.0,1/5/2023 3:39:49 AM,Johnson & Johnson's Consumer Health Unit Kenvue Files For IPO ,RTTNews,/news/stocks/johnson-johnson-s-consumer-health-unit-kenvue-files-for-ipo-1032001078
3080.0,1/5/2023 10:42:21 PM,"Fate Therapeutics shares crater ~50% on ending tie-up with Janssen, layoffs",Seeking Alpha,https://seekingalpha.com/news/3922552-fate-therapeutics-shares-crater-50-on-ending-tie-up-with-janssen-layoffs?utm_source=businessinsider&utm_medium=referral
3081.0,1/6/2023 10:26:55 AM,"Alvotech, Teva get FDA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3922582-alvotech-teva-get-fda-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral
3082.0,1/6/2023 4:27:19 PM,"Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff",Benzinga,/news/stocks/fate-therapeutics-ends-collaboration-deal-with-janssen-cuts-staff-1032004507
3083.0,1/6/2023 5:41:34 PM,Fate faces slew of analyst downgrades after J&J's Janssen unit ends agreement,Seeking Alpha,https://seekingalpha.com/news/3922756-fate-faces-slew-of-analyst-downgrades-after-johnson-johnson-janssen-unit-ends-agreement?utm_source=businessinsider&utm_medium=referral
3084.0,1/6/2023 8:48:56 PM,"CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC",InvestorPlace,/news/stocks/crispr-layoffs-2023-job-cuts-hit-gene-editing-stocks-fate-tcrr-ipsc-1032005093
3085.0,1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182
3086.0,1/10/2023 11:34:49 AM,7 Warren Buffet Stocks to Buy and Hold for the Next Decade,InvestorPlace,/news/stocks/warren-buffett-stocks-to-buy-and-hold-1031558120
3087.0,1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral
3088.0,1/10/2023 6:45:11 PM,Cosmos extends and updates deal to acquire Cana Laboratories,Seeking Alpha,https://seekingalpha.com/news/3923434-cosmos-extends-and-updates-deal-to-acquire-cana-laboratories?utm_source=businessinsider&utm_medium=referral
3089.0,1/10/2023 6:48:19 PM,"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-here-s-how-much-you-d-have-now-1032010420
3090.0,1/11/2023 9:49:15 AM,Alvotech starts study of biosimilar of J&J's rheumatoid arthritis drug Simponi,Seeking Alpha,https://seekingalpha.com/news/3923570-alvotech-starts-study-of-biosimilar-of-jjs-rheumatoid-arthritis-drug-simponi?utm_source=businessinsider&utm_medium=referral
3091.0,1/11/2023 6:06:37 PM,7 Hot Healthcare Stocks to Watch in 2023,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-to-watch-in-2023-1032013193
3092.0,1/11/2023 8:35:28 PM,Medicare to publish drugs targeted for pricing negotiations in September,Seeking Alpha,https://seekingalpha.com/news/3923880-medicare-publish-drugs-targeted-pricing-negotiations-in-september?utm_source=businessinsider&utm_medium=referral
3093.0,1/12/2023 6:52:33 PM,White House COVID coordinator warns winter surges of infections will be new normal,Seeking Alpha,https://seekingalpha.com/news/3924266-white-house-covid-coordinator-warns-winter-surges-of-infections-will-be-new-normal?utm_source=businessinsider&utm_medium=referral
3094.0,1/13/2023 3:54:22 PM,Omicron subvariant XBB.1.5 makes up 43% of COVID cases in U.S. ‚Äì CDC,Seeking Alpha,https://seekingalpha.com/news/3924549-omicron-subvariant-xbb15-makes-up-43-of-covid-cases-in-us-cdc?utm_source=businessinsider&utm_medium=referral
3095.0,1/13/2023 4:16:22 PM,Johnson & Johnson is scaling back COVID-19 vaccine production ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3924553-jnj-stock-falls-as-company-scaling-back-covid-19-vaccine-production?utm_source=businessinsider&utm_medium=referral
3096.0,1/13/2023 7:22:37 PM,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",Benzinga,/news/stocks/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot-1032018165
3097.0,1/18/2023 12:34:06 PM,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,Benzinga,/news/stocks/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today-1032025074
3098.0,1/18/2023 4:12:04 PM,Johnson & Johnson scraps HIV vaccine program after Phase 3 setback,Seeking Alpha,https://seekingalpha.com/news/3925478-johnson-johnson-scraps-hiv-vaccine-program-after-phase-3-setback?utm_source=businessinsider&utm_medium=referral
3099.0,1/19/2023 4:29:43 PM,3 Safe Stock Bets for an Unpredictable Market,InvestorPlace,/news/stocks/3-safe-stock-bets-for-an-unpredictable-market-1032029023
3100.0,1/19/2023 10:05:01 PM,BeiGene's Brukinsa gains approval for two additional types of leukemia,Seeking Alpha,https://seekingalpha.com/news/3926154-beigene-brukinsa-gains-approval-for-two-additional-types-of-leukemia?utm_source=businessinsider&utm_medium=referral
3101.0,1/20/2023 12:30:20 PM,Japan to consider downgrading COVID to same level as seasonal flu,Seeking Alpha,https://seekingalpha.com/news/3926268-japan-to-consider-downgrading-covid-to-same-level-as-seasonal-flu?utm_source=businessinsider&utm_medium=referral
3102.0,1/20/2023 12:31:18 PM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), BeiGene (BGNE)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-beigene-bgne-1032030702
3103.0,1/20/2023 2:30:47 PM,Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/draganfly-to-rally-around-87-here-are-10-other-analyst-forecasts-for-friday-1032030827
3104.0,1/20/2023 4:01:21 PM,What 5 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-johnson-johnson-1032031057
3105.0,1/20/2023 5:16:36 PM,"Earnings week ahead: Tesla, Microsoft, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3926380-earnings-week-ahead-tesla-microsoft-att-and-more?utm_source=businessinsider&utm_medium=referral
3106.0,1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral
3107.0,1/21/2023 9:40:00 PM,"AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs",Seeking Alpha,https://seekingalpha.com/news/3926479-astrazeneca-biogen-bristol-and-eli-lilly-among-companies-with-blockbuster-potential-drugs?utm_source=businessinsider&utm_medium=referral
3108.0,1/23/2023 12:15:10 PM,Morphic says Johnson & Johnson unit ended research collaboration,Seeking Alpha,https://seekingalpha.com/news/3926626-morf-stock-slips-johnson--johnson-unit-end-research-deal?utm_source=businessinsider&utm_medium=referral
3109.0,1/23/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1032033991
3110.0,1/23/2023 3:01:19 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3926753-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
3111.0,1/23/2023 3:26:55 PM,"Nasdaq, S&P, and Dow move higher as Wall Street gears up for an earnings-packed week",Seeking Alpha,https://seekingalpha.com/news/3926606-sp500-nasdaq-dow-jones-stock-market?utm_source=businessinsider&utm_medium=referral
3112.0,1/23/2023 3:33:42 PM,FDA plans an annual schedule for updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3926754-fda-plans-an-annual-schedule-for-updated-covid-shots?utm_source=businessinsider&utm_medium=referral
3113.0,1/23/2023 5:05:09 PM,Johnson & Johnson to report Q4 earnings amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3926788-johnson-johnson-to-report-q4-earnings-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral
3114.0,1/23/2023 9:04:41 PM,"Risk-on bet sends Dow, S&P 500, Nasdaq higher",Seeking Alpha,https://seekingalpha.com/news/3926863-risk-on-bet-sends-dow-sp-500-nasdaq-higher?utm_source=businessinsider&utm_medium=referral
3115.0,1/23/2023 9:53:36 PM,The 7 Best Income Stocks to Buy in January,InvestorPlace,/news/stocks/the-7-best-income-stocks-to-buy-in-january-1032035035
3116.0,1/24/2023 10:02:31 AM,"Microsoft, Verizon Communications And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/microsoft-verizon-communications-and-3-stocks-to-watch-heading-into-tuesday-1032036073
3117.0,1/24/2023 11:26:17 AM,"Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M",Seeking Alpha,https://seekingalpha.com/news/3927039-johnson-and-johnson-non-gaap-eps-of-2_35-beats-0_11-revenue-of-23_7b-misses-200m?utm_source=businessinsider&utm_medium=referral
3118.0,1/24/2023 12:10:41 PM,"J&J trades higher despite Q4 revenue hit by forex, COVID vaccine impact, FY23 outlook above estimates",Seeking Alpha,https://seekingalpha.com/news/3927066-jj-trades-higher-despite-q4-revenue-hit-by-forex-covid-vaccine-impact-fy23-outlook-above-estimates?utm_source=businessinsider&utm_medium=referral
3119.0,1/24/2023 12:39:27 PM,"Johnson & Johnson Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1032036379
3120.0,1/24/2023 1:23:33 PM,"Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-down-26-but-adj-eps-tops-estimates-1032036523
3121.0,1/24/2023 1:41:20 PM,Wall Street Might Open Lower ,RTTNews,/news/stocks/wall-street-might-open-lower-1032036579
3122.0,1/24/2023 3:07:45 PM,Why Are Stocks Down Today?,InvestorPlace,/news/stocks/why-are-stocks-down-today-14-1032037244
3123.0,1/24/2023 3:20:26 PM,"Nasdaq, S&P, and Dow trade lower after sharp rally and stronger manufacturing data",Seeking Alpha,https://seekingalpha.com/news/3927033-sp500-nasdaq-dow-jones-stock-market-earnings?utm_source=businessinsider&utm_medium=referral
3124.0,1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral
3125.0,1/24/2023 8:14:48 PM,"Nasdaq, S&P, Dow stumble after two-day win streak as earnings take spotlight",Seeking Alpha,https://seekingalpha.com/news/3927246-nasdaq-sp500-dow-jones-stock-market-earnings-economic-data?utm_source=businessinsider&utm_medium=referral
3126.0,1/24/2023 9:06:22 PM,"Dow, S&P 500, Nasdaq finish mixed as earnings season picks up steam",Seeking Alpha,https://seekingalpha.com/news/3927392-dow-sp-500-nasdaq-finish-mixed-as-earnings-season-picks-up-steam?utm_source=businessinsider&utm_medium=referral
3127.0,1/25/2023 12:25:24 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032040034
3128.0,1/25/2023 1:37:14 PM,Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/union-pacific-to-rally-over-11-here-are-10-other-analyst-forecasts-for-wednesday-1032040092
3129.0,1/25/2023 4:31:36 PM,"Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Idexx Laboratories (IDXX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-danaher-dhr-idexx-laboratories-idxx-and-johnson-johnson-jnj-1032041134
3130.0,1/26/2023 8:39:21 AM,Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies ,RTTNews,/news/stocks/evotec-partners-with-janssen-biotech-to-develop-immune-based-cancer-therapies-1032042835
3131.0,1/26/2023 10:52:21 AM,Evotec stock rises on licensing deal with J&J to develop immune-based drugs,Seeking Alpha,https://seekingalpha.com/news/3928233-evotec-stock-rises-on-licensing-deal-with-jj-to-develop-immune-based-drugs?utm_source=businessinsider&utm_medium=referral
3132.0,1/26/2023 11:06:46 PM,The 3 Best Biotech Stocks Under $1 to Buy for January,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-under-1-to-buy-for-january-1032045234
3133.0,1/27/2023 1:15:17 AM,Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1032045301
3134.0,1/27/2023 4:31:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Aurinia Pharmaceuticals (AUPH) and POINT Biopharma Global (PNT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-aurinia-pharmaceuticals-auph-and-point-biopharma-global-pnt-1032045403
3135.0,1/27/2023 12:52:31 PM,J&J pulls Imbruvica combo filing in EU as EMA cites potential 'serious side effects',Seeking Alpha,https://seekingalpha.com/news/3928895-jj-pulls-imbruvica-combo-filing-in-eu-as-ema-cites-potential-serious-side-effects?utm_source=businessinsider&utm_medium=referral
3136.0,1/27/2023 2:09:13 PM,JNJ/ Legend CAR-T therapy succeeds in Phase 3 multiple myeloma trial,Seeking Alpha,https://seekingalpha.com/news/3928956-jnj-legend-car-t-therapy-succeeds-late-stage-multiple-myeloma-trial?utm_source=businessinsider&utm_medium=referral
3137.0,1/28/2023 6:00:40 PM,The use of artificial intelligence in medical devices and drug development,Seeking Alpha,https://seekingalpha.com/news/3929184-the-growing-use-of-artificial-intelligence-in-medical-devices-diagnostics-drug-development?utm_source=businessinsider&utm_medium=referral
3138.0,1/29/2023 5:00:25 PM,AbbVie‚Äôs global bestseller to face knockoffs starting this week,Seeking Alpha,https://seekingalpha.com/news/3929211-abbvies-global-bestseller-to-face-knockoffs-starting-this-week?utm_source=businessinsider&utm_medium=referral
3139.0,1/30/2023 9:54:14 AM,Are You Seeking Passive Income? Try These 2 Dividend Kings,TipRanks,/news/stocks/are-you-seeking-passive-income-try-these-2-dividend-kings-1032050273
3140.0,1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral
3141.0,1/30/2023 4:28:17 PM,"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",Benzinga,/news/stocks/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yielded-returns-1032051302
3142.0,1/30/2023 7:57:21 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-2-1032051840
3143.0,1/30/2023 9:32:36 PM,J&J falls after appeals court rules company can't use bankruptcy to end cancer suits (update),Seeking Alpha,https://seekingalpha.com/news/3929431-jj-falls-after-losing-appeals-court-ruling-in-talc-litigation?utm_source=businessinsider&utm_medium=referral
3144.0,1/30/2023 11:04:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032052020
3145.0,1/31/2023 10:34:31 AM,Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits ,RTTNews,/news/stocks/court-rejects-j-j-bankruptcy-petition-to-end-talc-cancer-lawsuits-1032053415
3146.0,1/31/2023 12:35:28 PM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032053930
3147.0,1/31/2023 2:24:45 PM,Haleon said to evaluate potential deals to increase its size - report,Seeking Alpha,https://seekingalpha.com/news/3929851-haleon-said-to-evaluate-potential-deals-to-increase-its-size-report?utm_source=businessinsider&utm_medium=referral
3148.0,1/31/2023 3:29:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032054544
3149.0,1/31/2023 11:17:47 PM,The 7 Best Climate Change Stocks to Buy for 2023,InvestorPlace,/news/stocks/the-7-best-climate-change-stocks-to-buy-for-2023-1032055998
3150.0,2/1/2023 3:16:38 AM,Johnson & Johnson Stock (NYSE:JNJ): Time Heals All Wounds,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-heals-all-wounds-1032056074
3151.0,2/1/2023 4:18:52 PM,"Novavax, JNJ dispute pre-payments for canceled COVID shots sought for world‚Äôs poor - NYT",Seeking Alpha,https://seekingalpha.com/news/3930507-novavax-jnj-dispute-pre-payments-cancelled-covid-shots-worlds-poor?utm_source=businessinsider&utm_medium=referral
3152.0,2/1/2023 4:48:33 PM,The most overbought and oversold S&P 500 stocks to start February,Seeking Alpha,https://seekingalpha.com/news/3930472-tmost-overbought-oversold-sp500-stocks-february?utm_source=businessinsider&utm_medium=referral
3153.0,2/2/2023 5:44:50 PM,3 Defensive Stocks to Buy If You Think the Market Is Headed Lower,InvestorPlace,/news/stocks/3-defensive-stocks-to-buy-if-you-think-the-market-is-headed-lower-1032063814
3154.0,2/2/2023 7:11:33 PM,U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates,Seeking Alpha,https://seekingalpha.com/news/3931486-uk-pharma-lobby-urges-govt-to-halt-plans-to-raise-revenue-recovery-rates?utm_source=businessinsider&utm_medium=referral
3155.0,2/2/2023 7:21:22 PM,"Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst",Benzinga,/news/stocks/johnson-johnson-s-upcoming-lung-cancer-data-could-offer-another-blockbuster-opportunity-says-analyst-1032063869
3156.0,2/4/2023 9:00:00 PM,"Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023",Seeking Alpha,https://seekingalpha.com/news/3932049-ambulatory-surgery-centers-robotics-seen-as-trends-for-orthopedic-devices-in-2023?utm_source=businessinsider&utm_medium=referral
3157.0,2/5/2023 12:13:24 AM,Danaher said to be interested in acquiring contract manufacturer Catalent,Seeking Alpha,https://seekingalpha.com/news/3932097-danaher-shows-takeover-interest-contract-manufacturer-catalent?utm_source=businessinsider&utm_medium=referral
3158.0,2/5/2023 5:00:57 PM,Drug price inflation continues upward momentum at 3.8% ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3932101-drug-price-inflation-continues-upward-momentum-at-38-report?utm_source=businessinsider&utm_medium=referral
3159.0,2/6/2023 2:15:33 PM,Johnson & Johnson succeeds in mid-stage trial for fetal disorder candidate,Seeking Alpha,https://seekingalpha.com/news/3932298-johnson-johnson-succeeds-mid-stage-trial-fetal-disorder-candidate?utm_source=businessinsider&utm_medium=referral
3160.0,2/6/2023 3:48:48 PM,Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?,InvestorPlace,/news/stocks/why-is-catalent-nysectlt-stock-up-20-today-1032070835
3161.0,2/6/2023 5:56:09 PM,Teva follows AbbVie to leave top pharma industry group,Seeking Alpha,https://seekingalpha.com/news/3932426-teva-follows-abbvie-to-leave-top-pharma-industry-group?utm_source=businessinsider&utm_medium=referral
3162.0,2/6/2023 6:15:50 PM,How to Score Profits In Every Trade With Minimal Risk,InvestorPlace,/news/stocks/how-to-score-profits-in-every-trade-with-minimal-risk-1032071173
3163.0,2/6/2023 7:49:01 PM,Arrowhead drops as Cantor flags risks to Johnson & Johnson licensing deal,Seeking Alpha,https://seekingalpha.com/news/3932504-arwr-stock-drops-cantor-flags-risks-johnson-johnson-licensing-deal?utm_source=businessinsider&utm_medium=referral
3164.0,2/7/2023 3:01:23 AM,The 3 Best Forever Stocks to Buy for February 2023,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-for-february-2023-1032071770
3165.0,2/8/2023 11:49:09 AM,Australia to offer fifth COVID shot to all adults later this month,Seeking Alpha,https://seekingalpha.com/news/3933402-australia-to-offer-fifth-covid-shot-to-all-adults-later-this-month?utm_source=businessinsider&utm_medium=referral
3166.0,2/8/2023 4:26:42 PM,Johnson & Johnson reports positive mid-stage data for rare fetus disease drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/3933603-johnson-johnson-reports-positive-mid-stage-data-for-rare-fetus-disease-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral
3167.0,2/9/2023 7:36:13 AM,"Roche, Janssen Biotech To Advance Personalised Healthcare Through Companion Diagnostics ",RTTNews,/news/stocks/roche-janssen-biotech-to-advance-personalised-healthcare-through-companion-diagnostics-1032081753
3168.0,2/9/2023 10:07:22 AM,7 Dividend Stocks to Buy for a Reliable Income Stream,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-reliable-income-stream-1032082235
3169.0,2/9/2023 10:39:40 AM,"Alvotech, Stada get EMA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3934076-alvotech-stada-get-ema-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral
3170.0,2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral
3171.0,2/10/2023 4:46:18 PM,"Bristol-Myers, 2seventy post late-stage data for CAR-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3934866-bristol-myers-2seventy-late-stage-data-car-t-therapy-multiple-myeloma?utm_source=businessinsider&utm_medium=referral
3172.0,2/10/2023 6:19:06 PM,3 of the Best Dividend Stocks to Buy for February¬†,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-february-1032087085
3173.0,2/12/2023 5:00:59 PM,COVID-19 emergency is ending; What it means for free vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3935039-pandemic-emergency-ending-impact-covid-shots-drugs?utm_source=businessinsider&utm_medium=referral
3174.0,2/13/2023 4:11:05 AM,"Alcon, J&J Surgical To Settle Litigation On Femtosecond Laser Assisted Cataract Surgery Devices ",RTTNews,/news/stocks/alcon-j-j-surgical-to-settle-litigation-on-femtosecond-laser-assisted-cataract-surgery-devices-1032088325
3175.0,2/13/2023 3:57:12 PM,"Wainwright initiates Arcellx with a buy on CAR-T pipeline, partnership with Gilead's Kite",Seeking Alpha,https://seekingalpha.com/news/3935243-wainwright-initiates-arcellx-with-a-buy-on-car-t-pipeline-partnership-with-gilead-kite?utm_source=businessinsider&utm_medium=referral
3176.0,2/13/2023 7:18:57 PM,"OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships",Seeking Alpha,https://seekingalpha.com/news/3935341-omniab-initiated-with-a-buy-at-hc-wainwright-on-antibody-collaborations-partnerships?utm_source=businessinsider&utm_medium=referral
3177.0,2/14/2023 10:40:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Mettler-Toledo (MTD) and Bioxcel Therapeutics (BTAI)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-mettler-toledo-mtd-and-bioxcel-therapeutics-btai-1032094127
3178.0,2/14/2023 12:21:21 PM,Johnson & Johnson poaches Sanofi R&D head,Seeking Alpha,https://seekingalpha.com/news/3935652-johnson-johnson-poaches-sanofi-rd-head?utm_source=businessinsider&utm_medium=referral
3179.0,2/14/2023 6:59:53 PM,J&J faces dismissal in talc unit bankruptcy filing after appeals court ruling,Seeking Alpha,https://seekingalpha.com/news/3935926-johnson-johnson-faces-dismissal-in-talc-unit-bankruptcy-filing-after-appeals-court-ruling?utm_source=businessinsider&utm_medium=referral
3180.0,2/15/2023 2:12:03 PM,J&J returns rights to NASH RNAi candidate to Arrowhead Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3936329-johnson-johnson-returns-rights-to-nash-rnai-candidate-to-arrowhead-pharmaceuticals?utm_source=businessinsider&utm_medium=referral
3181.0,2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral
3182.0,2/15/2023 7:09:07 PM,3 ETFs Investors Can Buy to Weather a Recession,TipRanks,/news/stocks/3-etfs-investors-can-buy-to-weather-a-recession-1032100105
3183.0,2/15/2023 7:15:00 PM,"Immunovant Could Potentially Be An M&A Target, Writes Analyst",Benzinga,/news/stocks/immunovant-could-potentially-be-an-m-a-target-writes-analyst-1032100005
3184.0,2/16/2023 11:17:26 PM,Johnson & Johnson files for debt securities offering,Seeking Alpha,https://seekingalpha.com/news/3937530-johnson-johnson-files-for-debt-securities-offering?utm_source=businessinsider&utm_medium=referral
3185.0,2/17/2023 9:05:38 PM,"S&P 500, Dow, Nasdaq finish mixed as Fed debate continues",Seeking Alpha,https://seekingalpha.com/news/3937828-sp-500-dow-nasdaq-finish-mixed-as-fed-debate-continues?utm_source=businessinsider&utm_medium=referral
3186.0,2/19/2023 5:00:10 PM,The next big wave of patent cliffs is ahead; expect biopharma M&A to rise ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3937885-next-big-wave-of-patent-cliffs-ahead-biopharma-m-and-a-to-rise?utm_source=businessinsider&utm_medium=referral
3187.0,2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/ko-jnj-mmm-the-3-best-dividend-stocks-for-beginner-investors-1032109636
3188.0,2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-for-beginner-investors-1032109629
3189.0,2/21/2023 4:15:14 PM,Johnson & Johnson fails in bid to overturn $302M vaginal-mesh award ‚Äì Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3938462-johnson-johnson-fails-overturn-302m-vaginal-mesh-award?utm_source=businessinsider&utm_medium=referral
3190.0,2/24/2023 7:12:47 PM,Johnson & Johnson wins EU nod for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3940807-johnson-johnson-wins-eu-nod-for-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral
3191.0,2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral
3192.0,2/27/2023 10:34:00 PM,Emergent BioSolutions off 4% on Q4 2022 bottom line miss,Seeking Alpha,https://seekingalpha.com/news/3941487-emergent-biosolutions-off-4-on-q4-2022-bottom-line-miss?utm_source=businessinsider&utm_medium=referral
3193.0,3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral
3194.0,3/1/2023 1:00:35 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032135739
3195.0,3/1/2023 2:12:06 PM,7 Stocks to Protect Against the Massive Inflation Shock of 2023,InvestorPlace,/news/stocks/7-stocks-to-protect-against-the-massive-inflation-shock-of-2023-1032136605
3196.0,3/1/2023 2:23:39 PM,Cidara stock pops as CD388 helps cut influenza risk in phase 2a trial,Seeking Alpha,https://seekingalpha.com/news/3942600-cidara-stock-pops-as-cd388-helps-cut-influenza-risk-in-phase-2a-trial?utm_source=businessinsider&utm_medium=referral
3197.0,3/1/2023 3:21:14 PM,"J&J initiated at neutral at Guggenheim on need for pharma, medtech growth visibility",Seeking Alpha,https://seekingalpha.com/news/3942649-johnson-johnson-initiated-at-neutral-at-guggenheim-on-need-for-pharma-medtech-growth-visibility?utm_source=businessinsider&utm_medium=referral
3198.0,3/1/2023 4:00:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-1-2023-1032136808
3199.0,3/1/2023 7:21:42 PM,"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'",Benzinga,/news/stocks/jim-cramer-says-he-s-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-promotional-1032137450
3200.0,3/1/2023 8:55:25 PM,JNJ's Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility,Benzinga,/news/stocks/jnj-s-consumer-health-business-separation-will-remove-uncertainty-cloud-from-company-why-this-analyst-wants-visibility-1032137596
3201.0,3/2/2023 1:01:02 PM,"Bristol-Myers, Janssen launch late-stage Librexia program evaluating milvexian",Seeking Alpha,https://seekingalpha.com/news/3943202-bristol-myers-janssen-launch-late-stage-librexia-program-evaluating-milvexian?utm_source=businessinsider&utm_medium=referral
3202.0,3/2/2023 2:39:19 PM,Merck and AstraZeneca to face FDA AdCom meeting for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3943282-merck-astrazeneca-face-fda-adcom-meeting-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral
3203.0,3/4/2023 5:21:29 PM,Johnson & Johnson's Stelara demonstrates long-term efficacy in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3944202-johnson-johnson-stelara-demonstrates-long-term-efficacy-in-crohns-disease?utm_source=businessinsider&utm_medium=referral
3204.0,3/4/2023 6:45:00 PM,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,Seeking Alpha,https://seekingalpha.com/news/3944195-pharma-research-developmeny-funding-soared-to-a-new-record-in-2022-as-oncology-candidates-dominate-pipelines?utm_source=businessinsider&utm_medium=referral
3205.0,3/6/2023 3:00:29 PM,"Janssen's macitentan, tadalafil combo improves pulmonary hemodynamics vs. monotherapies",Seeking Alpha,https://seekingalpha.com/news/3944464-janssens-macitentan-tadalafil-combo-improves-pulmonary-hemodynamics-vs-monotherapies?utm_source=businessinsider&utm_medium=referral
3206.0,3/6/2023 7:24:23 PM,5 Stocks ChatGPT Says Will Make Me Rich in 20 Years,InvestorPlace,/news/stocks/5-growth-stocks-to-buy-according-to-chatgpt-1032148311
3207.0,3/6/2023 9:51:35 PM,7 Dividend Kings to Buy for an Uncertain Market Environment,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-an-uncertain-market-environment-1032148499
3208.0,3/6/2023 10:07:52 PM,7 Stocks to Buy for the Worrying Climate Change Crisis,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-worrying-climate-change-crisis-1032148516
3209.0,3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral
3210.0,3/7/2023 3:54:10 PM,Why Protagonist Therapeutics Shares Are Trading Higher Today,Benzinga,/news/stocks/why-protagonist-therapeutics-shares-are-trading-higher-today-1032150761
3211.0,3/8/2023 11:41:29 AM,Sleep-at-night stocks for those hedging or risk averse,Seeking Alpha,https://seekingalpha.com/news/3945026-sleep-at-night-stocks-for-those-hedging-or-risk-averse?utm_source=businessinsider&utm_medium=referral
3212.0,3/8/2023 12:27:39 PM,Johnson & Johnson in pact with Biocytogen for antibody-based therapeutics,Seeking Alpha,https://seekingalpha.com/news/3945267-johnson-johnson-pact-with-biocytogen-antibody-based-therapeutics?utm_source=businessinsider&utm_medium=referral
3213.0,3/8/2023 1:31:08 PM,Wall Street Analysts Are Neutral on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-neutral-on-top-healthcare-picks-1032153556
3214.0,3/8/2023 1:33:18 PM,3 Must-Buy Income Champs as Fed Rates Head to 5%,InvestorPlace,/news/stocks/3-must-buy-income-champs-as-fed-rates-head-to-5-1032153538
3215.0,3/8/2023 4:35:41 PM,J&J consumer health spinoff Kenvue begins bond sale to fund separation - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3945427-johnson-johnson-consumer-health-spinoff-kenvue-begins-bond-sale-to-fund-separation-bloomberg?utm_source=businessinsider&utm_medium=referral
3216.0,3/8/2023 9:05:24 PM,7 Stocks at 52-Week Lows and Highly Attractive From Here,InvestorPlace,/news/stocks/7-stocks-at-52-week-lows-and-highly-attractive-from-here-1032154824
3217.0,3/9/2023 4:05:45 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032155153
3218.0,3/9/2023 7:58:02 AM,How to Invest in 2023 If You Are Looking To Avoid Losses,TipRanks,/news/stocks/how-to-invest-in-2023-if-you-are-looking-to-avoid-losses-1032155910
3219.0,3/9/2023 10:36:32 AM,Kenvue prices $7.75B offering in a series of senior unsecured notes to fund separation,Seeking Alpha,https://seekingalpha.com/news/3945803-kenvue-prices-775b-offering-in-a-series-of-senior-unsecured-notes-to-fund-separation?utm_source=businessinsider&utm_medium=referral
3220.0,3/10/2023 11:42:47 AM,"3 of the Best Dividend Stocks, According to Analysts‚Äî3/10/2023",TipRanks,/news/stocks/3-of-the-best-dividend-stocks-according-to-analysts‚Äî3-10-2023-1032159708
3221.0,3/10/2023 1:25:42 PM,Zimmer Biomet upgraded at Piper Sandler citing conservative guidance,Seeking Alpha,https://seekingalpha.com/news/3946438-zbh-stock-upgraded-piper-sandler-conservative-guidance?utm_source=businessinsider&utm_medium=referral
3222.0,3/10/2023 3:59:27 PM,Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts,InvestorPlace,/news/stocks/johnson-johnson-layoffs-2023-what-to-know-about-the-latest-jnj-job-cuts-1032160387
3223.0,3/10/2023 4:17:44 PM,Halted Stocks Alert: Nasdaq Halts Trading in SVB Financial (SIVB) Stock,InvestorPlace,/news/stocks/halted-stocks-alert-nasdaq-halts-trading-in-svb-financial-sivb-stock-1032160421
3224.0,3/12/2023 2:00:00 PM,Biosimilars expected to save $180B over next five years as more gain approval,Seeking Alpha,https://seekingalpha.com/news/3946583-biosimilars-expected-to-save-180b-over-next-five-years-as-more-gain-approval?utm_source=businessinsider&utm_medium=referral
3225.0,3/13/2023 2:05:19 AM,7 Blue-Chip Stocks to Buy in March,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-in-march-1032161708
3226.0,3/13/2023 12:07:25 PM,"Pfizer, AbbVie, BMS among firms at risk of U.S. drug price negotiations - report",Seeking Alpha,https://seekingalpha.com/news/3946793-pfizer-abbvie-bristol-myers-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3227.0,3/15/2023 1:32:54 PM,Halozyme sees no impact on royalties after EU body revokes J&J's Darzalex patent,Seeking Alpha,https://seekingalpha.com/news/3947661-halozyme-sees-no-impact-on-royalties-after-eu-body-revokes-jjs-darzalex-patent?utm_source=businessinsider&utm_medium=referral
3228.0,3/15/2023 2:03:55 PM,3 Blue-Chip Dividend Stocks to Buy on the Dip Now,InvestorPlace,/news/stocks/jnj-low-o-blue-chip-dividend-stocks-to-buy-on-the-dip-now-1032169816
3229.0,3/15/2023 4:18:45 PM,7 Blue-Chip Stocks to Buy and Hold for Decades,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-and-hold-for-decades-1032170208
3230.0,3/15/2023 4:40:00 PM,Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study,Benzinga,/news/stocks/protagonist-therapeutics-touts-positive-data-from-bone-marrow-disorder-study-1032170095
3231.0,3/15/2023 6:07:56 PM,Johnson & Johnson oral dengue therapy enters mid-stage trials,Seeking Alpha,https://seekingalpha.com/news/3947805-johnson-johnson-oral-dengue-therapy-enters-mid-stage-trials?utm_source=businessinsider&utm_medium=referral
3232.0,3/16/2023 6:15:32 PM,Medicare publishes initial guidance on drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3948265-medicare-publishes-initial-guidance-on-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3233.0,3/19/2023 4:00:30 PM,Pfizer CEO pockets $33M for 2022 after 36% pay hike,Seeking Alpha,https://seekingalpha.com/news/3948694-pfizer-ceo-pockets-33m-for-2022-after-36-percent-pay-hike?utm_source=businessinsider&utm_medium=referral
3234.0,3/19/2023 7:47:43 PM,Easing COVID pandemic sees many pharmas seeking alternate revenue streams,Seeking Alpha,https://seekingalpha.com/news/3948704-easing-covid-pandemic-pfizer-astrazeneca-seeking-alternate-revenue-streams?utm_source=businessinsider&utm_medium=referral
3235.0,3/21/2023 4:44:41 PM,FDA may authorize another round of COVID booster shots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3949556-fda-may-authorize-another-round-covid-booster-shots-wsj?utm_source=businessinsider&utm_medium=referral
3236.0,3/21/2023 10:28:03 PM,Johnson & Johnson‚Äôs (NYSE:JNJ) Decade-Low P/E Ratio Deserves Your Attention,TipRanks,/news/stocks/johnson-johnson-s-nyse-jnj-decade-low-p-e-ratio-deserves-your-attention-1032183355
3237.0,3/22/2023 6:21:00 PM,J&J turns to Supreme Court to OK unit bankruptcy plan for talc lawsuits - report,Seeking Alpha,https://seekingalpha.com/news/3950072-jnj-turns-to-supreme-court-ok-unit-bankruptcy-plan-for-talc-lawsuits?utm_source=businessinsider&utm_medium=referral
3238.0,3/22/2023 9:27:00 PM,Talc Plaintiffs Will Press to Reopen Courthouse Doors,PR Newswire,/news/stocks/talc-plaintiffs-will-press-to-reopen-courthouse-doors-1032186045
3239.0,3/23/2023 6:33:09 PM,White House seeking alternative supply chains for pharmaceutical ingredients,Seeking Alpha,https://seekingalpha.com/news/3950575-white-house-alternative-supply-chains-pharmaceutical-ingredients-drug-shortages?utm_source=businessinsider&utm_medium=referral
3240.0,3/23/2023 9:57:53 PM,"J&J, AbbVie's Imbruvica gets expanded blood cancer indication in Canada",Seeking Alpha,https://seekingalpha.com/news/3950766-johnson-johnson-abbvie-imbruvica-expanded-blood-cancer-indication-canada?utm_source=businessinsider&utm_medium=referral
3241.0,3/24/2023 2:44:49 PM,"Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories",Benzinga,/news/stocks/binance-suspends-trading-european-bank-trouble-twitter-to-remove-legacy-verified-checkmarks-today-s-top-stories-1032190957
3242.0,3/27/2023 12:20:41 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Eli Lilly & Co (LLY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-eli-lilly-co-lly-and-johnson-johnson-jnj-1032193916
3243.0,3/27/2023 10:03:59 PM,3 Blue-Chip Stocks to Buy for Stability and Safety,InvestorPlace,/news/stocks/3-safe-blue-chip-stocks-to-buy-1032195324
3244.0,3/28/2023 10:51:51 AM,argenx sells global rights for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3951760-argenx-stock-sells-global-rights-for-cancer-therapy?utm_source=businessinsider&utm_medium=referral
3245.0,3/28/2023 4:05:00 PM,WHO updates COVID vaccine guidance; low priority for children and adolescents,Seeking Alpha,https://seekingalpha.com/news/3951932-who-updates-covid-vaccine-guidance-low-priority-for-children?utm_source=businessinsider&utm_medium=referral
3246.0,3/28/2023 6:29:37 PM,7 Dividend Aristocrats to Buy for Consistent Income Growth,InvestorPlace,/news/stocks/7-dividend-aristocrats-to-buy-for-consistent-income-growth-1032198244
3247.0,3/29/2023 1:25:57 PM,Johnson & Johnson drops RSV vaccine program,Seeking Alpha,https://seekingalpha.com/news/3952263-jnj-stock-drops-rsv-vaccine-program?utm_source=businessinsider&utm_medium=referral
3248.0,3/29/2023 4:01:29 PM,Analyst Expectations for Johnson & Johnson's Future,Benzinga,/news/stocks/analyst-expectations-for-johnson-johnson-s-future-1032200727
3249.0,3/29/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-29-2023-1032200913
3250.0,3/29/2023 8:13:14 PM,J&J unveils long-term data on Rybrevant for non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/3952439-johnson-johnson-unveils-long-term-data-on-rybrevant-for-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral
3251.0,3/30/2023 2:32:15 PM,The 3 Best Stocks to Buy if You Want to Retire Early,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-if-you-want-to-retire-early-1032204079
3252.0,3/31/2023 7:00:41 PM,"Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week",Seeking Alpha,https://seekingalpha.com/news/3953276-catalyst-watch-tesla-deliveries-walmart-event-and-jobs-report-headline-big-week?utm_source=businessinsider&utm_medium=referral
3253.0,3/31/2023 8:44:06 PM,3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio,InvestorPlace,/news/stocks/3-top-dividend-stocks-to-buy-now-for-an-income-based-portfolio-1032208246
3254.0,4/3/2023 9:45:11 AM,Morgan Stanley Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-johnson-johnson-jnj-1032210053
3255.0,4/3/2023 8:47:21 PM,Delaware court finds in favor of Bayer in talc disagreement with Merck,Seeking Alpha,https://seekingalpha.com/news/3953932-delaware-court-finds-in-favor-of-bayer-in-talc-disagreement-with-merck?utm_source=businessinsider&utm_medium=referral
3256.0,4/4/2023 4:20:43 PM,Biogen names Adam Keeney to head corporate development,Seeking Alpha,https://seekingalpha.com/news/3954410-biogen-names-adam-keeney-head-corporate-development?utm_source=businessinsider&utm_medium=referral
3257.0,4/4/2023 5:56:20 PM,JNJ weighs second bankruptcy to halt talc-related cancer suits,Seeking Alpha,https://seekingalpha.com/news/3954443-jnj-weighs-second-bankruptcy-halt-talc-cancer-suits?utm_source=businessinsider&utm_medium=referral
3258.0,4/4/2023 8:26:08 PM,J&J unit refiles for bankruptcy over talc litigation; offers to pay $8.9B,Seeking Alpha,https://seekingalpha.com/news/3954482-johnson-johnson-unit-ltl-refile-bankruptcy-talc-litigation-offers-to-pay-89b?utm_source=businessinsider&utm_medium=referral
3259.0,4/4/2023 10:57:02 PM,Johnson & Johnson To Set Aside $8.9 Bln To Resolve Talc-based Cancer Lawsuits ,RTTNews,/news/stocks/johnson-johnson-to-set-aside-8-9-bln-to-resolve-talc-based-cancer-lawsuits-1032215019
3260.0,4/5/2023 9:05:12 AM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032215938
3261.0,4/5/2023 1:24:37 PM,JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today,InvestorPlace,/news/stocks/jnj-stock-the-8-9-billion-reason-johnson-johnson-is-up-today-1032216845
3262.0,4/5/2023 2:06:55 PM,InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization,InvestorPlace,/news/stocks/inflarx-ifrx-stock-pops-as-fda-grants-emergency-use-authorization-1032217011
3263.0,4/5/2023 2:11:22 PM,J&J's potential talc litigation settlement draws mostly positive Street reaction,Seeking Alpha,https://seekingalpha.com/news/3954668-johnson-johnson-talc-litigation-settlement-mostly-positive-street-reaction?utm_source=businessinsider&utm_medium=referral
3264.0,4/5/2023 3:55:10 PM,Johnson & Johnson (JNJ) Receives a Hold from Bernstein,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-bernstein-1032217283
3265.0,4/5/2023 8:38:01 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-april-2023-1032217741
3266.0,4/5/2023 8:42:41 PM,The 3 Most Undervalued Warren Buffett Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-warren-buffett-stocks-to-buy-in-april-2023-1032217789
3267.0,4/5/2023 9:00:58 PM,Why did Johnson & Johnson stock go up today? Renewed hope for talc settlements,Seeking Alpha,https://seekingalpha.com/news/3954829-why-did-johnson-johnson-stock-go-up-today-renewed-hope-talc-settlements?utm_source=businessinsider&utm_medium=referral
3268.0,4/6/2023 7:50:24 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), AbbVie (ABBV)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-abbvie-abbv-1032218380
3269.0,4/6/2023 2:14:00 PM,The 3 Best Bargain Stocks to Buy for April 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-for-april-2023-1032219441
3270.0,4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral
3271.0,4/7/2023 6:45:24 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032220374
3272.0,4/7/2023 9:20:34 PM,S&P 500 Volatility Continues As Investors Digest Latest Labor Market Data,Benzinga,/news/stocks/s-p-500-volatility-continues-as-investors-digest-latest-labor-market-data-1032220884
3273.0,4/10/2023 6:57:17 PM,3 Best Stocks to Buy in April for the Looming Recession,InvestorPlace,/news/stocks/3-best-stocks-to-buy-in-april-for-the-looming-recession-1032222569
3274.0,4/10/2023 7:00:37 PM,Morgan Stanley Maintains Equal-Weight Rating for Johnson & Johnson: Here's What You Need To Know,Benzinga,/news/stocks/morgan-stanley-maintains-equal-weight-rating-for-johnson-johnson-here-s-what-you-need-to-know-1032222446
3275.0,4/11/2023 2:25:44 AM,U.S. launches $5B program to speed up development of next-gen COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3955481-us-launches-5b-program-develop-next-gen-covid-vaccines?utm_source=businessinsider&utm_medium=referral
3276.0,4/11/2023 11:30:32 AM,3 Blue-Chip Stocks to Buy at an All-Time Low in April,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-at-an-all-time-low-in-april-1032224051
3277.0,4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral
3278.0,4/11/2023 12:56:42 PM,US DOJ asks appeals court to block Texas judge abortion pill ruling,Seeking Alpha,https://seekingalpha.com/news/3955611-us-doj-asks-appeals-court-block-texas-judge-abortion-pill-ruling?utm_source=businessinsider&utm_medium=referral
3279.0,4/11/2023 5:40:48 PM,Johnson & Johnson talc victims seek dismissal of latest bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/3955718-jnj-talc-victims-seek-dismissal-latest-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral
3280.0,4/13/2023 9:02:47 AM,"Appeals court permits limited access to abortion pill, blocks part of Texas ruling",Seeking Alpha,https://seekingalpha.com/news/3956187-appeals-court-partially-allows-access-abortion-pill?utm_source=businessinsider&utm_medium=referral
3281.0,4/14/2023 9:32:00 AM,Ghana 1st in world to approve new malaria vaccine by Oxford,Seeking Alpha,https://seekingalpha.com/news/3956507-ghana-1st-in-world-approve-new-malaria-vaccine-oxford?utm_source=businessinsider&utm_medium=referral
3282.0,4/14/2023 5:30:11 PM,"Catalyst Watch: Earnings season picks up steam, housing data due",Seeking Alpha,https://seekingalpha.com/news/3956620-catalyst-watch-earnings-season-picks-up-steam-housing-data-due?utm_source=businessinsider&utm_medium=referral
3283.0,4/14/2023 6:30:56 PM,"Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more",Seeking Alpha,https://seekingalpha.com/news/3956682-earnings-week-ahead-tesla-att-charles-schwab-netflix-and-more?utm_source=businessinsider&utm_medium=referral
3284.0,4/15/2023 1:38:31 PM,3 Dividend Stocks to Buy for a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-a-recession-proof-portfolio-1032234092
3285.0,4/17/2023 7:03:15 AM,Could Johnson & Johnson (NYSE:JNJ) Once Again Beat Earnings Forecast?,TipRanks,/news/stocks/could-johnson-johnson-nyse-jnj-once-again-beat-earnings-forecast-1032235509
3286.0,4/17/2023 7:20:14 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-unitedhealth-unh-johnson-johnson-jnj-and-merck-company-mrk-1032235548
3287.0,4/17/2023 1:11:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3956915-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
3288.0,4/17/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1032236413
3289.0,4/17/2023 5:27:26 PM,Johnson & Johnson Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3957017-johnson-johnson-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral
3290.0,4/17/2023 5:49:38 PM,JNJ vs. PG: Which Blue-Chip Stock is Better?,TipRanks,/news/stocks/jnj-vs-pg-which-blue-chip-stock-is-better-1032237284
3291.0,4/18/2023 10:22:27 AM,"Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance",Seeking Alpha,https://seekingalpha.com/news/3957230-johnson-and-johnson-non-gaap-eps-of-2_68-beats-0_18-revenue-of-24_7b-beats-1_09b?utm_source=businessinsider&utm_medium=referral
3292.0,4/18/2023 10:35:59 AM,3 Dividend Stocks to Sell Before They Get Sued by Customers,InvestorPlace,/news/stocks/3-dividend-stocks-to-sell-before-they-get-sued-by-customers-1032239171
3293.0,4/18/2023 10:44:16 AM,Johnson & Johnson lifts dividend by 5.3% to $1.19/share,Seeking Alpha,https://seekingalpha.com/news/3957233-johnson--johnson-lifts-dividend-by-53-to-119share?utm_source=businessinsider&utm_medium=referral
3294.0,4/18/2023 11:18:21 AM,"J&J stock pops as Q1 revenue boosted by Darzalex, COVID vaccine; raises FY23 outlook",Seeking Alpha,https://seekingalpha.com/news/3957246-jj-stock-pops-revenue-boosted-by-darzalex-covid-shot-raises-outlook?utm_source=businessinsider&utm_medium=referral
3295.0,4/18/2023 12:30:10 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1032239142
3296.0,4/18/2023 1:04:58 PM,Johnson & Johnson Q1 Profit Tops Estimates; Raises 2023 Guidance Midpoints ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-raises-2023-guidance-midpoints-1032239244
3297.0,4/18/2023 4:51:53 PM,"Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday",Benzinga,/news/stocks/ericsson-johnson-johnson-goldman-sachs-and-other-big-stocks-moving-lower-on-tuesday-1032240248
3298.0,4/18/2023 5:10:07 PM,"Nasdaq, S&P, Dow fluctuate as traders parse earnings reports from major names",Seeking Alpha,https://seekingalpha.com/news/3957380-nasdaq-sp500-dow-jones-stock-market-first-quarter-earnings?utm_source=businessinsider&utm_medium=referral
3299.0,4/19/2023 1:20:23 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1032241274
3300.0,4/19/2023 1:44:12 AM,Judge to decide if he will halt J&J talc lawsuits on Thursday,Seeking Alpha,https://seekingalpha.com/news/3957545-judge-to-decide-if-he-will-halt-jj-talc-lawsuits-on-thursday?utm_source=businessinsider&utm_medium=referral
3301.0,4/19/2023 8:45:04 AM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032242698
3302.0,4/19/2023 10:04:20 AM,Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-intuitive-surgical-isrg-and-johnson-johnson-jnj-1032242868
3303.0,4/19/2023 11:48:49 AM,Legend Biotech adds 18% after leaked report on JNJ-partnered CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3957646-jnj-stock-legend-biotech-stock-gain-on-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral
3304.0,4/19/2023 2:32:27 PM,Legend Biotech announces private placement for ~7.7M shares,Seeking Alpha,https://seekingalpha.com/news/3957778-legend-biotech-stock-private-placement?utm_source=businessinsider&utm_medium=referral
3305.0,4/19/2023 4:25:57 PM,Atlantic Equities Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032244205
3306.0,4/19/2023 6:00:09 PM,"Geron, CTI rally after leaked data for Legend Biotech‚Äôs blood cancer drug",Seeking Alpha,https://seekingalpha.com/news/3957879-geron-stock-cti-stock-rally-after-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral
3307.0,4/19/2023 7:00:57 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032244305
3308.0,4/20/2023 2:07:07 PM,Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names,Benzinga,/news/etf/where-is-the-current-bull-market-scan-of-stocks-gaining-over-20-over-the-past-week-almost-exclusively-yields-biotech-names-1032246765
3309.0,4/20/2023 4:37:01 PM,Judge extends stay for Johnson & Johnson talc claims another 60 days,Seeking Alpha,https://seekingalpha.com/news/3958357-judge-extends-stay-johnson-johnson-talc-claims-another-60-days?utm_source=businessinsider&utm_medium=referral
3310.0,4/21/2023 10:55:13 AM,Genmab's claims dismissed by arbitral tribunal in Darzalex royalty feud with J&J,Seeking Alpha,https://seekingalpha.com/news/3958594-genmab-claims-dismissed-arbitral-tribunal-darzalex-royalty-feud-with-jj?utm_source=businessinsider&utm_medium=referral
3311.0,4/21/2023 12:30:59 PM,"Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Johnson & Johnson (JNJ) and Lucid Diagnostics (LUCD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insmed-insm-johnson-johnson-jnj-and-lucid-diagnostics-lucd-1032249875
3312.0,4/21/2023 2:36:56 PM,OmniAb a new buy at Benchmark on technology to develop monoclonal antibodies,Seeking Alpha,https://seekingalpha.com/news/3958719-omniab-new-buy-benchmark-technology-develop-monoclonal-antibodies?utm_source=businessinsider&utm_medium=referral
3313.0,4/21/2023 5:09:23 PM,Legend Biotech up 10% on confirming Carvykti multiple myeloma data,Seeking Alpha,https://seekingalpha.com/news/3958762-legend-biotech-up-10-confirming-carvykti-multiple-myeloma-data?utm_source=businessinsider&utm_medium=referral
3314.0,4/21/2023 5:51:00 PM,Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,PR Newswire,/news/stocks/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-j-j-settlement-1032250401
3315.0,4/22/2023 8:00:00 PM,Ulcerative colitis market set to hit $9.6B by 2031,Seeking Alpha,https://seekingalpha.com/news/3958777-ulcerative-colitis-market-set-to-hit-96b-by-2031?utm_source=businessinsider&utm_medium=referral
3316.0,4/24/2023 12:50:13 AM,Johnson & Johnson to launch IPO roadshow for consumer health unit ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3958878-johnson-johnson-ipo-roadshow-consumer-health-unit-kenvue?utm_source=businessinsider&utm_medium=referral
3317.0,4/24/2023 9:37:42 AM,Genmab to file appeal against tribunal award in Darzalex royalty dispute with J&J,Seeking Alpha,https://seekingalpha.com/news/3958915-genmab-file-appeal-tribunal-award-in-darzalex-royalty-dispute-jj?utm_source=businessinsider&utm_medium=referral
3318.0,4/24/2023 12:39:37 PM,"Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate",Seeking Alpha,https://seekingalpha.com/news/3959032-lantheus-point-biopharma-receive-fda-fast-track-status-prostate-cancer-candidate?utm_source=businessinsider&utm_medium=referral
3319.0,4/24/2023 1:35:06 PM,DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032254479
3320.0,4/24/2023 5:22:16 PM,The 3 Greatest Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-greatest-dividend-stocks-to-buy-now-1032255133
3321.0,4/24/2023 8:53:12 PM,J&J's Kenvue consumer health spinoff sets IPO terms,Seeking Alpha,https://seekingalpha.com/news/3959418-johnson-johnson-kenvue-consumer-health-spinoff-sets-ipo-terms?utm_source=businessinsider&utm_medium=referral
3322.0,4/24/2023 9:16:11 PM,Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways: Analyst,Benzinga,/news/stocks/focus-on-genmab-s-pipeline-if-darzalex-arbitration-with-janssen-goes-sideways-analyst-1032255374
3323.0,4/25/2023 1:42:32 PM,Alkermes gets tribunal award in J&J license deal arbitration,Seeking Alpha,https://seekingalpha.com/news/3959713-alkermes-gets-tribunal-award-in-jj-license-deal-arbitration?utm_source=businessinsider&utm_medium=referral
3324.0,4/25/2023 3:38:42 PM,Bipartisan agreement reached in Senate prescription drug price legislation,Seeking Alpha,https://seekingalpha.com/news/3959793-bipartisan-agreement-reached-senate-prescription-drug-price-legislation?utm_source=businessinsider&utm_medium=referral
3325.0,4/25/2023 6:40:22 PM,3 Dividend Aristocrats to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-buy-for-consistent-income-1032259710
3326.0,4/26/2023 5:15:33 PM,"Pfizer, BioNTech hit new 52-week lows",Seeking Alpha,https://seekingalpha.com/news/3960630-pfizer-stock-biontech-stock-hit-new-52-week-lows?utm_source=businessinsider&utm_medium=referral
3327.0,4/26/2023 5:21:35 PM,Democratic senators introduce bill to enhance CMS drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3960629-democratic-senators-introduce-bill-enhance-cms-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3328.0,4/26/2023 9:35:22 PM,7 Stocks That Are Strong Buys on the Heels of Impressive Earnings,InvestorPlace,/news/stocks/7-stocks-that-are-strong-buys-on-the-heels-of-impressive-earnings-1032265412
3329.0,4/27/2023 12:50:04 AM,Get Defensive with These 3 Cash Flow Producing Machines,InvestorPlace,/news/stocks/get-defensive-with-these-3-cash-flow-producing-machines-1032265641
3330.0,4/27/2023 7:16:00 PM,3 Long-Term Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-and-hold-forever-1032270173
3331.0,4/28/2023 2:51:27 PM,J&J to 'indemnify' Kenvue from any talc-related costs,Seeking Alpha,https://seekingalpha.com/news/3962118-johnson-johnson-indemnify-kenvue-talc-related-costs?utm_source=businessinsider&utm_medium=referral
3332.0,4/29/2023 8:00:00 PM,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",Seeking Alpha,https://seekingalpha.com/news/3962345-pfizer-gsk-abbvie-among-pharmas-rise-may-catalysts?utm_source=businessinsider&utm_medium=referral
3333.0,4/29/2023 11:19:13 PM,Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April,Benzinga,/news/etf/here-are-the-best-sector-etfs-and-major-sector-moving-stocks-in-april-1032275372
3334.0,4/30/2023 6:48:26 PM,7 High-Yield Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-buy-and-hold-forever-1032276200
3335.0,5/1/2023 4:17:45 PM,Johnson & Johnson reports 73% complete remission for bladder cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3962692-jnj-stock-posts-complete-remission-bladder-cancer-therapy?utm_source=businessinsider&utm_medium=referral
3336.0,5/1/2023 5:32:54 PM,KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?,InvestorPlace,/news/stocks/kvue-stock-ipo-when-does-kenvue-go-public-what-is-the-kenvue-ipo-price-range-1032279016
3337.0,5/1/2023 6:22:43 PM,The 7 Best Dividend Stocks to Buy for May 2023,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-for-may-2023-1032279106
3338.0,5/2/2023 1:41:11 AM,"U.S. to end COVID vaccine mandates for foreign travelers, others next week",Seeking Alpha,https://seekingalpha.com/news/3963092-us-to-end-covid-vaccine-mandate-foreign-travelers-others?utm_source=businessinsider&utm_medium=referral
3339.0,5/2/2023 12:47:50 PM,Johnson & Johnson projects earnings impact from CAR-T deal,Seeking Alpha,https://seekingalpha.com/news/3963317-jnj-stock-projects-earnings-impact-car-t-deal?utm_source=businessinsider&utm_medium=referral
3340.0,5/2/2023 6:20:57 PM,"EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations",Benzinga,/news/stocks/exclusive-ama-moves-toward-psychedelic-therapy-reimbursement-filing-a-gap-in-regulations-1032283416
3341.0,5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral
3342.0,5/3/2023 1:43:13 PM,Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-lyts-stock-to-gain-9-by-may-30-1032288024
3343.0,5/3/2023 1:50:11 PM,Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-huya-stock-to-gain-6-by-may-30-1032288022
3344.0,5/3/2023 1:57:50 PM,Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tcmd-stock-to-gain-5-by-may-30-1032288068
3345.0,5/3/2023 3:00:54 PM,KVUE Stock: Should You Buy Into the Kenvue IPO?,InvestorPlace,/news/stocks/kvue-stock-should-you-buy-into-the-kenvue-ipo-1032288193
3346.0,5/4/2023 1:10:17 AM,"J&J spinout Kenvue raises $3.8B through upsized IPO, making it largest of year",Seeking Alpha,https://seekingalpha.com/news/3965269-jj-spinout-kenvue-raises-4b-through-upsized-ipo-making-it-largest-of-year?utm_source=businessinsider&utm_medium=referral
3347.0,5/4/2023 9:04:27 AM,3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows,InvestorPlace,/news/stocks/3-must-buy-blue-chip-stocks-if-the-market-retests-2022-lows-1032291477
3348.0,5/4/2023 10:04:53 AM,Alvotech starts confirmatory patient trial of J&J Simponi biosimilar,Seeking Alpha,https://seekingalpha.com/news/3965372-alvotech-starts-confirmatory-trial-of-jj-simponi-biosimilar?utm_source=businessinsider&utm_medium=referral
3349.0,5/4/2023 2:42:44 PM,Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-atec-stock-to-gain-5-by-june-1-1032293386
3350.0,5/4/2023 2:49:03 PM,Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-eght-stock-to-gain-4-by-june-1-1032293385
3351.0,5/4/2023 2:53:11 PM,KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading,InvestorPlace,/news/stocks/kvue-stock-alert-10-things-to-know-as-kenvue-starts-trading-1032293384
3352.0,5/4/2023 2:54:21 PM,Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-asrt-stock-to-gain-3-by-june-1-1032293383
3353.0,5/4/2023 3:42:31 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in May 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-may-2023-1032293508
3354.0,5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral
3355.0,5/4/2023 6:52:18 PM,SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?,InvestorPlace,/news/stocks/slrn-stock-ipo-when-does-acelyrin-go-public-what-is-the-acelyrin-ipo-price-range-1032294002
3356.0,5/4/2023 7:29:16 PM,Which Healthcare Stock Is a Compelling Pick for the Long Haul?,InvestorPlace,/news/stocks/which-healthcare-stock-is-a-compelling-pick-for-the-long-haul-1032294048
3357.0,5/4/2023 8:19:47 PM,J&J spinout Kenvue shares climb 22% following $3.8B upsized IPO (update),Seeking Alpha,https://seekingalpha.com/news/3965768-jnj-spinout-kenvue-shares-jump-following-upsized-ipo?utm_source=businessinsider&utm_medium=referral
3358.0,5/4/2023 10:31:43 PM,3 Dividend Stocks to Count on No Matter What the Market Does¬†,InvestorPlace,/news/stocks/3-dividend-stocks-to-count-on-no-matter-what-the-market-does-1032294553
3359.0,5/5/2023 5:32:36 PM,Rochelle Walensky stepping down as CDC director on June 30,Seeking Alpha,https://seekingalpha.com/news/3966632-rochelle-walensky-stepping-down-cdc-director-june-30?utm_source=businessinsider&utm_medium=referral
3360.0,5/5/2023 5:41:20 PM,Artificial Intelligence Engine Predicts GOOG Stock to Gain 2.6% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-goog-stock-to-gain-2-by-june-2-1032298453
3361.0,5/5/2023 5:45:07 PM,Artificial Intelligence Engine Predicts IQ Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-iq-stock-to-gain-3-by-june-2-1032298452
3362.0,5/5/2023 5:57:16 PM,Artificial Intelligence Engine Predicts TME Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tme-stock-to-gain-3-by-june-2-1032298451
3363.0,5/5/2023 6:07:27 PM,Artificial Intelligence Engine Predicts GENI Stock to Gain 2% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-geni-stock-to-gain-2-by-june-2-1032298450
3364.0,5/5/2023 6:30:34 PM,Kenvue cools off on second trading day,Seeking Alpha,https://seekingalpha.com/news/3966653-kenvue-cools-off-second-trading-day?utm_source=businessinsider&utm_medium=referral
3365.0,5/5/2023 9:59:37 PM,S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility,Benzinga,/news/stocks/s-p-500-finishes-strong-following-wild-week-of-bank-stock-volatility-1032298618
3366.0,5/8/2023 10:15:58 AM,The 7 Best Long-Term Dividend Stocks to Buy in May,InvestorPlace,/news/stocks/the-7-best-long-term-dividend-stocks-to-buy-in-may-1032301505
3367.0,5/9/2023 12:43:07 AM,The 7 Best Mutual Funds to Invest in for May 2023,InvestorPlace,/news/stocks/the-7-best-mutual-funds-to-invest-in-for-may-2023-1032303980
3368.0,5/9/2023 10:45:43 AM,3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-as-the-healthcare-sector-booms-in-2023-1032306053
3369.0,5/9/2023 11:00:36 AM,"Analysts Offer Insights on Healthcare Companies: Cigna (CI), Johnson & Johnson (JNJ) and Crinetics Pharmaceuticals (CRNX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cigna-ci-johnson-johnson-jnj-and-crinetics-pharmaceuticals-crnx-1032306181
3370.0,5/9/2023 12:56:49 PM,Big pharma maps legal strategy against U.S. drug pricing regulation ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3967966-big-pharma-maps-legal-strategy-against-drug-pricing-regulation?utm_source=businessinsider&utm_medium=referral
3371.0,5/9/2023 2:38:56 PM,J&J's Tremfya succeeds in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3968060-johnson-johnson-janssen-tremfya-succeeds-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral
3372.0,5/10/2023 1:19:15 PM,Halozyme gains as Piper Sandler upgrades despite Q1 miss,Seeking Alpha,https://seekingalpha.com/news/3969086-halozyme-stock-gains-piper-sandler-upgrades-despite-q1-miss?utm_source=businessinsider&utm_medium=referral
3373.0,5/10/2023 2:32:01 PM,Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-pacw-stock-to-gain-11-by-june-7-1032313141
3374.0,5/10/2023 4:57:05 PM,3 Dividend Stocks Set to Hike Payouts in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-set-to-hike-payouts-in-2023-1032313635
3375.0,5/10/2023 8:23:34 PM,Shockwave Medical ticks higher amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3969501-shockwave-medical-ticks-higher-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral
3376.0,5/10/2023 8:33:44 PM,Is ChatGPT A Better Financial Advisor? We're Going To Find Out,Benzinga,/news/etf/is-chatgpt-a-better-financial-advisor-we-re-going-to-find-out-1032313893
3377.0,5/11/2023 10:28:29 PM,J&J talc victim group seeking $30B in fraudulent conveyance complaint,Seeking Alpha,https://seekingalpha.com/news/3970598-johnson-johnson-talc-group-seeking-30b-fraudulent-conveyance-complaint?utm_source=businessinsider&utm_medium=referral
3378.0,5/12/2023 7:00:44 PM,"Catalyst watch: AI talk, ON Semiconductor event, hedge fund reports and Walmart earnings",Seeking Alpha,https://seekingalpha.com/news/3970895-catalyst-watch-ai-talk-on-semiconductor-event-hedge-fund-reports-and-walmart-earnings?utm_source=businessinsider&utm_medium=referral
3379.0,5/12/2023 7:14:31 PM,Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment,Benzinga,/news/stocks/promising-phase-1-results-protagonist-therapeutics-and-janssen-biotech-unlock-new-potential-in-colitis-and-inflammation-treatment-1032323629
3380.0,5/13/2023 8:00:00 PM,Cancer therapies spending set to surge through end of decade,Seeking Alpha,https://seekingalpha.com/news/3971001-cancer-therapies-spending-set-surge-through-end-decade?utm_source=businessinsider&utm_medium=referral
3381.0,5/14/2023 7:16:13 PM,3 Bargain Dividend Stocks to Boost Your Passive Income,InvestorPlace,/news/stocks/3-bargain-dividend-stocks-to-boost-your-passive-income-1032324953
3382.0,5/14/2023 7:30:40 PM,Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks,InvestorPlace,/news/stocks/investing-for-the-long-term-here-are-7-must-have-dividend-stocks-1032324961
3383.0,5/16/2023 12:52:10 PM,AstraZeneca to exit leading U.S. drug industry group PhRMA,Seeking Alpha,https://seekingalpha.com/news/3972045-astrazeneca-stock-exits-leading-us-drug-lobby-phrma?utm_source=businessinsider&utm_medium=referral
3384.0,5/16/2023 9:53:16 PM,Don‚Äôt Panic. 3 Defensive Stocks to Diversify Into ASAP,InvestorPlace,/news/stocks/dont-panic-3-defensive-stocks-to-diversify-into-asap-1032332746
3385.0,5/17/2023 4:55:50 PM,Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears,TipRanks,/news/stocks/billionaire-paul-tudor-jones-pours-millions-into-these-2-stocks-amid-recession-fears-1032335705
3386.0,5/18/2023 10:20:56 AM,3 Reliable Dividend Stocks That Fit in Any Investor‚Äôs Portfolio,InvestorPlace,/news/stocks/3-reliable-dividend-stocks-that-fit-in-any-investors-portfolio-1032336948
3387.0,5/18/2023 11:13:15 AM,7 High-Quality Dow Stocks to Buy on the Dip,InvestorPlace,/news/stocks/7-high-quality-dow-stocks-to-buy-on-the-dip-1032337109
3388.0,5/18/2023 3:23:30 PM,Arcellx a buy at Truist on unique cancer cell therapies,Seeking Alpha,https://seekingalpha.com/news/3973091-arcellx-buy-at-truist-unique-cancer-cell-therapies?utm_source=businessinsider&utm_medium=referral
3389.0,5/18/2023 3:50:47 PM,Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-nvax-stock-to-gain-7-by-june-15-1032337978
3390.0,5/18/2023 4:13:46 PM,Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron,Seeking Alpha,https://seekingalpha.com/news/3973082-supreme-court-rules-against-amgen-rapatha-patent-dispute?utm_source=businessinsider&utm_medium=referral
3391.0,5/18/2023 6:13:29 PM,WHO recommends updating COVID shots to add XBB.1 variants,Seeking Alpha,https://seekingalpha.com/news/3973169-who-recommends-updating-covid-shots-to-add-xbb1-variants?utm_source=businessinsider&utm_medium=referral
3392.0,5/19/2023 11:22:36 AM,"Dividend Roundup: Johnson & Johnson, Northrop Grumman, JPMorgan and more",Seeking Alpha,https://seekingalpha.com/news/3973203-dividend-roundup-johnson--johnson-northrop-grumman-jpmorgan-and-more?utm_source=businessinsider&utm_medium=referral
3393.0,5/19/2023 4:51:21 PM,"WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake",Benzinga,/news/stocks/who-recommends-new-covid-booster-shots-to-target-xbb-variants-despite-slower-uptake-1032340045
3394.0,5/20/2023 8:32:40 PM,Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%,Seeking Alpha,https://seekingalpha.com/news/3973618-teva-long-acting-schizophrenia-drug-uzedy-reduces-relapse-risk?utm_source=businessinsider&utm_medium=referral
3395.0,5/21/2023 4:00:17 PM,Billions of dollars at stake as FDA shortcut allows half-proven drugs - report,Seeking Alpha,https://seekingalpha.com/news/3973623-billions-fda-shortcut-allows-half-proven-drugs?utm_source=businessinsider&utm_medium=referral
3396.0,5/22/2023 12:58:00 AM,HDV: This Dividend ETF Proves That High Yield Isn‚Äôt Always Best,TipRanks,/news/stocks/hdv-this-dividend-etf-proves-that-high-yield-isn-t-always-best-1032341360
3397.0,5/23/2023 9:50:11 AM,Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and Coherus Biosciences (CHRS),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-coherus-biosciences-chrs-1032344701
3398.0,5/23/2023 11:15:28 AM,Debt ceiling crisis is already changing market dynamics - what could come next?,Seeking Alpha,https://seekingalpha.com/news/3974100-debt-ceiling-crisis-is-already-changing-market-dynamics-what-could-come-next?utm_source=businessinsider&utm_medium=referral
3399.0,5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral
3400.0,5/23/2023 6:30:03 PM,"Amgen, J&J settle lawsuit over Stelara biosimilar",Seeking Alpha,https://seekingalpha.com/news/3974310-amgen-johnson-johnson-settle-lawsuit-stelara-biosimilar?utm_source=businessinsider&utm_medium=referral
3401.0,5/23/2023 11:18:50 PM,7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-for-protection-from-a-u-s-debt-default-disaster-1032346801
3402.0,5/24/2023 10:33:55 AM,"Alvotech, Advanz Pharma ink pact for five potential biosimilars in Europe",Seeking Alpha,https://seekingalpha.com/news/3974490-alvotech-advanz-pharma-ink-pact-five-potential-biosimilars-in-europe?utm_source=businessinsider&utm_medium=referral
3403.0,5/24/2023 2:35:39 PM,Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields-1032348428
3404.0,5/25/2023 1:22:09 PM,"Bristol Myers, J&J's blood clot therapy milvexian gets FDA fast track status",Seeking Alpha,https://seekingalpha.com/news/3975069-bristol-myers-jjs-blood-clot-drug-milvexian-gets-fda-fast-track-tag?utm_source=businessinsider&utm_medium=referral
3405.0,5/25/2023 5:00:55 PM,Legend Biotech a market perform at William Blair on commercial execution,Seeking Alpha,https://seekingalpha.com/news/3975167-legend-biotech-market-perform-william-blair-commercial-execution?utm_source=businessinsider&utm_medium=referral
3406.0,5/25/2023 6:07:05 PM,J&J files for expanded approval of blood cancer drug Carvykti in EU,Seeking Alpha,https://seekingalpha.com/news/3975181-jj-files-for-expanded-use-of-blood-cancer-drug-carvykti-in-eu?utm_source=businessinsider&utm_medium=referral
3407.0,5/26/2023 10:38:37 AM,Elon Musk's Neuralink gets FDA nod to start human trial of brain implant,Seeking Alpha,https://seekingalpha.com/news/3975338-elon-musks-neuralink-gets-fda-nod-to-start-human-trial-of-brain-implant?utm_source=businessinsider&utm_medium=referral
3408.0,5/26/2023 12:03:25 PM,J&J Janssen unit net drug prices decline for sixth straight year,Seeking Alpha,https://seekingalpha.com/news/3975379-johnson-johnson-janssen-net-drug-prices-decline-sixth-straight-year?utm_source=businessinsider&utm_medium=referral
3409.0,5/26/2023 6:03:49 PM,3 Dow Stocks Poised for a Roaring Relief Rally,InvestorPlace,/news/stocks/3-dow-stocks-poised-for-a-roaring-relief-rally-1032355012
3410.0,5/26/2023 7:00:30 PM,"Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event",Seeking Alpha,https://seekingalpha.com/news/3975507-catalyst-watch-c3ai-and-salesforce-earnings-knife-river-debut-kenvue-ratings-faraday-future-event?utm_source=businessinsider&utm_medium=referral
3411.0,5/27/2023 8:00:00 PM,Why 2023 is turning into the year of the healthcare spinoff,Seeking Alpha,https://seekingalpha.com/news/3975499-why-2023-turning-into-year-healthcare-spinout?utm_source=businessinsider&utm_medium=referral
3412.0,5/28/2023 11:27:47 PM,7 Undervalued Blue-Chip Stocks to Buy for June 2023,InvestorPlace,/news/stocks/7-undervalued-blue-chip-stocks-to-buy-for-june-2023-1032355843
3413.0,5/30/2023 8:55:12 AM,Johnson & Johnson (JNJ) Receives a New Rating from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-new-rating-from-citi-1032357663
3414.0,5/30/2023 10:56:03 AM,Next set of COVID boosters to target new Omicron variants ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3975713-next-set-of-covid-boosters-to-target-new-omicron-variants?utm_source=businessinsider&utm_medium=referral
3415.0,5/30/2023 3:17:57 PM,JP Morgan starts coverage of Kenvue with Overweight rating,Seeking Alpha,https://seekingalpha.com/news/3975845-jp-morgan-kenvue-overweight-rating?utm_source=businessinsider&utm_medium=referral
3416.0,5/30/2023 4:40:22 PM,"Goldman starts Kenvue at neutral, cites J&J divestiture as potential overhang",Seeking Alpha,https://seekingalpha.com/news/3975876-goldman-starts-kenvue-neutral-jj-divestiture-potential-overhang?utm_source=businessinsider&utm_medium=referral
3417.0,5/30/2023 5:59:07 PM,"Citi starts Kenvue at neutral, cites uncertainly around brand performance",Seeking Alpha,https://seekingalpha.com/news/3975904-citi-starts-kenvue-at-neutral-cites-uncertainly-around-brand-performance?utm_source=businessinsider&utm_medium=referral
3418.0,5/30/2023 6:02:18 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032358850
3419.0,5/30/2023 7:30:57 PM,Eli Lilly partners with XtalPi on AI drug discovery in up to $250M deal,Seeking Alpha,https://seekingalpha.com/news/3975939-eli-lilly-partners-xtalpi-artificial-intelligence-drug-discovery-250m-deal?utm_source=businessinsider&utm_medium=referral
3420.0,5/30/2023 7:57:28 PM,Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out,Benzinga,/news/stocks/kenvue-s-growth-forecast-exploring-the-future-of-johnson-johnson-s-carve-out-1032359086
3421.0,5/30/2023 8:53:50 PM,"RBC Capital starts Kenvue at overweight, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-at-overweight-sees-significant-upside-to-stock?utm_source=businessinsider&utm_medium=referral
3422.0,5/30/2023 9:11:02 PM,"RBC Capital starts Kenvue at outperform, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-outperform-sees-significant-upside-stock?utm_source=businessinsider&utm_medium=referral
3423.0,5/31/2023 3:24:07 PM,Johnson & Johnson says Tremfya sustained improvements in psoriatic arthritis,Seeking Alpha,https://seekingalpha.com/news/3976262-jnj-tremfya-sustains-improvements-psoriatic-arthritis?utm_source=businessinsider&utm_medium=referral
3424.0,6/1/2023 6:25:38 AM,Bernstein Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/bernstein-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032363218
3425.0,6/1/2023 4:49:40 PM,3 Warren Buffett Stocks to Buy (and Never Sell)¬†,InvestorPlace,/news/stocks/3-warren-buffett-stocks-to-buy-and-never-sell-1032365360
3426.0,6/1/2023 5:01:15 PM,Eli Lilly beats Johnson & Johnson to become world's most valuable drugmaker,Seeking Alpha,https://seekingalpha.com/news/3976741-lilly-stock-pips-jnj-stock-become-most-valuable-pharma?utm_source=businessinsider&utm_medium=referral
3427.0,6/1/2023 6:59:10 PM,"AI, Tech Fuel Rebound Of Vanguard Growth ETF, Eroding Value's 2022 Outperformance",Benzinga,/news/etf/ai-tech-fuel-rebound-of-vanguard-growth-etf-eroding-value-s-2022-outperformance-1032365404
3428.0,6/2/2023 10:30:45 AM,3 Retirement Stocks to Buy to Sleep Like a Baby,InvestorPlace,/news/stocks/3-retirement-stocks-to-buy-to-sleep-like-a-baby-1032366907
3429.0,6/2/2023 11:20:06 AM,Whistleblower lawsuit against Johnson & Johnson dismissed over leaked trade secrets,Seeking Alpha,https://seekingalpha.com/news/3977056-johnson-johnson-wins-dismissal-whistleblower-case?utm_source=businessinsider&utm_medium=referral
3430.0,6/2/2023 3:37:31 PM,Lava Therapeutics up 26% as J&J chooses antibody candidate for development,Seeking Alpha,https://seekingalpha.com/news/3977175-lava-therapeutics-up-26-johnson-johnson-janssen-chooses-antibody-candidate?utm_source=businessinsider&utm_medium=referral
3431.0,6/2/2023 7:26:08 PM,3 Stocks That High-Yield ETFs Are Betting On,InvestorPlace,/news/stocks/3-stocks-that-high-yield-etfs-are-betting-on-1032368191
3432.0,6/2/2023 8:18:41 PM,Johnson & Johnson COVID vaccine authorization revoked by FDA,Seeking Alpha,https://seekingalpha.com/news/3977355-johnson-johnson-janssen-covid-vaccine-authorization-revoked-by-fda?utm_source=businessinsider&utm_medium=referral
3433.0,6/3/2023 12:55:55 PM,SVB Securities Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-keeps-their-buy-rating-on-johnson-johnson-jnj-1032368564
3434.0,6/4/2023 2:21:49 PM,The 3 Best Bargain Stocks to Buy in June 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-in-june-2023-1032368900
3435.0,6/4/2023 4:00:08 PM,Morgan Stanley sees broader MedTech impact from weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3977410-morgan-stanley-sees-medtech-impact-from-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral
3436.0,6/6/2023 9:11:58 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (SGHT), Johnson & Johnson (JNJ) and Ultragenyx Pharmaceutical (RARE)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-sight-sciences-sght-johnson-johnson-jnj-and-ultragenyx-pharmaceutical-rare-1032372220
3437.0,6/6/2023 10:42:00 AM,"Narrow market proving a headwind for mutual funds, opportunity for hedge funds",Seeking Alpha,https://seekingalpha.com/news/3977589-narrow-market-a-headwind-for-active-mutual-funds-opportunity-for-hedge-funds?utm_source=businessinsider&utm_medium=referral
3438.0,6/6/2023 11:25:55 AM,Alkermes lifts outlook after arbitration payment from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3977816-alkermes-lifts-outlook-after-arbitration-payment-jnj?utm_source=businessinsider&utm_medium=referral
3439.0,6/6/2023 1:20:37 PM,Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration ,RTTNews,/news/stocks/alkermes-raises-fy23-guidance-with-final-award-in-johnson-johnson-unit-arbitration-1032372582
3440.0,6/7/2023 9:55:41 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032375291
3441.0,6/7/2023 1:28:17 PM,3 Defensive Stocks to Guard Against Too Much Market Optimism,InvestorPlace,/news/stocks/3-defensive-stocks-to-guard-against-too-much-market-optimism-1032376095
3442.0,6/7/2023 4:23:36 PM,J&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concerns,Seeking Alpha,https://seekingalpha.com/news/3978270-jnj-abiomed-unit-recalls-impella-heart-pumps-over-safety-concerns?utm_source=businessinsider&utm_medium=referral
3443.0,6/8/2023 10:30:23 AM,The 3 Best Long-Term Dividend Stocks to Buy in June,InvestorPlace,/news/stocks/the-3-best-long-term-dividend-stocks-to-buy-in-june-1032378017
3444.0,6/8/2023 10:33:33 AM,3 Blue-Chip Stocks to Buy for 100% Returns¬†,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-100-returns-1032378016
3445.0,6/8/2023 3:47:28 PM,3 Bargain Stocks to Buy in June Before They Bounce,InvestorPlace,/news/stocks/3-bargain-stocks-to-buy-in-june-before-they-bounce-1032379049
3446.0,6/9/2023 1:26:24 PM,"AbbVie, Amgen among firms targeted for Medicare inflation penalties",Seeking Alpha,https://seekingalpha.com/news/3978943-abbvie-among-firms-targeted-for-medicare-inflation-penalties?utm_source=businessinsider&utm_medium=referral
3447.0,6/11/2023 8:25:20 PM,7 Top Blue-Chip Stocks to Buy in June 2023,InvestorPlace,/news/stocks/7-top-blue-chip-stocks-to-buy-in-june-2023-1032382217
3448.0,6/12/2023 11:58:31 AM,"Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff",Seeking Alpha,https://seekingalpha.com/news/3979152-teva-stock-alvotech-pact-jnj-stelara-knockoff?utm_source=businessinsider&utm_medium=referral
3449.0,6/12/2023 7:43:39 PM,"COVID shots should be updated for XBB variants, FDA says",Seeking Alpha,https://seekingalpha.com/news/3979315-covid-shots-should-reflect-xbb-variants-fda?utm_source=businessinsider&utm_medium=referral
3450.0,6/12/2023 7:55:55 PM,Build a Millionaire‚Äôs Portfolio With These 3 Dividend-Paying Stocks,InvestorPlace,/news/stocks/build-a-millionaires-portfolio-with-these-3-dividend-paying-stocks-1032384457
3451.0,6/14/2023 9:57:16 AM,"Biggest stock movers today: MicroVision, UnitedHealth and more",Seeking Alpha,https://seekingalpha.com/news/3979733-biggest-stock-movers-today-microvision-unitedhealth-and-more?utm_source=businessinsider&utm_medium=referral
3452.0,6/14/2023 2:48:24 PM,Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada,Seeking Alpha,https://seekingalpha.com/news/3979858-jj-stock-wins-canadian-nod-prostate-cancer-drug?utm_source=businessinsider&utm_medium=referral
3453.0,6/14/2023 3:21:47 PM,3 Long-term Healthcare Stocks to Add to Your Portfolio,InvestorPlace,/news/stocks/3-long-term-healthcare-stocks-to-add-to-your-portfolio-1032389488
3454.0,6/15/2023 12:51:12 AM,Amgen reportedly hires Moderna chief medical officer as new CMO,Seeking Alpha,https://seekingalpha.com/news/3980001-amgen-reportedly-hires-moderna-chief-medical-officer-as-new-cmo?utm_source=businessinsider&utm_medium=referral
3455.0,6/15/2023 10:54:18 AM,AbbVie files patent lawsuit over BeiGene‚Äôs cancer drug - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3980076-beigene-stock-down-abbvie-patent-lawsuit-brukinsa?utm_source=businessinsider&utm_medium=referral
3456.0,6/15/2023 11:26:41 AM,What Are the 3 Top Dividend Aristocrat Stocks That Are Too Cheap to Ignore?,TipRanks,/news/stocks/what-are-the-3-top-dividend-aristocrat-stocks-that-are-too-cheap-to-ignore-1032391402
3457.0,6/16/2023 5:10:44 PM,"3 Stocks to Buy for Long-Term, Life-Changing Returns¬†",InvestorPlace,/news/stocks/3-stocks-to-buy-for-long-term-life-changing-returns-1032394970
3458.0,6/17/2023 8:00:00 PM,Biologic drugs will lead European pharmas to surpass US counterparts in sales,Seeking Alpha,https://seekingalpha.com/news/3979912-biologic-drugs-lead-european-pharmas-surpass-us-counterparts-sales?utm_source=businessinsider&utm_medium=referral
3459.0,6/21/2023 3:44:52 PM,Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3981469-top-pharma-lobby-sues-us-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral
3460.0,6/22/2023 9:55:26 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032403910
3461.0,6/22/2023 12:51:40 PM,Cidara gains as FDA grants fast track status for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3981898-cidara-stock-gains-fda-fast-track-status-flu-asset?utm_source=businessinsider&utm_medium=referral
3462.0,6/22/2023 10:25:30 PM,J&J talc bankruptcy unit to establish $750M trust fund with insurers,Seeking Alpha,https://seekingalpha.com/news/3982247-johnson-johnson-talc-bankruptcy-unit-establishes-750m-trust-fund-insurers?utm_source=businessinsider&utm_medium=referral
3463.0,6/23/2023 2:13:12 PM,"Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host",Benzinga,/news/stocks/cramer-says-datadog-will-put-up-some-good-numbers-and-9-more-stock-takes-from-mad-money-host-1032406785
3464.0,6/23/2023 8:30:41 PM,The AI Tool That Beat Out Top Wall Street Analysts,InvestorPlace,/news/stocks/ai-tool-that-beat-wall-street-analysts-1032407726
3465.0,6/25/2023 4:00:43 PM,What is behind big pharma's underperformance?,Seeking Alpha,https://seekingalpha.com/news/3982575-pharma-underperforms-amid-regulatory-woes?utm_source=businessinsider&utm_medium=referral
3466.0,6/26/2023 3:10:25 PM,J&J submits application to EMA for combination PAH drug,Seeking Alpha,https://seekingalpha.com/news/3982795-johnson-johnson-janssen-submits-application-ema-combination-pah-drug?utm_source=businessinsider&utm_medium=referral
3467.0,6/29/2023 9:08:31 AM,Morgan Stanley shakes up its global dividend portfolio,Seeking Alpha,https://seekingalpha.com/news/3983853-morgan-stanley-shakes-up-its-global-dividend-portfolio?utm_source=businessinsider&utm_medium=referral
3468.0,6/29/2023 12:27:46 PM,The 3 Most Undervalued Dow Stocks to Buy Now: June 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-now-june-2023-1032417770
3469.0,6/29/2023 8:49:59 PM,7 Up-and-Coming Stocks to Buy for the Next Decade,InvestorPlace,/news/stocks/7-up-and-coming-stocks-to-buy-for-the-next-decade-1032418996
3470.0,6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3471.0,6/30/2023 6:06:43 PM,"15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023",Benzinga,/news/etf/15-stocks-up-15-stocks-down-a-look-at-the-dow-jones-industrial-average-halfway-through-2023-1032421047
3472.0,6/30/2023 8:34:52 PM,3 Dividend Stocks to Buy Right This Minute,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-right-this-minute-1032421610
3473.0,7/3/2023 4:25:13 PM,Johnson & Johnson psoriasis pill disappoints in phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3985036-johnson-johnson-psoriasis-pill-disappoints-phase-2-trial?utm_source=businessinsider&utm_medium=referral
3474.0,7/3/2023 7:59:21 PM,3 Long-Term Stocks to Make Your ‚ÄòGet Rich‚Äô Dreams Come True,InvestorPlace,/news/stocks/3-long-term-stocks-to-make-your-get-rich-dreams-come-true-1032424274
3475.0,7/5/2023 1:33:37 PM,Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment,Benzinga,/news/stocks/protagonist-therapeutics-janssen-partnered-psoriasis-candidate-fall-short-of-rival-treatment-1032427164
3476.0,7/5/2023 4:02:44 PM,Sorrento sees promising phase 2 results for abivertinib for lymphoma,Seeking Alpha,https://seekingalpha.com/news/3985616-sorrento-promising-phase-2-results-abivertinib-lymphoma?utm_source=businessinsider&utm_medium=referral
3477.0,7/6/2023 7:25:11 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032429223
3478.0,7/6/2023 11:52:22 AM,Bausch + Lomb buys Blink eye drops from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3985886-bausch--lomb-buys-blink-eye-drops-from-johnson--johnson?utm_source=businessinsider&utm_medium=referral
3479.0,7/6/2023 3:53:25 PM,3 Super-Safe Dividend Stocks to Buy for the Rest of 2023,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-for-the-rest-of-2023-1032430565
3480.0,7/6/2023 6:50:32 PM,The 3 Best Defensive Stocks to Buy Now (and Never Sell),InvestorPlace,/news/stocks/the-3-best-defensive-stocks-to-buy-now-and-never-sell-1032430906
3481.0,7/7/2023 10:07:14 PM,3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback¬†,InvestorPlace,/news/stocks/3-beaten-down-dividend-stocks-primed-for-a-profitable-comeback-1032433010
3482.0,7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral
3483.0,7/10/2023 11:46:52 AM,"Dividend Stocks: Here‚Äôs Where to Invest $1,000 Right Now",InvestorPlace,/news/stocks/dividend-stocks-heres-where-to-invest-1000-right-now-1032434675
3484.0,7/10/2023 12:54:19 PM,Nanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Market ,RTTNews,/news/stocks/nanobiotix-in-license-deal-with-johnson-johnson-unit-stock-climbs-in-pre-market-1032434507
3485.0,7/12/2023 3:26:59 PM,FDA classifies J&J electrode recall as most serious type,Seeking Alpha,https://seekingalpha.com/news/3987100-fda-classifies-johnson-johnson-electrode-recall-most-serious-type?utm_source=businessinsider&utm_medium=referral
3486.0,7/13/2023 8:00:47 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032445607
3487.0,7/14/2023 12:15:24 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1032445946
3488.0,7/14/2023 9:35:13 AM,SVB Securities Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-remains-a-buy-on-johnson-johnson-jnj-1032446893
3489.0,7/14/2023 11:21:59 AM,"7 Failing Dividend Stocks to Stay Far, Far Away From",InvestorPlace,/news/stocks/7-failing-dividend-stocks-to-stay-far-far-away-from-1032447153
3490.0,7/14/2023 7:00:24 PM,"Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown",Seeking Alpha,https://seekingalpha.com/news/3987769-catalyst-watch-microsoft-activision-blizzard-drama-splunk-event-and-nasdaq-100-rebalancing-countdown?utm_source=businessinsider&utm_medium=referral
3491.0,7/15/2023 6:00:00 PM,Atrial fibrillation drug market expected to decline as brand therapies go generic,Seeking Alpha,https://seekingalpha.com/news/3987824-atrial-fibrillation-drug-market-expected-decline-brand-therapies-generic?utm_source=businessinsider&utm_medium=referral
3492.0,7/17/2023 2:13:13 PM,"Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more",Seeking Alpha,https://seekingalpha.com/news/3987892-biggest-stock-movers-today-bridgebio-pharma-zai-lab-argenx-and-more?utm_source=businessinsider&utm_medium=referral
3493.0,7/18/2023 4:33:38 AM,3 Healthcare Stocks to Buy as the Market Gets Defensive,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-market-gets-defensive-1032453336
3494.0,7/18/2023 10:22:03 AM,3 Biotech Stocks for Getting Rich in 2023,InvestorPlace,/news/stocks/3-biotech-stocks-for-getting-rich-in-2023-1032454309
3495.0,7/18/2023 2:26:11 PM,Nanobiotix partners with J&J's Janssen for radiotherapy treatment,Seeking Alpha,https://seekingalpha.com/news/3988403-nanobiotix-lianbio-partners-johnson-johnson-janssen-radiotherapy?utm_source=businessinsider&utm_medium=referral
3496.0,7/18/2023 5:33:04 PM,J&J becomes latest Big Pharma to sue over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/3988476-jj-becomes-latest-big-pharma-to-sue-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral
3497.0,7/18/2023 11:30:37 PM,"J&J ordered to pay $18.8M over man's talc-cancer claim, jury rules",Seeking Alpha,https://seekingalpha.com/news/3988564-jj-requried-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral
3498.0,7/19/2023 12:33:17 AM,"J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)",Seeking Alpha,https://seekingalpha.com/news/3988566-jj-ordered-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral
3499.0,7/19/2023 3:01:13 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q2-1032458861
3500.0,7/19/2023 3:12:42 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3988764-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral
3501.0,7/19/2023 5:35:35 PM,J&J looks to continue long streak of EPS beats with Q2 results,Seeking Alpha,https://seekingalpha.com/news/3988839-johnson-johnson-looks-continue-long-streak-eps-beats-q2-results?utm_source=businessinsider&utm_medium=referral
3502.0,7/19/2023 8:20:28 PM,Johnson & Johnson Sues HHS Over Medicare Drug Price Negotiation Program ,RTTNews,/news/stocks/johnson-johnson-sues-hhs-over-medicare-drug-price-negotiation-program-1032460109
3503.0,7/20/2023 10:25:11 AM,"Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M",Seeking Alpha,https://seekingalpha.com/news/3989064-johnson-and-johnson-non-gaap-eps-of-2_80-beats-0_18-revenue-of-25_53b-beats-860m?utm_source=businessinsider&utm_medium=referral
3504.0,7/20/2023 11:07:34 AM,"Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform",Seeking Alpha,https://seekingalpha.com/news/3989091-johnson-johnson-posts-q2-thanks-to-pharma-medtech?utm_source=businessinsider&utm_medium=referral
3505.0,7/20/2023 12:28:02 PM,"Johnson & Johnson Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-increases-beats-estimates-1032461968
3506.0,7/20/2023 1:12:12 PM,"Johnson & Johnson Raises Guidance For 2023 Adj. Operational EPS, Adj. Operational Sales ",RTTNews,/news/stocks/johnson-johnson-raises-guidance-for-2023-adj-operational-eps-adj-operational-sales-1032462138
3507.0,7/20/2023 1:24:00 PM,"4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989180-4-stocks-to-watch-on-thursday-tesla-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral
3508.0,7/20/2023 2:48:21 PM,"Biggest stock movers today: Netflix, American Airlines, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989052-biggest-stock-movers-today-tesla-discover-financial-services-and-more?utm_source=businessinsider&utm_medium=referral
3509.0,7/20/2023 3:40:59 PM,"J&J could reportedly launch Kenvue exchange offer in ""coming days""",Seeking Alpha,https://seekingalpha.com/news/3989250-jj-could-reportedly-launch-kenvue-exchange-offer-in-coming-days?utm_source=businessinsider&utm_medium=referral
3510.0,7/20/2023 4:02:29 PM,"Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday",Benzinga,/news/stocks/johnson-johnson-zions-bancorporation-heritage-crystal-clean-and-other-big-stocks-moving-higher-on-thursday-1032463026
3511.0,7/20/2023 4:30:51 PM,"Johnson & Johnson Rises On Upbeat Quarterly Results, Outlook ",RTTNews,/news/stocks/johnson-johnson-rises-on-upbeat-quarterly-results-outlook-1032463165
3512.0,7/20/2023 6:12:39 PM,Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings,Benzinga,/news/stocks/dow-surges-300-points-johnson-johnson-posts-upbeat-earnings-1032463441
3513.0,7/20/2023 6:36:15 PM,Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?,InvestorPlace,/news/stocks/is-johnson-johnson-giving-up-on-kenvue-kvue-stock-1032463738
3514.0,7/20/2023 7:09:02 PM,Legend Biotech up 7% on strong Carvykti Q2 sales,Seeking Alpha,https://seekingalpha.com/news/3989343-legend-biotech-up-7-on-strong-carvykti-q2-sales?utm_source=businessinsider&utm_medium=referral
3515.0,7/20/2023 8:18:18 PM,3 of the Best Dividend Stocks to Buy for Passive Income Growth,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-passive-income-growth-1032463888
3516.0,7/20/2023 10:27:30 PM,Cidara says J&J development deal for CD388 remains intact,Seeking Alpha,https://seekingalpha.com/news/3989482-cidara-says-jj-development-deal-for-cd388-remains-intact?utm_source=businessinsider&utm_medium=referral
3517.0,7/21/2023 10:11:22 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sangamo-biosciences-sgmo-johnson-johnson-jnj-and-intuitive-surgical-isrg-1032465400
3518.0,7/21/2023 10:21:28 AM,"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Legend Biotech (LEGN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-legend-biotech-legn-and-johnson-johnson-jnj-1032465431
3519.0,7/21/2023 4:00:58 PM,Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD,Benzinga,/news/stocks/jim-cramer-says-it-s-time-to-buy-this-financial-services-stock-down-32-ytd-1032466285
3520.0,7/21/2023 4:42:47 PM,J&J sues researchers who wrote talc powder linked to cancer,Seeking Alpha,https://seekingalpha.com/news/3989733-johnson-johnson-sues-researchers-talc-powder-linked-cancer?utm_source=businessinsider&utm_medium=referral
3521.0,7/21/2023 7:32:16 PM,"Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance",Benzinga,/news/stocks/johnson-johnson-medtech-business-has-promising-momentum-analysts-say-after-good-q2-performance-1032466689
3522.0,7/23/2023 4:00:31 PM,Johnson & Johnson‚Äôs Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral
3523.0,7/24/2023 10:41:39 AM,Johnson & Johnson launches Kenvue exchange offer,Seeking Alpha,https://seekingalpha.com/news/3989959-johnson-johnson-launches-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral
3524.0,7/24/2023 12:28:09 PM,Syndax and Incyte gain on mid-stage win for immune disorder therapy,Seeking Alpha,https://seekingalpha.com/news/3990001-syndax-stock-incyte-stock-gain-on-mid-stage-win-gvhd?utm_source=businessinsider&utm_medium=referral
3525.0,7/24/2023 1:10:36 PM,Johnson & Johnson Launches Exchange Offer To Separate Kenvue ,RTTNews,/news/stocks/johnson-johnson-launches-exchange-offer-to-separate-kenvue-1032469717
3526.0,7/24/2023 1:45:00 PM,Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday-1032469793
3527.0,7/24/2023 10:50:38 PM,"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-biogen-biib-and-johnson-johnson-jnj-1032471681
3528.0,7/25/2023 12:20:27 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Tonix Pharma (TNXP) and Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-tonix-pharma-tnxp-and-gilead-sciences-gild-1032474207
3529.0,7/25/2023 4:25:00 PM,"GSK, J&J tout Cabenuva preference over Gilead's Biktarvy",Seeking Alpha,https://seekingalpha.com/news/3990613-gsk-johnson-johnson-tout-cabenuva-preference-over-gilead-biktarvy?utm_source=businessinsider&utm_medium=referral
3530.0,7/25/2023 10:30:48 PM,Wall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE),TipRanks,/news/stocks/wall-street-goes-the-irrational-route-with-kenvue-stock-nyse-kvue-1032476357
3531.0,7/27/2023 3:35:45 AM,‚ÄòSet It and Forget It‚Äô With These 3 Stocks to Buy,InvestorPlace,/news/stocks/set-it-and-forget-it-with-these-3-stocks-to-buy-1032482027
3532.0,7/27/2023 11:00:14 AM,3 Biotech Stocks You Better Be Buying on Each and Every Dip,InvestorPlace,/news/stocks/3-biotech-stocks-you-better-be-buying-on-each-and-every-dip-1032483984
3533.0,7/27/2023 1:42:27 PM,7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes,InvestorPlace,/news/stocks/7-millionaire-maker-healthcare-stocks-to-buy-before-the-window-closes-1032484989
3534.0,7/28/2023 9:15:20 AM,The 3 Best Blue-Chip Dividend Stocks to Buy for July,InvestorPlace,/news/stocks/the-3-best-blue-chip-dividend-stocks-to-buy-for-july-1032489162
3535.0,7/28/2023 1:47:07 PM,2seventy bio downgraded at Morgan Stanley after Abecma sales,Seeking Alpha,https://seekingalpha.com/news/3992869-2seventy-bio-stock-downgraded-at-morgan-stanley-abecma?utm_source=businessinsider&utm_medium=referral
3536.0,7/28/2023 6:00:40 PM,"Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?",Seeking Alpha,https://seekingalpha.com/news/3992944-catalyst-watch-amazon-earnings-jobs-report-and-will-apple-talk-ai?utm_source=businessinsider&utm_medium=referral
3537.0,7/28/2023 9:04:08 PM,J&J talc lawsuits bankruptcy plan rejected for a second time,Seeking Alpha,https://seekingalpha.com/news/3993189-johnson-johnson-talc-bankruptcy-plan-rejected-second-time?utm_source=businessinsider&utm_medium=referral
3538.0,7/28/2023 9:32:26 PM,J&J seeks pediatric indication for HIV drug Edurant,Seeking Alpha,https://seekingalpha.com/news/3993196-johnson-johnson-janssen-seeks-pediatric-indication-hiv-drug-edurant?utm_source=businessinsider&utm_medium=referral
3539.0,7/29/2023 2:01:46 PM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Zoetis (ZTS),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-zoetis-zts-1032491624
3540.0,7/31/2023 12:55:04 AM,Johnson & Johnson (JNJ) Gets a Buy from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-citi-1032492468
3541.0,7/31/2023 1:24:00 PM,"5 stocks to watch on Monday: J&J, ON Semiconductor, Yum China and more",Seeking Alpha,https://seekingalpha.com/news/3993420-5-stocks-to-watch-on-monday-jj-on-semiconductor-yum-china-and-more?utm_source=businessinsider&utm_medium=referral
3542.0,7/31/2023 5:57:09 PM,J&J falls after bankruptcy plan rejected for second time,Seeking Alpha,https://seekingalpha.com/news/3993571-jj-falls-after-bankruptcy-plan-rejected-for-second-time?utm_source=businessinsider&utm_medium=referral
3543.0,7/31/2023 6:00:46 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032496288
3544.0,7/31/2023 7:35:33 PM,"US Stocks Take A Breather, Nasdaq Notches Fifth Straight Month Of Gains: Investors Gear Up For Pivotal Week",Benzinga,/news/etf/us-stocks-take-a-breather-nasdaq-notches-fifth-straight-month-of-gains-investors-gear-up-for-pivotal-week-1032496673
3545.0,7/31/2023 7:52:35 PM,7 Stocks to Buy Before They Surpass 2021 Highs,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-surpass-2021-highs-stocks-to-watch-before-new-peaks-1032496877
3546.0,7/31/2023 10:46:32 PM,Cidara antifungal drug Rezzayo launched in US by partner Melinta,Seeking Alpha,https://seekingalpha.com/news/3993866-cidara-antifungal-drug-rezzayo-launched-in-us-by-partner-melinta?utm_source=businessinsider&utm_medium=referral
3547.0,8/1/2023 4:20:24 AM,Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-orthopediatrics-kids-and-johnson-johnson-jnj-1032497694
3548.0,8/1/2023 3:45:48 PM,3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-2-1032501863
3549.0,8/2/2023 1:47:57 PM,3 Consumer Staples Stocks to Dump ASAP,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-dump-asap-1032507199
3550.0,8/3/2023 10:00:39 AM,Sell Alert: 3 Healthcare Stocks to Dump ASAP,InvestorPlace,/news/stocks/sell-alert-3-healthcare-stocks-to-dump-asap-1032511779
3551.0,8/3/2023 11:40:27 AM,"Goldman in, Microsoft out of BofA Alpha Surprise Portfolio",Seeking Alpha,https://seekingalpha.com/news/3996317-goldman-in-microsoft-out-of-bofa-alpha-surprise-portfolio?utm_source=businessinsider&utm_medium=referral
3552.0,8/3/2023 1:24:55 PM,Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights,InvestorPlace,/news/stocks/buckle-up-3-healthcare-stocks-set-to-soar-to-new-heights-1032512866
3553.0,8/3/2023 11:24:57 PM,Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.¬†,InvestorPlace,/news/stocks/buckle-up-3-blue-chip-stocks-set-to-soar-to-new-heights-1032514745
3554.0,8/4/2023 1:42:55 PM,Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/ralph-lauren-to-rally-17-here-are-10-other-analyst-forecasts-for-friday-1032517652
3555.0,8/4/2023 3:42:21 PM,J&J gets expanded approval for cardiac ablation products,Seeking Alpha,https://seekingalpha.com/news/3997619-jj-gets-expanded-approval-for-cardiac-ablation-products?utm_source=businessinsider&utm_medium=referral
3556.0,8/4/2023 7:35:57 PM,3 of the Safest Dividend Kings,InvestorPlace,/news/stocks/3-of-the-safest-dividend-kings-1032519166
3557.0,8/5/2023 8:25:28 AM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032519524
3558.0,8/8/2023 3:01:25 AM,WKLY: Want Weekly Dividends? Check Out This ETF from SoFi,TipRanks,/news/stocks/wkly-want-weekly-dividends-check-out-this-etf-from-sofi-1032525874
3559.0,8/8/2023 6:42:48 PM,The 7 Best Warren Buffett Stocks to Buy for August 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-for-august-2023-1032530460
3560.0,8/9/2023 1:18:29 PM,The Year‚Äôs Top 3 Value ETFs as of August 2023,InvestorPlace,/news/stocks/the-years-top-3-value-etfs-as-of-august-2023-1032535221
3561.0,8/9/2023 10:26:06 PM,Kenvue set to join S&P 500,Seeking Alpha,https://seekingalpha.com/news/4000663-kenvue-set-to-join-sp500?utm_source=businessinsider&utm_medium=referral
3562.0,8/10/2023 12:42:00 AM,Kenvue Set to Join S&P 500,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-1032536990
3563.0,8/10/2023 2:43:43 AM,Kenvue To Join S&P 500 ,RTTNews,/news/stocks/kenvue-to-join-s-p-500-1032537031
3564.0,8/10/2023 9:15:25 AM,The 7 Safest Stocks to Buy in August,InvestorPlace,/news/stocks/the-7-safest-stocks-to-buy-in-august-1032539574
3565.0,8/10/2023 12:06:33 PM,Johnson & Johnson wins FDA nod for new multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4000875-johnson-johnson-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral
3566.0,8/10/2023 1:53:32 PM,JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma ,RTTNews,/news/stocks/jnj-s-janssen-pharma-reports-fda-approval-for-talvey-to-treat-heavily-pretreated-multiple-myeloma-1032540112
3567.0,8/10/2023 2:25:52 PM,KVUE Stock Alert: Kenvue to Join the S&P 500,InvestorPlace,/news/stocks/kvue-stock-alert-kenvue-to-join-the-sp-500-1032541132
3568.0,8/10/2023 3:00:00 PM,Medicare Part D drug price increases far exceed inflation - AARP,Seeking Alpha,https://seekingalpha.com/news/4000101-medicare-part-d-drug-price-increases-far-exceed-inflation?utm_source=businessinsider&utm_medium=referral
3569.0,8/10/2023 8:38:11 PM,Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement,Seeking Alpha,https://seekingalpha.com/news/4001356-supreme-court-hear-arguments-purdue-pharma-sacklers-6b-bankruptcy-settlement?utm_source=businessinsider&utm_medium=referral
3570.0,8/11/2023 8:52:36 AM,"Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies",Seeking Alpha,https://seekingalpha.com/news/3999208-uber-crowded-battleground-and-sweet-16-stock-portfolios-from-jefferies?utm_source=businessinsider&utm_medium=referral
3571.0,8/11/2023 6:53:19 PM,Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval,Benzinga,/news/stocks/boston-scientific-s-farapulse-eyes-stronger-us-market-position-with-potential-fda-approval-1032547558
3572.0,8/12/2023 1:52:53 PM,"HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street‚Äôs ‚ÄúStrong Buy‚Äù Rating?",TipRanks,/news/stocks/hd-msft-or-jnj-which-blue-chip-stock-earns-wall-street-s-strong-buy-rating-1032548261
3573.0,8/13/2023 4:00:00 PM,Inside COVID-19 vaccine makers: Hope vs hype,Seeking Alpha,https://seekingalpha.com/news/4002033-inside-covid-19-vaccine-makers-hope-vs-hype?utm_source=businessinsider&utm_medium=referral
3574.0,8/13/2023 6:00:00 PM,Pharma under threat from bill to expand drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4002034-pharma-under-threat-bill-expand-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3575.0,8/14/2023 12:58:36 PM,Johnson & Johnson wins FDA nod for new prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4002230-johnson-johnson-wins-fda-nod-prostate-cancer-drug-akeega?utm_source=businessinsider&utm_medium=referral
3576.0,8/14/2023 7:08:13 PM,Pfizer wins FDA nod for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4002480-pfizer-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral
3577.0,8/14/2023 7:38:52 PM,7 Dividend Stocks to Buy as Investor Sentiment Falters,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-as-investor-sentiment-falters-1032552786
3578.0,8/14/2023 9:58:46 PM,Catalent accused of misleading investors in shareholder suit,Seeking Alpha,https://seekingalpha.com/news/4002679-catalent-accused-misleading-investors-shareholder-suit?utm_source=businessinsider&utm_medium=referral
3579.0,8/15/2023 3:17:38 PM,Citi sees Kenvue stock outperforming after exchange offer closes,Seeking Alpha,https://seekingalpha.com/news/4003018-citi-sees-kenvue-stock-outperforming-after-exchange-offer-closes?utm_source=businessinsider&utm_medium=referral
3580.0,8/15/2023 5:24:19 PM,"What investors need to know about Johnson & Johnson, Kenvue exchange offer",Seeking Alpha,https://seekingalpha.com/news/4003103-investors-need-know-johnson-johnson-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral
3581.0,8/16/2023 8:14:29 PM,The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-retirement-stocks-to-buy-now-august-2023-1032561164
3582.0,8/17/2023 6:28:12 AM,Johnson & Johnson finalizes an exchange ratio of 8.0324 in Kenvue split-off,Seeking Alpha,https://seekingalpha.com/news/4003772-johnson-johnson-finalizes-an-exchange-ratio-of-80324-in-kenvue-split-off?utm_source=businessinsider&utm_medium=referral
3583.0,8/18/2023 2:45:09 PM,Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet,Benzinga,/news/stocks/benzinga-s-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet-1032566457
3584.0,8/20/2023 8:52:21 PM,The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-now-august-2023-1032568162
3585.0,8/21/2023 10:48:51 AM,"Johnson & Johnson, Kenvue share exchange offer oversubscribed",Seeking Alpha,https://seekingalpha.com/news/4004598-johnson-johnson-kenvue-share-exchange-offer-oversubscribed?utm_source=businessinsider&utm_medium=referral
3586.0,8/21/2023 1:21:00 PM,"4 stocks to watch on Monday: Kenvue, VMware and more",Seeking Alpha,https://seekingalpha.com/news/4004696-4-stocks-to-watch-on-monday-kenvue-vmware-and-more?utm_source=businessinsider&utm_medium=referral
3587.0,8/21/2023 5:38:12 PM,KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer,InvestorPlace,/news/stocks/kvue-stock-alert-johnson-johnson-reveals-results-of-kenvue-exchange-offer-1032570776
3588.0,8/21/2023 6:27:40 PM,Kenvue rises on exchange offer oversubscription; JNJ falls,Seeking Alpha,https://seekingalpha.com/news/4004886-kenvue-rises-exchange-offer-oversubscription-jnj-falls?utm_source=businessinsider&utm_medium=referral
3589.0,8/21/2023 7:26:37 PM,Lawsuits unlikely to hinder Medicare drug price negotiations ‚Äì UBS,Seeking Alpha,https://seekingalpha.com/news/4004908-lawsuits-wont-hurt-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3590.0,8/21/2023 7:58:31 PM,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",Seeking Alpha,https://seekingalpha.com/news/4004913-lillys-market-cap-soared-in-q2-eclipsing-jnj-merck-novo-nordisk?utm_source=businessinsider&utm_medium=referral
3591.0,8/21/2023 8:02:32 PM,These Are the ONLY 7 Warren Buffett Stocks to Consider in August 2023,InvestorPlace,/news/stocks/these-are-the-only-7-warren-buffett-stocks-to-consider-in-august-2023-1032570974
3592.0,8/21/2023 10:12:53 PM,"Kenvue to join S&P 500, replacing Advance Auto Parts",Seeking Alpha,https://seekingalpha.com/news/4004990-kenvue-join-sp-500-replacing-advance-auto-parts?utm_source=businessinsider&utm_medium=referral
3593.0,8/22/2023 12:01:00 AM,Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-advance-auto-parts-to-join-s-p-smallcap-600-1032571156
3594.0,8/22/2023 6:52:24 PM,"Regeneron, J&J receive millions to develop new COVID therapies",Seeking Alpha,https://seekingalpha.com/news/4005267-regeneron-johnson-johnson-receive-millions-develop-covid-therapies?utm_source=businessinsider&utm_medium=referral
3595.0,8/22/2023 9:00:56 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032574267
3596.0,8/22/2023 10:31:00 PM,"Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends",Benzinga,/news/etf/did-apple-shower-warren-buffett-with-645m-this-year-yes-they-did-the-power-of-dividends-1032574433
3597.0,8/23/2023 8:25:29 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032575468
3598.0,8/23/2023 11:00:39 AM,Johnson & Johnson completes Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4005442-johnson-johnson-completes-kenvue-separation?utm_source=businessinsider&utm_medium=referral
3599.0,8/23/2023 12:06:02 PM,Megacap stocks setting up for potential breakout - Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/4005201-megacap-stocks-setting-up-for-potential-breakout?utm_source=businessinsider&utm_medium=referral
3600.0,8/23/2023 1:15:00 PM,"4 stocks to watch on Wednesday: NVIDIA, Kohl's and more",Seeking Alpha,https://seekingalpha.com/news/4005510-4-stocks-to-watch-on-wednesday-nvidia-kohls-and-more?utm_source=businessinsider&utm_medium=referral
3601.0,8/23/2023 7:11:32 PM,J&J‚Äôs Janssen said to be closing much of Dutch vaccine division,Seeking Alpha,https://seekingalpha.com/news/4005711-jnj-close-much-dutch-vaccine-division?utm_source=businessinsider&utm_medium=referral
3602.0,8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday ‚Äì Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral
3603.0,8/24/2023 2:12:30 PM,Johnson & Johnson goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/4005984-johnson-and-johnson-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral
3604.0,8/24/2023 2:55:38 PM,Galapagos cut to Neutral at Citi on lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/4006038-galapagos-stock-cut-neutral-citi-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral
3605.0,8/25/2023 1:05:20 PM,J&J submits sBLA for Rybrevant for first-line non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/4006326-johnson-johnson-janssen-sbla-rybrevant-first-line-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral
3606.0,8/25/2023 3:54:51 PM,AstraZeneca latest drugmaker to challenge Medicare drug price negotiation,Seeking Alpha,https://seekingalpha.com/news/4006445-astrazeneca-latest-drugmaker-challenge-medicare-drug-price-negotiation?utm_source=businessinsider&utm_medium=referral
3607.0,8/26/2023 6:00:00 PM,Crohn's disease drugmakers set to benefit from expected rise in cases,Seeking Alpha,https://seekingalpha.com/news/4006563-crohns-disease-drugmakers-benefit-expected-rise-cases?utm_source=businessinsider&utm_medium=referral
3608.0,8/27/2023 4:00:00 PM,Wall Street lists potential targets for Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4006581-wall-street-lists-targets-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
3609.0,8/27/2023 6:33:00 PM,7 Very Oversold Warren Buffett Stocks to Buy Right Now,InvestorPlace,/news/stocks/7-very-oversold-warren-buffett-stocks-to-buy-right-now-1032584294
3610.0,8/28/2023 10:35:42 AM,Hedge and mutual funds rotate from tech; see the stocks they love and shun,Seeking Alpha,https://seekingalpha.com/news/4006637-hedge-and-mutual-funds-rotate-from-tech-see-the-stocks-they-love-and-shun?utm_source=businessinsider&utm_medium=referral
3611.0,8/28/2023 4:37:09 PM,"Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories",Benzinga,/news/stocks/hawaiian-electric-says-power-lines-not-responsible-for-deadly-lahaina-fire-china-targets-stock-market-revival-ftc-pauses-legal-battle-with-amgen-s-28b-horizon-deal-today-s-top-stories-1032586588
3612.0,8/28/2023 9:11:59 PM,Johnson & Johnson seeks full approval of Balversa for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4006866-johnson-johnson-janssen-seeks-full-approval-balversa-bladder-cancer?utm_source=businessinsider&utm_medium=referral
3613.0,8/29/2023 1:58:53 AM,7 Reliable Retirement Stocks to Secure a Golden Future,InvestorPlace,/news/stocks/7-reliable-retirement-stocks-to-secure-a-golden-future-1032587337
3614.0,8/29/2023 2:36:45 AM,The 7 Most Promising Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/the-7-most-promising-blue-chip-stocks-to-own-now-1032587347
3615.0,8/29/2023 11:45:20 AM,Medicare lists first ten drugs selected for pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4006764-medicare-lists-first-ten-drugs-picked-pricing-talks?utm_source=businessinsider&utm_medium=referral
3616.0,8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral
3617.0,8/29/2023 6:31:22 PM,Initial Medications Chosen By HHS For Medicare Drug Price Negotiations ,RTTNews,/news/stocks/initial-medications-chosen-by-hhs-for-medicare-drug-price-negotiations-1032590160
3618.0,8/29/2023 7:29:57 PM,Republicans say Medicare drug negotiations will mean fewer new meds,Seeking Alpha,https://seekingalpha.com/news/4007245-republicans-say-medicare-drug-negotiations-fewer-new-meds?utm_source=businessinsider&utm_medium=referral
3619.0,8/30/2023 12:58:15 AM,SPLG: The Market‚Äôs Lowest-Cost S&P 500 ETF,TipRanks,/news/stocks/splg-the-market-s-lowest-cost-s-p-500-etf-1032590792
3620.0,8/30/2023 11:29:28 AM,Johnson & Johnson updates financials and outlook after Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4007395-jj-updates-financials-outlook-kenvue-separation?utm_source=businessinsider&utm_medium=referral
3621.0,8/30/2023 1:07:00 PM,"4 stocks to watch on Wednesday: Salesforce, Texas Instruments and more",Seeking Alpha,https://seekingalpha.com/news/4007444-4-stocks-to-watch-on-wednesday-salesforce-texas-instruments-and-more?utm_source=businessinsider&utm_medium=referral
3622.0,8/30/2023 1:07:39 PM,"Johnson & Johnson Trims FY23 Earnings, Net Sales Outlook ",RTTNews,/news/stocks/johnson-johnson-trims-fy23-earnings-net-sales-outlook-1032592301
3623.0,8/30/2023 9:36:41 PM,Set and Forget: 3 Dividend Stocks Perfect for Your IRA,InvestorPlace,/news/stocks/set-and-forget-3-dividend-stocks-perfect-for-your-ira-1032594347
3624.0,8/31/2023 12:15:32 AM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1032594434
3625.0,8/31/2023 12:55:17 AM,Johnson & Johnson (JNJ) Gets a Hold from Bank of America Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-bank-of-america-securities-1032594449
3626.0,8/31/2023 1:02:33 AM,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), BioMarin Pharmaceutical (BMRN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-patterson-companies-pdco-biomarin-pharmaceutical-bmrn-and-johnson-johnson-jnj-1032594470
3627.0,8/31/2023 1:10:06 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-ptc-therapeutics-ptct-1032594464
3628.0,8/31/2023 11:00:10 AM,When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong,InvestorPlace,/news/stocks/when-chatgpt-misses-the-mark-3-stocks-it-got-very-wrong-1032595840
3629.0,8/31/2023 6:33:14 PM,3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth,InvestorPlace,/news/stocks/3-brilliant-blue-chip-stocks-for-lucrative-long-term-growth-1032597634
3630.0,9/1/2023 2:47:51 PM,EU regulators warn pregnant women not to use topiramate,Seeking Alpha,https://seekingalpha.com/news/4008363-eu-regulators-warn-pregnant-women-not-to-use-topiramate?utm_source=businessinsider&utm_medium=referral
3631.0,9/1/2023 4:51:41 PM,7 Cash Cow Stocks for Recession-Resilient Dividends,InvestorPlace,/news/stocks/7-cash-cow-stocks-for-recession-resilient-dividends-1032600357
3632.0,9/2/2023 6:00:00 PM,"Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag",Seeking Alpha,https://seekingalpha.com/news/4008548-lilly-novo-nordisk-top-pharma-performers-august-astrazeneca-roche-lag?utm_source=businessinsider&utm_medium=referral
3633.0,9/3/2023 4:00:00 PM,Why is big pharma unmoved despite Medicare pricing threat?,Seeking Alpha,https://seekingalpha.com/news/4008703-why-big-pharma-unmoved-despite-medicare-pricing-threat?utm_source=businessinsider&utm_medium=referral
3634.0,9/4/2023 2:05:22 AM,Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032601422
3635.0,9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral
3636.0,9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral
3637.0,9/4/2023 10:21:27 PM,3 Dow Stocks to Sell in September Before They Crash and Burn,InvestorPlace,/news/stocks/3-dow-stocks-to-sell-in-september-before-they-crash-and-burn-1032603561
3638.0,9/6/2023 12:26:49 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032607025
3639.0,9/6/2023 12:26:57 AM,Raymond James Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/raymond-james-remains-a-buy-on-johnson-johnson-jnj-1032607021
3640.0,9/6/2023 12:27:41 PM,7 Retirement Stocks That Every Long-Term Investor Should Own Now,InvestorPlace,/news/stocks/7-retirement-stocks-that-every-long-term-investor-should-own-now-1032608972
3641.0,9/6/2023 12:53:21 PM,Idorsia In Deal With JNJ's Janssen Biotech For Return Of Rights For Aprocitentan; Stock Down ,RTTNews,/news/stocks/idorsia-in-deal-with-jnj-s-janssen-biotech-for-return-of-rights-for-aprocitentan-stock-down-1032608309
3642.0,9/6/2023 3:13:51 PM,Johnson & Johnson succeeds in lung cancer trial for Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4009524-johnson-johnson-wins-lung-cancer-trial-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3643.0,9/6/2023 5:00:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-6-2023-1032609929
3644.0,9/7/2023 11:08:02 AM,7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth,InvestorPlace,/news/stocks/7-pharma-stocks-to-buy-for-groundbreaking-treatments-and-robust-revenue-growth-1032612381
3645.0,9/7/2023 7:39:56 PM,Astellas withdraws federal lawsuit over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/4010044-astellas-withdraws-federal-lawsuit-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3646.0,9/7/2023 9:29:38 PM,"Canaccord starts Kenvue at buy; cites global reach, consumer demand",Seeking Alpha,https://seekingalpha.com/news/4010111-canaccord-starts-kenvue-at-buy-cites-global-reach-consumer-demand?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3647.0,9/8/2023 10:00:13 AM,The 7 Best Dow Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-dow-stocks-to-buy-now-september-2023-1032615597
3648.0,9/8/2023 10:17:43 AM,3 Shaky Stocks to Sell in September Before It‚Äôs Too Late,InvestorPlace,/news/stocks/3-shaky-stocks-to-sell-in-september-before-its-too-late-1032615594
3649.0,9/8/2023 12:14:43 PM,Janssen Pharma Submits Marketing Authorisation Application For Erdafitinib ,RTTNews,/news/stocks/janssen-pharma-submits-marketing-authorisation-application-for-erdafitinib-1032615568
3650.0,9/8/2023 3:56:55 PM,September Rally? 3 Healthcare Stocks to Buy Before Liftoff.,InvestorPlace,/news/stocks/september-rally-3-healthcare-stocks-to-buy-before-liftoff-1032616887
3651.0,9/8/2023 11:00:31 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032617279
3652.0,9/8/2023 11:13:21 PM,The 5 Best Healthcare Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-5-best-healthcare-stocks-to-buy-now-september-2023-1032617337
3653.0,9/10/2023 5:54:29 PM,The 7 Best Warren Buffett Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-now-september-2023-1032618280
3654.0,9/10/2023 7:17:31 PM,"HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead",Seeking Alpha,https://seekingalpha.com/news/4010430-hsbc-bullish-on-iqvia-zoetis-bluebird-actinium-bearish-on-gilead?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3655.0,9/11/2023 12:28:17 AM,Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit,Seeking Alpha,https://seekingalpha.com/news/4010432-kenvue-shares-may-gain-after-fda-comments-in-tylenol-autisim-warning-label-lawsuit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3656.0,9/11/2023 10:27:12 AM,3 Bulletproof Stocks to Buy Before the Next Recession Strikes,InvestorPlace,/news/stocks/3-bulletproof-stocks-to-buy-before-the-next-recession-strikes-1032619507
3657.0,9/11/2023 1:28:48 PM,"Kenvue gains after upgrade, bullish notes on Tylenol-Autism warning label suit",Seeking Alpha,https://seekingalpha.com/news/4010574-kenvue-gains-after-upgrade-bullish-notes-on-tylenol-autism-warning-label-suit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3658.0,9/11/2023 4:04:11 PM,Sandoz to commercialize biosimilar to J&J blockbuster drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4010646-sandoz-to-commercialize-biosimilar-to-jnj-blockbuster-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3659.0,9/11/2023 7:30:31 PM,AI Integration In Biotech & Pharma: Companies Positioned To Benefit,Benzinga,/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068
3660.0,9/11/2023 8:31:10 PM,AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst,Benzinga,/news/stocks/astrazeneca-s-tagrisso-chemo-combo-data-in-lung-cancer-sets-high-bar-for-johnson-johnson-s-cancer-drug-analyst-1032621133
3661.0,9/12/2023 2:22:07 PM,AbbVie's Skyrizi outperforms JNJ‚Äôs Stelara in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4010983-abbvie-skyrizi-bested-jnj-stelara-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3662.0,9/12/2023 10:35:45 PM,"Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts",Benzinga,/news/stocks/ny-consulting-firm-predicts-psychedelic-drugs-market-will-generate-over-12b-in-next-12-years-1032624903
3663.0,9/13/2023 8:23:48 PM,Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains,InvestorPlace,/news/stocks/buy-the-dip-3-healthcare-stocks-to-snag-now-for-supercharged-gains-1032628467
3664.0,9/14/2023 7:05:25 PM,3 Blue-Chip Stocks to Watch in the ‚ÄòGreen Zone‚Äô,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-watch-in-the-tradesmith-green-zone-1032631792
3665.0,9/15/2023 9:10:49 AM,The 3 Most Undervalued Dow Stocks to Buy in September 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-september-2023-1032632969
3666.0,9/15/2023 9:26:39 PM,"VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks",TipRanks,/news/stocks/vti-etf-this-diversified-powerhouse-owns-over-3-800-stocks-1032634771
3667.0,9/15/2023 10:39:20 PM,Johnson & Johnson Unveils Modernized Logo After 135 Years ,RTTNews,/news/stocks/johnson-johnson-unveils-modernized-logo-after-135-years-1032634743
3668.0,9/19/2023 12:15:28 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032638337
3669.0,9/19/2023 3:36:33 PM,7 Safe and Steady Dividend Stocks to Buy for Volatile Time,InvestorPlace,/news/stocks/7-safe-and-steady-dividend-stocks-to-buy-for-volatile-time-1032641007
3670.0,9/26/2023 3:13:34 PM,This Is the Holy Grail of Investing,InvestorPlace,/news/stocks/this-is-the-holy-grail-of-investing-1032656835
3671.0,9/27/2023 7:05:22 PM,What's Going On Pfizer's Subsidiary Biohaven Stock?,Benzinga,/news/stocks/what-s-going-on-pfizer-s-subsidiary-biohaven-stock-1032660550
3672.0,9/28/2023 7:30:23 PM,What to Note in the AI Megatrend,InvestorPlace,/news/stocks/what-to-note-in-the-ai-megatrend-1032664425
3673.0,9/29/2023 1:52:14 AM,SCHX ETF: A Large-Cap ETF for Large Gains,TipRanks,/news/stocks/schx-etf-a-large-cap-etf-for-large-gains-1032664747
3674.0,9/29/2023 10:01:12 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-maravai-lifesciences-holdings-mrvi-johnson-johnson-jnj-and-amicus-fold-1032665877
3675.0,9/29/2023 12:12:49 PM,Don‚Äôt Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.,InvestorPlace,/news/stocks/dont-miss-out-3-dividend-stocks-to-buy-on-every-single-dip-1032666285
3676.0,9/29/2023 12:31:59 PM,Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times,InvestorPlace,/news/stocks/recession-proof-royals-3-stocks-that-thrive-in-tough-economic-times-1032666337
3677.0,10/1/2023 2:32:42 AM,"LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?",TipRanks,/news/stocks/lly-isrg-or-jnj-which-healthcare-stock-could-generate-the-best-returns-1032668067
3678.0,10/2/2023 9:31:15 AM,Food Stocks: Worth a Bite,TipRanks,/news/stocks/food-stocks-worth-a-bite-1032669628
3679.0,10/3/2023 4:15:23 AM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1032672066
3680.0,10/3/2023 3:13:57 PM,"Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say",Benzinga,/news/stocks/higher-rates-lower-leverage-growth-stocks-to-struggle-while-ai-offers-hope-goldman-sachs-analysts-say-1032674601
3681.0,10/3/2023 4:11:21 PM,"'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories",Benzinga,/news/stocks/airbnb-has-foundational-cracks-disney+-follows-netflix-on-subscription-sharing-crackdown-microsoft-s-nadella-criticizes-google-s-exclusive-content-deals-today-s-top-stories-1032675117
3682.0,10/5/2023 12:08:41 AM,7 Top Healthcare Stocks That Pay Dividends,InvestorPlace,/news/stocks/7-top-healthcare-stocks-that-pay-dividends-1032679547
3683.0,10/5/2023 2:01:04 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032681119
3684.0,10/5/2023 5:00:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-5-2023-1032682175
3685.0,10/5/2023 6:40:12 PM,"Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst",Benzinga,/news/stocks/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bullish-analyst-1032682493
3686.0,10/8/2023 12:00:48 PM,3 Pharma Stocks to Dump Before the Damage Is Done,InvestorPlace,/news/stocks/3-pharma-stocks-to-dump-before-the-damage-is-done-1032686332
3687.0,10/8/2023 7:18:42 PM,J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder ,RTTNews,/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618
3688.0,10/9/2023 6:46:32 PM,3 Artificial Intelligence Stocks That Could Outperform the ‚ÄòGodfather of AI‚Äô,InvestorPlace,/news/stocks/3-artificial-intelligence-stocks-that-could-outperform-the-godfather-of-ai-1032689930
3689.0,10/10/2023 4:20:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-bristol-myers-squibb-bmy-johnson-johnson-jnj-1032690640
3690.0,10/10/2023 5:55:05 AM,Johnson & Johnson (JNJ) Receives a Hold from DBS,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-dbs-1032690762
3691.0,10/12/2023 5:52:18 PM,7 High-Growth S&P 500 Stocks to Buy Now,InvestorPlace,/news/stocks/7-high-growth-sp-500-stocks-to-buy-now-1032701698
3692.0,10/12/2023 6:41:33 PM,Beat the Market With These 7 Warren Buffett Stocks,InvestorPlace,/news/stocks/beat-the-market-with-these-7-warren-buffett-stocks-1032701803
3693.0,10/13/2023 10:33:32 PM,"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets",Benzinga,/news/etf/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets-1032705050
3694.0,10/14/2023 1:00:44 PM,Johnson & Johnson Stock: Is Now the Time to Sell?,InvestorPlace,/news/stocks/johnson-johnson-stock-is-now-the-time-to-sell-1032705305
3695.0,10/16/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1032708397
3696.0,10/16/2023 10:50:24 PM,"Analysts Conflicted on These Healthcare Names: Merus (MRUS), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-merus-mrus-elevance-health-elv-and-johnson-johnson-jnj-1032710047
3697.0,10/17/2023 9:45:54 AM,"Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1032711225
3698.0,10/17/2023 12:28:37 PM,Johnson & Johnson Q3 Profit Beats Estimates,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-1032711846
3699.0,10/17/2023 12:56:57 PM,"Johnson & Johnson Lifts 2023 Guidance Midpoints For Sales, Adj. EPS ",RTTNews,/news/stocks/johnson-johnson-lifts-2023-guidance-midpoints-for-sales-adj-eps-1032711920
3700.0,10/17/2023 6:57:12 PM,Johnson & Johnson‚Äôs Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector‚Äôs Influence,TipRanks,/news/stocks/johnson-johnson-s-strong-q3-performance-and-upward-guidance-evokes-buy-rating-an-analysis-of-the-innovative-medicine-sector-s-influence-1032713926
3701.0,10/17/2023 7:46:33 PM,"Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?",Benzinga,/news/stocks/stocks-rise-on-positive-earnings-treasury-volatility-returns-nvidia-stumbles-what-s-driving-markets-tuesday-1032713829
3702.0,10/18/2023 1:01:28 AM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-johnson-johnson-jnj-and-thermo-fisher-tmo-1032714341
3703.0,10/18/2023 6:27:59 AM,Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-a-balance-of-strong-performance-and-ongoing-challenges-1032715487
3704.0,10/18/2023 6:36:32 AM,Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges,TipRanks,/news/stocks/positive-analyst-outlook-on-johnson-johnson-accelerated-growth-and-raised-guidance-despite-potential-challenges-1032715508
3705.0,10/18/2023 2:01:37 PM,"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-johnson-johnson-jnj-1032717614
3706.0,10/18/2023 8:44:06 PM,Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug,Benzinga,/news/stocks/positive-outlook-on-johnson-johnson-s-partner-legend-biotech-analyst-confident-on-blood-cancer-drug-1032718213
3707.0,10/19/2023 12:15:26 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032718609
3708.0,10/19/2023 10:45:10 AM,7 Dividend Aristocrats That Are Built to Last,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-are-built-to-last-1032720311
3709.0,10/19/2023 12:00:23 PM,Johnson & Johnson‚Äôs Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain,TipRanks,/news/stocks/johnson-johnson-s-stock-receives-buy-rating-amid-promising-mariposa-trial-results-and-potential-market-share-gain-1032720633
3710.0,10/19/2023 8:11:36 PM,7 Healthcare Stocks That Can Cure a Lackluster Portfolio,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-4-1032722294
3711.0,10/19/2023 8:36:20 PM,The 7 Best Forever Stocks To Buy Now: October 2023,InvestorPlace,/news/stocks/7-best-forever-stocks-to-buy-now-october-2023-1032722370
3712.0,10/20/2023 1:53:35 PM,3 Mutual Funds to Invest in for Pro Management and Low Fees,InvestorPlace,/news/stocks/3-mutual-funds-to-invest-in-for-pro-management-and-low-fees-1032724440
3713.0,10/24/2023 12:15:53 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1032734736
3714.0,10/24/2023 10:56:18 AM,Johnson & Johnson‚Äôs Stock: A Stable Transition and Promising Future Despite Leadership Change,TipRanks,/news/stocks/johnson-johnson-s-stock-a-stable-transition-and-promising-future-despite-leadership-change-1032735321
3715.0,10/25/2023 1:43:12 AM,VTV: A Must-Watch ETF for Value Investors,TipRanks,/news/stocks/vtv-a-must-watch-etf-for-value-investors-1032739060
3716.0,10/25/2023 6:18:06 AM,Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials,TipRanks,/news/stocks/positive-prospects-for-johnson-johnson-buy-rating-assigned-due-to-superior-performance-of-rybrevant-in-mariposa-trials-1032740152
3717.0,10/25/2023 10:15:00 AM,The 7 Best Forever Stocks to Buy for October 2023,InvestorPlace,/news/stocks/the-7-best-forever-stocks-to-buy-for-october-2023-1032737998
3718.0,10/25/2023 8:04:04 PM,Dow Jones Bear Market: 3 Cheap Stocks to Buy Now,InvestorPlace,/news/stocks/dow-jones-bear-market-3-cheap-stocks-to-buy-now-1032740344
3719.0,10/26/2023 5:21:52 PM,3 Stocks to Buy (and Never Ever Sell),InvestorPlace,/news/stocks/3-stocks-to-buy-and-never-ever-sell-1032745222
3720.0,10/27/2023 6:19:56 AM,Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/goldman-sachs-reaffirms-their-sell-rating-on-johnson-johnson-jnj-1032749668
3721.0,10/27/2023 1:25:10 PM,SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff,InvestorPlace,/news/stocks/sny-stock-sinks-15-as-sanofi-plans-consumer-unit-spinoff-1032748736
3722.0,10/27/2023 1:30:30 PM,"Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-universal-health-uhs-insmed-insm-and-johnson-johnson-jnj-1032750294
3723.0,10/30/2023 9:50:50 AM,"Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-arcellx-inc-aclx-biogen-biib-1032755860
3724.0,10/31/2023 6:30:49 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-boston-scientific-bsx-and-ptc-therapeutics-ptct-1032760969
3725.0,11/2/2023 7:25:38 PM,"EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'",Benzinga,/news/etf/exclusive-roundhill-launches-dividend-kings-etf-with-the-gold-standard-of-dividend-growers-companies-with-incredible-resilience-1032771912
3726.0,11/2/2023 8:01:04 PM,"Amgen Wins Big With FDA, Analyst Sees Soaring Potential",Benzinga,/news/stocks/amgen-wins-big-with-fda-analyst-sees-soaring-potential-1032771966
3727.0,11/2/2023 10:52:30 PM,Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-to-buy-the-dip-1032775761
3728.0,11/3/2023 12:42:56 PM,The 3 Best Forever Stocks to Buy in November,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-in-november-1032776148
3729.0,11/6/2023 6:30:58 PM,Long-Term Winners: Ray Dalio‚Äôs Top 3 Stock Recommendations for a Prosperous Future,InvestorPlace,/news/stocks/long-term-winners-ray-dalios-top-3-stock-recommendations-for-a-prosperous-future-1032783431
3730.0,11/8/2023 10:12:22 AM,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bluebird-bio-blue-biogen-biib-and-johnson-johnson-jnj-1032796738
3731.0,11/8/2023 11:29:22 AM,Johnson & Johnson‚Äôs Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-ottava-robotic-system-and-untapped-general-surgery-robotics-market-1032796865
3732.0,11/9/2023 10:35:00 AM,3 Dividend Stocks to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-consistent-income-1032799884
3733.0,11/9/2023 12:52:37 PM,3 Dividend Stocks That Could Pay for Your Holiday Shopping,InvestorPlace,/news/stocks/3-dividend-stocks-that-could-pay-for-your-holiday-shopping-1032800353
3734.0,11/9/2023 2:26:17 PM,7 Safe Stocks to Buy if You Think Q3‚Äôs Gangbuster Growth Won‚Äôt Last,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-if-you-think-q3s-gangbuster-growth-wont-last-1032801059
3735.0,11/15/2023 2:10:36 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cormedix-crmd-immatics-imtx-and-johnson-johnson-jnj-1032823185
3736.0,11/15/2023 3:20:10 AM,It‚Äôs Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows,InvestorPlace,/news/stocks/its-time-to-buy-these-3-dividend-aristocrats-trading-near-52-week-lows-1032819984
3737.0,11/15/2023 4:23:44 AM,Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors,InvestorPlace,/news/stocks/blue-chip-bargains-top-3-oversold-aristocrats-for-value-investors-1032820035
3738.0,11/15/2023 7:20:34 AM,Buffett‚Äôs Berkshire Sells JNJ and UPS Stocks; Should You Follow?,TipRanks,/news/stocks/buffett-s-berkshire-sells-jnj-and-ups-stocks-should-you-follow-1032824425
3739.0,11/16/2023 2:07:22 AM,Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio,InvestorPlace,/news/stocks/storm-proof-income-7-dividend-aristocrats-to-fortify-your-portfolio-1032825013
3740.0,11/16/2023 6:09:48 PM,3 Strong-Buy Dividend Stocks That Analysts Love,InvestorPlace,/news/stocks/3-strong-buy-dividend-stocks-that-analysts-love-1032828896
3741.0,11/16/2023 6:31:57 PM,3 Must-Buy Stocks on Every Market Dip,InvestorPlace,/news/stocks/3-must-buy-stocks-on-every-market-dip-1032828986
3742.0,11/17/2023 8:23:34 PM,7 High-Yield Blue Chips Suitable for Any Retiree,InvestorPlace,/news/stocks/7-high-yield-blue-chip-stocks-suitable-for-any-reitree-1032832622
3743.0,11/17/2023 9:00:13 PM,21 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/21-analysts-have-this-to-say-about-johnson-johnson-1032832598
3744.0,11/18/2023 8:25:40 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032833159
3745.0,11/28/2023 2:29:47 AM,The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold),InvestorPlace,/news/stocks/the-shocking-stock-that-warren-buffet-just-bought-and-2-he-sold-1032852883
3746.0,11/28/2023 10:10:00 AM,3 Robotics Stocks That Could Be Multibaggers in the Making,InvestorPlace,/news/stocks/3-robotics-stocks-that-could-be-multibaggers-in-the-making-1032853990
3747.0,11/28/2023 10:20:30 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-masimo-masi-and-regeneron-regn-1032856472
3748.0,11/29/2023 11:42:45 AM,The 7 Biggest Dividend Stocks in Warren Buffett‚Äôs Portfolio,InvestorPlace,/news/stocks/the-7-biggest-dividend-stocks-in-warren-buffetts-portfolio-1032857965
3749.0,11/30/2023 9:21:06 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864340
3750.0,11/30/2023 9:31:01 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864431
3751.0,11/30/2023 2:06:00 PM,Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF,InvestorPlace,/news/stocks/fresh-on-the-market-3-top-picks-from-the-renaissance-ipo-etf-1032862745
3752.0,11/30/2023 3:52:29 PM,"Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 ",RTTNews,/news/stocks/johnson-johnson-medtech-completes-laminar-acquisition-sees-0-15-share-negative-impact-in-fy24-1032862857
3753.0,11/30/2023 4:06:08 PM,Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns,InvestorPlace,/news/stocks/income-kings-7-blue-chip-dividend-stocks-for-reliable-returns-1032863431
3754.0,11/30/2023 5:23:00 PM,"7 Blue-Chip Stocks to Buy for 2024, According to AI",InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-2024-according-to-ai-1032863884
3755.0,12/1/2023 2:40:05 AM,Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-and-walgreens-boots-alliance-wba-1032866516
3756.0,12/1/2023 10:05:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-johnson-johnson-jnj-humana-hum-1032867703
3757.0,12/1/2023 12:04:04 PM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-harmony-biosciences-holdings-hrmy-and-johnson-johnson-jnj-1032867821
3758.0,12/1/2023 1:59:46 PM,Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio,InvestorPlace,/news/stocks/wealth-from-wellness-7-healthcare-stocks-to-inoculate-your-portfolio-1032866432
3759.0,12/1/2023 7:05:11 PM,Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections,Benzinga,/news/stocks/johnson-johnson-gets-analyst-upgrade-noting-bullish-pharma-medtech-projections-1032867327
3760.0,12/4/2023 2:21:11 PM,"The 7 Best Ways to Invest $1,000 in the Stock Market Now",InvestorPlace,/news/stocks/the-7-best-ways-to-invest-1000-in-the-stock-market-now-1032870680
3761.0,12/5/2023 8:56:06 AM,Johnson & Johnson: Navigating Growth and Regulatory Challenges in Medical Technology,TipRanks,/news/stocks/johnson-johnson-navigating-growth-and-regulatory-challenges-in-medical-technology-1032875925
3762.0,12/5/2023 2:15:16 PM,Johnson & Johnson Guides FY24 Adj. EPS Below Estimates ,RTTNews,/news/stocks/johnson-johnson-guides-fy24-adj-eps-below-estimates-1032874082
3763.0,12/5/2023 10:40:36 PM,Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3,InvestorPlace,/news/stocks/is-buffett-turning-bearish-7-stocks-warren-completely-dumped-in-q3-1032876122
3764.0,12/6/2023 3:06:08 AM,Buy Rating Affirmed for Johnson & Johnson: Long-Term Growth and Strategic Positioning Underpin Optimistic Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-long-term-growth-and-strategic-positioning-underpin-optimistic-outlook-1032878894
3765.0,12/6/2023 10:20:29 AM,"Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Johnson & Johnson (JNJ) and IGM Biosciences (IGMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-merus-mrus-johnson-johnson-jnj-and-igm-biosciences-igms-1032879903
3766.0,12/6/2023 11:50:15 AM,"Analysts Offer Insights on Healthcare Companies: Ping An Healthcare and Technology Company (OtherPANHF), Healthequity (HQY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ping-an-healthcare-and-technology-company-otherpanhf-healthequity-hqy-and-johnson-johnson-jnj-1032879985
3767.0,12/6/2023 12:41:32 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cvs-health-cvs-and-vertex-pharmaceuticals-vrtx-1032880041
3768.0,12/6/2023 1:56:21 PM,Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential,InvestorPlace,/news/stocks/bargain-buys-7-stocks-lagging-the-sp-500-with-big-potential-1032878330
3769.0,12/6/2023 5:23:37 PM,"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities",Benzinga,/news/stocks/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities-1032879077
3770.0,12/7/2023 8:02:26 AM,Strong Growth Ahead: Buy Rating for Johnson & Johnson Amid Exceeding Long-Term Projections,TipRanks,/news/stocks/strong-growth-ahead-buy-rating-for-johnson-johnson-amid-exceeding-long-term-projections-1032883435
3771.0,12/7/2023 12:21:03 PM,"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Johnson & Johnson (JNJ) and Veeva Systems (VEEV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-johnson-johnson-jnj-and-veeva-systems-veev-1032883851
3772.0,12/7/2023 12:50:14 PM,"Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Johnson & Johnson (JNJ) and Elanco Animal Health (ELAN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-qiagen-qgen-johnson-johnson-jnj-and-elanco-animal-health-elan-1032883942
3773.0,12/7/2023 1:19:15 PM,"Vanda Pharmaceuticals Acquires U.S., Canadian Rights To PONVORY From Janssen ",RTTNews,/news/stocks/vanda-pharmaceuticals-acquires-u-s-canadian-rights-to-ponvory-from-janssen-1032881574
3774.0,12/7/2023 6:53:44 PM,Investing in the Aging Population: 3 Healthcare Stocks to Watch,InvestorPlace,/news/stocks/investing-in-the-aging-population-3-healthcare-stocks-to-watch-1032883283
3775.0,12/8/2023 12:30:00 PM,7 Tech Stocks to Light Up Your Portfolio This Holiday Season,InvestorPlace,/news/stocks/7-tech-stocks-to-light-up-your-portfolio-this-holiday-season-1032885360
3776.0,12/11/2023 8:33:58 PM,"Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say",Benzinga,/news/stocks/blood-cancer-player-arcellx-s-lead-product-exceeds-expectations-analysts-say-1032890784
3777.0,12/11/2023 8:42:45 PM,Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul,InvestorPlace,/news/stocks/life-changing-investments-3-stocks-that-will-set-you-up-for-the-long-haul-1032890918
3778.0,12/13/2023 12:00:00 PM,Seeking Passive Income? 7 Dividend Stocks You Don‚Äôt Want to Miss.,InvestorPlace,/news/stocks/seeking-passive-income-7-dividend-stocks-you-dont-want-to-miss-1032896670
3779.0,12/13/2023 12:37:44 PM,Integra LifeSciences To Acquire Acclarent For $275 Mln Cash ,RTTNews,/news/stocks/integra-lifesciences-to-acquire-acclarent-for-275-mln-cash-1032896532
3780.0,12/13/2023 1:44:23 PM,D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/d-r-horton-to-rally-around-19-here-are-10-top-analyst-forecasts-for-wednesday-1032896816
3781.0,12/13/2023 1:44:56 PM,Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability,InvestorPlace,/news/stocks/economic-safety-nets-7-defensive-stocks-providing-portfolio-stability-1032897100
3782.0,12/14/2023 1:30:00 PM,Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett,InvestorPlace,/news/stocks/ryan-cohen-plans-to-save-gamestop-by-becoming-warren-buffett-1032900985
3783.0,12/14/2023 7:56:41 PM,3 Dow Stocks I Wouldn‚Äôt Touch With a 10-Foot Pole,InvestorPlace,/news/stocks/3-dow-stocks-i-wouldnt-touch-with-a-10-foot-pole-1032902603
3784.0,12/15/2023 2:28:33 PM,AC Immune Advances Anti-pTau Active Immunotherapy For Alzheimer's Disease Into Phase 2b Trial ,RTTNews,/news/stocks/ac-immune-advances-anti-ptau-active-immunotherapy-for-alzheimer-s-disease-into-phase-2b-trial-1032904707
3785.0,12/15/2023 4:58:43 PM,"AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial",Benzinga,/news/stocks/ac-immune-raises-50m-its-alzheimer-s-targeting-immunotherapy-advances-into-phase-2b-trial-1032905427
3786.0,12/15/2023 5:26:22 PM,The 7 Most Undervalued Dividend Stocks to Buy in December,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-in-december-1032905710
3787.0,12/15/2023 8:01:28 PM,The Dogs of the Dow May Pay Big Dividends in 2024,InvestorPlace,/news/stocks/the-dogs-of-the-dow-may-pay-big-dividends-in-2024-1032905944
3788.0,12/17/2023 7:00:00 PM,3 of the Most Attractive Dividend Stocks in the Pharma Space,InvestorPlace,/news/stocks/3-of-the-most-attractive-dividend-stocks-in-the-pharma-space-1032907116
3789.0,12/19/2023 1:51:10 PM,7 New Year‚Äôs Stocks to Buy to Get 2024 Off to a Bright Start,InvestorPlace,/news/stocks/7-new-years-stocks-to-buy-to-get-2024-off-to-a-bright-start-1032912438
3790.0,12/19/2023 10:00:50 PM,Forever Favorites: 7 Dividend Stocks to Buy and Never Sell,InvestorPlace,/news/stocks/forever-favorites-7-dividend-stocks-to-buy-and-never-sell-1032914179
3791.0,12/21/2023 2:02:22 PM,7 Stocks That Might Win on Election Year Uncertainty,InvestorPlace,/news/stocks/7-stocks-that-might-win-on-election-year-uncertainty-1032919400
3792.0,12/21/2023 5:11:14 PM,Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?,Benzinga,/news/stocks/why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today-1032920039
3793.0,12/21/2023 9:45:14 PM,Build Your Future Portfolio: 3 Generous Dividend Stocks,InvestorPlace,/news/stocks/build-your-future-portfolio-3-generous-dividend-stocks-1032920683
3794.0,12/22/2023 2:53:47 AM,Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-a-smart-dividend-pick-for-2024-1032922422
3795.0,12/26/2023 2:37:48 AM,7 Rock-Solid Dividend Stocks to Trust in Difficult Times,InvestorPlace,/news/stocks/7-rock-solid-dividend-stocks-to-trust-in-difficult-times-1032925151
3796.0,12/26/2023 10:44:33 AM,LianBio Transfers Rights For NBTXR3 In China And Other Asian Markets To Janssen Pharma; Stock Up ,RTTNews,/news/stocks/lianbio-transfers-rights-for-nbtxr3-in-china-and-other-asian-markets-to-janssen-pharma-stock-up-1032925465
3797.0,12/27/2023 10:31:53 PM,Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness,InvestorPlace,/news/stocks/healthcare-heroes-3-stocks-innovating-in-medicine-and-wellness-1032928865
3798.0,12/28/2023 1:33:14 PM,"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts",Benzinga,/news/stocks/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-street-s-most-accurate-analysts-1032929866
3799.0,12/28/2023 6:16:37 PM,Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024,InvestorPlace,/news/stocks/safe-havens-3-fixed-income-securities-for-a-balanced-portfolio-in-2024-1032930815
3800.0,12/29/2023 10:01:50 AM,Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times,InvestorPlace,/news/stocks/disaster-proof-dividends-3-stocks-with-resilient-payouts-in-tough-times-1032931885
3801.0,12/31/2023 11:00:00 AM,Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires,InvestorPlace,/news/stocks/legacy-investments-7-stocks-to-make-your-grandkids-millionaires-1032933656
3802.0,1/1/2024 7:15:07 PM,2024‚Äôs Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns,InvestorPlace,/news/stocks/2024s-blue-chip-winners-top-3-stocks-for-rock-solid-returns-1032935426
3803.0,1/2/2024 7:22:32 PM,"Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024",Benzinga,/news/etf/dogs-of-the-dow-top-10-highest-yielding-dow-jones-stocks-how-to-get-dividends-of-3-to-7-4-in-2024-1032937754
3804.0,1/3/2024 4:26:53 PM,Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth,Benzinga,/news/etf/tech-sell-off-triggers-market-reset-value-stocks-reach-7-month-high-versus-growth-1032940596
3805.0,1/3/2024 6:29:31 PM,"This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns",Benzinga,/news/stocks/this-analyst-downgrades-bristol-myers-squibb-cautions-amid-product-launch-and-revenue-concerns-1032940889
3806.0,1/3/2024 7:43:03 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/best-blue-chip-stocks-1031627772
3807.0,1/3/2024 9:00:19 PM,Revenge of the Boring Stocks! Dividends Are Sexy Again.,InvestorPlace,/news/stocks/revenge-of-the-boring-stocks-dividends-are-sexy-again-1032941212
3808.0,1/3/2024 10:42:40 PM,The 7 Best Meme Stocks to Buy Now,InvestorPlace,/news/stocks/best-meme-stocks-1031269612
3809.0,1/4/2024 8:15:24 AM,Johnson & Johnson (JNJ) Gets a Buy from Raymond James,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-raymond-james-1032944360
3810.0,1/4/2024 11:28:12 PM,Still Worried About a 2024 Recession? 7 Stocks to Watch.,InvestorPlace,/news/stocks/still-worried-about-a-2024-recession-7-stocks-to-watch-1032944595
3811.0,1/6/2024 8:00:00 PM,Dow Darlings: Top 3 Stocks That Will Lead the Charge in 2024,InvestorPlace,/news/stocks/dow-darlings-top-3-stocks-that-will-lead-the-charge-in-2024-1032947480
3812.0,1/8/2024 1:57:22 PM,Johnson & Johnson To Acquire Ambrx For $28.00 Per Share - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-ambrx-for-28-00-per-share-quick-facts-1032950099
3813.0,1/8/2024 4:18:52 PM,Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal,Benzinga,/news/stocks/today-is-cancer-focused-deals-day-johnson-johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cancer-portfolio-with-harpoon-deal-1032950939
3814.0,1/8/2024 5:22:00 PM,Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-ambrx-biopharma-amam-stock-up-100-today-1032951235
3815.0,1/9/2024 10:06:31 AM,Johnson & Johnson: A Steady Hold Amidst Strategic Expansion and Pipeline Potential,TipRanks,/news/stocks/johnson-johnson-a-steady-hold-amidst-strategic-expansion-and-pipeline-potential-1032955160
3816.0,1/9/2024 12:20:15 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Prothena (PRTA), Johnson & Johnson (JNJ) and Zimmer Biomet Holdings (ZBH)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prothena-prta-johnson-johnson-jnj-and-zimmer-biomet-holdings-zbh-1032955314
3817.0,1/10/2024 10:22:51 PM,7 Stable Stocks to Buy No Matter What Happens to Interest Rates,InvestorPlace,/news/stocks/7-stable-stocks-to-buy-no-matter-what-happens-to-interest-rates-1032958678
3818.0,1/10/2024 10:49:21 PM,3 Unshakeable Dividend Stocks for Lifelong Wealth,InvestorPlace,/news/stocks/3-unshakeable-dividend-stocks-for-lifelong-wealth-1032958695
3819.0,1/11/2024 6:37:42 AM,Buy Rating on Johnson & Johnson: Strategic Oncology Acquisition Promises Growth,TipRanks,/news/stocks/buy-rating-on-johnson-johnson-strategic-oncology-acquisition-promises-growth-1032959789
3820.0,1/11/2024 8:05:07 PM,Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation,InvestorPlace,/news/stocks/dividend-dynasty-7-high-yield-stocks-for-long-term-wealth-accumulation-1032961916
3821.0,1/13/2024 1:11:11 PM,"Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Idexx Laboratories (IDXX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-unitedhealth-unh-johnson-johnson-jnj-and-idexx-laboratories-idxx-1032965145
3822.0,1/14/2024 11:15:00 AM,Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends¬†,InvestorPlace,/news/stocks/7-overlooked-high-yield-dividend-stocks-for-your-2024-portfolio-1032965321
3823.0,1/15/2024 10:29:48 PM,The 3 Most Undervalued Value Stocks to Buy in January,InvestorPlace,/news/stocks/the-3-most-undervalued-value-stocks-to-buy-in-january-1032968457
3824.0,1/16/2024 1:50:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), GoodRx Holdings (GDRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-arrowhead-pharmaceuticals-arwr-goodrx-holdings-gdrx-and-johnson-johnson-jnj-1032968640
3825.0,1/18/2024 7:17:40 PM,7 Must-Have Stocks for Serious Wealth Accumulation,InvestorPlace,/news/stocks/7-must-have-stocks-for-serious-wealth-accumulation-1032978135
3826.0,1/18/2024 10:24:47 PM,3 Reasons to Rely on Dividend Stocks,InvestorPlace,/news/stocks/3-reasons-to-rely-on-dividend-stocks-1032978398
3827.0,1/19/2024 1:05:15 PM,Senate panel to consider subpoenas for J&J and Merck CEOs,Seeking Alpha,https://seekingalpha.com/news/4056351-sen-bernie-sanders-weighs-subpoenas-jj-merck-ceos?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3828.0,1/19/2024 4:18:03 PM,Eli Lilly production plant said to be under renewed FDA scrutiny,Seeking Alpha,https://seekingalpha.com/news/4056498-eli-lilly-plant-renewed-fda-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3829.0,1/19/2024 8:00:29 PM,"Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional",Seeking Alpha,https://seekingalpha.com/news/4056553-catalyst-watch-tesla-netflix-and-procter-gamble-head-into-the-earnings-confessional?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3830.0,1/19/2024 8:10:19 PM,"Alvotech stock jumps 15% on Stelara, Humira biosimilars updates (update)",Seeking Alpha,https://seekingalpha.com/news/4056530-fda-flags-possible-violation-at-alvotech-biosimilars-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3831.0,1/19/2024 8:39:27 PM,Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa,Seeking Alpha,https://seekingalpha.com/news/4056579-johnson--johnson-fda-approval-for-bladder-cancer-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3832.0,1/21/2024 1:00:00 PM,"Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more",Seeking Alpha,https://seekingalpha.com/news/4056510-earnings-week-ahead-tesla-netflix-att-johnson-johnson-general-electric-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3833.0,1/21/2024 5:00:01 PM,Anti-obesity meds can expand the market for weight loss surgery: Bernstein,Seeking Alpha,https://seekingalpha.com/news/4056663-glp-1s-can-expand-market-weight-loss-surgery-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3834.0,1/21/2024 6:30:00 PM,New ADHD drugs could pay off for pharmaceutical companies,Seeking Alpha,https://seekingalpha.com/news/4056645-new-adhd-drugs-could-pay-off-pharmaceutical-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3835.0,1/22/2024 3:01:13 PM,Johnson Johnson earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q4-earnings-preview-1032983615
3836.0,1/22/2024 3:23:05 PM,"BoFA picks Johnson & Johnson, Halliburton and Tesla for options opportunity ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4056847-bofa-picks-johnson-johnson-halliburton-and-tesla-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3837.0,1/22/2024 3:55:24 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4056909-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3838.0,1/22/2024 4:48:10 PM,JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report,Seeking Alpha,https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3839.0,1/22/2024 5:21:31 PM,Johnson & Johnson to kick off pharma earnings season amid talc overhang,Seeking Alpha,https://seekingalpha.com/news/4056961-johnson-johnson-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3840.0,1/22/2024 7:34:59 PM,"S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?",Benzinga,/news/etf/stock-indexes-trade-at-all-time-highs-ahead-of-key-earnings-this-week-what-s-driving-markets-monday-1032984660
3841.0,1/23/2024 4:09:28 AM,CAR-T therapies to get boxed warning on blood cancer risk,Seeking Alpha,https://seekingalpha.com/news/4057175-car-t-therapies-get-boxed-warning-blood-cancer-risk?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3842.0,1/23/2024 11:24:18 AM,Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4057235-johnson-johnson-beats-top-and-bottom-line-estimates-reaffirms-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3843.0,1/23/2024 11:41:22 AM,Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4057244-johnson-johnson-in-charts-medtech-segment-sales-surged-13-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3844.0,1/23/2024 12:08:06 PM,Johnson & Johnson posts Q4 beat as pharma and MedTech outperform,Seeking Alpha,https://seekingalpha.com/news/4057264-johnson-johnson-posts-q4-beat-pharma-medtech-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3845.0,1/23/2024 12:36:49 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1032986879
3846.0,1/23/2024 12:56:29 PM,Johnson & Johnson wins arbitration appeal against Genmab,Seeking Alpha,https://seekingalpha.com/news/4057288-johnson-johnson-wins-arbitration-appeal-against-genmab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3847.0,1/23/2024 1:29:22 PM,Teva raised to Buy at Jefferies citing a positive setup ahead of 2024 outlook,Seeking Alpha,https://seekingalpha.com/news/4057313-teva-stock-raised-buy-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3848.0,1/23/2024 1:51:06 PM,"Johnson & Johnson Backs FY24 Earnings View, Sales To Rise ",RTTNews,/news/stocks/johnson-johnson-backs-fy24-earnings-view-sales-to-rise-1032987558
3849.0,1/23/2024 2:18:00 PM,"5 stocks to watch on Tuesday: 3M, Johnson & Johnson, Netflix and more",Seeking Alpha,https://seekingalpha.com/news/4057367-5-stocks-to-watch-on-tuesday-3m-johnson-johnson-netflix-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3850.0,1/23/2024 2:35:39 PM,Strong Performance and Growth Prospects Justify Buy Rating for Johnson & Johnson,TipRanks,/news/stocks/strong-performance-and-growth-prospects-justify-buy-rating-for-johnson-johnson-1032989073
3851.0,1/23/2024 5:23:49 PM,Johnson & Johnson‚Äôs MedTech performance augurs well for industry: analysts,Seeking Alpha,https://seekingalpha.com/news/4057471-johnson--johnsons-medtech-beat-augurs-well-industry?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3852.0,1/23/2024 5:29:14 PM,J&J may pay $700M to settle state AG probe into talcum powder marketing,Seeking Alpha,https://seekingalpha.com/news/4057476-jj-may-pay-700m-to-settle-state-ag-probe-into-talcum-powder-marketing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3853.0,1/23/2024 8:07:44 PM,"US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?",Benzinga,/news/etf/us-stocks-pause-as-treasury-yields-dollar-surge-on-trimmed-fed-rate-cut-bets-what-s-driving-markets-tuesday-1032989224
3854.0,1/24/2024 4:15:44 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032990861
3855.0,1/24/2024 4:20:18 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032990859
3856.0,1/24/2024 12:15:16 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1032993143
3857.0,1/24/2024 12:36:46 PM,Hold Rating on Johnson & Johnson Amid Moderate Growth Projections and Upcoming Exclusivity Challenges,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-moderate-growth-projections-and-upcoming-exclusivity-challenges-1032993190
3858.0,1/24/2024 8:57:44 PM,Johnson & Johnson inks ~$150M deal with Washington State to settle opioid claims,Seeking Alpha,https://seekingalpha.com/news/4058114-jj-inks-150m-deal-washington-state-opioid-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3859.0,1/24/2024 9:31:05 PM,JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims ,RTTNews,/news/stocks/jnj-agrees-to-700-mln-settlement-to-resolve-talc-consumer-protection-claims-1032993979
3860.0,1/24/2024 10:01:32 PM,The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts,Benzinga,/news/stocks/the-analyst-verdict-johnson-johnson-in-the-eyes-of-12-experts-1032994021
3861.0,1/25/2024 8:55:30 AM,Market-Perform Rating for Johnson & Johnson Amid Mixed Financial Signals and MedTech Margin Concerns,TipRanks,/news/stocks/market-perform-rating-for-johnson-johnson-amid-mixed-financial-signals-and-medtech-margin-concerns-1032996242
3862.0,1/25/2024 11:22:00 AM,7 Dividend Stocks to Buy and Never Sell: January 2024 Edition,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-never-sell-january-2024-edition-1032996124
3863.0,1/26/2024 5:50:28 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-johnson-johnson-jnj-and-abbott-labs-abt-1032999669
3864.0,1/26/2024 12:16:34 PM,PBMs ramp up lobbying efforts amid growing public scrutiny,Seeking Alpha,https://seekingalpha.com/news/4058952-pbms-ramp-up-lobbying-amid-growing-public-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3865.0,1/26/2024 10:03:52 PM,Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year,InvestorPlace,/news/stocks/dividend-dynamos-7-stocks-delivering-consistent-cash-flow-this-year-1033002407
3866.0,1/27/2024 12:24:31 AM,JNJ Stock: What to Consider Before Its Next Dividend Hike,TipRanks,/news/stocks/jnj-stock-what-to-consider-before-its-next-dividend-hike-1033002499
3867.0,1/28/2024 5:00:53 PM,Big Pharma earnings season in spotlight amid positive sentiment,Seeking Alpha,https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3868.0,1/29/2024 1:30:18 PM,AbbVie raised to Outperform at William Blair ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4059465-abbvie-stock-upgraded-william-blair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3869.0,1/29/2024 6:28:50 PM,"Evolus, Alvotech gain as Barclays raises to Ovrweight",Seeking Alpha,https://seekingalpha.com/news/4059650-evolus-stock-alvotech-stock-gain-barclays-upgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3870.0,1/29/2024 9:02:31 PM,Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now,InvestorPlace,/news/stocks/hedge-fund-favorites-7-stocks-the-big-money-is-loving-now-1033007086
3871.0,1/30/2024 7:14:41 PM,Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot,InvestorPlace,/news/stocks/buy-alert-3-healthcare-stocks-sitting-in-the-sweet-spot-1033011521
3872.0,1/30/2024 9:40:26 PM,J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4060348-jj-seeks-expanded-fda-approval-of-darzalex-faspro-for-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3873.0,1/31/2024 4:56:52 PM,The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-blue-chip-stocks-to-invest-in-for-big-gains-in-2024-1033016372
3874.0,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-ppening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3875.0,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-opening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3876.0,2/1/2024 6:22:16 PM,"Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan",Seeking Alpha,https://seekingalpha.com/news/4061498-lilly-zoetis-abbott-least-shorted-stocks-in-health-sector-till-mid-jan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3877.0,2/4/2024 5:00:49 PM,Pharma giants turn to China in search of targeted cancer drugs,Seeking Alpha,https://seekingalpha.com/news/4062374-pharma-antibody-drug-conjugates-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3878.0,2/5/2024 3:24:50 PM,Johnson & Johnson succeeds in trials for autoimmune drug,Seeking Alpha,https://seekingalpha.com/news/4062626-johnson-johnson-wins-studies-autoimmune-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3879.0,2/5/2024 9:08:41 PM,J&J releases positive data on PFA system for arrhythmia,Seeking Alpha,https://seekingalpha.com/news/4062841-jj-releases-positive-data-on-pfa-system-for-arrhythmia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3880.0,2/6/2024 11:15:00 AM,The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-invest-in-for-big-gains-in-2024-1033035941
3881.0,2/6/2024 12:38:17 PM,GSK blood cancer therapy nearly triples survival in late stage trial,Seeking Alpha,https://seekingalpha.com/news/4063050-gsk-blood-cancer-therapy-nearly-triples-survival?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3882.0,2/6/2024 12:46:21 PM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1033036045
3883.0,2/6/2024 2:11:29 PM,7 Dividend Stocks Worth Holding for the Long Haul,InvestorPlace,/news/stocks/7-dividend-stocks-worth-holding-for-the-long-haul-1033035440
3884.0,2/6/2024 3:07:57 PM,Johnson & Johnson sued over mismanaging company‚Äôs health plan,Seeking Alpha,https://seekingalpha.com/news/4063173-johnson-johnson-sued-over-mismanaging-companys-health-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3885.0,2/8/2024 7:07:57 PM,The Watch List: Is Warren Buffett Still Selling These 3 Stocks?,InvestorPlace,/news/stocks/the-watch-list-is-warren-buffett-still-selling-these-3-stocks-1033048002
3886.0,2/9/2024 11:30:00 AM,3 Dividend Stocks to Cling to This Year,InvestorPlace,/news/stocks/3-dividend-stocks-to-cling-to-this-year-1033050512
3887.0,2/9/2024 12:24:06 PM,Pharma CEOs defend high drug prices; blame PBMs at Senate hearing,Seeking Alpha,https://seekingalpha.com/news/4065061-pharma-ceos-defend-high-drug-prices-blame-pbms-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3888.0,2/9/2024 1:27:08 PM,Johnson & Johnson antibody therapy gets FDA breakthrough designation for HDFN indication,Seeking Alpha,https://seekingalpha.com/news/4065092-johnson-johnson-antibody-therapy-gets-fda-breakthrough-designation-for-hdfn-indication?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3889.0,2/9/2024 1:57:00 PM,"7 stocks to watch on Friday: Major drugmakers on Senate hearing, PepsiCo and more",Seeking Alpha,https://seekingalpha.com/news/4065116-7-stocks-to-watch-on-friday-major-drugmakers-on-senate-hearing-pepsico-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3890.0,2/9/2024 2:12:32 PM,Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income,InvestorPlace,/news/stocks/dividend-dynasties-3-stocks-set-to-deliver-consistent-income-1033051230
3891.0,2/12/2024 11:10:00 AM,Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/passive-income-powerhouses-7-blue-chip-stocks-to-own-now-1033056427
3892.0,2/13/2024 2:01:27 AM,Federal judge dismisses PhRMA challenge to Medicare price negotiations,Seeking Alpha,https://seekingalpha.com/news/4065840-federal-judge-tosses-phrma-lawsuit-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3893.0,2/13/2024 2:30:44 PM,GSK raised to Buy at Citi after cancer drug data,Seeking Alpha,https://seekingalpha.com/news/4066061-gsk-stock-raised-buy-citi-blenrep-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3894.0,2/13/2024 7:13:49 PM,7 Stable Dividend Stocks to Ease Lingering Market Jitters,InvestorPlace,/news/stocks/7-stable-dividend-stocks-to-ease-lingering-market-jitters-1033062743
3895.0,2/14/2024 6:07:31 PM,Johnson & Johnson wins FDA nod for first frostbite therapy,Seeking Alpha,https://seekingalpha.com/news/4066959-jj-wins-fda-nod-first-frostbite-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3896.0,2/14/2024 9:14:33 PM,"Dalio's Bridgewater adds Apple, Wells Fargo; exits Netflix, Thermo Fisher",Seeking Alpha,https://seekingalpha.com/news/4067120-dalios-bridgewater-adds-apple-wells-fargo-exits-netflix-thermo-fisher?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3897.0,2/15/2024 2:05:35 AM,Buy Rating Justified by Johnson & Johnson‚Äôs Strong Performance and Growth Prospects,TipRanks,/news/stocks/buy-rating-justified-by-johnson-johnson-s-strong-performance-and-growth-prospects-1033068841
3898.0,2/15/2024 3:04:10 PM,7 Small-Cap Stocks With Significant Upside Potential in 2024,InvestorPlace,/news/stocks/7-small-cap-stocks-with-significant-upside-potential-in-2024-1033072455
3899.0,2/15/2024 3:10:42 PM,Johnson & Johnson settles with Alvotech for off-patent Stelara,Seeking Alpha,https://seekingalpha.com/news/4067680-alvotech-stock-gains-deals-jj-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3900.0,2/15/2024 4:57:01 PM,The 3 Biotech Stocks That Could Make Your February Unforgettable,InvestorPlace,/news/stocks/the-3-biotech-stocks-that-could-make-your-february-unforgettable-1033073000
3901.0,2/18/2024 5:00:00 PM,Medtronic Q3 in focus amid MedTech‚Äôs post-COVID gains,Seeking Alpha,https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3902.0,2/18/2024 6:49:00 PM,Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul,InvestorPlace,/news/stocks/steady-eddies-3-blue-chip-stocks-to-buy-for-the-long-haul-1033078317
3903.0,2/20/2024 11:25:00 AM,Income Lover‚Äôs Paradise: 3 Dividend Stocks with Stellar Track Records,InvestorPlace,/news/stocks/income-lovers-paradise-3-dividend-stocks-with-stellar-track-records-1033082598
3904.0,2/20/2024 6:54:06 PM,Top 7 Contenders to Join the Trillion-Dollar Club,InvestorPlace,/news/stocks/top-7-contenders-to-join-the-trillion-dollar-club-1033084666
3905.0,2/20/2024 9:39:11 PM,"Cantor starts CG Oncology at overweight, cites bladder cancer treatment",Seeking Alpha,https://seekingalpha.com/news/4069286-cantor-starts-cg-oncology-at-overweight-cites-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3906.0,2/20/2024 10:13:56 PM,FDA approves biweekly dosing of J&J multiple myeloma drug,Seeking Alpha,https://seekingalpha.com/news/4069329-fda-approves-biweekly-dosing-of-jj-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3907.0,2/21/2024 8:20:05 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1033087099
3908.0,2/22/2024 2:40:53 PM,Ambrx Biopharma ticks higher as HSR waiting period for J&J deal expires,Seeking Alpha,https://seekingalpha.com/news/4070360-ambrx-biopharma-ticks-higher-as-hsr-waiting-period-for-jj-deal-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3909.0,2/22/2024 10:33:00 PM,3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List,InvestorPlace,/news/stocks/3-undervalued-small-cap-stocks-to-add-to-your-must-buy-list-1033095199
3910.0,2/23/2024 1:03:10 PM,Janssen Pharma's Carvykti Gets Positive CHMP Opinion For Earlier Multiple Myeloma Treatment ,RTTNews,/news/stocks/janssen-pharma-s-carvykti-gets-positive-chmp-opinion-for-earlier-multiple-myeloma-treatment-1033097034
3911.0,2/23/2024 2:58:33 PM,Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/4071098-jj-wins-eu-backing-expand-labeling-car-t-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3912.0,2/23/2024 6:22:45 PM,Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4071255-legend-biotech-stock-rises-after-eu-backs-label-expansion-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3913.0,2/23/2024 7:08:15 PM,"BMO upgrades Genmab to outperform, cites diversification potential",Seeking Alpha,https://seekingalpha.com/news/4071279-bmo-upgrades-genmab-to-outperform-cites-diversification-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3914.0,2/24/2024 1:30:00 PM,Pension Plan Redux: 3 Companies That Could Take a Page From IBM‚Äôs Playbook,InvestorPlace,/news/stocks/pension-plan-redux-3-companies-that-could-take-a-page-from-ibms-playbook-1033099231
3915.0,2/25/2024 7:30:22 PM,7 Stocks to Buy Now if You Think the S&P 500‚Äôs Winning Streak Will Continue,InvestorPlace,/news/stocks/7-stocks-to-buy-now-if-you-think-the-sp-500s-winning-streak-will-continue-1033099958
3916.0,2/25/2024 11:50:34 PM,"Needham sees orthopedics market slowing; favors Enovis, Paragon 28",Seeking Alpha,https://seekingalpha.com/news/4071389-needham-sees-orthopedics-market-slowing-favors-enovis-paragon-28?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3917.0,2/26/2024 5:53:41 PM,3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition,InvestorPlace,/news/stocks/3-dividend-stocks-that-are-too-good-to-ignore-q1-edition-1033104041
3918.0,2/27/2024 9:00:02 PM,"Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end",Seeking Alpha,https://seekingalpha.com/news/4072568-waters-moderna-most-shorted-stocks-in-sp-500-health-sector-till-jan-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3919.0,2/27/2024 10:12:21 PM,7 Dividend Stocks Every Investor Should Own to Survive a Market Crash,InvestorPlace,/news/stocks/7-dividend-stocks-every-investor-should-own-to-survive-a-market-crash-2-1033109768
3920.0,2/28/2024 9:52:49 AM,Biotech Stocks Facing FDA Decision In March 2024 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-2024-1033111344
3921.0,2/28/2024 10:38:50 AM,Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-anticipated-varipulse-approval-and-afib-market-dynamics-1033112661
3922.0,2/28/2024 12:23:37 PM,"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-masimo-masi-and-johnson-johnson-jnj-1033113716
3923.0,2/28/2024 5:00:16 PM,Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock,Benzinga,/news/stocks/beyond-the-numbers-13-analysts-discuss-johnson-johnson-stock-1033114014
3924.0,2/29/2024 11:32:10 AM,Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-keeps-their-hold-rating-on-johnson-johnson-jnj-1033118567
3925.0,2/29/2024 7:26:32 PM,Don‚Äôt Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.,InvestorPlace,/news/stocks/dont-panic-7-smart-stocks-to-buy-if-the-markets-take-a-tumble-1033120307
3926.0,3/1/2024 6:10:27 PM,Medicare price negotiations survive another legal challenge,Seeking Alpha,https://seekingalpha.com/news/4074801-medicare-price-negotiations-survive-legal-challenge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3927.0,3/1/2024 9:30:02 PM,J&J gets full approval for Rybrevant for EGFR exon 20 lung cancer,Seeking Alpha,https://seekingalpha.com/news/4074903-jnj-gets-full-approval-for-rebrevant-for-egfr-exon-20-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3928.0,3/1/2024 10:34:27 PM,Johnson & Johnson's Rybrevant Gets FDA Approval For Lung Cancer Treatment ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-gets-fda-approval-for-lung-cancer-treatment-1033125304
3929.0,3/4/2024 11:25:00 AM,Secure Your Future: 7 Dividend Kings with Solid Growth Potential,InvestorPlace,/news/stocks/7-dividend-kings-that-offer-more-than-just-a-pretty-dividend-1033127903
3930.0,3/4/2024 7:08:25 PM,Biden says drugmakers to continue to engage in Medicare drug price negoiations,Seeking Alpha,https://seekingalpha.com/news/4075531-biden-says-drugmakers-continue-engage-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3931.0,3/5/2024 9:08:02 PM,7 No-Frills Dividend Stocks for Your Must-Own List,InvestorPlace,/news/stocks/7-no-frills-dividend-stocks-for-your-must-own-list-1033134714
3932.0,3/6/2024 11:17:00 AM,The Top 7 Dividend Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-march-2024-1033136900
3933.0,3/6/2024 3:18:51 PM,J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma ,RTTNews,/news/stocks/j-j-seeks-ema-approval-for-darzalex-quadruplet-therapy-for-multiple-myeloma-1033137717
3934.0,3/6/2024 7:31:39 PM,ViiV‚Äôs long-acting HIV therapy outperforms daily therapy in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/4076783-viivs-long-acting-hiv-therapy-outperforms-daily-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3935.0,3/6/2024 10:40:54 PM,Biden to push for expanding Medicare drug pricing program,Seeking Alpha,https://seekingalpha.com/news/4076912-biden-to-push-for-expanding-medicare-drug-pricing-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3936.0,3/7/2024 2:48:43 PM,Johnson & Johnson Buys Ambrx Biopharma In $2 Bln Cash Deal ,RTTNews,/news/stocks/johnson-johnson-buys-ambrx-biopharma-in-2-bln-cash-deal-1033142226
3937.0,3/7/2024 3:50:14 PM,J&J completes $2B acquisition of ADC developer Ambrx,Seeking Alpha,https://seekingalpha.com/news/4077247-jj-completes-acquisition-of-adc-developer-ambrx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3938.0,3/7/2024 4:11:38 PM,The Top 3 Blue-Chip Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-blue-chip-stocks-to-buy-in-march-2024-1033143201
3939.0,3/7/2024 5:27:11 PM,The Top 3 Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-healthcare-stocks-to-buy-in-march-2024-1033143533
3940.0,3/7/2024 8:52:40 PM,"Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley",Benzinga,/news/stocks/arcellx-s-lead-asset-can-potentially-outperform-bristol-myers-squibb-johnson-johnson-s-multiple-myeloma-cell-therapies-morgan-stanley-1033143791
3941.0,3/8/2024 9:32:49 PM,3 Dividend Aristocrat Stocks to Buy And Hold: March 2024,InvestorPlace,/news/stocks/3-dividend-aristocrat-stocks-to-buy-and-hold-march-2024-1033147709
3942.0,3/9/2024 6:00:00 PM,The Top 3 Pharma Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-pharma-stocks-to-buy-in-march2024-1033148079
3943.0,3/9/2024 6:34:43 PM,Johnson & Johnson highlights psoriasis candidate with long-term data,Seeking Alpha,https://seekingalpha.com/news/4077809-jj-psoriasis-drug-long-term-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3944.0,3/10/2024 5:08:00 PM,Cantor sees strong year ahead for oncology M&A,Seeking Alpha,https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3945.0,3/11/2024 4:03:46 PM,The Dow‚Äôs Best Friends: 3 ‚ÄòDogs‚Äô Ready to Fetch Huge Returns,InvestorPlace,/news/stocks/the-dows-best-friends-3-dogs-ready-to-fetch-huge-returns-1033151926
3946.0,3/11/2024 10:10:18 PM,J&J submits sBLA for Tremfya for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4078241-johnson-johnson-submits-sbla-tremfya-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3947.0,3/12/2024 12:09:00 PM,3 Must-Have Dividend Kings for a Steady Income Stream,InvestorPlace,/news/stocks/3-must-have-dividend-kings-for-a-steady-income-stream-1033154748
3948.0,3/12/2024 7:41:22 PM,7 High-Quality Blue-Chip Stocks to Buy if You‚Äôre Looking for Stability,InvestorPlace,/news/stocks/7-high-quality-blue-chip-stocks-to-buy-if-youre-looking-for-stability-1033156716
3949.0,3/13/2024 1:44:45 PM,"J&J, Bristol Myers slip as FDA comments on CAR-T drugs ahead of AdCom",Seeking Alpha,https://seekingalpha.com/news/4078882-jj-bristol-myers-slip-fda-comments-car-t-drugs-adcom?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3950.0,3/14/2024 4:15:21 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033162448
3951.0,3/14/2024 12:02:33 PM,The 3 Most Undervalued Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-march-2024-1033163673
3952.0,3/15/2024 1:29:14 PM,"Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end",Seeking Alpha,https://seekingalpha.com/news/4079885-johnson-johnson-boston-scientific-least-shorted-stocks-in-sp-500-healthcare-sector-for-feb-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3953.0,3/15/2024 4:56:13 PM,The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough,InvestorPlace,/news/stocks/the-taxman-cometh-3-stocks-to-soften-the-blow-and-grow-your-dough-1033169255
3954.0,3/15/2024 5:25:53 PM,Johnson & Johnson wins FDA AdCom backing for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4080088-jj-wins-fda-adcom-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3955.0,3/16/2024 11:58:13 AM,Bristol Myers wins FDA AdCom backing for Abecma label expansion,Seeking Alpha,https://seekingalpha.com/news/4080229-bristol-myers-wins-fda-adcom-backing-abecma-labeling?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3956.0,3/16/2024 7:00:00 PM,Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own,InvestorPlace,/news/stocks/guardians-of-your-golden-years-7-stocks-every-retiree-needs-to-own-1033169872
3957.0,3/18/2024 10:50:06 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-aveanna-healthcare-holdings-avah-1033172494
3958.0,3/19/2024 5:18:58 PM,"Johnson & Johnson, Nvidia ink AI deal for surgical applications",Seeking Alpha,https://seekingalpha.com/news/4081225-johnson-johnson-nvidia-ink-ai-deal-for-surgical-applications?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3959.0,3/19/2024 5:40:16 PM,MS drug developer Contineum files for $150M IPO,Seeking Alpha,https://seekingalpha.com/news/4081227-ms-drug-developer-contineum-files-for-150m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3960.0,3/19/2024 6:18:28 PM,7 Defensive Stocks to Build a Moat Around Your Portfolio,InvestorPlace,/news/stocks/7-defensive-stocks-to-build-a-moat-around-your-portfolio-1033177894
3961.0,3/19/2024 7:25:59 PM,A New Frontier: Nvidia Reveals the ‚ÄòWorld‚Äôs Most Powerful‚Äô AI Chip,InvestorPlace,/news/stocks/a-new-frontier-nvidia-reveals-the-worlds-most-powerful-ai-chip-1033178025
3962.0,3/20/2024 1:35:50 PM,J&J alleges ex-staffer downloaded thousands of files in move to Pfizer,Seeking Alpha,https://seekingalpha.com/news/4081583-jj-alleges-staffer-downloaded-thousands-files-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3963.0,3/21/2024 4:17:03 PM,"Dear 3M Stock Fans, Mark Your Calendars for April 1",InvestorPlace,/news/stocks/dear-3m-stock-fans-mark-your-calendars-for-april-1-1033185826
3964.0,3/21/2024 8:03:47 PM,Johnson & Johnson stock closes in red for a seventh consecutive session,Seeking Alpha,https://seekingalpha.com/news/4082384-johnson-and-johnson-stock-closes-in-red-for-seventh-consecutive-session?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3965.0,3/22/2024 2:14:46 AM,Wall Street‚Äôs Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich,InvestorPlace,/news/stocks/wall-streets-favorite-long-term-stocks-3-names-that-could-make-you-filthy-rich-1033186874
3966.0,3/22/2024 6:42:10 PM,3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff,InvestorPlace,/news/stocks/3m-stock-alert-7-things-to-know-about-the-upcoming-3m-healthcare-spinoff-1033189957
3967.0,3/23/2024 12:44:57 PM,"J&J wins FDA nod for blood vessel disorder therapy, Opsynvi",Seeking Alpha,https://seekingalpha.com/news/4083065-jj-wins-fda-nod-blood-vessel-disorder-therapy-opsynvi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3968.0,3/24/2024 2:13:20 PM,7 Dividend Darlings to Scoop Up Every Time the Market Dips,InvestorPlace,/news/stocks/7-dividend-darlings-to-scoop-up-every-time-the-market-dips-1033191000
3969.0,3/25/2024 2:47:11 PM,Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†,InvestorPlace,/news/stocks/hot-stocks-the-3-best-opportunities-for-investing-in-the-sp-500-1033193515
3970.0,3/26/2024 12:24:47 PM,J&J experimental therapy gets FDA fast track status to reduce FNAIT in pregnancy,Seeking Alpha,https://seekingalpha.com/news/4083654-jj-experimental-therapy-gets-fda-fast-track-to-reduce-fnait-in-pregnancy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3971.0,3/26/2024 5:30:34 PM,7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-can-safeguard-your-income-through-any-crisis-1033198293
3972.0,3/26/2024 6:01:03 PM,Cytokinetics gains amid renewed takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4083918-cytokinetics-gains-amid-renewed-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3973.0,3/26/2024 7:12:20 PM,Shockwave Medical surges as Johnson & Johnson in talks to acquire - report,Seeking Alpha,https://seekingalpha.com/news/4083938-shockwave-medical-surges-johnson-johnson-talks-acquire?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3974.0,3/27/2024 12:02:08 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-healthequity-hqy-and-bluebird-bio-blue-1033199008
3975.0,3/27/2024 10:00:00 AM,7 Dow Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-on-the-dip-march-2024-1033200339
3976.0,3/27/2024 1:13:34 PM,Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields-1033200819
3977.0,3/27/2024 1:50:45 PM,Merck hits all-time high after FDA nod for lung disease therapy,Seeking Alpha,https://seekingalpha.com/news/4084361-merck-stock-jumps-fda-nod-winrevair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3978.0,3/27/2024 7:04:20 PM,J&J-Shockwave deal makes strategic sense: analysts,Seeking Alpha,https://seekingalpha.com/news/4084616-shockwave-medical-stock-gains-jj-deal-makes-sense?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3979.0,3/27/2024 8:14:11 PM,Johnson & Johnson gets major break in talc cancer link cases,Seeking Alpha,https://seekingalpha.com/news/4084630-johnson-johnson-gets-major-break-talc-cancer-link-cases?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3980.0,3/27/2024 9:23:27 PM,"Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst",Benzinga,/news/stocks/johnson-johnson-strong-strategic-fit-for-shockwave-medical-but-medtronic-boston-scientific-could-be-other-bidder-says-analyst-1033202897
3981.0,3/28/2024 2:28:44 PM,J&J to settle Mississippi baby powder suit for $75M: report,Seeking Alpha,https://seekingalpha.com/news/4084978-jj-to-settle-mississippi-baby-powder-suit-for-75m-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3982.0,3/28/2024 4:55:21 PM,J&J Agrees To Pay $75 Mln In Mississippi's Baby Powder Case ,RTTNews,/news/stocks/j-j-agrees-to-pay-75-mln-in-mississippi-s-baby-powder-case-1033206269
3983.0,3/28/2024 6:46:33 PM,3 Value Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/3-value-stocks-to-buy-on-the-dip-march-2024-1033206804
3984.0,3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3985.0,4/1/2024 4:17:16 PM,Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent,Seeking Alpha,https://seekingalpha.com/news/4085739-teva-and-viatris-revives-chance-to-dispute-jjs-schizophrenia-drug-patent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3986.0,4/4/2024 12:48:00 AM,Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows,InvestorPlace,/news/stocks/rich-returns-at-a-discount-3-dividend-aristocrats-trading-at-52-week-lows-1033220639
3987.0,4/5/2024 12:41:50 AM,Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender,Seeking Alpha,https://seekingalpha.com/news/4087441-johnson-johnson-urges-shareholders-rebuff-trc-capital-mini-tender?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3988.0,4/5/2024 1:00:19 PM,Johnson & Johnson To Buy Shockwave In $13.1 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-shockwave-in-13-1-bln-deal-1033225311
3989.0,4/5/2024 1:13:00 PM,"4 stocks to watch on Friday: SWAV on JNJ deal, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4087566-4-stocks-to-watch-on-friday-swav-on-jnj-deal-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3990.0,4/5/2024 1:31:18 PM,SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson,InvestorPlace,/news/stocks/swav-stock-alert-shockwave-medical-lands-big-buyer-in-johnson-johnson-1033225858
3991.0,4/5/2024 2:00:01 PM,Johnson & Johnson to acquire Shockwave Medical for $13.1B (update),Seeking Alpha,https://seekingalpha.com/news/4087511-johnson--johnson-acquire-shockwave-medical-13b-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3992.0,4/5/2024 5:20:47 PM,Contineum Therapeutics stock slides 10% following $110M IPO,Seeking Alpha,https://seekingalpha.com/news/4087646-contineum-therapeutics-stock-slides-following-110m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3993.0,4/5/2024 8:30:00 PM,The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-russell-2000-stocks-to-buy-in-april-1033226998
3994.0,4/6/2024 12:38:09 PM,Johnson & Johnson wins FDA nod for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4087716-jj-wins-fda-nod-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3995.0,4/7/2024 5:31:00 PM,Morgan Stanley sees Fed rate cut fueling biotech stocks,Seeking Alpha,https://seekingalpha.com/news/4087727-fed-rate-cut-should-fuel-biotech-outperformance-morgan-stanley-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3996.0,4/8/2024 7:27:10 PM,"Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says",Benzinga,/news/stocks/johnson-johnson-s-13b-shockwave-medical-deal-accelerates-medtech-strategy-analyst-says-1033230884
3997.0,4/8/2024 8:19:36 PM,Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population,Benzinga,/news/stocks/johnson-johnson-s-carvykti-stands-ahead-of-bristol-myers-rival-blood-cancer-therapy-with-fda-approval-for-wider-population-1033230972
3998.0,4/9/2024 8:15:32 PM,Johnson and Johnson traded in the green after six day of losses,Seeking Alpha,https://seekingalpha.com/news/4088363-johnson-and-johnson-traded-in-the-green-after-six-day-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
3999.0,4/10/2024 6:21:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Axsome Therapeutics (AXSM) and Premier (PINC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-axsome-therapeutics-axsm-and-premier-pinc-1033236272
4000.0,4/10/2024 10:25:00 AM,"If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dividend-stock-in-april-it-better-be-one-of-these-3-names-1033236532
4001.0,4/10/2024 4:10:12 PM,"Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-shattuck-labs-sttk-johnson-johnson-jnj-and-tilray-tlry-1033238690
4002.0,4/10/2024 4:50:16 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), PainReform (PRFX) and IN8bio (INAB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-painreform-prfx-and-in8bio-inab-1033238738
4003.0,4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450
4004.0,4/10/2024 7:27:29 PM,Johnson & Johnson cough syrup recalled in Nigeria over toxicity concerns,Seeking Alpha,https://seekingalpha.com/news/4088708-johnson-johnson-cough-syrup-recalled-in-nigeria-over-toxicity-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4005.0,4/10/2024 9:45:00 PM,Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-dividend-stocks-with-strong-buy-ratings-for-april-2024-1033238979
4006.0,4/11/2024 1:08:17 AM,Maintaining Stability Amidst Challenges: Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/maintaining-stability-amidst-challenges-hold-rating-for-johnson-johnson-1033239177
4007.0,4/11/2024 1:45:35 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033239503
4008.0,4/11/2024 10:50:00 AM,Joby‚Äôs $3.5B Air Taxi Dream Worth Less Than Trump‚Äôs Truth Social Nightmare?,InvestorPlace,/news/stocks/jobys-3-5b-air-taxi-dream-worth-less-than-trumps-truth-social-nightmare-1033240436
4009.0,4/11/2024 11:00:37 AM,Rallybio shares gain on investment from J&J for rare fetal condition treatment,Seeking Alpha,https://seekingalpha.com/news/4088840-rallybio-shares-gain-on-investment-from-jj-for-rare-fetal-condition-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4010.0,4/11/2024 11:19:51 AM,Today‚Äôs Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on¬†Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-11th-1033240549
4011.0,4/11/2024 11:43:59 AM,Why Is Rallybio (RLYB) Stock Up 93% Today?,InvestorPlace,/news/stocks/why-is-rallybio-rlyb-stock-up-93-today-1033240640
4012.0,4/11/2024 1:47:56 PM,The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today,InvestorPlace,/news/stocks/the-5-billion-reason-alpine-immune-sciences-alpn-stock-is-up-30-today-1033241236
4013.0,4/11/2024 4:17:59 PM,All-Time High Flyers: 7 Stocks to Buy as the Market Peaks,InvestorPlace,/news/stocks/all-time-high-flyers-7-stocks-to-buy-as-the-market-peaks-1033242102
4014.0,4/11/2024 5:10:22 PM,Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-biotech-stocks-with-strong-buy-ratings-for-april-2024-1033242187
4015.0,4/12/2024 5:17:44 PM,"Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",Seeking Alpha,https://seekingalpha.com/news/4089272-short-interest-in-sp-500-healthcare-sector-rises-lilly-least-shorted-industry-at-march-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4016.0,4/12/2024 7:00:09 PM,"Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",Seeking Alpha,https://seekingalpha.com/news/4089283-catalyst-watch-boeing-hearing-bitcoin-halving-event-and-new-eyes-on-reddit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4017.0,4/13/2024 7:56:54 PM,J&J cough syrup recall classified as most serious in South Africa,Seeking Alpha,https://seekingalpha.com/news/4089418-jj-cough-syrup-recall-most-serious-south-africa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4018.0,4/14/2024 12:00:00 PM,"Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4089249-earnings-week-ahead-bac-jnj-tsm-unh-abt-slb-ual-pg-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4019.0,4/14/2024 1:00:00 PM,The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-to-survive-the-coming-sp-500-crash-1033246554
4020.0,4/15/2024 11:45:10 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033250034
4021.0,4/15/2024 3:01:13 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q1-quarterly-earnings-preview-stock-1033249247
4022.0,4/15/2024 3:36:45 PM,Tanzania and Rwanda join its African counterparts to recall J&J's cough syrup - report,Seeking Alpha,https://seekingalpha.com/news/4089679-tanzania-and-rwanda-join-its-african-counterparts-to-recall-jjs-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4023.0,4/15/2024 4:11:23 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4089690-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4024.0,4/15/2024 5:01:07 PM,A Closer Look at 9 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/a-closer-look-at-9-analyst-recommendations-for-johnson-johnson-1033250047
4025.0,4/15/2024 5:49:52 PM,JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results,Seeking Alpha,https://seekingalpha.com/news/4089736-jnj-q1-earnings-preview-a-lot-of-moving-factors-expected-to-bring-in-line-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4026.0,4/15/2024 8:42:59 PM,"Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA",Benzinga,/news/stocks/medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-market-earns-upgrade-from-bofa-1033250649
4027.0,4/16/2024 8:09:47 AM,Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%,Benzinga,/news/stocks/fear-greed-index-moves-to-fear-zone-s-p-500-down-over-1-1033251804
4028.0,4/16/2024 8:10:20 AM,"Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-morgan-stanley-and-3-stocks-to-watch-heading-into-tuesday-1033251803
4029.0,4/16/2024 8:15:29 AM,Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/johnson-johnson-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033251805
4030.0,4/16/2024 9:32:32 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Amylyx Pharmaceuticals Inc (AMLX) and Rhythm Pharmaceuticals (RYTM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-amylyx-pharmaceuticals-inc-amlx-and-rhythm-pharmaceuticals-rytm-1033253120
4031.0,4/16/2024 10:21:57 AM,"Johnson & Johnson Non-GAAP EPS of $2.71 beats by $0.06, revenue of $21.4B in-line",Seeking Alpha,https://seekingalpha.com/news/4089941-johnson-and-johnson-non-gaap-eps-of-2_71-beats-0_06-revenue-of-21_4b-in-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4032.0,4/16/2024 10:44:48 AM,Johnson & Johnson raises dividend by 4% to $1.24,Seeking Alpha,https://seekingalpha.com/news/4089942-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4033.0,4/16/2024 10:46:28 AM,Johnson & Johnson in charts: Q1 Y/Y revenue growth slows across all categories,Seeking Alpha,https://seekingalpha.com/news/4089946-johnson-johnson-in-charts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4034.0,4/16/2024 11:20:23 AM,J&J sets guidance below consensus as MedTech underperforms,Seeking Alpha,https://seekingalpha.com/news/4089962-jj-stock-slips-medtech-underperforms?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4035.0,4/16/2024 12:15:24 PM,Balancing Act: Hold Rating on Johnson & Johnson Amid Steady Growth and Legal Challenges,TipRanks,/news/stocks/balancing-act-hold-rating-on-johnson-johnson-amid-steady-growth-and-legal-challenges-1033254214
4036.0,4/16/2024 12:25:00 PM,Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges,InvestorPlace,/news/stocks/buyback-bonanza-the-top-7-etfs-to-profit-from-corporate-cash-splurges-1033253162
4037.0,4/16/2024 12:26:20 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1033252603
4038.0,4/16/2024 1:17:00 PM,"4 stocks to watch on Tuesday: JNJ, BAC and more",Seeking Alpha,https://seekingalpha.com/news/4090040-4-stocks-to-watch-on-tuesday-jnj-bac-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4039.0,4/16/2024 1:19:00 PM,Genmab's Q1 Darzalex Sales By Johnson & Johnson Reach $2.692 Bln ,RTTNews,/news/stocks/genmab-s-q1-darzalex-sales-by-johnson-johnson-reach-2-692-bln-1033252793
4040.0,4/16/2024 1:22:39 PM,"Johnson & Johnson Updates FY24 Earnings, Sales Outlook - Update ",RTTNews,/news/stocks/johnson-johnson-updates-fy24-earnings-sales-outlook-update-1033252806
4041.0,4/16/2024 2:45:00 PM,Johnson & Johnson hosts conference call for investors,Markets Insider Automation,/news/stocks/johnson_johnson_conference-1032643375
4042.0,4/16/2024 2:52:55 PM,"JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024",InvestorPlace,/news/stocks/jnj-stock-earnings-johnson-johnson-for-q1-of-2024-1033254073
4043.0,4/16/2024 4:23:16 PM,Bayer dethroned as Germany‚Äôs top drugmaker,Seeking Alpha,https://seekingalpha.com/news/4090165-bayer-beaten-top-german-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4044.0,4/16/2024 5:30:12 PM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-cullinan-management-cgem-johnson-johnson-jnj-and-unitedhealth-unh-1033255011
4045.0,4/16/2024 5:35:45 PM,Steady Performance and Aligned Guidance Justify Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/steady-performance-and-aligned-guidance-justify-hold-rating-for-johnson-johnson-1033255008
4046.0,4/16/2024 7:28:15 PM,"Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?",Benzinga,/news/etf/stocks-grapple-with-geopolitical-pressures-gold-eyes-2-400-bitcoin-falls-below-62-000-what-s-driving-markets-tuesday-1033254617
4047.0,4/16/2024 10:22:06 PM,FDA approves Alvotech biosimilar of J&J top-selling drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4090292-fda-approves-alvotech-biosimilar-of-jj-top-selling-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4048.0,4/17/2024 7:59:36 AM,RBC Capital Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033257341
4049.0,4/17/2024 9:20:09 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-intra-cellular-therapies-itci-1033257677
4050.0,4/17/2024 12:58:00 PM,"Put $10,000 in These 3 Dividend Stocks by 2025",InvestorPlace,/news/stocks/put-10000-in-these-3-dividend-stocks-by-2025-1033257941
4051.0,4/17/2024 2:21:45 PM,Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/visa-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday-1033257667
4052.0,4/17/2024 4:55:22 PM,Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough,InvestorPlace,/news/stocks/invest-like-a-hawk-7-stocks-to-own-if-the-fed-stays-tough-1033259055
4053.0,4/17/2024 7:51:24 PM,Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results,Benzinga,/news/stocks/johnson-johnson-analysts-cut-their-forecasts-after-q1-results-1033259210
4054.0,4/17/2024 8:35:54 PM,Scotiabank upgrades Legend Biotech to sector outperform,Seeking Alpha,https://seekingalpha.com/news/4090714-scotiabank-upgrades-legend-biotech-to-sector-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4055.0,4/17/2024 9:37:35 PM,"Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future",Benzinga,/news/stocks/johnson-johnson-shares-hold-steady-after-q1-earnings-analysts-optimistic-about-future-1033259391
4056.0,4/18/2024 4:30:44 AM,"Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-savara-svra-johnson-johnson-jnj-and-lantheus-lnth-1033260721
4057.0,4/18/2024 5:56:25 AM,"Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal Challenges",TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amidst-growth-competition-and-legal-challenges-1033261085
4058.0,4/18/2024 2:23:15 PM,Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.,InvestorPlace,/news/stocks/want-to-double-your-tax-refund-in-2024-7-stocks-to-buy-now-1033262864
4059.0,4/18/2024 4:08:11 PM,Recession-Proof Riches: 3 Stocks That Thrive in Any Economy,InvestorPlace,/news/stocks/recession-proof-riches-3-stocks-that-thrive-in-any-economy-1033263265
4060.0,4/19/2024 10:13:03 AM,FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk,Seeking Alpha,https://seekingalpha.com/news/4091378-fda-requires-changes-car-t-cell-therapy-boxed-warning?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4061.0,4/19/2024 12:13:02 PM,"Dividend Roundup: Johnson & Johnson, Dell, Lowe‚Äôs, Qualcomm and more",Seeking Alpha,https://seekingalpha.com/news/4091414-dividend-roundup-johnson-johnson-dell-lowes-qualcomm-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4062.0,4/19/2024 3:51:54 PM,Johnson & Johnson wins trial over talc-related cancer claim in Florida,Seeking Alpha,https://seekingalpha.com/news/4091543-johnson-johnson-wins-trial-talc-related-cancer-claim-florida?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4063.0,4/19/2024 6:30:20 PM,These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?,InvestorPlace,/news/stocks/these-3-small-cap-stocks-are-up-304-in-2024-can-they-run-higher-1033267239
4064.0,4/19/2024 6:48:52 PM,WHO considering safety alert on Kenvue kids cough syrup (update),Seeking Alpha,https://seekingalpha.com/news/4091569-who-considering-safety-alert-on-kenvue-kids-cough-syrup?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4065.0,4/19/2024 7:00:19 PM,"Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",Seeking Alpha,https://seekingalpha.com/news/4091531-catalyst-watch-tesla-boeing-and-general-motors-brace-for-earnings-fireworks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4066.0,4/20/2024 10:37:00 AM,Investing for the Long-Term: 3 Stocks With Proven Track Records,InvestorPlace,/news/stocks/investing-for-the-long-term-3-stocks-with-proven-track-records-1033267570
4067.0,4/20/2024 7:38:42 PM,J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim,Seeking Alpha,https://seekingalpha.com/news/4091712-jj-kenvue-told-pay-45m--talc-related-cancer-claim?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4068.0,4/21/2024 6:42:04 PM,Goldman picks top capex and R&D stocks,Seeking Alpha,https://seekingalpha.com/news/4091724-goldman-picks-top-capex-and-rd-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4069.0,4/22/2024 12:00:00 PM,5 Crash-Proof Stocks to Buy Immediately,InvestorPlace,/news/stocks/5-crash-proof-stocks-to-buy-immediately-1033270786
4070.0,4/22/2024 12:00:00 PM,3 Dividend Kings Down 11% You‚Äôll Regret Not Buying on the Dip,InvestorPlace,/news/stocks/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip-1033270787
4071.0,4/22/2024 2:59:00 PM,3 Dividend Stocks to Buy Now for Lifelong Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-lifelong-income-1033272979
4072.0,4/22/2024 6:21:51 PM,WHO no longer planning safety alert on Kenvue cough syrup: report,Seeking Alpha,https://seekingalpha.com/news/4092121-who-no-longer-planning-safety-alert-on-kenvue-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4073.0,4/23/2024 5:32:13 PM,Sanofi reportedly lining up banks for consumer products spinoff,Seeking Alpha,https://seekingalpha.com/news/4092701-sanofi-reportedly-lining-up-banks-for-consumer-products-spinoff?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4074.0,4/23/2024 8:30:00 PM,Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red,InvestorPlace,/news/stocks/warning-these-3-blue-chip-stocks-will-have-you-seeing-red-1033278030
4075.0,4/24/2024 11:25:00 AM,The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-2024-to-build-lasting-wealth-1033281279
4076.0,4/24/2024 3:59:30 PM,Neurocrine Biosciences upgraded at Wells Fargo on pipeline,Seeking Alpha,https://seekingalpha.com/news/4093140-neurocrine-bioscienes-upgraded-wells-fargo-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4077.0,4/24/2024 8:45:57 PM,"Cidara stock rallies amid $240M private placement, drug update",Seeking Alpha,https://seekingalpha.com/news/4093687-cidara-stock-rallies-amid-240m-private-placement-drug-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4078.0,4/24/2024 10:40:03 PM,Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar,InvestorPlace,/news/stocks/surprise-these-3-dividend-giants-are-at-52-week-lows-buy-them-before-they-soar-1033284469
4079.0,4/25/2024 10:00:00 AM,Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024,InvestorPlace,/news/stocks/medtech-marvels-3-groundbreaking-medical-device-stocks-to-watch-in-2024-1033286961
4080.0,4/25/2024 10:50:00 AM,7 Blue-Chip Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-on-the-dip-april-2024-1033287300
4081.0,4/25/2024 3:14:00 PM,3 Long-Term Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-on-the-dip-april-2024-1033290693
4082.0,4/25/2024 7:00:00 PM,The Top 3 Small-Cap Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-top-3-small-cap-stocks-to-buy-in-april-2024-1033290120
4083.0,4/26/2024 10:00:00 AM,How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?,InvestorPlace,/news/stocks/how-much-will-10k-invested-in-these-dividend-aristocrats-grow-to-by-2025-1033293175
4084.0,4/26/2024 10:00:00 AM,Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April,InvestorPlace,/news/stocks/steady-eddies-7-rock-solid-stocks-to-anchor-your-portfolio-in-april-1033293172
4085.0,4/26/2024 3:41:48 PM,JNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLC ,RTTNews,/news/stocks/jnj-receives-positive-chmp-opinion-for-rybrevant-for-treatment-of-patients-with-advanced-nsclc-1033294244
4086.0,4/27/2024 10:00:00 AM,Generational Wealth Builders: 3 Stocks to Own for Decades of Gains,InvestorPlace,/news/stocks/three-stocks-to-own-for-decades-of-gains-1033296018
4087.0,4/27/2024 10:38:00 AM,7 Stocks to Buy if Inflation Continues to Reign in 2024¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-if-inflation-continues-to-be-a-problem-in-2024-1033296028
4088.0,4/28/2024 5:00:22 PM,"J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",Seeking Alpha,https://seekingalpha.com/news/4095228-johnson-johnson-roche-astrazeneca-poised-have-highest-orphan-drug-sales-by-end-decade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4089.0,4/29/2024 2:03:13 PM,7 Retirement Stocks to Buy at a 52-Week Low in April,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-at-a-52-week-low-in-april-1033300969
4090.0,4/29/2024 3:20:01 PM,EU regulators recommend full approval for J&J TB drug Sirturo,Seeking Alpha,https://seekingalpha.com/news/4095555-eu-regulators-recommend-full-approval-for-jj-tb-drug-sirturo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4091.0,4/29/2024 4:01:27 PM,Addex stock plunges 50% on failed study for epilepsy drug,Seeking Alpha,https://seekingalpha.com/news/4095619-addex-stock-plunges-50-on-failed-study-for-epilepsy-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4092.0,4/29/2024 9:07:42 PM,Cutting Edge Picks: 3 Med Tech Stocks With Room to Run,InvestorPlace,/news/stocks/cutting-edge-picks-3-med-tech-stocks-with-room-to-run-1033302252
4093.0,4/30/2024 11:17:00 AM,Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn,InvestorPlace,/news/stocks/slump-survivors-3-stocks-that-will-outlast-the-sp-500-downturn-1033305592
4094.0,4/30/2024 1:42:51 PM,Stock Market Crash Warning: Don‚Äôt Get Caught Holding These 3 Healthcare Stocks,InvestorPlace,/news/stocks/stock-market-crash-warning-dont-get-caught-holding-these-3-healthcare-stocks-1033306829
4095.0,4/30/2024 1:49:06 PM,"J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",Seeking Alpha,https://seekingalpha.com/news/4096283-jj-bristol-myers-lose-bid-halt-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4096.0,4/30/2024 5:10:58 PM,"Stifel, Morgan Stanley bullish on newly public Contineum",Seeking Alpha,https://seekingalpha.com/news/4096594-stifel-morgan-stanley-bullish-on-newly-public-contineum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4097.0,4/30/2024 8:30:00 PM,7 Dividend Aristocrats Paying Sky-High Yields: April 2024,InvestorPlace,/news/stocks/7-dividend-aristocrats-paying-sky-high-yields-april-2024-1033308879
4098.0,5/1/2024 11:45:36 AM,J&J seeks over $6B settlement to resolve talc-related cancer claims,Seeking Alpha,https://seekingalpha.com/news/4097160-jj-plans-6b-deal-talc-related-cancer-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4099.0,5/1/2024 12:18:08 PM,J&J's proposed $6B+ talc settlement negatively impacts some Q1 results,Seeking Alpha,https://seekingalpha.com/news/4097204-johnson-johnson-proposed-6b-talc-settlement-negatively-impacts-some-q1-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4100.0,5/1/2024 3:26:33 PM,JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits,InvestorPlace,/news/stocks/jnj-stock-jj-proposes-6-5-billion-settlement-for-talc-cancer-lawsuits-1033314430
4101.0,5/1/2024 3:43:59 PM,Why Is CytomX (CTMX) Stock Up 180% Today?,InvestorPlace,/news/stocks/why-is-cytomx-ctmx-stock-up-180-today-1033314629
4102.0,5/1/2024 4:11:15 PM,"Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally",InvestorPlace,/news/stocks/cannabis-stocks-cgc-acb-tlry-drop-after-huge-rescheduling-rally-1033314763
4103.0,5/1/2024 7:57:17 PM,Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge,InvestorPlace,/news/stocks/stock-market-crash-alert-3-must-buy-healthcare-stocks-when-prices-plunge-1033315341
4104.0,5/1/2024 8:12:21 PM,"BeiGene, AbbVie patent spat to get trial from USPTO appeals board",Seeking Alpha,https://seekingalpha.com/news/4097839-beigene-abbvie-patent-spat-get-trial-uspto-appeals-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4105.0,5/1/2024 9:09:50 PM,J&J Proposes $6.475 Bln To Settle Ovarian Cancer Lawsuits ,RTTNews,/news/stocks/j-j-proposes-6-475-bln-to-settle-ovarian-cancer-lawsuits-1033315188
4106.0,5/2/2024 9:16:46 AM,Hold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement Efforts,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-ongoing-talc-litigation-uncertainties-and-settlement-efforts-1033319546
4107.0,5/2/2024 9:19:33 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-for-ovarian-cancer-talc-claims-financial-implications-and-outlook-1033319538
4108.0,5/3/2024 5:04:03 PM,J&J releases new Erleada data buoying benefit of prostate cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4099835-johnson-johnson-releases-new-erleada-data-buoying-benefit-prostate-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4109.0,5/4/2024 7:30:00 PM,Pharma R&D productivity seen improving for the first time in years - Deloitte,Seeking Alpha,https://seekingalpha.com/news/4099974-pharma-research-development-productivity-improving-first-time-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4110.0,5/5/2024 10:45:44 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan Bolsters Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-bolsters-buy-rating-1033329616
4111.0,5/5/2024 8:50:40 PM,J&J delivers promising phase 1 data for localized bladder cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4100058-jj-delivers-promising-phase-1-data-for-localized-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4112.0,5/6/2024 10:58:00 AM,Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?,InvestorPlace,/news/stocks/investor-alert-are-these-3-spinoff-stocks-destined-to-sizzle-or-fizzle-1033332372
4113.0,5/6/2024 5:37:50 PM,Steady Dividend Plays: 3 Aristocrat Stocks to Own Now,InvestorPlace,/news/stocks/steady-dividend-plays-3-aristocrat-stocks-to-own-now-1033334877
4114.0,5/6/2024 6:06:06 PM,How the Medical Industry Could Produce the Biggest AI Stock Winners,InvestorPlace,/news/stocks/how-the-medical-industry-could-produce-the-biggest-ai-stock-winners-1032600921
4115.0,5/6/2024 6:30:17 PM,3 Biotech Stocks to Double Your Money in the Next 24 Months,InvestorPlace,/news/stocks/3-biotech-stocks-to-double-your-money-in-the-next-24-months-1033334986
4116.0,5/7/2024 4:15:32 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033337550
4117.0,5/7/2024 9:16:02 AM,Johnson & Johnson: Navigating Legal Challenges with a Strategic Settlement Outlook,TipRanks,/news/stocks/johnson-johnson-navigating-legal-challenges-with-a-strategic-settlement-outlook-1033339000
4118.0,5/7/2024 12:03:23 PM,"Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Johnson & Johnson (JNJ) and Hims & Hers Health (HIMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pliant-therapeutics-plrx-johnson-johnson-jnj-and-hims-hers-health-hims-1033340734
4119.0,5/7/2024 4:51:32 PM,Kenvue to slash global workforce by 4% in cost savings move,Seeking Alpha,https://seekingalpha.com/news/4101532-kenvue-slash-global-workforc-4-cost-savings-move?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4120.0,5/7/2024 7:35:37 PM,Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts,InvestorPlace,/news/stocks/kenvue-layoffs-2024-what-to-know-about-the-latest-kvue-job-cuts-1033341843
4121.0,5/7/2024 8:31:51 PM,Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy,Benzinga,/news/stocks/johnson-johnson-s-taris-platform---goldman-sachs-outlines-potential-for-the-bladder-cancer-therapy-1033341693
4122.0,5/8/2024 4:00:05 AM,Buy Rating Affirmed: Johnson & Johnson‚Äôs Bladder Cancer Treatments Poised to Transform Standard of Care,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-s-bladder-cancer-treatments-poised-to-transform-standard-of-care-1033345376
4123.0,5/8/2024 11:06:13 AM,AstraZeneca is withdrawing COVID shot worldwide due to vaccine glut,Seeking Alpha,https://seekingalpha.com/news/4102264-astrazeneca-withdrawing-covid-shot-vaccine-glut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4124.0,5/8/2024 5:55:30 PM,Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024,InvestorPlace,/news/stocks/three-stocks-promising-reliable-payouts-in-2024-1033349779
4125.0,5/8/2024 8:39:38 PM,The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-sp-500-stocks-to-buy-in-may-2024-1033350343
4126.0,5/9/2024 10:47:57 AM,Hold Rating on Johnson & Johnson Amid Varipulse PFA Catheter Recall and Approval Uncertainties,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-varipulse-pfa-catheter-recall-and-approval-uncertainties-1033356512
4127.0,5/9/2024 10:49:00 AM,Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine,InvestorPlace,/news/stocks/biotech-breakthroughs-3-stocks-on-the-verge-of-revolutionizing-medicine-1033355184
4128.0,5/9/2024 4:41:08 PM,A Look at Pharma ETFs Post Q1 Earnings,Benzinga,/news/etf/a-look-at-pharma-etfs-post-q1-earnings-1033357001
4129.0,5/10/2024 10:30:00 AM,3 Biotech Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-biotech-stocks-to-sell-in-may-before-they-crash-burn-1033362353
4130.0,5/10/2024 11:10:00 AM,The 3 Most Undervalued Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-stocks-to-buy-in-may-2024-1033362566
4131.0,5/11/2024 1:46:00 PM,The 3 Best Mutual Funds to Buy in May 2024,InvestorPlace,/news/stocks/the-3-best-mutual-funds-to-buy-in-may-2024-1033365205
4132.0,5/13/2024 10:00:00 AM,7 Reliable Dividend Stocks to Keep Your Portfolio Upright,InvestorPlace,/news/stocks/7-reliable-dividend-stocks-to-keep-your-portfolio-upright-1033369987
4133.0,5/13/2024 10:00:00 AM,The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-stocks-with-strong-fundamentals-to-buy-in-may-2024-1033369992
4134.0,5/13/2024 11:34:21 AM,Johnson & Johnson to exit Kenvue in debt-for-equity deal,Seeking Alpha,https://seekingalpha.com/news/4105044-johnson-johnson-to-exit-kenvue-in-debt-for-equity-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4135.0,5/13/2024 2:39:45 PM,Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock,InvestorPlace,/news/stocks/johnson-johnson-is-officially-getting-out-of-kenvue-kvue-stock-1033371606
4136.0,5/15/2024 7:01:54 AM,Kenvue prices secondary stock offering as Johnson & Johnson exits,Seeking Alpha,https://seekingalpha.com/news/4106258-kenvue-prices-secondary-stock-offering-johnson-johnson-exit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4137.0,5/15/2024 2:21:25 PM,"Short interest in S&P 500 healthcare sector dips in April, biotechnology companies most shorted",Seeking Alpha,https://seekingalpha.com/news/4106501-short-interest-in-sp-500-healthcare-sector-dips-in-april-biotechnology-companies-most-shorted?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4138.0,5/16/2024 10:30:00 AM,Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio,InvestorPlace,/news/stocks/consumer-staples-standouts-3-defensive-gems-to-safeguard-your-portfolio-1033392042
4139.0,5/16/2024 10:30:53 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033393200
4140.0,5/16/2024 10:31:42 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Cullinan Management (CGEM) and Omeros (OMER)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cullinan-management-cgem-and-omeros-omer-1033393197
4141.0,5/16/2024 12:24:55 PM,Johnson & Johnson to buy dermatology-focused biotech Proteologix,Seeking Alpha,https://seekingalpha.com/news/4107278-j-j-to-buy-dermatology-biotech-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4142.0,5/16/2024 2:18:27 PM,Johnson & Johnson To Acquire Proteologix For $850 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-proteologix-for-850-mln-1033392575
4143.0,5/16/2024 8:37:23 PM,Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market,InvestorPlace,/news/stocks/divide-and-conquer-3-stock-spinoffs-set-to-trounce-the-market-1033395145
4144.0,5/17/2024 10:24:00 AM,3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-robotics-and-automation-stocks-to-sell-in-may-before-they-crash-burn-1033398672
4145.0,5/17/2024 10:30:00 AM,3 Cheap Healthcare Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/3-cheap-healthcare-stocks-to-buy-now-may-2024-1033398668
4146.0,5/17/2024 11:11:00 AM,7 Value Stocks to Buy and Hold for a Decade of Dominance,InvestorPlace,/news/stocks/7-value-stocks-to-buy-and-hold-for-a-decade-of-dominance-1033398745
4147.0,5/17/2024 12:04:10 PM,"Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more",Seeking Alpha,https://seekingalpha.com/news/4107861-dividend-roundup-home-depot-alibaba-johnson-johnson-yum-brands-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4148.0,5/17/2024 9:05:31 PM,Medtronic study of Affera Sphere-9 Catheter meets endpoints,Seeking Alpha,https://seekingalpha.com/news/4108078-medtronic-study-of-affera-sphere-9-catheter-meets-endpoints?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4149.0,5/18/2024 12:55:42 PM,Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108103-jj-backed-rapport-therapeutics-seeks-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4150.0,5/18/2024 4:19:14 PM,"Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch",Benzinga,/news/stocks/cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch-1033400987
4151.0,5/18/2024 6:52:07 PM,"Novo Nordisk, J&J lead R&D rankings in big pharma: report",Seeking Alpha,https://seekingalpha.com/news/4108110-novo-nordisk-j-j-lead-rd-big-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4152.0,5/19/2024 6:00:55 PM,Biopharma M&A surges year over year in Q1,Seeking Alpha,https://seekingalpha.com/news/4108148-biopharma-mergers-acquisitions-surges-year-over-year-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4153.0,5/19/2024 7:05:03 PM,SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?,Seeking Alpha,https://seekingalpha.com/news/4108152-sa-roundtable-are-eli-lilly-and-novo-nordisk-overvalued?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4154.0,5/20/2024 10:02:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Eli Lilly & Co (LLY) and Coherus Biosciences (CHRS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-eli-lilly-co-lly-and-coherus-biosciences-chrs-1033403373
4155.0,5/20/2024 11:17:08 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033403924
4156.0,5/20/2024 3:51:21 PM,Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4108390-johnson-johnson-tremfya-meets-goals-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4157.0,5/20/2024 5:22:03 PM,The AI Stock Underdogs: 7 Underappreciated Companies Poised for Greatness,InvestorPlace,/news/stocks/the-ai-stock-underdogs-7-underappreciated-companies-poised-for-greatness-1033404434
4158.0,5/20/2024 7:18:17 PM,Should You Invest in the Vanguard Health Care ETF?,Benzinga,/news/etf/should-you-invest-in-the-vanguard-health-care-etf-1033404417
4159.0,5/20/2024 10:40:41 PM,J&J-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108575-jj-backed-rapport-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4160.0,5/21/2024 10:51:13 AM,"Teva, Alvotech launch biosimilar against AbbVie‚Äôs Humira",Seeking Alpha,https://seekingalpha.com/news/4108668-teva-alvotech-launch-biosimilar-against-humira?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4161.0,5/21/2024 5:41:34 PM,7 Dividend Kings to Buy for Royal Passive Income: May Edition,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-royal-passive-income-may-edition-1033408667
4162.0,5/21/2024 7:35:16 PM,Buy Recommendation for Johnson & Johnson on Promising Tremfya Clinical Data and Market Expansion Potential,TipRanks,/news/stocks/buy-recommendation-for-johnson-johnson-on-promising-tremfya-clinical-data-and-market-expansion-potential-1033409089
4163.0,5/21/2024 8:46:22 PM,Shockwave Medical gains after HSR waiting period for sale to J&J expires,Seeking Alpha,https://seekingalpha.com/news/4109075-shockwave-medical-gains-after-hsr-waiting-period-for-sale-to-jj-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4164.0,5/22/2024 10:27:05 AM,RBC Capital Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033411707
4165.0,5/22/2024 1:48:14 PM,7 Safe-Haven Stocks to Weather Any Storm,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-weather-any-storm-1033411814
4166.0,5/22/2024 3:11:31 PM,"The 500 Top Stocks to Buy in May, According to AI",InvestorPlace,/news/stocks/the-500-top-stocks-to-buy-in-may-according-to-ai-1033412478
4167.0,5/22/2024 5:00:57 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1033412391
4168.0,5/23/2024 11:16:29 AM,J&J faces lawsuit over talc-related bankruptcy filings,Seeking Alpha,https://seekingalpha.com/news/4109765-j-j-faces-lawsuit-over-talc-related-bankruptcies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4169.0,5/23/2024 3:59:46 PM,Legend Biotech a new buy at Deutsche Bank on Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/4109908-legend-biotech-new-buy-deutsche-bank-carvykti-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4170.0,5/23/2024 7:23:43 PM,DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies,InvestorPlace,/news/stocks/dd-stock-separation-plan-what-to-know-as-dupont-splits-into-3-companies-1033417299
4171.0,5/23/2024 7:41:25 PM,The Time Traveler‚Äôs Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034,InvestorPlace,/news/stocks/the-time-travelers-portfolio-3-stocks-to-buy-now-for-massive-returns-by-2034-1033417347
4172.0,5/23/2024 8:16:31 PM,"ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC",Seeking Alpha,https://seekingalpha.com/news/4110015-adhd-diagnoses-increasing-becoming-expanding-public-health-concern-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4173.0,5/24/2024 5:50:59 AM,Optimistic Buy Rating for JNJ‚Äôs Tremfya Based on Strong Market Penetration Potential in IBD,TipRanks,/news/stocks/optimistic-buy-rating-for-jnj-s-tremfya-based-on-strong-market-penetration-potential-in-ibd-1033419153
4174.0,5/24/2024 5:00:00 PM,3 Stocks to Safeguard Your Investments During a Market Meltdown,InvestorPlace,/news/stocks/3-stocks-to-safeguard-your-investments-during-a-market-meltdown-1033420974
4175.0,5/25/2024 11:30:00 AM,3 Dow Stocks to Buy on the Dip: May 2024,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-on-the-dip-may-2024-1033421474
4176.0,5/27/2024 10:00:00 AM,7 Dividend Stocks That Could Soar After Q1 Earnings Reports,InvestorPlace,/news/stocks/7-dividend-stocks-that-could-soar-after-q1-earnings-reports-1033423794
4177.0,5/28/2024 12:01:49 PM,J&J to buy eczema drug developer Yellow Jersey for over $1B,Seeking Alpha,https://seekingalpha.com/news/4110675-jj-buy-yellow-jersey-over-1b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4178.0,5/28/2024 2:13:43 PM,Johnson & Johnson To Acquire Rights To Numab Therapeutics' Clinical-Stage Bispecific Antibody NM26 ,RTTNews,/news/stocks/johnson-johnson-to-acquire-rights-to-numab-therapeutics-clinical-stage-bispecific-antibody-nm26-1033426797
4179.0,5/28/2024 6:15:48 PM,HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/healthtech-heroes-3-medical-technology-stocks-to-buy-before-they-boom-1033428394
4180.0,5/29/2024 9:10:25 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Insmed (INSM), Arcturus Therapeutics (ARCT) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insmed-insm-arcturus-therapeutics-arct-and-johnson-johnson-jnj-1033431427
4181.0,5/29/2024 12:48:00 PM,Johnson & Johnson depression candidate seltorexant meets phase 3 goals,Seeking Alpha,https://seekingalpha.com/news/4111111-johnson-johnson-depression-candidate-seltorexant-meets-phase-3-goals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4182.0,5/30/2024 6:45:27 AM,Sarepta Therapeutics set to join S&P MidCap 400,Seeking Alpha,https://seekingalpha.com/news/4111366-sarepta-therapeutics-set-to-join-sp-midcap-400?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4183.0,5/30/2024 11:30:00 AM,Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit,InvestorPlace,/news/stocks/blue-chip-bubble-trouble-7-stocks-to-short-as-valuations-stretch-to-the-limit-1033435720
4184.0,5/30/2024 11:41:20 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT), Johnson & Johnson (JNJ) and American Well (AMWL)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-immunovant-imvt-johnson-johnson-jnj-and-american-well-amwl-1033436795
4185.0,5/30/2024 7:03:57 PM,Should You Invest in the iShares U.S. Healthcare ETF?,Benzinga,/news/stocks/should-you-invest-in-the-ishares-u-s-healthcare-etf-1033437375
4186.0,5/30/2024 9:57:18 PM,"J&J transfers Ponvory FDA applications to Vanda, launch seen in Q3",Seeking Alpha,https://seekingalpha.com/news/4111797-jj-transfers-ponvory-fda-applications-to-vanda-launch-seen-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4187.0,5/31/2024 11:00:00 AM,3 Sorry Biotech Stocks to Sell in May While You Still Can,InvestorPlace,/news/stocks/3-sorry-biotech-stocks-to-sell-in-may-while-you-still-can-1033440710
4188.0,5/31/2024 1:35:26 PM,J&J completes acquisition of cardiac device maker Shockwave,Seeking Alpha,https://seekingalpha.com/news/4111939-jj-completes-acquisition-of-medtech-shockwave?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4189.0,5/31/2024 3:00:25 PM,Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/boring-is-beautiful-3-blue-chip-stocks-to-buy-and-hold-forever-1033441780
4190.0,5/31/2024 6:05:44 PM,Psychedelic stocks mixed as FDA comments on MDMA therapy (update),Seeking Alpha,https://seekingalpha.com/news/4111983-psychedelic-stocks-mixed-fda-comments-mdma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4191.0,5/31/2024 9:53:13 PM,J&J says Rybrevant combo bests AstraZeneca's Tagrisso in type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/4112105-johnson-johnson-says-rybrevant-combo-bests-astrazeneca-tagrisso-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4192.0,6/3/2024 10:00:00 AM,7 Overlooked Stocks That Belong in Every Portfolio¬†,InvestorPlace,/news/stocks/7-must-own-overlooked-stocks-that-can-work-in-any-portfolio-1033445074
4193.0,6/3/2024 4:03:10 PM,"GSK says Blenrep combo cuts disease progression, death in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/4112369-gsk-says-belnrep-combo-cuts-disease-progression-death-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4194.0,6/3/2024 5:06:04 PM,J&J-backed Rapport Therapeutics sets terms for $136M IPO,Seeking Alpha,https://seekingalpha.com/news/4112393-jj-backed-rapport-therapeutics-sets-terms-for-136m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4195.0,6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4196.0,6/3/2024 10:09:10 PM,"J&J, Legend release promising results on Carvykti in earlier treatment line",Seeking Alpha,https://seekingalpha.com/news/4112513-johnson-johnson-legend-release-promising-results-carvykti-earlier-treatment-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4197.0,6/3/2024 10:42:13 PM,Sanofi says Sarclisa improves progression-free survival in some multiple myeloma patients,Seeking Alpha,https://seekingalpha.com/news/4112515-sanofi-says-sarclisa-improves-progression-free-survival-in-some-multiple-myeloma-patients?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4198.0,6/4/2024 2:03:20 AM,Oregon jury awards talc plaintiff $260M in verdict against Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/4112519-oregon-jury-awards-talc-plaintiff-260m-verdict-against-johnson-johnson?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4199.0,6/4/2024 10:00:00 AM,3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-scoop-up-during-market-pullbacks-in-june-1033448656
4200.0,6/4/2024 12:06:20 PM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033450356
4201.0,6/4/2024 2:00:00 PM,The 3 Most Undervalued Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-june-2024-1033450053
4202.0,6/4/2024 8:56:46 PM,J&J seeks to expand HIV med Prezcobix indication to children as young as six,Seeking Alpha,https://seekingalpha.com/news/4112875-johnson-johnson-seeks-expand-hiv-med-prezcobix-indication-children-young-six?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4203.0,6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4204.0,6/5/2024 9:31:08 PM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Vir Biotechnology (VIR) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-vir-biotechnology-vir-and-madrigal-pharmaceuticals-mdgl-1033455521
4205.0,6/6/2024 10:55:44 AM,Sleep Easy: 3 Safe Stocks That Won‚Äôt Have You Stressin‚Äô,InvestorPlace,/news/stocks/sleep-easy-3-safe-stocks-that-wont-have-you-stressin-1033458349
4206.0,6/6/2024 2:47:18 PM,"Goldman cuts 2seventy bio to neutral, cites competition concerns",Seeking Alpha,https://seekingalpha.com/news/4113699-goldman-cuts-2seventy-bio-to-neutral-cites-competition-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4207.0,6/6/2024 4:51:08 PM,Halozyme hits 52-week high as patent win prompts guidance raise,Seeking Alpha,https://seekingalpha.com/news/4113757-halozyme-stock-hits-52-week-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4208.0,6/6/2024 9:36:29 PM,Halozyme's ENHANZE Product Gets New Patent Grant in EU,Benzinga,/news/stocks/halozyme-s-enhanze-product-gets-new-patent-grant-in-eu-1033459113
4209.0,6/7/2024 5:44:02 AM,J&J-backed Rapport Therapeutics prices IPO at $17 per share,Seeking Alpha,https://seekingalpha.com/news/4113928-jj-backed-rapport-therapeutics-prices-ipo-at-17-per-share?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4210.0,6/7/2024 11:10:00 AM,The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash,InvestorPlace,/news/stocks/the-dividend-darlings-3-stocks-that-will-shower-your-portfolio-with-cash-1033460743
4211.0,6/7/2024 12:40:30 PM,J&J cleared to expand use of Velys robotic system in U.S.,Seeking Alpha,https://seekingalpha.com/news/4114053-jj-cleared-expand-use-velys-robotic-system?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4212.0,6/7/2024 1:16:13 PM,Halozyme downgraded at Piper Sandler despite guidance raise,Seeking Alpha,https://seekingalpha.com/news/4114090-halozyme-stock-slips-piper-sandler-downgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4213.0,6/7/2024 4:04:12 PM,Rapport Therapeutics starts trading above IPO price,Seeking Alpha,https://seekingalpha.com/news/4114176-rapport-therapeutics-starts-trading-above-ipo-price?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4214.0,6/7/2024 4:39:04 PM,The 3 Best Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-best-dow-stocks-to-buy-in-june-2024-1033462133
4215.0,6/10/2024 10:00:00 AM,The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns,InvestorPlace,/news/stocks/the-safety-net-seven-7-stocks-to-own-for-unshakeable-returns-1033464998
4216.0,6/10/2024 10:36:12 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1033465708
4217.0,6/11/2024 1:20:17 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Oculis Holding (OCS) and Moderna (MRNA)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-oculis-holding-ocs-and-moderna-mrna-1033467355
4218.0,6/11/2024 8:33:48 AM,Alvotech and Stada add to strategic alliance through denosumab partnership,Seeking Alpha,https://seekingalpha.com/news/4114679-alvotech-and-stada-add-to-strategic-alliance-through-denosumab-partnership?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4219.0,6/11/2024 5:00:00 PM,The 3 Most Undervalued Robinhood Stocks to Buy in June 2024,InvestorPlace,/news/stocks/undervalued-robinhood-stocks-3-names-skeptics-may-not-expect-1033470123
4220.0,6/11/2024 6:04:25 PM,J&J in $700M settlement with states over marketing of talc products,Seeking Alpha,https://seekingalpha.com/news/4114930-johnson-johnson-700m-settlement-states-marketing-talc-products?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4221.0,6/11/2024 6:49:39 PM,7 Recession-Proof Stocks to Buy Now for Peace of Mind,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-now-for-peace-of-mind-1033470311
4222.0,6/12/2024 6:41:22 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Insmed (INSM)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-insmed-insm-1033471867
4223.0,6/12/2024 3:15:53 PM,Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yields-1033472721
4224.0,6/12/2024 7:34:26 PM,Cancer victims seek court order to block J&J‚Äôs bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4115339-cancer-victims-seek-court-order-block-jjs-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4225.0,6/13/2024 11:10:00 AM,Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June,InvestorPlace,/news/stocks/dividend-heaven-7-standout-stocks-for-income-investors-to-buy-in-june-1033475672
4226.0,6/13/2024 6:23:10 PM,Payout Powerhouses: 7 Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/payout-powerhouses-7-dividend-stocks-to-buy-now-1033477569
4227.0,6/13/2024 7:02:59 PM,Xencor to regain rights from J&J for plamotamab,Seeking Alpha,https://seekingalpha.com/news/4115886-xencor-to-regain-rights-from-jj-for-plamotamab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4228.0,6/14/2024 2:25:58 PM,Johnson & Johnson Reports Long-term Data From Phase 1/2 Study With TALVEY ,RTTNews,/news/stocks/johnson-johnson-reports-long-term-data-from-phase-1-2-study-with-talvey-1033479488
4229.0,6/14/2024 3:23:25 PM,J&J's Talvey demonstrates robust long-term response in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4116283-johnson-johnson-talvey-demonstrates-robust-long-term-response-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4230.0,6/14/2024 7:55:36 PM,EU to require additional cancer risk labeling on CAR T therapies,Seeking Alpha,https://seekingalpha.com/news/4116402-eu-to-require-additional-cancer-risk-labeling-on-car-t-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4231.0,6/15/2024 10:00:00 AM,Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices,InvestorPlace,/news/stocks/blue-chip-jackpots-3-top-notch-stocks-at-bottom-barrel-prices-1033481228
4232.0,6/15/2024 10:42:00 AM,The 7 Best Under $20 Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-7-best-under-20-stocks-to-buy-in-june-2024-1033481242
4233.0,6/16/2024 12:05:29 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033481640
4234.0,6/17/2024 10:40:58 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033483787
4235.0,6/17/2024 3:25:08 PM,J&J Submits BLA For Subcutaneous Amivantamab Combination In EGFR-mutated NSCLC Patients ,RTTNews,/news/stocks/j-j-submits-bla-for-subcutaneous-amivantamab-combination-in-egfr-mutated-nsclc-patients-1033483713
4236.0,6/17/2024 4:01:29 PM,In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/in-depth-examination-of-11-analyst-recommendations-for-johnson-johnson-1033484211
4237.0,6/17/2024 6:15:06 PM,"Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst",Benzinga,/news/stocks/legend-biotech-s-cancer-drug-the-most-attractive-product-set-for-growth-analyst-1033484619
4238.0,6/20/2024 11:30:00 AM,7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027,InvestorPlace,/news/stocks/7-high-value-blue-chip-stocks-to-boost-your-wealth-by-2027-1033492560
4239.0,6/20/2024 12:39:51 PM,3 Healthcare Stocks to Buy Now: June 2024,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-now-june-2024-1033492821
4240.0,6/20/2024 2:29:07 PM,J&J Phase 3 study shows subcutaneous Tremfya effective in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4117538-jnj-phase-3-study-shows-subcutaneous-tremfya-effective-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4241.0,6/20/2024 2:32:08 PM,Johnson & Johnson: TREMFYA Phase 3 Study Meets Primary And Secondary Endpoints ,RTTNews,/news/stocks/johnson-johnson-tremfya-phase-3-study-meets-primary-and-secondary-endpoints-1033492766
4242.0,6/20/2024 9:11:21 PM,J&J applies for FDA approval of Tremfya for Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4117764-jj-applies-for-fda-approval-of-tremfya-for-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4243.0,6/21/2024 3:00:32 AM,Johnson & Johnson Seeks FDA Approval For Tremfya For Moderate To Severe Crohn's Disease ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-tremfya-for-moderate-to-severe-crohn-s-disease-1033494558
4244.0,6/21/2024 4:25:45 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033494966
4245.0,6/21/2024 11:47:27 AM,Johnson & Johnson closes acquisition of biotechnology company Proteologix,Seeking Alpha,https://seekingalpha.com/news/4117872-johnson-johnson-closes-acquisition-of-biotechnology-company-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4246.0,6/21/2024 9:31:14 PM,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly",Benzinga,/news/stocks/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly-1033497156
4247.0,6/25/2024 7:03:18 PM,J&J mid-stage trial for Tremfya against immune disorder fails,Seeking Alpha,https://seekingalpha.com/news/4119121-jj-stock-drops-as-tremfya-fails-clinical-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4248.0,6/26/2024 4:25:57 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033506194
4249.0,6/26/2024 4:53:40 PM,The 3 Smartest Dow Stocks to Buy With $1000 Right Now,InvestorPlace,/news/stocks/the-3-smartest-dow-stocks-to-buy-with-1000-right-now-1033508753
4250.0,6/27/2024 7:22:09 PM,"AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway",Benzinga,/news/stocks/abbvie-genmab-s-epkinly-fda-approval-is-a-positive-step-analyst-says-additional-expansion-opportunities-underway-1033512703
4251.0,6/28/2024 1:30:58 PM,Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields-1033514650
4252.0,6/28/2024 1:58:24 PM,Janssen-Cilag Says CHMP Recommended Balversa For Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-says-chmp-recommended-balversa-for-urothelial-carcinoma-1033514717
4253.0,6/28/2024 4:45:53 PM,J&J reports positive phase 3 data for nipocalimab for neuromuscular disease,Seeking Alpha,https://seekingalpha.com/news/4120678-johnson-johnson-reports-positive-phase-3-data-nipocalimab-neuromuscular-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4254.0,6/28/2024 5:13:58 PM,J&J: Rybrevant In Combination Gets Approval In Europe For First-Line Treatment Of NSCLC ,RTTNews,/news/stocks/j-j-rybrevant-in-combination-gets-approval-in-europe-for-first-line-treatment-of-nsclc-1033515841
4255.0,6/29/2024 1:11:15 PM,J&J talc claimants lose bid to block company's bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4120801-jj-talc-victims-lose-bid-block-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4256.0,6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4257.0,6/30/2024 2:13:35 PM,Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn‚Äôt Discovered Yet,InvestorPlace,/news/stocks/treasure-hunt-3-small-cap-stocks-wall-street-hasnt-discovered-yet-1033517243
4258.0,7/1/2024 12:30:56 AM,"Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2",Seeking Alpha,https://seekingalpha.com/news/4120874-alnylam-lilly-astrzeneca-best-performing-pharmas-biotechs-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4259.0,7/1/2024 7:31:13 AM,Sandoz To Commercialize Samsung Bioepis' FDA Approved Biosimilar Pyzchiva In US ,RTTNews,/news/stocks/sandoz-to-commercialize-samsung-bioepis-fda-approved-biosimilar-pyzchiva-in-us-1033518094
4260.0,7/1/2024 10:00:00 AM,Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.,InvestorPlace,/news/stocks/boing-7-undervalued-stocks-that-could-surprise-the-skeptics-1033518931
4261.0,7/1/2024 10:08:03 AM,Hold Rating on Johnson & Johnson‚Äôs Nipocalimab: Weighing Efficacy Against Uncertainties and Market Potential,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-s-nipocalimab-weighing-efficacy-against-uncertainties-and-market-potential-1033519619
4262.0,7/1/2024 4:19:57 PM,3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks,InvestorPlace,/news/stocks/3-dividend-stocks-yielding-over-3-with-multi-decade-payout-growth-streaks-1033520688
4263.0,7/1/2024 4:35:40 PM,"Piper downgrades Zimmer to neutral, cites lack of catalysts",Seeking Alpha,https://seekingalpha.com/news/4121268-piper-downgrades-zimmer-to-neutral-cites-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4264.0,7/1/2024 8:30:00 PM,3 Retirement All-Stars for Steady Growth and Income,InvestorPlace,/news/stocks/3-retirement-all-stars-for-steady-growth-and-income-1033521039
4265.0,7/2/2024 12:23:40 PM,J&J says Carvykti beat standard drugs in late-stage blood cancer trial,Seeking Alpha,https://seekingalpha.com/news/4121567-jj-carvykti-beat-standard-drugs-blood-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4266.0,7/2/2024 1:51:44 PM,J&J Reports Positive Data From Phase 3 CARTITUDE-4 Study Of Carvykti In Multiple Myeloma ,RTTNews,/news/stocks/j-j-reports-positive-data-from-phase-3-cartitude-4-study-of-carvykti-in-multiple-myeloma-1033522603
4267.0,7/2/2024 8:45:00 PM,7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-will-have-investors-in-high-yield-heaven-1033524556
4268.0,7/3/2024 2:00:00 PM,7 Safe Haven Stocks to Buy Before the Next Market Correction,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-before-the-next-market-correction-1033527117
4269.0,7/3/2024 2:10:23 PM,Johnson & Johnson Announces Health Canada NOC For RYBREVANT Combination - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-announces-health-canada-noc-for-rybrevant-combination-quick-facts-1033526326
4270.0,7/3/2024 3:06:31 PM,U.S. indicated dividend payments rose in Q2 led by Alphabet's initiation,Seeking Alpha,https://seekingalpha.com/news/4122113-common-indicated-dividend-payments-rise-in-q2-driven-by-alphabets-initiation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4271.0,7/3/2024 7:21:43 PM,Johnson & Johnson receives Canadian approval for Rybrevant in first-line NSCLC,Seeking Alpha,https://seekingalpha.com/news/4122211-johnson-johnson-receives-canadian-approval-for-rybrevant-in-first-line-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4272.0,7/3/2024 7:32:59 PM,7 Blue-Chip Cash Cows to Milk for Steady Income,InvestorPlace,/news/stocks/7-blue-chip-cash-cows-to-milk-for-steady-income-1033527829
4273.0,7/4/2024 4:00:00 PM,Upcoming Stock Spinoffs: Should You Pounce or Pass?¬†,InvestorPlace,/news/stocks/upcoming-stock-spinoffs-should-you-pounce-or-pass-1033530130
4274.0,7/4/2024 6:13:23 PM,FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals,InvestorPlace,/news/stocks/fda-favorites-3-biotech-stocks-on-the-verge-of-major-approvals-1033530265
4275.0,7/5/2024 3:32:01 PM,3 Dividend Aristocrats Now Cheaper Than During the 2008 Financial Crisis,InvestorPlace,/news/stocks/3-dividend-aristocrats-now-cheaper-than-during-the-2008-financial-crisis-1033532641
4276.0,7/5/2024 5:43:24 PM,3 Rock-Solid Income Machines to Hold for Decades,InvestorPlace,/news/stocks/3-rock-solid-income-machines-to-hold-for-decades-1033532857
4277.0,7/8/2024 9:26:24 AM,Maintaining Hold on JNJ: Anticipated EPS Beat Offset by Medtech and Currency Challenges,TipRanks,/news/stocks/maintaining-hold-on-jnj-anticipated-eps-beat-offset-by-medtech-and-currency-challenges-1033535629
4278.0,7/8/2024 10:45:00 AM,7 Diversified Income Powerhouses for Lifelong Cash Flow,InvestorPlace,/news/stocks/7-diversified-income-powerhouses-for-lifelong-cash-flow-1033535386
4279.0,7/8/2024 11:45:19 AM,Johnson & Johnson Q2 Outlook: Steady Growth Amid Challenges with a Hold Rating,TipRanks,/news/stocks/johnson-johnson-q2-outlook-steady-growth-amid-challenges-with-a-hold-rating-1033536453
4280.0,7/8/2024 2:41:56 PM,Pulse stock rallies 22% on FDA breakthrough designation,Seeking Alpha,https://seekingalpha.com/news/4122631-pulse-stock-rallies-on-fda-breakthrough-designation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4281.0,7/9/2024 10:00:29 AM,"Emergent, J&J resolve dispute over COVID vaccine manufacturing deal",Seeking Alpha,https://seekingalpha.com/news/4122799-emergent-jj-resolve-dispute-over-covid-vaccine-manufacturing-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4282.0,7/9/2024 8:53:43 PM,Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs,Benzinga,/news/stocks/johnson-johnson-faces-medtech-challenges-but-is-on-track-to-meet-2024-guidance-goldman-sachs-1033540847
4283.0,7/10/2024 10:37:55 AM,Wells Fargo Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033543393
4284.0,7/10/2024 11:00:00 AM,3 Undervalued Stocks Set to Outperform the Market in 2024,InvestorPlace,/news/stocks/3-undervalued-stocks-set-to-outperform-the-market-in-2024-1033542723
4285.0,7/11/2024 12:45:34 PM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033548030
4286.0,7/11/2024 1:17:59 PM,J&J to recognize $1.25B impact from Yellow Jersey acquisition,Seeking Alpha,https://seekingalpha.com/news/4123663-jj-to-recognize-125b-impact-yellow-jersey-acquisition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4287.0,7/12/2024 10:23:00 AM,3 Essential Stocks for Building a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-essential-stocks-for-building-a-recession-proof-portfolio-1033549924
4288.0,7/12/2024 11:05:58 AM,Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-remains-a-hold-on-johnson-johnson-jnj-1033550894
4289.0,7/12/2024 6:50:39 PM,Legend Biotech surges amid takeover speculation (update),Seeking Alpha,https://seekingalpha.com/news/4124018-legend-biotech-surges-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4290.0,7/12/2024 7:00:29 PM,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",Seeking Alpha,https://seekingalpha.com/news/4123992-catalyst-watch-netflix-taiwan-semi-amazon-and-hashicorp-are-in-the-spotlight?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4291.0,7/13/2024 2:47:00 PM,Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4124042-wall-street-closes-higher-as-financials-stocks-deliver-profits-with-a-rebound-in-investments-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4292.0,7/13/2024 6:03:47 PM,"Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A",Seeking Alpha,https://seekingalpha.com/news/4124109-morgan-stanley-sees-180b-patent-cliff-380b-deal-capacity-fueling-biopharma-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4293.0,7/14/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4124006-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4294.0,7/15/2024 9:45:47 AM,Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns,TipRanks,/news/stocks/hold-rating-maintained-amid-johnson-johnson-acquisition-and-foreign-exchange-concerns-1033555232
4295.0,7/15/2024 9:08:59 PM,Genmab upgraded at RBC on valuation,Seeking Alpha,https://seekingalpha.com/news/4124419-genmab-upgraded-rbc-valuation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4296.0,7/16/2024 10:13:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-envista-holdings-nvst-johnson-johnson-jnj-and-cvs-health-cvs-1033559368
4297.0,7/16/2024 10:15:00 AM,"If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dow-stock-in-july-it-better-be-one-of-these-3-names-1033558594
4298.0,7/16/2024 2:35:17 PM,Johnson & Johnson Q2 Preview: Focus on SWAV deal implications and guidance,Seeking Alpha,https://seekingalpha.com/news/4124636-johnson-johnson-q2-preview-focus-on-swav-deal-implications-and-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4299.0,7/16/2024 3:01:13 PM,Johnson Johnson earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-quarter-earnings-preview-q2-1033559159
4300.0,7/16/2024 3:29:28 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4124676-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4301.0,7/16/2024 6:46:17 PM,Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings,Benzinga,/news/stocks/johnson-johnson-bullish-charts-signal-strong-setup-before-q2-earnings-1033560469
4302.0,7/16/2024 7:04:01 PM,3 Safe Dividend Kings to Recession-Proof Your Portfolio,InvestorPlace,/news/stocks/3-safe-dividend-kings-to-recession-proof-your-portfolio-1033560680
4303.0,7/16/2024 9:07:10 PM,Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?,Benzinga,/news/stocks/johnson-johnson-q2-earnings-preview-can-new-drugs-lift-sagging-stock-1033560686
4304.0,7/16/2024 9:59:38 PM,"ORIC collaborates with Bayer, J&J on prostate cancer study",Seeking Alpha,https://seekingalpha.com/news/4124823-oric-collaborates-with-bayer-jj-on-prostate-cancer-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4305.0,7/17/2024 5:26:18 AM,"ORIC Enters Into Clinical Trial Collaboration And Supply Agreements With Bayer
and J&J; Stock Up ",RTTNews,/news/stocks/oric-enters-into-clinical-trial-collaboration-and-supply-agreements-with-bayer-and-j-j-stock-up-1033561062
4306.0,7/17/2024 10:22:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.82 beats by $0.12, revenue of $22.4B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/4124888-johnson-and-johnson-non-gaap-eps-of-2_82-beats-0_12-revenue-of-22_4b-beats-60m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4307.0,7/17/2024 10:29:46 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4124891-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4308.0,7/17/2024 10:40:16 AM,"Earnings Summary: Johnson & Johnson tops consensus in Q2, updates FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4124896-earnings-summary-johnson-johnson-tops-consensus-in-q2-updates-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4309.0,7/17/2024 10:51:43 AM,"Johnson & Johnson in charts: Innovative Medicine, MedTech and total U.S. sales highest in Q2",Seeking Alpha,https://seekingalpha.com/news/4124903-johnson-johnson-in-charts-innovative-medicine-medtech-and-total-us-sales-highest-in-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4310.0,7/17/2024 11:05:00 AM,3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income,InvestorPlace,/news/stocks/3-dividend-stocks-with-3-yields-to-upgrade-your-annual-income-1033563483
4311.0,7/17/2024 12:27:48 PM,"Johnson & Johnson Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1033563319
4312.0,7/17/2024 1:17:00 PM,"4 stocks to watch on Wednesday: JNJ, UAL and more",Seeking Alpha,https://seekingalpha.com/news/4125011-4-stocks-to-watch-on-wednesday-jnj-ual-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4313.0,7/17/2024 1:47:03 PM,"Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast ",RTTNews,/news/stocks/johnson-johnson-q2-adj-eps-beats-view-cuts-fy24-earnings-forecast-1033563555
4314.0,7/17/2024 1:52:11 PM,J&J beats in Q2 as pharma segment outperforms,Seeking Alpha,https://seekingalpha.com/news/4124925-jj-stock-focus-after-q2-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4315.0,7/17/2024 3:51:26 PM,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-crinetics-pharmaceuticals-crnx-elevance-health-elv-and-johnson-johnson-jnj-1033565293
4316.0,7/17/2024 6:09:20 PM,Big pharma rally after J&J earnings,Seeking Alpha,https://seekingalpha.com/news/4125149-big-pharma-rally-after-jj-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4317.0,7/17/2024 6:15:30 PM,Watchful Optimism: Balancing Johnson & Johnson‚Äôs Innovative Success and MedTech Challenges,TipRanks,/news/stocks/watchful-optimism-balancing-johnson-johnson-s-innovative-success-and-medtech-challenges-1033565874
4318.0,7/17/2024 8:27:47 PM,Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?,Benzinga,/news/etf/nasdaq-100-suffers-worst-day-in-11-months-as-chipmakers-tumble-on-china-curbs-magnificent-7-wipe-out-500b-what-s-driving-markets-wednesday-1033565208
4319.0,7/17/2024 9:05:24 PM,Buy Rating Affirmed for Johnson & Johnson on Robust Q2 Performance and Strategic Growth Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-robust-q2-performance-and-strategic-growth-outlook-1033565943
4320.0,7/18/2024 12:37:17 AM,Positive Outlook: Joanne Wuensch Recommends ‚ÄòBuy‚Äô on Johnson & Johnson Amid Strong Q2 Performance and Promising Growth Prospects,TipRanks,/news/stocks/positive-outlook-joanne-wuensch-recommends-buy-on-johnson-johnson-amid-strong-q2-performance-and-promising-growth-prospects-1033566071
4321.0,7/18/2024 12:38:52 AM,Maintaining Hold on Johnson & Johnson: Balancing MedTech Challenges with Pharmaceutical Strengths and Steady Long-Term Growth,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-balancing-medtech-challenges-with-pharmaceutical-strengths-and-steady-long-term-growth-1033566064
4322.0,7/18/2024 10:39:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033568691
4323.0,7/18/2024 1:08:04 PM,Balanced Outlook for Johnson & Johnson: Hold Rating Amidst Growth and Challenges,TipRanks,/news/stocks/balanced-outlook-for-johnson-johnson-hold-rating-amidst-growth-and-challenges-1033569703
4324.0,7/18/2024 1:08:41 PM,Johnson & Johnson (JNJ) Receives a Buy from Argus Research,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-argus-research-1033569698
4325.0,7/18/2024 1:45:20 PM,Maintaining Hold on Johnson & Johnson: A Balanced View Amidst Q2 Results and Future Challenges,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-a-balanced-view-amidst-q2-results-and-future-challenges-1033569806
4326.0,7/18/2024 2:36:47 PM,Microsoft To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/microsoft-to-rally-around-12-here-are-10-top-analyst-forecasts-for-thursday-1033568315
4327.0,7/18/2024 3:00:00 PM,3 Blue-Chip Stocks to Buy If the Dow Crashes,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-if-the-dow-crashes-1033569354
4328.0,7/18/2024 3:34:12 PM,Med-tech and healthcare stocks with upside during 2Q earnings - Baird,Seeking Alpha,https://seekingalpha.com/news/4125556-med-tech-and-healthcare-stocks-with-upside-during-2q-earnings-baird?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4329.0,7/18/2024 6:09:15 PM,3 Dividend Stocks That Demand Investor Attention,InvestorPlace,/news/stocks/3-dividend-stocks-that-demand-investor-attention-1033569948
4330.0,7/18/2024 6:12:41 PM,These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results,Benzinga,/news/stocks/these-analysts-revise-their-forecasts-on-johnson-johnson-after-q2-results-1033569714
4331.0,7/18/2024 8:51:35 PM,"Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst",Benzinga,/news/stocks/johnson-johnson-prioritizes-sustainable-growth-in-m-a-amid-sector-diversification-says-analyst-1033569993
4332.0,7/18/2024 9:52:22 PM,J&J ends work on Addex epilepsy drug candidate ADX71149: report,Seeking Alpha,https://seekingalpha.com/news/4125712-jj-ends-work-on-addex-epilepsy-drug-candidate-adx71149-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4333.0,7/19/2024 12:05:17 PM,"Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more",Seeking Alpha,https://seekingalpha.com/news/4125792-dividend-roundup-goldman-sachs-johnson-johnson-qualcomm-caterpillar-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4334.0,7/19/2024 8:45:00 PM,7 Consumer Staples Stocks to Buy at a 52-Week Low in July,InvestorPlace,/news/stocks/7-consumer-staples-stocks-ready-for-sector-rotation-1033573603
4335.0,7/19/2024 8:45:00 PM,3 Blue-Chip Stocks to Buy for Christmas in July,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-3-names-offering-a-gift-to-investors-1033573606
4336.0,7/21/2024 11:00:00 AM,Here are Big Pharma‚Äôs leading blockbuster makers,Seeking Alpha,https://seekingalpha.com/news/4126044-eli-lilly-astrazeneca-top-blockbuster-makers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4337.0,7/22/2024 1:02:13 AM,Kamala Harris' potential impact on health care stocks,Seeking Alpha,https://seekingalpha.com/news/4126065-kamala-harris-potential-impact-health-care-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4338.0,7/22/2024 5:45:56 AM,Buy Rating Affirmed for Johnson & Johnson on Strong Growth and Strategic Acquisitions,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-strong-growth-and-strategic-acquisitions-1033576818
4339.0,7/22/2024 12:33:47 PM,Johnson & Johnson seeks FDA approval of Spravato as depression monotherapy,Seeking Alpha,https://seekingalpha.com/news/4126173-johnson-johnson-seeks-fda-approval-of-its-monotherapy-for-treatment-resistant-depression?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4340.0,7/22/2024 2:18:44 PM,Johnson & Johnson Seeks FDA Approval For SPRAVATO Nasal Spray For Treatment-Resistant Depression ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-spravato-nasal-spray-for-treatment-resistant-depression-1033577430
4341.0,7/22/2024 3:34:24 PM,Alvotech launches first biosimilar of J&J's Stelara in Europe,Seeking Alpha,https://seekingalpha.com/news/4126333-alvotech-launches-first-biosimilar-of-johnson-johnson-stelara-europe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4342.0,7/22/2024 7:11:56 PM,Oppenheimer starts ArriVent BioPharma at outperform,Seeking Alpha,https://seekingalpha.com/news/4126431-oppenheimer-starts-arrivent-biopharma-at-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4343.0,7/24/2024 5:06:57 PM,Bio-Thera biosimilar to J&J‚Äôs Stelara under FDA review,Seeking Alpha,https://seekingalpha.com/news/4127721-new-biosimilar-jjs-stelara-under-fda-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4344.0,7/24/2024 9:25:04 PM,Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation,Benzinga,/news/stocks/newly-listed-psoriasis-focused-alumis-attracts-analysts-attention-with-promising-lead-program-and-modest-valuation-1033590627
4345.0,7/25/2024 11:45:00 AM,3 Beaten-Down Value Stocks Poised for a Massive Comeback: July 2024,InvestorPlace,/news/stocks/3-beaten-down-value-stocks-poised-for-a-massive-comeback-july-2024-1033594252
4346.0,7/25/2024 12:19:08 PM,AbbVie raises outlook as new immunology drugs offset Humira impact,Seeking Alpha,https://seekingalpha.com/news/4128262-abbvie-stock-in-focus-improved-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4347.0,7/25/2024 4:51:47 PM,AC Immune stock climbs 7% on FDA fast track status for Alzheimer's drug,Seeking Alpha,https://seekingalpha.com/news/4128487-ac-immune-stock-climbs-on-fda-fast-track-status-for-alzheimers-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4348.0,7/25/2024 7:19:00 PM,3 Stocks Reeling From Ruined Reputations: Can They Recover?,InvestorPlace,/news/stocks/3-stocks-reeling-from-ruined-reputations-can-they-recover-1033596326
4349.0,7/26/2024 2:31:45 AM,J&J talc bankruptcy plan appeal denied,Seeking Alpha,https://seekingalpha.com/news/4128759-johnson-johnson-talc-bankruptcy-plan-appeal-denied?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4350.0,7/26/2024 2:18:51 PM,Johnson & Johnson's Yuvanci Gets Positive CHMP Opinion In Europe For Pulmonary Arterial Hypertension ,RTTNews,/news/stocks/johnson-johnson-s-yuvanci-gets-positive-chmp-opinion-in-europe-for-pulmonary-arterial-hypertension-1033599993
4351.0,7/26/2024 3:55:32 PM,J&J: CHMP Recommends RYBREVANT With Chemo To Treat Advanced EGFR-mutated NSCLC ,RTTNews,/news/stocks/j-j-chmp-recommends-rybrevant-with-chemo-to-treat-advanced-egfr-mutated-nsclc-1033600327
4352.0,7/27/2024 4:00:00 PM,7 Long-Term Stocks to Buy on the Dip: July 2024,InvestorPlace,/news/stocks/7-long-term-stocks-that-may-lead-the-markets-next-move-higher-1033602115
4353.0,7/28/2024 2:00:00 PM,Most U.S. pharmas don't pay any U.S. income tax,Seeking Alpha,https://seekingalpha.com/news/4129257-most-us-pharmas-dont-pay-any-us-income-tax?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4354.0,7/30/2024 10:31:38 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033612324
4355.0,7/30/2024 10:34:26 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Sotera Health (SHC) and Hologic (HOLX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-sotera-health-shc-and-hologic-holx-1033612314
4356.0,7/30/2024 4:35:39 PM,Q3‚Äôs Rising Stars: 3 Dow Stocks for Your Must-Watch List,InvestorPlace,/news/stocks/q3s-rising-stars-3-dow-stocks-for-your-must-watch-list-1033613434
4357.0,7/30/2024 8:25:28 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033614322
4358.0,7/31/2024 5:34:24 AM,Johnson & Johnson : FDA Approves Darzalex Faspro Combination For Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-fda-approves-darzalex-faspro-combination-for-multiple-myeloma-1033614529
4359.0,7/31/2024 11:00:00 AM,Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?,InvestorPlace,/news/stocks/kazia-therapeutics-stock-is-kzia-a-buyout-candidate-in-the-making-1033617326
4360.0,7/31/2024 12:51:19 PM,J&J wins another FDA label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4131026-jj-wins-label-expansion-for-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4361.0,7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457
4362.0,8/1/2024 2:00:00 PM,Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/bargain-hunters-paradise-7-value-stocks-that-are-too-cheap-to-ignore-1033627397
4363.0,8/6/2024 10:17:00 AM,3 Dividend Growth Stocks to Accumulate on Dips: August Edition,InvestorPlace,/news/stocks/3-dividend-growth-stocks-to-accumulate-on-dips-august-edition-1033644207
4364.0,8/8/2024 11:00:00 AM,The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024,InvestorPlace,/news/stocks/the-3-best-dividend-aristocrats-to-buy-for-sustainable-income-august-2024-1033660107
4365.0,8/8/2024 11:35:39 AM,Maintaining Hold on J&J Amid Talc Litigation Developments and Settlement Prospects,TipRanks,/news/stocks/maintaining-hold-on-j-j-amid-talc-litigation-developments-and-settlement-prospects-1033661465
4366.0,8/8/2024 6:46:23 PM,"J&J, Stryker among potential suitors for Nevro: Wolfe",Seeking Alpha,https://seekingalpha.com/news/4137462-nevro-stock-gains-wolfe-cites-buyout-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4367.0,8/10/2024 12:13:27 PM,Gilead exits J&J royalty deal for liver drug ahead of potential FDA nod,Seeking Alpha,https://seekingalpha.com/news/4138389-gilead-exits-jj-royalty-deal-for-liver-drug-ahead-of-potential-fda-nod?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4368.0,8/11/2024 2:27:02 PM,Johnson & Johnson (JNJ): An Undervalued Dividend King With Strong Financials,TipRanks,/news/stocks/johnson-johnson-jnj-an-undervalued-dividend-king-with-strong-financials-1033672043
4369.0,8/12/2024 9:01:06 PM,J&J makes headway in settling talc baby powder litigation: reports,Seeking Alpha,https://seekingalpha.com/news/4138841-jnj-makes-headway-in-settling-talc-baby-powder-litigation-reports?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4370.0,8/13/2024 11:30:00 AM,3 Blue-Chip Stocks to Buy on the Dip: August 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-on-the-dip-august-2024-1033681382
4371.0,8/13/2024 11:55:50 AM,Maintaining Hold on JNJ Amid Progress and Uncertainty in Talc Litigation,TipRanks,/news/stocks/maintaining-hold-on-jnj-amid-progress-and-uncertainty-in-talc-litigation-1033682808
4372.0,8/13/2024 2:13:11 PM,Buy Rating Affirmed: Johnson & Johnson Nears Resolution of Talc Litigations,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-nears-resolution-of-talc-litigations-1033683489
4373.0,8/14/2024 10:44:00 AM,7 Dependable Dividend Stocks for Long-Term Income,InvestorPlace,/news/stocks/7-dependable-dividend-stocks-for-long-term-income-1033687408
4374.0,8/14/2024 5:12:03 PM,J&J expected to declare voting support for talc bankruptcy plan as early as Friday,Seeking Alpha,https://seekingalpha.com/news/4139924-jnj-to-declare-win-talc-bankruptcy-plan-friday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4375.0,8/15/2024 11:00:00 AM,7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024,InvestorPlace,/news/stocks/7-recession-resistant-stocks-to-hold-onto-for-dear-life-in-2024-1033694445
4376.0,8/15/2024 11:27:19 AM,U.S. government targets $6B in savings from first Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4140341-us-government-targets-6b-in-saving-from-first-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4377.0,8/15/2024 11:44:07 AM,U.S. announces final drug prices after Medicare negotiations,Seeking Alpha,https://seekingalpha.com/news/4140356-us-posts-final-drug-prices-medicare-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4378.0,8/17/2024 2:09:07 PM,Trending stocks this week as U.S. equities notch their best week of 2024,Seeking Alpha,https://seekingalpha.com/news/4141247-trending-stocks-this-week-as-us-equities-notch-their-best-week-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4379.0,8/17/2024 6:00:44 PM,"J&J, Roche come out on top in S&P ratings of strongest pharma companies",Seeking Alpha,https://seekingalpha.com/news/4141255-johnson-johnson-roche-come-out-top-in-ratings-strongest-pharma-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4380.0,8/20/2024 11:30:03 AM,J&J‚Äôs chemotherapy-free drug combo wins FDA nod for advanced lung cancer,Seeking Alpha,https://seekingalpha.com/news/4141786-jjs-chemotherapy-free-drug-combo-wins-fda-nod-for-advanced-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4381.0,8/20/2024 11:49:22 AM,J&J to acquire V-Wave for $600M upfront,Seeking Alpha,https://seekingalpha.com/news/4141793-jj-to-acquire-v-wave-for-600m-upfront?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4382.0,8/20/2024 1:51:45 PM,Johnson & Johnson's Chemotherapy-free Lung Cancer Treatment Rybrevant Plus Lazcluze Gets FDA Nod ,RTTNews,/news/stocks/johnson-johnson-s-chemotherapy-free-lung-cancer-treatment-rybrevant-plus-lazcluze-gets-fda-nod-1033706946
4383.0,8/20/2024 2:09:23 PM,Johnson & Johnson To Acquire V-Wave For Initial Payment Of $600 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-v-wave-for-initial-payment-of-600-mln-1033707027
4384.0,8/20/2024 6:07:51 PM,"FTC says FDA biosimilar guidance would increase competition, lead to lower prices",Seeking Alpha,https://seekingalpha.com/news/4142026-ftc-says-fda-biosimilar-guidance-would-increase-competition-lead-lower-prices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4385.0,8/23/2024 12:27:22 PM,"Dividend Roundup: Johnson & Johnson, Hyatt, Northrop Grumman, Altria Group, and more",Seeking Alpha,https://seekingalpha.com/news/4143257-dividend-roundup-johnson-johnson-hyatt-northrop-grumman-altria-group-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4386.0,8/23/2024 2:51:56 PM,Janssen-Cilag's Balversa Gets EC Approval For Metastatic Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-s-balversa-gets-ec-approval-for-metastatic-urothelial-carcinoma-1033718013
4387.0,8/23/2024 7:00:25 PM,J&J faces backlash from hospitals after revised drug-discount program: WSJ,Seeking Alpha,https://seekingalpha.com/news/4143479-jjs-drug-discount-program-criticized-hospitals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4388.0,8/23/2024 7:43:10 PM,J&J reportedly seeking additional support for talc bankruptcy plan,Seeking Alpha,https://seekingalpha.com/news/4143484-jj-additional-support-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4389.0,8/23/2024 8:12:11 PM,Johnson & Johnson continues gains for eight straight sessions,Seeking Alpha,https://seekingalpha.com/news/4143475-johnson-johnson-continues-gains-for-eight-straight-sessions?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4390.0,8/25/2024 5:57:37 AM,"Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug ",RTTNews,/news/stocks/weekly-biotech-buzz-aadi-trims-r-d-jobs-jnj-loosens-purse-strings-fda-snubs-regn-s-myeloma-drug-1033719571
4391.0,8/27/2024 3:28:46 PM,Addex stock rallies 45% on Indivior collaboration update,Seeking Alpha,https://seekingalpha.com/news/4144187-addex-stock-rallies-on-indivior-collaboration-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4392.0,8/29/2024 10:26:46 AM,"New Medicare drug price caps could help seniors save over $1,000 a year - AARP",Seeking Alpha,https://seekingalpha.com/news/4144962-new-medicare-drug-price-caps-could-help-seniors-save-over-1000-a-year-aarp?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4393.0,8/29/2024 2:43:09 PM,J&J Files For FDA Approval Of Nipocalimab To Treat Generalized Myasthenia Gravis ,RTTNews,/news/stocks/j-j-files-for-fda-approval-of-nipocalimab-to-treat-generalized-myasthenia-gravis-1033732590
4394.0,8/29/2024 3:49:40 PM,J&J submits FDA application for myasthenia gravis drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/4145151-jj-submits-fda-application-for-myasthenia-gravis-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4395.0,9/1/2024 7:26:06 PM,"Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies ",RTTNews,/news/stocks/weekly-biotech-buzz-bmrn-cuts-jobs-fda-approves-new-mpox-vaccine-mrk-halts-2-keytruda-studies-1033738673
4396.0,9/3/2024 11:48:43 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033744314
4397.0,9/3/2024 7:29:35 PM,Keros gains after trial update on lung disorder therapy,Seeking Alpha,https://seekingalpha.com/news/4146385-keros-stock-gains-trial-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4398.0,9/4/2024 3:30:13 PM,"J&J owes over $1B in damages related to 2019 Auris deal, judge rules",Seeking Alpha,https://seekingalpha.com/news/4146914-jj-owes-over-1b-linked-auris-deal-judge-rules?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4399.0,9/4/2024 8:47:30 PM,J&J talc powder settlement backed by key attorney: report,Seeking Alpha,https://seekingalpha.com/news/4147074-jj-talc-powder-settlement-backed-by-key-attorney-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4400.0,9/5/2024 6:07:36 PM,Cigna to offer biosimilar to J&J‚Äôs arthritis drug Stelara at $0 out-of-pocket,Seeking Alpha,https://seekingalpha.com/news/4147414-cigna-touts-biosimilar-jj-arthritis-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4401.0,9/6/2024 10:37:24 AM,Balancing Growth and Challenges: A Hold Rating for Johnson & Johnson‚Äôs Medtech Division Amidst China Headwinds,TipRanks,/news/stocks/balancing-growth-and-challenges-a-hold-rating-for-johnson-johnson-s-medtech-division-amidst-china-headwinds-1033753866
4402.0,9/6/2024 7:00:22 PM,"Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print",Seeking Alpha,https://seekingalpha.com/news/4147709-catalyst-watch-apples-iphone-event-oracle-earnings-google-antitrust-trial-and-the-august-cpi-print?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4403.0,9/9/2024 3:06:44 AM,J&J : Phase 3 Data Show RYBREVANT + LAZCLUZE Outperforms Osimertinib In Non-small Cell Lung Cancer ,RTTNews,/news/stocks/j-j-phase-3-data-show-rybrevant-lazcluze-outperforms-osimertinib-in-non-small-cell-lung-cancer-1033755629
4404.0,9/9/2024 12:25:43 PM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033758084
4405.0,9/9/2024 5:25:27 PM,J&J Rybrevant/Lazcluze study shows superiority over Tagrisso,Seeking Alpha,https://seekingalpha.com/news/4148096-jj-rybrevant-lazcluze-study-shows-superiority-over-tagrisso?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4406.0,9/10/2024 10:56:30 PM,16 new GLP-1 weight-loss drugs could be launched by 2029: report,Seeking Alpha,https://seekingalpha.com/news/4148522-16-new-glp-1-weight-loss-drugs-could-be-launched-by-2029-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4407.0,9/11/2024 5:39:36 AM,J&J's Dexamethasone Regimen Reduces Infusion Reactions In EGFR-Mutated NSCLC Patients On RYBREVANT ,RTTNews,/news/stocks/j-j-s-dexamethasone-regimen-reduces-infusion-reactions-in-egfr-mutated-nsclc-patients-on-rybrevant-1033762197
4408.0,9/11/2024 1:56:19 PM,J&J mid-stage trial for lung cancer drug Rybrevant hits main goal,Seeking Alpha,https://seekingalpha.com/news/4148686-jj-trial-lung-cancer-drug-rybrevant-succeeds?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4409.0,9/11/2024 8:55:28 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033765212
4410.0,9/12/2024 3:01:10 AM,J&J's TREMFYA Receives FDA Approval For Moderately To Severely Active Ulcerative Colitis In Adults ,RTTNews,/news/stocks/j-j-s-tremfya-receives-fda-approval-for-moderately-to-severely-active-ulcerative-colitis-in-adults-1033765228
4411.0,9/12/2024 10:52:10 AM,J&J Tremfya label expanded in the U.S. for inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/4148926-jj-tremfya-us-label-expanded-bowel-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4412.0,9/12/2024 3:48:46 PM,Janssen-Cilag Announces First EMA Submission For Nipocalimab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-announces-first-ema-submission-for-nipocalimab-quick-facts-1033767160
4413.0,9/12/2024 4:28:27 PM,JNJ submits application to EMA for nipocalimab for generalized myasthenia gravis,Seeking Alpha,https://seekingalpha.com/news/4149162-johnson-johnson-submits-application-ema-nipocalimab-generalized-myasthenia-gravis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4414.0,9/14/2024 9:54:37 AM,J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial ,RTTNews,/news/stocks/j-j-rybrevant-chemotherapy-shows-strong-benefits-and-improved-survival-in-phase-3-nsclc-trial-1033771563
4415.0,9/14/2024 4:39:16 PM,J&J Announces Promising Phase 1b/2 Data For Amivantamab Combination In Metastatic Colorectal Cancer ,RTTNews,/news/stocks/j-j-announces-promising-phase-1b-2-data-for-amivantamab-combination-in-metastatic-colorectal-cancer-1033771648
4416.0,9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4417.0,9/15/2024 10:15:01 AM,J&J's TAR-200 Phase 2b SunRISe-1 Study Shows 84% Complete Response In High-Risk Bladder Cancer ,RTTNews,/news/stocks/j-j-s-tar-200-phase-2b-sunrise-1-study-shows-84-complete-response-in-high-risk-bladder-cancer-1033771793
4418.0,9/15/2024 2:07:52 PM,Do queasy side effects mean the end of weight-loss drug stock hype?,Seeking Alpha,https://seekingalpha.com/news/4149819-do-nauseating-side-effects-mean-the-end-of-weight-loss-drug-stock-hype?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4419.0,9/16/2024 9:33:31 AM,Johnson & Johnson Reports Promising Interim Data From Phase 2 SunRISe-4 Study ,RTTNews,/news/stocks/johnson-johnson-reports-promising-interim-data-from-phase-2-sunrise-4-study-1033772973
4420.0,9/16/2024 4:46:07 PM,CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data,Seeking Alpha,https://seekingalpha.com/news/4150038-cg-oncology-surges-7-seen-benefitting-from-johnson-johnson-bladder-cancer-asset-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4421.0,9/16/2024 4:54:08 PM,Edwards Lifesciences gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4150042-edwards-lifesciences-gains-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4422.0,9/18/2024 10:36:38 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033780374
4423.0,9/18/2024 8:18:20 PM,BeiGene initiated at outperform at JMP Securities on strength of Brukinsa,Seeking Alpha,https://seekingalpha.com/news/4150909-beigene-initiated-outperform-jmp-securities-strength-brukinsa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4424.0,9/19/2024 11:50:20 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Progyny (PGNY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-progyny-pgny-1033784078
4425.0,9/20/2024 2:47:43 AM,FDA Okays J&J's RYBREVANT For Advanced Non-Small Cell Lung Cancer In Combination With Chemotherapy ,RTTNews,/news/stocks/fda-okays-j-j-s-rybrevant-for-advanced-non-small-cell-lung-cancer-in-combination-with-chemotherapy-1033784908
4426.0,9/20/2024 7:10:29 AM,J&J said to boost offer to settle baby powder lawsuits to over $8.2B,Seeking Alpha,https://seekingalpha.com/news/4151443-johnson-johnson-settlement-offer-baby-powder-lawsuits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4427.0,9/20/2024 10:47:13 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033786632
4428.0,9/20/2024 2:04:14 PM,Janssen-Cilag Reports CHMP Recommendation For Daratumumab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-reports-chmp-recommendation-for-daratumumab-quick-facts-1033786211
4429.0,9/20/2024 8:07:36 PM,Johnson & Johnson unit seeks third Chapter 11 bankruptcy filing to settle talc claims,Seeking Alpha,https://seekingalpha.com/news/4151707-johnson-johnson-unit-seeks-third-chapter-11-bankruptcy-filing-settle-talc-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4430.0,9/20/2024 8:43:49 PM,Sanofi Sarclisa combo gains approval as first-line multiple myeloma treatment,Seeking Alpha,https://seekingalpha.com/news/4151719-sanofi-sarclisa-combo-gains-approval-first-line-multiple-myeloma-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4431.0,9/21/2024 7:21:32 AM,J&J's Subsidiary Red River Talc Files For Chapter 11 Bankruptcy To Resolve Ovarian Cancer Claims ,RTTNews,/news/stocks/j-j-s-subsidiary-red-river-talc-files-for-chapter-11-bankruptcy-to-resolve-ovarian-cancer-claims-1033787796
4432.0,9/21/2024 8:00:07 PM,Novartis' Pluvicto expected to dominate prostate cancer radiopharmaceutical market,Seeking Alpha,https://seekingalpha.com/news/4151752-novartis-pluvicto-expected-dominate-prostate-cancer-radiopharmaceutical-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4433.0,9/23/2024 7:17:40 PM,UCB gets expanded FDA approval for psoriasis drug Bimzelx,Seeking Alpha,https://seekingalpha.com/news/4152277-ucb-gets-expanded-fda-approval-for-psoriasis-drug-bimzelx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4434.0,9/24/2024 9:10:15 AM,Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-and-johnson-johnson-jnj-1033793366
4435.0,9/24/2024 4:49:21 PM,J&J unit third bankruptcy attempt location to be determined by Texas judge,Seeking Alpha,https://seekingalpha.com/news/4152793-johnson-johnson-unit-third-bankruptcy-attempt-location-determined-texas-judge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4436.0,9/25/2024 8:45:35 AM,Strategic Legal Maneuvers Brighten Johnson & Johnson‚Äôs Financial Outlook Amid Talc Litigation,TipRanks,/news/stocks/strategic-legal-maneuvers-brighten-johnson-johnson-s-financial-outlook-amid-talc-litigation-1033796491
4437.0,9/25/2024 10:49:50 AM,"Bristol Myers, 2seventy bio halt enrollment in Abecma late-stage trial",Seeking Alpha,https://seekingalpha.com/news/4153004-bristol-myers-2seventy-bio-halt-abecma-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4438.0,9/26/2024 2:27:34 PM,"J&J to shutter cardiovascular, metabolic drug unit: report",Seeking Alpha,https://seekingalpha.com/news/4153734-jj-to-shutter-cardiovascular-metabolic-drug-unit-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4439.0,9/26/2024 8:01:55 PM,J&J snaps six straight sessions of losses,Seeking Alpha,https://seekingalpha.com/news/4153849-jj-snaps-six-straight-sessions-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4440.0,9/27/2024 2:30:36 PM,J&J Reports Data From Investigational Phase 1b RedirecTT-1 Study - Quick Facts ,RTTNews,/news/stocks/j-j-reports-data-from-investigational-phase-1b-redirectt-1-study-quick-facts-1033803603
4441.0,9/27/2024 2:48:53 PM,Johnson & Johnson Reports New Data From Phase 1b TRIMM-2 Study ,RTTNews,/news/stocks/johnson-johnson-reports-new-data-from-phase-1b-trimm-2-study-1033803657
4442.0,9/27/2024 5:59:43 PM,"Bristol Cobenfy approval draws optimism from Street, though with caveats",Seeking Alpha,https://seekingalpha.com/news/4154179-bristol-cobenfy-approval-draws-optimism-from-street-though-with-caveats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4443.0,9/27/2024 8:42:26 PM,J&J releases encouraging data on Talvey combination therapies,Seeking Alpha,https://seekingalpha.com/news/4154260-jj-releases-encouraging-data-on-talvey-combination-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4444.0,9/27/2024 9:18:34 PM,"J&J, Legend report Carvykti cut death risk by 45% in multiple myeloma study",Seeking Alpha,https://seekingalpha.com/news/4154285-jj-legend-report-carvykti-cut-death-risk-by-45-in-multiple-myeloma-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4445.0,9/27/2024 10:26:45 PM,Johnson & Johnson Says Darzalex Regimens Show Meaningful Responses In Patients With Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-says-darzalex-regimens-show-meaningful-responses-in-patients-with-multiple-myeloma-1033804874
4446.0,9/28/2024 8:14:19 AM,J&J : Phase 3 Trial Results Show CARVYKTI Extends Overall Survival In Relapsed Multiple Myeloma ,RTTNews,/news/stocks/j-j-phase-3-trial-results-show-carvykti-extends-overall-survival-in-relapsed-multiple-myeloma-1033805058
4447.0,9/28/2024 9:01:55 AM,J&J : DARZALEX FASPRO Quadruplet Regimen Improves MRD Negativity In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-darzalex-faspro-quadruplet-regimen-improves-mrd-negativity-in-newly-diagnosed-multiple-myeloma-1033805065
4448.0,9/28/2024 5:06:10 PM,Here are the Medicare Part D drugs expected to face 2025 price negotiations,Seeking Alpha,https://seekingalpha.com/news/4154318-these-medicare-drugs-set-to-face-2025-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4449.0,9/30/2024 12:15:10 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033808278
4450.0,9/30/2024 3:04:44 PM,Johnson & Johnson Expands Roll-out Of TECNIS Odyssey IOL - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-expands-roll-out-of-tecnis-odyssey-iol-quick-facts-1033807447
4451.0,9/30/2024 8:42:43 PM,J&J submits supplemental BLA for Darzalex Faspro to FDA,Seeking Alpha,https://seekingalpha.com/news/4154769-jj-submits-supplemental-bla-for-darzalex-faspro-to-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4452.0,10/1/2024 8:38:43 AM,Hold Rating on Johnson & Johnson Amid Market Potential and Competitive Positioning Analysis,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-market-potential-and-competitive-positioning-analysis-1033810782
4453.0,10/1/2024 7:35:29 PM,U.S. port strike expected to have limited impact on healthcare supply chain: HHS,Seeking Alpha,https://seekingalpha.com/news/4155196-us-port-strike-have-limited-impact-medical-supplies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4454.0,10/2/2024 10:42:51 AM,J&J to invest over $2B to build new North Carolina plant,Seeking Alpha,https://seekingalpha.com/news/4155360-johnson-johnson-builds-2b-north-carolina-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4455.0,10/2/2024 2:07:42 PM,J&J prostate cancer therapy outperforms in real-world study,Seeking Alpha,https://seekingalpha.com/news/4155516-jj-prostate-cancer-therapy-outperforms-in-real-world-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4456.0,10/2/2024 4:31:17 PM,JNJ's Erleada Shows Statistically Significant Overall Survival In Metastatic Prostate Cancer ,RTTNews,/news/stocks/jnj-s-erleada-shows-statistically-significant-overall-survival-in-metastatic-prostate-cancer-1033815796
4457.0,10/3/2024 12:02:11 PM,U.S. tweaks 2025 Medicare price negotiation process,Seeking Alpha,https://seekingalpha.com/news/4155891-us-tweaks-2025-medicare-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4458.0,10/4/2024 8:30:19 AM,"Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Johnson & Johnson (JNJ) and Avidity Biosciences (RNA)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-livanova-livn-johnson-johnson-jnj-and-avidity-biosciences-rna-1033820918
4459.0,10/4/2024 9:33:39 AM,DBS Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-remains-a-hold-on-johnson-johnson-jnj-1033821117
4460.0,10/4/2024 1:28:54 PM,Johnson & Johnson halts mid-stage study for dengue antiviral,Seeking Alpha,https://seekingalpha.com/news/4156465-johnson--johnson-halts-dengue-antiviral-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4461.0,10/4/2024 4:55:00 PM,JNJ To Terminate Phase 2 Field Study Of Mosnodenvir For Prevention Of Dengue Virus ,RTTNews,/news/stocks/jnj-to-terminate-phase-2-field-study-of-mosnodenvir-for-prevention-of-dengue-virus-1033821767
4462.0,10/7/2024 9:04:58 PM,J&J discontinues Phase 2 study for bladder cancer drug TAR-200,Seeking Alpha,https://seekingalpha.com/news/4156861-jj-discontinues-phase-2-study-for-bladder-cancer-drug-tar-200?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4463.0,10/8/2024 12:15:50 PM,Johnson & Johnson: Hold Rating Affirmed Amid Balanced Growth and Caution,TipRanks,/news/stocks/johnson-johnson-hold-rating-affirmed-amid-balanced-growth-and-caution-1033828860
4464.0,10/8/2024 6:03:33 PM,Harris home health care benefit likely funded through Medicare drug negotiations savings,Seeking Alpha,https://seekingalpha.com/news/4157079-harris-home-health-care-benefit-could-funded-through-medicare-drug-negotiations-savings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4465.0,10/9/2024 12:26:28 PM,"J&J closes V-Wave deal, to incur IPR&D charge of $600M in Q4",Seeking Alpha,https://seekingalpha.com/news/4157237-jj-closes-v-wave-deal-to-incur-iprd-charge-of-600m-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4466.0,10/9/2024 2:32:12 PM,Johnson & Johnson Buys Privately-held V-Wave; Sees In-process R&D Charge Of Around $600 Mln In Q4 ,RTTNews,/news/stocks/johnson-johnson-buys-privately-held-v-wave-sees-in-process-r-d-charge-of-around-600-mln-in-q4-1033831535
4467.0,10/10/2024 2:47:06 AM,Maintaining Buy Rating on Johnson & Johnson: Promising Pipeline and Financial Prospects Despite Clinical Setback,TipRanks,/news/stocks/maintaining-buy-rating-on-johnson-johnson-promising-pipeline-and-financial-prospects-despite-clinical-setback-1033834010
4468.0,10/10/2024 9:26:21 AM,Johnson & Johnson: Hold Rating Justified by Subdued EPS Growth and Margin Pressures,TipRanks,/news/stocks/johnson-johnson-hold-rating-justified-by-subdued-eps-growth-and-margin-pressures-1033835260
4469.0,10/10/2024 1:58:11 PM,J&J Submits For EMA Approval For DARZALEX SC Quadruplet Regimen In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-submits-for-ema-approval-for-darzalex-sc-quadruplet-regimen-in-newly-diagnosed-multiple-myeloma-1033835175
4470.0,10/10/2024 3:12:01 PM,J&J Says TREMFYA Showed Strong Results In Biologic-Naive & Refractory Patients With CD And UC ,RTTNews,/news/stocks/j-j-says-tremfya-showed-strong-results-in-biologic-naive-refractory-patients-with-cd-and-uc-1033835517
4471.0,10/11/2024 12:36:35 PM,Johnson & Johnson (JNJ) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-morgan-stanley-1033839274
4472.0,10/11/2024 2:04:36 PM,Texas court rules J&J didn't skirt bankruptcy rules in talc case: report,Seeking Alpha,https://seekingalpha.com/news/4157903-texas-court-rules-jj-didnt-skirt-bankruptcy-rules-in-talc-case-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4473.0,10/11/2024 7:00:23 PM,"Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil",Seeking Alpha,https://seekingalpha.com/news/4157956-catalyst-watch-netflix-earnings-lenovo-tech-event-paris-motor-show-and-eyes-on-oil?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4474.0,10/13/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4157923-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-pg-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4475.0,10/14/2024 2:37:06 PM,Lilly reports positive data for Omvoh versus Stelara in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4158237-lilly-reports-positive-data-for-omvoh-versus-stelara-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4476.0,10/14/2024 2:42:56 PM,Earnings Scorecard: 7 out of 8 S&P 500 companies deliver EPS wins this week,Seeking Alpha,https://seekingalpha.com/news/4157977-7-out-of-8-sp-500-companies-deliver-eps-wins-this-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4477.0,10/14/2024 5:51:54 PM,Johnson & Johnson Q3 Preview: Decline in profit is in the cards,Seeking Alpha,https://seekingalpha.com/news/4158319-johnson-johnson-q3-preview-decline-in-profit-is-in-the-cards?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4478.0,10/14/2024 10:00:09 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4158228-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4479.0,10/15/2024 9:27:16 AM,Johnson & Johnson: Navigating Pharmaceutical Opportunities and Patent Challenges ‚Äì A Hold Rating Analysis,TipRanks,/news/stocks/johnson-johnson-navigating-pharmaceutical-opportunities-and-patent-challenges-‚Äì-a-hold-rating-analysis-1033846642
4480.0,10/15/2024 10:21:20 AM,"Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M",Seeking Alpha,https://seekingalpha.com/news/4159016-johnson-and-johnson-non-gaap-eps-of-2_42-beats-0_21-revenue-of-22_5b-beats-330m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4481.0,10/15/2024 10:31:13 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4159095-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4482.0,10/15/2024 10:37:10 AM,Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3,Seeking Alpha,https://seekingalpha.com/news/4159099-johnson-johnson-in-charts-innovative-medicine-recorded-highest-sales-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4483.0,10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4484.0,10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge-raises-fy24-sales-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4485.0,10/15/2024 12:27:41 PM,"Johnson & Johnson Q3 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q3-profit-decreases-but-beats-estimates-1033846024
4486.0,10/15/2024 12:45:15 PM,Johnson & Johnson Hold Rating: Strong Pharma Gains Offset by MedTech Challenges and Acquisition Costs,TipRanks,/news/stocks/johnson-johnson-hold-rating-strong-pharma-gains-offset-by-medtech-challenges-and-acquisition-costs-1033847669
4487.0,10/15/2024 12:53:22 PM,Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact,Seeking Alpha,https://seekingalpha.com/news/4159512-jnj-stock-falls-amid-cut-to-earnings-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4488.0,10/15/2024 1:11:42 PM,"Johnson & Johnson Cuts FY24 Earnings View, Lifts Sales Forecast - Update ",RTTNews,/news/stocks/johnson-johnson-cuts-fy24-earnings-view-lifts-sales-forecast-update-1033846179
4489.0,10/15/2024 1:18:00 PM,"4 stocks to watch on Tuesday: BAC, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4160035-4-stocks-to-watch-on-tuesday-bac-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4490.0,10/15/2024 5:09:53 PM,JNJ releases positive data on nipocalimab for myasthenia gravis in adolescents,Seeking Alpha,https://seekingalpha.com/news/4161434-jnj-releases-positive-data-nipocalimab-myasthenia-gravis-adolescents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4491.0,10/15/2024 6:45:09 PM,"Johnson & Johnson: Strong Performance Yet Fairly Priced, Leading to Hold Rating",TipRanks,/news/stocks/johnson-johnson-strong-performance-yet-fairly-priced-leading-to-hold-rating-1033848306
4492.0,10/15/2024 8:25:11 PM,Johnson & Johnson: Strong Q3 Performance and Upward Sales Guidance Bolster Buy Rating,TipRanks,/news/stocks/johnson-johnson-strong-q3-performance-and-upward-sales-guidance-bolster-buy-rating-1033848374
4493.0,10/15/2024 11:55:13 PM,Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks,TipRanks,/news/stocks/johnson-johnson-balancing-growth-potential-with-market-challenges-and-legal-risks-1033848437
4494.0,10/15/2024 11:56:34 PM,Hold Rating Maintained for Johnson & Johnson Amid Mixed Sector Performance and EPS Guidance Concerns,TipRanks,/news/stocks/hold-rating-maintained-for-johnson-johnson-amid-mixed-sector-performance-and-eps-guidance-concerns-1033848428
4495.0,10/15/2024 11:57:07 PM,Hold Rating for Johnson & Johnson Amid 2024 Growth Deceleration and 2025 Optimism,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-2024-growth-deceleration-and-2025-optimism-1033848461
4496.0,10/16/2024 10:45:51 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033851665
4497.0,10/16/2024 11:26:25 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033852068
4498.0,10/16/2024 12:25:29 PM,Johnson & Johnson‚Äôs Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-highlighted-by-strong-q3-earnings-and-promising-pipeline-1033852299
4499.0,10/16/2024 4:21:34 PM,Least shorted S&P 500 stocks in September,Seeking Alpha,https://seekingalpha.com/news/4166027-least-shorted-sp-500-stocks-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4500.0,10/18/2024 7:37:15 PM,Tyra raised to buy by BofA ahead of TYRA-300 data readout,Seeking Alpha,https://seekingalpha.com/news/4176885-tyra-raised-to-buy-by-bofa-ahead-of-tyra-300-data-readout?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4501.0,10/19/2024 1:30:00 PM,Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4175834-over-60-of-companies-that-reported-earnings-this-week-beat-eps-and-revenue-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4502.0,10/20/2024 11:05:04 PM,Johnson & Johnson treatment of acute myeloid leukemia granted orphan status,TipRanks,/news/stocks/johnson-johnson-treatment-of-acute-myeloid-leukemia-granted-orphan-status-1033861351
4503.0,10/21/2024 12:49:18 AM,Activist investor Starboard takes stake in Kenvue - WSJ,Seeking Alpha,https://seekingalpha.com/news/4181820-activist-investor-starboard-takes-stake-in-kenvue-wsj?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4504.0,10/21/2024 10:30:16 AM,"Prescriptions Johnson & Johnson‚Äôs Spravato are booming, WSJ reports",TipRanks,/news/stocks/prescriptions-johnson-johnson-s-spravato-are-booming-wsj-reports-1033864764
4505.0,10/21/2024 2:09:26 PM,"Biggest stock movers Monday: LUMN, VFC, BA, SAVE, and more",Seeking Alpha,https://seekingalpha.com/news/4182108-biggest-stock-movers-monday-ba-save-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4506.0,10/21/2024 6:15:19 PM,Boeing machinists announce proposal to end strike: Morning Buzz,TipRanks,/news/stocks/boeing-machinists-announce-proposal-to-end-strike-morning-buzz-1033866571
4507.0,10/21/2024 8:08:24 PM,Johnson & Johnson snaps six straight days of gains,Seeking Alpha,https://seekingalpha.com/news/4187020-johnson-johnson-snaps-six-straight-days-of-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4508.0,10/22/2024 10:55:28 AM,Kenvue price target raised to $27 from $24 at BofA,TipRanks,/news/stocks/kenvue-price-target-raised-to-27-from-24-at-bofa-1033871030
4509.0,10/25/2024 12:37:01 PM,Johnson & Johnson reports results from Phase 3b SPECTREM study,TipRanks,/news/stocks/johnson-johnson-reports-results-from-phase-3b-spectrem-study-1033894082
4510.0,10/25/2024 1:56:25 PM,J&J reports positive data for Tremfya in low body surface area psoriasis,Seeking Alpha,https://seekingalpha.com/news/4204907-jj-reports-positive-data-for-tremfya-in-low-body-surface-area-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4511.0,10/25/2024 3:01:57 PM,J&J Phase 3b SPECTREM Study Of Tremfya In Low Body Surface Area Plaque Psoriasis Meets Primary Goal ,RTTNews,/news/stocks/j-j-phase-3b-spectrem-study-of-tremfya-in-low-body-surface-area-plaque-psoriasis-meets-primary-goal-1033892577
4512.0,10/28/2024 11:35:21 AM,Johnson & Johnson‚Äôs Tremfya shows efficacy in Crohn‚Äôs disease Phase 3 study,TipRanks,/news/stocks/johnson-johnson-s-tremfya-shows-efficacy-in-crohn-s-disease-phase-3-study-1033902176
4513.0,10/28/2024 12:51:07 PM,Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study,TipRanks,/news/stocks/johnson-johnson-says-impella-ecp-met-primary-endpoint-in-high-risk-pci-study-1033902891
4514.0,10/28/2024 1:21:21 PM,J&J Reports Positive Results From GRAVITI Study Of Tremfya In SC Induction And Maintenance Therapy ,RTTNews,/news/stocks/j-j-reports-positive-results-from-graviti-study-of-tremfya-in-sc-induction-and-maintenance-therapy-1033901277
4515.0,10/28/2024 3:23:50 PM,JNJ's subcutaneous Tremfya demonstrates efficacy in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4213133-johnson-johnson-subcutaneous-tremfya-demonstrates-efficacy-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4516.0,10/28/2024 3:41:20 PM,J&J Impella ECP heart pump meets primary endpoint,Seeking Alpha,https://seekingalpha.com/news/4214084-johnson-johnson-abiomed-impella-ecp-heart-pump-meets-primary-endpoint?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4517.0,10/28/2024 7:33:46 PM,DOJ throws wrench into J&J bankruptcy plan to settle talc suits,Seeking Alpha,https://seekingalpha.com/news/4215334-doj-throws-wrench-into-johnson-johnson-bankruptcy-plan-settle-talc-suits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4518.0,10/30/2024 12:10:44 PM,AbbVie lifts outlook again on immunology demand; dividend raised,Seeking Alpha,https://seekingalpha.com/news/4222641-abbvie-lifts-outlook-again-on-immunology-demand-dividend-raised?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4519.0,11/2/2024 7:36:20 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk‚Äôs-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4520.0,11/4/2024 1:36:04 PM,Option Care Health downgraded to Neutral at Goldman on Stelara headwinds,TipRanks,/news/stocks/option-care-health-downgraded-to-neutral-at-goldman-on-stelara-headwinds-1033945678
4521.0,11/4/2024 2:50:17 PM,"Roblox, Peloton upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/roblox-peloton-upgraded-wall-street-s-top-analyst-calls-1033946237
4522.0,11/4/2024 6:23:55 PM,Alvotech application for Simponi biosimilar accepted by EMA,Seeking Alpha,https://seekingalpha.com/news/4243237-alvotech-application-simponi-biosimilar-accepted-ema?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4523.0,11/4/2024 6:41:14 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4524.0,11/5/2024 6:50:16 PM,Johnson & Johnson Darzalex shows efficacy in early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4250819-johnson-and-johnson-darzalex-shows-efficacy-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4525.0,11/6/2024 1:06:49 PM,Johnson & Johnson price target raised to $162 from $156 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-162-from-156-at-guggenheim-1033962578
4526.0,11/6/2024 8:17:19 PM,SA Asks: How will the U.S. election results impact healthcare stocks?,Seeking Alpha,https://seekingalpha.com/news/4257322-sa-asks-how-will-the-us-election-results-impact-healthcare-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4527.0,11/7/2024 5:48:20 PM,J&J wins approval of Varipulse atrial fibrillation device,Seeking Alpha,https://seekingalpha.com/news/4261997-johnson-and-johnson-wins-approval-varipulse-atrial-fibrillation-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4528.0,11/8/2024 12:21:33 PM,Johnson & Johnson submits applications for new indications for Darzalex,TipRanks,/news/stocks/johnson-johnson-submits-applications-for-new-indications-for-darzalex-1033983117
4529.0,11/8/2024 2:59:21 PM,J&J seeks approval of Darzalex for early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4266211-johnson-and-johnson-seeks-approval-darzalex-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4530.0,11/8/2024 3:25:08 PM,"Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment ",RTTNews,/news/stocks/johnson-johnson-seeks-approval-of-darzalex-faspro-in-us-darzalex-in-eu-for-myeloma-treatment-1033982191
4531.0,11/11/2024 9:10:32 PM,Johnson & Johnson: FDA grants nipocalimab Breakthrough Therapy designation,TipRanks,/news/stocks/johnson-johnson-fda-grants-nipocalimab-breakthrough-therapy-designation-1033994750
4532.0,11/11/2024 9:28:05 PM,J&J gets FDA breakthrough therapy status for nipocalimab in Sjogren's,Seeking Alpha,https://seekingalpha.com/news/4276778-jj-gets-fda-breakthrough-therapy-status-for-nipocalimab-in-sjogrens?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4533.0,11/12/2024 8:43:07 PM,J&J sues HHS over 340B hospital drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4281964-johnson-and-johnson-sues-hhs-over-340-b-hospital-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4534.0,11/12/2024 8:55:09 PM,Johnson & Johnson MedTech receives IDE approval for Ottava system,TipRanks,/news/stocks/johnson-johnson-medtech-receives-ide-approval-for-ottava-system-1034002797
4535.0,11/13/2024 2:40:32 PM,"J&J sues government agency over payment terms for 340B hospitals, STAT says",TipRanks,/news/stocks/j-j-sues-government-agency-over-payment-terms-for-340b-hospitals-stat-says-1034010502
4536.0,11/13/2024 5:16:07 PM,"Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz",TipRanks,/news/stocks/charter-to-acquire-liberty-broadband-spotify-reports-q3-beat-morning-buzz-1034011067
4537.0,11/14/2024 3:12:05 PM,Johnson & Johnson announces results from analyses of Phase 2 DAHLIAS study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-analyses-of-phase-2-dahlias-study-1034020093
4538.0,11/14/2024 4:39:41 PM,JNJ's Phase 2 Study Of Nipocalimab Shows Improvement In Disease Activity In Sj√∂gren's Disease ,RTTNews,/news/stocks/jnj-s-phase-2-study-of-nipocalimab-shows-improvement-in-disease-activity-in-sjoegren-s-disease-1034018859
4539.0,11/14/2024 9:15:44 PM,Johnson & Johnson initiated with an Outperform at Wolfe Research,TipRanks,/news/stocks/johnson-johnson-initiated-with-an-outperform-at-wolfe-research-1034021187
4540.0,11/14/2024 10:48:03 PM,"Renaissance Tech adds Micron, exits Broadcom, among Q3 trades",Seeking Alpha,https://seekingalpha.com/news/4292581-renaissance-tech-adds-micron-exits-broadcom-among-q3-trades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4541.0,11/14/2024 11:07:05 PM,Vaccine makers close lower amid reports RFK Jr may head HHS (update),Seeking Alpha,https://seekingalpha.com/news/4292433-vaccines-makers-close-lower-on-reports-rfk-jr-may-head-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4542.0,11/14/2024 11:50:43 PM,"Wolfe starts J&J at Outperform, sees growth drivers as ‚Äòbest-in-class‚Äô",TipRanks,/news/stocks/wolfe-starts-j-j-at-outperform-sees-growth-drivers-as-best-in-class-1034021597
4543.0,11/15/2024 12:19:45 PM,Eli Lilly follows JNJ in suing govt. over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4294034-eli-lilly-follows-jnj-suing-over-340-b-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4544.0,11/15/2024 3:32:00 PM,Least shorted S&P 500 stocks in October,Seeking Alpha,https://seekingalpha.com/news/4294512-least-shorted-sp-500-stocks-in-october?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4545.0,11/15/2024 5:26:07 PM,"Eli Lilly sues to change hospital drug discount payments, WSJ reports",TipRanks,/news/stocks/eli-lilly-sues-to-change-hospital-drug-discount-payments-wsj-reports-1034026316
4546.0,11/15/2024 7:15:09 PM,"Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says",Seeking Alpha,https://seekingalpha.com/news/4296173-medtech-shouldnt-be-greatly-impacted-by-rfk-jr-at-hhs-wells-fargo-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4547.0,11/15/2024 7:29:29 PM,U.S. Pharma is largely immune from 'MAHA' impact: Wolfe,Seeking Alpha,https://seekingalpha.com/news/4296178-us-pharma-largely-immune-from-maha-impact-wolfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4548.0,11/15/2024 8:00:56 PM,"Catalyst Watch: Nvidia earnings, Microsoft Ignite, crypto confidence, and P&G event",Seeking Alpha,https://seekingalpha.com/news/4295258-catalyst-watch-nvidia-earnings-microsoft-ignite-crypto-confidence-and-pg-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4549.0,11/18/2024 1:25:07 PM,CHMP Recommends Approval Of Lazcluze + Rybrevant In EU For EGFR-mutated Advanced NSCLC ,RTTNews,/news/stocks/chmp-recommends-approval-of-lazcluze-rybrevant-in-eu-for-egfr-mutated-advanced-nsclc-1034029899
4550.0,11/18/2024 9:36:09 PM,Johnson & Johnson announces results from ICONIC-LEADa Phase 3 study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-iconic-leada-phase-3-study-1034033175
4551.0,11/18/2024 9:51:09 PM,Protagonist and JNJ say icotrokinra study for PsO meets endpoint,TipRanks,/news/stocks/protagonist-and-jnj-say-icotrokinra-study-for-pso-meets-endpoint-1034033226
4552.0,11/18/2024 9:59:37 PM,J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis,Seeking Alpha,https://seekingalpha.com/news/4304472-johnson-and-johnson-unveils-positive-phase-3-results-icotrokinra-plaque-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4553.0,11/19/2024 10:56:17 AM,Balanced Hold Rating for JNJ‚Äôs Icotrokinra Amid Efficacy Concerns and Healthcare Policy Uncertainties,TipRanks,/news/stocks/balanced-hold-rating-for-jnj-s-icotrokinra-amid-efficacy-concerns-and-healthcare-policy-uncertainties-1034036356
4554.0,11/20/2024 9:56:25 AM,Johnson & Johnson‚Äôs M&A Strategy in Cardiovascular Devices Supports Hold Rating,TipRanks,/news/stocks/johnson-johnson-s-m-a-strategy-in-cardiovascular-devices-supports-hold-rating-1034041712
4555.0,11/20/2024 2:36:50 PM,"Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-merck-cutting-jobs-in-china-bloomberg-reports-1034043953
4556.0,11/20/2024 5:01:17 PM,"Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz",TipRanks,/news/stocks/target-reports-downbeat-q3-comcast-plans-cable-tv-spinoff-morning-buzz-1034044336
4557.0,11/21/2024 6:17:53 AM,Johnson & Johnson‚Äôs Promising Pharmaceutical Developments Justify Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-promising-pharmaceutical-developments-justify-buy-rating-1034047194
4558.0,11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4559.0,11/21/2024 10:29:47 PM,Zevra Niemann-Pick disease type C drug Miplyffa now available,Seeking Alpha,https://seekingalpha.com/news/4319157-zevra-niemann-pick-disease-type-c-drug-miplyffa-now-available?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4560.0,11/22/2024 1:42:34 AM,J&J : Canada Approves CARVYKTI For Relapsed Or Refractory Multiple Myeloma After 1-3 Prior Therapies ,RTTNews,/news/stocks/j-j-canada-approves-carvykti-for-relapsed-or-refractory-multiple-myeloma-after-1-3-prior-therapies-1034051780
4561.0,11/22/2024 1:05:50 PM,JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya,TipRanks,/news/stocks/jnj-seeks-fda-approval-of-subcutaneous-induction-regimen-of-tremfya-1034055824
4562.0,11/22/2024 1:40:48 PM,"Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others",Seeking Alpha,https://seekingalpha.com/news/4321067-dividend-roundup-general-mills-halliburton-johnson-johnson-coca-cola-and-others?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4563.0,11/22/2024 1:48:17 PM,Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment,Seeking Alpha,https://seekingalpha.com/news/4321118-johnson-johnson-seeks-fda-approval-for-its-ulcerative-colitis-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4564.0,11/22/2024 2:39:02 PM,Johnson & Johnson Submits SBLA Seeking Approval Of TREMFYA In Ulcerative Colitis ,RTTNews,/news/stocks/johnson-johnson-submits-sbla-seeking-approval-of-tremfya-in-ulcerative-colitis-1034054545
4565.0,11/22/2024 4:35:10 PM,"Sanofi planning changes to 340B hospital drug discount plan, WSJ reports",TipRanks,/news/stocks/sanofi-planning-changes-to-340b-hospital-drug-discount-plan-wsj-reports-1034056551
4566.0,11/22/2024 4:50:49 PM,Sanofi becomes latest drugmaker to challenge HHS over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4322264-sanofi-becomes-latest-drugmakert-challenge-hhs-340-b-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4567.0,11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4568.0,11/27/2024 9:00:25 PM,Janssen treatment of multiple myeloma granted FDA orphan status,TipRanks,/news/stocks/janssen-treatment-of-multiple-myeloma-granted-fda-orphan-status-1034073527
4569.0,11/28/2024 3:33:22 PM,AstraZeneca cancer drug Enhertu added for reimbursement in China despite probe,Seeking Alpha,https://seekingalpha.com/news/4344692-astrazeneca-enhertu-added-for-china-reimbursement?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4570.0,12/2/2024 1:05:25 PM,J&J seeks U.S. FDA approval for pediatric indications for TREMFYA,TipRanks,/news/stocks/j-j-seeks-u-s-fda-approval-for-pediatric-indications-for-tremfya-1034087206
4571.0,12/2/2024 1:40:00 PM,Johnson & Johnson seeks approval of pediatric indications for TREMFYA,Seeking Alpha,https://seekingalpha.com/news/4353860-johnson-johnson-seeks-approval-of-pediatric-indications-for-tremfya?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
4572.0,12/2/2024 2:20:35 PM,Johnson & Johnson Files SBLAs In Pediatric Indications For TREMFYA - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-files-sblas-in-pediatric-indications-for-tremfya-quick-facts-1034085713
,12/6/2024 7:30:19 PM,"J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital",TipRanks,/news/stocks/j-j-trial-news-may-have-positive-read-for-neumora-therapeutics-says-rbc-capital-1034110005
,12/8/2024 9:30:10 PM,J&J announces new frontline data featuring TECVAYLI fro 2 studies in NDMM,TipRanks,/news/stocks/j-j-announces-new-frontline-data-featuring-tecvayli-fro-2-studies-in-ndmm-1034111198
,12/9/2024 1:48:06 AM,"J&J : DARZALEX FASPRO Regimens Improve MRD Negativity, Survival In Newly Diagnosed Multiple Myeloma ",RTTNews,/news/stocks/j-j-darzalex-faspro-regimens-improve-mrd-negativity-survival-in-newly-diagnosed-multiple-myeloma-1034111200
,12/9/2024 4:27:45 AM,J&J : TECVAYLI Shows Promise As Frontline Therapy For Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-tecvayli-shows-promise-as-frontline-therapy-for-newly-diagnosed-multiple-myeloma-1034111388
,12/9/2024 9:11:33 PM,Gilead price target raised to $115 from $105 at Oppenheimer,TipRanks,/news/stocks/gilead-price-target-raised-to-115-from-105-at-oppenheimer-1034116246
,12/9/2024 9:13:31 PM,Johnson & Johnson snaps six days of losing streak,Seeking Alpha,https://seekingalpha.com/news/4379903-johnson-johnson-snaps-six-days-of-losing-streak?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/10/2024 12:50:15 AM,J&J‚Äôs CARVYKTI shows higher rates of minimal residual disease negativity,TipRanks,/news/stocks/j-j-s-carvykti-shows-higher-rates-of-minimal-residual-disease-negativity-1034116663
,12/10/2024 1:43:21 AM,J&J : CARVYKTI Shows Higher MRD Negativity Rates Vs. Standard Therapies In Phase 3 Study ,RTTNews,/news/stocks/j-j-carvykti-shows-higher-mrd-negativity-rates-vs-standard-therapies-in-phase-3-study-1034116381
,12/10/2024 2:45:24 PM,"eBay downgraded, GM upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/ebay-downgraded-gm-upgraded-wall-street-s-top-analyst-calls-1034120783
,12/10/2024 10:01:32 PM,BofA restarts coverage of 11 large-cap biopharmas,Seeking Alpha,https://seekingalpha.com/news/4384456-bofa-restarts-coverage-of-11-large-cap-biopharmas?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/13/2024 12:08:04 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034135636
,12/16/2024 2:51:27 PM,"Johnson & Johnson sues Cigna‚Äôs Express Scripts, Accredo, WSJ reports",TipRanks,/news/stocks/johnson-johnson-sues-cigna-s-express-scripts-accredo-wsj-reports-1034142231
,12/16/2024 3:15:24 PM,GSK‚Äôs ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria,TipRanks,/news/stocks/gsk-s-viiv-healthcare-says-the-chmp-of-ema-issued-positive-opinion-for-vocabria-1034142336
,12/16/2024 4:33:48 PM,J&J submits sBLA for pediatric indication for Simponi in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4386867-johnson-johnson-submits-sbla-pediatric-indication-simponi-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/16/2024 5:01:01 PM,"Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz",TipRanks,/news/stocks/honeywell-still-exploring-alternatives-capri-weighs-versace-sale-morning-buzz-1034142630
,12/16/2024 6:05:00 PM,Moderna remains the most shorted among S&P 500 healthcare stocks in November,Seeking Alpha,https://seekingalpha.com/news/4386556-moderna-remains-the-most-shorted-among-sp-500-healthcare-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/17/2024 11:48:13 AM,Johnson & Johnson says injectable Rybrevant rejected by FDA,Seeking Alpha,https://seekingalpha.com/news/4387220-johnson-johnson-rybrevant-version-rejected-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/17/2024 1:10:11 PM,Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-fibrogen-fgen-and-johnson-johnson-jnj-1034146790
,12/17/2024 6:45:36 PM,Barclays fact-checked Trump comments on pharmacy benefit managers,TipRanks,/news/stocks/barclays-fact-checked-trump-comments-on-pharmacy-benefit-managers-1034148099
,12/18/2024 2:50:54 PM,"PBMs took payments from manufacturers to allow free flow of opioids, NYT reports",TipRanks,/news/stocks/pbms-took-payments-from-manufacturers-to-allow-free-flow-of-opioids-nyt-reports-1034152640
,12/18/2024 2:51:03 PM,FDA approves Celltrion's biosimilar of J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/4387650-fda-approves-celltrion-biosimilar-of-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/18/2024 3:20:29 PM,Trump Trade: Analyst says Trump win ‚Äònot as positive as you‚Äôd think‚Äô for Tesla,TipRanks,/news/stocks/trump-trade-analyst-says-trump-win-not-as-positive-as-you-d-think-for-tesla-1034152752
,12/18/2024 3:37:04 PM,Least shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387575-least-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/19/2024 10:30:50 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034155967
,12/20/2024 12:55:11 AM,RxSight downgraded to Hold from Buy at Stifel,TipRanks,/news/stocks/rxsight-downgraded-to-hold-from-buy-at-stifel-1034159325
,12/20/2024 3:43:03 PM,RxSight cut to hold at Stifel on competition concerns,Seeking Alpha,https://seekingalpha.com/news/4389305-rxsight-stock-cut-hold-at-stifel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/23/2024 6:05:07 PM,Johnson & Johnson call volume above normal and directionally bullish,TipRanks,/news/stocks/johnson-johnson-call-volume-above-normal-and-directionally-bullish-1034169499
,12/26/2024 1:05:19 PM,Johnson & Johnson licensing STAT6 program from Kaken Pharmaceutical,TipRanks,/news/stocks/johnson-johnson-licensing-stat6-program-from-kaken-pharmaceutical-1034174100
,12/26/2024 9:25:06 PM,Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal,TipRanks,/news/stocks/leerink-sees-positive-readthrough-for-kymera-therapeutics-from-j-j-kaken-deal-1034174495
,12/26/2024 11:44:47 PM,FDA proposes asbestos-testing standards for talc products (update),Seeking Alpha,https://seekingalpha.com/news/4391021-fda-proposes-testing-talc-products-for-asbestos-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/30/2024 11:25:06 AM,Piper lowers sales estimates for Legend Biotech‚Äôs Carvykti,TipRanks,/news/stocks/piper-lowers-sales-estimates-for-legend-biotech-s-carvykti-1034179567
,1/2/2025 1:00:59 PM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4391934-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/2/2025 2:20:13 PM,"Neumora trial failure a ‚Äòbig blow‚Äô to bull case, says Stifel",TipRanks,/news/stocks/neumora-trial-failure-a-big-blow-to-bull-case-says-stifel-1034187755
,1/2/2025 4:10:12 PM,RBC downgrades Neumora Therapeutics to Sector Perform after trial failure,TipRanks,/news/stocks/rbc-downgrades-neumora-therapeutics-to-sector-perform-after-trial-failure-1034188027
,1/3/2025 1:29:47 PM,"Dividend Roundup: Johnson & Johnson, JPMorgan, Oracle, Mastercard, and more",Seeking Alpha,https://seekingalpha.com/news/4392264-dividend-roundup-johnson-johnson-jpmorgan-oracle-mastercard-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/5/2025 10:32:40 PM,SA Asks: Which biotechs are most likely to be acquired near-term?,Seeking Alpha,https://seekingalpha.com/news/4392553-sa-asks-which-biotechs-are-most-likely-to-be-acquired-near-term?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/7/2025 1:05:24 PM,Johnson & Johnson‚Äôs rybrevant plus lazcluze improve survival in lung cancer,TipRanks,/news/stocks/johnson-johnson-s-rybrevant-plus-lazcluze-improve-survival-in-lung-cancer-1034201090
,1/7/2025 3:27:12 PM,J&J Rybrevant/Lazcluze combo bests AstraZeneca's Tagrisso in NSCLC,Seeking Alpha,https://seekingalpha.com/news/4393029-johnson-and-johnson-rybrevant-lazcluze-combo-bests-astrazeneca-tagrisso-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/8/2025 1:46:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1034202968
,1/8/2025 10:50:31 AM,Hold Recommendation for Johnson & Johnson Amid Promising Drug Trials and Regulatory Challenges,TipRanks,/news/stocks/hold-recommendation-for-johnson-johnson-amid-promising-drug-trials-and-regulatory-challenges-1034205057
,1/8/2025 10:50:50 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj-1034205054
,1/8/2025 1:06:04 PM,Johnson & Johnson‚Äôs posdinemab granted FDA Fast Track designation,TipRanks,/news/stocks/johnson-johnson-s-posdinemab-granted-fda-fast-track-designation-1034206392
,1/8/2025 1:43:55 PM,Johnson & Johnson's posdinemab receives FDA fast track designation for its Alzheimer's treatment,Seeking Alpha,https://seekingalpha.com/news/4393419-johnson-johnsons-posdinemab-receives-fda-fast-track-designation-for-its-alzheimers-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/8/2025 3:26:38 PM,J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment ,RTTNews,/news/stocks/j-j-s-posdinemab-granted-fda-fast-track-designation-for-alzheimer-s-treatment-1034205345
,1/8/2025 6:31:34 PM,Johnson & Johnson falls after pausing U.S. Varipulse cases,Seeking Alpha,https://seekingalpha.com/news/4393544-johnson-johnson-stock-slips-varipulse-pause?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/8/2025 9:00:26 PM,Johnson & Johnson announces pause of all U.S. Varipulse cases,TipRanks,/news/stocks/johnson-johnson-announces-pause-of-all-u-s-varipulse-cases-1034207742
,1/8/2025 9:11:16 PM,"J&J pause ‚Äòvery good‚Äô for Boston Scientific, says Piper Sandler",TipRanks,/news/stocks/j-j-pause-very-good-for-boston-scientific-says-piper-sandler-1034207729
,1/8/2025 11:30:40 PM,Johnson & Johnson price target lowered to $160 from $177 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-177-at-bernstein-1034208061
,1/9/2025 1:25:59 PM,Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges,TipRanks,/news/stocks/cautious-outlook-on-johnson-johnson-amid-currency-and-legal-challenges-1034210893
,1/9/2025 1:45:16 PM,Johnson & Johnson reports nipocalimab granted FDA Priority Review,TipRanks,/news/stocks/johnson-johnson-reports-nipocalimab-granted-fda-priority-review-1034211009
,1/9/2025 1:56:22 PM,"Novo, Eli Lilly to dominate global pharma sales in 2025: report",Seeking Alpha,https://seekingalpha.com/news/4393716-novo-eli-lilly-lead-2025-global-pharma-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/9/2025 2:49:28 PM,J&J gets Priority Review designation for nipocalimab BLA,Seeking Alpha,https://seekingalpha.com/news/4393771-jj-gets-priority-review-designation-for-nipocalimab-bla?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/9/2025 7:55:26 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034211701
,1/10/2025 12:16:44 PM,Boston Scientific upgraded to Buy from Hold at Deutsche Bank,TipRanks,/news/stocks/boston-scientific-upgraded-to-buy-from-hold-at-deutsche-bank-1034215133
,1/10/2025 6:39:09 PM,J&J gets EU okay for Dual Energy Thermocool Smarttouch Catheter,Seeking Alpha,https://seekingalpha.com/news/4394094-jj-gets-eu-okay-for-dual-energy-thermocool-smarttouch-catheter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/12/2025 10:40:17 AM,"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj-1034217592
,1/12/2025 9:50:17 PM,Johnson & Johnson in talks to acquire Intra-Cellular - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/4394354-johnson-johnson-exploring-takeover-of-intra-cellular-bloomberg?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/12/2025 10:05:06 PM,"Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-exploring-bid-for-intra-cellular-therapies-bloomberg-reports-1034217895
,1/13/2025 2:49:37 AM,Johnson & Johnson In Talks To Acquire Intra-Cellular Therapies : Report ,RTTNews,/news/stocks/johnson-johnson-in-talks-to-acquire-intra-cellular-therapies-report-1034217902
,1/13/2025 10:30:57 AM,"Illumina launches pilot proteomics program with UK Biobank, collaborators",TipRanks,/news/stocks/illumina-launches-pilot-proteomics-program-with-uk-biobank-collaborators-1034220270
,1/13/2025 11:35:58 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220740
,1/13/2025 11:36:56 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220720
,1/13/2025 11:54:36 AM,J&J to buy Intra-Cellular for $132/share in cash,Seeking Alpha,https://seekingalpha.com/news/4394424-jj-to-buy-intra-cellular-for-132share-in-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/13/2025 12:49:14 PM,Johnson & Johnson To Buy Intra-Cellular Therapies For $132.00/shr In $14.6 Bln All-cash Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-intra-cellular-therapies-for-132-00-shr-in-14-6-bln-all-cash-deal-1034219706
,1/13/2025 1:30:01 PM,M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal,Seeking Alpha,https://seekingalpha.com/news/4394487-ma-snapshot-johnson-johnson-to-acquire-intra-cellular-therapies-in-146b-cns-focused-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/13/2025 1:35:42 PM,Oric Pharmaceuticals announces clinical supply agreement with Janssen,TipRanks,/news/stocks/oric-pharmaceuticals-announces-clinical-supply-agreement-with-janssen-1034221869
,1/13/2025 2:06:33 PM,Morning Movers: Intra-Cellular surges following deal to be bought by J&J,TipRanks,/news/stocks/morning-movers-intra-cellular-surges-following-deal-to-be-bought-by-j-j-1034222103
,1/13/2025 2:27:15 PM,Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago  - report,Seeking Alpha,https://seekingalpha.com/news/4394546-johnson-and-johnson-made-approach-to-intra-cellular-6-weeks-to-2-months-ago-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/13/2025 2:46:12 PM,Hold Rating on JNJ Amid Uncertainty over Intra-Cellular Therapies Acquisition Impact,TipRanks,/news/stocks/hold-rating-on-jnj-amid-uncertainty-over-intra-cellular-therapies-acquisition-impact-1034222391
,1/13/2025 3:00:21 PM,Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley,TipRanks,/news/stocks/intra-cellular-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-1034222444
,1/13/2025 5:10:43 PM,"J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz",TipRanks,/news/stocks/j-j-to-acquire-intra-cellular-clearwater-to-buy-enfusion-morning-buzz-1034222650
,1/13/2025 7:25:14 PM,BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal,TipRanks,/news/stocks/bofa-moves-to-no-rating-on-intra-cellular-after-johnson-johnson-deal-1034222909
,1/14/2025 1:06:45 AM,Cautious Optimism: Evaluating Johnson & Johnson‚Äôs Hold Rating Amid ITCI Acquisition Uncertainties,TipRanks,/news/stocks/cautious-optimism-evaluating-johnson-johnson-s-hold-rating-amid-itci-acquisition-uncertainties-1034223279
,1/14/2025 9:57:00 AM,Johnson & Johnson‚Äôs Strategic Acquisition of Intra-Cellular Therapies: Balancing Short-term Dilution with Long-term Growth Potential,TipRanks,/news/stocks/johnson-johnson-s-strategic-acquisition-of-intra-cellular-therapies-balancing-short-term-dilution-with-long-term-growth-potential-1034224942
,1/14/2025 1:37:21 PM,ORIC Pharma Stock Climbs On Clinical Supply Deal With J&J's Janssen For ORIC-114 ,RTTNews,/news/stocks/oric-pharma-stock-climbs-on-clinical-supply-deal-with-j-j-s-janssen-for-oric-114-1034224824
,1/14/2025 2:40:39 PM,"Drugmakers to push Trump to pause price negotiations, Bloomberg reports",TipRanks,/news/stocks/drugmakers-to-push-trump-to-pause-price-negotiations-bloomberg-reports-1034226968
,1/15/2025 7:04:11 AM,Strategic Acquisition Boosts JNJ‚Äôs Neuroscience Portfolio: Analyst Recommends Buy,TipRanks,/news/stocks/strategic-acquisition-boosts-jnj-s-neuroscience-portfolio-analyst-recommends-buy-1034229544
,1/15/2025 1:06:38 PM,Johnson & Johnson submits NDA with FDA for TAR-200,TipRanks,/news/stocks/johnson-johnson-submits-nda-with-fda-for-tar-200-1034231461
,1/15/2025 2:38:15 PM,Johnson & Johnson Initiates IND Submission Of TAR-200 To Treat High-risk Bladder Cancer ,RTTNews,/news/stocks/johnson-johnson-initiates-ind-submission-of-tar-200-to-treat-high-risk-bladder-cancer-1034230264
,1/15/2025 2:47:30 PM,J&J submits NDA for TAR-200 for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4395303-jj-submits-nda-for-tar-200-for-bladder-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/15/2025 3:00:00 PM,Moderna remains the most shorted stock among S&P 500 healthcare stocks in the last month of 2024,Seeking Alpha,https://seekingalpha.com/news/4395003-moderna-remains-the-most-shorted-stock-among-sp-500-healthcare-stocks-in-the-last-month-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/16/2025 10:19:54 AM,Johnson & Johnson (JNJ) Gets a Hold from Barclays,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-barclays-1034235106
,1/16/2025 4:22:28 PM,Johnson & Johnson's RYBREVANT Plus Chemotherapy Approved In Canada For Advanced Lung Cancer ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-plus-chemotherapy-approved-in-canada-for-advanced-lung-cancer-1034236239
,1/16/2025 4:30:04 PM,Least shorted S&P 500 stocks in December,Seeking Alpha,https://seekingalpha.com/news/4395791-least-shorted-sp-500-stocks-in-december?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/16/2025 8:15:11 PM,Roth MKM biotech analyst holds an analyst/industry conference call,TipRanks,/news/stocks/roth-mkm-biotech-analyst-holds-an-analyst-industry-conference-call-1034237745
,1/17/2025 11:28:17 AM,Hold Rating for Johnson & Johnson Amid Modest Growth Outlook and Legal Uncertainties,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-modest-growth-outlook-and-legal-uncertainties-1034240120
,1/17/2025 1:25:47 PM,Johnson & Johnson price target lowered to $160 from $166 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-166-at-bofa-1034240867
,1/17/2025 7:54:43 PM,Argenx cut to Sell at Deutsche Bank on valuation,Seeking Alpha,https://seekingalpha.com/news/4396303-argenx-stock-cut-sell-deutsche-bank?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/17/2025 8:00:19 PM,"Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility",Seeking Alpha,https://seekingalpha.com/news/4396184-catalyst-watch-netflix-earnings-monster-beverage-event-drug-data-and-quantum-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772
,1/17/2025 9:16:37 PM,Odyssey Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4396327-odyssey-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/17/2025 10:01:19 PM,Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market,TipRanks,/news/stocks/count-on-dividend-king-pepsi-pep-for-stability-in-a-volatile-market-1034241826
,1/18/2025 6:05:00 PM,14 out of 20 names post earnings beat with blockbuster wins from banks-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4396193-14-out-of-20-names-post-earnings-beat-with-blockbuster-wins-from-banks-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/19/2025 1:12:00 PM,"Earnings week ahead: JNJ, NFLX, AAL, UAL, AXP, ABT, VZ, PG, and more",Seeking Alpha,https://seekingalpha.com/news/4396093-earnings-week-ahead-jnj-nflx-aal-ual-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 10:35:22 AM,Nanobiotix doses first patient in CONVERGE study,TipRanks,/news/stocks/nanobiotix-doses-first-patient-in-converge-study-1034249062
,1/21/2025 11:26:13 AM,Johnson & Johnson price target lowered to $159 from $160 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-barclays-1034249312
,1/21/2025 1:06:03 PM,Johnson & Johnson announces FDA approves sNDA for Spravato,TipRanks,/news/stocks/johnson-johnson-announces-fda-approves-snda-for-spravato-1034250428
,1/21/2025 1:18:09 PM,Johnson & Johnson (JNJ) Receives a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-morgan-stanley-1034250560
,1/21/2025 1:54:12 PM,J&J wins label expansion for depression therapy Spravato,Seeking Alpha,https://seekingalpha.com/news/4396680-jj-stock-in-focus-spravato-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 3:22:54 PM,JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression ,RTTNews,/news/stocks/jnj-s-snda-for-spravato-monotherapy-gets-fda-approval-for-treatment-resistant-depression-1034249288
,1/21/2025 5:45:00 PM,Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/4396470-top-seeking-alpha-quant-picks-in-technology-ahead-of-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 6:25:51 PM,Johnson & Johnson Q4 2024 Earnings Preview: Double-digit decline in profit expected,Seeking Alpha,https://seekingalpha.com/news/4397013-johnson-johnson-q4-2024-earnings-preview-double-digit-decline-in-profit-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 6:45:12 PM,Notable companies reporting before tomorrow‚Äôs open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034251583
,1/21/2025 9:25:51 PM,Intra-Cellular downgraded to Sector Perform from Outperform at RBC Capital,TipRanks,/news/stocks/intra-cellular-downgraded-to-sector-perform-from-outperform-at-rbc-capital-1034251809
,1/21/2025 11:00:20 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4396897-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 11:21:13 AM,Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright,TipRanks,/news/stocks/reviva-pharmaceuticals-price-target-lowered-to-11-from-14-at-h-c-wainwright-1034254662
,1/22/2025 11:21:18 AM,"Johnson & Johnson Non-GAAP EPS of $2.04 beats by $0.02, revenue of $22.5B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4397192-johnson-johnson-non-gaap-eps-of-204-beats-by-002-revenue-of-225b-beats-by-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 11:25:28 AM,Johnson & Johnson sees FY25 operational revenue $90.9B-$91.7B,TipRanks,/news/stocks/johnson-johnson-sees-fy25-operational-revenue-90-9b--91-7b-1034254654
,1/22/2025 11:25:51 AM,"Johnson & Johnson sees FY25 adjusted EPS $10.75-$10.95, consensus $10.60",TipRanks,/news/stocks/johnson-johnson-sees-fy25-adjusted-eps-10-75--10-95-consensus-10-60-1034254650
,1/22/2025 11:26:33 AM,"Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02",TipRanks,/news/stocks/johnson-johnson-reports-q4-adjusted-eps-2-04-consensus-2-02-1034254646
,1/22/2025 11:30:26 AM,Genmab reports 2024 net sales of Darzalex $11.67B,TipRanks,/news/stocks/genmab-reports-2024-net-sales-of-darzalex-11-67b-1034254735
,1/22/2025 11:36:42 AM,Genmab says net sales of DARZALEX in 2024 totalled $11.67B,Seeking Alpha,https://seekingalpha.com/news/4397204-genmab-says-net-sales-of-darzalex-in-2024-totalled-1167b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 11:46:50 AM,Johnson & Johnson in Charts: DARZALEX sales surge 20.9% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4397201-johnson-johnson-in-charts-darzalex-sales-surge-209-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 11:48:43 AM,Earnings Snapshot: Johnson & Johnson tops Q4 earnings estimate; initiates FY25 revenue below estimates,Seeking Alpha,https://seekingalpha.com/news/4397202-earnings-snapshot-johnson-johnson-tops-q4-earnings-estimate-initiates-fy25-revenue-below-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:09:46 PM,Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness,Seeking Alpha,https://seekingalpha.com/news/4397193-jnj-stock-flat-despite-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:20:32 PM,Johnson & Johnson sees 2H25 operational sales growth higher than 1H25,TipRanks,/news/stocks/johnson-johnson-sees-2h25-operational-sales-growth-higher-than-1h25-1034255344
,1/22/2025 12:32:59 PM,"Johnson & Johnson Q4 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1034253859
,1/22/2025 1:25:43 PM,"Johnson & Johnson Projects 2025 Adj. Operational EPS Growth Of 8.7% At Midpoint, Excl. ITCI ",RTTNews,/news/stocks/johnson-johnson-projects-2025-adj-operational-eps-growth-of-8-7-at-midpoint-excl-itci-1034254050
,1/22/2025 1:46:35 PM,Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond,TipRanks,/news/stocks/johnson-johnson-says-positioned-for-5--7-growth-through-2030-and-beyond-1034255944
,1/22/2025 1:55:22 PM,Morning Movers: Netflix shares rise following subscriber blowout,TipRanks,/news/stocks/morning-movers-netflix-shares-rise-following-subscriber-blowout-1034255934
,1/22/2025 2:47:47 PM,"4 stocks to watch on Wednesday: PG, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4397307-4-stocks-to-watch-on-wednesday-pg-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 3:30:36 PM,Intra-Cellular ticks higher as J&J forecasts early Q2 close,Seeking Alpha,https://seekingalpha.com/news/4397347-intra-cellular-ticks-higher-as-jj-forecasts-early-q2-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 4:04:42 PM,J&J beats in Q4 with in line guidance; so why is its stock falling?,Seeking Alpha,https://seekingalpha.com/news/4397351-jj-stock-falls-despite-q4-2024-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 5:05:34 PM,"Netflix, Seagate, J&J report quarterly beats: Morning Buzz",TipRanks,/news/stocks/netflix-seagate-j-j-report-quarterly-beats-morning-buzz-1034256527
,1/22/2025 6:46:05 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034256828
,1/23/2025 10:57:17 AM,Cautious Hold Rating for Johnson & Johnson Amid Conservative 2025 Outlook and Foreign Exchange Headwinds,TipRanks,/news/stocks/cautious-hold-rating-for-johnson-johnson-amid-conservative-2025-outlook-and-foreign-exchange-headwinds-1034259606
,1/23/2025 11:05:55 AM,Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued,TipRanks,/news/stocks/balanced-expectations-amid-challenges-and-opportunities-for-johnson-johnson-hold-rating-issued-1034259768
,1/23/2025 11:20:54 AM,Johnson & Johnson price target lowered to $152 from $166 at Wells Fargo,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-152-from-166-at-wells-fargo-1034259868
,1/23/2025 11:26:06 AM,Johnson & Johnson publishes nipocalimab study results in The Lancet Neurology,TipRanks,/news/stocks/johnson-johnson-publishes-nipocalimab-study-results-in-the-lancet-neurology-1034259858
,1/23/2025 11:26:46 AM,Johnson & Johnson price target lowered to $158 from $160 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-158-from-160-at-bernstein-1034259849
,1/23/2025 11:26:53 AM,Cautious Hold Recommendation for Johnson & Johnson Amid ITCI Acquisition Concerns and Market Challenges,TipRanks,/news/stocks/cautious-hold-recommendation-for-johnson-johnson-amid-itci-acquisition-concerns-and-market-challenges-1034259847
,1/23/2025 11:30:12 AM,"Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-abbvie-abbv-johnson-johnson-jnj-1034260045
,1/23/2025 11:35:51 AM,Johnson & Johnson price target lowered to $163 from $175 at Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-163-from-175-at-morgan-stanley-1034260023
,1/23/2025 11:55:20 AM,Johnson & Johnson price target lowered to $159 from $160 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-bofa-1034260137
,1/23/2025 11:55:52 AM,Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties,TipRanks,/news/stocks/johnson-johnson-hold-rating-amid-mixed-performance-and-future-uncertainties-1034260134
,1/23/2025 11:56:45 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034260121
,1/23/2025 12:30:20 PM,Johnson & Johnson price target lowered to $155 from $170 at Stifel,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-155-from-170-at-stifel-1034260728
,1/23/2025 12:45:29 PM,Johnson & Johnson price target lowered to $165 from $170 at Raymond James,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-165-from-170-at-raymond-james-1034260811
,1/24/2025 7:06:51 AM,"‚ÄúJohnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted‚Äù",TipRanks,/news/stocks/johnson-johnson-buy-rating-reaffirmed-despite-price-target-cut-growth-prospects-highlighted-1034265012
,1/24/2025 1:08:16 PM,Argus Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/argus-research-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1034266886
,1/25/2025 6:46:00 PM,Over 80% of companies deliver EPS wins this week-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4398494-over-80-companies-deliver-eps-wins-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/27/2025 3:59:54 PM,"FDA accepts Teva, Alvotech BLAs for Simponi biosimilars",Seeking Alpha,https://seekingalpha.com/news/4398859-fda-accepts-teva-alvotech-blas-for-simponi-biosimilars?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/27/2025 8:28:45 PM,"J&J talc claimants urge judge to reject $8B settlement, bankruptcy plan",Seeking Alpha,https://seekingalpha.com/news/4399016-johnson-johnson-talc-claimants-urge-judge-to-reject-8b-settlement-bankruptcy-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/27/2025 8:30:12 PM,"Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says",TipRanks,/news/stocks/johnson-johnson-backed-medical-device-company-seeks-u-s-ipo-bloomberg-says-1034274082
,1/28/2025 10:10:16 AM,Johnson & Johnson price target raised to $166 from $159 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-159-at-barclays-1034276588
,1/29/2025 9:16:26 PM,"Artiva expands Board with appointment of Dan Baker, M.D",TipRanks,/news/stocks/artiva-expands-board-with-appointment-of-dan-baker-m-d-1034284784
,1/30/2025 5:19:44 PM,Alumis draws Outperform at Oppenheimer on valuation disconnect,Seeking Alpha,https://seekingalpha.com/news/4400899-alumis-draws-outperform-at-oppenheimer-on-valuation-disconnect?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/30/2025 5:27:47 PM,Global stocks with the highest market share within their product groups,Seeking Alpha,https://seekingalpha.com/news/4400904-global-stocks-with-the-highest-market-share-within-their-product-groups?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/31/2025 11:25:30 AM,European Commission authorizes Vocabria + Rekambys for HIV treatment,TipRanks,/news/stocks/european-commission-authorizes-vocabria-+-rekambys-for-hiv-treatment-1034294678
,1/31/2025 1:25:06 PM,AbbVie swings to Q4 loss amid Cerevel impact; sets in-line guidance,Seeking Alpha,https://seekingalpha.com/news/4401344-abbvie-stock-spikes-q4-revenue-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/31/2025 7:10:17 PM,Opening Day: Infinity Natural Resources valued at $1.3B in market debut,TipRanks,/news/stocks/opening-day-infinity-natural-resources-valued-at-1-3b-in-market-debut-1034297591
,2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/1/2025 3:52:02 PM,HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney,Seeking Alpha,https://seekingalpha.com/news/4401703-hhs-seeks-1b-from-jj-talc-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/1/2025 5:30:29 PM,SA Asks: Which Big Pharmas would be most impacted by higher tariffs?,Seeking Alpha,https://seekingalpha.com/news/4401641-sa-asks-which-big-pharmas-would-be-most-impacted-by-higher-tariffs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/1/2025 11:45:00 PM,"Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus",Seeking Alpha,https://seekingalpha.com/news/4400864-notable-healthcare-headlines-for-the-week-moderna-thermo-fisher-jj-in-focus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/3/2025 12:36:10 PM,Johnson & Johnson price target raised to $166 from $162 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-162-at-guggenheim-1034303204
,2/3/2025 12:37:41 PM,Guggenheim Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/guggenheim-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1034303197
,2/3/2025 12:41:03 PM,Halozyme announces positive opinion in EU for rybrevant with Enhanze technology,TipRanks,/news/stocks/halozyme-announces-positive-opinion-in-eu-for-rybrevant-with-enhanze-technology-1034303178
,2/3/2025 3:49:57 PM,J&J gets positive EU opinion for subcutaneous Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4401949-jj-gets-positive-eu-opinion-for-subcutaneous-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/4/2025 5:15:16 PM,"Senate panel advances Kennedy‚Äôs nomination for HHS secretary, CNBC reports",TipRanks,/news/stocks/senate-panel-advances-kennedy-s-nomination-for-hhs-secretary-cnbc-reports-1034310628
,2/5/2025 4:11:53 PM,Kenvue confirms activist Starboard nominations for board,Seeking Alpha,https://seekingalpha.com/news/4403582-kenvue-confirms-activist-starboard-nominations-for-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/6/2025 1:40:33 PM,Kura Oncology price target raised to $36 from $34 at Wedbush,TipRanks,/news/stocks/kura-oncology-price-target-raised-to-36-from-34-at-wedbush-1034322810
,2/6/2025 5:07:38 PM,Dr. Reddy‚Äôs in licenses biosimilar for J&J‚Äôs multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4404547-dr-reddys-licenses-biosimilar-jjs-darzalex?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/6/2025 6:35:50 PM,"White House readying order to fire thousands of federal health workers, WSJ says",TipRanks,/news/stocks/white-house-readying-order-to-fire-thousands-of-federal-health-workers-wsj-says-1034324421
,2/7/2025 3:21:13 PM,Trump Trade: President advocates to close carried interest tax loophole,TipRanks,/news/stocks/trump-trade-president-advocates-to-close-carried-interest-tax-loophole-1034328479
